<SEC-DOCUMENT>0001193125-25-250744.txt : 20251027
<SEC-HEADER>0001193125-25-250744.hdr.sgml : 20251027
<ACCEPTANCE-DATETIME>20251027075626
ACCESSION NUMBER:		0001193125-25-250744
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		123
CONFORMED PERIOD OF REPORT:	20250630
FILED AS OF DATE:		20251027
DATE AS OF CHANGE:		20251027

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Sanofi
		CENTRAL INDEX KEY:			0001121404
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				133529324
		STATE OF INCORPORATION:			I0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31368
		FILM NUMBER:		251417510

	BUSINESS ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017
		BUSINESS PHONE:		33153774400

	MAIL ADDRESS:	
		STREET 1:		46 AVENUE DE LA GRANDE ARMEE
		CITY:			PARIS
		STATE:			I0
		ZIP:			75017

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI-AVENTIS
		DATE OF NAME CHANGE:	20040826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SANOFI SYNTHELABO SA
		DATE OF NAME CHANGE:	20010104
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>d69958d6k.htm
<DESCRIPTION>6-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:sny="http://www.Sanofi.com/20250630" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>6-K</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" contextRef="P01_01_2025To06_30_2025" id="ixv-135">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="P01_01_2025To06_30_2025" id="ixv-136">0001121404</ix:nonNumeric><ix:nonNumeric name="dei:CurrentFiscalYearEndDate" contextRef="P01_01_2025To06_30_2025" id="ixv-137">--12-31</ix:nonNumeric><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="P01_01_2025To06_30_2025" id="ixv-138">2025-06-30</ix:nonNumeric><ix:nonNumeric name="dei:DocumentFiscalPeriodFocus" contextRef="P01_01_2025To06_30_2025" id="ixv-139">Q2</ix:nonNumeric><ix:footnote id="FN_601990" xml:lang="en-US">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</ix:footnote><ix:footnote id="FN_601986" xml:lang="en-US">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</ix:footnote><ix:footnote id="FN_602025" xml:lang="en-US">This line comprises the impact of the derecognition of the non-controlling interests in Opella (see Note B.1.).</ix:footnote><ix:footnote id="FN_602024" xml:lang="en-US">For 2025, this line comprises the impact of the issuance of restricted shares to former employees of Opella subsequent to the date on which Sanofi lost control of Opella.</ix:footnote><ix:footnote id="FN_602013" xml:lang="en-US">See Note B.8.2. (for amounts relating to 2024, see Note D.15.4. to the consolidated financial statements for the year ended December 31, 2024).</ix:footnote><ix:footnote id="FN_601997" xml:lang="en-US">For the six months ended June 30, 2025, this amount includes &#8364;(667) million in respect of cash and cash equivalents held by Opella as of April 30, 2025.</ix:footnote><ix:footnote id="FN_601999" xml:lang="en-US">For the six months ended June 30, 2025, this line item mainly comprises a commercial paper program in the United States for &#8364;3,353 million, compared with &#8364;6,060 million in the six months ended June 30, 2024. This line item also includes realized foreign exchange gains and losses on cash and cash equivalents in non-functional currencies, mainly the US dollar, and on derivatives used to manage them.</ix:footnote><ix:footnote id="FN_602014" xml:lang="en-US">For 2024, this line comprises the impact of the issuance of restricted shares to former employees of EUROAPI subsequent to the date on which Sanofi lost control of EUROAPI.</ix:footnote><ix:footnote id="FN_601991" xml:lang="en-US">Includes non-current financial assets.</ix:footnote><ix:footnote id="FN_601992" xml:lang="en-US">This line item includes contributions paid to pension funds (see Note B.12.).</ix:footnote><ix:footnote id="FN_601993" xml:lang="en-US">This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items</ix:footnote><ix:footnote id="FN_602005" xml:lang="en-US">Of which: June 30, 2025 (6 months) June 30, 2024 (6 months) (a) &#8226;Income tax paid (1,355) (1,434) &#8226;Interest paid (206) (320) &#8226;Interest received 170 261 &#8226;Dividends received from non-consolidated entities 5 &#8212;</ix:footnote><ix:footnote id="FN_601995" xml:lang="en-US">This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For the six months ended June 30, 2025, this line item includes the net cash outflow arising from the acquisition of Dren-0201 (see Note B.1.2.). For the six months ended June 30, 2024 it includes the net cash outflow arising from the acquisition of Inhibrx, Inc.</ix:footnote><ix:footnote id="FN_601996" xml:lang="en-US">For the six months ended June 30, 2025 and June 30, 2024, this line item mainly comprises proceeds from disposals of (i) assets and businesses due to portfolio rationalization, and (ii) equity and debt instruments.</ix:footnote><ix:footnote id="FN_602034" xml:lang="en-US">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar.</ix:footnote><ix:footnote id="FN_602035" xml:lang="en-US">Includes reclassifications to profit or loss: &#8364;2&#160;million in the first half of 2025, immaterial in the first half of 2024.</ix:footnote><ix:footnote id="FN_602036" xml:lang="en-US">Includes reclassifications to profit or loss: immaterial over all periods.</ix:footnote><ix:footnote id="FN_602033" xml:lang="en-US">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025.</ix:footnote><ix:footnote id="FN_602022" xml:lang="en-US">In October 2024, Sanofi raised its investment in EUROAPI by &#8364;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#8364;189&#160;million (and was also &#8364;189&#160;million as of December&#160;31, 2024).</ix:footnote><ix:footnote id="FN_602021" xml:lang="en-US">Includes loans to joint ventures and associates.</ix:footnote><ix:footnote id="FN_602019" xml:lang="en-US">Figures for 2024 comparative periods have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</ix:footnote><ix:footnote id="FN_602020" xml:lang="en-US">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025.</ix:footnote><ix:footnote id="FN_602009" xml:lang="en-US">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV.</ix:footnote><ix:footnote id="FN_602008" xml:lang="en-US">Joint venture.</ix:footnote><ix:footnote id="FN_602039" xml:lang="en-US">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</ix:footnote><ix:footnote id="FN_602038" xml:lang="en-US">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period.</ix:footnote><ix:footnote id="FN_602045" xml:lang="en-US">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024. </ix:footnote><ix:footnote id="FN_602006" xml:lang="en-US">Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June 30, 2025, the investment includes a &#8364;241 million loan to OPAL JV Co being in substance part of the investment.</ix:footnote><ix:footnote id="FN_602007" xml:lang="en-US">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#8364;2.89 as of June&#160;30, 2025, and &#8364;2.88 as of December&#160;31, 2024).</ix:footnote><ix:footnote id="FN_602040" xml:lang="en-US">In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments.</ix:footnote><ix:footnote id="FN_601984" xml:lang="en-US">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.).</ix:footnote><ix:footnote id="FN_601985" xml:lang="en-US">In 2025, this line includes an expense of &#8364;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella.</ix:footnote><ix:footnote id="FN_602037" xml:lang="en-US">Includes &#8364;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#8364;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#8364;2,293&#160;million.</ix:footnote><ix:footnote id="FN_602026" xml:lang="en-US">As of January 1, 2025, this comprised a non-current portion of &#8364;569 million and a current portion of &#8364;72 million.</ix:footnote><ix:footnote id="FN_602028" xml:lang="en-US">Amounts mainly reported within the income statement line item &#8220;Fair value remeasurement of contingent consideration&#8221;.</ix:footnote><ix:footnote id="FN_601998" xml:lang="en-US">Joint ventures and associates with which Sanofi has entered into a strategic alliance.</ix:footnote><ix:footnote id="FN_602000" xml:lang="en-US">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</ix:footnote><ix:footnote id="FN_602001" xml:lang="en-US">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#8364;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#8364;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights.</ix:footnote><ix:footnote id="FN_602002" xml:lang="en-US">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</ix:footnote><ix:footnote id="FN_602003" xml:lang="en-US">See Note B.16.</ix:footnote><ix:footnote id="FN_602004" xml:lang="en-US">See Note B.17.</ix:footnote><ix:footnote id="FN_602050" xml:lang="en-US">Carrying amount at the end of the reporting period.</ix:footnote><ix:footnote id="FN_602049" xml:lang="en-US">As of June 30, 2025, current other bank borrowings include &#8364;4,535&#160;million related to the US commercial paper program and &#8364;230&#160;million related to the Negotiable European Commercial Paper program in France. </ix:footnote><ix:footnote id="FN_602042" xml:lang="en-US">Includes actuarial gains/ (losses) related to Opella of &#8364;(4)&#160;million for the first half of 2025 and &#8364;(6)&#160;million for the first half of 2024.</ix:footnote><ix:footnote id="FN_602044" xml:lang="en-US">Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024.</ix:footnote><ix:footnote id="FN_602043" xml:lang="en-US">Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the -0.30% change in the inflation rate in the United Kingdom in the first half of 2025.</ix:footnote><ix:footnote id="FN_602041" xml:lang="en-US">Mainly transfers to Current provisions and other current liabilities.</ix:footnote><ix:footnote id="FN_602048" xml:lang="en-US">Includes forward purchases with a notional amount of $1,000 million expiring in 2025, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of June 30, 2025, the fair value of these contracts represented a liability of &#8364;25 million, with &#8364;0 million credited to Other comprehensive income to recognize the hedging cost. </ix:footnote><ix:footnote id="FN_602047" xml:lang="en-US">Includes forward sales with a notional amount of $3,615 million expiring in 2025, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of June 30, 2025, the fair value of these forward contracts represented an asset of &#8364;77 million; the opposite entry was recognized in Other comprehensive income, with the impact on financial income and expense being immaterial. </ix:footnote><ix:footnote id="FN_602046" xml:lang="en-US">Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#8364;5&#160;million, with &#8364;18&#160;million debited to Other comprehensive income under the cost of hedging accounting treatment. </ix:footnote><ix:footnote id="FN_602010" xml:lang="en-US">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.).</ix:footnote><ix:footnote id="FN_602011" xml:lang="en-US">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties.</ix:footnote><ix:footnote id="FN_602012" xml:lang="en-US">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights).</ix:footnote><ix:footnote id="FN_602015" xml:lang="en-US">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</ix:footnote><ix:footnote id="FN_602016" xml:lang="en-US">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.).</ix:footnote><ix:footnote id="FN_602017" xml:lang="en-US">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France.</ix:footnote><ix:footnote id="FN_602018" xml:lang="en-US">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#8364;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#8217;s current understanding of Pillar Two rules, and &#8364;52&#160;million for the six months ended June&#160;30, 2024.</ix:footnote><ix:footnote id="FN_602023" xml:lang="en-US">Reflects new regulations implemented on the taxation of share cancellations in Article 95 of the French Finance Bill for 2025.</ix:footnote><ix:footnote id="FN_602027" xml:lang="en-US">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</ix:footnote><ix:footnote id="FN_602029" xml:lang="en-US">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#8364;(25)&#160;million in the first half of 2025 and &#8364;(24)&#160;million in the first half of 2024.</ix:footnote><ix:footnote id="FN_602030" xml:lang="en-US">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;(4)&#160;million in the first half of 2025 and &#8364;(18)&#160;million in the first half of 2024.</ix:footnote><ix:footnote id="FN_602031" xml:lang="en-US">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.).</ix:footnote><ix:footnote id="FN_602032" xml:lang="en-US">Includes a financial expense of &#8364;50&#160;million for the six months ended June&#160;30, 2025 and &#8364;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US.</ix:footnote></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="sny-20250630.xsd"/></ix:references><ix:resources><xbrli:context id="PAsOn06_30_2025"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn10_31_2024"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-10-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2025To06_30_2025"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_01_2025"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-01-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ManufacturingAndSupplyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CDRMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:CDRMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OPALJVCoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:BpifranceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sny:ExcludingChiefExecutiveOfficerMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CNifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_FRifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CertainWholesalersInTheUnitedStatesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CustomerOneMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CustomerTwoMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CustomerThreeMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OthersCounterpartyMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarUSBondMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_MCMVaccineBVMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_MSPVaccineCompanyMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-01</xbrli:startDate> <xbrli:endDate>2025-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_TRifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_LaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_NotLaterThanOneMonthMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AdjustmentToDebtMeasuredAtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AmortizedCostNettingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInHungarianFlorintMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInHungarianFlorintMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:NonCurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInJune2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2031MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2031Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2027MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2027Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInMarch2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondIssueFromApril2022MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondIssueFromApril2022Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondIssueFromApril2020MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondIssueFromApril2020Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FourBillionFacilityMaturingMarch2030MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FourBillionFacilityMaturingMarch2030Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FourBillionFacilityMaturingDecember2027MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FourBillionFacilityMaturingDecember2027Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2032MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2032Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FixedRateBondMaturingJune2029MemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingJune2029Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtMarketValueMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_GBifrsfullGeographicalAreasAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CrossCurrencySwapExpiring2029MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapExpiring2029Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CrossCurrencySwapExpiring2032MemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapExpiring2032Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarUSBondMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2023Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_UKZONEMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:UKZONEMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ActionForWhichWeAreDefendantMemberSNYDefendantAxis_GoldBondProductLitigationInTheUSMemberSNYLegalAndArbitralProceedingsAxis_ProductLiabilitiesMemberifrsfullClassesOfContingentLiabilitiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:GoldBondProductLitigationInTheUSMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_EuroapiMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:EuroapiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_LaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_NotLaterThanOneMonthMemberifrsfullMaturityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:NonCurrentLiabilitiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AtMarketValueMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_EuroapiMemberdeiLegalEntityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:EuroapiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ManufacturingAndSupplyMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OpellaMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CNifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_FRifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CustomerOneMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CustomerTwoMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CustomerThreeMemberifrsfullMajorCustomersAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OthersCounterpartyMembersrtCounterpartyNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To06_30_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-06-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-01</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OPALJVCoMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-01</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-01</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2025To04_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BpifranceMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-01</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_01_2025To04_30_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:EarendilLabsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-01</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-04-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VicebioLtdMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-07-22</xbrli:startDate> <xbrli:endDate>2025-07-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:AssetsAcquisitionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-05-27</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:AssetsAcquisitionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-27</xbrli:startDate> <xbrli:endDate>2025-05-27</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VigilNeuroscienceIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-22</xbrli:startDate> <xbrli:endDate>2025-05-22</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VigilNeuroscienceIncMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-05-22</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:BlueprintMedicinesCorporationMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-02</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-07-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2023Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_EUROZONEMemberifrsfullGeographicalAreasAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:EUROZONEMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P04_30_2025To04_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-04-30</xbrli:startDate> <xbrli:endDate>2025-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichSanofiAreDefendantMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixAttorneyGeneralActionInHawaiiMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-05-01</xbrli:startDate> <xbrli:endDate>2025-05-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:EarendilLabsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-04-01</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P01_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-01-01</xbrli:startDate> <xbrli:endDate>2024-12-31</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-01-29</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-01-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="P01_29_2025To01_29_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-01-29</xbrli:startDate> <xbrli:endDate>2025-01-29</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2025-02-02</xbrli:startDate> <xbrli:endDate>2025-02-02</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="P04_30_2024To04_30_2024_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2024-04-30</xbrli:startDate> <xbrli:endDate>2024-04-30</xbrli:endDate> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2024_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2025-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn12_31_2023_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2023-12-31</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:context id="PAsOn06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001121404</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:instant>2024-06-30</xbrli:instant> </xbrli:period> </xbrli:context><xbrli:unit id="Unit_EUR"> <xbrli:measure>iso4217:EUR</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_pure"> <xbrli:measure>xbrli:pure</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_shares"> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD"> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Year"> <xbrli:measure>utr:Year</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_Month"> <xbrli:measure>utr:Month</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_EUR_per_Share"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:EUR</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><xbrli:unit id="Unit_Proceeding"> <xbrli:measure>sny:Proceeding</xbrli:measure> </xbrli:unit><xbrli:unit id="Unit_USD_per_Share"> <xbrli:divide> <xbrli:unitNumerator> <xbrli:measure>iso4217:USD</xbrli:measure> </xbrli:unitNumerator> <xbrli:unitDenominator> <xbrli:measure>xbrli:shares</xbrli:measure> </xbrli:unitDenominator> </xbrli:divide> </xbrli:unit><ix:relationship fromRefs="Fact_148326473" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326474" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326475" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326476" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326477" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326478" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326479" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326480" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326481" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326482" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326483" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326484" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326485" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326486" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326487" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326488" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326489" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326490" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326491" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326492" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326493" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326494" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326495" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326496" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326497" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326498" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326499" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326500" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326501" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326502" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326503" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326504" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326505" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326506" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326507" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326508" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326509" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326510" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326511" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326512" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326513" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326514" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326515" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326516" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326517" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326518" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326519" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326520" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326521" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326522" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326523" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326524" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326525" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326526" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326527" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326528" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326529" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326530" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326531" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326532" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326533" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326534" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326535" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326536" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326537" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326538" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326539" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326540" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326543" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326544" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326545" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326546" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326546" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326547" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326548" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326548" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326549" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326550" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326550" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326551" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326552" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326552" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326553" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326554" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326554" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326555" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326556" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326556" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326557" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326558" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326558" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326559" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326560" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326560" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326561" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326562" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326562" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326563" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326564" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326564" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326565" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326566" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326566" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326567" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326568" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326568" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326569" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326570" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326570" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326571" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326572" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326572" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326573" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326574" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326574" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326575" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326576" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326576" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326577" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326578" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326578" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326579" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326580" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326580" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326581" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326582" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326582" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326583" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326584" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326584" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326585" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326586" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326586" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326587" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326588" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326588" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326589" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326590" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326591" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326592" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326593" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326594" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326595" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326596" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326597" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326598" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326599" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326600" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326601" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326602" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326603" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326604" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326605" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326607" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326608" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326609" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326615" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326616" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326617" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326618" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326619" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326620" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326621" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326625" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326625" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326626" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326627" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326627" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326628" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326629" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326629" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326630" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326631" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326631" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326632" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326633" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326633" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326634" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326635" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326635" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326636" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326637" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326637" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326638" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326649" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326650" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326651" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326652" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326653" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326654" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326655" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326656" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326657" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326658" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326659" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326660" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326661" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326662" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326663" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326664" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326665" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326666" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326667" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326668" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326669" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326670" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326670" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326671" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326672" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326672" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326673" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326674" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326674" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326675" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326676" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326676" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326677" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326678" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326678" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326679" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326680" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326680" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326681" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326682" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326682" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326683" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326684" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326684" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326685" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326686" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326686" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326687" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326688" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326688" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326689" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326690" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326690" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326691" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326692" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326692" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326693" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326694" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326694" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326695" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326696" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326696" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326697" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326698" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326698" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326699" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326700" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326700" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326701" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326702" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326702" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326703" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326704" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326704" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326705" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326706" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326706" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326707" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326708" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326708" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326709" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326710" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326710" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326711" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326712" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326712" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326713" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326714" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326715" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326716" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326717" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326718" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326719" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326720" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326722" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326723" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326724" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326726" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326727" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326728" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326729" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326729" toRefs="FN_602025"/><ix:relationship fromRefs="Fact_148326730" toRefs="FN_602025"/><ix:relationship fromRefs="Fact_148326730" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326731" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326731" toRefs="FN_602024"/><ix:relationship fromRefs="Fact_148326732" toRefs="FN_602024"/><ix:relationship fromRefs="Fact_148326732" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326733" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326733" toRefs="FN_602024"/><ix:relationship fromRefs="Fact_148326734" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326735" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326736" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326737" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326738" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326739" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326740" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326741" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326742" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326743" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326744" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326745" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326746" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326746" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326747" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326747" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326748" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326748" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326749" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326749" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326750" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326750" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326751" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326751" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326752" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326753" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326754" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326755" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326756" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326780" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326781" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326782" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326783" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326784" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326785" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326785" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326786" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326787" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326787" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326788" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326789" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326789" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326790" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326791" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326791" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326792" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326792" toRefs="FN_601997"/><ix:relationship fromRefs="Fact_148326793" toRefs="FN_601997"/><ix:relationship fromRefs="Fact_148326793" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326793" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326794" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326795" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326795" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326796" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326797" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326797" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326798" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326799" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326799" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326800" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326801" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326801" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326802" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326803" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326803" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326804" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326805" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326805" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326806" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326807" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326807" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326808" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326808" toRefs="FN_601999"/><ix:relationship fromRefs="Fact_148326809" toRefs="FN_601999"/><ix:relationship fromRefs="Fact_148326809" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326809" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326810" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326811" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326811" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326812" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326813" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326813" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326814" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326815" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326815" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326816" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326832" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326833" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326834" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326835" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326836" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326836" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326837" toRefs="FN_602013"/><ix:relationship fromRefs="Fact_148326837" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326838" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326839" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326840" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326841" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326842" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326843" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326844" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326845" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326846" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326847" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326848" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326849" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326850" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326851" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326851" toRefs="FN_602014"/><ix:relationship fromRefs="Fact_148326852" toRefs="FN_602014"/><ix:relationship fromRefs="Fact_148326852" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326853" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326854" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326855" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326856" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326857" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326858" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326859" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326860" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326861" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326862" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326862" toRefs="FN_602014"/><ix:relationship fromRefs="Fact_148326863" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326864" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326865" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326866" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326867" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326868" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326871" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326872" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326873" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326874" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326875" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326876" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326877" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326878" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326879" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326880" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326881" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326882" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326883" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326884" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326885" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326886" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326887" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326888" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326889" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326890" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326891" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326892" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326893" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326894" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326895" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326896" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326897" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326898" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326899" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326900" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326901" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326902" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326902" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326903" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326904" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326904" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326905" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326906" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326906" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326907" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326908" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326908" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326909" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326909" toRefs="FN_601991"/><ix:relationship fromRefs="Fact_148326910" toRefs="FN_601991"/><ix:relationship fromRefs="Fact_148326910" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326910" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326911" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326912" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326912" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326913" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326913" toRefs="FN_601992"/><ix:relationship fromRefs="Fact_148326914" toRefs="FN_601992"/><ix:relationship fromRefs="Fact_148326914" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326914" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326915" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326916" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326917" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326917" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326918" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326918" toRefs="FN_601993"/><ix:relationship fromRefs="Fact_148326919" toRefs="FN_601993"/><ix:relationship fromRefs="Fact_148326919" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326919" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326920" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326921" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326921" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326922" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326923" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326923" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326924" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326925" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326925" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326926" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326927" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326927" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326928" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326929" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326929" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326930" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326931" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326931" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326932" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326933" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326933" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326934" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326934" toRefs="FN_602005"/><ix:relationship fromRefs="Fact_148326935" toRefs="FN_602005"/><ix:relationship fromRefs="Fact_148326935" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326935" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326936" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326937" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326937" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326938" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326938" toRefs="FN_601995"/><ix:relationship fromRefs="Fact_148326939" toRefs="FN_601995"/><ix:relationship fromRefs="Fact_148326939" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326939" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326940" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326941" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326941" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326942" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326942" toRefs="FN_601996"/><ix:relationship fromRefs="Fact_148326943" toRefs="FN_601996"/><ix:relationship fromRefs="Fact_148326943" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326943" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326944" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326945" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326945" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326946" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326947" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326947" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326948" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326948" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326949" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326950" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326950" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326951" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326952" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326952" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326953" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326954" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326954" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326955" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326956" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326956" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326957" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326958" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326958" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326959" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326960" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148326960" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326962" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326964" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326966" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148326968" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327008" toRefs="FN_602034"/><ix:relationship fromRefs="Fact_148327009" toRefs="FN_602034"/><ix:relationship fromRefs="Fact_148327014" toRefs="FN_602035"/><ix:relationship fromRefs="Fact_148327015" toRefs="FN_602035"/><ix:relationship fromRefs="Fact_148327020" toRefs="FN_602036"/><ix:relationship fromRefs="Fact_148327021" toRefs="FN_602036"/><ix:relationship fromRefs="Fact_148327107" toRefs="FN_602033"/><ix:relationship fromRefs="Fact_148327108" toRefs="FN_602033"/><ix:relationship fromRefs="Fact_148327122" toRefs="FN_602022"/><ix:relationship fromRefs="Fact_148327123" toRefs="FN_602022"/><ix:relationship fromRefs="Fact_148327124" toRefs="FN_602021"/><ix:relationship fromRefs="Fact_148327125" toRefs="FN_602021"/><ix:relationship fromRefs="Fact_148327126" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327126" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327127" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327127" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327128" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327128" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327129" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327129" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327130" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327130" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327131" toRefs="FN_602020"/><ix:relationship fromRefs="Fact_148327131" toRefs="FN_602019"/><ix:relationship fromRefs="Fact_148327153" toRefs="FN_602009"/><ix:relationship fromRefs="Fact_148327154" toRefs="FN_602009"/><ix:relationship fromRefs="Fact_148327155" toRefs="FN_602009"/><ix:relationship fromRefs="Fact_148327156" toRefs="FN_602008"/><ix:relationship fromRefs="Fact_148327157" toRefs="FN_602008"/><ix:relationship fromRefs="Fact_148327158" toRefs="FN_602008"/><ix:relationship fromRefs="Fact_148327160" toRefs="FN_602039"/><ix:relationship fromRefs="Fact_148327161" toRefs="FN_602039"/><ix:relationship fromRefs="Fact_148327162" toRefs="FN_602038"/><ix:relationship fromRefs="Fact_148327264" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327271" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327452" toRefs="FN_602006"/><ix:relationship fromRefs="Fact_148327453" toRefs="FN_602006"/><ix:relationship fromRefs="Fact_148327454" toRefs="FN_602006"/><ix:relationship fromRefs="Fact_148327455" toRefs="FN_602007"/><ix:relationship fromRefs="Fact_148327456" toRefs="FN_602007"/><ix:relationship fromRefs="Fact_148327457" toRefs="FN_602007"/><ix:relationship fromRefs="Fact_148327489" toRefs="FN_602040"/><ix:relationship fromRefs="Fact_148327494" toRefs="FN_602040"/><ix:relationship fromRefs="Fact_148327518" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327520" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327584" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148327585" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148327602" toRefs="FN_601984"/><ix:relationship fromRefs="Fact_148327603" toRefs="FN_601984"/><ix:relationship fromRefs="Fact_148327604" toRefs="FN_601984"/><ix:relationship fromRefs="Fact_148327605" toRefs="FN_601984"/><ix:relationship fromRefs="Fact_148327610" toRefs="FN_601985"/><ix:relationship fromRefs="Fact_148327611" toRefs="FN_601985"/><ix:relationship fromRefs="Fact_148327632" toRefs="FN_602037"/><ix:relationship fromRefs="Fact_148327633" toRefs="FN_602037"/><ix:relationship fromRefs="Fact_148327649" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327650" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327651" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327655" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327659" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327659" toRefs="FN_602028"/><ix:relationship fromRefs="Fact_148327660" toRefs="FN_602028"/><ix:relationship fromRefs="Fact_148327661" toRefs="FN_602028"/><ix:relationship fromRefs="Fact_148327662" toRefs="FN_602028"/><ix:relationship fromRefs="Fact_148327663" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327667" toRefs="FN_602026"/><ix:relationship fromRefs="Fact_148327676" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327680" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327681" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327682" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327683" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327684" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327685" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327686" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327687" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327688" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327689" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327690" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327691" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327692" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327693" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327694" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327695" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327696" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327697" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327698" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327699" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327700" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327701" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327702" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327703" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327704" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327705" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327707" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327708" toRefs="FN_601998"/><ix:relationship fromRefs="Fact_148327709" toRefs="FN_601998"/><ix:relationship fromRefs="Fact_148327709" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327710" toRefs="FN_602000"/><ix:relationship fromRefs="Fact_148327711" toRefs="FN_602000"/><ix:relationship fromRefs="Fact_148327711" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327712" toRefs="FN_602001"/><ix:relationship fromRefs="Fact_148327713" toRefs="FN_602001"/><ix:relationship fromRefs="Fact_148327713" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327715" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327716" toRefs="FN_602002"/><ix:relationship fromRefs="Fact_148327717" toRefs="FN_602002"/><ix:relationship fromRefs="Fact_148327717" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327718" toRefs="FN_602003"/><ix:relationship fromRefs="Fact_148327719" toRefs="FN_602003"/><ix:relationship fromRefs="Fact_148327719" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327720" toRefs="FN_602004"/><ix:relationship fromRefs="Fact_148327721" toRefs="FN_602004"/><ix:relationship fromRefs="Fact_148327721" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327723" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327725" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327727" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327729" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327730" toRefs="FN_602050"/><ix:relationship fromRefs="Fact_148327731" toRefs="FN_602050"/><ix:relationship fromRefs="Fact_148327737" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327739" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327741" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327743" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327745" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327747" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148327861" toRefs="FN_602049"/><ix:relationship fromRefs="Fact_148327880" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327887" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327896" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327902" toRefs="FN_602045"/><ix:relationship fromRefs="Fact_148327908" toRefs="FN_602042"/><ix:relationship fromRefs="Fact_148327908" toRefs="FN_602044"/><ix:relationship fromRefs="Fact_148327909" toRefs="FN_602043"/><ix:relationship fromRefs="Fact_148327909" toRefs="FN_602042"/><ix:relationship fromRefs="Fact_148327910" toRefs="FN_602042"/><ix:relationship fromRefs="Fact_148327911" toRefs="FN_602042"/><ix:relationship fromRefs="Fact_148327925" toRefs="FN_602040"/><ix:relationship fromRefs="Fact_148327926" toRefs="FN_602041"/><ix:relationship fromRefs="Fact_148327927" toRefs="FN_602041"/><ix:relationship fromRefs="Fact_148327928" toRefs="FN_602041"/><ix:relationship fromRefs="Fact_148327929" toRefs="FN_602041"/><ix:relationship fromRefs="Fact_148327930" toRefs="FN_602041"/><ix:relationship fromRefs="Fact_148327936" toRefs="FN_602048"/><ix:relationship fromRefs="Fact_148327946" toRefs="FN_602047"/><ix:relationship fromRefs="Fact_148327950" toRefs="FN_602046"/><ix:relationship fromRefs="Fact_148328037" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328038" toRefs="FN_602010"/><ix:relationship fromRefs="Fact_148328039" toRefs="FN_602010"/><ix:relationship fromRefs="Fact_148328039" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328041" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328042" toRefs="FN_602011"/><ix:relationship fromRefs="Fact_148328043" toRefs="FN_602011"/><ix:relationship fromRefs="Fact_148328043" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328045" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328046" toRefs="FN_602012"/><ix:relationship fromRefs="Fact_148328047" toRefs="FN_602012"/><ix:relationship fromRefs="Fact_148328047" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328049" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328117" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328121" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328125" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328129" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328133" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328137" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328141" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328145" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328149" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328153" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328157" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328161" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328165" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328169" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328173" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328177" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328187" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328189" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328191" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328193" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328194" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328195" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328195" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328196" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328196" toRefs="FN_602017"/><ix:relationship fromRefs="Fact_148328197" toRefs="FN_602017"/><ix:relationship fromRefs="Fact_148328197" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328197" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328198" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328199" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328199" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328200" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328200" toRefs="FN_602018"/><ix:relationship fromRefs="Fact_148328201" toRefs="FN_602018"/><ix:relationship fromRefs="Fact_148328201" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328201" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328202" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328203" toRefs="FN_602016"/><ix:relationship fromRefs="Fact_148328203" toRefs="FN_601986"/><ix:relationship fromRefs="Fact_148328206" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148328206" toRefs="FN_602023"/><ix:relationship fromRefs="Fact_148328207" toRefs="FN_602023"/><ix:relationship fromRefs="Fact_148328207" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148328208" toRefs="FN_601990"/><ix:relationship fromRefs="Fact_148328208" toRefs="FN_602023"/><ix:relationship fromRefs="Fact_148328215" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328216" toRefs="FN_602027"/><ix:relationship fromRefs="Fact_148328217" toRefs="FN_602027"/><ix:relationship fromRefs="Fact_148328217" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328219" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328221" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328223" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328226" toRefs="FN_602029"/><ix:relationship fromRefs="Fact_148328227" toRefs="FN_602029"/><ix:relationship fromRefs="Fact_148328227" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328228" toRefs="FN_602030"/><ix:relationship fromRefs="Fact_148328229" toRefs="FN_602030"/><ix:relationship fromRefs="Fact_148328229" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328234" toRefs="FN_602031"/><ix:relationship fromRefs="Fact_148328235" toRefs="FN_602031"/><ix:relationship fromRefs="Fact_148328235" toRefs="FN_602015"/><ix:relationship fromRefs="Fact_148328240" toRefs="FN_602032"/><ix:relationship fromRefs="Fact_148328241" toRefs="FN_602032"/><ix:relationship fromRefs="Fact_148328241" toRefs="FN_602015"/></ix:resources></ix:header></div><div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div><div style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM&#160;<ix:nonNumeric name="dei:DocumentType" contextRef="P01_01_2025To06_30_2025" id="ixv-6201">6-K</ix:nonNumeric> </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">REPORT OF FOREIGN PRIVATE ISSUER </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">PURSUANT TO RULE 13a-16 OR 15d-16 </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNDER THE SECURITIES EXCHANGE ACT OF 1934 </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">October 27, <ix:nonNumeric name="dei:DocumentFiscalYearFocus" contextRef="P01_01_2025To06_30_2025" id="ixv-6202">2025</ix:nonNumeric> </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Commission File Number: 001-31368 </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="P01_01_2025To06_30_2025" id="ixv-6203">SANOFI</ix:nonNumeric> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Translation of registrant&#8217;s name into English) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">46, avenue de la Grande Arm&#233;e, 75017 Paris, France </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices) </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="text-align:center"><div style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</div></div><div style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover Form&#160;20-F or Form&#160;40-F. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">Form&#160;20-F&#8194;&#9746;&#8195;&#8195;&#8195;Form&#160;40-F&#8194;&#9744; </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">THIS REPORT ON FORM&#160;6-K SHALL BE DEEMED TO BE INCORPORATED BY REFERENCE IN THE REGISTRATION STATEMENT ON FORM&#160;F-3 FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON APRIL&#160;4, 2024 (NO. 333-278506) AND REGISTRATION STATEMENT ON FORM&#160;S-8 FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MARCH 27, 2024 (NO. 333- 286161) AND TO BE PART&#160;THEREOF FROM THE DATE ON WHICH THIS REPORT IS FURNISHED, TO THE EXTENT NOT SUPERSEDED BY DOCUMENTS OR REPORTS SUBSEQUENTLY FILED OR FURNISHED BY SANOFI. </div><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</div><div style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</div></div></div></div></div></div>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit List </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border-spacing:0;margin:0 auto">


<tr>

<td/>

<td style="vertical-align:bottom;width:3%"/>
<td style="width:88%"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Exhibit&#160;No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap;text-align:center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d69958dex991.htm">Condensed Half-Year Consolidated Financial Statements for the Six Months Ended June 30, 2025 </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d69958dex992.htm">Information on H1 2025 Financial Results </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td style="height:6pt" colspan="2"/></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">Exhibit&#160;99.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d69958dex993.htm">Information on Q3 2025 Financial Results </a></td></tr>
</table>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">2 </p>

</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%;clear:both"/>

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: October 27, 2025 </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p><div>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:40%;border-spacing:0;margin-left:auto">


<tr>

<td style="width:12%"/>

<td style="vertical-align:bottom;width:1%"/>
<td style="width:87%"/></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top" colspan="3"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">SANOFI</p> <p style="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&#160;</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Alexandra Roger</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Alexandra Roger</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Head of Legal Corporate &amp; Finance</td></tr>
</table></div>
 <p style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:center">3 </p>

</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d69958dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:sny="http://www.Sanofi.com/20250630" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/deprecated" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2025" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16" xmlns:xbrll="http://www.xbrl.org/2003/linkbase" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>EX-99.1</title>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type"/>
</head>
<body style="line-height:normal;background-color:white;"><div style="display: none"><ix:header><ix:references><link:schemaRef xlink:type="simple" xlink:href="sny-20250630.xsd"/></ix:references></ix:header></div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div> <div style="margin-top:24pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">Exhibit 99.1 </div></div> <div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div id="toc" style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;">&#8195;&#8195;&#8195;TABLE OF CONTENTS </div></div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:97%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:9pt">
<td style="vertical-align:top"><div style="font-family:Arial;color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">1. Condensed half-year consolidated financial statements</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#7802e6;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#7802e6;display:inline;">2</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#7802e6;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3.75pt"/>
<td colspan="4" style="height:3.75pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated balance sheets - assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">2</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated balance sheets - equity and liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">3</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated income statements</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">4</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated statements of comprehensive income</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">5</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated statements of changes in equity</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Consolidated statement of cash flows</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">8</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Notes to the condensed half-year consolidated financial statements as of June&#160;30, 2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Introduction</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">A/ Basis of preparation of the half-year financial statements and accounting policies</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">B/ Significant information for the first half of 2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">13</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"/>
<td colspan="4" style="height:6pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"> <div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">C/ Events subsequent to June&#160;30, 2025</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">34</div></td>
<td style="white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr> </table> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;1 </div></div></div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div id="ex99_169958_1" style="margin-top:0pt; margin-bottom:0pt; font-size:26pt; font-family:Arial"><div style="font-style:italic;display:inline;">1. Condensed half-year consolidated financial statements </div></div><div id="ex99_169958_2" style="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated balance sheets - assets </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(1)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:75%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:arial;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Property, plant and equipment owned</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.2.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326473">9,574</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326475">10,091</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">&#8201;Right-of-use</div></div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326474">1,433</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326476">1,510</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Goodwill</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.3.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326477">40,283</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326483">43,384</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.3.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326478">20,431</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326484">22,629</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.5.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326479">3,563</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326485">316</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other <div style="white-space:nowrap;display:inline;">non-current</div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326480">4,109</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326486">3,753</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> income tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxAssetsNoncurrent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326481">541</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxAssetsNoncurrent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326487">560</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Deferred tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326482">8,008</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DeferredTaxAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326488">7,967</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> assets</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326489">87,942</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326491">90,210</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Inventories" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326490">9,618</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Inventories" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326492">9,431</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.7.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326493">7,810</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326498">7,677</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other current assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326494">3,595</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326499">3,826</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Current income tax assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxAssetsCurrent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326495">397</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxAssetsCurrent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326500">724</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Cash and cash equivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326496">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326501">7,441</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Assets held for sale</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.22.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326497">238</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326502">13,489</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Current assets</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327584">37,017</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327585">42,588</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Total assets</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Assets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326503">124,959</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Assets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326504">132,798</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accompanying notes on pages 10 to 34 are an integral part of the condensed half-year consolidated financial statements. </div><div style="font-size:135pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">2&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:130pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div id="ex99_169958_3" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated balance sheets - equity and liabilities </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">1)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:75%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Equity attributable to equity holders of Sanofi</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326505">70,008</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326506">77,507</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Equity attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326507">271</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326508">350</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Total equity</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326509">70,279</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326510">77,857</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Long-term debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326511">13,200</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326512">11,791</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326513">1,524</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326514">1,645</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> liabilities related to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326515">564</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326516">569</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> provisions and other <div style="white-space:nowrap;display:inline;">non-current</div> liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.12.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326517">7,116</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326518">8,096</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> income tax liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326519">1,502</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesNoncurrent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326520">1,512</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Deferred tax liabilities</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326521">1,715</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DeferredTaxLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326522">2,166</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">&#8201;Non-current</div> liabilities</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326523">25,621</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326524">25,779</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326525">7,075</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326526">7,551</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Current liabilities related to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326527">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326528">72</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Current provisions and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CurrentProvisionsAndOtherCurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326529">13,697</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CurrentProvisionsAndOtherCurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326530">14,241</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Current income tax liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326531">724</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326532">697</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Current lease liabilities<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"> </div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326533">252</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326534">261</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326535">7,309</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326536">4,209</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Liabilities related to assets held for sale</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.22.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326537">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326538">2,131</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Current liabilities</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326539">29,059</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326540">29,162</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Total equity and liabilities</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326543">124,959</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326544">132,798</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accompanying notes on pages 10 to 34 are an integral part of the condensed half-year consolidated financial statements. </div><div style="font-size:110pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;3 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div id="ex99_169958_4" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated income statements </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(1)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6 months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">B.20.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326545">19,889</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326546">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other revenues</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.20.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326547">1,452</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326548">1,529</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Cost of sales</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326549">5,881</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326550">5,966</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Gross profit</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326551">15,460</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326552">13,923</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Research and development expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326553">3,717</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326554">3,335</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Selling and general expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326555">4,506</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326556">4,303</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other operating income</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.15.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326557">533</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326558">563</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other operating expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.15.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326559">2,476</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326560">1,977</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Amortization of intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.3.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326561">777</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326562">898</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Impairment of intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.4.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326563">210</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326564">371</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Fair value remeasurement of contingent consideration</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;<br/></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.6.<br/>B.11.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;<br/>&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326565">61</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326566">66</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Restructuring costs and similar items</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.16.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326567">430</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326568">1,060</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other gains and losses, and litigation</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.17.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326569">57</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326570">450</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326571">3,759</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326572">2,768</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Financial expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.18.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326573">361</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326574">583</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Financial income</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.18.</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326575">184</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326576">277</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326577">3,582</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326578">2,462</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Income tax expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.19.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326579">711</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326580">379</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Share of profit/(loss) from investments accounted for using the&#160;equity method</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326581">85</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326582">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net income from continuing operations</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326585">2,956</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326586">2,061</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #795c8c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Net income from discontinued operations</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.22</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326587">2,881</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326588">202</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326583">5,837</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326584">2,263</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326669">25</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326670">17</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net income attributable to equity holders of Sanofi</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326671">5,812</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326672">2,246</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Average number of shares outstanding (million)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.7.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="Fact_148326673">1,225.5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="Fact_148326674">1,249.4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Average number of shares after dilution (million)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.7.</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="Fact_148326675">1,230.7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="Fact_148326676">1,253.8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-weight:bold;display:inline;">&#8226;</div>&#8195;Basic earnings per share from continuing operations (<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326677">2.40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326678">1.64</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-weight:bold;display:inline;">&#8226;</div>&#8195;Basic earnings per share from discontinued operations (<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326679">2.34</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326680">0.16</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Basic earnings per share (&#8364;)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BasicEarningsLossPerShareAttributableToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326681">4.74</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BasicEarningsLossPerShareAttributableToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326682">1.80</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-weight:bold;display:inline;">&#8226;</div>&#8195;Diluted earnings per share from continuing operations (<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326683">2.39</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326684">1.63</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-weight:bold;display:inline;">&#8226;</div>&#8195;Diluted earnings per share from discontinued operations (<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326685">2.33</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326686">0.16</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Diluted earnings per share (&#8364;)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326687">4.72</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="Fact_148326688">1.79</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(a) Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div><div style="margin-top:16pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accompanying notes on pages 10 to 34 are an integral part of the condensed half-year consolidated financial statements. </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">4&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div></div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div id="ex99_169958_5" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated statements of comprehensive income </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">1</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:77%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326689">5,837</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326690">2,263</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8201;Attributable to equity holders of Sanofi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326691">5,812</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326692">2,246</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8201;Attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326626">25</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326625">17</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Other comprehensive income:</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Actuarial gains/(losses)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326693">111</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326694">235</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Change in fair value of equity instruments included in financial assets and financial liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326695">222</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326696">10</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Tax effects</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326697">92</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326698">59</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Subtotal: items not subsequently reclassifiable to profit or loss from continuing operations (A)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326699">241</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326700">166</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Change in fair value of debt instruments included in financial assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326701">3</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326702">5</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Change in fair value of cash flow hedges</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326703">23</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326704">3</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Change in currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326705">5,203</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326706">1,040</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Tax effects</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.8.</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326707">95</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326708">35</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Subtotal: items subsequently reclassifiable to profit or loss from continuing operations (B)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326709">5,318</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326710">1,067</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Other comprehensive income/(loss) from continuing operations for the period, net of taxes (A+B)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:OtherComprehensiveIncomeFromContinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326711">5,077</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OtherComprehensiveIncomeFromContinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326712">1,233</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Other comprehensive income/(loss) for the period from discontinued operations, net of taxes (C)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OtherComprehensiveIncomeFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326638">303</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:OtherComprehensiveIncomeFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326637">23</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Comprehensive income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326636">1,063</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326635">3,496</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8201;Attributable to equity holders of Sanofi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326634">1,076</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326633">3,471</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;<div style="font-style:italic;display:inline;">&#8195;Continuing operations</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326632">2,097</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326631">3,264</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;<div style="font-style:italic;display:inline;">&#8195;Discontinued operations</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326630">3,173</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326629">207</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8201;Attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326628">13</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #200f45;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326627">25</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #200f45;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accompanying notes on pages 10 to 34 are an integral part of the condensed half-year consolidated financial statements. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"></div></td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;5 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div id="ex99_169958_6" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated statements of changes in equity </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">1</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:55%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/>capital</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Additional<br/><div style="white-space:nowrap;display:inline;">paid-in</div><br/>capital</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Treasury<br/>shares</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Reserves<br/>and<br/>retained<br/>earnings</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Stock<br/>options&#160;and<br/>other<br/>share-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">based<br/>payments</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>compre-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">hensive<br/>income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Attribut-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">able to<br/>equity<br/>holders&#160;of<br/>Sanofi</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Attribut-</div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">able&#160;to&#160;non-</div></div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">controlling<br/>interests</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Balance at January&#160;1, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326649">2,530</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326650">313</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326651">1,184</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326652">67,499</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326653">4,944</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326654">62</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326655">74,040</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326656">313</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2023" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326657">74,353</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other comprehensive income for the period</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326658">166</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326659">1,059</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326660">1,225</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326661">8</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326662">1,233</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Net income for the period</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326663">2,246</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326664">2,246</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326665">17</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326666">2,263</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Comprehensive income for the period</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326716">2,412</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326832">1,059</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326833">3,471</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326834">25</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326835">3,496</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Dividend paid out of 2023 earnings (<div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:DividendsPaidOrdinarySharesPerShare" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-31821">3.76</ix:nonFraction> per share)</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326780">4,704</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326781">4,704</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326782">4,704</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Payment of dividends to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326783">31</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326784">31</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Share repurchase program <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326785">302</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326836">302</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326837">302</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Share-based payment plans:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326838">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326839">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326840">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Issuance of restricted shares and vesting of existing restricted shares</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2024To06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326841">3</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326842">3</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326843">115</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326844">115</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Value of services obtained from employees</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326845">173</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326846">173</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326847">173</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Tax effects of share-based payments</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326848">4</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326849">4</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326850">4</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other changes arising from issuance of restricted shares <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326862">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326851">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326852">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Balance at June&#160;30, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326853">2,533</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326854">317</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326855">1,371</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326856">65,093</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326857">5,121</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326858">997</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326859">72,690</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326860">307</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326861">72,997</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other comprehensive income for the period</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326615">194</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326616">1,379</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326617">1,185</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326618">14</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326619">1,199</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Net income for the period</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326620">3,314</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326621">3,314</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326667">41</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326668">3,355</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Comprehensive income for the&#160;period</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326863">3,120</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326864">1,379</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326865">4,499</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326866">55</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326867">4,554</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Payment of dividends to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326868">13</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326717">13</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Share repurchase program <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Reduction in share capital</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326871">12</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326872">492</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326873">530</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326874">26</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Share-based payment plans:</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326875">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326876">25</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326877">26</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326878">26</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Issuance of restricted shares and vesting of existing restricted shares</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326879">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326880">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Employee share ownership plan</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326881">4</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326882">150</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326883">154</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326884">154</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Value of services obtained from employees</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326885">132</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326886">132</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326887">132</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Tax effects of share-based payments</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326786">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326888">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P07_01_2024To12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326889">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Change in <div style="white-space:nowrap;display:inline;">non-controlling</div> interests without loss of control</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326890">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326891">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326892">1</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Balance at December&#160;31, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326893">2,526</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326894">840</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326895">68,185</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326896">5,260</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326897">2,376</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326898">77,507</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326899">350</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326900">77,857</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top;text-align:left">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"></div></td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">6&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div></div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:55%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Share<br/>capital</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Additional<br/><div style="white-space:nowrap;display:inline;">paid-in</div><br/>capital</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Treasury<br/>shares</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Reserves<br/>and<br/>retained<br/>earnings</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Stock<br/>options<br/>and&#160;other<br/>share-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">based<br/>payments</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>compre-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">hensive<br/>income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Attribut-</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">able to<br/>equity<br/>holders&#160;of<br/>Sanofi</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Attribut-</div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">able&#160;to&#160;non-</div></div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">controlling<br/>interests</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total<br/>equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Balance at January&#160;1, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326609">2,526</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326608">&#8212;</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326607">840</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326605">68,185</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326604">5,260</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326603">2,376</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326602">77,507</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326601">350</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326600">77,857</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Other comprehensive income for the period</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326599">243</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326598">4,979</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">)&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326597">4,736</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326596">38</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">)&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326595">4,774</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#8201;Net income for the period</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326594">5,812</ix:nonFraction></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326593">5,812</ix:nonFraction></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326592">25</ix:nonFraction></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326591">5,837</ix:nonFraction></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Comprehensive income for the&#160;period</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326715">6,055</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326714">4,979</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326713">1,076</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326590">13</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326589">1,063</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Dividend paid out of 2024 earnings (<div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:DividendsPaidOrdinarySharesPerShare" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-31925">3.92</ix:nonFraction> per share)</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326756">4,772</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326755">4,772</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326754">4,772</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Payment of dividends to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326753">32</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">)&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326752">32</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Share repurchase program <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326751">3,988</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326750">3,988</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:PurchaseOfTreasuryShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326749">3,988</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style="color:#23004c;display:inline;">&#8201;Reduction in share capital <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">(<ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326748">74</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326747">3,868</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">(<ix:nonFraction name="ifrs-full:ReductionOfIssuedCapital" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326746">3,794</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;">&#8212;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style="color:#23004c;display:inline;">&#8201;Tax on share cancellations <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">(<ix:nonFraction name="sny:TaxesOnShareCancellations" contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328206">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="sny:TaxesOnShareCancellations" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328207">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="sny:TaxesOnShareCancellations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328208">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Share-based payment plans:</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-style:italic;display:inline;"></div>&#8226;&#8195;Exercise of stock options</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326745">1</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326744">14</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326743">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughExerciseOfOptions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326742">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-style:italic;display:inline;">&#8226;</div>&#8195;Issuance of restricted shares and vesting of existing restricted shares&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326741">3</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" contextRef="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326740">3</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">)&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;<div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#8226;&#8195;</div></div>Value of services obtained from employees</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326739">177</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326738">177</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326737">177</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Tax effects of share-based payments</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326736">7</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326735">7</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326734">7</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Other changes arising from issuance of restricted shares <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326733">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326732">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326731">15</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom">&#8201;Other changes in <div style="white-space:nowrap;display:inline;">non-controlling</div> interests <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(e)</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">&#8212;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326730">34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle">)&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326729">34</ix:nonFraction></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">)&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="vertical-align:bottom;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Balance at June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326728">2,456</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326727">11</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326726">975</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326724">65,689</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326723">5,430</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326722">2,603</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326720">70,008</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326719">271</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Equity" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326718">70,279</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:16pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.8.2. (for amounts relating to 2024, see Note D.15.4. to the consolidated financial statements for the year ended December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Reflects new regulations implemented on the taxation of share cancellations in Article 95 of the French Finance Bill for 2025. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For 2024, this line comprises the impact of the issuance of restricted shares to former employees of EUROAPI subsequent to the date on which Sanofi lost control of EUROAPI. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For 2025, this line comprises the impact of the issuance of restricted shares to former employees of Opella subsequent to the date on which Sanofi lost control of Opella. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line comprises the impact of the derecognition of the <div style="white-space:nowrap;display:inline;">non-controlling</div> interests in Opella (see Note&#160;B.1.). </div></div></td></tr></table><div style="margin-top:16pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accompanying notes on pages 10 to 34 are an integral part of the condensed half-year consolidated financial statements. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;7 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div id="ex99_169958_7" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Consolidated statement of cash flows </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">1</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">)</div>) </div></div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net income attributable to equity holders of Sanofi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326901">5,812</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326902">2,246</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net (income)/loss from the discontinued Opella business</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:AdjustmentsForLossesGainsOnTransferOfBusiness" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326959">2,881</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:AdjustmentsForLossesGainsOnTransferOfBusiness" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326960">202</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">&#8201;Non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326903">25</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326904">17</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Share of undistributed earnings from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326905">15</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326906">96</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Depreciation, amortization and impairment of property, plant and equipment, <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">right-of-use</div></div> assets and intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326907">1,779</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326908">1,242</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Gains and losses on disposals of <div style="white-space:nowrap;display:inline;">non-current</div> assets, net of tax <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326909">266</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326910">229</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net change in deferred taxes</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForDeferredTaxExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326911">539</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForDeferredTaxExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326912">749</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net change in <div style="white-space:nowrap;display:inline;">non-current</div> provisions and other <div style="white-space:nowrap;display:inline;">non-current</div> liabilities <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326913">212</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326914">1,002</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Cost of employee benefits (stock options and other share-based payments)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326915">171</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326787">157</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Impact of the workdown of acquired inventories remeasured at fair value</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326916">&#8212;</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326917">7</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Other profit or loss items with no cash effect on cash flows generated by operating activities&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326918">106</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherAdjustmentsToReconcileProfitLoss" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326919">21</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Operating cash flow before changes in working capital</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326920">3,980</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326921">3,608</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;(Increase)/decrease in inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326922">635</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326923">917</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;(Increase)/decrease in accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326924">785</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326925">81</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Increase/(decrease) in accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326926">187</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326927">78</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net change in other current assets and other current liabilities</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326928">620</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326929">1,612</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) continuing operating activities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326930">3,367</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326931">1,238</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) operating activities of the discontinued Opella business</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326932">188</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326933">184</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) operating activities <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(e)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326934">3,555</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326935">1,422</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Acquisitions of property, plant and equipment and intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">B.2.&#8201;-&#8201;B.3.</div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326936">1,420</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326937">1,804</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Acquisitions of consolidated undertakings and investments accounted for using the equity method<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"> (f)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.1.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326938">538</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326939">1,885</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Acquisitions of other equity investments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326940">423</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326941">208</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Proceeds from disposals of property, plant and equipment, intangible assets and other <div style="white-space:nowrap;display:inline;">non-current</div> assets, net of tax&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(g)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326942">434</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326943">516</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Disposals of consolidated undertakings and investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326944">&#8212;</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326945">42</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net change in other <div style="white-space:nowrap;display:inline;">non-current</div> assets</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:NetChangeInOtherNonCurrentAssets" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326946">32</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:NetChangeInOtherNonCurrentAssets" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326947">16</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) continuing investing activities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:NetCashProvidedByusedInContinuingInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326788">1,979</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:NetCashProvidedByusedInContinuingInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326789">3,355</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) investing activities of the discontinued Opella business</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:NetCashProvidedByusedInDiscontinuingInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326790">36</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:NetCashProvidedByusedInDiscontinuingInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326791">58</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash inflow from the Opella transaction <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(h)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">B.1.</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:NetCashInflowFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326792">10,742</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:NetCashInflowFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326793">&#8212;</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) investing activities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326794">8,727</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326795">3,413</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Issuance of Sanofi shares</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.8.1.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326796">29</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromIssuingShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326797">21</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Dividends paid:</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;&#8226;&#8195;to equity holders of Sanofi</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326798">4,772</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326799">4,704</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;&#8226;&#8195;to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326800">27</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326801">25</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Additional long-term debt contracted</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.9.1.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromNoncurrentBorrowings" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326802">2,993</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProceedsFromNoncurrentBorrowings" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326803">&#8212;</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Repayments of long-term debt</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">B.9.1.</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:RepaymentsOfNoncurrentBorrowings" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326804">1,859</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:RepaymentsOfNoncurrentBorrowings" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326805">638</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Repayment of lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326806">124</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326807">136</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Net change in short-term debt and other financial instruments <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(i)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326808">3,322</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326809">5,876</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8201;Acquisitions of treasury shares and related tax effect</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">B.8.2</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326810">4,003</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:PaymentsToAcquireOrRedeemEntitysShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326811">302</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) continuing financing activities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326812">4,441</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326813">92</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) financing activities of the discontinued Opella business</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326814">48</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326815">3</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net cash provided by/(used in) financing activities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326816">4,489</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326948">89</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8201;Impact of exchange rates on cash and cash equivalents</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326949">42</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326950">13</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"><div style="font-family:Arial;display:inline;">&#8201;Cash and cash equivalents reclassified to <div style="font-style:italic;display:inline;">Assets held for sale</div> as of December&#160;31, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326951">167</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326952">&#8212;</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Net change in cash and cash equivalents</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326953">7,918</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148326954">1,915</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Cash and cash equivalents, beginning of period</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326955">7,441</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2023" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326956">8,710</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8201;Cash and cash equivalents, end of period</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;">B.9.</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326957">15,359</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326958">6,795</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">8&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div></div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"></div><div style="font-weight:bold;display:inline;"></div><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes <div style="white-space:nowrap;display:inline;">non-current</div> financial assets. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line item includes contributions paid to pension funds (see Note B.12.). </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in <div style="white-space:nowrap;display:inline;">non-functional</div> currencies and on instruments used to hedge such items. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Of which: </div></div></td></tr></table><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Income tax paid</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32056">1,355</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326962">1,434</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Interest paid</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32058">206</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestPaidClassifiedAsOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326964">320</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Interest received</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32060">170</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InterestReceivedClassifiedAsOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148326966">261</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;&#8226;&#8195;Dividends received from <div style="white-space:nowrap;display:inline;">non-consolidated</div> entities</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32062">5</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148326968">&#8212;</ix:nonFraction></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(f)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For the six months ended June&#160;30, 2025, this line item includes the net cash outflow arising from the acquisition of Dren-0201 (see Note B.1.2.). For the six months ended June&#160;30, 2024 it includes the net cash outflow arising from the acquisition of Inhibrx, Inc. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(g)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025 and June&#160;30, 2024, this line item mainly comprises proceeds from disposals of (i)&#160;assets and businesses due to portfolio rationalization, and (ii)&#160;equity and debt instruments. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(h)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, this amount includes &#8364;(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32064">667</ix:nonFraction>)&#160;million in respect of cash and cash equivalents held by Opella as of April&#160;30, 2025. </div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(i)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, this line item mainly comprises a commercial paper program in the United States for &#8364;<ix:nonFraction name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32065">3,353</ix:nonFraction>&#160;million, compared with &#8364;<ix:nonFraction name="sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" contextRef="P01_01_2024To06_30_2024_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32066">6,060</ix:nonFraction>&#160;million in the six months ended June&#160;30, 2024. This line item also includes realized foreign exchange gains and losses on cash and cash equivalents in <div style="white-space:nowrap;display:inline;">non-functional</div> currencies, mainly the US dollar, and on derivatives used to manage them. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;9 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div id="ex99_169958_8" style="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Notes to the condensed half-year consolidated financial statements as of June&#160;30, 2025 </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">(Unaudited<div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">(</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">1</div><div style="font-size:75%; vertical-align:top;display:inline;font-size:7.1px">)</div>) </div></div><ix:nonNumeric name="ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14725"><div id="ex99_169958_9" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">Introduction </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi, together with its subsidiaries (collectively &#8220;Sanofi&#8221;, &#8220;the Group&#8221; or &#8220;the Company&#8221;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The condensed consolidated financial statements for the six months ended June&#160;30, 2025 were reviewed by the Sanofi Board of Directors at the Board meeting on July&#160;30, 2025. </div></ix:nonNumeric><ix:nonNumeric name="ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327303" id="ixv-14730"><div id="ex99_169958_10" style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">A/ Basis of preparation of the half-year financial statements and accounting policies </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.1. International financial reporting standards (IFRS) </div></div></div><ix:nonNumeric name="ifrs-full:StatementOfIFRSCompliance" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14735"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The half-year consolidated financial statements have been prepared and presented in condensed format in accordance with IAS&#160;34 (Interim Financial Reporting). The accompanying notes therefore relate to significant events and transactions of the period, and should be read in conjunction with the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies used in the preparation of the consolidated financial statements as of June&#160;30,&#160;2025 comply with international financial reporting standards (IFRS) as endorsed by the European Union and as issued by the International Accounting Standards Board (IASB). IFRS as endorsed by the European Union as of June&#160;30, 2025 are available via the following web link: </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">https://www.efrag.org/Endorsement </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies applied effective January&#160;1, 2025 are identical to those presented in the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On August&#160;15, 2023, the IASB issued &#8220;Lack of Exchangeability&#8221;, an amendment to IAS 21 (The Effects of Changes in Foreign Exchange Rates), relating to how to determine the exchange rate when a currency is not exchangeable. The amendment became applicable on January&#160;1, 2025, and does not have a material impact on the Sanofi financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In its 2025 half-year financial statements, Sanofi has used an average effective tax rate that takes into account the Pillar Two <div style="white-space:nowrap;display:inline;">top-up</div> tax applicable from January&#160;1, 2024. The effective tax rate also includes a <div style="white-space:nowrap;display:inline;">one-off</div> impact from the 2024 component of the exceptional contribution in respect of French corporate income taxes (see Note B.19.). </div></ix:nonNumeric><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.2. Use of estimates and judgments </div></div></div><ix:nonNumeric name="ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14747"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date the financial statements are finalized. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">impairment of property, plant and equipment and intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the valuation of goodwill and the valuation and useful life of acquired intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of contingent consideration receivable in connection with asset divestments and of contingent consideration payable; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of financial assets and financial liabilities at amortized cost; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of post-employment benefit obligations; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences. </div></td></tr></table><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actual results could differ from these estimates. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For half-year financial reporting purposes, and as allowed under IAS 34, Sanofi has determined income tax expense on the basis of an estimate of the effective tax rate for the full financial year. That rate is applied to business operating income plus financial income and minus financial expenses, and before (i)&#160;the share of profit/loss of investments accounted for using the equity method and (ii)&#160;net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. The estimated full-year effective tax rate is based on the tax rates that will be applicable to projected <div style="white-space:nowrap;display:inline;">pre-tax</div> profits or losses arising in the various tax jurisdictions in which Sanofi operates. </div></ix:nonNumeric><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">10&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_148327303" continuedAt="TextSelectionAppend_148327303_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_1" continuedAt="TextSelectionAppend_148327303_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_2" continuedAt="TextSelectionAppend_148327303_3"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327303_3" continuedAt="TextSelectionAppend_148327303_4"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_4" continuedAt="TextSelectionAppend_148327303_5"><ix:exclude><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_5" continuedAt="TextSelectionAppend_148327303_6"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.3. Seasonal trends </div></div></div><ix:nonNumeric name="sny:SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14851"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi&#8217;s activities are not subject to significant seasonal fluctuations. </div></ix:nonNumeric><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.4. Consolidation and foreign currency translation of the financial statements of subsidiaries in hyperinflationary economies </div></div></div><ix:nonNumeric name="ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14856"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In 2025, Sanofi continues to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that<div style="display:inline;"> the </div>criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. The contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Argentina, the cumulative rate of inflation over the last three years is in excess of <ix:nonFraction name="sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears" contextRef="PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32069">100</ix:nonFraction>%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since July&#160;1, 2018) treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Turkey, the cumulative rate of <div style="display:inline;">inflation </div>over the last three years is in excess of <ix:nonFraction name="sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears" contextRef="PAsOn06_30_2025_TRifrsfullGeographicalAreasAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32070">100</ix:nonFraction>%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since January&#160;1, 2022) treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div></ix:nonNumeric><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.5. Fair value of financial instruments </div></div></div><ix:nonNumeric name="ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327458" id="ixv-14865"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under IFRS 13 (Fair Value Measurement) and IFRS 7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>Level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging); </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;2: quoted prices in active markets for similar assets or liabilities, or valuation techniques in which all important inputs are derived from observable market data; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;3: valuation techniques in which not all important inputs are derived from observable market data. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;11 </div></div></ix:exclude></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_148327303_6" continuedAt="TextSelectionAppend_148327303_7"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_7" continuedAt="TextSelectionAppend_148327303_8"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_8" continuedAt="TextSelectionAppend_148327303_9"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327303_9" continuedAt="TextSelectionAppend_148327303_10"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-14918"><ix:continuation id="TextSelection_148327458"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:13%"/>
<td style="vertical-align:bottom"/>
<td style="width:9%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:6%"/>
<td style="vertical-align:bottom;width:3%"/>
<td style="width:7%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:10%"/>
<td style="vertical-align:bottom"/>
<td style="width:14%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:12%"/>
<td style="vertical-align:bottom;width:1%"/>
<td style="width:11%"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td rowspan="3" style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Type&#160;of&#160;financial</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">instrument</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Measurement</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">principle</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;in<br/>fair&#160;value<br/>hierarchy</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>technique</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Method used to determine fair value</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Market data</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>model</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exchange</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">rate</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Interest&#160;rate</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Volatilities</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets<br/>measured at fair value (quoted equity instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value (quoted debt instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost/ Peer comparison (primarily)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(contingent consideration receivable)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">Long-term&#160;loans</div> and&#160;advances&#160;and <div style="white-space:nowrap;display:inline;">other&#160;non-current</div> receivables</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The amortized cost of long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables at the end of the reporting period is not materially different from their fair value.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under <div style="white-space:nowrap;display:inline;">post-employment</div> benefit plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Investments in mutual funds</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Net asset value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div><br/> <div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial">B.12.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial&#160;liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Lease liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Future lease payments are discounted using the incremental borrowing rate.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Forward&#160;currency contracts</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Present value of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Market Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Interest&#160;rate&#160;swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Cross-currency</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Liabilities&#160;related&#160;to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.</div></td></tr></table><div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). </div></div></td></tr></table></ix:continuation></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">12&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_148327303_10" continuedAt="TextSelectionAppend_148327303_11"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_11" continuedAt="TextSelectionAppend_148327303_12"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327303_12" continuedAt="TextSelectionAppend_148327303_13"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327303_13"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.6. New pronouncements issued by the IASB and applicable from 2026 </div></div></div><ix:nonNumeric name="ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-15390"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;9, 2024, the IASB issued IFRS 18 (Presentation and Disclosure in Financial Statements), applicable from January&#160;1, 2027 (subject to endorsement by the European Union). An impact assessment is currently under way. Sanofi will not early adopt this new standard. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;30, 2024, the IASB issued amendments to IFRS 9 and IFRS 7 relating to the classification and measurement of financial instruments, applicable no earlier than January&#160;1, 2026. Sanofi does not expect any material impact, and will not early adopt these amendments. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;18, 2024, the IASB issued Volume 11 of &#8220;Annual Improvements to IFRS&#8221;, applicable from January&#160;1, 2026. Sanofi does not expect any material impact from those improvements to various standards, which are essentially in the nature of clarifications, and will not early adopt them. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On December&#160;18, 2024, the IASB issued &#8220;Contracts referencing nature-dependent electricity&#8221;, amendments to IFRS 9 and IFRS&#160;7, applicable from January&#160;1, 2026. The amendments clarify the application of the &#8216;own use&#8217; exemption to Power Purchase Agreements (PPAs) with physical delivery of renewable electricity, and modify the hedge accounting requirements for contracts without physical delivery (VPPAs). Sanofi does not expect any material impact and will not early adopt these amendments. Renewable energy purchase contracts entered into by Sanofi as of December&#160;31, 2024 are described in Note D.21. to the consolidated financial statements included in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F</div> for the year ended December&#160;31, 2024 (the &#8220;2024 <div style="white-space:nowrap;display:inline;">20-F&#8221;).</div> </div></ix:nonNumeric></ix:continuation><div id="ex99_169958_11" style="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">B/ Significant information for the first half of 2025 </div><ix:nonNumeric name="sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327314" id="ixv-15398"><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.1. Significant transactions for the first half of 2025 </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.1. Opella - Loss of control and equity interest in OPAL JV Co </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2025, Sanofi and CD&amp;R closed the Opella transaction following the signature of the share purchase agreement (SPA) on February&#160;18, 2025. Sanofi retains a significant shareholding in Opella, through a <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="ixv-32077">48.2</ix:nonFraction>% equity interest in OPAL JV Co (formed in Luxembourg), which indirectly holds <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32078">100</ix:nonFraction>% of Opella. Bpifrance owns a <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P04_01_2025To04_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="ixv-32079">1.8</ix:nonFraction>% equity interest, and is represented on Opella&#8217;s Board. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Completion of the deal resulted in the loss of control of Opella by Sanofi and the derecognition of Opella&#8217;s assets and liabilities. This resulted in a net gain of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32080">2.7</ix:nonFraction>&#160;billion, reported within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations </div></div>in the consolidated income statement. The proceeds from the divestment of Opella, determined on the basis of a <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ProceedsFromSalesOfInvestmentProperty" contextRef="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32081">16</ix:nonFraction>&#160;billion enterprise value, reflected the estimated share price. That price is subject to adjustments following finalization of the Opella completion accounts, expected at the earliest in the fourth quarter of 2025. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of the closing date of the transaction, the carrying amount of Opella&#8217;s assets and liabilities in the Sanofi consolidated balance sheet was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NetAssetsLiabilities" contextRef="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32082">11.3</ix:nonFraction>&#160;billion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The gain took into account the following components: (i)&#160;a reclassification of unrealized foreign exchange losses amounting to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32083">0.5</ix:nonFraction>&#160;billion associated with Opella operations, in accordance with IAS 21 (&#8220;The Effects of Changes in Foreign Exchange Rates&#8221;); (ii) recognition of the retained <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="ixv-32084">48.2</ix:nonFraction>% equity interest in OPAL JV Co (over which Sanofi exercises significant influence as defined in IAS 28 &#8220;Investments in Associates and Joint Ventures&#8221;), reported within the balance sheet line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Investments accounted for using the equity method</div></div> at an amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32085">3.2</ix:nonFraction>&#160;billion (representing the fair value of the equity interest at the date of initial recognition in accordance with IFRS 10 and included in the estimated share price, plus capitalized transaction costs); and (iii)&#160;other items, mainly comprising compensation as agreed under the separation agreements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The Opella transaction generated a net cash inflow of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:NetCashInflowFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32086">10.7</ix:nonFraction>&#160;billion, presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net cash inflow from the Opella transaction</div></div> in the statement of cash flows. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As a reminder, on October&#160;21, 2024, Sanofi and CD&amp;R entered into exclusive negotiations for the transfer of a controlling interest in Opella. As of December&#160;31, 2024, completion of the transaction was considered highly probable. In accordance with the classification and presentation requirements of IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), all assets of Opella and all liabilities directly related to those assets were classified from October&#160;21, 2024 in the line items <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Assets held for sale </div></div><div style="font-weight:bold;display:inline;"></div>and<div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"> Liabilities related to assets held for sale</div></div>, respectively, in the consolidated balance sheet (see Notes D.8. and D.36. to the consolidated financial statements for the year ended December&#160;31, 2024). Opella (formerly known as Consumer Healthcare) constituted an operating segment of Sanofi until October&#160;21, 2024 (see Note D.35., &#8220;Segment Information&#8221; to the consolidated financial statements for the year ended December&#160;31, 2024). Consequently, Opella met the definition of a discontinued operation under IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), as a result of which the net income from that business was presented separately within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations</div></div> in the consolidated income statement. This presentation in a separate income statement line item applied to operations for the year ended December&#160;31, 2024, and on a consistent basis for the comparative periods presented. The cash flows arising from operating, investing and financing activities of the Opella business were also presented in separate line items in the consolidated statements of cash flows for the year ended December&#160;31, 2024 and for the comparative periods presented. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;13 </div></div></ix:exclude></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_148327314" continuedAt="TextSelectionAppend_148327314_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327314_1" continuedAt="TextSelectionAppend_148327314_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327314_2" continuedAt="TextSelectionAppend_148327314_3"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327314_3"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.2. Acquisition of Dren-0201, Inc. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;27, 2025, Sanofi announced the completion of the acquisition of 100% of Dren-0201, Inc., adding SAR448501 (formerly <div style="white-space:nowrap;display:inline;">DR-0201)</div> to Sanofi&#8217;s immunology pipeline. <div style="white-space:nowrap;display:inline;">DR-0201,</div> now named SAR448501, has shown robust <div style="white-space:nowrap;display:inline;">B-cell</div> depletion in <div style="white-space:nowrap;display:inline;">pre-clinical</div> and early clinical studies. This potential <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">first-in-class</div></div> targeted bispecific myeloid cell engager targets and engages specific tissue-resident and trafficking myeloid cells to induce deep <div style="white-space:nowrap;display:inline;">B-cell</div> depletion via targeted phagocytosis. Recent <div style="white-space:nowrap;display:inline;">pre-clinical</div> and early clinical study data in autoimmune diseases suggest that deep <div style="white-space:nowrap;display:inline;">B-cell</div> depletion has the potential to reset the adaptive immune system, leading to sustained treatment-free remission in patients with refractory <div style="white-space:nowrap;display:inline;">B-cell</div> mediated autoimmune diseases such as lupus, where significant unmet medical needs remain. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The transaction did not meet the criteria for a business combination under IFRS 3, and consequently was accounted for as an acquisition of a group of assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition price was $<ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32090">600</ix:nonFraction>&#160;million. Of that amount (plus acquisition-related costs), $<ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32091">562</ix:nonFraction>&#160;million was allocated to <div style="white-space:nowrap;display:inline;">in-process</div> development in respect of SAR448501, and recognized within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other intangible assets</div></div> in accordance with IAS 38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed in the transaction. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, potential future payments totalling $<ix:nonFraction name="sny:PotentialFuturePayments" contextRef="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32092">1.3</ix:nonFraction>&#160;billion contingent on attainment of certain development and launch milestones have been recognized as off balance sheet commitments. These milestones will be added to the value of the SAR448501 intangible asset if and when attained. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of this acquisition, as reflected within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Acquisitions of consolidated undertakings and investments accounted for using the equity method</div></div> in the consolidated statement of cash flows, is a net cash outflow of $<ix:nonFraction name="ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" contextRef="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32093">602</ix:nonFraction>&#160;million. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.3. Agreed transactions expected to be finalized in the second half of 2025 </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Acquisition of Vigil Neuroscience, Inc. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vigil Neuroscience, Inc. (&#8220;Vigil&#8221;), a publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. This acquisition in neurology, one of Sanofi&#8217;s four strategic disease areas, enhances Sanofi&#8217;s early-stage pipeline and includes <div style="white-space:nowrap;display:inline;">VG-3927,</div> which will be evaluated in a phase 2 clinical study in Alzheimer&#8217;s disease. <div style="white-space:nowrap;display:inline;">VG-3927</div> is an oral small molecule TREM2 agonist. Activating TREM2 is expected to enhance the neuroprotective function of microglia in Alzheimer&#8217;s disease. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under the terms of a share purchase agreement (including the exclusive right of first negotiation for an exclusive license to <div style="white-space:nowrap;display:inline;">VG-3927</div> or for transfer of the rights to research, develop, manufacture, and commercialize <div style="white-space:nowrap;display:inline;">VG-3927)</div> entered into by Sanofi and Vigil in June 2024 for an amount of $<ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32094">40</ix:nonFraction>&#160;million, Sanofi already held an equity interest in Vigil Neuroscience, Inc., representing approximately <ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal" id="ixv-32095">12</ix:nonFraction>% of Vigil&#8217;s share capital. That equity interest was remeasured at market value as at June&#160;30, 2025 through <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div>. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">VGL101, Vigil&#8217;s second molecule program, is not being acquired by Sanofi. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi will acquire all outstanding common shares of Vigil for $8.00 per share in cash at closing. Based on $<ix:nonFraction name="sny:EquityInterestsOfAcquirerPerShare" contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32096">8.00</ix:nonFraction> per share, the total equity value of Vigil represents approximately $<ix:nonFraction name="ifrs-full:EquityInterestsOfAcquirer" contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32097">470</ix:nonFraction>&#160;million (on a fully diluted basis). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, Vigil&#8217;s shareholders will receive one <div style="white-space:nowrap;display:inline;">non-transferable</div> and <div style="white-space:nowrap;display:inline;">non-tradeable</div> contractual contingent value right (CVR) per Vigil share entitling the holder to receive a deferred cash payment of $<ix:nonFraction name="sny:DeferredCashPayments" contextRef="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32098">2.00</ix:nonFraction>, contingent upon the first commercial sales of <div style="white-space:nowrap;display:inline;">VG-3927.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition is expected to close in the third quarter of 2025 subject to closing conditions. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Acquisition of Blueprint Medicines Corporation </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On June&#160;2, 2025, Sanofi and Blueprint Medicines Corporation (Blueprint), a <div style="white-space:nowrap;display:inline;">US-based,</div> publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other <div style="white-space:nowrap;display:inline;">KIT-driven</div> diseases, entered into an agreement under which Sanofi agreed to acquire Blueprint. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition included a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Blueprint&#8217;s established presence among allergists, dermatologists, and immunologists is expected to enhance Sanofi&#8217;s growing immunology pipeline. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under the terms of the acquisition, Sanofi agreed to pay $<ix:nonFraction name="sny:CashTransferredPerShare" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32099">129.00</ix:nonFraction> per share in cash at closing, representing an equity value of approximately $<ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32100">9.1</ix:nonFraction>&#160;billion for <ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_pure" decimals="INF" scale="-2" format="ixt:num-dot-decimal" id="ixv-32101">100</ix:nonFraction>% of the shares. Blueprint shareholders also received one <div style="white-space:nowrap;display:inline;">non-tradable</div> contractual contingent value right (CVR) per share which entitles the holder to receive two potential milestone payments of $<ix:nonFraction name="sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32102">2.00</ix:nonFraction> and $<ix:nonFraction name="sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32103">4.00</ix:nonFraction> per CVR on the attainment of future development and regulatory milestones within the applicable milestone period, respectively, for <div style="white-space:nowrap;display:inline;">BLU-808.</div> The total equity value of the transaction, including potential CVR payments, represents approximately $<ix:nonFraction name="ifrs-full:EquityInterestsOfAcquirer" contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32104">9.5</ix:nonFraction>&#160;billion on a fully diluted basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In July 2025, Sanofi obtained control of Blueprint after all tender offer and merger conditions had been met. </div></ix:continuation> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">14&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-15524"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.2. Property, plant and equipment </div></div></div> <ix:nonNumeric name="sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-15528"> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below sets forth acquisitions and capitalized interest by operating segment for the first half of 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquisitions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32105">702</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32106">591</ix:nonFraction></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Biopharma</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32107">663</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32108">535</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">Of which Manufacturing&#160;&amp; Supply</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32109">453</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32110">366</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Opella (discontinued operation, see Note B.1.)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32111">39</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="P01_01_2024To06_30_2024_OpellaMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32112">56</ix:nonFraction></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Of which capitalized interest</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:InterestCostsCapitalised" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32113">22</ix:nonFraction></div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:InterestCostsCapitalised" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32114">22</ix:nonFraction></div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td></tr></table> </ix:nonNumeric> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Firm orders for property, plant and equipment stood at <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:FirmOrdersOfPropertyPlantAndEquipment" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32115">732</ix:nonFraction>&#160;million as of June&#160;30, 2025. </div> </ix:nonNumeric><ix:nonNumeric name="ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-15697"> <div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.3. Goodwill and other intangible assets </div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Goodwill amounted to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32116">40,283</ix:nonFraction>&#160;million as of <div style="display:inline;">June&#160;</div>30, 2025, versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32117">43,384</ix:nonFraction>&#160;million as of December&#160;31, 2024. The movement during the period was mainly due to the impact of changes in exchange rates. </div> <ix:nonNumeric name="sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-15705"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in other intangible assets during the first half of 2025 were as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:65%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">&#8199;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquired&#160;R&amp;D</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Products,<br/> trademarks&#160;and<br/> other rights</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Software</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;other<br/> intangible&#160;assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32118">12,866</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32119">66,348</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32120">1,852</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32121">81,066</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Changes in scope of consolidation<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"> (b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32122">500</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32123">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32124">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32125">500</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Acquisitions and other increases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32126">332</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32127">302</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32128">42</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32129">676</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32130">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32131">199</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32132">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32133">228</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32134">1,339</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32135">5,159</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32136">49</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32137">6,547</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32138">40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32139">244</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32140">8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32141">292</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32142">12,297</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32143">61,048</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32144">1,830</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32145">75,175</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at January&#160;1, 2025</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32146">4,497</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32147">52,507</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32148">1,433</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32149">58,437</ix:nonFraction></div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Amortization expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32150">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32151">800</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32152">52</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32153">852</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impairment losses, net of reversals <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32154">201</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32155">9</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32156">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32157">210</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32158">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32159">199</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32160">8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32161">229</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32162">427</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32163">3,772</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32164">40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32165">4,239</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32166">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32167">281</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32168">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32169">287</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32170">4,249</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32171">49,064</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32172">1,431</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32173">54,744</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32174">8,369</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32175">13,841</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32176">419</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32177">22,629</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32178">8,048</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="PAsOn06_30_2025_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32179">11,984</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32180">399</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherIntangibleAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32181">20,431</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Transfers&#8221; line mainly comprises (i)&#160;acquired R&amp;D that came into commercial use during the period and (ii)&#160;reclassifications of assets to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Assets held for sale</div></div><div style="font-style:italic;display:inline;">. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Changes in scope of consolidation&#8221; line mainly comprises the intangible asset recognized as part of the Dren-0201, Inc. acquisition (see Note B.1.) </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.4. </div></div></td></tr></table> </ix:nonNumeric> <div style="margin-top:16pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Products, trademarks and other products&#8221; mainly comprise: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">marketed products, with a carrying amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32182">11.0</ix:nonFraction>&#160;billion as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32183">12.7</ix:nonFraction>&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately <ix:nonNumeric name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" format="ixt-sec:duryear" id="ixv-32184">10</ix:nonNumeric> years; and </div></td></tr></table> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">technological platforms brought into service, with a carrying amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32185">1.0</ix:nonFraction>&#160;billion as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32186">1.1</ix:nonFraction>&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately <ix:nonNumeric name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" format="ixt-sec:duryear" id="ixv-32187">18</ix:nonNumeric> years. </div></td></tr></table> </ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-16484"> <div style="margin-top:22pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.4. Impairment of intangible assets </div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32188">210</ix:nonFraction>&#160;million in the first half of 2025 linked to research and development projects. </div> </ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;15 </div></div></div> </div></div></div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div> </div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327449" id="ixv-16514"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.5. Investments accounted for using the equity method </div></div></div><ix:nonNumeric name="sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-16518"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Investments accounted for using the equity method consist of associates and joint ventures (see Note B.1. to the consolidated financial statements for the year ended December&#160;31, 2024), and comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:71%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;interest</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">OPAL JV Co <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148327452">48.2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327453">3,239</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327454">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">EUROAPI <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2025To06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148327455">29.6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327456">82</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327457">82</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="P01_01_2025To06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148327158">31.2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327157">93</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327156">102</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">MSP Vaccine Company <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="P01_01_2025To06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148327155">50.0</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327154">79</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024_MSPVaccineCompanyMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327153">81</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other investments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInJointVenture" contextRef="P01_01_2025To06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis" unitRef="Unit_pure" decimals="-2" scale="-2" format="ixt:fixed-zero" id="ixv-32201">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32202">70</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32203">51</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32204">3,563</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32205">316</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Following the loss of control of Opella, Sanofi holds <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2025To06_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="ixv-32206">48.2</ix:nonFraction>% of OPAL JV Co (CD&amp;R holds <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2025To06_30_2025_CDRMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32207">50</ix:nonFraction>% and Bpifrance holds <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInAssociate" contextRef="P01_01_2025To06_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="ixv-32208">1.8</ix:nonFraction>%), see Note B.1.. As of June&#160;30, 2025, the investment includes a &#8364;<ix:nonFraction name="sny:LoansToAssociates" contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32209">241</ix:nonFraction>&#160;million loan to OPAL JV Co being in substance part of the investment. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#8364;<ix:nonFraction name="sny:StockPrice" contextRef="PAsOn06_30_2025_EuroapiMemberdeiLegalEntityAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32210">2.89</ix:nonFraction> as of June&#160;30, 2025, and &#8364;<ix:nonFraction name="sny:StockPrice" contextRef="PAsOn12_31_2024_EuroapiMemberdeiLegalEntityAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32211">2.88</ix:nonFraction> as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. MSP Vaccine Company owns <ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="P01_01_2025To06_30_2025_MCMVaccineBVMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_MSPVaccineCompanyMemberdeiLegalEntityAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32212">100</ix:nonFraction>% of MCM Vaccine BV. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Share of profit/(loss) from investments accounted for using the equity method</div></div> showed net income of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32213">85</ix:nonFraction>&#160;million for the first half of 2025 (versus a net loss of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32214">22</ix:nonFraction>&#160;million for the first half of 2024), including <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" contextRef="P05_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32215">11</ix:nonFraction>&#160;million for Sanofi&#8217;s share of profits from OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. </div><ix:nonNumeric name="ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-16778"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The financial statements include commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Sales <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c) (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327131">29</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions" contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327130">59</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Royalties and other income <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327129">63</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions" contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327128">33</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Purchases of goods and services (including research expenses) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchasesOfGoodsRelatedPartyTransactions" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327127">371</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchasesOfGoodsRelatedPartyTransactions" contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327126">333</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts receivable and other receivables <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327125">299</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327124">184</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other assets <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherAssetsRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327123">189</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherAssetsRelatedPartyTransactions" contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327122">189</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts payable and other payables</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32226">637</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32227">160</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes loans to joint ventures and associates. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In October 2024, Sanofi raised its investment in EUROAPI by &#8364;<ix:nonFraction name="sny:SubordinateHybridBondRelatedPartyTransactions" contextRef="PAsOn10_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32228">200</ix:nonFraction>&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#8364;<ix:nonFraction name="sny:OtherAssetsRelatedPartyTransactions" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32229">189</ix:nonFraction>&#160;million (and was also &#8364;<ix:nonFraction name="sny:OtherAssetsRelatedPartyTransactions" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32230">189</ix:nonFraction>&#160;million as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative periods have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. </div></div></td></tr></table></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148328185" id="ixv-17006"><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Key items from the OPAL JV Co 2025 unaudited half-year consolidated financial statements, as provided in accordance with Sanofi&#8217;s consolidation timelines, are presented below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated income statement</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net sales and other revenues <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NetSalesAndOtherRevenuesRelatedPartyDisclosures" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327108">887</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net income <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NetIncomeRelatedPartyDisclosures" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327107">24</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated statement of comprehensive income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:OtherComprehensiveIncomeRelatedPartyDisclosures" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32233">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ComprehensiveIncomeRelatedPartyDisclosures" contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32234">23</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">16&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:nonNumeric></ix:nonNumeric></div></div><ix:continuation id="TextSelection_148328185" continuedAt="TextSelectionAppend_148328185_1"><ix:continuation id="TextSelection_148327449" continuedAt="TextSelectionAppend_148327449_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327449_1" continuedAt="TextSelectionAppend_148327449_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327449_2" continuedAt="TextSelectionAppend_148327449_3"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327449_3"><ix:continuation id="TextSelectionAppend_148328185_1"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated balance sheet</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> assets</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:NonCurrentAssetsRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32238">16,179</ix:nonFraction></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current assets</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:CurrentAssetsRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32239">2,937</ix:nonFraction></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:AssetsRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32240">19,116</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top">&#8194;Equity attributable to equity holders of OPAL JV Co</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:EquityAttributableToEquityHoldersRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32241">5,754</ix:nonFraction></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Equity attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:EquityAttributableToNonControllingInterestRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32242">541</ix:nonFraction></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:EquityRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32243">6,295</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> liabilities</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:NonCurrentLiabilitiesRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32244">11,039</ix:nonFraction></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current liabilities</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><ix:nonFraction name="sny:CurrentLiabilitiesRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32245">1,782</ix:nonFraction></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:LiabilitiesRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32246">12,821</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity and liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:EquityAndLiabilitiesRelatedPartyTransactions" contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32247">19,116</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table></ix:continuation></ix:continuation><ix:nonNumeric name="ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17300"><div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.6. Other <div style="white-space:nowrap;display:inline;">non-current</div> assets </div></div></div><ix:nonNumeric name="sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17305"><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Other <div style="white-space:nowrap;display:inline;">non-current</div> assets comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Equity instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="PAsOn06_30_2025_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32248">2,105</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="PAsOn12_31_2024_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32249">1,559</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Debt instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="PAsOn06_30_2025_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32250">362</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" contextRef="PAsOn12_31_2024_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32251">357</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Other financial assets at fair value through profit or loss</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32252">965</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32253">1,027</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Pre-funded</div> pension obligations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PreFundedPensionObligations" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32254">146</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PreFundedPensionObligations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32255">156</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Long-term prepaid expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:LongTermPrepaidExpenses" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32256">143</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:LongTermPrepaidExpenses" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32257">152</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;Long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentLoansAndReceivables" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32258">382</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentLoansAndReceivables" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32259">502</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Derivative financial instruments</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32260">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentDerivativeFinancialAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32261">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32262">4,109</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32263">3,753</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfTradeReceivablesTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17515"><div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.7. Accounts receivable </div></div></div><ix:nonNumeric name="sny:DisclosureOfCurrentTradeReceivablesTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17519"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Accounts receivable break down as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Gross value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32264">7,896</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32265">7,777</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Allowances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn06_30_2025_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32266">86</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn12_31_2024_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32267">100</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Carrying amount</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32268">7,810</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32269">7,677</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of allowances against accounts receivable in the first half of 2025 was a net expense of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32270">4</ix:nonFraction>&#160;million (versus a net expense of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32271">3</ix:nonFraction>&#160;million for the first half of 2024). </div><ix:nonNumeric name="sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17624"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the ageing profile of overdue accounts receivable, based on gross value: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:49%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;accounts<br/>gross value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&lt;1&#160;month</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">1-3</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">3-6</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">6-12&#160;months</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&gt;&#160;12&#160;months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;As of June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32272">386</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025_NotLaterThanOneMonthMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32273">122</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32274">103</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32275">73</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32276">48</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn06_30_2025_LaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32277">40</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;As of December&#160;31, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32278">650</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024_NotLaterThanOneMonthMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32279">316</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32280">194</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32281">87</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32282">9</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OverdueReceivablesGrossValue" contextRef="PAsOn12_31_2024_LaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32283">44</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Amounts overdue by more than one month relate mainly to public-sector customers. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables that met the conditions described in Note B.8.6. to the consolidated financial statements for the year ended December&#160;31, 2024 and hence were derecognized was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:DerecognizedReceivables" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32284">12</ix:nonFraction>&#160;million as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:DerecognizedReceivables" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32285">14</ix:nonFraction>&#160;million as of December&#160;31, 2024). The residual guarantees relating to those transfers were immaterial as of June&#160;30, 2025. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;17 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327048" id="ixv-17870"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.8. Consolidated shareholders&#8217; equity </div></div></div><ix:nonNumeric name="ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-17874"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.1. Share capital </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, the share capital was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="0" scale="0" format="ixt:num-dot-decimal" id="ixv-32286">2,455,512,548</ix:nonFraction> and consisted of <ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="PAsOn06_30_2025" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32287">1,227,756,274</ix:nonFraction> shares (the total number of shares outstanding) with a par value of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32288">2</ix:nonFraction>. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Treasury shares held by Sanofi are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:73%"/>
<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:10%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;shares</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;of&#160;share&#160;capital</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">for the period</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:NumberOfSharesHeld" contextRef="PAsOn06_30_2025" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal" id="ixv-32289">10.66</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:PercentageOfShareCapitalForThePeriod" contextRef="PAsOn06_30_2025" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-32290">0.868</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">December&#160;31, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NumberOfSharesHeld" contextRef="PAsOn12_31_2024" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal" id="ixv-32291">9.53</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PercentageOfShareCapitalForThePeriod" contextRef="PAsOn12_31_2024" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-32292">0.755</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">June&#160;30, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NumberOfSharesHeld" contextRef="PAsOn06_30_2024" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal" id="ixv-32293">15.33</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PercentageOfShareCapitalForThePeriod" contextRef="PAsOn06_30_2024" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-32294">1.211</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">January&#160;1, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NumberOfSharesHeld" contextRef="PAsOn12_31_2023" unitRef="Unit_shares" decimals="-4" scale="6" format="ixt:num-dot-decimal" id="ixv-32295">13.45</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PercentageOfShareCapitalForThePeriod" contextRef="PAsOn12_31_2023" unitRef="Unit_pure" decimals="5" scale="-2" format="ixt:num-dot-decimal" id="ixv-32296">1.063</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A total of <ix:nonFraction name="sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32297">171,150</ix:nonFraction> shares were issued in the first half of 2025 as a result of the exercise of Sanofi stock subscription options. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, <ix:nonFraction name="sny:NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32298">2,682,051</ix:nonFraction> shares vested under Sanofi restricted share plans during the first half of 2025, of which <ix:nonFraction name="sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32299">1,156,205</ix:nonFraction>&#160;were fulfilled by issuance of new shares and <ix:nonFraction name="sny:NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" contextRef="PAsOn06_30_2025" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32300">1,525,846</ix:nonFraction> by allotment of existing shares free of charge. </div></ix:nonNumeric><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.2. Repurchase of Sanofi shares </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2024, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of <ix:nonNumeric name="sny:PeriodOfShareRepurchaseProgram" contextRef="P04_30_2024To04_30_2024_ShareRepurchase2024ProgramMemberSNYShareProgramAxis" format="ixt-sec:durmonth" id="ixv-32301">18</ix:nonNumeric>&#160;months. Under that program, Sanofi repurchased <ix:nonFraction name="sny:NumberOfSharesRepurchased" contextRef="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32302">39,344,633</ix:nonFraction> of its own shares during the first half of 2025 for a total amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:AmountOfSharesRepurchased" contextRef="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32303">3,988</ix:nonFraction>&#160;million. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the meeting of the Board of Directors on January&#160;29, 2025, the Board authorized Sanofi to repurchase the Company&#8217;s shares, for an amount not exceeding <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:AmountOfSharesRepurchased" contextRef="P01_29_2025To01_29_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32304">5</ix:nonFraction>&#160;billion, under the terms and conditions set by the General Meeting of April&#160;30, 2024 in its 19th resolution. As part of this authorization, Sanofi entered into a share buyback agreement with its historical shareholder L&#8217;Or&#233;al on February&#160;2, 2025 for the acquisition of <div style="display:inline;">2.34</div>% of Sanofi&#8217;s share capital, equivalent to <ix:nonFraction name="sny:NumberOfSharesRepurchased" contextRef="P01_01_2025To06_30_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32305">29,556,650</ix:nonFraction> shares, for a total amount of approximately <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:AmountOfSharesRepurchased" contextRef="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32306">3</ix:nonFraction>&#160;billion, representing a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:PerShareValueOfSharesRepurchased" contextRef="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32307">101.50</ix:nonFraction> per share. The conclusion of that agreement was approved by the Board of Directors on the same day prior to the signing of the agreement, and in accordance with the procedure set forth in Articles L. <div style="white-space:nowrap;display:inline;">225-38</div> et seq. of the French Commercial Code. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2025, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of <ix:nonNumeric name="sny:PeriodOfShareRepurchaseProgram" contextRef="P04_30_2025To04_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis" format="ixt-sec:durmonth" id="ixv-32308">18</ix:nonNumeric> months. Sanofi did not use that authorization during the first half of 2025. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.3. Reduction in share capital </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025, treasury shares amounting to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:CancellationOfTreasuryShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32309">3,868</ix:nonFraction>&#160;million were cancelled further to decisions taken by the Sanofi Board of Directors on March&#160;13, 2025 and April&#160;23, 2025. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Those reductions have no impact on shareholders&#8217; equity, except for the impact of the tax on share cancellations. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.4. Restricted share plans </div><ix:nonNumeric name="sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-18025"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. to the consolidated financial statements for the year ended December&#160;31, 2024. The principal features of the plans awarded in 2025 are set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:83%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Type of plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">Performance&#160;share&#160;plan</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Date of Board meeting approving the plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">30&#160;April, 2025</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total number of shares subject to a <div style="white-space:nowrap;display:inline;"><ix:nonNumeric name="sny:NumberOfYearsServicePeriod" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" format="ixt-sec:duryear" id="ixv-32310">3</ix:nonNumeric>-year</div> service period</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32311">4,021,370</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with no market condition</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32312">2,599,478</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="Fact_148327162">83.94</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with market conditions</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32314">1,421,892</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded other than to the Chief Executive Officer (<ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32315">1,331,892</ix:nonFraction> shares in total) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" contextRef="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="Fact_148327161">79.25</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded to the Chief Executive Officer (<ix:nonFraction name="ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted" contextRef="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32317">90,000</ix:nonFraction> shares) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:FairValuePerShareAwardedForThreeYearServicePeriod" contextRef="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="Fact_148327160">75.10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair value of plan at the date of grant (&#8364; million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:FairValueOfPlanAtDateOfGrant" contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32319">331</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">18&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_148327048" continuedAt="TextSelectionAppend_148327048_1"><div></div></ix:continuation></div><div><div style="line-height:normal;display: inline;"><ix:continuation id="TextSelectionAppend_148327048_1" continuedAt="TextSelectionAppend_148327048_2"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_2" continuedAt="TextSelectionAppend_148327048_3"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_3" continuedAt="TextSelectionAppend_148327048_4"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327048_4" continuedAt="TextSelectionAppend_148327048_5"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_5" continuedAt="TextSelectionAppend_148327048_6"><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-18222"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total expense for restricted share plans (<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32321">146</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="P01_01_2024To06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32322">128</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Number of shares not yet fully vested</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32323">11,550,347</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32324">11,192,984</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2025 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32325">4,020,451</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero" id="ixv-32326">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2024 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32327">4,110,089</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32328">4,498,109</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2023 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32329">3,313,588</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32330">3,652,352</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2022 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32331">106,219</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32332">3,031,060</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2021 plans</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2025_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:fixed-zero" id="ixv-32333">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:NumberOfRestrictedSharesNotYetFullyVested" contextRef="PAsOn06_30_2024_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32334">11,463</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.5. Capital increases </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On January&#160;29, 2025, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:SubscriptionPricePerShare" contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32335">72.97</ix:nonFraction> per share. The subscription period was open from June&#160;10 through June&#160;30, 2025. Sanofi employees subscribed for a total of <ix:nonFraction name="sny:NumberOfSharesSubscribed" contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32336">2,260,776</ix:nonFraction> shares, and this capital increase was supplemented by the immediate issuance of a further <ix:nonFraction name="sny:IssuanceOfFurtherSharesAsAnEmployersContribution" contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32337">116,794</ix:nonFraction> shares for the employer&#8217;s contribution. The total expense recognized for this capital increase in the first half of 2025 was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="P01_01_2025To06_30_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32338">31</ix:nonFraction>&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On January&#160;31, 2024, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:SubscriptionPricePerShare" contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32339">72.87</ix:nonFraction> per share. The subscription period was open from June&#160;4 through June&#160;24, 2024. Sanofi employees subscribed for a total of <ix:nonFraction name="sny:NumberOfSharesSubscribed" contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32340">2,124,445</ix:nonFraction> shares, and this capital increase was supplemented by the immediate issuance of a further <ix:nonFraction name="sny:IssuanceOfFurtherSharesAsAnEmployersContribution" contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32341">119,951</ix:nonFraction> shares for the employer&#8217;s contribution. The total expense recognized for this capital increase in the first half of 2024 was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" contextRef="P01_01_2024To06_30_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32342">45</ix:nonFraction>&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.6. Stock subscription option plans </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">No stock subscription option plans were awarded in the first half of 2025 or in 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">No further stock option plan expenses were recognized through equity in either the first half of 2025 or 2024. </div><ix:nonNumeric name="sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-18445"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below provides summary information about options outstanding and exercisable as of June&#160;30, 2025: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"/>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Range of exercise prices per share</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exercisable</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average</div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">residual life</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(years)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32343">60.00</ix:nonFraction> to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32344">70.00</ix:nonFraction> per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32345">168,784</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonNumeric name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" format="ixt-sec:duryear" id="ixv-32346">2.84</ix:nonNumeric></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32347">65.84</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32348">168,784</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32349">65.84</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32350">70.00</ix:nonFraction> to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32351">80.00</ix:nonFraction> per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32352">299,250</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonNumeric name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" format="ixt-sec:duryear" id="ixv-32353">2.98</ix:nonNumeric></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32354">76.48</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32355">299,250</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32356">76.48</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32357">80.00</ix:nonFraction> to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ExercisePriceOfOutstandingShareOptions2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32358">90.00</ix:nonFraction> per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32359">257,010</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonNumeric name="ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" format="ixt-sec:duryear" id="ixv-32360">1.86</ix:nonNumeric></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32361">88.97</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32362">257,010</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_EUR_per_Share" decimals="2" scale="0" format="ixt:num-dot-decimal" id="ixv-32363">88.97</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32364">725,044</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" contextRef="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis" unitRef="Unit_shares" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32365">725,044</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/></tr></table></ix:nonNumeric><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.7. Number of shares used to compute diluted earnings per share </div><ix:nonNumeric name="sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-18762"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Average number of shares outstanding</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32366">1,225.5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32367">1,249.4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for stock options with dilutive effect</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32368">0.1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32369">0.1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for restricted shares</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32370">5.1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32371">4.3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Average number of shares used to compute diluted earnings per share</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32372">1,230.7</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="-5" scale="6" format="ixt:num-dot-decimal" id="ixv-32373">1,253.8</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, December&#160;31, 2024 and June&#160;30, 2024, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;19 </div></div></ix:exclude></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_148327048_6" continuedAt="TextSelectionAppend_148327048_7"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_7" continuedAt="TextSelectionAppend_148327048_8"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_8" continuedAt="TextSelectionAppend_148327048_9"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div> <div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327048_9" continuedAt="TextSelectionAppend_148327048_10"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327048_10"><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.8. Other comprehensive income </div><ix:nonNumeric name="sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-18923"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements within other comprehensive income are shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8199;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;&#8194;&#8194;&#8194;June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses):</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) excluding investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32375">105</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32376">235</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32377">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32378">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32379">25</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32380">57</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Equity instruments included in financial assets and financial liabilities:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32381">222</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32382">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32383">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32384">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Equity risk hedging instruments designated as fair value hedges</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32385">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32386">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32387">60</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32388">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items not subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32389">243</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32390">166</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Debt instruments included in financial assets:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327021">3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327020">5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32393">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32394">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32395">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32396">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash flow hedges and fair value hedges:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327015">23</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327014">4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32399">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32400">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32401">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32402">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Change in currency translation differences:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:middle;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin: 0pt 0.63em 0pt 1.13em; text-indent: -0.63em; font-size: 8pt; font-family: Arial; text-align: justify; line-height: normal;">&#8226;&#8201;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327009">5,266</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327008">1,167</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Currency translation differences (investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32405">26</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32406">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Hedges of net investments in foreign operations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32407">390</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32408">126</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:ChangeInCurrencyTranslationOnTaxEffects" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32409">101</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:ChangeInCurrencyTranslationOnTaxEffects" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32410">33</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32411">5,017</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32412">1,067</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: immaterial over all periods. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: &#8364;<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32413">2</ix:nonFraction>&#160;million in the first half of 2025, immaterial in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">&#8194;</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: a &#8364;<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32414">459</ix:nonFraction>&#160;million loss in the first half of 2025 relating to the deconsolidation of Opella (see Note B.1.)., a &#8364;<ix:nonFraction name="ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" contextRef="P01_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32415">5</ix:nonFraction>&#160;million profit in 2024, and immaterial in the first half of 2024. </div></div></div></td></tr></table></ix:nonNumeric></ix:continuation><ix:nonNumeric name="sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327375" id="ixv-19503"><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.9. Debt, cash and cash equivalents </div></div></div></div><ix:nonNumeric name="sny:DisclosureOfChangesInFinancialPositionTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-19508"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Changes in financial position during the period were as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8198;&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32416">13,200</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32417">11,791</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32418">7,309</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32419">4,209</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32420">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32421">137</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32422">20,519</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32423">16,137</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32424">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32425">7,441</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32426">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32427">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327271">5,102</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327264">8,772</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;<ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32430">1,776</ix:nonFraction>&#160;million as of June&#160;30, 2025 and &#8364;<ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32431">1,906</ix:nonFraction>&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Net debt&#8221; is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-IFRS</div> financial measure used by management and investors to measure Sanofi&#8217;s overall net indebtedness. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">20&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div></div>HALF-YEAR FINANCIAL REPORT<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div><div style="font-family: Arial; color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;">2025</div></ix:exclude><div style="font-family: Arial; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="background: none; text-decoration: none;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div></div></div></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_148327375" continuedAt="TextSelectionAppend_148327375_1"><div></div></ix:continuation></div><div><div style="line-height:normal;display: inline;"><ix:continuation id="TextSelectionAppend_148327375_1" continuedAt="TextSelectionAppend_148327375_2"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327375_2" continuedAt="TextSelectionAppend_148327375_3"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327375_3" continuedAt="TextSelectionAppend_148327375_4"><ix:exclude><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bolder;display:inline;"><a href="#toc">Table of Contents</a></div></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327375_4" continuedAt="TextSelectionAppend_148327375_5"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;"><ix:exclude>Exhibit 99.1</ix:exclude></div></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"><ix:exclude>1. Condensed half-year consolidated financial statements</ix:exclude> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.9.1. Net debt at value on redemption </div><ix:nonNumeric name="sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-19769"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A reconciliation of the carrying amount of net debt in the balance sheet to value on redemption as of June&#160;30, 2025 is shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Value on redemption</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Carrying&#160;amount&#160;at</div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Amortized&#160;cost</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Adjustment&#160;to&#160;debt<br/>measured at fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32435">13,200</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32436">39</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32437">78</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32438">13,317</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32439">11,940</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32440">7,309</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32441">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32442">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32443">7,311</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32444">4,218</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32445">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32446">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32447">78</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32448">68</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32449">13</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32450">20,519</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32451">41</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32452">&#8212;</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32453">20,560</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32454">16,171</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32455">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32456">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32457">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32458">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32459">7,441</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32460">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32461">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32462">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32463">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32464">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327902">5,102</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327896">41</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327676">&#8212;</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327887">5,143</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327880">8,806</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;<ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32470">1,776</ix:nonFraction>&#160;million as of June&#160;30, 2025 and &#8364;<ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32471">1,906</ix:nonFraction>&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-20250"><div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows an analysis of net debt by type, at value on redemption: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:26%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="12" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bond issues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32472">13,259</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32473">2,322</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32474">15,581</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32475">11,876</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32476">2,716</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BondsIssued" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32477">14,592</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other bank borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32478">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327861">4,847</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32480">4,905</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32481">64</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32482">1,290</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32483">1,354</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32484">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32485">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32486">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32487">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32488">3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherBorrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32489">3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bank credit balances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32490">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32491">141</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32492">141</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32493">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32494">209</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:BankOverdraftsClassifiedAsCashEquivalents" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32495">209</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32496">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32497">68</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32498">68</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"/>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"/>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"/>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32499">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32500">13</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageDebt" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32501">13</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32502">13,317</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32503">7,243</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32504">20,560</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"/>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"/>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"/>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32505">11,940</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32506">4,231</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32507">16,171</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32508">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32509">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32510">15,359</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32511">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32512">7,441</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32513">7,441</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32514">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32515">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32516">58</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32517">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32518">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32519">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32520">13,317</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32521">8,174</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32522">5,143</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32523">11,940</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32524">3,134</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:DebtNetOfCashAndCashEquivalents" contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32525">8,806</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of June 30, 2025, current other bank borrowings include &#8364;<ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32526">4,535</ix:nonFraction>&#160;million related to the US commercial paper program and &#8364;<ix:nonFraction name="sny:OtherBankBorrowings" contextRef="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32527">230</ix:nonFraction>&#160;million related to the Negotiable European Commercial Paper program in France. </div></div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div></ix:nonNumeric><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;21 </div></div></ix:exclude></div></ix:continuation></div></div><ix:continuation id="TextSelectionAppend_148327375_5" continuedAt="TextSelectionAppend_148327375_6"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327375_6" continuedAt="TextSelectionAppend_148327375_7"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327375_7" continuedAt="TextSelectionAppend_148327375_8"><ix:exclude><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bolder;display:inline;"><a href="#toc">Table of Contents</a></div></div></ix:exclude></ix:continuation></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327375_8" continuedAt="TextSelectionAppend_148327375_9"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327375_9"><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial">Principal financing and debt reduction transactions during the period </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi carried out the following bond issues during the period: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify">i. March 2025: a bond issue of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32529">1.5</ix:nonFraction>&#160;billion in <ix:nonFraction name="sny:NumberOfTranches" contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt-sec:numwordsen" id="ixv-32530">two</ix:nonFraction> tranches: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2027MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32531">850</ix:nonFraction>&#160;million of floating-rate bonds maturing March 2027, with quarterly coupons and bearing interest at an annual rate of <div style="white-space:nowrap;display:inline;">3-month</div> Euribor plus 30 basis points; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2031MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32532">650</ix:nonFraction>&#160;million of fixed-rate bonds maturing March 2031, with annual coupons and bearing interest at an annual rate of 2.750%. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify">ii. June 2025: a bond issue of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32533">1.5</ix:nonFraction>&#160;billion in <ix:nonFraction name="sny:NumberOfTranches" contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt-sec:numwordsen" id="ixv-32534">two</ix:nonFraction> tranches: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondMaturingJune2029MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32535">750</ix:nonFraction>&#160;million of fixed-rate bonds maturing June 2029, with annual coupons and bearing interest at an annual rate of 2.625%; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2032MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32536">750</ix:nonFraction>&#160;million of fixed-rate bonds maturing June 2032, with annual coupons and bearing interest at an annual rate of 3.000%. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Two bond issues were redeemed in 2025: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondIssueFromApril2020MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32537">1</ix:nonFraction>&#160;billion fixed-rate bond issue from April 2020, which was redeemed at maturity on April&#160;1, 2025; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FixedRateBondIssueFromApril2022MemberifrsfullBorrowingsByNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32538">850</ix:nonFraction>&#160;million fixed-rate bond issue from April 2022, which was redeemed at maturity on April&#160;6, 2025. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi had two syndicated credit facilities linked to social and environmental criteria in place to manage its liquidity in connection with current operations: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a syndicated credit facility of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FourBillionFacilityMaturingDecember2027MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32539">4</ix:nonFraction>&#160;billion, drawable in euros and US dollars and expiring on December&#160;6, 2027, for which no further extension options are available; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a syndicated credit facility of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_FourBillionFacilityMaturingMarch2030MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32540">4</ix:nonFraction>&#160;billion, drawable in euros and US dollars and expiring on March&#160;6, 2030, for which no further extension options are available. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, neither facility was drawn down. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi also has two short-term debt programs: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:CommercialPapersIssued" contextRef="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_EUR" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32541">6</ix:nonFraction>&#160;billion Negotiable European Commercial Paper program in France; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a $<ix:nonFraction name="ifrs-full:CommercialPapersIssued" contextRef="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_USD" decimals="-9" scale="9" format="ixt:num-dot-decimal" id="ixv-32542">10</ix:nonFraction>&#160;billion Commercial Paper program in the United States. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the average drawdown under the US Commercial Paper program was $<ix:nonFraction name="sny:BorrowingAverageDrawdown" contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_USD" decimals="-7" scale="9" format="ixt:num-dot-decimal" id="ixv-32543">2.63</ix:nonFraction>&#160;billion; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the average drawdown under the Negotiable European Commercial Paper program in France was <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:BorrowingAverageDrawdown" contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis" unitRef="Unit_EUR" decimals="-7" scale="9" format="ixt:num-dot-decimal" id="ixv-32544">0.02</ix:nonFraction>&#160;billion. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The financing in place as of June&#160;30, 2025 at the level of the holding company (which manages most of Sanofi&#8217;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking credit spreads or fees to the credit rating. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.9.2. Market value of net debt </div><ix:nonNumeric name="sny:DisclosureOfMarketValueOfNetDebtTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-21101"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Market value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn06_30_2025_AtMarketValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32545">4,589</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Borrowings" contextRef="PAsOn12_31_2024_AtMarketValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32546">8,165</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Value on redemption</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RedemptionOfDebtInstrumentIssued" contextRef="P01_01_2025To06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32547">5,143</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RedemptionOfDebtInstrumentIssued" contextRef="P01_01_2024To12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32548">8,806</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table></ix:nonNumeric></ix:continuation><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">22&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327041" id="ixv-21194"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.10. Derivative financial instruments </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.10.1 Currency derivatives used to manage operating risk exposures </div><ix:nonNumeric name="sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-21199"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows operating currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:46%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="12" style="height:3pt"/>
<td colspan="8" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which derivatives designated<br/>as&#160;cash&#160;flow hedges</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge<br/>accounting</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which<br/>recognized<br/>in&#160;equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32549">6,619</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32550">133</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32551">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32552">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32553">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32554">6,619</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32555">133</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32556">3,351</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32557">100</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32558">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32559">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32560">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32561">3,351</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32562">100</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32563">539</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32564">10</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32565">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32566">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32567">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32568">539</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32569">10</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32570">480</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32571">14</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32572">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32573">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32574">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32575">480</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32576">14</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32577">253</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32578">9</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32579">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32580">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32581">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32582">253</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32583">9</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which pound sterling</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32584">173</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32585">2</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32586">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32587">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32588">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32589">173</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32590">2</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32591">4,418</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32592">84</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32593">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32594">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32595">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32596">4,418</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32597">84</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32598">2,540</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32599">55</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32600">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32601">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32602">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32603">2,540</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32604">55</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32605">610</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32606">15</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32607">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32608">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32609">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32610">610</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32611">15</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32612">277</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32613">5</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32614">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32615">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32616">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32617">277</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32618">5</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Turkish lira</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32619">159</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32620">4</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32621">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32622">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32623">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32624">159</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32625">4</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which United Arab Emirates dirham</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32626">120</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32627">5</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32628">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32629">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32630">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32631">120</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32632">5</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32633">11,037</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32634">49</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32635">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32636">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32637">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32638">11,037</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstruments" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32639">49</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The above positions mainly hedge material foreign currency cash flows arising after the end of the reporting period in relation to transactions carried out during the six months ended June&#160;<div style="display:inline;">30,</div> 2025 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange difference on those items (hedging instruments and hedged transactions) will be immaterial in the second half of 2025. </div></ix:nonNumeric><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.10.2. Currency and interest rate derivatives used to manage financial exposure </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The cash pooling arrangements for foreign subsidiaries outside the eurozone, and some of Sanofi&#8217;s financing activities, expose certain Sanofi entities to financial foreign exchange risk (i.e.&#160;the risk of changes in the value of loans and borrowings denominated in a currency other than the functional currency of the lender or borrower). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">That foreign exchange exposure is hedged using derivative instruments (currency swaps or forward contracts) that alter the currency split of Sanofi&#8217;s debt once those instruments are taken into account. </div><ix:nonNumeric name="sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327039" id="ixv-22402"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows financial currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional&#160;amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Maximum<br/>&#8195;&#8195;expiry&#160;date</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Cross currency seller swaps</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32640">1,476</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32641">5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327950">1,476</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32643">5</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2032</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32644">7,723</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32645">176</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327946">6,007</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(b)</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32647">148</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Pound sterling</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32648">601</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32649">7</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32650">303</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32651">9</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32652">3,609</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32653">44</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32654">1,289</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32655">14</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327936">1,094</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(c)&#160;</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(<ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32657">33</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2026</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Hungarian forint</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32658">639</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32659">7</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32660">12,808</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:DerivativeFinancialInstrumentsToManageFinancialExposure" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32661">137</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/>
<td style="vertical-align:middle;background-color:#7802e6"/></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Comprises two cross currency swaps, (i)&#160;with a notional amount of $<ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_CrossCurrencySwapExpiring2029MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32662">870</ix:nonFraction>&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $<ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_CrossCurrencySwapExpiring2032MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32663">870</ix:nonFraction>&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#8364;<ix:nonFraction name="ifrs-full:DerivativeFinancialAssets" contextRef="PAsOn06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32664">5</ix:nonFraction>&#160;million, with &#8364;<ix:nonFraction name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" contextRef="P01_01_2025To06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32665">18</ix:nonFraction>&#160;million debited to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div><div style="font-style:italic;display:inline;"> under the cost of hedging accounting treatment. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;23 </div></div></ix:exclude></div></ix:nonNumeric></ix:nonNumeric></div></div></div><ix:continuation id="TextSelection_148327039" continuedAt="TextSelectionAppend_148327039_1"><ix:continuation id="TextSelection_148327041" continuedAt="TextSelectionAppend_148327041_1"><div></div></ix:continuation></ix:continuation></div><ix:continuation id="TextSelectionAppend_148327039_1" continuedAt="TextSelectionAppend_148327039_2"><ix:continuation id="TextSelectionAppend_148327041_1" continuedAt="TextSelectionAppend_148327041_2"><div><div style="line-height:normal;display: inline;"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></div></div></ix:continuation></ix:continuation> <div><div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327039_2" continuedAt="TextSelectionAppend_148327039_3"><ix:continuation id="TextSelectionAppend_148327041_2" continuedAt="TextSelectionAppend_148327041_3"><ix:exclude> <div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div></div> </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div> <div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> </ix:exclude></ix:continuation> </ix:continuation><ix:continuation id="TextSelectionAppend_148327041_3"><ix:continuation id="TextSelectionAppend_148327039_3"><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward sales with a notional amount of $<ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32666">3,615</ix:nonFraction>&#160;million expiring in 2025, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of June&#160;30, 2025, the fair value of these forward contracts represented an asset of &#8364;<ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32667">77</ix:nonFraction>&#160;million; the opposite entry was recognized in </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">, with the impact on financial income and expense being immaterial. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward purchases with a notional amount of $<ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32668">1,000</ix:nonFraction>&#160;million expiring in 2025, designated as a fair value hedge of the exposure of $<ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32669">1,000</ix:nonFraction>&#160;million of bond issues to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of these contracts represented a liability of &#8364;<ix:nonFraction name="ifrs-full:DerivativeFinancialLiabilities" contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32670">25</ix:nonFraction>&#160;million, with &#8364;<ix:nonFraction name="ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax" contextRef="P01_01_2025To06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32671">0</ix:nonFraction>&#160;million credited to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;"> to recognize the hedging cost. </div></div></div></td></tr></table> </ix:continuation> <div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">To optimize the cost of debt or reduce the volatility of debt, Sanofi uses derivative instruments (interest rate swaps and cross currency swaps) to alter the fixed/floating rate split of its net debt. </div> <ix:nonNumeric name="sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-22946"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows instruments of this type in place as of June&#160;30, 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:36%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="8" style="height:3pt"/>
<td colspan="12" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>designated&#160;as&#160;fair<br/>value&#160;hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which designated<br/>as&#160;cash&#160;flow hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2026</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2027</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2028</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2029<br/>and<br/>beyond</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>recognized<br/>in equity</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Interest rate swaps</div></div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized SOFR USD / receive 1.17%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32672">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32673">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32674">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32675">848</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32676">848</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32677">54</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32678">848</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"></div><div style="display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32679">54</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32680">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay 2.08% / receive Euribor 3m</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32681">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32682">850</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32683">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32684">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32685">850</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32686">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32687">850</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32688">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32689">3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized Ester / receive 0.92%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32690">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32691">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32692">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32693">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32694">650</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32695">650</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32696">27</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32697">650</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32698">27</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32699">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32700">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32701">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32702">&#8212;</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32703">&#8212;</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32704">850</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32705">848</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32706">650</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32707">2,348</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32708">88</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32709">1,498</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32710">81</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32711">850</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32712">7</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(<ix:nonFraction name="sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32713">3</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td></tr></table> </ix:nonNumeric></ix:continuation><ix:nonNumeric name="sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-23679"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.11. Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests </div></div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For a description of the nature of the liabilities reported in the line item <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests</div></div></div>, refer to Note B.8.4. to the consolidated financial statements for the year ended December&#160;31, 2024. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests shown in the table below are level&#160;3 instruments under the IFRS 13 and IFRS 7 fair value hierarchy (see Note A.5.). </div> <ix:nonNumeric name="sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-23692"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests in the first half of 2025 are shown below: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">MSD&#160;contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Shire&#160;contingent<br/>consideration<br/>arising from<br/>acquisition&#160;of<br/>Translate&#160;Bio</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn12_31_2024_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32714">72</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32715">568</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn12_31_2024_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32716">1</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327667">641</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Payments made</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32718">72</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32719">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32720">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327663">72</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327662">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327661">71</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327660">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327659">72</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32726">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32727">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32728">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327655">77</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32730">&#8212;</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32731">563</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32732">1</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327651">564</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Of which:</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Current portion</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:middle;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327650">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> portion</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327649">564</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of January&#160;1, 2025, this comprised a <div style="white-space:nowrap;display:inline;">non-current</div> portion of &#8364;<ix:nonFraction name="sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn01_01_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32736">569</ix:nonFraction>&#160;million and a current portion of &#8364;<ix:nonFraction name="sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" contextRef="PAsOn01_01_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32737">72</ix:nonFraction>&#160;million. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Amounts mainly reported within the income statement line item &#8220;Fair value remeasurement of contingent consideration&#8221;. </div></div></div></td></tr></table> </ix:nonNumeric> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests</div></div></div> mainly comprised the contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi&#8217;s acquisition of Translate Bio in September 2021. The fair value of the Shire liability is determined by applying the contractual terms to development and sales projections that are weighted to reflect the probability of success, and discounted. The liability was measured at <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32738">563</ix:nonFraction>&#160;million as of June&#160;30, 2025, compared with <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination" contextRef="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32739">568</ix:nonFraction>&#160;million as of December&#160;31, 2024. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately <ix:nonFraction name="sny:PercentageIncreaseInFairValueLiabilities" contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-32740">10</ix:nonFraction>%. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture was extinguished during 2024 in accordance with the contractual terms. Sanofi has no further liability in respect of this contingent consideration following settlement of the milestone linked to 2024 sales. </div> </ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">24&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div></div>HALF-YEAR FINANCIAL REPORT<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div><div style="font-family: Arial; color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;">2025</div><div style="font-family: Arial; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="background: none; text-decoration: none;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div></div></div> </div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/> <div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bolder;display:inline;"><a href="#toc">Table of Contents</a></div></div> <div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div></div> </div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div> <div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <ix:nonNumeric name="sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-24141"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.12. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> provisions and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities </div></div></div></div> <ix:nonNumeric name="sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-24148"> <div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The line item <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> provisions and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities</div></div></div> comprises the following: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Provisions</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32741">5,003</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32742">5,762</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327633">2,113</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327632">2,334</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; background-color: rgb(120, 2, 230); width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;Total</div></div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32745">7,116</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32746">8,096</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes &#8364;<ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32747">1,756</ix:nonFraction>&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#8364;<ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32748">1,027</ix:nonFraction>&#160;million; the nominal value of payments estimated to be due after more than five years is &#8364;<ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32749">2,293</ix:nonFraction>&#160;million. </div></div></div></td></tr></table> </ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfNonCurrentProvisionsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-24267"> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows movements in provisions: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/>pensions&#160;&amp;&#160;other<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">post-employment</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">other&#160;long-term</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Restructuring<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32750">1,992</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32751">821</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32752">799</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32753">2,150</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32754">5,762</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Increases in provisions and other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:ChangesInOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327489">69</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:ChangesInOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32756">78</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:ChangesInOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32757">175</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:ChangesInOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32758">293</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:ChangesInOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32759">615</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Provisions utilized</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327494">167</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32761">61</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32762">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32763">378</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ProvisionUsedOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32764">616</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Reversals of unutilized provisions</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327925">17</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32766">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32767">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32768">178</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32769">197</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327930">4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327929">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327928">158</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327927">93</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327926">255</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Net interest related to employee benefits, and unwinding of discount</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32775">37</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32776">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32777">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32778">20</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32779">60</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32780">94</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32781">74</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32782">4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32783">83</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32784">255</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains and losses on defined-benefit plans&#160;(B.12.1.)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32785">111</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32786">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32787">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32788">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32789">111</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32790">1,705</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32791">765</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32792">802</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32793">1,731</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><ix:nonFraction name="ifrs-full:NoncurrentProvisions" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32794">5,003</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Mainly transfers to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Current provisions and other current liabilities</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">. </div></div></div></td></tr></table> </ix:nonNumeric> <div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Provisions for pensions and other post-employment benefits </div> <div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For an analysis of the sensitivity of obligations in respect of pensions and other employee benefits as of December&#160;31, 2024, and of the assumptions used as of that date, see Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The principal assumptions used (in particular, discount and inflation rates) and the market value of plan assets for the eurozone, the United States and the United Kingdom were reviewed as of June&#160;30, 2025 to take into account changes during the first half of the year. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025, Sanofi completed a further <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">buy-in</div> (amounting to <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:LiabilityAssetOfDefinedBenefitPlans" contextRef="PAsOn06_30_2025_GBifrsfullGeographicalAreasAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32795">101</ix:nonFraction>&#160;million) to cover the remaining uninsured liabilities arising under the main defined benefit pension scheme in the United Kingdom. Consequently, all scheme members are now fully insured as a result of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">buy-in</div> transactions, except for liabilities rising from guaranteed minimum pension equalization (as described in Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024). </div> <ix:nonNumeric name="sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-24849"> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actuarial gains and losses arising on pensions and other post-employment benefits and recognized in equity are as follows (amounts reported before tax): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2024<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on plan assets</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327911">45</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<ix:nonFraction name="ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327910">138</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on benefit obligations</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327909">152</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><ix:nonFraction name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327908">373</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(b)</div>&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between <ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" contextRef="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32800">0.00</ix:nonFraction>% and +<ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" contextRef="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32801">0.30</ix:nonFraction>%) and (ii)&#160;the <div style="white-space:nowrap;display:inline;">-<ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" contextRef="PAsOn06_30_2025_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_UKZONEMemberifrsfullGeographicalAreasAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32802">0.30</ix:nonFraction>%</div> change in the inflation rate in the United Kingdom in the first half of 2025. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between +<ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" contextRef="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32803">0.40</ix:nonFraction>% and +<ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" contextRef="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32804">0.65</ix:nonFraction>%) and (ii)&#160;the +<ix:nonFraction name="ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" contextRef="PAsOn06_30_2024_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_EUROZONEMemberifrsfullGeographicalAreasAxis" unitRef="Unit_pure" decimals="4" scale="-2" format="ixt:num-dot-decimal" id="ixv-32805">0.10</ix:nonFraction>% change in the inflation rate in the United Kingdom in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes actuarial gains/ (losses) related to Opella of &#8364;(<ix:nonFraction name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32806">4</ix:nonFraction>)&#160;million for the first half of 2025 and &#8364;(<ix:nonFraction name="ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" contextRef="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32807">6</ix:nonFraction>)&#160;million for the first half of 2024 . </div></div></div></td></tr></table> </ix:nonNumeric></ix:nonNumeric> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div> <div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;">SANOFI&#8194;&#8195;&#160;</div></div>HALF-YEAR FINANCIAL REPORT<div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div><div style="font-family: Arial; color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;">2025</div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8195;&#8195;25 </div></div></div></div> </div></div> </div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size: 10pt; margin-top: 1.67em; margin-bottom: 1.67em;font-weight: bold;"><div style="font-weight:bolder;display:inline;"><a href="#toc">Table of Contents</a></div></div></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25008"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.13. Off balance sheet commitments </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Off balance sheet commitments to third parties as of December&#160;31, 2024 are presented in Note D.21.1. to the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The principal commitments entered into, amended or discontinued during the period are described below: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>In April 2025, Sanofi entered into a license and collaboration agreement with Earendil Labs for two bispecific antibodies in the field of autoimmune and inflammatory bowel diseases: <div style="white-space:nowrap;display:inline;">HXN-1002</div> (targeting <div style="font-family:Times New Roman;display:inline;"><div style="FONT-FAMILY:SYMBOL;display:inline;">a</div></div>4&#223;7 and TL1A for potential treatment of moderate to severe ulcerative colitis and Crohn&#8217;s disease) and <div style="white-space:nowrap;display:inline;">HXN-1003</div> (targeting TL1A and IL23 for potential treatment of colitis and skin inflammation). Under the terms of the agreement, Earendil Labs received an upfront payment of $<ix:nonFraction name="ifrs-full:Prepayments" contextRef="PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32808">125</ix:nonFraction>&#160;million, is eligible to receive up to a total of $<ix:nonFraction name="ifrs-full:CommitmentsMadeByEntityRelatedPartyTransactions" contextRef="P04_01_2025To04_30_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-8" scale="9" format="ixt:num-dot-decimal" id="ixv-32809">1.7</ix:nonFraction>&#160;billion in development and commercial milestone payments, and is eligible to receive tiered royalties on product sales. </div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi has not entered into any material new long-term renewable energy contract agreements as part of its sustainability strategy. The main existing agreements are presented in Note D.21.1. to the consolidated financial statements in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F.</div> </div></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfLegalAndArbitralProceedingsTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327115" id="ixv-25028"><div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.14. Litigation and arbitration proceedings </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The matters discussed below constitute the most significant developments since publication of the financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.1. Products </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Zantac product litigation in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As regards the ongoing Zantac product litigation in the US, the Separation Agreement (see Notes D.1 and D.22 to the consolidated financial statements in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F)</div> entered into between Sanofi and Opella specifies that Sanofi will indemnify the Opella group in respect of liabilities relating to (i)&#160;the commercialization of any Zantac branded products (i.e. products containing ranitidine as their active pharmaceutical ingredient) prior to closing, and (ii)&#160;all personal injury claims resulting from the manufacturing or handling of Zantac prior to closing. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In April 2025, Sanofi reached several settlement deals that in total resolve a majority of the Delaware State Court consolidated litigation. In addition, in May 2025, Sanofi reached settlements with the City of Baltimore and the New Mexico Attorney General, amicably resolving both those matters. Other cases are pending in various state courts. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;10, 2025, the Delaware Supreme Court unanimously reversed the Superior Court&#8217;s denial of Defendants&#8217; <div style="font-style:italic;display:inline;">Daubert </div>motion based on the lack of reliability of plaintiff&#8217;s experts on causation and remanded its findings back to the Superior Court for proceedings consistent with the rulings in the opinion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Talc product litigation in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi was named as a defendant in approximately <ix:nonFraction name="sny:NumberOfClassActionLawsuits" contextRef="PAsOn06_30_2025_ActionForWhichWeAreDefendantMemberSNYDefendantAxis_GoldBondProductLitigationInTheUSMemberSNYLegalAndArbitralProceedingsAxis_ProductLiabilitiesMemberifrsfullClassesOfContingentLiabilitiesAxis" unitRef="Unit_Proceeding" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-32810">900</ix:nonFraction> ongoing product liability actions. To date, no cases have proceeded to trial. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.2. Patents </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Praluent (alirocumab)-related Amgen patent litigation in Europe </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Regarding Amgen&#8217;s EP 3 666 797, in April 2025, the Opposition Division of the European Patent Office ruled in Amgen&#8217;s favor and decided to maintain the patent as granted. Sanofi has appealed this decision to the Technical Board of Appeals of the European Patent Office, and the appeal hearing is scheduled for April 2026. <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div> </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel) Litigation (Commonwealth) Litigation in Australia </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">This matter has been finalized with no possibility of appeal. The matter is closed. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.3. Other litigation </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel) - Attorney General action in Hawaii </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In May 2025, the parties agreed to settle the Hawaii action, with Sanofi US to pay $<ix:nonFraction name="sny:PaymentOfDamagesClaimedByCounterparty" contextRef="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32811">350</ix:nonFraction>&#160;million pursuant to its settlement agreement and Bristol-Myers Squibb to pay $<ix:nonFraction name="sny:PenaltyFeeIncurred" contextRef="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32812">350</ix:nonFraction>&#160;million pursuant to its separate settlement agreement. The appeal and the underlying case were dismissed pursuant to the settlement. This matter is closed. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">26&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_148327115" continuedAt="TextSelectionAppend_148327115_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327115_1" continuedAt="TextSelectionAppend_148327115_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327115_2" continuedAt="TextSelectionAppend_148327115_3"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327115_3" continuedAt="TextSelectionAppend_148327115_4"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327115_4"><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"><ix:exclude>&#160;</ix:exclude></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel)-related litigation in France </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In the claim filed by the <div style="font-style:italic;display:inline;">Caisse Nationale d&#8217;Assurance Maladie</div> <div style="font-style:italic;display:inline;">&#8211; CNAM</div> (French Social Security), hearings were held in June 2025. </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">340B drug pricing program in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In the action filed by Sanofi against the Department of Health and Human Services (HHS), the Health Resources and Services Administration (HRSA) and their respective administrators, following a joint hearing held on April&#160;29, 2025 in Sanofi&#8217;s case and the similar cases filed by Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos, the district court held on May&#160;15, 2025 that, although Section&#160;340B does not categorically prohibit the use of manufacturer rebates, it does not allow HRSA to require preapproval of a manufacturer rebate program. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The district court also held that HRSA&#8217;s letter determining that Sanofi would violate Section&#160;340B if it launched its Credit (rebate) Model was arbitrary and capricious and remanded the Sanofi matter back to HRSA for further consideration. Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos appealed the district court&#8217;s decision to the Circuit Court. Those appeals, along with a similar appeal by Johnson&#160;&amp; Johnson, have been expedited and consolidated. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"><div style="text-decoration:underline;display:inline;">ADR Proceedings in the US</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In June 2025, Sanofi received notice that Hudson Headwaters Health Network (Hudson Headwaters) had filed a petition for monetary relief against Sanofi before the HRSA ADR (Administrative Dispute Resolution) Panel. Hudson Headwaters alleges that Sanofi has violated Section&#160;340B by allowing only one contract pharmacy to be selected and utilized per covered entity, if the covered entity does not have an <div style="white-space:nowrap;display:inline;">in-house</div> pharmacy capable of dispensing its drug. Hudson Headwaters alleges that this Sanofi policy is an &#8220;overcharge&#8221; under Section&#160;340B. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"><div style="text-decoration:underline;display:inline;">State Litigation in the US</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In lawsuits filed by PhRMA and certain other manufacturers challenging a contract pharmacy law passed by the State of Mississippi, the court denied for each of the plaintiffs their preliminary injunctions in their respective lawsuits. The plaintiffs appealed the denials of the preliminary injunction motions. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Various other challenges to similar state laws have been filed by PhRMA and/or certain manufacturers in a number of other states, including in Colorado, Kansas, Louisiana, Maryland, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, Tennessee, Utah, South Dakota, and Vermont. </div></ix:continuation><ix:nonNumeric name="ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25113"><div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.15. Other operating income and expenses </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating income</div></div> amounted to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32814">533</ix:nonFraction>&#160;million in the first half of 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327520">563</ix:nonFraction>&#160;million in the first half of 2024), and <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating expenses</div></div> to <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32816">2,476</ix:nonFraction>&#160;million (<div style="font-style:italic;display:inline;">versus</div> <div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327518">1,977</ix:nonFraction>&#160;million in the first half of 2024). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The main items included in <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating income</div></div> were: in the first half of 2025, (i) income from pharmaceutical partners of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32818">87</ix:nonFraction>&#160;million (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32819">121</ix:nonFraction>&#160;million in the first half of 2024), of which <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32820">70</ix:nonFraction>&#160;million came from Regeneron (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32821">96</ix:nonFraction>&#160;million in the first half of 2024, see table below) and (ii)&#160;gains on disposals of assets and operations of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:GainsOnDivestmentOfProducts" contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32822">344</ix:nonFraction>&#160;million, primarily on divestments of non strategic products (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:GainsOnDivestmentOfProducts" contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32823">319</ix:nonFraction>&#160;million in the first half of 2024). </div><ix:nonNumeric name="sny:OtherOperatingExpensesTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25138"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating expenses</div></div> for the first half of 2025 included <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32824">2,331</ix:nonFraction>&#160;million of expenses related to Regeneron (compared with <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32825">1,841</ix:nonFraction>&#160;million in the first half of 2024), as shown in the table below. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Income&#160;&amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32826">2,475</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32827">1,934</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Additional share of profit paid by Regeneron towards development costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32828">494</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32829">389</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Reimbursement to Regeneron of selling expenses incurred</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32830">346</ix:nonFraction>)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32831">292</ix:nonFraction>)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total: Monoclonal Antibody Alliance</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32832">2,327</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingExpense" contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32833">1,837</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other (mainly Zaltrap and Libtayo)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2025To06_30_2025_OthersCounterpartyMembersrtCounterpartyNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32834">66</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2024To06_30_2024_OthersCounterpartyMembersrtCounterpartyNameAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32835">92</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Other operating income/(expenses), net related to Regeneron</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32836">2,261</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:OtherOperatingIncomeExpense" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32837">1,745</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.75em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which amount presented in &#8220;Other operating income&#8221;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32838">70</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:MiscellaneousOtherOperatingIncome" contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32839">96</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;27 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="sny:DisclosureOfRestructuringTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25381"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.16. Restructuring costs and similar items </div></div></div><ix:nonNumeric name="sny:DisclosureOfRestructuringCostsDetailsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25385"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Restructuring costs and similar items </div></div>comprise the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Employee-related expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32840">201</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328215">810</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Charges, gains or losses on assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328216">109</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328217">27</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Costs of transformation programs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32844">80</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328219">114</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other restructuring costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherRestructuringCosts" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32846">40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherRestructuringCosts" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328221">163</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32848">430</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328223">1,060</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Restructuring and similar costs decreased by <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32850"><ix:nonFraction name="sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32851">630</ix:nonFraction></ix:nonFraction>&#160;million between June&#160;30, 2024 and June&#160;30, 2025. In the first half of 2024, restructuring and similar costs mainly comprised the impacts of (i)&#160;the renewal of the Job Management and Career Paths (GEPP) program in France to cover the 2024-2026 period, including scope extensions in the job profiles affected by transformations and (ii)&#160;a voluntary redundancy <div style="display:inline;">program</div> <div style="display:inline;">announced</div> in 2024 in connection with the reorganization of R&amp;D operations to make Sanofi a leader in <div style="display:inline;">immunology</div>. </div></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25563"><div style="margin-top:20pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.17. Other gains and losses, and litigation </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For the first half of 2025, <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div> is a charge of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32852">57</ix:nonFraction>&#160;million, mainly related to major litigation. That compares with a charge of <div style="font-family:Times New Roman;display:inline;">&#8364;</div><ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32853">450</ix:nonFraction>&#160;million in the first half of 2024, mainly comprising a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US state of Hawaii. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></ix:nonNumeric><ix:nonNumeric name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25574"><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.18. Financial expenses and income </div></div></div><ix:nonNumeric name="sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25578"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">An analysis of financial expenses and income is set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestExpenseOnBorrowings" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328226">219</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestExpenseOnBorrowings" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328227">306</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Interest income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:InterestIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328228">162</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:InterestIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328229">239</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Cost of net debt</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:CostOfDebtNet" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32858">57</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="sny:CostOfDebtNet" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32859">67</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">Non-operating</div> foreign exchange gains/(losses)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonOperatingForeignExchangeGainsLosses" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32860">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonOperatingForeignExchangeGainsLosses" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32861">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Unwinding of discounting of provisions <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328234">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328235">19</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest cost related to employee benefits</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:NetInterestCostRelatedToEmployeeBenefits" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32864">37</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:NetInterestCostRelatedToEmployeeBenefits" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32865">39</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest expense on lease liabilities</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32866">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32867">20</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:OtherFinanceIncomeCost" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328240">40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:OtherFinanceIncomeCost" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328241">161</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Net financial income/(expenses)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32870">177</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32871">306</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">comprising: Financial expenses</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32872">361</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32873">583</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8196;Financial income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32874">184</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32875">277</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#8364;(<ix:nonFraction name="sny:GainLossOnDerivativesUsedToManageDebt" contextRef="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32876">25</ix:nonFraction>)&#160;million in the first half of 2025 and &#8364;(<ix:nonFraction name="sny:GainLossOnDerivativesUsedToManageDebt" contextRef="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32877">24</ix:nonFraction>)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;(<ix:nonFraction name="sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents" contextRef="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32878">4</ix:nonFraction>)&#160;million in the first half of 2025 and &#8364;(<ix:nonFraction name="sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents" contextRef="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32879">18</ix:nonFraction>)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes a financial expense of &#8364;<ix:nonFraction name="sny:LiabilityRecognisedForEstimatedFutureRoyalties" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32880">50</ix:nonFraction>&#160;million for the six months ended June&#160;30, 2025 and &#8364;<ix:nonFraction name="sny:LiabilityRecognisedForEstimatedFutureRoyalties" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32881">176</ix:nonFraction>&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of the ineffective portion of hedging relationships was not material in either 2025 or 2024. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">28&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfIncomeTaxExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25941"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.19. Income tax expense </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States. </div><ix:nonNumeric name="sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-25946"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the allocation of income tax expense between current and deferred taxes: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:69%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Current taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32882">1,202</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328187">1,108</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Deferred taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8199;&#8194;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;<ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-32884">491</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;<ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148328189">729</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32886">711</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328191">379</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32888">3,582</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328193">2,462</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-26093"><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The difference between the effective tax rate (on income before tax and investments accounted for using the equity method) and the standard corporate income tax rate applicable in France is explained as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:7%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(as a percentage)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Standard tax rate applicable in France</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328194">25.8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328195">25.8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Difference between the standard French tax rate and the rates applicable to Sanofi<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:TaxRateEffectOfForeignTaxRates" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_pure" decimals="3" scale="-2" sign="-" format="ixt:num-dot-decimal" id="Fact_148328196">7.3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:TaxRateEffectOfForeignTaxRates" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_pure" decimals="3" scale="-2" sign="-" format="ixt:num-dot-decimal" id="Fact_148328197">15.5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Revisions to tax exposures and settlements of tax disputes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328198">2.3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328199">2.3</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_pure" decimals="3" scale="-2" sign="-" format="ixt:num-dot-decimal" id="Fact_148328200">1.0</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328201">2.8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Effective tax rate</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AverageEffectiveTaxRate" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328202">19.8</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:AverageEffectiveTaxRate" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_pure" decimals="3" scale="-2" format="ixt:num-dot-decimal" id="Fact_148328203">15.4</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">&#8194;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The 2024 component of the temporary exceptional corporate income tax contribution, introduced under the 2025 French Finance Bill, is included in the tax charge but excluded from the calculation of the annual average effective tax rate in accordance with IAS 34. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#8364;<ix:nonFraction name="sny:CurrentTaxExpenseRelatedToPillarTwo" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32900">17</ix:nonFraction>&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#8217;s current understanding of Pillar Two rules, and &#8364;<ix:nonFraction name="sny:CurrentTaxExpenseRelatedToPillarTwo" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32901">52</ix:nonFraction>&#160;million for the six months ended June&#160;30, 2024. </div></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;29 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfRevenueExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-26301"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.20. Revenue from contracts with customers </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.20.1. Analysis of net sales </div><ix:nonNumeric name="ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-26306"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below sets forth net sales for the six months ended June&#160;30, 2025 and June&#160;30, 2024: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:8%"/>
<td style="vertical-align:bottom"/>
<td style="width:33%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:1%"/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United<br/>States</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">States</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2024 <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/>
<td colspan="4" style="height:3pt;background-color:#23004c"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#23004c"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total Group</div></div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32902">4,144</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32903">9,535</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32904">6,210</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32905">19,889</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32906">4,072</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32907">8,292</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32908">5,996</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328117">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Immunology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Dupixent</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32910">944</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32911">5,283</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32912">1,085</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32913">7,312</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32914">770</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32915">4,437</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32916">931</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328121">6,138</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Rare diseases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">ALTUVIIIO</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32918">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32919">456</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32920">86</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32921">542</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32922">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32923">259</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32924">21</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328125">280</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Nexviazyme/Nexviadyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32926">132</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32927">195</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32928">60</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32929">387</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32930">95</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32931">174</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32932">51</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328129">320</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Cablivi</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32934">55</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32935">71</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32936">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32937">136</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32938">43</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32939">60</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32940">10</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328133">113</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Xenpozyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32942">44</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32943">47</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32944">19</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32945">110</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32946">24</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32947">37</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32948">11</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328137">72</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Neurology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Aubagio</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32950">40</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32951">76</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32952">22</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32953">138</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32954">95</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32955">96</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32956">18</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328141">209</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Oncology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Sarclisa</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32958">83</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32959">119</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32960">74</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32961">276</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32962">64</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32963">100</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32964">63</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328145">227</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other medicines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Rezurock</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32966">23</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32967">220</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32968">20</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32969">263</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32970">12</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32971">188</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32972">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328149">207</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Tzield</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32974">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32975">27</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32976">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32977">29</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32978">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32979">20</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32980">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328153">21</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Industrial sales</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32982">241</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32983">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32984">9</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32985">251</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32986">273</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32987">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-32988">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328157">274</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Vaccines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial">Polio/Pertussis/</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial">Hib Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32990">223</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32991">320</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32992">818</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32993">1,361</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32994">248</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32995">311</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32996">789</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328161">1,348</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:middle"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Meningitis, travel and endemics vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32998">96</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-32999">319</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33000">194</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33001">609</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33002">97</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33003">301</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33004">185</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328165">583</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">RSV vaccine (Beyfortus)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33006">85</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33007">68</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33008">203</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33009">356</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33010">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33011">116</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33012">77</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328169">200</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="2" style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Influenza Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33014">52</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33015">54</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33016">108</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33017">214</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33018">30</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33019">16</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33020">142</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328173">188</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total net sales</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33022">4,144</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33023">9,535</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33024">6,210</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33025">19,889</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33026">4,072</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33027">8,292</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_OtherCountriesMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33028">5,996</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328177">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.20.2. Other revenues </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><ix:nonNumeric name="sny:DisclosureOfOtherRevenueTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-28055">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;VaxServe sales of <div style="white-space:nowrap;display:inline;">non-Sanofi</div> products</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevenueFromVaxServeSalesOfNonSanofiProducts" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33030">842</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevenueFromVaxServeSalesOfNonSanofiProducts" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328037">854</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales to Opella <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328038">61</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328039">95</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Royalties</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromRoyalties" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33034">68</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromRoyalties" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328041">62</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:MiscellaneousOtherRevenue" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328042">275</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:MiscellaneousOtherRevenue" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328043">341</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Biopharma Other revenues</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33038">1,246</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328045">1,352</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales / Revenues from Opella products<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328046">206</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328047">177</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Other revenues</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33042">1,452</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148328049">1,529</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </div></div></td></tr></table></ix:nonNumeric></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">30&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div></div><div></div></div><div><div style="line-height:normal;display: inline;"><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327322" id="ixv-28307"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.21. Segment information </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The segment information presented by Sanofi consists of a single operating segment: Biopharma. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Specialty Care, General Medicines and Vaccines franchises plus support and corporate functions, for all geographical territories. It also includes revenues generated from the manufacture of Consumer Healthcare products invoiced to Opella, which constitutes a related party with effect from the deconsolidation date (April 30, 2025). Those revenues, which before that date represented intragroup transactions classified within continuing operations, are presented within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other Revenues</div></div> in the income statement. The Biopharma operating segment also includes the purchase price of Biopharma products manufactured by Opella. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The &#8220;Other&#8221; category comprises primarily, but not exclusively, Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.1. Segment results </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Sanofi reports segment results on the basis of &#8220;Business operating income&#8221;. This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of the operating segment and to allocate resources. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Business operating income&#8221; is derived from <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Operating income</div></div>, adjusted as follows: </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature), are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>fair value remeasurements of contingent consideration relating to business combinations (IFRS 3) or business divestments, and presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Fair value remeasurement of contingent consideration</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>expenses arising from the remeasurement of inventories following business combinations (IFRS 3) or acquisitions of groups of assets that do not constitute a business within the meaning of paragraph 2b of IFRS 3, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>amounts reported within the line items <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Restructuring costs and similar items </div></div>are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>other gains and losses (including gains and losses on major divestments), presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>other costs and provisions related to litigation, presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to joint ventures and associates with which Sanofi has a strategic alliance; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>the portion attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests related to continuing operations and excluding the effects of the above reconciliation items, is deducted. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><ix:exclude><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;31 </div></div></ix:exclude></div></ix:nonNumeric></div></div><ix:continuation id="TextSelection_148327322" continuedAt="TextSelectionAppend_148327322_1"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_1" continuedAt="TextSelectionAppend_148327322_2"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_2" continuedAt="TextSelectionAppend_148327322_3"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327322_3" continuedAt="TextSelectionAppend_148327322_4"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_4" continuedAt="TextSelectionAppend_148327322_5"><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-28425"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Segment results are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:2%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="36" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="34" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025 (6 months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33044">19,889</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33045">19,889</ix:nonFraction></div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33046">1,246</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-7.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-6.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33047">206</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+15.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33048">1,452</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-5.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-3.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33049">5,753</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-0.1</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33050">128</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+14.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33051">5,881</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+0.2</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33052">3,716</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33053">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33054">3,717</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33055">4,447</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33056">59</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33057">4,506</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33058">1,941</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33059">2</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33060">1,943</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33061">77</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33062">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33063">77</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33064">8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33065">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33066">8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/>
<td style="vertical-align:bottom;background-color:#e7e7e8"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33067">5,347</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+11.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33068">16</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33069">5,363</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+10.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;As % of net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">26.9</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;&#8199;27.0%</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:75%"/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:4%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2024 (6 months) (a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Other</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Total</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327680">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327681">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327682">1,352</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327683">177</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327684">1,529</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327685">5,849</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327686">110</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327687">5,959</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327688">3,334</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327689">1</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ResearchAndDevelopmentExpense" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327690">3,335</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327691">4,247</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327692">56</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:SellingGeneralAndAdministrativeExpense" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327693">4,303</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327694">1,426</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327695">12</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:MiscellaneousOtherOperatingIncomeExpenses" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327696">1,414</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327697">66</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327698">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327699">66</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327700">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327701">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327702">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327703">4,916</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327704">22</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327705">4,938</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table></ix:nonNumeric><ix:nonNumeric name="sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-29815"><div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below, presented in compliance with IFRS 8, shows a reconciliation between &#8220;Business operating income&#8221; and <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Income before tax and investments accounted for using the equity method</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2025To06_30_2025_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33096">5,363</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:BusinessOperatingIncome" contextRef="P01_01_2024To06_30_2024_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327707">4,938</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327708">77</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327709">66</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327710">8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327711">6</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Amortization and impairment of intangible assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327712">987</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327713">527</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Fair value remeasurement of contingent consideration</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33104">61</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327715">66</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Expense arising from the impact of acquisitions on inventories<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="Fact_148327716">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327717">7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Restructuring costs and similar items<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(f)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327718">430</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:ExpenseOfRestructuringActivities" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327719">1,060</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other gains and losses, and litigation<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(g)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327720">57</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:OtherGainsLossesAndLitigation" contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327721">450</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33112">3,759</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327723">2,768</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33114">361</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327725">583</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial income</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33116">184</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327727">277</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33118">3,582</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327729">2,462</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint ventures and associates with which Sanofi has entered into a strategic alliance. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#8364;<ix:nonFraction name="sny:ImpairmentLossOnIntangibleAssetOtherThanGoodwill" contextRef="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33120">210</ix:nonFraction>&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#8364;<ix:nonFraction name="ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="ixv-33121">371</ix:nonFraction>&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(f)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.16. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(g)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.17. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><ix:exclude><div style="font-weight:bold;display:inline;">32&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div></ix:exclude><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></ix:continuation></div></div></div><ix:continuation id="TextSelectionAppend_148327322_5" continuedAt="TextSelectionAppend_148327322_6"><div></div></ix:continuation></div><div><div style="line-height:normal;display: inline;"><ix:continuation id="TextSelectionAppend_148327322_6" continuedAt="TextSelectionAppend_148327322_7"><ix:exclude><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_7" continuedAt="TextSelectionAppend_148327322_8"><ix:exclude><hr style="color:#999999;height:3px;width:100%;clear:both"/></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_8" continuedAt="TextSelectionAppend_148327322_9"><ix:exclude><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></ix:exclude></ix:continuation><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><ix:continuation id="TextSelectionAppend_148327322_9" continuedAt="TextSelectionAppend_148327322_10"><ix:exclude><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div></ix:exclude></ix:continuation><ix:continuation id="TextSelectionAppend_148327322_10"><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.2. Other segment information </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The tables below show the split by operating segment of (i)&#160;the carrying amount of investments in joint ventures and associates accounted for using the equity method with which Sanofi has entered into a collaboration agreement; (ii)&#160;acquisitions of property, plant and equipment; and (iii)&#160;acquisitions of intangible assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Investments accounted for using the equity method mainly comprise MSP Vaccine Company and Infraserv GmbH&#160;&amp; Co. H&#246;chst&#160;KG (see Note B.5.). </div><ix:nonNumeric name="sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-30224"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:8%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="8" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Investments accounted for using the equity method <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327730">483</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:InvestmentAccountedForUsingEquityMethod" contextRef="PAsOn06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327731">229</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of property, plant and equipment</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33124">845</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33125">882</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of other intangible assets</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33126">575</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33127">922</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Carrying amount at the end of the reporting period. </div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.3. Information by geographical region </div><ix:nonNumeric name="ifrs-full:DisclosureOfGeographicalAreasExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-30339"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The geographical information on net sales provided below is based on the geographical location of the customer. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="8" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33128">4,144</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327737">4,072</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33130">835</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327739">855</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33132">9,535</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327741">8,292</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33134">6,210</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327743">5,996</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33136">1,388</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327745">1,406</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33138">19,889</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:RevenueFromSaleOfGoods" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327747">18,360</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 8, the <div style="white-space:nowrap;display:inline;">non-current</div> assets reported below exclude financial instruments, deferred tax assets, <div style="white-space:nowrap;display:inline;">pre-funded</div> pension obligations, and <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">right-of-use</div></div> assets as determined under IFRS 16. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:47%"/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:3%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="12" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33140">5,438</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33141">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33142">3,167</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33143">5,550</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33144">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33145">3,307</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33146">2,953</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33147">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33148">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33149">3,112</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33150">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33151">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33152">2,080</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33153">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33154">16,725</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33155">2,411</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33156">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33157">18,711</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33158">2,056</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33159">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33160">539</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33161">2,130</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33162">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33163">611</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33164">83</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33165">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33166">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33167">96</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33168">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33169">&#8212;</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#7802e6"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33170">9,574</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33171">40,283</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33172">20,431</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33173">10,091</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33174">43,384</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33175">22,629</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table></ix:nonNumeric><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As stated in Note D.5. to the consolidated financial statements for the year ended December&#160;31, 2024, goodwill is not allocated by geographical region. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.4. Disclosures about major customers </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33176">35</ix:nonFraction>% of net sales in the first half of 2025. Sanofi&#8217;s three largest customers respectively accounted for approximately <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2025To06_30_2025_CustomerOneMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33177">18</ix:nonFraction>%, <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2025To06_30_2025_CustomerTwoMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33178">12</ix:nonFraction>% and <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2025To06_30_2025_CustomerThreeMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33179">5</ix:nonFraction>% of consolidated net sales in the first half of 2025 (versus approximately <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2024To06_30_2024_CustomerOneMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33180">13</ix:nonFraction>%, <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2024To06_30_2024_CustomerTwoMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33181">9</ix:nonFraction>% and <ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="P01_01_2024To06_30_2024_CustomerThreeMemberifrsfullMajorCustomersAxis" unitRef="Unit_pure" decimals="2" scale="-2" format="ixt:num-dot-decimal" id="ixv-33182">7</ix:nonFraction>% in the first half of 2024). </div></ix:continuation><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="font-weight:bold;display:inline;">SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;33 </div></div></div></div></div><div style="margin-top:1em; margin-bottom:0em; page-break-before:always"></div><hr style="color:#999999;height:3px;width:100%;clear:both"/><div style="font-size:10pt;font-weight:bold; margin-top: 1.67em; margin-bottom: 1.67em;"><a href="#toc">Table of Contents</a></div></div></div> <div><div style="line-height:normal;display: inline;"><div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Exhibit 99.1</div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">1. Condensed half-year consolidated financial statements </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&#160;</div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><ix:nonNumeric name="ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-31026"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.22. Information related to Opella, presented within assets held for sale and discontinued operations </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30 2025, the Opella transaction was closed (see Note B.1.) triggering loss of control, and resulting in the derecognition of all assets and liabilities of Opella subsidiaries. <ix:nonNumeric name="sny:DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" contextRef="P01_01_2025To06_30_2025" escape="true" continuedAt="TextSelection_148327581" id="ixv-33183">As of December&#160;31, 2024, all Opella assets and associated liabilities were classified as held for sale, in accordance with IFRS 5. </ix:nonNumeric></div><ix:continuation id="TextSelection_148327581"><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:86%"/>
<td style="vertical-align:bottom;width:9%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#ffffff"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Assets</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/>
<td style="vertical-align:bottom;background-color:#ffffff"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Property, plant and equipment owned</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33184">760</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Right-of-use</div></div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33185">116</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Goodwill</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:GoodwillDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33186">7,255</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33187">2,928</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:InventoriesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33188">600</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33189">989</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherAssetsDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33190">841</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#661de8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:AssetsOfDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33191">13,489</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Liabilities</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/>
<td style="vertical-align:bottom"/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33192">112</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> provisions and other <div style="white-space:nowrap;display:inline;">non-current</div> liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33193">204</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:AccountsPayableDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33194">797</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Current provisions and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33195">570</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33196">448</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"/>
<td colspan="4" style="height:3pt;background-color:#661de8"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities related to assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" contextRef="PAsOn12_31_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33197">2,131</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 5, the Opella held for sale asset group, and the related liabilities, were measured at the lower of carrying amount and fair value less costs to sell. This valuation did not result in the recognition of any impairment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the main items presented within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:6%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net sales and other revenues <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327602">1,736</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327603">2,645</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Operating income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327604">266</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="Fact_148327605">277</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33202">2,781</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:fixed-zero" id="ixv-33203">&#8212;</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:Arial">Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33204">3,039</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33205">278</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Income tax expense <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327610">158</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(<ix:nonFraction name="sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" sign="-" format="ixt:num-dot-decimal" id="Fact_148327611">85</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33208">2,881</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33209">202</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In 2025, this line includes an expense of &#8364;<ix:nonFraction name="sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33210">88</ix:nonFraction>&#160;million related to the tax impact on the gain arising on the loss of control of Opella. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below presents basic and diluted earnings per share from discontinued operations (Opella), in accordance with IAS 33 (Earnings per Share): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/>
<td style="vertical-align:bottom;width:5%"/>
<td/>
<td/>
<td/></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33211">2,881</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><ix:nonFraction name="ifrs-full:ProfitLossFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33212">202</ix:nonFraction></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares outstanding (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="INF" scale="6" format="ixt:num-dot-decimal" id="ixv-33213">1,225.5</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="INF" scale="6" format="ixt:num-dot-decimal" id="ixv-33214">1,249.4</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares after dilution (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_shares" decimals="INF" scale="6" format="ixt:num-dot-decimal" id="ixv-33215">1,230.7</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_shares" decimals="INF" scale="6" format="ixt:num-dot-decimal" id="ixv-33216">1,253.8</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Basic earnings per share (in euros)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-33217">2.34</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-33218">0.16</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"/>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"/>
<td colspan="4" style="height:3pt"/></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Diluted earnings per share (in euros)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2025To06_30_2025" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-33219">2.33</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations" contextRef="P01_01_2024To06_30_2024" unitRef="Unit_EUR_per_Share" decimals="INF" scale="0" format="ixt:num-dot-decimal" id="ixv-33220">0.16</ix:nonFraction></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table></ix:continuation></ix:nonNumeric><ix:nonNumeric name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory" contextRef="P01_01_2025To06_30_2025" escape="true" id="ixv-31611"><div id="ex99_169958_12" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">C/ Events subsequent to June&#160;30, 2025 </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vicebio Ltd (&#8220;Vicebio&#8221;), a privately held biotechnology company headquartered in London, UK. The acquisition brings to Sanofi an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands Sanofi&#8217;s capabilities in vaccine design and development with Vicebio&#8217;s &#8216;Molecular Clamp&#8217; technology. Under the terms of the agreement, Sanofi would acquire all of Vicebio&#8217;s share capital for a total upfront payment of $<ix:nonFraction name="sny:UpfrontPayments" contextRef="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-7" scale="9" format="ixt:num-dot-decimal" id="ixv-33221">1.15</ix:nonFraction>&#160;billion, with potential milestone payments of up to $<ix:nonFraction name="sny:TotalMilestonePayments" contextRef="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis" unitRef="Unit_USD" decimals="-6" scale="6" format="ixt:num-dot-decimal" id="ixv-33222">450</ix:nonFraction>&#160;million based on development and regulatory achievements. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including receipt of regulatory approvals. </div></ix:nonNumeric><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-weight:bold;display:inline;">34&#8195;&#8195;SANOFI&#8194;&#8195;&#160;</div>HALF-YEAR FINANCIAL REPORT<div style="font-weight:bold;display:inline;"> </div><div style="font-family:Arial;color:#7802e6;display:inline;">2025</div><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div></div></div></div></div>
</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d69958dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="98%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:9pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:9pt; font-family:Arial"><FONT COLOR="#7802e6"><I>INFORMATION ON HALF-YEAR 2025 FINANCIAL RESULTS</I></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.14em; font-size:7pt; font-family:Arial">A. Significant events of the first half of 2025<I> </I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.14em; font-size:7pt; font-family:Arial">B. Events subsequent to June 30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.14em; font-size:7pt; font-family:Arial">C. Comments to the condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">5</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.14em; font-size:7pt; font-family:Arial">D. Risk factors and related party transactions</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.14em; font-size:7pt; font-family:Arial">E. Appendix - research and development pipeline</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>A. Significant events of the first half of 2025 </I></FONT></P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>A.1. First-half 2025 overview </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">During the first half of
2025, Sanofi continued to implement its growth and innovation strategy, focused on launching major innovations, reallocating resources and developing innovative research and development (R&amp;D). Significant events connected with the implementation
of this strategy are described below (for additional information on developments related to R&amp;D see also Section &#8220;A.2. Research and Development&#8221;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">During the meeting of the Board of Directors on January&nbsp;29, 2025, the Board authorized Sanofi to
<FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>repurchase the Company&#8217;s shares</I></FONT><FONT STYLE="font-family:Arial">, for an amount not exceeding <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5&nbsp;billion, under the terms
and conditions set by the General Meeting of April&nbsp;30, 2024 in its 19th resolution. As part of this authorization, Sanofi entered into a share buyback agreement with its historical shareholder L&#8217;Or&eacute;al on February&nbsp;2, 2025 for
the acquisition of 2.34% of Sanofi&#8217;s share capital, equivalent to 29,556,650 shares, for a total amount of approximately <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3&nbsp;billion, representing a price of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>101.50 per share. The conclusion of that agreement was approved by the Board of Directors on the same day prior to the signing of the agreement, and in accordance with the procedure set forth in
Articles L. <FONT STYLE="white-space:nowrap">225-38</FONT> et seq. of the French Commercial Code. In addition, on February&nbsp;6, 2025 Sanofi entered into a mandate with an investment services provider to repurchase its own shares for a maximum
amount of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2&nbsp;billion, between February&nbsp;7, 2025 and December&nbsp;31, 2025. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">As part of its Euro Medium Term Note program, Sanofi carried out <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>two bond</I></FONT><FONT
STYLE="font-family:Arial"> issues in the first half of 2025. On March&nbsp;5, 2025, a first issue of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1.5&nbsp;billion was completed, comprising
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>850&nbsp;million of floating-rate bonds <FONT STYLE="white-space:nowrap">(3-month</FONT> Euribor + 0.300%) maturing in March 2027, and
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>650&nbsp;million of fixed-rate bonds (2.750% per annum) maturing in March 2031. On June&nbsp;17, 2025; a second issue of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1.5&nbsp;billion
was completed, consisting of two tranches of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>750&nbsp;million each: one at a fixed rate of 2.625% per annum maturing in June 2029, and the other at a fixed rate of 3.000% per annum maturing in
June 2032. Sanofi will use the net proceeds from the issuance of these bonds for general corporate purposes. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On April&nbsp;30, 2025, Sanofi
announced the completion of the transaction with Clayton, Dubilier&nbsp;&amp; Rice (&#8220;CD&amp;R&#8221;) relating to Sanofi&#8217;s consumer healthcare business, <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Opella</I></FONT><FONT
STYLE="font-family:Arial">. Pursuant to the transaction, Sanofi retains a 48.2% equity interest in OPAL JV Co, which indirectly holds 100% of Opella. Bpifrance holds a minority stake of 1.8% and will be represented on Opella&#8217;s Board. As a
result of the transaction, Sanofi has recognized a net gain of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.7&nbsp;billion, reported within the line item <B><I>Net income from discontinued operations</I></B> in the consolidated income
statement (see Note B.7. to the consolidated financial statements for the year ended December&nbsp;31, 2024). Sanofi has received total net cash proceeds of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>10.7&nbsp;billion pursuant to the
transaction, presented within the line item<B><I> Net cash inflow from the Opella transaction</I></B> in the statement of cash flows. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On
May&nbsp;22, 2025, Sanofi announced that it had entered into an agreement to acquire <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Vigil Neuroscience, Inc</I></FONT><FONT STYLE="font-family:Arial">. (&#8220;Vigil&#8221;), a <FONT
STYLE="white-space:nowrap">US-based</FONT> publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. This acquisition in neurology is expected to enhance Sanofi&#8217;s early-stage
pipeline, and includes <FONT STYLE="white-space:nowrap">VG-3927,</FONT> an oral small molecule TREM2 agonist currently in development for Alzheimer&#8217;s disease. Sanofi had previously invested $40&nbsp;million in June 2024, including a <FONT
STYLE="white-space:nowrap">pre-emptive</FONT> right to <FONT STYLE="white-space:nowrap">VG-3927.</FONT> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On May&nbsp;27, 2025, Sanofi
announced the completion of the acquisition of <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I><FONT STYLE="white-space:nowrap">DR-0201</FONT></I></FONT><FONT STYLE="font-family:Arial">, a targeted bispecific antibody developed by Dren Bio, Inc.,
a privately held clinical-stage biopharmaceutical company. The definitive agreement was signed on March&nbsp;19, 2025. <FONT STYLE="white-space:nowrap">DR-0201,</FONT> now named SAR448501, engages myeloid cells for robust <FONT
STYLE="white-space:nowrap">B-cell</FONT> depletion, as demonstrated in preclinical and early clinical studies. Under the merger agreement, Sanofi acquired Dren-0201, a subsidiary of Dren Bio, for an upfront payment of $600&nbsp;million, supplemented
by potential milestone payments of up to $1.3&nbsp;billion contingent upon attainment of development and commercialization milestones. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On
June&nbsp;2, 2025, Sanofi and <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Blueprint Medicines Corporation</I></FONT><FONT STYLE="font-family:Arial"> (&#8220;Blueprint&#8221;), a <FONT STYLE="white-space:nowrap">US-based,</FONT> publicly
traded biopharmaceutical company specializing in systemic mastocytosis (&#8220;SM&#8221;), a rare immunological disease, and other <FONT STYLE="white-space:nowrap">KIT-driven</FONT> diseases, entered into an agreement under which Sanofi agreed to
acquire Blueprint. </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Net sales for the first half of 2025 amounted to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>19,889&nbsp;million, 8.3% higher than in the first half of 2024. At constant exchange rates (&#8220;CER&#8221;)<SUP STYLE="font-size:75%; vertical-align:top">(</SUP><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP><SUP STYLE="font-size:75%; vertical-align:top">)</SUP>, net sales rose by 9.9%, driven mainly by strong performances for Dupixent, ALTUVIIIO and Beyfortus.
</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Non-IFRS financial measure: see definition in Section C.3.,&#8220;Net sales.&#8221; </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>&#8195;&#8195;1 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income attributable to equity holders of Sanofi </I></B>amounted to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>5,812&nbsp;million in the first half of 2025, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,246&nbsp;million in the first half of 2024. Earnings per share was <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>4.74 for the first half of 2025, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1.80 for the first half of 2024. Business net
income<SUP STYLE="font-size:75%; vertical-align:top">(</SUP><SUP STYLE="font-size:75%; vertical-align:top">2</SUP><SUP STYLE="font-size:75%; vertical-align:top">)</SUP> was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,152&nbsp;million,
an increase of 7.6% compared to the first half of 2024, while business earnings per share (&#8220;business EPS&#8221;<SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3.39, an
increase of 9.7% compared to the first half of 2024. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>A.2. Research and development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">During the first half of 2025, Sanofi maintained its R&amp;D efforts with the aim of improving quality of life for people around the globe by developing
innovative vaccines and medicines. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Progress made in R&amp;D during the period is described in detail below, and an update on the R&amp;D pipeline
is presented in Section E. of this document. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Immunology </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Dupixent (dupilumab) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">After evaluation under priority review
by the US Food and Drug Administration (&#8220;FDA&#8221;), Dupixent was approved for the treatment of adult patients with <B>bullous pemphigoid</B> (&#8220;BP&#8221;), a chronic, debilitating, and relapsing skin disease with underlying <FONT
STYLE="white-space:nowrap">type-2</FONT> inflammation that typically occurs in an elderly population. The approval is based on data from the pivotal ADEPT phase 2/3 study that evaluated the efficacy and safety of Dupixent compared to placebo in
adults with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> BP. Additional regulatory applications are under review around the world, including in the European Union (&#8220;EU&#8221;), Japan, and
China. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Dupixent was granted marketing and manufacturing authorization in Japan for the treatment of chronic obstructive pulmonary disease
(&#8220;COPD&#8221;) in adults whose disease is not adequately controlled with existing therapy. The approval in Japan was based on data from the BOREAS phase 3 study. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>itepekimab (IL33 mAb) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The
<FONT STYLE="white-space:nowrap">AERIFY-1</FONT> phase 3 study evaluating itepekimab in former smokers with inadequately controlled COPD met the primary endpoint of a statistically significant reduction in moderate or severe acute exacerbations
compared to placebo of 27% at week 52, a clinically meaningful benefit. With a reduction of only 2% at week 52, the <FONT STYLE="white-space:nowrap">AERIFY-2</FONT> phase 3 study did not meet the same primary endpoint. In the studies, patients were
randomized to receive itepekimab every two weeks, every four weeks, or placebo, which was added to inhaled triple or double <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT> therapy. The safety of
itepekimab was consistent across the studies, and adverse events were generally comparable between treatment and placebo groups. Sanofi and Regeneron are reviewing the data, including the apparent loss of benefit in
<FONT STYLE="white-space:nowrap">AERIFY-2,</FONT> and will discuss with regulatory authorities to evaluate next steps. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The CEREN 1 and CEREN 2
phase 3 studies of two dose regimens of itepekimab compared with placebo as <FONT STYLE="white-space:nowrap">add-on</FONT> therapy to intranasal corticosteroids in patients with inadequately controlled CRSwNP<B> </B>commenced dosing the first
patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>amlitelimab (CD40 mAb) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The COAST 1 and SHORE
phase 3 studies, part of the OCEANA study program in atopic dermatitis (&#8220;AD&#8221;),<B> </B>have completed patient recruitment ahead of schedule. Patient recruitment proceeded efficiently, providing an opportunity to optimize the overall
sample sizes and robustness of the studies. The OCEANA program is anticipated to read out in 2025 (initial data) and 2026 (full data) and will provide the foundation for potential regulatory submissions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Rezurock (belumosudil) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Based on a <FONT
STYLE="white-space:nowrap">pre-specified</FONT> interim analysis, a decision was made to discontinue the <FONT STYLE="white-space:nowrap">ROCKnrol-1</FONT> phase 3 study evaluating belumosudil in first-line chronic graft-versus-host disease. No
major safety concerns were identified. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>riliprubart (C1s mAb) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The US FDA granted orphan drug designation to riliprubart for the treatment of antibody-mediated rejection<B> </B>(&#8220;AMR&#8221;) in solid organ
transplantation. This designation reflects Sanofi&#8217;s commitment to addressing a critical unmet need in transplant medicine, where AMR remains a significant challenge with no <FONT STYLE="white-space:nowrap">FDA-approved</FONT> treatments
available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Rare diseases </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Qfitlia
(fitusiran) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The US FDA approved Qfitlia, the first antithrombin (&#8220;AT&#8221;)-lowering medicine for routine prophylaxis to prevent or
reduce the frequency of bleeding episodes in adult and pediatric patients (aged 12 or older) with hemophilia A or B with or without factor VIII or IX inhibitors. The approval is based on data from the ATLAS phase 3 studies that demonstrated
clinically meaningful bleed protection as measured by annualized bleeding rates across hemophilia patients with or without inhibitors. In conjunction with the Qfitlia approval, the FDA also cleared Siemens
</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:75%; vertical-align:top">(2)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Non-IFRS financial measure: see definition in Section C.2., &#8220;Net income attributable to equity holders of
Sanofi (IFRS measure) and Business net income (non-IFRS financial measure).&#8221; </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>2 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Healthineers&#8217;
INNOVANCE<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> AT assay as a companion diagnostic for Qfitlia to measure AT levels. The medicine is also under regulatory review in China. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Cerezyme (imiglucerase) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The US FDA accepted for review the
submission of a supplemental biologics license application (&#8220;sBLA&#8221;) for Cerezyme to treat patients with Gaucher disease type 3 (&#8220;GD3&#8221;), with no age limitation, for patients with GD1 and GD3. The FDA decision is expected in
the first quarter of 2026. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>rilzabrutinib (BTK inhibitor) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The US FDA granted orphan drug designation to rilzabrutinib, a novel, advanced, oral, reversible Bruton&#8217;s tyrosine kinase (&#8220;BTK&#8221;)
inhibitor that works via multi-immune modulation to target a reduction in vaso-occlusive crises (which may occur via inflammation), in sickle cell disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT
 COLOR="#7802e6"><I>Neurology </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>tolebrutinib (BTK inhibitor) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The US FDA is evaluating under priority review the regulatory submission of tolebrutinib, the submission of which was accepted in the first half of
2025, to treat <FONT STYLE="white-space:nowrap">non-relapsing</FONT> secondary progressive multiple sclerosis<B> </B>(&#8220;nrSPMS&#8221;) and to slow disability accumulation independent of relapse activity. The FDA decision is expected before the
end of 2025. A regulatory submission has also been accepted and is under review in the EU. The positive results from the HERCULES phase 3 study that form the basis for these regulatory submissions were published in the <I>New England Journal of
Medicine</I> (&#8220;NEJM&#8221;) in April 2025. As part of the ongoing regulatory review, discussions with the FDA and the EMA are continuing with respect to efficacy and safety, including liver safety, from the clinical studies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>riliprubart (C1s mAb) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In Japan, riliprubart was granted
orphan drug designation for people with chronic inflammatory demyelinating polyneuropathy (&#8220;CIDP&#8221;). Despite available therapies, many CIDP patients are left with residual symptoms, including weakness, numbness, and fatigue that can lead
to long-term morbidity and diminished quality of life. Approximately 30% of people with CIDP do not respond to standard therapies. The orphan drug designation is granted to medicines that address rare medical diseases or conditions with unmet
medical needs. There are currently approximately 4,000 people diagnosed with CIDP in Japan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Oncology </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Sarclisa (isatuximab) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Following the adoption of a positive
opinion by the European Medicines Agency&#8217;s (&#8220;EMA&#8221;) Committee for Medicinal Products for Human Use (&#8220;CHMP&#8221;), Sarclisa in combination with the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">standard-of-care</FONT></FONT> regimen bortezomib, lenalidomide, and dexamethasone (&#8220;VRd&#8221;) was approved in January in the EU for the treatment of adult patients with newly
diagnosed multiple myeloma ineligible for autologous stem cell transplant (&#8220;NDMM, TI&#8221;). Sarclisa in combination with VRd was also approved in Japan and China for the treatment of adult patients with NDMM, TI. These approvals are based on
data from the IMROZ phase&nbsp;3 study. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In January, Sarclisa in combination with pomalidomide and dexamethasone was approved in China for the
treatment of adult patients with MM who have received at least one prior line of therapy, including lenalidomide and a proteasome inhibitor. This approval is based on results from the pivotal <FONT STYLE="white-space:nowrap">ICARIA-MM</FONT> phase 3
study, using the China-based IsaFiRsT real-world study as bridging data. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Following the positive opinion by the CHMP, Sarclisa in combination with
VRd was approved in the EU for the induction treatment of adult patients with NDMM who are eligible for autologous stem cell transplant. The positive CHMP opinion was based on part one results from the
<FONT STYLE="white-space:nowrap">two-part,</FONT> double-randomized, German-speaking Myeloma Multicenter Group <FONT STYLE="white-space:nowrap">(&#8220;GMMG&#8221;)-HD7</FONT> study. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Results from the IRAKLIA phase 3 study demonstrated that Sarclisa administered at a fixed dose subcutaneously (&#8220;SC&#8221;) via an <FONT
STYLE="white-space:nowrap">on-body</FONT> delivery system in combination with pomalidomide and dexamethasone (&#8220;Pd&#8221;) met its <FONT STYLE="white-space:nowrap">co-primary</FONT> endpoints of
<FONT STYLE="white-space:nowrap">non-inferior</FONT> objective response rate and observed concentration before dosing at steady state compared to intravenous Sarclisa administered at a weight-based dose in combination with Pd in patients with
relapsed or refractory (&#8220;R/R&#8221;) MM. These results will be the basis for regulatory submissions in the US and in the EU in 2025. Additional studies evaluating Sarclisa SC formulations across different combinations and lines of therapy are
ongoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Vaccines </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>MenQuadfi
(meningitis, six weeks+) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In May, the US FDA updated MenQuadfi&#8217;s approval, which now includes active immunization in children aged six
weeks to 23 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W, and Y. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Nuvaxovid <FONT
STYLE="white-space:nowrap">(COVID-19)</FONT> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sanofi&#8217;s collaboration partner Novavax, Inc. announced that the US FDA had approved the
biologics license application (&#8220;BLA) for Nuvaxovid for active immunization to prevent coronavirus disease 2019 <FONT STYLE="white-space:nowrap">(&#8220;COVID-19&#8221;)</FONT> caused by severe acute respiratory syndrome coronavirus 2 <FONT
STYLE="white-space:nowrap">(&#8220;SARS-CoV-2&#8221;)</FONT> in adults aged 65 years and older and individuals aged 12 through 64 years who have at least one underlying condition that puts them at high risk for severe outcomes from <FONT
STYLE="white-space:nowrap">COVID-19</FONT> (e.g. asthma, cancer, diabetes, obesity, smoking). Nuvaxovid has been available for use in the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>&#8195;&#8195;3 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">US under Emergency Use Authorization since July 2022 and has full market
approvals in the EU, UK and other countries. Under a May 2024 agreement, Sanofi has a <FONT STYLE="white-space:nowrap">co-exclusive</FONT> license to <FONT STYLE="white-space:nowrap">co-commercialize</FONT> Nuvaxovid in most countries worldwide and
a sole license to Nuvaxovid for use in combination with Sanofi&#8217;s flu vaccines, currently in phase 1 clinical studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>SP0087 (rabies) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The phase 3 study of the vero cell vaccine for the prevention of rabies read out positively on safety and immunogenicity. It is intended for use as a
vaccine, and as a booster after two to three years. This study and previous studies support a US regulatory submission for prevention of rabies before and after exposure in all populations in the second half of 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>SP0282 (E. coli sepsis) </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In February, a scheduled review of
the E.mbrace phase 3 study conducted by an independent data monitoring committee (IDMC) determined that Sanofi&#8217;s and Johnson&nbsp;&amp; Johnson&#8217;s vaccine candidate for extraintestinal pathogenic E. coli was not sufficiently effective at
preventing invasive E. coli disease<B> </B>(&#8220;IED&#8221;) compared to placebo. No safety signals related to the vaccine candidate were identified and, throughout the study, investigators ensured that participants who developed IED received
prompt treatment and care. As a result of the IDMC&#8217;s determination, the E.mbrace study was discontinued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>SP0218 (yellow fever) </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">A vaccine candidate is in development to prevent yellow fever<B> </B>infection in populations aged nine months and older. A phase 3 study in adults has
commenced dosing the first patient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>A.3. Other significant events </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT
 COLOR="#7802e6"><I>A.3.1. Corporate governance </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The Combined General Shareholders&#8217; Meeting of Sanofi was held on April&nbsp;30,
2025 at the Palais des Congr&egrave;s in Paris, and was chaired by Fr&eacute;d&eacute;ric Oud&eacute;a. All resolutions submitted to the vote were adopted by the shareholders. Decisions taken by the General Meeting included approving the individual
company and consolidated financial statements for the year ended December&nbsp;31, 2024 and distributing an ordinary annual dividend of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3.92 per share. The meeting also approved the
reappointment of Carole Ferrand, Barbara Lavernos, Emile Voest and Antoine Yver as directors, and ratified the <FONT STYLE="white-space:nowrap">co-opting</FONT> of Jean-Paul Kress as an independent director to replace Gilles Schnepp, who resigned
from office effective December&nbsp;31, 2024. On a proposal from the Appointments, Governance and CSR Committee, the Board of Directors appointed Clotilde Delbos, independent director, as Chairwoman of the Compensation Committee; she succeeds
Patrick Kron, who will remain as a member of the Committee. Following the expiry of Fabienne Lecorvaisier&#8217;s term of office at the close of the Annual General Meeting of April&nbsp;30, 2025, the Board of Directors now comprises 16 members, of
whom two are directors representing employees. The Board of Directors retains a large majority of independent directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>A.3.2. Legal and
arbitration proceedings </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">For a further description of certain significant developments in legal and arbitration proceedings since
publication of the financial statements for the year ended December&nbsp;31, 2024, refer to Note B.14. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;
30, 2025 available as <A HREF="d69958dex991.htm">Exhibit 99.1</A> to our Report on Form <FONT STYLE="white-space:nowrap">6-K</FONT> dated October 27, 2025. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><FONT COLOR="#7802e6"><I>US Department of Health and Human Services (&#8220;HHS&#8221;), Office of Inspector General (&#8220;OIG&#8221;) Philadelphia
Subpoena </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In May 2025, Sanofi US received a subpoena from the Philadelphia Office of the US Department of Health and Human Services
Office of Inspector General <FONT STYLE="white-space:nowrap">(&#8220;HHS-OIG&#8221;).</FONT> The subpoena seeks information about Sanofi&#8217;s agreements with pharmacy benefit managers (&#8220;PBMs&#8221;) and group purchasing organizations
(&#8220;GPOs&#8221;), particularly regarding the provision of drug utilization data from 2020 to the present. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The investigation is being conducted
jointly by the US Department of Justice (&#8220;DOJ&#8221;), the US Attorney&#8217;s Office for the Eastern District of Pennsylvania, and the <FONT STYLE="white-space:nowrap">HHS-OIG.</FONT> Sanofi is cooperating with this investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><FONT COLOR="#7802e6"><I>US Department of Justice (DOJ) - Civil Investigative Demand (&#8220;CID&#8221;) - Beyfortus </I></FONT></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In March 2025, Sanofi US received a CID from the DOJ under the False Claims Act. The CID requests information related to the Respiratory Syncytial Virus
(&#8220;RSV&#8221;) vaccine Beyfortus, which Sanofi <FONT STYLE="white-space:nowrap">co-develops</FONT> and <FONT STYLE="white-space:nowrap">co-commercializes</FONT> with a partner company. The CID specifically references a May 2024 FDA inspection
of a manufacturing facility in North Carolina where Beyfortus was filled into syringes. Sanofi is cooperating with this investigation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>A.3.3. Other events </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On
June&nbsp;5, 2025. Sanofi announced the launch of Action 2025, a global employee share ownership plan open to around 70,000 employees in 55 countries. Now in its eleventh year, the program demonstrates the ongoing commitment of Sanofi and its Board
of Directors to ensuring that employees benefit from the company&#8217;s growth and success. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The shares were offered at a subscription price of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>72.97, representing a 20% discount to the average of the 20 opening prices of Sanofi shares from May&nbsp;7 to June&nbsp;3, 2025. For every five shares subscribed, employees were entitled to receive
one free share (up to a maximum of four free shares per employee). Every eligible employee was able to purchase up to 1,500 Sanofi shares, subject to the maximum legal limit set at 25% </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>4 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">of their gross annual salary, minus any voluntary deductions already made under
employee savings schemes such as the Company Savings Plan and/or Group Savings Plan and/or Group Retirement Savings Plan (PERCO) during 2025; the above limit does not apply to voluntary contributions to the &#8220;PERCOL&#8221; retirement savings
plan. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>B. Events subsequent to June 30, 2025 </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">For information relating to events subsequent to June 30, 2025, refer to Note C to the Condensed half-year consolidated financial statements for the
six months ended June 30, 2025 available as <A HREF="d69958dex991.htm">Exhibit 99.1</A> to our Report on Form 6-K dated October 27, 2025. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C. Comments to the condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025 </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Unless otherwise indicated, all financial data in this report are presented in accordance with International Financial Reporting Standards (IFRS),
including international accounting standards and interpretations (see Note A.1. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025). </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Comments to the condensed half-year consolidated income statements for the six months ended June&nbsp;30, 2025 and&nbsp;June&nbsp;30,&nbsp;2024 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="92%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8201;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>&nbsp;million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2025</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>(6&nbsp;months)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>as&nbsp;%&nbsp;of&nbsp;net&nbsp;sales</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2024</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>(6&nbsp;months) (a)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>as&nbsp;%&nbsp;of&nbsp;net&nbsp;sales</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Net sales</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>19,889</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>100.0</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18,360</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>100.0%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other revenues</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,452</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">7.3</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,529</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">8.3%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cost of sales</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,881</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">-29.6</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,966</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-32.5%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Gross profit</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>15,460</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>77.7</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>13,923</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>75.8%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Research and development expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,717</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.7</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,335</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.2%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Selling and general expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4,506</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">-22.7</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4,303</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-23.4%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating income</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">533</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">563</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,476</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,977</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(777</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(898</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impairment of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(210</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">371</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Fair value remeasurement of contingent consideration</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(61</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(66</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Restructuring costs and similar items</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(430</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,060</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other gains and losses, and
litigation</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(57</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(450</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Operating income</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,759</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18.9</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,768</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>15.1%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Financial expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(361</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(583</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Financial income</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">184</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">277</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Income before tax and investments accounted for using the equity method</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,582</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18.0</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,462</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>13.4%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Income tax expense</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(711</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(379</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Share of profit/(loss) from
investments accounted for using the equity method</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">85</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(22</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Net income
from continuing operations</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,956</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>14.9</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,061</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>11.2%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #795c8c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net income from discontinued
operations</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,881</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">14.5</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">202</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.1%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #795c8c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Net income</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,837</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>29.3</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,263</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12.3%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net income attributable to <FONT
STYLE="white-space:nowrap">non-controlling</FONT> interests</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">25</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">17</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Net income attributable to equity holders of Sanofi</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,812</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>29.2</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,246</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12.2%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Average number of shares outstanding (million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,225.5</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,249.4</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Average number of shares after dilution (million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,230.7</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,253.8</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#149; &#8195;Basic earnings per share from continuing operations
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2.40</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.64</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#149; &#8195;Basic earnings per share from discontinued
operations (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2.34</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">0.16</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Basic earnings per share (in euros)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">4.74</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">1.80</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#149; &#8195;Diluted earnings per share from continuing
operations (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2.39</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.63</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#149; &#8195;Diluted earnings per share from discontinued
operations (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2.33</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">0.16</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" COLSPAN="3" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="3" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT
 COLOR="#23004c"><B>Diluted earnings per share (in euros)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">4.72</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">1.79</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:-2%; font-size:7pt; font-family:Arial" ALIGN="justify"><I>(a) Figures for the 2024 comparative period have been
<FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect the classification of Opella as a discontinued operation</I> (see Note B.7. to the Consolidated financial statements for the year ended December&nbsp;31, 2024).
</P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.1. Segment information </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.1.1. Operating
segments </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In accordance with IFRS&nbsp;8 (Operating Segments), the segment information reported by Sanofi is prepared on the basis of
internal management data provided to our Chief Executive Officer, who is the chief operating decision maker of Sanofi. The performance of the single operating segment is monitored individually using internal reports and common indicators. The
operating segment disclosures required under IFRS 8 are provided in Note B.21. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The segment information presented by Sanofi consists of a single operating segment: Biopharma. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Specialty Care,
General Medicines and Vaccines franchises plus support and corporate functions, for all geographical territories. It also includes </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>5 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">revenues generated from the manufacture of Consumer Healthcare products invoiced
to Opella, which constitutes a related party with effect from the deconsolidation date (April 30, 2025). Those revenues, which before that date represented intragroup transactions classified within continuing operations, are presented within
<B><I>Other Revenues</I></B> in the income statement. The Biopharma operating segment also includes the purchase price of Biopharma products manufactured by Opella. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Arial">The &#8220;Other&#8221; category comprises primarily, but not exclusively, Consumer Healthcare activities not transferred on the effective date of loss of control of
Opella. These are primarily (i)&nbsp;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital
(Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the
distribution agreement); and (iii)&nbsp;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.1.2. Income before tax and investments accounted for using the equity method (IFRS measure) and Business operating income <FONT
STYLE="white-space:nowrap">(non-IFRS</FONT> measure) </I></FONT></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We report segment results on the basis of &#8220;Business operating income&#8221;.
This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of the operating segment and to allocate resources. For a definition of &#8220;Business operating income&#8221;, and a reconciliation
between that indicator and &#8220;Income before tax and investments accounted for using the equity method,&#8221; refer to Section C.5. &#8220;Income before tax and investments accounted for using the equity method and Business operating income and
segment results&#8221; and Note B.21.1. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, &#8220;Income before tax and investments accounted for using the equity method&#8221; (IFRS measure) amounted to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>3,582&nbsp;million (compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,462&nbsp;million for the first half of 2024). In the first half of 2025, &#8220;Business operating
income&#8221; <FONT STYLE="white-space:nowrap">(non-IFRS</FONT> measure) amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,363&nbsp;million (compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,938&nbsp;million for
the first half of 2024). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Because our &#8220;Business operating income&#8221; and &#8220;Business operating income margin&#8221; are not
standardized measures, they may not be directly comparable with the <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures.
Despite the use of <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures by management in setting goals and measuring performance, these are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures that have no standardized meaning prescribed
by IFRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.2. Net income attributable to equity holders of Sanofi (IFRS measure) and Business net income <FONT STYLE="white-space:nowrap">(non-IFRS</FONT>
financial measure) </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">&#8220;Net income attributable to equity holders of Sanofi&#8221; (IFRS measure) for the first half of 2025 was to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>5,812&nbsp;million, 158.8% higher than the first half of 2024 (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,246 million). &#8220;Business net income&#8221;
<FONT STYLE="white-space:nowrap">(non-IFRS</FONT> measure) for the first half of 2025 amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,152&nbsp;million, 7.6% up on the first half of 2024
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,859 million). That represents 20.9% of net sales, versus 21.0% for the first half of 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We also report &#8220;Business earnings per share&#8221; (business EPS), a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure which we
define as business net income divided by the weighted average number of shares outstanding. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, &#8220;net income
attributable to equity holders of Sanofi&#8221; divided by the weighted average number of shares outstanding was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,812 (an increase of 163.3% compared to the first-half figure of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>2,246 for the first half of 2024). Business EPS was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3.39 for the first half of 2025, an increase of 9.7% compared to the 2024 first-half figure
of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3.09, based on an average number of shares outstanding of 1,225.5&nbsp;million for the first half of 2025 and 1,249.4&nbsp;million for the first half of 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We define &#8220;Business net income&#8221; as <B><I>Net income attributable to equity holders of Sanofi </I></B>determined under IFRS, excluding the
following items: </P> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">net income from discontinued operations, including Opella; </P></TD></TR></TABLE>
<P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">amortization and impairment losses charged against intangible assets (other than software and other rights of an
industrial or operational nature); </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">fair value remeasurements of contingent consideration relating to business combinations (IFRS&nbsp;3), or to
divestments of operations meeting the definition of a business; </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">expenses arising from the remeasurement of inventories following business combinations (IFRS&nbsp;3) or acquisitions of
groups of assets that do not constitute a business within the meaning of paragraph&nbsp;2b of IFRS&nbsp;3; </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">restructuring costs and similar items (presented within the line item <B><I>Restructuring costs and similar
items)</I></B>; </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">other gains and losses (including gains and losses on major divestments), presented within the line item <B><I>Other
gains and losses, and litigation</I></B>; </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">other costs and provisions related to litigation (presented within the line item <B><I>Other gains and losses, and
litigation</I></B>); </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">(income)/expenses related to financial liabilities accounted for at amortized cost and subject to periodic
remeasurement in accordance with paragraph&nbsp;B5.4.6 of IFRS&nbsp;9 (Financial Instruments); </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">tax effects related to the items listed above as well as effects of major tax disputes; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>6 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">the share of profits/losses from investments accounted for using the equity method, except for joint ventures and
associates with which Sanofi has a strategic alliance; and </P></TD></TR></TABLE> <P STYLE="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">the portion attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests of the items listed
above. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The table below reconciles <B><I>Net income attributable to equity holders of Sanofi </I></B>to our &#8220;Business net
income&#8221;: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; ">&#8201;&#8201;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>&nbsp;million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>June&nbsp;30,&nbsp;2025<BR>(6&nbsp;months)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months)&nbsp;(a)</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Net income attributable
to equity holders of Sanofi (IFRS)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,812</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,246</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Net (income)/loss from the discontinued Opella business
<SUP STYLE="font-size:75%; vertical-align:top">(b)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,881</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">(202</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">777</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">898</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Impairment of intangible assets<SUP STYLE="font-size:75%; vertical-align:top">(c)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">210</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">(371</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Fair value remeasurement of contingent consideration</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">68</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">72</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Expenses arising from the impact of acquisitions on inventories</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">7</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Restructuring costs and similar items</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">430</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,060</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Other gains and losses, and litigation<SUP STYLE="font-size:75%; vertical-align:top">(d)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">450</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Financial (income)/expenses relating to financial liabilities accounted for at amortized cost and subject to
periodic remeasurement<SUP STYLE="font-size:75%; vertical-align:top">(e)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">50</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">176</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Tax effects of the items listed above:</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(384</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">(577</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"><DIV STYLE="display: table-row;" ALIGN="justify"><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.428571em; font-size:7pt; font-family:Arial">&#149;</P></DIV><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.078571em; font-size:7pt; font-family:Arial"><I>amortization and impairment of intangible assets</I></P></DIV></DIV></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(173</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(48</I></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"><DIV STYLE="display: table-row;" ALIGN="justify"><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.428571em; font-size:7pt; font-family:Arial">&#149;</P></DIV><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.078571em; font-size:7pt; font-family:Arial"><I>fair value remeasurement of contingent consideration</I></P></DIV></DIV></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(17</I></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"><DIV STYLE="display: table-row;" ALIGN="justify"><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.428571em; font-size:7pt; font-family:Arial">&#149;</P></DIV><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.078571em; font-size:7pt; font-family:Arial"><I>tax effects of restructuring costs and similar items</I></P></DIV></DIV></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(113</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(343</I></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"><DIV STYLE="display: table-row;" ALIGN="justify"><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.428571em; font-size:7pt; font-family:Arial">&#149;</P></DIV><DIV STYLE="display: table-cell">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.078571em; font-size:7pt; font-family:Arial"><I>other items</I></P></DIV></DIV></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(84</I></FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(169</I></FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Other tax effects</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">11</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">7</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Other
items<SUP STYLE="font-size:75%; vertical-align:top">&nbsp;(f)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">93</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Business net income <FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>4,152</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,859</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Average number of shares outstanding (million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,225.5</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,249.4</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Basic earnings per share (IFRS) (in euros)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">4.74</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.80</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Reconciling items per share (in euros) <SUP STYLE="font-size:75%; vertical-align:top">(g)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1.35</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.29</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#ffffff"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Business earnings per share <FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT> (in euros)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">3.39</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">3.09</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Figures for the 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a
consistent basis to reflect the classification of Opella as a discontinued operation. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(b)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>In 2025, this line includes &#128;2,693&nbsp;million related to the net gain on the Opella divestment, recognized on
the date of loss of control (refer to Note B1.1 to our condensed half-year statements). </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(c)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of
&#128;210&nbsp;million in the first half of 2025 linked to research and development projects. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>&#8201;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>For the six months ended June&nbsp;30, 2024, this line corresponds to a net reversal of impairment losses amounting
to &#128;371&nbsp;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights in the Biopharma segment. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(d)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>For the first half of 2025, Other gains and losses, and litigation is a charge of &#128;57&nbsp;million, mainly
related to major litigation. That compares with a charge of &#128;450&nbsp;million in the first half of 2024, mainly comprising a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US state of Hawaii.
</I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(e)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>This line corresponds to the financial expense arising from remeasurement of the financial liability recognized in
the balance sheet to reflect estimated future royalties on sales of Beyfortus in the United States. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(f)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>In the first half of 2024, this line mainly comprised an impairment loss taken against the equity interest in
EUROAPI, based on the quoted market price: &#128;2.89 as of June&nbsp;30, 2025, &#128;2.55 as of June&nbsp;30, 2024. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(g)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Corresponds to the reconciliation between basic earnings per share (IFRS) and business earnings per share <FONT
STYLE="white-space:nowrap">(non-IFRS):</FONT> sum total of reconciling items divided by the weighted average number of shares outstanding. </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The most significant reconciling items between &#8220;Business net income&#8221; and <B><I>Net income attributable to equity holders of Sanofi</I></B>
relate to&nbsp;(i)&nbsp;the purchase accounting effects of our acquisitions of groups of assets and business combinations, particularly the amortization and impairment of intangible assets (other than software and other rights of an industrial or
operational nature); (ii)&nbsp;the impacts of restructuring actions or transactions regarded as <FONT STYLE="white-space:nowrap">non-recurring,</FONT> where the amounts involved are particularly significant; (iii)&nbsp;the remeasurements recognized
through profit or loss in respect of (a)&nbsp;amounts receivable in respect of business divestments and accounted for at fair value, (b)&nbsp;liabilities arising from business combinations (IFRS&nbsp;3) and accounted for at fair value,
(c)&nbsp;liabilities accounted for at amortized cost and subject to periodic remeasurement under IFRS&nbsp;9; and (iv)&nbsp;the net income from discontinued operations, including Opella. We believe that excluding those impacts enhances an
investor&#8217;s understanding of our underlying economic performance, because it gives a better representation of our recurring operating performance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We believe that eliminating charges related to the purchase accounting effects (particularly amortization and impairment of some intangible assets)
enhances comparability of our ongoing operating performance relative to our peers. Those intangible assets (principally rights relating to research and development, technology platforms and commercialization of products) are accounted for in
accordance with IAS&nbsp;38 (Intangible Assets) and IFRS&nbsp;3 (Business Combinations). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>7 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We also believe that eliminating the other effects of business combinations (such
as the incremental cost of sales arising from the workdown of acquired inventories remeasured at fair value in business combinations) gives a better understanding of our recurring operating performance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Eliminating restructuring costs and similar items enhances comparability with our peers because those costs are incurred in connection with
reorganization and transformation Company&#8217;s programs, integration or separation as part of material deals. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We believe that eliminating the
effects of transactions that we regard as <FONT STYLE="white-space:nowrap">non-recurring</FONT> and that involve particularly significant amounts (such as major gains and losses on disposals, and costs and provisions associated with major litigation
and other major <FONT STYLE="white-space:nowrap">non-recurring</FONT> items) improves comparability from one period to the next. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Finally,
remeasurements recognized in profit or loss during the period in respect of (i)&nbsp;assets or liabilities accounted for at fair value and recognized in the balance sheet in connection with business acquisitions or divestments or
(ii)&nbsp;liabilities accounted for at amortized cost and subject to periodic remeasurement, generally determined on the basis of revised sales forecasts, are not reflective of our operating performance. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In addition to the items mentioned above relating to our continuing operations, &#8220;Business net income&#8221; excludes net income from the Opella
discontinued operation, the results of which have been presented separately in the consolidated income statement since October 2024 (comparative figures have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis). Under
IFRS 5 <FONT STYLE="white-space:nowrap">(Non-Current</FONT> Assets Held for Sale and Discontinued Operations), a discontinued operation is defined as a component of an entity that has been disposed of or is classified as held for sale, and
represents a separate major line of business. With effect from October 2024, &#8220;Business net income&#8221; from continuing operations is used by management to measure Sanofi&#8217;s financial performance on an ongoing basis. We believe that
providing a performance measure aligned with our management approach is useful for investors and analysts. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We remind investors, however, that
&#8220;Business net income&#8221; should not be considered in isolation from, or as a substitute for, <B><I>Net income attributable to equity holders of Sanofi</I></B> reported in accordance with IFRS. In addition, we strongly encourage investors
and potential investors not to rely on any single financial measure but to review our financial statements, including the notes thereto, carefully and in their entirety. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We compensate for the material limitations described above by using &#8220;Business net income&#8221; only to supplement our IFRS financial reporting
and by ensuring that our disclosures provide sufficient information for a full understanding of all adjustments included in&nbsp;&#8220;Business net income&#8221;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Because our &#8220;Business net income&#8221; and &#8220;Business EPS&#8221; are not standardized measures, they may not be directly comparable with the
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.3. Net sales </B></P> <P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Net sales for the first half of 2025
amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>19,889&nbsp;million, 8.3% higher than in the first half of 2024. Exchange rate fluctuations had a negative effect of 1.6 percentage points overall, due mainly to adverse trends in
the euro exchange rate against the US dollar, Brazilian real and Mexican peso. At constant exchange rates (CER, see definition below), net sales rose by 9.9%, driven mainly by strong performances for Dupixent, ALTUVIIIO and Beyfortus. Divestments
and medicines/portfolio streamlining had a negative impact of 0.4 percentage points on sales growth. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Reconciliation of net sales (IFRS) to net sales at constant
exchange&nbsp;rates <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; ">&#8201;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>&nbsp;million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>June&nbsp;30,&nbsp;2025<BR>(6&nbsp;months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months)&nbsp;(a)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8201;Net sales</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>19,889</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18,360</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>+8.3%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#ffffff"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Effect of exchange rates</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">286</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8201;Net sales at constant exchange rates</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>20,175</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18,360</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>+9.9%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Figures for the 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a
consistent basis to reflect the classification of Opella as a discontinued operation. </I></P></TD></TR></TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">When we refer to changes in our net
sales at constant exchange rates (CER), that means we have excluded the effect of exchange rates by recalculating net sales for the relevant period using the exchange rates that were used for the previous period, with the exception of countries
treated as hyperinflationary economies under IAS 29 (i.e. Argentina and Turkey, see Note A.4 to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025). </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.3.1. Net sales by segment </I></FONT></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Our net sales comprise the net sales generated by our Biopharma segment. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; ">&#8201;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>June&nbsp;30,&nbsp;2025<BR>(6&nbsp;months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change&nbsp;on</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>a reported</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>basis</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change&nbsp;at</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>constant</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>exchange&nbsp;rates</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Biopharma segment</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">19,889</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">18,360</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.3%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.9%</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>&#8201;Total net
sales</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>19,889</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>18,360</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+8.3%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+9.9%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>8 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.3.2. Net sales by medicine, vaccine and geography </I></FONT></P>
<P STYLE="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Net sales by main product and geographical region break down as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; "><I>(&#128; million)</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Total&nbsp;sales</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change<BR>(reported)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change<BR>(CER)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>United<BR>States</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change<BR>(CER)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Europe</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change<BR>(CER)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Rest&nbsp;of<BR>the&nbsp;world</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change<BR>(CER)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Immunology</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1px solid #23004c; BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Dupixent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">7,312</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">5,283</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">944</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,085</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Kevzara</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">245</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+30.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">151</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+46.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">65</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">29</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+12.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Rare diseases</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Fabrazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">525</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">261</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">134</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">130</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">ALTUVIIIO (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">542</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+93.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+95.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">456</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+78.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">86</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+304.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Nexviazyme / Nexviadyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">387</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">195</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">132</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+38.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">60</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cerezyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">363</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-10.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">91</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">119</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">153</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Alprolix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">305</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+12.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">240</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">65</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+43.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Myozyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">275</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-25.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-24.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">91</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-24.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">97</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-33.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">87</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Aldurazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">163</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">36</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">43</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">84</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cerdelga</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">166</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">89</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">68</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Eloctate</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">135</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-29.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-28.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">97</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-22.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">38</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-40.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cablivi (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">136</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">71</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+18.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">55</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+25.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Xenpozyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">110</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+52.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+54.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+27.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">44</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+83.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">19</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+81.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Qfitlia (Fitusiran) (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Neurology</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Aubagio</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">138</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-34.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-33.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">76</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">40</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-57.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">22</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Oncology</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Sarclisa (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">276</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">119</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">83</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">74</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Jevtana</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">141</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">108</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-50.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-16.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Fasturtec</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">88</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">25</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Other medicines</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Lantus</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">876</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">395</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+47.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">149</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">332</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Toujeo</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">692</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">126</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">248</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">318</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Plavix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">473</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">44</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">426</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Lovenox</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">447</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+50.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">247</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-19.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">191</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Rezurock (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">263</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+27.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">220</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+18.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">23</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+91.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+185.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Praluent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">267</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">209</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">58</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-23.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Thymoglobulin</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">248</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">154</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">21</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">73</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Aprovel</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">212</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+50.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">35</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">174</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Multaq</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">160</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">145</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-16.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Soliqua/iGlarLixi</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">136</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">44</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">26</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">66</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Tzield (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">29</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+38.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+38.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">27</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+35.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Mozobil</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-65.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-63.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-60.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-82.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-23.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,971</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-10.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">176</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-16.7%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">584</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,211</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Industrial Sales</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">251</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">241</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Vaccines</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">RSV vaccine (Beyfortus) (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">356</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+78.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+79.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">68</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-43.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">85</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1114.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">203</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+168.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Polio / Pertussis / Hib Vaccines&nbsp;&amp;&nbsp;Boosters</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,361</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">320</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">223</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-10.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">818</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Influenza Vaccines</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">214</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">54</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+237.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">52</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+73.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">108</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-21.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Meningitis, Travel and Endemics Vaccines</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">609</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">319</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">96</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">194</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Biopharma</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>19,889</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+8.3%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+9.9%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>9,535</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+16.4%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>4,144</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+1.8%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>6,210</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>+6.4%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#ffffff">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Launches (*)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">2,100</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+45.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">+46.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">1,204</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">+27.1%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">423</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">+71.5%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">473</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c">+100.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&nbsp;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I>Figures for the 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect
the classification of Opella as a discontinued operation, forming the basis for the percentage change data calculated in the above table. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>9 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.3.3. Biopharma segment </I></FONT></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, revenue from the Biopharma business (see Section C.1. &#8220;Segment Information&#8221; for detailed segment information) was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>19,889&nbsp;million, up 8.3% on a reported basis and 9.9% at constant exchange rates (&#8220;CER&#8221;), driven by Dupixent and new launches. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Comments on the performances of our major Biopharma segment products are provided below. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>New pharmaceutical product launches </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT
STYLE="font-family:Arial" COLOR="#7802e6"><I>ALTUVIIIO</I></FONT><FONT STYLE="font-family:Arial"> (hemophilia A) generated sales of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>542&nbsp;million in the first half of 2025, primarily in the
United States, driven by continued patient switches from older plasma-derived and recombinant factor medicines and to a lesser extent from <FONT STYLE="white-space:nowrap">non-factor</FONT> treatments. Sales in the Rest of the World region, at <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>86&nbsp;million, benefited from the launch in Japan and sales of supplies to Sanofi&#8217;s collaboration partner Sobi in Europe. Sales of the hemophilia A franchise (ALTUVIIIO + Eloctate) reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>683&nbsp;million (an increase compared to the first half of 2024), due to the strong commercial performance of ALTUVIIIO. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Nexviazyme/Nexviadyme</I></FONT><FONT STYLE="font-family:Arial"> (Pompe disease) sales reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>387&nbsp;million, up 20.9% on a reported basis and 21.6% at CER, driven by Europe (+38.9% at CER) and the United States (an increase of +13.2% at CER to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>195 million) where all <FONT STYLE="white-space:nowrap">eligible/non-pediatric</FONT> patients have converted from Myozyme/Lumizyme. Sales of the Pompe disease franchise (Nexviazyme/Nexviadyme
and Myozyme/Lumizyme combined) reached <FONT STYLE="font-family:Times New Roman">&#128;</FONT>668&nbsp;million, a decrease compared to the first half of 2024. Nexviazyme/Nexviadyme sales now represent 58% of the Pompe disease franchise. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Over the same period, sales of <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Sarclisa</I></FONT><FONT STYLE="font-family:Arial"> (multiple myeloma)
reached <FONT STYLE="font-family:Times New Roman">&#128;</FONT>276&nbsp;million, an increase of 21.6% on a reported basis and 22.5% at CER compared to first half of 2024, driven by increased use in the front-line setting and market share gains
globally. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Rezurock</I></FONT><FONT STYLE="font-family:Arial"> (chronic
graft-versus-host disease, third line) reached <FONT STYLE="font-family:Times New Roman">&#128;</FONT>263&nbsp;million in the first half, an increase of 27.1% on a reported basis and 28.0% at CER, driven by the United States (increase of 18.1% at
CER) and by a significant increase in volumes in Europe (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>23 million) and the Rest of the World (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>20&nbsp;million). </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Cablivi</I></FONT><FONT STYLE="font-family:Arial"> (acquired thrombotic thrombocytopenic
purpura) reached <FONT STYLE="font-family:Times New Roman">&#128;</FONT>136&nbsp;million (an increase of 20.4% on a reported basis and 20.4% at CER) in the first half compared to first half of 2024, driven by an increase in the number of patients
identified for this treatment (aided by artificial intelligence in the United States), and by launches in Europe and the Rest of the World. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Xenpozyme</FONT></I> (acid sphingomyelinase deficiency) were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>110&nbsp;million in the first half, an increase of 52.8% on a reported basis and 54.2% at CER, reflecting an increase in the number of patients identified for this treatment across all regions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Tzield</FONT></I> (delayed onset of type 1 diabetes) reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>29&nbsp;million (an increase of 38.1% on a reported basis and 38.1% at CER) with sales benefiting from ongoing investment in education and progress in screening. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Qfitlia</I></FONT><FONT STYLE="font-family:Arial"> (hemophilia A and B) received marketing
authorization in the United States on March&nbsp;28, 2025, with sales in the first half of 2025 amounting to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1&nbsp;million. </FONT></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Immunology </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Dupixent</I></FONT><FONT STYLE="font-family:Arial"> generated net sales of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>7,312&nbsp;million in the first half of 2025, up 19.1% on a reported basis and 20.7% at CER. Global sales were driven by increased use in all approved indications, including atopic dermatitis, asthma,
chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, prurigo nodularis and chronic spontaneous urticaria, plus emerging use in COPD and bullous pemphigoid. In the United States, sales of Dupixent reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>5,283&nbsp;million in the first half of 2025, driven by volume across all established and newly approved indications. In Europe, the product&#8217;s net sales for the first half of 2025 totaled <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>944&nbsp;million, an increase compared to first half of 2024, reflecting strong momentum in all approved indications. In the Rest of the World region, Dupixent posted net sales of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>1,085&nbsp;million (an increase compared to first half of 2024). </FONT></P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Other main medicines </B></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Lantus</I></FONT><FONT STYLE="font-family:Arial"> sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>876&nbsp;million (an increase of 15.4% on a reported basis and 17.7% at CER) in the first half of 2025. In the United States, sales increased by 47.8% at CER, benefiting from a temporary
increase in demand due to the unavailability of competing medicines during this period. In the Rest of the World region, sales increased by 9.9% at CER; conversely, sales in Europe decreased by 14.9% at CER. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Toujeo</I></FONT><FONT STYLE="font-family:Arial"> sales rose by 9.1% on a reported basis and 10.3% at
CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>692&nbsp;million, driven by the Rest of the World region (increase of 17.4% at CER), where the product continued to increase its share of the buoyant basal insulin market. </FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of the Fabry disease treatment <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Fabrazyme</FONT></I> reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>525&nbsp;million in the first half of 2025 (no change on a reported basis and an increase of 1.0% at CER compared to first half of 2024), reflecting slight growth in the number of patients. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Plavix</I></FONT><FONT STYLE="font-family:Arial"> sales stayed the same as the first half of 2024 on
a reported basis and were up 1.9% at CER at <FONT STYLE="font-family:Times New Roman">&#128;</FONT>473&nbsp;million, reflecting volume growth in the Rest of the World region offset by volume-based procurement in China. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Lovenox</I></FONT><FONT STYLE="font-family:Arial"> sales decreased by 13.7% on a reported basis and
11.0% at CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>447&nbsp;million, mainly as a result of the impact from biosimilar competition in Europe. </FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>10 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Cerezyme</I></FONT><FONT
STYLE="font-family:Arial"> sales decreased by 10.8% on a reported basis and 8.6% at CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>363&nbsp;million, due to the absence of inflationary pressure in 2025 and the cessation of treatment by
some patients. Sales for the Gaucher disease franchise (Cerezyme and Cerdelga) were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>539&nbsp;million, a decrease compared to first half of 2024. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Alprolix</FONT></I> amounted to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>305&nbsp;million, an increase of 12.5% on a reported basis and 13.7% at CER, driven by the Rest of the Word region and the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Myozyme/Lumizyme</FONT></I> decreased by 25.9% on a reported basis and 24.8% at CER in the
first half of 2025 to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>275&nbsp;million compared to first half of 2024, due to the ongoing shift to Nexviazyme/Nexviadyme as mentioned above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">First-half net sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Praluent</FONT></I> reached
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>267&nbsp;million, an increase of 8.1% on a reported basis and 8.5% at CER driven by higher sales in Europe, partly offset by lower sales in the Rest of the World region. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Thymoglobulin</I></FONT><FONT STYLE="font-family:Arial"> sales rose by 0.8% on a reported basis and
2.4% at CER in the first half of 2025 to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>248&nbsp;million, driven by the Rest of the World region. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Cerdelga</I></FONT><FONT STYLE="font-family:Arial"> sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>166&nbsp;million, an increase of 0.6% on a reported basis and 1.2% at CER, reflecting continued growth in Europe but a decline in sales in the United States. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Eloctate </I></FONT><FONT STYLE="font-family:Arial">posted sales of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>135&nbsp;million in the first half of 2025, a decrease of 29.3% on a reported basis and 28.8% at CER, reflecting switches to ALTUVIIIO. </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Aubagio</FONT></I> were down 34.0% on a reported basis and 33.0% at CER at <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>138&nbsp;million, in line with the loss of exclusivity in the United States and Europe in 2023. Aubagio sales are expected to continue to decline. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Vaccines </B></P> <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, Vaccines sales
increased 9.5% on a reported basis and 10.9% at CER at <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,540&nbsp;million compared to first half of 2024, driven by expansion of Beyfortus into new markets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of<I> <FONT STYLE="font-family:Arial" COLOR="#7802e6">Polio/Pertussis/Hib (PPH) Vaccines</FONT></I>, including Boosters, rose by 1.0% on a
reported basis and 2.4% at CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,361&nbsp;million, primarily driven by demand for boosters to <FONT STYLE="white-space:nowrap">re-vaccinate</FONT> adolescents and adults and by pediatric
combos in the United States and international markets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial" COLOR="#7802e6"><I>Meningitis, Travel and Endemics
Vaccines</I></FONT><FONT STYLE="font-family:Arial"> sales increased by 4.5% on a reported basis and 5.5% at CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>609&nbsp;million, reflecting a favorable ordering pattern in meningitis in the
United States and the Rest of the World region, partly offset by phasing of travel and endemics vaccines. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT
STYLE="font-family:Arial" COLOR="#7802e6"><I>Beyfortus</I></FONT><FONT STYLE="font-family:Arial"> sales reached <FONT STYLE="font-family:Times New Roman">&#128;</FONT>356&nbsp;million, driven by additional sales in the Northern Hemisphere, in
particular Germany. In the Rest of the World region, sales were driven by the <FONT STYLE="white-space:nowrap">roll-out</FONT> in Japan and Brazil, and by expansion in Australia. Beyfortus is routinely used to protect infants in more than 25
countries. Sanofi entered into an agreement effective April&nbsp;1, 2025 to deliver Beyfortus, among other vaccines, to the Centers for Disease Control and Prevention (CDC) to be further delivered by the CDC in the United States, for a total order
amount of approximately $2&nbsp;billion. </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sales of <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Influenza</FONT> Vaccines</I> reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>214&nbsp;million, an increase of 13.8% on a reported basis and 15.4% at CER, due to <FONT STYLE="white-space:nowrap">one-offs</FONT> from late-season immunizations in the US and Europe, while sales in
the Rest of the World region decreased by 21.8% at CER due to increased competition. </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.3.4. Net sales by geographical region
</I></FONT></P> <P STYLE="font-size:13pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c">&#8201;(<FONT STYLE="font-family:Times New Roman; " COLOR="#23004c">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2025<BR>(6&nbsp;
months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change on a<BR>&#8195;reported&nbsp;basis</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change&nbsp;at&nbsp;constant<BR>exchange rates</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;United States</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9,535</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">8,292</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.0%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.4%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Europe</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,144</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,072</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.8%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.8%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Rest of the World</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">6,210</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">5,996</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.6%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.4%</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8201;of which China</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>1,388</I></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>1,406</I></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>-1.3%</I></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>+0.1%</I></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8201;Total net sales</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">19,889</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">18,360</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">+8.3%</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">+9.9%</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; text-indent:-1%; font-size:7pt; font-family:Arial" ALIGN="justify"><I>Figures for the 2024 comparative period have been
<FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect the classification of Opella as a discontinued operation, which is used as the baseline in 2024 for the percentage change data calculated in the above table.
</I></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, net sales in the <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">United States</FONT></I> reached <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>9,535&nbsp;million, an increase of 15.0% on a reported basis and 16.4% at CER compared to first half of 2024, driven by strong growth for Dupixent, new pharmaceutical product launches and a temporary
increase in demand for Lantus, although sales of some legacy medicines were lower. Vaccines sales were broadly stable, though Beyfortus sales decreased. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Europe</FONT></I>, 2025 first-half net sales rose by 1.8% both on a reported basis and at CER, to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>4,144&nbsp;million. Growth was driven by Dupixent and launches, partially offset by lower sales of other main medicines and vaccines. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the <I><FONT STYLE="font-family:Arial" COLOR="#7802e6">Rest of the World region</FONT></I>, first-half net sales increased by 3.6% on a reported
basis and 6.4% at CER compared to first half of 2024, to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>6,210&nbsp;million, driven mainly by Dupixent, Beyfortus, pharmaceutical product launches, insulins, and PPH and booster vaccines, while
other medicines and flu vaccines declined. Sales in China declined 1.3% on a reported basis but increased 0.1% at CER to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,388&nbsp;million, and were
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>11 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">generally impacted by the declining market and by lower prices as a result of the renewed national reimbursement drug list and volume-based procurement.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.4. Other income statement items </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.1.
Other revenues </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Other revenues</I></B> decreased by 5.0% to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,452&nbsp;million in the first half of 2025 (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,529&nbsp;million in the first half of 2024). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The <B><I>Other revenues</I></B> line item includes VaxServe sales of <FONT STYLE="white-space:nowrap">non-Sanofi</FONT> products, amounting to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>842&nbsp;million (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>854&nbsp;million in 2024). In addition, <B><I>Other revenues</I></B> includes sales of Opella products in markets
retained by Sanofi (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>206 million); sales to Opella (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>61 million); royalties (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>68
million); and sales of other services/manufacturing services (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>275 million). </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.2.
Gross profit </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Gross profit</I></B> for the first half of 2025 was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>15,460&nbsp;million, versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>13,923&nbsp;million for the first half of 2024, a rise of 11.0%, driven by a portfolio shift towards specialty
care and an enhanced product mix. Gross margin (the ratio of gross profit to net sales) also increased, reaching 77.7% in the first half of 2025 (versus 75.9% in the first half of 2024). </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.3. Research and development expenses </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Research and development expenses</I></B> (R&amp;D expenses) in the first half of 2025 totaled
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,717&nbsp;million (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,335&nbsp;million in the first half of 2024). The increase is explained mainly by (i)&nbsp;a <FONT
STYLE="white-space:nowrap">one-time</FONT> reimbursement in the first half of 2024 (the comparative period) for past ALTUVIIIO development, and (ii)&nbsp;wind-down costs for the discontinued E. coli sepsis vaccine candidate. R&amp;D expenses
represent 18.7% of net sales, compared with 18.2% in the first half of 2024, and a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-on-year</FONT></FONT> increase of 11.5%. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.4. Selling and general expenses </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Selling and general expenses</I></B> amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,506&nbsp;million in the first half of
2025 (22.7%&nbsp;of net sales), versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,303&nbsp;million in the first half of 2024 (23.4% of net sales). The overall increase of 4.7% reflects continued support for launches and newer medicines
in specialty care and vaccines. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The ratio of selling and general expenses to net sales was 0.8 of a percentage point lower than in the first half
of 2024. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.5. Other operating income and expenses </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, <B><I>Other operating income</I></B> amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>533&nbsp;million,
slightly lower than in the first half of 2024, and <B><I>Other operating expenses</I></B> increased to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,476&nbsp;million (versus
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,977&nbsp;million in the first half of 2024). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Overall, <B><I>other operating income and
expenses</I></B> represented a net expense of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,943&nbsp;million in the first half of 2025, compared with a net expense of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,414&nbsp;million in the first half of 2024. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;June&nbsp;30,&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;June&nbsp;30,&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;Change</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating income</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">533</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">563</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(30</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,476</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,977</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(499</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Other operating income/(expenses),
net</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(1,943</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(1,414</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(529</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">For the first half of 2025, this item included
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,261&nbsp;million of net expenses related to Regeneron (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,745&nbsp;million in the first half of 2024), as shown in the table below.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;June&nbsp;30,&nbsp;2025<BR>(6&nbsp;
months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Income&nbsp;&amp; expense related to (profit)/loss sharing under the
Monoclonal Antibody&nbsp;Alliance</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,475</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,934</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Additional share of profit paid by Regeneron towards development
costs</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">494</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">389</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Reimbursement to Regeneron of selling
expenses incurred</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(346</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(292</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Total: Monoclonal
Antibody Alliance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(2,327</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(1,837</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Other (mainly Zaltrap and
Libtayo)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>66</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>92</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Other operating income/(expenses),
net related to Regeneron Alliance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(2,261</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(1,745</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>of which amount
presented in &#8220;Other operating income&#8221;</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>70</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>96</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Other operating income and expenses</I></B> (net) also includes gains on divestments of assets and operations
totaling <FONT STYLE="font-family:Times New Roman">&#128;</FONT>344&nbsp;million, mainly related to portfolio rationalization (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>319&nbsp;million for the first half of 2024). </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.6. Amortization of intangible assets </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Amortization charged against intangible assets in the first half of 2025 amounted to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>777&nbsp;million, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>898&nbsp;million in the first half of 2024. This decrease was mainly driven by intangible assets reaching the
end of their amortization periods. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>12 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.7. Impairment of intangible assets </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>210&nbsp;million in the first half of 2025 linked to R&amp;D projects. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2024,
the results of impairment tests on other intangible assets led to a net reversal of impairment losses amounting to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>371&nbsp;million recognized in connection with the divestments of the ProXTen
technology platform and of the marketed product Enjaymo, for which some related assets had been subject to impairment losses in previous years. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT
 COLOR="#7802e6"><I>C.4.8. Fair value remeasurement of contingent consideration </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Fair value remeasurements of contingent consideration
assets and liabilities relating to business combinations (recognized in accordance with IFRS 3) represented a net expense of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>61&nbsp;million in the first half of 2025, versus a net expense of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>66&nbsp;million in the first half of 2024. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.9. Restructuring costs and similar items
</I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Restructuring costs and similar items</I></B> amounted to a charge of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>430&nbsp;million in the first half of 2025, compared with a charge of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,060&nbsp;million in the first half of 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Restructuring and similar costs decreased by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>630&nbsp;million between June&nbsp;30, 2024 and
June&nbsp;30, 2025. In the first half of 2024, restructuring and similar costs mainly comprised the impacts of (i)&nbsp;the renewal of the Job Management and Career Paths (GEPP) program in France to cover changes in employment status during the
2024-2026 period, including an extension of the kinds of job profiles affected by potential changes in employee status under this program and (ii)&nbsp;a voluntary redundancy program announced in 2024 in connection with the reorganization of
Sanofi&#8217;s R&amp;D operations to focus on making Sanofi a leader in immunology. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.10. Other gains and losses, and litigation
</I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">For the first half of 2025, <B><I>Other gains and losses, and litigation</I></B> recognized a charge of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>57&nbsp;million, mainly related to major litigation. That compares with a charge of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>450&nbsp;million in the first half of 2024, which mainly was
comprised a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US state of Hawaii (see Note B.14. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025). </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.11. Operating income </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Operating income</I></B> amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,759&nbsp;million in the first half of 2025, versus <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>2,768&nbsp;million in the first half of 2024. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-on-year</FONT></FONT> change was mainly due to the increase in <B><I>Gross
profit</I></B>. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.12. Financial income and expenses </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Net financial expenses were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>177&nbsp;million in the first half of 2025, <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>129&nbsp;million lower than the 2024 first-half amount of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>306&nbsp;million. The 2025 first half amount includes a financial expense of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>50&nbsp;million (compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>176&nbsp;million for the first half of 2024) in respect of the remeasurement of the liability recorded in the
balance sheet for estimated future royalties on Beyfortus sales in the US. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Our cost of total debt was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>219&nbsp;million in the first half of 2025, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>306&nbsp;million in the first half of 2024. Our cost of net debt (see&nbsp;the
definition in Section C.7. &#8220;Consolidated balance sheet&#8221; below) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>57&nbsp;million in the first half of 2025, compared to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>67&nbsp;million in the first half of 2024. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.13. Income before tax and
investments accounted for using the equity method </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Income before tax and investments accounted for using the equity method</I></B>
for the first half of 2025 was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,582&nbsp;million, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,462&nbsp;million in the first half of 2024. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>C.4.14. Income tax expense </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Income tax expense</I></B> totaled <FONT STYLE="font-family:Times New Roman">&#128;</FONT>711&nbsp;million in the first half of 2025, compared <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>379&nbsp;million in the first half of 2024, giving an effective tax rate (based on consolidated net income) of 19.8%, compared to 15.4% in the first half of 2024. The increase in income tax expense
was mainly due to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-on-year</FONT></FONT> decrease in restructuring costs relating to severance plans announced in the first half of 2025 and to Sanofi&#8217;s ongoing employee
status transformation projects (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>113&nbsp;million in the first half of 2025, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>343&nbsp;million in the first half of 2024). This
was partly offset by a rise in the tax effects of amortization and impairment of intangible assets (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>173&nbsp;million in the first half of 2025, compared
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>48&nbsp;million in the first half of 2024).When calculated on business net income, our effective tax rate was 21.0% in the first half of 2025, compared with 20.0% in the first half of 2024 and
19.8% for 2024 as a whole. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The main factors in this <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-on-year</FONT></FONT>
change were (i)&nbsp;the impact of the OECD Pillar Two model rules, which aim to ensure that large multinationals pay a minimum level of tax on the income arising in each jurisdiction where they operate; and (ii)&nbsp;the full effect of the 2024
portion of the temporary exceptional corporate income tax contribution introduced under the 2025 French Finance Bill. This latter item is excluded from the annual average effective tax rate calculation in accordance with IAS 34. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>13 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The effective tax rate on our &#8220;Business net income&#8221;<SUP STYLE="font-size:75%; vertical-align:top">(</SUP><SUP
STYLE="font-size:75%; vertical-align:top">3</SUP><SUP STYLE="font-size:75%; vertical-align:top">)</SUP> is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure. &#8220;Business net income&#8221; is calculated on the basis of business
operating income, minus net financial expenses and before (i)&nbsp;the share of profit/loss from investments accounted for using the equity method and (ii)&nbsp;net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT>
interests. We believe the presentation of this measure, used by our management, is also useful for investors as it provides a mean of analyzing the effective tax cost of our current business activities. It should not be seen as a substitute for the
effective tax rate based on consolidated net income. Because our &#8220;Business net income&#8221; and effective tax rate on our &#8220;Business net income&#8221; are not standardized measures, they may not be directly comparable with the <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. Despite the use of <FONT STYLE="white-space:nowrap">non-IFRS</FONT>
measures by management in setting goals and measuring performance, these are <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures that have no standardized meaning prescribed by IFRS. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>C.4.15. Share of profit/(loss) from investments accounted for using the equity method </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Share of profit/(loss) from investments accounted for using the equity method</I></B> showed net income of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>85&nbsp;million for the first half of 2025 (versus a net loss of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>22&nbsp;million for the first half of 2024), including <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>11&nbsp;million for Sanofi&#8217;s share of profits from OPAL JV Co for the period starting May 1st, 2025 until June&nbsp;30, 2025. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>C.4.16. Net income from continuing operations </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income from continuing operations </I></B>amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,956&nbsp;million in the first
half of 2025, compared with <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,061&nbsp;million in the first half of 2024. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT
 COLOR="#7802e6"><I>C.4.17. Net income from discontinued operations </I></FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Due to (i)&nbsp;the classification of Opella&#8217;s assets and
liabilities as held for sale since the announcement on October&nbsp;21, 2024 of the opening of exclusive negotiations with CD&amp;R for the transfer of those assets and liabilities and (ii)&nbsp;the assessment that Opella qualifies as a principal
line of business within the meaning of IFRS 5, the net income or loss of Opella is presented in a separate line item, <B><I>Net income from discontinued operations </I></B>(see Notes B.1. and B.22. to our Condensed half-year consolidated financial
statements for the six months ended June&nbsp;30, 2025). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, <B><I>Net income from discontinued operations </I></B>amounted
to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,881&nbsp;million, reflecting the net income of Opella until the date of loss of control and also including a net gain of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,693&nbsp;million resulting from the divestment of Opella as of the date of loss of control. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2024, <B><I>Net income from discontinued operations </I></B>amounted to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>&nbsp;202&nbsp;million. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>C.4.18. Net income </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income</I></B> amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,837&nbsp;million in the first half of 2025, including a
gain of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,693&nbsp;million on the divestment of Opella, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,263&nbsp;million in the first half of 2024. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>C.4.19. Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</I></B> for the first half of 2025 was <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>25&nbsp;million, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>17&nbsp;million for the first half of 2024. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>C.4.20. Net income attributable to equity holders of Sanofi </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income attributable to equity holders of Sanofi</I></B> amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,812&nbsp;million
in the first half of 2025, compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,246&nbsp;million in the first half of 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Basic
earnings per share (EPS) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4.74, compared with <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1.80 for the first half of 2024, based on an average number of shares outstanding of
1,225.5&nbsp;million for the first half of 2025 and 1,249.4&nbsp;million for the first half of 2024. Diluted earnings per share was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4.72, versus
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1.79 for the first half of 2024, based on an average number of shares after dilution of 1,230.7&nbsp;million for the first half of 2025 and 1,253.8&nbsp;million for the first half of 2024. </P>
<P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>C.5. Income before tax and investments accounted for using the equity method and Business operating income and segment results </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In the first half of 2025, our &#8220;Business operating income&#8221; (see below and Note B.21.1. to our Condensed half-year consolidated financial
statements for a definition and reconciliation of this <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure and further details) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,363&nbsp;million, compared to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>4,938&nbsp;million for the first half of 2024, an increase of 8.6%. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Our business operating income <FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT> is reconciled with our Income before tax and investments accounted for using the equity method (IFRS) in Note &#8220;B.21. Segment information &#8212; B.21.1. Segment results&#8221; to our Condensed
half-year consolidated financial statements for the six months ended June&nbsp;30, 2025. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The table below sets forth our business operating income
for the Biopharma segment: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="73%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8201;(&#128; million)</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2025<BR>(6&nbsp;
months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months) <SUP
STYLE="font-size:75%; vertical-align:top">(a)</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;Change</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Biopharma segment business operating income <FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">5,347&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,916&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>+8.8%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8201;As percentage of sales</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>26.9%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>26.8%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8201;Other</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">16&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;" ALIGN="right"><FONT STYLE="font-family:Arial; ">22&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>-27.3%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Figures for the 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a
consistent basis to reflect the classification of Opella as a discontinued operation. </I></P></TD></TR></TABLE><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #7802e6;width:24%">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">(3)</SUP> See definition in Section C.2., &#8220;Net income attributable to equity holders of Sanofi (IFRS measure) and
Business net income (non-IFRS financial measure).&#8221; </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>14 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.6. Consolidated statements of cash flows </B></P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Summarized consolidated
statements of cash flows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8195;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2025<BR>(6&nbsp;
months)</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;June&nbsp;30,&nbsp;2024<BR>(6&nbsp;months) <SUP
STYLE="font-size:75%; vertical-align:top">(a)</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) continuing operating activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">3,367</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,238</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) operating activities of the discontinued
Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">188</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">184</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Net cash provided by/(used in)
operating activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>3,555</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>1,422</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) continuing investing activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,979</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,355</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) investing activities of the discontinued
Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(36</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(58</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash inflow from the Opella transaction <SUP
STYLE="font-size:75%; vertical-align:top">(b)</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">10,742</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Net cash provided by/(used in)
investing activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>8,727</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(3,413</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) continuing financing activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4,441</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">92</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net cash provided by/(used in) financing activities of the discontinued
Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(48</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Net cash provided by/(used in)
financing activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(4,489</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>89</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impact of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(42</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(13</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cash and cash equivalents reported as held for sale as of December&nbsp;31,
2024</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">167</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Net change in cash and cash
equivalents</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>7,918</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>(1,915</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Cash and cash equivalents,
beginning of period</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>7,441</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>8,710</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Cash and cash equivalents, end of
period</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>15,359</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>6,795</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Figures for the 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a
consistent basis to reflect the classification of Opella as a discontinued operation. </I></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(b)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>For the six months ended June&nbsp;30, 2025, this amount includes &#128;(667)&nbsp;million in respect of cash and
cash equivalents held by Opella as of April&nbsp;30, 2025. </I></P></TD></TR></TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net cash provided by/(used in) continuing operating
activities</I></B> represented a net cash inflow of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,367&nbsp;million in the first half of 2025, against <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,238&nbsp;million in the first
half of 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Operating cash flow before changes in working capital for the first half of 2025 was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,980&nbsp;million, versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,608&nbsp;million in the first half of 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Working capital requirements decreased by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>613&nbsp;million in the first half of 2025, versus a
decrease of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,370&nbsp;million in the first half of 2024; the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">year-on-year</FONT></FONT> change mainly reflects a reduction in
provisions for rebates in the United States as a consequence of the reduction in the list price of Lantus from January&nbsp;1, 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net cash
provided by/(used in) continuing investing activities </I></B>represented a net cash outflow of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,979&nbsp;million in the first half of 2025, including the impact of the acquisition of
Dren-0201, Inc. for $602&nbsp;million (see Note B.1.2. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025). That compares with a net cash outflow of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,355&nbsp;million in the first half of 2024, resulting mainly from the acquisition of Inhibrx, Inc. for $2,035&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Acquisitions of property, plant and equipment and intangible assets totaled <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,420&nbsp;million,
versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,804&nbsp;million in the first half of 2024. There were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>845&nbsp;million of acquisitions of property, plant and equipment (versus <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>882&nbsp;million in the first half of 2024), corresponding primarily to investments in industrial facilities. Acquisitions of intangible assets
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>575&nbsp;million, versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>922&nbsp;million in the first half of 2024) mainly comprised contractual payments for intangible rights,
primarily under license and collaboration agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="white-space:nowrap">After-tax</FONT> proceeds from disposals (excluding
disposals of consolidated entities and investments in joint ventures and associates) amounted to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>434&nbsp;million in the first half of 2025, compared with
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>516&nbsp;million for the first half of 2024, and related mainly to divestments of assets and operations relating to portfolio streamlining and to disposals of equity and debt instruments. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net cash provided by/(used in) continuing financing activities</I></B> represented a net cash outflow of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,441&nbsp;million in the first half of 2025, compared with a net inflow of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>92&nbsp;million in the first half of 2024. The 2025 first-half
figure includes (i)&nbsp;the dividend payout to our shareholders of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,772&nbsp;million (versus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,704&nbsp;million in the first half
of&nbsp;2024); (ii) <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,332&nbsp;million of net external debt contracted (versus net external debt contracted of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,102&nbsp;million in the
first half of&nbsp;2024); (iii) movements in Sanofi&#8217;s share capital, including purchases of treasury shares and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>15 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">related tax effects (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,003&nbsp;million, versus
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>302&nbsp;million in the first half of 2024); and (iv)&nbsp;share capital increases of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>29&nbsp;million (compared with <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>21&nbsp;million in the first half of 2024). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The<B><I> net change in cash and cash
equivalents</I></B> in the first half of 2025 was an increase of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>7,918&nbsp;million, compared with a decrease of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,915&nbsp;million in the
first half of 2024. </P> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>C.7. Consolidated balance sheet </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Total assets were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>124,959&nbsp;million as of June&nbsp;30, 2025, versus <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>132,798&nbsp;million as of December&nbsp;31, 2024, representing a decrease of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>7,839&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Total debt</I></B> was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>20,519&nbsp;million as of June&nbsp;30, 2025, compared to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>16,137&nbsp;million as of December&nbsp;31, 2024. <B><I>Net debt</I></B> was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,102&nbsp;million as of June&nbsp;30, 2025, compared to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>8,772&nbsp;million as of December&nbsp;31, 2024. &#8220;Net debt&#8221; is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measure that is not a standardized measure, and may not be directly
comparable with the <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. Despite the use of <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measures by management in setting goals and measuring performance, this measure has no standardized meaning prescribed by IFRS. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We believe the presentation of this <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure, which is reviewed by our management, provides
useful information to measure our overall liquidity and capital resources. We define &#8220;net debt&#8221; as (i)&nbsp;the sum total of short-term debt, long-term debt, and interest rate derivatives and currency derivatives used to manage debt,
minus (ii)&nbsp;the sum total of cash and cash equivalents and interest rate derivatives and currency derivatives used to manage cash and cash equivalents. However, it should not be seen as a substitute for an IFRS measure. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;June&nbsp;30,&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" COLSPAN="2" NOWRAP ALIGN="right" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>December&nbsp;31,&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Long-term debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">13,200&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,791&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Short-term debt and current portion of long-term debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">7,309&#8196;&#8194;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,209&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Interest rate and currency derivatives used to manage debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">10&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">137&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD HEIGHT="4" COLSPAN="4" STYLE="BORDER-TOP:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Total
debt</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>20,519&#8194;&#8196;&#8194;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>16,137&#8194;&#8196;&#8194;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(15,359)&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(7,441)&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Interest rate and currency derivatives used to manage cash and cash
equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(58)&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">76&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Net debt <SUP
STYLE="font-size:75%; vertical-align:top">(a) </SUP><FONT STYLE="white-space:nowrap">(non-IFRS)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>5,102&#8194;&#8196;&#8196;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>8,772&#8194;&#8196;&#8194;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Total equity</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">70,279&#8196;&#8194;&#8196;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">77,857&#8194;&#8196;&#8194;</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.71em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Gearing ratio <FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>7.3&#8196;%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>11.3&#8196;%</B></FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Net debt does not include lease liabilities, which amounted to &#128;1,776&nbsp;million as of June&nbsp;30, 2025 and
&#128;1,906&nbsp;million as of December&nbsp;31, 2024. </I></P></TD></TR></TABLE> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The ratio of total debt to total equity increased from 20.7% as of
December&nbsp;31, 2024 to 29.2% as of June&nbsp;30, 2025. To assess our financing risk, we use the &#8220;gearing ratio&#8221;, a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure, the presentation of which we believe provides
useful information and is used by our management. This ratio (which we define as the ratio of net debt to total equity) decreased from 11.3% as of December&nbsp;31, 2024 to 7.3% as of June&nbsp;30,&nbsp;2025. Analyses of our debt as of June&nbsp;30,
2025 and December&nbsp;31,&nbsp;2024 are provided in Note B.9. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Our &#8220;gearing ratio&#8221; is not a standardized measure, and may not be directly comparable with the
<FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. Despite the use of <FONT STYLE="white-space:nowrap">non-IFRS</FONT>
measures by management in setting goals and measuring performance, this measure has no standardized meaning prescribed by IFRS and should not be seen as a substitute for any IFRS measures. </P>
<P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We expect that the future cash flows generated by our operating activities will be sufficient to repay our debt. The financing arrangements in place as
of June&nbsp;30, 2025 at the Sanofi parent company level are not subject to covenants regarding financial ratios and do not contain any clauses linking credit spreads or fees to Sanofi&#8217;s credit rating. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Other key movements in the balance sheet are described below. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Total equity was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>70,279&nbsp;million as of June&nbsp;30, 2025, versus <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>77,857&nbsp;million as of December&nbsp;31,&nbsp;2024. The net change reflects the following principal factors: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">an increase representing our net income for the first half of 2025
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,837 million); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">an decrease of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,203&nbsp;million due to currency translation
differences arising on the financial statements of foreign subsidiaries, mainly due to movements in the US dollar; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">a decrease representing the dividend payout to our shareholders of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,772&nbsp;million; and </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="1%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt">the repurchase by Sanofi of 39,344,633 of its own shares during the first half of 2025 for a total amount of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>3,988&nbsp;million, plus <FONT STYLE="font-family:Times New Roman">&#128;</FONT>15&nbsp;million of related tax payments. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">As of June&nbsp;30, 2025 we held 10.66&nbsp;million of our own shares, recorded as a deduction from equity and representing 0.868% of our
share&nbsp;capital. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Goodwill </I></B>and<B><I> Other intangible assets</I></B>
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>60,714&nbsp;million in total) decreased by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,299&nbsp;million, due mainly to the impact of exchange rates and particularly to the
fluctuation in the US dollar. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>16gggg </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Investments accounted for using the equity method</I></B> (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,563 million) increased by <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>3,247&nbsp;million. This increase primarily results from Sanofi retaining a 48.2% equity interest in OPAL JV Co following the loss of control of Opella, with CD&amp;R holding 50% and Bpifrance holding
1.8%. For further details, please refer to Note B.1. to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets</I></B>
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,109&nbsp;million) increased by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>356&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net deferred tax assets </I></B>were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>6,293&nbsp;million as of June&nbsp;30, 2025, compared
with <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,801&nbsp;million as of December&nbsp;31, 2024, an increase of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>492&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I><FONT STYLE="white-space:nowrap">Non-current</FONT> provisions and other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</I></B> (<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>7,116&nbsp;million) fell by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>980&nbsp;million relative to December&nbsp;31,&nbsp;2024. This reduction is mainly due to foreign exchange impacts (<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>522 million), and to the settlement reached on the litigation related to Plavix (clopidogrel) in the US state of Hawaii (see Note B.14. to our Condensed half-year consolidated financial statements for
the six months ended June&nbsp;30, 2025). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Liabilities related to business combinations and to
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</I></B> (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>564&nbsp;million) decreased by <FONT STYLE="font-family:Times New Roman">&#128;</FONT>77&nbsp;million. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>D. Risk factors and related party transactions </I></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>D.1. Risk factors </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The main risk factors to which Sanofi is
exposed are described in the Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2024 (the 2024 <FONT STYLE="white-space:nowrap">20-F)</FONT> filed with the US Securities and Exchange Commission on
February&nbsp;13, 2025<SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The risk &#8220;Completion of the separation of Opella is subject
to conditions that may not be satisfied and we may fail to realize any or all of the anticipated benefits of the separation and/or face unintended adverse impacts on our business&#8221; is replaced by the risk &#8220;<B>We</B> <B>may fail to realize
any or all of the anticipated benefits of the separation of Opella and/or face unintended adverse impacts on our business</B>;&#8221; and should be read as follows:<I> </I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">&#8220;On April&nbsp;30, 2025, we announced that the Opella transaction had been completed. Completion of the separation, for which we have incurred and
are expected to incur significant costs, may not achieve the expected benefits in full or in part and there is no guarantee as to the timing of when or if any such benefits may be realized. The success of the transaction and its expected benefits
will depend on several factors, including many factors outside of our control, and a number of assumptions that may prove incorrect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Further to the
separation, we may face a number of challenges relating to the implementation of the separation and to operating without the Opella business. There may be adverse financial, operational, regulatory, consumer, patient and reputational implications if
we fail (either wholly or in part) to meet such challenges. Such adverse implications could impact our financial condition, results of operations and/or prospects. For example, since the separation our business is smaller and less diversified than
previously, and is more susceptible to adverse developments in the remaining business and markets in which we operate. Accordingly, should any part of our remaining business underperform, this could have a greater adverse impact on our results or
financial condition following separation than would have been the case prior to the separation. In addition, post-separation we have greater relative exposure to the global pharmaceuticals and vaccines markets and the associated risks and will no
longer benefit from exposure to the Consumer Healthcare market we had prior to separation from the Opella business; this change makes us more reliant on R&amp;D processes (see &#8220;&#8212;Several factors may hinder or delay Sanofi&#8217;s research
and development efforts to renew Sanofi&#8217;s portfolio of medicines and vaccines&#8221; in Item 3.D. of the 2024 Form <FONT STYLE="white-space:nowrap">20-F).</FONT> There is a risk that the anticipated benefits of the separation may not be
realized as expected. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The process of separating Opella from our remaining operations may be complex, time-consuming, and resource-intensive, and
will require the separation of previously shared systems, processes, and infrastructure, which could result in unanticipated costs, delays, or ongoing operational inefficiencies. In connection with the divestiture, we are required to provide
transitional services to Opella, which will require further resources and could expose us to additional liabilities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Finally, as we retain a
holding in Opella of 48.2% with veto rights only on certain matters, we will not control operational decisions and Opella&#8217;s success will depend on its ability to retain talent and skilled professionals and take advantage of the opportunities
that lie ahead in its segment. Therefore, our remaining holding in Opella may fall in value if Opella&#8217;s strategy does not deliver the expected benefits.&#8221; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The risk &#8220;Our largest shareholder owns a significant percentage of the share capital and voting rights of Sanofi&#8221; is modified and should now
be read as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">&#8220;Following the <FONT STYLE="white-space:nowrap">buy-back</FONT> we made of a block of shares from L&#8217;Or&eacute;al in
February 2025, and after cancellation on March&nbsp;13, 2025 of said shares, as of June&nbsp;30, 2025 L&#8217;Or&eacute;al held 7.23% of Sanofi&#8217;s share capital and 13.12% of Sanofi&#8217;s effective voting rights (excluding treasury shares).
Individuals linked to L&#8217;Or&eacute;al currently serve on Sanofi&#8217;s Board of Directors. For as long as L&#8217;Or&eacute;al retains its interest in our share capital and voting rights, it will remain in a position to exert influence in the
appointment of directors and officers of Sanofi and in other corporate actions that require shareholder approval.&#8221; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Any of those risks, and
others that we may not yet have identified, could materialize during the second half of 2025 or during subsequent periods, and could cause actual results to differ materially from those described elsewhere in this report. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #7802e6;width:24%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:75%; vertical-align:top">(4)</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Available on the website of the SEC. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>17 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>D.2. Related party transactions </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Our principal related
parties are defined in Note D.33. to our consolidated financial statements included in the 2024 Form <FONT STYLE="white-space:nowrap">20-F</FONT> (page
<FONT STYLE="white-space:nowrap">F-92)</FONT><SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP>. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Note B.5. to our Condensed half-year
consolidated financial statements for the six months ended June&nbsp;30, 2025 provides a description of the main transactions and balances for the six months ended June&nbsp;30, 2025 with equity-accounted entities that qualify as related parties.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sanofi did not enter into any transactions with key management personnel during the first half of 2025. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Financial relations with the Group&#8217;s principal shareholders fall within the ordinary course of business and were immaterial in the first half of
2025. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:16pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>E. Appendix - research and development pipeline </I></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>R&amp;D Pipeline </I></FONT></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="11%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="53%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt"><FONT COLOR="#7802e6"><B>&#8201;&#8201;Registration</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Dupixent <SUP STYLE="font-size:75%; vertical-align:top">(a)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">IL4xIL13 mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Bullous pemphigoid (EU, JP, CN) Chronic spontaneous urticaria (EU)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Qfitlia <SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">RNAi targeting anti-thrombin</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Hemophilia A and B (CN)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;rilzabrutinib</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">BTK inhibitor</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Immune thrombocytopenia (US, EU, CN)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Cerezyme</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Enzyme replacement therapy</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Gaucher disease type 3 (US)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;tolebrutinib</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">BTK inhibitor</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">Non-relapsing</FONT> secondary progressive MS (US, EU)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Sarclisa</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD38 mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">NDMM, TE (HD7) (EU)</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>18 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial" ALIGN="right">2. Information on H1 2025 Financial Results </P>
<P STYLE="font-size:60pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="27%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="36%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="33%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:8.5pt" COLOR="#7802e6"><B>&#8194;Phase 3</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="5"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">&#8194;Immunology</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Dupixent<SUP STYLE="font-size:75%; vertical-align:top">(a)</SUP></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">IL4xIL13 mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic pruritus of unknown origin</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Lichen simplex
chronicus</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;itepekimab<SUP STYLE="font-size:75%; vertical-align:top">(a) (2)</SUP></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">IL33 mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic obstructive pulmonary disease</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic rhinosinusitis
with nasal polyps</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;amlitelimab</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">OX40L mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Atopic dermatitis</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Rezurock</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">ROCK2 inhibitor</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Chronic lung allograft dysfunction</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Tzield</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">CD3 mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">Type 1 diabetes</FONT></TD></TR>
<TR BGCOLOR="#999999" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Rare diseases</FONT></B></FONT></P>
<P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Nexviazyme</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Enzyme replacement therapy</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Infantile-onset Pompe disease</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;venglustat</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">Oral GCS inhibitor</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Fabry disease</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Gaucher disease type
3</P></TD></TR>
</TABLE> </DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">
 <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="29%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR BGCOLOR="#0e8041" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" COLSPAN="5"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">&#8194;Neurology</FONT></B></FONT></P> <P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;tolebrutinib</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">BTK inhibitor</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Primary progressive MS</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;frexalimab<SUP STYLE="font-size:75%; vertical-align:top">(b)</SUP></FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD40L mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Relapsing MS</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial"><FONT STYLE="white-space:nowrap">&#149;&#8195;&#8202;Non-relapsing</FONT> secondary progressive MS</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;riliprubart</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2"><FONT STYLE="font-family:Arial; ">C1s inhibitor</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial"><FONT STYLE="white-space:nowrap">&#149;&#8195;&#8202;SOC-refractory</FONT> CIDP</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;IVIg-treated CIDP</P></TD></TR>
<TR BGCOLOR="#200f45" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" COLSPAN="5"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT
 COLOR="#ffffff">&#8194;Oncology</FONT></B></FONT></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="4" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Sarclisa</FONT></TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD38 mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; ">NDMM, TE (HD7) (US)</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; ">NDMM, TE (IsKia)</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Smoldering MM (ITHACA)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">CD38 mAb subcutaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Relapsed/refractory MM (IRAKLIA)</P></TD></TR>
<TR BGCOLOR="#f9ac1c" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" COLSPAN="5" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>&#8194;Vaccines</B></P> <P STYLE="font-size:3pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Fluzone HD</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Multivalent inactivated vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu (50 years+)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0087</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Vero cell vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Rabies</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0125</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Live attenuated vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">RSV (toddlers)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0202<SUP STYLE="font-size:75%; vertical-align:top">(c)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">21-valent</FONT> conjugate vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Pneumococcal disease</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0218</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">Vero cell vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">Yellow fever</FONT></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I>(1) Also known as fitusiran, currently in phase 3
in the EU </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I>(2) Subject to further analysis and regulatory discussions </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I>Collaborations (a)&nbsp;Regeneron - (b) ImmuNext - (c) SK bioscience </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I>Abbreviations </I></P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>BTK:</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="left"><I>Bruton&#8217;s tyrosine kinase - CD: Cluster of differentiation - C1s: Complement component 1s - CIDP: Chronic
inflammatory demyelinating polyneuropathy - CN: China - EU: Europe - GCS: Glucosylceramide synthase - HD: High dose - IL: Interleukin - IVIg: Intravenous immunoglobulin - JP: Japan - mAb: Monoclonal antibody - MM: Multiple myeloma - MS: Multiple
sclerosis - NDMM: Newly diagnosed multiple myeloma - RNAi: RNA interference - ROCK2: Rho Associated coiled-coil containing protein kinase 2 - RSV: Respiratory syncytial virus - SOC: Standard of care - TE: Transplant eligible - US: United States of
America </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>19 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Exhibit 99.2</I> </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial">2. Information on H1 2025 Financial Results </P> <P STYLE="font-size:60pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P><DIV STYLE="position:relative;float:left; width:48%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:8.5pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT COLOR="#7802e6"><B>&#8194;Phase 2</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Immunology</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;Dupixent<SUP STYLE="font-size:75%; vertical-align:top">(a)</SUP></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">IL4xIL13 mAb</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">Ulcerative colitis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;itepekimab<SUP STYLE="font-size:75%; vertical-align:top">(a)</SUP></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;">IL33 mAb</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Bronchiectasis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic rhinosinusitis
without nasal polyps</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;amlitelimab</TD>
<TD VALIGN="bottom" ROWSPAN="4" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #23004c;">OX40L mAb</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Alopecia areata</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Asthma</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Celiac disease</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Systemic
sclerosis</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;rilzabrutinib</TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #23004c;">BTK inhibitor</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Asthma</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic spontaneous urticaria</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;IgG4-related
disease</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;frexalimab <SUP STYLE="font-size:75%; vertical-align:top">(b)</SUP></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;">CD40L mAb</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Systemic lupus erythematosus</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Type 1
diabetes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;balinatunfib</TD>
<TD VALIGN="bottom" ROWSPAN="3" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="3" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Oral TNFR1</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">signaling inhibitor</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Rheumatoid arthritis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Crohn&#8217;s disease</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Ulcerative
colitis</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;lunsekimig</TD>
<TD VALIGN="bottom" ROWSPAN="4" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">IL13xTSLP</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">NANOBODY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> VHH</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Asthma</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;High-risk asthma</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Atopic dermatitis</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Chronic rhinosinusitis
with nasal polyps</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;eclitasertib<SUP STYLE="font-size:75%; vertical-align:top">(c)</SUP></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">RIPK1 inhibitor</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;">Ulcerative colitis</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;brivekimig</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">TNFaxOX40L</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">NANOBODY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> VHH</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Hidradenitis suppurativa</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Type 1
diabetes</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;duvakitug<SUP STYLE="font-size:75%; vertical-align:top">(e)</SUP></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;">TL1A mAb</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Crohn&#8217;s disease</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.50em; text-indent:-1.50em; font-size:7pt; font-family:Arial">&#149;&#8195;&#8202;Ulcerative
colitis</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&#8194;riliprubart</TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #23004c;">C1s inhibitor</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Antibody-mediated</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;">rejection</TD></TR>
</TABLE> <P STYLE="font-size:36pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:8.5pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#7802e6"><B>&#8194;Phase 1</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Immunology</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR444336</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Non-beta IL2 Synthorin<SUP STYLE="font-size:75%; vertical-align:top">TM</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Inflammatory indication</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR445399<SUP STYLE="font-size:75%; vertical-align:top">(1)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">IL1R3 mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Inflammatory indication</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR445514 <SUP STYLE="font-size:75%; vertical-align:top">(f)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Trifunctional anti- BCMA NK cell engager</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Inflammatory indication</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR446422</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD28xOX40 bispecific Ab</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Inflammatory indication</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR446959</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">MMP13xADAMTS5xCAP NANOBODY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> VHH</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Knee osteoarthritis</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR448501</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">CD20 bispecific mAb</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">Inflammatory indication</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#0e8041">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#0e8041" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;</FONT>Neurology</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR446159 <SUP STYLE="font-size:75%; vertical-align:top">(g)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">SynucleinxIGF1R mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Parkinson&#8217;s disease</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR402663</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">AAV2-sFLT01 gene therapy</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">Wet age-related macular degeneration</FONT></TD></TR>
</TABLE> </DIV><DIV STYLE="position:relative;float:left; margin-left:3%; width:49%;padding-right:0%;padding-bottom:8pt;overflow:visible;padding-top:3pt">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="19"></TD>
<TD HEIGHT="19" COLSPAN="2"></TD>
<TD HEIGHT="19" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#999999">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#999999" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Rare diseases</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="1" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="1" COLSPAN="2"></TD>
<TD HEIGHT="1" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;rilzabrutinib</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">BTK inhibitor</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Warm autoimmune hemolytic anemia</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR447537</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">AAT fusion protein</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Alpha-1 antitrypsin deficiency</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">&#8194;frexalimab rilzabrutinib</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;brivekimig</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD40L mAb BTK inhibitor TNFaxOX40L NANOBODY<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> VHH</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Focal segmental glomerulosclerosis/ minimal change disease</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#200f45">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#200f45" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:10pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;</FONT>Oncology</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;Sarclisa</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CD38 mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Relapsed/refractory MM</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR447873<SUP STYLE="font-size:75%; vertical-align:top">(e)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">SSTR targeting alpha-emitter therapy</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Gastroenteropancreatic neuroendocrine tumors</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:12pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR445877</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:12pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">PD1xIL15 fusion protein</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:12pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Solid tumors</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#f9ac1c">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#f9ac1c" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; "><B>&#8194;Vaccines</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0230</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">5-valent (ACWY+B) vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Meningitis</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0256<SUP STYLE="font-size:75%; vertical-align:top"> (1)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">RSV (older adults)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0268</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Acne</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0289</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu (H5 pandemic)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0335</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Inactivated adjuvanted vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu (H5 pandemic)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="133"></TD>
<TD HEIGHT="133" COLSPAN="2"></TD>
<TD HEIGHT="133" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;Name</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Description</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Indication</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#200f45">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#200f45" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Oncology</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR445953 <SUP STYLE="font-size:75%; vertical-align:top">(h)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">CEACAM5-Topo1 ADC</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Colorectal cancer</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SAR446523</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">GPRC5D mAb</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Multiple myeloma</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#f9ac1c">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#f9ac1c" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; "><B>&#8194;Vaccines</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0237</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0287</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Fluzone HD+Nuvaxovid</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu+COVID-19</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0287</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flublok+Nuvaxovid</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">Flu+COVID-19</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0256<SUP STYLE="font-size:75%; vertical-align:top"> (2)</SUP></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">RSV+hMPV (older adults)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0291</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">RSV+hMPV+PIV3 (older adults)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8194;SP0269</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">mRNA vaccine</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">Chlamydia</FONT></TD></TR>
</TABLE> </div><div style="clear:both; height:0pt; font-size:0pt">&nbsp;</div>
 <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="justify"><I>(1) Also known as MAB212, <FONT
STYLE="white-space:nowrap">in-licensed</FONT> from MAB Discovery </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="justify"><I>Collaborations (a)&nbsp;Regeneron - (b) ImmuNext - (c) Denali - (d) Teva
Pharmaceuticals - (e) RadioMedix and Orano Med - (f) Innate Pharma - (g) ABL Bio - (h) Pfizer </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="justify"><I>Abbreviations </I></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>AAT:</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I><FONT STYLE="white-space:nowrap">Alpha-1</FONT> antitrypsin - AAV2: Adeno-associated virus type 2 - Ab: Antibody -
ADAMTS5: A Disintegrin And Metalloproteinase with Thrombospondin Motifs 5 - ADC: Antibody-drug conjugate - BCMA: <FONT STYLE="white-space:nowrap">B-Cell</FONT> maturation antigen - BTK: Bruton&#8217;s tyrosine kinase - C1s: Complement component 1s -
CAP: Cartilage anchoring protein - CD: Cluster of differentiation - CEACAM5: Carcinoembryonic antigen cell adhesion molecule 5 - GPRC5D: <FONT STYLE="white-space:nowrap">G-protein</FONT> coupled receptor family C group 5 member D - H5: hemagglutinin
5 - hMPV: human Metapneumovirus - IGF1R: Insulin-like growth factor 1 receptor - IgG4: Immunoglobulin G4 - IL: Interleukin - IL1R3: <FONT STYLE="white-space:nowrap">Interleukin-1</FONT> receptor 3 - mAb: Monoclonal antibody - MM: Multiple myeloma -
MMP13: Matrix metallopeptidase 13 - mRNA: messenger RNA - NK: Natural killer - PD1: Programmed death protein 1 &#8211; PIV3: Parainfluenza virus type 3 - RIPK1: Receptor-interacting serine/threonine protein kinase 1 - RSV: Respiratory syncytial
virus - SSTR: Somatostatin receptor - TL1A: Tumor necrosis factor-like cytokine 1A - TNFa: Tumor necrosis factor alpha - TNFR1: Tumor necrosis factor receptor 1 - Topo1: Topoisomerase - TSLP: Thymic stromal lymphopoietin </I></P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Forward-looking statements </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">This document contains
forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their
underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance.
Words such as &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;can,&#8221; &#8220;contemplate,&#8221; &#8220;could,&#8221; &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;is designed to,&#8221; &#8220;may,&#8221;
&#8220;might,&#8221; &#8220;plan,&#8221; &#8220;potential,&#8221; &#8220;objective,&#8221; &#8220;target,&#8221; &#8220;estimate,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;forecast,&#8221; &#8220;ambition,&#8221;
&#8220;guideline,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;estimates,&#8221; &#8220;plans&#8221; or the negative of these and similar expressions are intended to identify forward-looking statements but are not the exclusive means of
identifying such statements. Forward-looking statements are generally identified by the words &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;may,&#8221; &#8220;is considering,&#8221; &#8220;believes,&#8221; &#8220;intends,&#8221;
&#8220;envisages,&#8221; &#8220;aims,&#8221; &#8220;plans,&#8221; &#8220;is designed to,&#8221; &#8220;could,&#8221; &#8220;forecasts,&#8221; &#8220;predicts,&#8221; &#8220;potential,&#8221; &#8220;objective,&#8221; &#8220;estimates,&#8221;
&#8220;projects,&#8221; &#8220;is programming,&#8221; &#8220;is likely to&#8221; and &#8220;wants&#8221; or the negative thereof, and similar expressions. Although Sanofi&#8217;s management believes that the expectations reflected in such
forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi,
that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis,
including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions
regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success
of therapeutic alternatives, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future
litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that global crisis
may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the
uncertainties discussed or identified in the public filings with the US Securities and Exchange Commission (SEC) and the French <I>Autorit&eacute; des march&eacute;s financiers</I> (AMF) made by Sanofi, including those listed under &#8220;Risk
Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking Statements&#8221; in Sanofi&#8217;s Annual Report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2024. For an update on significant
litigations, refer to Note B.14. &#8220;Legal and arbitration proceedings&#8221; to our Condensed half-year consolidated financial statements for the six months ended June&nbsp;30, 2025, and to Section &#8220;A.3.2. Legal and arbitration
proceedings,&#8221; and Section C. &#8220;Risk factors and related party transactions,&#8221; of this document. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Other than as required by
applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">All trademarks
mentioned in this document are protected and are either trademarks owned by Sanofi and/or its subsidiaries, or trademarks licensed to Sanofi and/or its subsidiaries, or trademarks owned by third parties (including Regeneron and Sobi). </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%" VALIGN="top" ALIGN="left"></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><B>20 </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.3
<SEQUENCE>4
<FILENAME>d69958dex993.htm
<DESCRIPTION>EX-99.3
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.3</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="right"><FONT COLOR="#7802e6"><I>Exhibit 99.3 </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Q3 and YTD 2025 summary </I></FONT></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">The information
presented in this document relates to the three-month period ended September&nbsp;30, 2025 (referred to as &#8220;the quarter&#8221; or &#8220;Q3 2025&#8221;) and the nine-month period ended September&nbsp;30, 2025 (referred to as &#8220;the year to
date&#8221; or &#8220;YTD 2025&#8221;) compared to the three-month period ended September&nbsp;30, 2024 (referred to as &#8220;Q3 2024&#8221;) and the nine-month period ended September&nbsp;30, 2024 (referred to as &#8220;YTD 2024&#8221;),
respectively. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="40%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #000000;">
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change&#8201;</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>at CER&#8201;</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"> <P STYLE="font-size:14pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>YTD&nbsp;2025&#8201;</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change&#8194;</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER&#8194;</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;IFRS net sales reported</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>12,434m</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.0%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>32,323m</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.7%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;IFRS net income reported</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,802m</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;&#8199;&#8194;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>8,614m</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+70.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;&#8194;&#8199;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;IFRS EPS reported</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.30&#8199;&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;&#8194;&#8199;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><FONT STYLE="font-family:Times New Roman">&#128;</FONT>7.04&#8194;&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+73.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;&#8199;&#8194;</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In Q3 2025, sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>12,434&nbsp;million and increased by 2.3%.
Exchange rate movements had a negative effect of 4.7&nbsp;percentage points (pp). The divestments of medicines/portfolio streamlining had a negative impact of 0.3pp on sales growth. In YTD 2025, sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>32,323&nbsp;million and increased by 5.9% (as reported). Exchange rate movements had a negative effect of 2.8pp. The divestments of medicines/portfolio streamlining had a negative impact of
0.4pp on sales growth. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Sales by geography </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="17%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net sales</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>YTD&nbsp;2025&#8201;</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;United States</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">6,838</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">16,373&#8201;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Europe</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">2,589</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">6,733&#8201;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Rest of World</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">3,007</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">9,217&#8201;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;of which China</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>689</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>2,077&#8201;</I></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>US</I></B><B> </B>sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>6,838&nbsp;million. The
performance was primarily driven by Immunology, pharma launches, and Lantus, partly offset by Vaccines. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Europe</I></B> sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>2,589&nbsp;million. Growth was primarily driven by Beyfortus, Immunology, and pharma launches. Sales of some legacy medicines and influenza vaccines were lower. <B><I> </I></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Rest of World</I></B><B> </B>sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,007&nbsp;million. The performance was led by
Immunology, Beyfortus, and pharma launches, while many legacy medicines and vaccines declined. <B><I>China</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>689&nbsp;million in a slightly declining market, impacted by the
renewed national reimbursement drug list and volume-based procurement. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Business development </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Business development, including strategic investments in external innovation is an integral part of Sanofi&#8217;s efforts to access optionality for
promising scientific developments to contribute to pipeline replenishment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On September&nbsp;24, 2025, Sanofi announced an additional
$625&nbsp;million multi-year capital commitment to Sanofi Ventures, increasing the total assets under management to over $1.4&nbsp;billion. This new commitment to the evergreen venture fund builds on more than a decade of investing in innovative
biotech and digital health companies that align with Sanofi&#8217;s long-term growth ambitions. Sanofi Ventures is the corporate venture capital arm of Sanofi, investing in <FONT STYLE="white-space:nowrap">top-tier</FONT> biotech and artificial
intelligence/digital health companies that focus on helping patients and transforming the practice of medicine. Since its inception in 2012, the fund has deployed over $800&nbsp;million across more than 70 innovative companies in biotech and digital
health. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On August&nbsp;6, 2025, Sanofi announced the completion of its $470&nbsp;million acquisition of Vigil Neuroscience, Inc. This acquisition
strengthens Sanofi&#8217;s early-stage pipeline in neurology with <FONT STYLE="white-space:nowrap">VG-3927,</FONT> a novel, oral, small-molecule TREM2 agonist targeting Alzheimer&#8217;s disease. In addition, the acquisition of Vigil&#8217;s
preclinical pipeline will further strengthen Sanofi&#8217;s research in various neurodegenerative diseases. In June 2024, Sanofi Capital made a $40&nbsp;million strategic investment in Vigil that included the exclusive right of first negotiation for
an exclusive license, grant, or transfer of rights to research, develop, manufacture, and commercialize <FONT STYLE="white-space:nowrap">VG-3927.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">On
July&nbsp;17, 2025, Sanofi completed its acquisition of Blueprint, a <FONT STYLE="white-space:nowrap">US-based,</FONT> publicly traded biopharmaceutical company specializing in SM, a rare immunological disease, and other <FONT
STYLE="white-space:nowrap">KIT-driven</FONT> diseases. The acquisition included a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline.
Blueprint&#8217;s established presence among allergists, dermatologists, and immunologists is expected to improve Sanofi&#8217;s ability to enhance its growing immunology pipeline. The acquisition also includes elenestinib, a next-generation
medicine for SM, as well as <FONT STYLE="white-space:nowrap">BLU-808,</FONT> a highly potent and selective oral wild-type KIT inhibitor that has the potential to treat a broad range of diseases in immunology. Under the terms of the acquisition,
Sanofi paid $129.00 per share in cash at closing, representing an equity value of $9.0&nbsp;billion for 100% of the shares. Blueprint shareholders also received one <FONT STYLE="white-space:nowrap">non-tradable</FONT> contractual contingent value
right (&#8220;CVR&#8221;) per share which entitles the holders thereof to receive two potential milestone payments of $2.00 and $4.00 per CVR on the attainment of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>1 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">
future development and regulatory milestones within the applicable milestone period, respectively, for <FONT STYLE="white-space:nowrap">BLU-808.</FONT> The total equity value of the transaction,
including potential CVR payments, represented approximately $9.5&nbsp;billion on a fully diluted basis. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On July&nbsp;22, 2025, Sanofi announced
that it had entered into an agreement to acquire Vicebio Ltd (&#8220;Vicebio&#8221;), a privately held biotechnology company headquartered in London, UK. The acquisition brings to Sanofi an early-stage combination vaccine candidate for respiratory
syncytial virus and human metapneumovirus, both respiratory viruses, and is expected to expand Sanofi&#8217;s capabilities in vaccine design and development with Vicebio&#8217;s &#8216;Molecular Clamp&#8217; technology. Under the terms of the
agreement, Sanofi would acquire all of Vicebio&#8217;s share capital for a total upfront payment of $1.15&nbsp;billion, with potential milestone payments of up to $450&nbsp;million based on development and regulatory achievements. The transaction is
expected to close in the fourth quarter of 2025, subject to customary closing conditions, including receipt of regulatory approvals. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>2 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Biopharma segment </I></FONT></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Pharma </B></P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Launches </I></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Net sales</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8199;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>As&nbsp;reported</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at&nbsp;CER</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>As</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>reported</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;ALTUVIIIO</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">294</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+70.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+81.4%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">836</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+85.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+90.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Nexviazyme/Nexviadyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+27.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">587</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Sarclisa</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">155</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+36.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+41.2%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">431</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Ayvakit</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Rezurock</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">114</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.9%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">377</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cablivi</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">66</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.5%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">202</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Xenpozyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+39.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+43.9%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">167</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+47.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+50.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Tzield</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">18</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.7%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+30.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+33.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Qfitlia</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:10pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Wayrilz</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">&#8199;Total</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">1,046</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">+49.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">+57.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">2,790</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">43.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">+47.2%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>ALTUVIIIO</I></B> (hemophilia A) sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>294&nbsp;million of which 84% was in the US. Growth was driven by continued patient switches from older, short half-life and extended half-life factor medicines, from Eloctate, and from <FONT
STYLE="white-space:nowrap">non-factor</FONT> treatments. Rest of World sales of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>47&nbsp;million benefited from the launches in Japan and Taiwan, and supply sales to the collaborator Sobi. The
hemophilia A franchise (ALTUVIIIO and Eloctate combined) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>371&nbsp;million, primarily driven by ALTUVIIIO&#8217;s strong performance of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>294&nbsp;million, while Eloctate contributed <FONT STYLE="font-family:Times New Roman">&#128;</FONT>77&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Nexviazyme/Nexviadyme</I></B> (Pompe disease) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>200&nbsp;million, driven by
Europe. In the US, most patients have switched from Myozyme/Lumizyme. The Pompe disease franchise (Nexviazyme/Nexviadyme and Myozyme/Lumizyme combined) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>322&nbsp;million. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Sarclisa</I></B> (multiple myeloma) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>155&nbsp;million, supported by high growth
in all regions and driven by increased use in the front-line combination treatment setting. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Rezurock</I></B> (chronic graft-versus-host
disease, third line) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>114&nbsp;million. Sales in the US decreased by due to mandatory rebates, and sales in Europe were
-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1&nbsp;million from a <FONT STYLE="white-space:nowrap">one-time</FONT> reimbursement. In Rest of World, sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>15&nbsp;million, the
overwhelming majority in China. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Ayvakit</I></B> (mastocytosis) sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>137&nbsp;million. Ayvakit was consolidated by Sanofi from <FONT STYLE="white-space:nowrap">mid-July</FONT> following the acquisition of Blueprint Medicines Corporation. Sales were split across
the US (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>119 million), Europe (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>16 million), and Rest of World (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2 million) and
performed in line with expectations with a large opportunity to increase penetration rates in all geographies. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Cablivi</I></B> (acquired
thrombotic thrombocytopenic purpura) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>66&nbsp;million, driven by more patients being identified for treatment in the US and Europe and lower use of the US access program. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Xenpozyme</I></B> (acid sphingomyelinase deficiency) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>57&nbsp;million, mainly
driven by Europe and Rest of World. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Tzield</I></B> (delay onset of type 1 diabetes) sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>18&nbsp;million (of which <FONT STYLE="font-family:Times New Roman">&#128;</FONT>17&nbsp;million in the US) with sales reflecting improved momentum in infusions benefiting from the continued
investment in education about autoimmune type 1 diabetes and progress in screening. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Qfitlia</I></B> (hemophilia A and B) sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>4&nbsp;million, all in the US, with more patients being treated following approval in March. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Wayrilz</I></B> (immune thrombocytopenia) sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1&nbsp;million, all in the US,
following approval in August. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>3 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Immunology </I></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net sales</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>As<BR>reported</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>As<BR>reported</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Dupixent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,156&#8201;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,468&#8201;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.3</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">+22.7%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Arial" ALIGN="justify"><B><I>Dupixent</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,156&nbsp;million. For the first
time, global sales exceeded <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4&nbsp;billion in a quarter and were driven by strong demand in all approved indications (atopic dermatitis (AD), asthma, chronic rhinosinusitis with nasal polyposis,
eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, chronic obstructive pulmonary disease (COPD), bullous pemphigoid). In the US sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,073&nbsp;million driven by
volume growth in all approved indications. For the first time, US sales exceeded <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3&nbsp;billion in a quarter. In Europe, sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>504&nbsp;million also reflecting volume growth in all approved indications. In Rest of World, sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>579&nbsp;million, mainly driven by
Brazil and Asia/Pacific, partially offset by the impact of the national reimbursement drug list renewal in China in January. In YTD 2025, sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>11,468&nbsp;million, driven by strong demand
across all indications and geographies.&#8201; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Other main medicines&#8201; </I></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net sales</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3 2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>As</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>reported</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT
 COLOR="#23004c"><B>Change</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at&nbsp;CER</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD 2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>As<BR>reported</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Lantus</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">438&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.7%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,314&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Toujeo</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">321&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.2%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,013&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Fabrazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">242&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.4%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">767&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Plavix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">223&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.3%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">696&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Lovenox</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">196&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">643&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Cerezyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">161&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">524&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Alprolix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">149&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.4%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">454&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Praluent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">127&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">394&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Myozyme/Lumizyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">122&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-27.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-25.0%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">397&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-24.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Thymoglobulin</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">118&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.3%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">366&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Cerdelga</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">86&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.1%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">252&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:10pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Eloctate</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">77&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-19.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-14.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">212&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-26.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-24.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Aubagio</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">49&#8201;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">-46.7%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">-44.6%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">187&#8201;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">-37.9%</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">-36.5%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Lantus</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>438&nbsp;million. US sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>214&nbsp;million benefiting from <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">gross-to-net</FONT></FONT> adjustments and an element of windfall sales due to the unavailability of
competing medicines. Customer demand is now expected to normalize in 2026. In Europe and Rest of World, combined sales decreased, reflecting growth of Toujeo. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Toujeo</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>321&nbsp;million, driven by Rest of World where Toujeo continued
to increase its basal insulin market share. Sales in Europe and US also increased. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Fabrazyme</I></B> sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>242&nbsp;million and broadly stable with a slight growth in the number of patients outside the US. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Plavix</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>223&nbsp;million, with volume growth in Rest of World (majority
of sales, <FONT STYLE="font-family:Times New Roman">&#128;</FONT>200 million), including from volume-based procurement in China. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Lovenox</I></B><SUP STYLE="font-size:75%; vertical-align:top"> </SUP>sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>196&nbsp;million, impacted by biosimilar competition in Europe. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Cerezyme</I></B><B>
</B>sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>161&nbsp;million, with a slight growth in the number of patients. The Gaucher disease franchise (Cerezyme and Cerdelga) sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>247&nbsp;million and increased by 4.1%. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Alprolix</I></B> sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>149&nbsp;million, driven by supply sales to the collaborator Sobi. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Praluent</I></B> sales
were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>127&nbsp;million with higher sales in Europe offset by lower sales in Rest of World. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Myozyme/Lumizyme</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>122&nbsp;million as patients switch to
Nexviazyme/Nexviadyme. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Thymoglobulin</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>118&nbsp;million, reflecting
higher sales in the US and Rest of World. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Cerdelga</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>86&nbsp;million
with growth in the number of patients. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>4 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Eloctate</I></B> sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>77&nbsp;million as patients switch to ALTUVIIIO. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Aubagio</I></B><SUP
STYLE="font-size:75%; vertical-align:top"> </SUP>sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>49&nbsp;million with loss of exclusivity in 2023. Aubagio sales will decrease further. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Vaccines </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net sales</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>As</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>reported</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>Change</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025&#8201;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>As</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>reported</B></FONT></P> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>Change</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>at CER</B></FONT></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Influenza, <FONT STYLE="white-space:nowrap">COVID-19</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,525&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-20.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-16.8%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,739&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-17.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Beyfortus</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">739&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.8%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,095&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+33.8%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Polio/Pertussis/Hib primary and booster vaccines</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">642&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.2%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">2,003&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.8%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:10pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Meningitis, travel, and endemic</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">451&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-6.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-1.9%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,060&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">-0.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:10pt ;"><FONT STYLE="font-family:Arial; ">+2.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">&#8194;Total</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:6pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">3,357&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:6pt ;"><FONT STYLE="font-family:Arial; " COLOR="#ffffff">5,897&#8201;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Vaccines</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,357&nbsp;million, driven by
lower sales of influenza vaccines. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Influenza, <FONT STYLE="white-space:nowrap">COVID-19</FONT> vaccines</I></B> sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>1,525&nbsp;million. Sales in Europe were impacted by competitive price pressure, mainly in Germany while sales in the US were also impacted by a lower vaccination rate early in the season. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Beyfortus</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>739&nbsp;million. Sales in Europe and Rest of World were
driven by geographical <FONT STYLE="white-space:nowrap">roll-out</FONT> of infant protection; Beyfortus now protects infants in more than 40 countries. Sales in the US were reduced by a high comparison and existing inventory levels at the beginning
of the season. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Polio/Pertussis/Hib (PPH) primary and booster vaccines</I></B> sales were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>642&nbsp;million, reduced by delivery phasing earlier in the year of primary vaccine sales in some public markets. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Meningitis, travel, and endemic vaccines</I></B> sales were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>451&nbsp;million, driven by
lower sales of meningitis vaccines in all geographies partly offset by higher sales of travel vaccines. </P> <P STYLE="margin-top:48pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Pipeline update </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Sanofi has 94 projects in a pipeline across four main disease areas (Immunology, Rare diseases, Neurology, and selectively in Oncology) and Vaccines,
including 44 potential new medicines and vaccines. The following section highlights significant developments in the late- and <FONT STYLE="white-space:nowrap">mid-stage</FONT> pipeline since the prior results press release. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Highlights </I></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="28%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="71%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Regulatory approvals</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000; BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Wayrilz &#8211; ITP (US)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Tzield &#8211; T1D, stage 2, delay onset of stage 3 (CN)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Regulatory submission acceptances</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Dupixent &#8211; CSU children (US, EU)</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Tzield &#8211; T1D, stage 3, delay progression (US, CNPV review)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Wayrilz &#8211; ITP
(JP)</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Sarclisa &#8211; subcutaneous formulation (US, EU, JP, CN)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Phase 3 data readouts</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">amlitelimab &#8211; AD (COAST 1) &#8211; primary endpoints
met</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Fluzone HD &#8211; influenza 50 years+ &#8211; primary endpoint met</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Phase 3 study starts</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">lunsekimig &#8211; COPD (PERESEPHONE)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">Wayrilz &#8211; SCD, wAIHA</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Regulatory designations</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-right:2pt;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Wayrilz &#8211;
<FONT STYLE="white-space:nowrap">IgG4-RD</FONT> orphan (EU)</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">SAR446268 &#8211; DM1 fast track (US)</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">SAR402663 &#8211; wet AMD fast track (US)</P></TD></TR>
</TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Immunology </I></FONT></P>
<P STYLE="margin-top:13pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>Dupixent</B> <FONT STYLE="font-family:Arial; font-size:8.5pt">(dupilumab)</FONT><FONT STYLE="font-family:Arial; font-size:10pt"> </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><STRIKE>


<IMG SRC="g69958dsp6c.jpg" ALT="LOGO">
</STRIKE></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B><STRIKE></STRIKE></B>The European Medicines Agency (EMA)&#8217;s Committee for Medicinal Products for Human Use
(CHMP) adopted a positive opinion recommending the approval of Dupixent in the EU for the treatment of <B>chronic</B> <B>spontaneous</B> <B>urticaria</B> (CSU) in adults and adolescents. This recommendation covers those aged 12 years and above with
moderate to severe disease, with inadequate response to <FONT STYLE="white-space:nowrap">histamine-1</FONT> antihistamines, and who are naive to anti-immunoglobulin E therapy. A final decision is expected in the coming months. Dupixent is approved
for CSU in certain adults and adolescents in several countries including Japan and the US. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6b.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>The US Food and Drug Administration (FDA) accepted for review the regulatory submission of the supplemental
biologics license application (sBLA) for Dupixent to treat <B>CSU</B> in children. The target action date for the FDA decision is April&nbsp;27, 2026. A regulatory submission was also accepted in the EU. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>5 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Rezurock</B></FONT><FONT
STYLE="font-family:Arial; font-size:8.5pt"> (belumosudil) </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The CHMP issued a negative opinion on the marketing authorisation application of
Rezurock for the third-line treatment of adults and children with <B>chronic</B> <B>graft-versus-host</B> <B>disease</B> (cGVHD). Sanofi will seek a <FONT STYLE="white-space:nowrap">re-examination</FONT> of the CHMP opinion. cGVHD is a
life-threatening complication that devastates the lives of up to 50% of patients who undergo a stem cell transplant. cGVHD is considered one of the main causes of morbidity and late <FONT STYLE="white-space:nowrap">non-relapse</FONT> mortality after
stem cell transplant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Tzield</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt">
(teplizumab) </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>The Chinese National Medical Products Administration (NMPA) approved Tzield as the first disease-modifying
therapy in <B>autoimmune</B> <B>type</B> <B>1</B> <B>diabetes</B> (T1D) indicated to delay the onset of stage 3 T1D in adult and children aged eight years and older with stage 2 T1D. The review was completed under priority review, following the
recognition by NMPA of Tzield&#8217;s innovative profile and the benefit it brings to children. Tzield is approved for the treatment of adults and children aged eight years and older, living with stage 2 T1D, in the US, with regulatory reviews
ongoing in the EU. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>The FDA accepted for expedited review the sBLA for Tzield to delay the progression of stage 3 T1D in adults
and children eight years of age and older recently diagnosed with stage 3 T1D. The FDA nominated Tzield for the Commissioner&#8217;s National Priority Voucher (CNPV) pilot program based on its potential to address a large unmet medical need. The
CNPV program aims to shorten the review process from what normally takes <FONT STYLE="white-space:nowrap">10-12</FONT> months to <FONT STYLE="white-space:nowrap">1-2</FONT> months, while maintaining FDA&#8217;s rigorous safety and efficacy
standards. Tzield had previously been granted priority review for the sBLA. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>amlitelimab</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (OX40L mAb) </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><STRIKE>


<IMG SRC="g69958dsp6c.jpg" ALT="LOGO">
</STRIKE></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B><STRIKE></STRIKE></B>Positive results from the global COAST 1 phase 3 study (clinical study identifier:
NCT06130566) showed that amlitelimab, a fully human <FONT STYLE="white-space:nowrap">non-T</FONT> cell depleting monoclonal antibody (mAb) that targets OX40-ligand (OX40L), dosed either every four weeks (Q4W) or every 12 weeks (Q12W), met all
primary and key secondary endpoints, demonstrating statistically significant and clinically meaningful skin clearance and disease severity compared to placebo at Week 24 in patients aged 12 years and older with <B><FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT></B> <B>atopic</B> <B>dermatitis</B> (AD). Amlitelimab was well-tolerated, with no new safety concerns identified in this study. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:8.5pt; font-family:Arial" ALIGN="justify">For US and US reference countries, the primary endpoint was the proportion of patients with a validated investigator global assessment
for AD <FONT STYLE="white-space:nowrap">(vIGA-AD)</FONT> of 0 (clear) or 1 (almost clear) and a reduction from baseline score of <FONT STYLE="font-family:Times New Roman">&#8805;</FONT>2 points. For the EU, EU reference countries and Japan, the <FONT
STYLE="white-space:nowrap">co-primary</FONT> endpoints comprised the proportion of patients with <FONT STYLE="white-space:nowrap">vIGA-AD</FONT> 0/1 and a reduction from baseline score of <FONT STYLE="font-family:Times New Roman">&#8805;</FONT>2
points along with the proportion of patients reaching a 75% or greater improvement in the eczema area and severity index total score <FONT STYLE="white-space:nowrap">(EASI-75).</FONT> In both treatment arms, a progressive increase in efficacy
without plateau was observed during the treatment period. The study&#8217;s key secondary endpoints were also achieved across both dosing arms at Week 24. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:8.5pt; font-family:Arial" ALIGN="justify">The OCEANA clinical development program of amlitelimab in AD, which includes COAST 1 and four other phase 3 studies (SHORE, COAST 2,
AQUA, and ESTUARY) is anticipated to read out through 2026 and comprises the foundation for potential global regulatory submissions. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>At the European Respiratory Society International Congress in Amsterdam, Netherlands, exploratory efficacy
data from the TIDE-Asthma phase 2 study (clinical study identifier: NCT05421598) in patients with <B><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT></B> <B>asthma</B> were presented. While the
primary endpoint of annualized asthma exacerbation rate (AAER) reduction at Week 48 did not reach statistical significance at the 250 mg dose, notable improvements were observed across key secondary endpoints, including <FONT
STYLE="white-space:nowrap">pre-bronchodilator</FONT> forced expiratory volume in one second <FONT STYLE="white-space:nowrap">(pre-BD</FONT> FEV<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB>) and improvements in asthma control
questionnaire <FONT STYLE="white-space:nowrap">(ACQ-5)</FONT> scores. In a <FONT STYLE="white-space:nowrap">post-hoc</FONT> analysis, patients with potential evidence of mixed-type inflammation based on elevated blood neutrophils (<FONT
STYLE="font-family:Times New Roman">&#8805;</FONT>4000 cells/&micro;L) and eosinophils (<FONT STYLE="font-family:Times New Roman">&#8805;</FONT>300 cells/&micro;L) showed the greatest benefit with amlitelimab, including greater reductions in AAER,
and larger improvements in <FONT STYLE="white-space:nowrap">pre-BD</FONT> FEV<SUB STYLE="font-size:75%; vertical-align:bottom">1</SUB> and <FONT STYLE="white-space:nowrap">ACQ-5</FONT> scores. Amlitelimab was well-tolerated, with no new safety
concerns identified in this study. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>lunsekimig</B></FONT><FONT
STYLE="font-family:Arial; font-size:8.5pt"> (IL13xTSLP Nanobody&reg; VHH) </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Two <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> phase 2b/3 studies of two dosing intervals of subcutaneous lunsekimig compared with placebo commenced dosing the first patient in the Chronic Obstructive Pulmonary Disease (<B>COPD</B>)<B>
</B>program; PERSEPHONE (clinical study identifier: NCT07190209) and THESEUS (clinical study identifier: NCT07190222). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT
STYLE="font-family:Arial; font-size:10pt"><B>brivekimig</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (TNFxOX4OL Nanobody&reg; VHH) </FONT></P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><STRIKE>


<IMG SRC="g69958dsp6c.jpg" ALT="LOGO">
</STRIKE></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B><STRIKE></STRIKE></B>At the European Academy of Dermatology and Venereology Congress in Paris, France, data from
the <FONT STYLE="white-space:nowrap">HS-OBTAIN</FONT> phase 2a study (clinical study identifier: NCT05849922) was presented. The <FONT STYLE="white-space:nowrap">HS-OBTAIN</FONT> phase 2a study is a randomized, double-blind, placebo-controlled, <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> study assessing the efficacy and safety of brivekimig in adults with
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> <B>hidradenitis</B> <B>suppurativa</B> (HS). The data showed that treatment with subcutaneous brivekimig 150 mg every two weeks led to clinically
meaningful improvements in the primary endpoint of Hidradenitis Suppurativa Clinical Response (HiSCR50) in patients na&iuml;ve to biologics with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT>
hidradenitis suppurativa. Brivekimig was well tolerated, with no serious adverse events. HS is a chronic and debilitating inflammatory skin disease characterized by painful cutaneous nodules, abscesses and draining tunnels. For example,
approximately 196,000 adults in the EU live with HS. </P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:2%; font-size:8.5pt; font-family:Arial" ALIGN="justify">The randomized, double-blind, placebo-controlled,
dose-ranging BRIGHTEN phase 2b study (clinical study identifier: NCT07170917) of brivekimig in patients with <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">moderate-to-severe</FONT></FONT> HS will commence soon. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>6 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>Two <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> phase 2
studies of different dose regimens of subcutaneous brivekimig compared with placebo commenced dosing the first patients in <B>Crohn&#8217;s disease</B> (clinical study identifier: NCT06958536) and <B>ulcerative colitis</B> (UC) (clinical study
identifier: NCT06975722). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>balinatunfib</B></FONT><FONT
STYLE="font-family:Arial; font-size:8.5pt"> (oral <FONT STYLE="white-space:nowrap">anti-TNF)</FONT> </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">During the quarter, data from a phase 2
study (clinical study identifier: NCT06073093) of balinatunfib in patients with <B>rheumatoid</B> <B>arthritis</B> (RA) not adequately controlled with methotrexate (MTX) and naive to advanced treatments finished its analysis. The study assessed the
safety and efficacy of balinatunfib at four dose schedules against placebo on a background of MTX standard treatment using established RA endpoints. The primary endpoint assessment using ACR20 did not achieve statistical significance due to a very
high placebo response of more than 50%. However, when assessing endpoints requiring deeper disease control, including ACR50, ACR70, and <FONT STYLE="white-space:nowrap">low-disease</FONT> activity <FONT STYLE="white-space:nowrap">DAS28-CRP</FONT><FONT
STYLE="font-family:Times New Roman">&#8804;</FONT>3.2, the efficacy signal was clinically meaningful. Balinatunfib was generally well tolerated over the short treatment period of 12 weeks and the safety profile was consistent with prior studies. The
future development strategy for balinatunfib is currently being evaluated, including the potential to become a combination backbone for internal as well as externally partnered oral medicines for the treatment of RA and other diseases in which TNF
plays a key role in the pathophysiology of the disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>Rare diseases </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Wayrilz</B> </FONT><FONT STYLE="font-family:Arial; font-size:8.5pt">(rilzabrutinib) </FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>The FDA approved Wayrilz for adults with persistent or chronic <B>immune</B> <B>thrombocytopenia</B> (ITP) who
have had an insufficient response to a previous treatment. The approval was based on the pivotal LUNA 3 phase 3 study, in which Wayrilz met the primary and secondary endpoints, showing a positive impact on sustained platelet counts and other ITP
symptoms. As a novel, oral, reversible, Bruton&#8217;s tyrosine kinase inhibitor, Wayrilz can help address the root causes of ITP through multi-immune modulation, targeting different pathways across the immune system. Wayrilz is currently under
regulatory review for ITP in the EU, Japan (submitted during the quarter), and China. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:2%; font-size:8.5pt; font-family:Arial" ALIGN="justify">The CHMP adopted a
positive opinion recommending the approval of Wayrilz as a new treatment for ITP in adult patients who are refractory to other treatments. A final decision is expected in the coming months. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B><STRIKE>


<IMG SRC="g69958dsp6c.jpg" ALT="LOGO">
</STRIKE></B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B><STRIKE></STRIKE></B>The EMA granted orphan designation to Wayrilz for <B>IgG4-related</B> <B>disease</B> <FONT
STYLE="white-space:nowrap">(IgG4-RD).</FONT> EMA grants orphan designation to potential new medicines addressing rare, life-threatening, or debilitating diseases or conditions that affect no more than 5 in 10,000 persons in the EU. In addition to <FONT
STYLE="white-space:nowrap">IgG4-RD,</FONT> Wayrilz has received orphan designations for ITP in the US, the EU, and Japan; and for warm autoimmune hemolytic anemia (wAIHA), <FONT STYLE="white-space:nowrap">IgG4-RD,</FONT> and sickle cell disease
(SCD) in the US. Wayrilz has also been granted fast track designation in the US in ITP and <FONT STYLE="white-space:nowrap">IgG4-RD.</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>Two phase 3 studies of Wayrilz commenced dosing the first patients in rare diseases. One study will assess the
medicine in <B>SCD</B>, LIBRA (clinical study identifier: NCT06975865) and one study in <B>wAIHA</B>, LUMINA 3 (clinical study identifier: NCT07086976). </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>A <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> phase 2
study (clinical study identifier: NCT06984627) of two dose regimens of Wayrilz in patients with <B>Graves&#8217;</B> <B>disease</B> commenced dosing the first patient. Graves&#8217; disease, also known as toxic diffuse goiter or Basedow&#8217;s
disease, is an autoimmune disease that affects the thyroid. It frequently results in and is the most common cause of hyperthyroidism and it also often results in an enlarged thyroid. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>SAR447537</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (efdoralprin alfa) </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Positive results from the global ElevAATe phase 2 study (clinical study identifier: NCT05856331) showed that efdoralprin alfa (formerly known as <FONT
STYLE="white-space:nowrap">INBRX-101),</FONT> met all primary and key secondary endpoints when dosed every three weeks (Q3W) or four weeks (Q4W) in adults with <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin deficiency (AATD) emphysema,
a rare disease. Efdoralprin alfa is a recombinant human <FONT STYLE="white-space:nowrap">alpha-1</FONT> antitrypsin <FONT STYLE="white-space:nowrap">(AAT)-Fc</FONT> fusion protein. It demonstrated a statistically significant greater mean increase in
functional AAT levels within normal range as measured by trough concentrations at steady state compared to those receiving weekly plasma-derived augmentation therapy at Week 32 [p&lt;0.0001]. The study also met key secondary endpoints, demonstrating
superior mean increase in fAAT average concentration as well as higher percentage of days above the lower limit of the normal range for both Q3W and Q4W dosing. Efdoralprin alfa was well tolerated with a similar adverse event profile to
plasma-derived therapy. Additional safety <FONT STYLE="white-space:nowrap">follow-up</FONT> is being assessed in the ElevAATe OLE phase 2 study (clinical study identifier: NCT05897424). Efdoralprin alfa was previously granted fast track and orphan
drug designation by FDA for the treatment of AATD emphysema. Sanofi plans to present the data at a forthcoming medical meeting and engage with global regulatory authorities on the appropriate next steps. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>SAR446268</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (DMPK-silencing gene therapy)
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The FDA granted fast-track designation to SAR446268, a <FONT STYLE="white-space:nowrap">one-time</FONT> gene therapy for the treatment of
<B><FONT STYLE="white-space:nowrap">non-congenital</FONT></B> <B>(juvenile</B> <B>and</B> <B>adult</B> <B>onset)</B> <B>myotonic</B> <B>dystrophy</B> <B>type</B> <B>1</B> (DM1), long known as Steinert disease. SAR446268 is the only potential new
gene therapy in clinical development for this disease, and there are no currently approved treatments for DM1. SAR446268 is expected to advance into a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human,</FONT></FONT>
phase 1/2 study (clinical study identifier: NCT06844214) in late 2025. Sanofi has already been granted orphan designations for SAR446268 in both the US (July 2024) and EU (October 2024). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>Neurology </I></FONT></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>7 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>tolebrutinib</B></FONT><FONT
STYLE="font-family:Arial; font-size:8.5pt"> (BTK inhibitor) </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The FDA extended by three months the target action date of its review of the new
drug application (NDA) of tolebrutinib to treat <FONT STYLE="white-space:nowrap">non-relapsing</FONT> <B>secondary</B> <B>progressive</B> <B>multiple</B> <B>sclerosis</B> (SPMS) and to slow disability accumulation independent of relapse activity in
adult patients. Based on the submission of additional analyses during the review, the FDA determined that the additional information constituted a major amendment to the NDA and extended the target action date accordingly. The revised target action
date for the FDA decision is December&nbsp;28, 2025. In addition to the extended regulatory review in the US, tolebrutinib is being reviewed by other regulatory agencies, including in the EU. As part of the ongoing regulatory dialogue to establish
the appropriate benefit/risk profile of tolebrutinib, agencies are focused on the target patient population, comparing efficacy across populations, and the proposed safety risk mitigation plan to address liver toxicity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>SAR402663</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (FLT01-encoding gene therapy)
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The FDA granted fast-track designation to SAR402663, a <FONT STYLE="white-space:nowrap">one-time,</FONT> intravitreal gene therapy for the
treatment of neovascular (or &#8216;wet&#8217;) <B><FONT STYLE="white-space:nowrap">age-related</FONT></B> <B>macular</B> <B>degeneration</B> (AMD). SAR402663 is currently in a phase 1/2 study (clinical study identifier: NCT06660667). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>Oncology </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT
STYLE="font-family:Arial; font-size:10pt"><B>Sarclisa</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (isatuximab) </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The FDA
accepted for review the regulatory submission of the sBLA for subcutaneous Sarclisa in <B>multiple</B> <B>myeloma</B>. The target action date for the FDA decision is April&nbsp;23, 2026. Regulatory submissions were also completed in the EU, Japan,
and China. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>SAR447873</B></FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"> (<SUP
STYLE="font-size:75%; vertical-align:top">212</SUP><FONT STYLE="white-space:nowrap">Pb-dotamtate)</FONT> </FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">At the 2025 European Society for
Medical Oncology Congress, Berlin, Germany, positive data from the <FONT STYLE="white-space:nowrap">ALPHAMEDIX-02</FONT> phase 2 study (clinical study identifier: NCT05153772) showed that SAR447873, a somatostatin receptor (SSTR)-targeted alpha
therapy using the <FONT STYLE="white-space:nowrap">lead-212</FONT> isotope, met all primary efficacy endpoints and showed clinically meaningful overall response rates and prolonged clinical benefits in both peptide receptor radionuclide therapy <FONT
STYLE="white-space:nowrap">(PRRT)-na&iuml;ve</FONT> and PRRT-exposed patients with unresectable or metastatic SSTR-positive <B>gastroenteropancreatic</B> <B>neuroendocrine</B> <B>tumors</B> <FONT STYLE="white-space:nowrap">(GEP-NETs).</FONT>
Benefits in key secondary endpoints, including progression-free survival and overall survival, were also observed across both cohorts. SAR447873 had a manageable safety profile that was similar across both cohorts. In February 2024, the medicine was
designated a breakthrough therapy by the FDA for treatment of <FONT STYLE="white-space:nowrap">PRRT-na&iuml;ve</FONT> patients with unresectable or metastatic, progressive SSTR-expressing <FONT STYLE="white-space:nowrap">GEP-NETs.</FONT> Next steps
for SAR447873 will be decided following discussions with health authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial" ALIGN="justify"><FONT COLOR="#7802e6"><I>Vaccines </I></FONT></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Efluelda</B> </FONT><FONT STYLE="font-family:Arial; font-size:8.5pt">(influenza) </FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">New data from the <FONT STYLE="white-space:nowrap">FLUNITY-HD</FONT> phase 4 study (clinical study identifier: NCT06506812), published in The Lancet,
demonstrated that Efluelda (Fluzone High-Dose in North America) significantly reduced the risk of hospitalizations in adults 65 years and older compared to standard-dose <B>influenza</B>
vaccines<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>. This was the largest influenza vaccine effectiveness study of individually randomized older adults, involving nearly half a million participants across multiple seasons and two
geographic areas. This study provided robust evidence that the high-dose influenza vaccine offers superior protection against the severe complications of influenza, including: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">- 31.9% (95% CI, 19.7 to 42.2; p&lt;0.001) additional reduction in <FONT STYLE="white-space:nowrap">lab-confirmed</FONT> influenza hospitalizations </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">- 8.8% (95% CI, 1.7 to 15.5; p=0.008) additional protection against pneumonia/influenza hospitalizations </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">- 6.3% (95% CI, 2.5 to 10.0; p&lt;0.001) additional reduction in hospitalizations for cardio-respiratory events </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">- 2.2% (95% CI, 0.3 to 4.1; p=0.012) additional protection against <FONT STYLE="white-space:nowrap">all-cause</FONT> hospitalizations, meaning one
additional hospitalization could be averted for every 515 (95% CI, 278 to 3,929) individuals vaccinated with Efluelda instead of a standard-dose flu vaccine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Nuvaxovid</B>
</FONT><FONT STYLE="font-family:Arial; font-size:8.5pt"><FONT STYLE="white-space:nowrap">(COVID-19)</FONT> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In October, Novavax announced
that it had completed the transfer of the EU marketing authorisation for Nuvaxovid in <B><FONT STYLE="white-space:nowrap">COVID-19</FONT></B> prevention to Sanofi, enabling Sanofi to take control of commercial and regulatory activities. The
marketing authorization transfer in the US is ongoing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><FONT STYLE="font-family:Arial; font-size:10pt"><B>Fluzone HD</B> </FONT><FONT
STYLE="font-family:Arial; font-size:8.5pt">(influenza 50 years+) </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Fluzone High-Dose (HD) / Efluelda is approved in many jurisdictions
(including the US and EU) to prevent <B>influenza</B> in people aged 65 years and above. A phase 3 study (clinical study identifier: NCT06641180) in people aged 50 to 64 years read out positively on safety and immunogenicity at an interim analysis,
supporting planned regulatory submissions in 2026 for a potential label extension down to adults aged 50 years and older. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP> The standard-dose influenza vaccines used in the
<FONT STYLE="white-space:nowrap">FLUNITY-HD</FONT> study were VaxigripTetra (Sanofi) and InfluvacTetra (a registered trademark of Viatris). </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><I>Standard-dose vaccines often serve as the primary influenza prevention option for the general population. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>8 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>SP0125 </B><FONT STYLE="font-family:Arial; font-size:8.5pt">(RSV toddler)</FONT><FONT
STYLE="font-family:Arial; font-size:10pt"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The SP0125 program for the prevention of respiratory syncytial virus (RSV)-related disease in
toddlers was recently discontinued following a planned futility analysis conducted by an independent data monitoring committee (IDMC). The decision was due to insufficient efficacy seen in the main PEARL phase 3 study (clinical study identifier:
NCT06252285). The safety profile was acceptable, and no signals of vaccine-associated enhanced respiratory disease were observed by the IDMC. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>SP0287 </B><FONT STYLE="font-family:Arial; font-size:8.5pt">(Fluzone HD/Flublok and Nuvaxovid)</FONT><FONT STYLE="font-family:Arial; font-size:10pt">
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The SP0287 program consists of two combination vaccine candidates: the inactivated <B>influenza</B> vaccine Fluzone High-Dose (HD) or the
recombinant-protein influenza vaccine Flublok and the adjuvanted recombinant <B><FONT STYLE="white-space:nowrap">COVID-19</FONT></B> vaccine Nuvaxovid. The phase 1/2 study of each combination (clinical study identifiers: NCT06695117 and NCT06695130)
completed with preliminary positive safety and immunogenicity results. Sanofi will engage with regulatory authorities to discuss next step for this program. </P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>SP0289 </B><FONT STYLE="font-family:Arial; font-size:8.5pt">(influenza, H5 pandemic, mRNA)</FONT><FONT STYLE="font-family:Arial; font-size:10pt">
</FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">The phase 1/2 study (clinical study identifier: NCT06744205) of the SP0289 vaccine candidate to prevent <B>H5</B> <B>pandemic</B>
<B>influenza</B> showed a good safety profile and strong immunogenicity results, with <FONT STYLE="white-space:nowrap">90-100%</FONT> of people achieving seroprotection after two doses across all formulations tested. Sanofi is evaluating the next
steps for this program. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial" ALIGN="justify"><B>SP0335 </B><FONT STYLE="font-family:Arial; font-size:8.5pt">(influenza, H5 pandemic, inactivated adjuvanted)</FONT><FONT
STYLE="font-family:Arial; font-size:10pt"> </FONT></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In September, Novavax announced that it had expanded Sanofi&#8217;s license to include use of
Novavax&#8217;s <FONT STYLE="white-space:nowrap">Matrix-M</FONT> adjuvant with SP0335, a second vaccine candidate to prevent <B>H5</B> <B>pandemic</B> <B>influenza</B>. Sanofi received funding from the Biomedical Advanced Research and Development
Authority within the Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services in the US, for early-stage clinical work on this vaccine candidate including the
<FONT STYLE="white-space:nowrap">Matrix-M</FONT> adjuvant. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Anticipated major upcoming pipeline milestones </I></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="42%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="26%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>Medicine/vaccine</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>Indication</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>Description</B></FONT></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="11" STYLE="BORDER-TOP:1px solid #000000; BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>Q4
2025</B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Dupixent</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">CSU</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">allergic fungal rhinosinusitis</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">teplizumab</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">T1D, stage 2, delay onset of stage 3</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">T1D, stage 3, delay progression</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Wayrilz</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">ITP</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Qfitlia</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">hemophilia A/B</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (CN)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">tolebrutinib</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SPMS</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">primary progressive multiple sclerosis (PPMS)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SP0087</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">rabies</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US, EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SP0230</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">meningitis</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 2 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SP0256</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">RSV (older adults)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 2 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="16" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>H1 2026</B></FONT></P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Dupixent</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">BP</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU, JP, CN)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">CSU children</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (US, EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">amlitelimab</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">AD</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data (full readout)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">lunsekimig</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">asthma</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 2 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">eclitasertib</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">UC</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 2 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Tzield</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">T1D, stage 3, delay progression</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Cerezyme</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">GD3</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Nexviazyme</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">infantile-onset Pompe disease (IOPD)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="4" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="4" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">venglustat</P></TD>
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Fabry disease</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">GD3</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Sarclisa</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">subcutaneous formulation</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (US, EU, JP)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" ROWSPAN="2" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" ROWSPAN="2" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">tolebrutinib</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SPMS</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">PPMS</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US, EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Fluzone HD</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">influenza (50 years+)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" ROWSPAN="7" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#23004c"><B>H2 2026</B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Dupixent</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">lichen simplex chronicus</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">amlitelimab</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">AD</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Wayrilz</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">ITP</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory decision (CN)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Nexviazyme</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">infantile-onset Pompe disease</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">efdoralprin alfa</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">AATD emphysema</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (US)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Fluzone HD</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">influenza (50 years+)</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">regulatory submission (EU)</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">SP0218</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">yellow fever</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">phase 3 data</P></TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><I>. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>9 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><B><I>Q3 and YTD 2025 financial results </I></B></FONT></P>
<P STYLE="margin-top:16pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Net income attributable to equity holders of Sanofi (IFRS measure) and Business net income <FONT STYLE="white-space:nowrap">(non-IFRS</FONT> measure)<SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net sales</I></B> were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>12,434&nbsp;million in Q3 2025 and increased by 2.3% (7.0% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>12,157&nbsp;million in Q3 2024. In YTD 2025, net sales were <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>32,323&nbsp;million and increased by 5.9% (8.7% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>30,517&nbsp;million in YTD 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Other revenues</I></B> were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>736&nbsp;million in Q3 2025 and decreased by 10.2% (5.9% at
CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>820&nbsp;million in Q3 2024. VaxServe sales of <FONT STYLE="white-space:nowrap">non-Sanofi</FONT> products were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>484&nbsp;million
and decreased by 5.7% at CER. In addition, other revenues included sales of Opella products in certain markets (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>125 million), manufacturing services and other (<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>67 million), royalties (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>32 million), and supply sales to Opella (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>28 million). In YTD 2025,
other revenues were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,188&nbsp;million and decreased by 6.9% (4.6% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,349&nbsp;million in YTD 2024. VaxServe sales of <FONT
STYLE="white-space:nowrap">non-Sanofi</FONT> products were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,326&nbsp;million and decreased by 2.3% at CER. In addition, other revenues included manufacturing services and other (<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>342 million), sales of Opella products in certain markets (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>331 million), royalties (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>100
million), and supply sales to Opella, etc. (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>89 million). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Gross profit
</I></B>(IFRS)<I> </I>was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>9,758&nbsp;million in Q3 2025 and <FONT STYLE="font-family:Times New Roman">&#128;</FONT>9,314&nbsp;million in Q3 2024. <B><I>Business gross profit</I></B><SUP
STYLE="font-size:75%; vertical-align:top">2</SUP> <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT> was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>9,815&nbsp;million in Q3 2025 and
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>9,317&nbsp;million in Q3 2024. Business gross profit in Q3 2025 is equal to the Gross profit for Q3 2025 excluding a <FONT STYLE="font-family:Times New Roman">&#128;</FONT>(57)&nbsp;million
release of the fair value step up to inventory, relating to the acquisition of Blueprint. In YTD 2025, gross profit was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>25,218&nbsp;million from
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>23,237&nbsp;million in YTD 2024, and business gross profit was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>25,275&nbsp;million and
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>23,247&nbsp;million in YTD 2024. Generally, the improvements in Q3 and YTD 2025 were driven by a portfolio shift towards specialty care and enhanced product mix. Specifically, in Q3 2025, the
improvement also benefitted from lower inventory <FONT STYLE="white-space:nowrap">write-off.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Research and Development expenses</I></B>
were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,834&nbsp;million in Q3 2025 and increased by 1.8% (4.9% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,802&nbsp;million in Q3 2024, broadly reflecting the
underlying activity level. The ratio of R&amp;D to net sales was 14.7% and decreased by 0.1pp (14.5% at CER, down by 0.3pp). In YTD 2025, R&amp;D expenses were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,551&nbsp;million and increased
by 8.1% (9.7% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,137&nbsp;million in YTD 2024. The higher increase in the YTD period includes a c. <FONT STYLE="font-family:Times New Roman">&#128;</FONT>200&nbsp;million<I> </I><FONT
STYLE="white-space:nowrap">one-time</FONT> reimbursement of past ALTUVIIIO development expenses, received in Q2 2024, lowering the comparative period, as well as wind-down costs in Q1 2025 for the discontinued E. coli sepsis vaccine candidate. The
ratio of R&amp;D to net sales was 17.2% and increased by 0.4pp (17.0% at CER, up by 0.2pp). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Selling, general and administrative
expenses</I></B> were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,291&nbsp;million in Q3 2025 and increased by 2.6% (7.1% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,232&nbsp;million in Q3 2024. The ratio of
SG&amp;A to net sales was 18.4% and stable (18.4% at CER, stable). In YTD 2025, SG&amp;A expenses were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>6,797&nbsp;million and increased by 4.0% (6.3% at CER) from <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>6,535&nbsp;million in YTD 2024. The ratio of SG&amp;A to net sales was 21.0% and decreased by 0.4pp (20.9% at CER, down by 0.5pp). Generally, the SG&amp;A developments in Q3 and YTD 2025 reflected
continued support of launches and newer medicines. Specifically, in Q3 2025, expenses also included the first-time consolidation of Blueprint following the closing of the acquisition in July. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Total operating expenses</I></B> were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,125&nbsp;million in Q3 2025 and increased by 2.3%
(6.1% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,034&nbsp;million in Q3 2024. In YTD 2025, total operating expenses were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>12,348&nbsp;million and increased by 5.8%
(7.8% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>11,672&nbsp;million in YTD 2024. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Other operating income net of
expenses</I></B> was -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,303&nbsp;million in Q3 2025 and increased by 31.2% (39.1% at CER) from -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>993&nbsp;million in Q3 2024. Income
included <FONT STYLE="font-family:Times New Roman">&#128;</FONT>144&nbsp;million from <FONT STYLE="white-space:nowrap">license-out</FONT> royalties, etc., including on Amvuttra<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>69&nbsp;million in Q3 2024), and <FONT STYLE="font-family:Times New Roman">&#128;</FONT>85&nbsp;million from divestments of medicines/portfolio streamlining
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>13&nbsp;million in Q3 2024). The income was more than offset by an expense of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,369&nbsp;million representing Regeneron&#8217;s share of
profit from the monoclonal antibody alliance (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,066&nbsp;million in Q3 2024), -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>101&nbsp;million relating to other pharmaceutical
collaborators (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>18&nbsp;million in Q3 2024), and -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>62&nbsp;million from other
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>9&nbsp;million in Q3 2024). Q3 2025 included the effect from a court decision on Plavix in France. In YTD 2025, other operating income net of expenses was -<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>3,246&nbsp;million and increased by 34.9% (39.2% at CER) from -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,407&nbsp;million in YTD 2024. Income included <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>419&nbsp;million from divestments (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>215&nbsp;million in YTD 2024), and <FONT STYLE="font-family:Times New Roman">&#128;</FONT>281&nbsp;million
from <FONT STYLE="white-space:nowrap">license-out</FONT> royalties, etc. (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>179&nbsp;million in YTD 2024). Expenses included
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,696&nbsp;million from Regeneron&#8217;s share of profit from the monoclonal antibody alliance (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,903&nbsp;million in YTD 2024), -<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>167&nbsp;million from other pharmaceutical collaborations (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>5&nbsp;million in YTD 2024), and
-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>83&nbsp;million from other (<FONT STYLE="font-family:Times New Roman">&#128;</FONT>107&nbsp;million in YTD 2024). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Share of profit from associates</I></B><B> </B>was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>62&nbsp;million in Q3 2025 compared to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>38&nbsp;million in Q3 2024 and mainly included the share of profit related to Vaxelis in the US. In YTD 2025, share of profit from associates was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>139&nbsp;million compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>104&nbsp;million in YTD 2024 and mainly included the share of profit related to Vaxelis. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net financial expenses</I></B> were <FONT STYLE="font-family:Times New Roman">&#128;</FONT>64&nbsp;million in Q3 2025 compared to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>71&nbsp;million in Q3 2024, reflecting lower net debt for part of the quarter and lower average interest rates. In YTD 2025, net financial expenses were
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>191&nbsp;million compared to <FONT STYLE="font-family:Times New Roman">&#128;</FONT>201&nbsp;million in YTD 2024, also reflecting lower net debt for part of the period and lower average interest
rates. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="justify"><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP> See Appendix 3 for the Q3 and YTD 2025 consolidated income statement; see Appendix 9 for
definitions of financial indicators, and Appendix 4 for reconciliation of IFRS net income reported to business net income. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="justify"><I><SUP
STYLE="font-size:75%; vertical-align:top">2</SUP> See Appendix 2 for the Q3 and YTD 2025 components of Business net income, Appendix 3 for the Q3 and YTD 2025 consolidated income statement and Appendix 9 for the definition and reconciliation of the
financial indicator. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>10 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>The effective tax rate</I></B> was 19.3% in Q3 2025 and decreased from 20.0% in Q3 2024.
Generally, the effective tax rate will fluctuate from quarter to quarter. In YTD 2025, the effective tax rate was 20.2% and increased from 20.0% in YTD 2024. Sanofi continues to target an effective tax rate in 2025 which is broadly stable versus
2024 (20%). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income attributable to equity holders of Sanofi (IFRS measure) </I></B>was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,802&nbsp;million in Q3 2025 and decreased by 0.5% from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,815&nbsp;million in Q3 2024.<B><I> Business net income</I></B> (<B><FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measure</B>) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,547&nbsp;million in Q3 2025 and increased by 4.0% from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,411&nbsp;million in
Q3 2024. The ratio of business net income to net sales was 28.5% and increased by 0.4pp (28.8% at CER, up by 0.7pp). In YTD 2025, business net income was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>7,699&nbsp;million and increased by 5.9%
(9.8% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>7,270&nbsp;million in YTD 2024. The ratio of business net income to net sales was 23.8% and stable (24.1% at CER, up by 0.3pp). See below and Appendix 4 for a reconciliation
of Net income attributable to equity holders of Sanofi to business net income. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify"><B><I>Net income attributable to equity holders of Sanofi
</I></B>divided by the weighted average number of shares outstanding was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.30 and increased from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.25 in Q3 2024.<B><I> Business earnings
per share</I></B><B> </B>(business EPS) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.91 in Q3 2025 and increased by 7.0% (13.2% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2.72 in Q3 2024. The average number
of shares outstanding was 1,218.1&nbsp;million compared to 1,253.0&nbsp;million in Q3 2024. In YTD 2025, Net income attributable to equity holders of Sanofi divided by the weighted number of shares outstanding was <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>7.04 and increased from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>4.05 in YTD 2024, and business EPS was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>6.30 and increased by 8.4%
(12.4% at CER) from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5.81 in YTD 2024. The average number of shares outstanding was 1,223.0&nbsp;million compared to 1,250.6&nbsp;million in YTD 2024. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">We remind investors, however, that &#8220;Business net income&#8221; should not be considered in isolation from, or as a substitute for, Net income attributable to
equity holders of Sanofi reported in accordance with IFRS. In addition, we strongly encourage investors and potential investors not to rely on any single financial measure but to review our financial statements, including the notes thereto,
carefully and in their entirety. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">We compensate for the material limitations described above by using &#8220;Business net income&#8221; only to supplement our IFRS
financial reporting and by ensuring that our disclosures provide sufficient information for a full understanding of all adjustments included in &#8220;Business net income&#8221;. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Because our &#8220;Business net income&#8221; and &#8220;Business EPS&#8221; are not standardized measures, they may not be directly comparable with the <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Influenza vaccines </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In late September, Sanofi confirmed that
representatives of the European Commission (EC) visited company premises in France and Germany in connection with an investigation into influenza vaccines. Sanofi is confident that it is compliant with the relevant rules and regulations and is
cooperating fully with the EC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Opella </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">On
April&nbsp;30, 2025, Sanofi and CD&amp;R closed the Opella transaction, creating an independent global consumer healthcare leader. Sanofi retained a significant shareholding in Opella through a 48.2% equity interest in OPAL JV Co, which indirectly
holds 100% of Opella. Bpifrance owns 1.8% and CD&amp;R the remaining 50.0%. The transaction was completed on the terms previously disclosed, and Sanofi received net cash proceeds of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>10.7&nbsp;billion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Reconciliation of IFRS net income reported to business net income (see Appendix 4)
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In YTD 2025, the IFRS net income was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>8,614&nbsp;million. The main items excluded from
the business net income were: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">Net income from the Opella discontinued operation amounted to
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,861&nbsp;million, including <FONT STYLE="font-family:Times New Roman">&#128;</FONT>2,674&nbsp;million related to an Opella divestment net gain following the loss of control date.
</P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">An amortization charge of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>1,238&nbsp;million, of which <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>1,199&nbsp;million related to intangible assets measured at their acquisition-date fair values (mainly Bioverativ <FONT STYLE="font-family:Times New Roman">&#128;</FONT>447&nbsp;million, Provention
Bio <FONT STYLE="font-family:Times New Roman">&#128;</FONT>155&nbsp;million, Ablynx <FONT STYLE="font-family:Times New Roman">&#128;</FONT>126&nbsp;million, Kadmon <FONT STYLE="font-family:Times New Roman">&#128;</FONT>119&nbsp;million, Beyfortus <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>92&nbsp;million, Blueprint <FONT STYLE="font-family:Times New Roman">&#128;</FONT>90&nbsp;million and Genzyme <FONT STYLE="font-family:Times New Roman">&#128;</FONT>51 million) and <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>39&nbsp;million related to intangible assets from separate acquisitions, measured initially at acquisition cost (licenses/products). These items had no cash impact. </P></TD></TR></TABLE>
<P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">A net impairment expense of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>228&nbsp;million linked to
research and development projects. </P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">A <FONT STYLE="font-family:Times New Roman">&#128;</FONT>57&nbsp;million
<FONT STYLE="white-space:nowrap">step-up</FONT> inventory amortization from the Blueprint acquisition reported in the costs of sales line. </P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">Restructuring costs and similar items of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>602&nbsp;million
mainly related to redundancy plans during YTD 2025. </P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">Other gains and losses, and litigation of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>57&nbsp;million.
</P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">A financial charge of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>99&nbsp;million related to the
remeasurement of expected future royalty on Beyfortus US sales. </P></TD></TR></TABLE> <P STYLE="font-size:1pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B></B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">A <FONT STYLE="font-family:Times New Roman">&#128;</FONT>543&nbsp;million tax effect arising from the items listed
above, mainly comprising <FONT STYLE="font-family:Times New Roman">&#128;</FONT>202&nbsp;million of deferred taxes generated by amortization of intangible assets and <FONT STYLE="font-family:Times New Roman">&#128;</FONT>147&nbsp;million associated
with restructuring costs and similar items. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>11 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Cash flow </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">In YTD 2025, net cash provided by/(used in) operating activities (IFRS) was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>7,305&nbsp;million
and free cash flow<SUP STYLE="font-size:75%; vertical-align:top">1</SUP><SUP STYLE="font-size:75%; vertical-align:top"> </SUP><FONT STYLE="white-space:nowrap">(non-IFRS)</FONT> was
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,452&nbsp;million. In YTD 2024, net cash provided by/(used in) operating activities was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5,270&nbsp;million and free cash flow<SUP
STYLE="font-size:75%; vertical-align:top"> </SUP>was <FONT STYLE="font-family:Times New Roman">&#128;</FONT>3,615&nbsp;million. </P> <P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Total debt and Net debt </B></P>
<P STYLE="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">After the acquisitions of Blueprint Medicines Corporation (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>8,381 million), of Dren-0201, Inc.
(-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>539 million) and of Vigil Neuroscience, Inc. (-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>363 million), the impact of the share buyback of
-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,128&nbsp;million, the dividend paid by Sanofi of -<FONT STYLE="font-family:Times New Roman">&#128;</FONT>4,772&nbsp;million, the cash provided by the discontinued Opella business of <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>136&nbsp;million, and the net cash inflow from the Opella transaction of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>10,662&nbsp;million, the change in net debt was -<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>2,285&nbsp;million compared to December&nbsp;31, 2024. Total debt increased from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>16,137&nbsp;million on December&nbsp;31, 2024, to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>19,968 million on September&nbsp;30, 2025, and net debt increased from <FONT STYLE="font-family:Times New Roman">&#128;</FONT>8,772&nbsp;million on December&nbsp;31, 2024, to <FONT
STYLE="font-family:Times New Roman">&#128;</FONT>11,057&nbsp;million on September&nbsp;30, 2025 (amount net of <FONT STYLE="font-family:Times New Roman">&#128;</FONT>8,906&nbsp;million in cash and cash equivalents). &#8220;Net debt&#8221; is a <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> measure that is not a standardized measure, and may not be directly comparable with the <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measures of other companies using the same or similar <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> financial measures. Despite the use of <FONT STYLE="white-space:nowrap">non-IFRS</FONT> measures by management in setting goals and measuring performance, this measure has no standardized meaning prescribed
by IFRS. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">We believe the presentation of this <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial measure, which is reviewed by our
management, provides useful information to measure our overall liquidity and capital resources. We define &#8220;net debt&#8221; as (i)&nbsp;the sum total of short-term debt, long-term debt, and interest rate derivatives and currency derivatives
used to manage debt, minus (ii)&nbsp;the sum total of cash and cash equivalents and interest rate derivatives and currency derivatives used to manage cash and cash equivalents. However, it should not be seen as a substitute for &#8220;total
debt.&#8221; </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="96%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&#8199;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="center"><B>&#8195;&#8195;September&nbsp;30,&nbsp;2025</B></P>
<P STYLE="font-size:1pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; "><B>&#8195;&#8195;&#8195;December&nbsp;31,&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Long-term debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,700</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,791</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Short-term debt and current portion of long-term debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">8,202</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,209</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:1px solid #000000;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Interest rate and currency derivatives used to manage
debt</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">67</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;" ALIGN="right"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP STYLE="BORDER-BOTTOM:1.50pt solid #000000;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8199;Total debt</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>19,968</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>16,137</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(8,906)</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(7,441)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Interest rate and currency derivatives used to manage cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6)</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">76</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="6" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="6" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="6" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8199;Net debt <SUP STYLE="font-size:75%; vertical-align:top">(a) </SUP><FONT
STYLE="white-space:nowrap">(non-IFRS)</FONT></B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>11,057</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>8,772</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left"><I>(a)</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>Net debt does not include lease liabilities, which amounted to &#128;1,853&nbsp;million as of September&nbsp;30,
2025 and &#128;1,906&nbsp;million as of December&nbsp;31, 2024. </I></P></TD></TR></TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Shareholder return </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">Following shareholder approval at the annual general meeting in April, shareholders received a dividend of
<FONT STYLE="font-family:Times New Roman">&#128;</FONT>3.92 per share for 2024, marking 30 consecutive years of dividend increases. Additionally, Sanofi is executing a <FONT STYLE="font-family:Times New Roman">&#128;</FONT>5&nbsp;billion share
buyback program in 2025, with the purpose of share cancellation. As of September&nbsp;30, 2025, 82.0% of the program had been completed, with the remaining shares to be purchased in the open market during the rest of 2025. In 2025, a total of
39,728,314 treasury shares of the Company were cancelled, including 2,664,871 that have been cancelled since June&nbsp;30, 2025. </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial; " ALIGN="justify"><I>See Appendix 9 for definition of financial indicator and Appendix 5 for reconciliation from net cash provided
by/(used in) operating activities to free cash flow.. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>12 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:16pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Appendices </I></FONT></P>
<P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:1.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.50pt solid #000000">&nbsp;</DIV>
<P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;1</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Net sales by medicine/vaccine and geography</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>14</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix 2</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Components of Business net income by segment</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>20</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;3</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Consolidated income statement</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>21</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;4</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Reconciliation of net income attributable to equity holders of Sanofi (IFRS) to&nbsp;business net income <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>22</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix 5</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Summarized statements of cash flow and reconciliation of free cash flow</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>23</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix 6</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Simplified consolidated balance sheet</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>24</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;7</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Other operating income net of expenses related to Regeneron</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>25</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;8</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Currency sensitivity</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>26</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="13"></TD>
<TD HEIGHT="13" COLSPAN="2"></TD>
<TD HEIGHT="13" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Appendix&nbsp;9</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><FONT STYLE="font-family:Arial; ">Definitions of <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial indicators</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>27</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>13 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 1: Q3 2025 net sales by medicine/vaccine and geography </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>14 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Q3 2025</B></FONT></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8199;(<FONT
STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Total&nbsp;sales</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>% at actual exchange rates</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>% CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>United States</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Europe</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>% CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Rest&nbsp;of World</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>% CER</B></FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Immunology</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Dupixent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">4,156</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">3,073</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+27.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">504</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">579</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Kevzara</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">131</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">87</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+41.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">13</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Rare diseases</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;ALTUVIIIO (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">294</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+70.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+81.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">247</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+64.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+308.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Fabrazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">242</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">124</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">62</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">56</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Nexviazyme/Nexviadyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+27.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">98</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">74</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+57.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">28</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Cerezyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">161</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">44</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">56</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">61</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Alprolix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">149</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">106</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">43</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">Ayvakit (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">119</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Myozyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">122</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-27.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-25.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">41</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-30.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">40</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-33.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">41</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Cerdelga</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">86</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">45</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">37</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Aldurazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">79</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">17</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">20</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">42</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+45.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Eloctate</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">77</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-19.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">41</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-21.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">36</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Cablivi (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">66</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">35</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">25</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">6</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Xenpozyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+39.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+43.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">23</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+25.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+57.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">12</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+71.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Qfitlia (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Wayrilz (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Neurology</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Aubagio</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">49</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-46.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-44.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">25</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-46.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-46.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-30.8%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Oncology</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Sarclisa (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">155</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+36.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+41.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">61</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+41.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">46</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+35.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">48</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+47.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Jevtana</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">62</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">14</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Fasturtec</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">43</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">26</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">12</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-50.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Other main medicines</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Lantus</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">438</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">214</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">75</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">149</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-7.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Toujeo</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">321</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">55</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">124</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">142</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Plavix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">223</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">200</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Lovenox</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">196</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">107</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">88</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Praluent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">127</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">106</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">21</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-43.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Thymoglobulin</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">118</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">72</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">9</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-10.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">37</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Rezurock (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">114</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">100</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1)</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-112.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+220.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Aprovel</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">100</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">18</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">81</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Multaq</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">78</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">71</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+15.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Soliqua/iGlarLixi</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">62</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+12.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+18.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">19</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">13</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">30</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Tzield (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">18</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">17</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Mozobil</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-37.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-43.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-75.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-71.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">7</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Others</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">905</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">77</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-27.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">273</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">555</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Industrial Sales</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">96</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-23.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-21.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">95</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-21.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:10pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; font-size:7pt" COLOR="#23004c"><B>&#8199;Vaccines</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Influenza, <FONT STYLE="white-space:nowrap">COVID-19</FONT> (**)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,525</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-20.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-16.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,038</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">356</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-25.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">131</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-29.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Beyfortus (**)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">739</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">389</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-21.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">261</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+166.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">89</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+526.7%</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>15 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Polio/Pertussis/Hib primary vaccines and boosters</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">642</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">205</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">106</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-20.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">331</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Meningitis, travel, and endemic</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">451</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">314</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">80</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-15.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" BGCOLOR="#7802e6"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt"><FONT COLOR="#FFFFFF">&#8199;Biopharma</FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">12,434</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">+2.3%</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">+7.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">6,838</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">2,589</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF">3,007</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Pharma launches (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,046</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+49.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+57.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">705</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+55.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">183</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+45.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">158</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+82.0%</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:1pt">
<TD COLSPAN="7" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:7pt">&#8199;Launches (*), (**)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,805</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+34.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+40.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,114</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">444</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+98.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">247</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+146.2%</FONT></TD></TR>
<TR STYLE="font-size:1px; font-family:ARIAL; font-size:7pt">
<TD COLSPAN="31" VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>16 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><B>Appendix 1: YTD 2025 net sales by medicine/vaccine and geography </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>17 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;YTD 2025</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"><B>&#8199;</B>(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)<B></B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Total&nbsp;sales</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="font-size:6pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial" ALIGN="right"><FONT COLOR="#23004c"><B>%
at<BR>actual<BR>&#8195;exchange<BR>rates</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;%&nbsp;CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;United<BR>States</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;%&nbsp;CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;Europe</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;%&nbsp;CER</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;Rest&nbsp;of<BR>World</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;%&nbsp;CER</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Immunology</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Dupixent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">11,468</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+22.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">8,356</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1,448</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1,664</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Kevzara</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">376</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">238</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+44.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">96</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">42</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+12.8%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Rare diseases</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;ALTUVIIIO (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">836</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+85.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+90.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">703</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+73.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">133</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+306.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Fabrazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">767</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">385</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">196</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">186</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Nexviazyme/Nexviadyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">587</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+21.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">293</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">206</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+45.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">88</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cerezyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">524</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">135</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">175</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">214</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Alprolix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">454</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">346</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">108</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+34.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Myozyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">397</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-24.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">132</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-33.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">128</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cerdelga</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">252</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">134</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">105</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">13</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Aldurazyme</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">242</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">53</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">63</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">126</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Eloctate</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">212</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-24.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">138</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-22.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">74</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cablivi (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">202</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">106</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">80</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+19.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Xenpozyme (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">167</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+47.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+50.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">70</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">66</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+73.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+77.8%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Ayvakit (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">137</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">119</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Qfitlia (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Wayrilz (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Neurology</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Aubagio</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">187</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-37.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-36.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">101</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-28.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">55</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-55.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Oncology</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Sarclisa (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">431</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">180</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">129</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+31.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">122</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Jevtana</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">203</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">155</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">3</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-40.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">45</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Fasturtec</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">131</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">83</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">37</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">11</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Other main medicines</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Lantus</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,314</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+13.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">609</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+40.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">224</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">481</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Toujeo</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,013</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+9.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">181</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+8.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">372</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">460</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Plavix</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">696</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">66</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">626</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Lovenox</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">643</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+42.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">354</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-18.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">279</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Praluent</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">394</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">315</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+23.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">79</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-30.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Rezurock (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">377</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+14.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">320</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+7.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">22</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+10.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">35</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+200.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Thymoglobulin</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">366</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">226</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">30</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">110</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Aprovel</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">312</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">4</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+33.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">53</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-3.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">255</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Multaq</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">238</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+1.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">216</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">7</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Soliqua/iGlarLixi</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">198</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+17.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+20.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">63</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+16.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">39</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+11.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">96</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+26.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Tzield (*)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+30.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+33.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">44</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+28.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+100.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Mozobil</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">26</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-58.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-58.1%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">3</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-66.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">7</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-80.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Others&#8195;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">2,876</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">253</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-20.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">857</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1,766</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-9.8%</FONT></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>18 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="20%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="6%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Industrial Sales</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">347</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-12.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">336</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-14.4%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+800.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Vaccines</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Influenza, <FONT STYLE="white-space:nowrap">COVID-19</FONT> (**)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,739</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-17.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1,092</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">408</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-19.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">239</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-26.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Beyfortus (**)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,095</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+29.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+33.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">457</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-25.3%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">346</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+229.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">292</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+227.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Polio/Pertussis/Hib primary vaccines and boosters</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">2,003</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-5.0%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-2.8%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">525</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.9%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">329</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-13.6%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">1,149</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.1%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Meningitis, travel, and endemic</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1,060</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-0.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.2%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">633</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+3.5%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">153</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+2.7%</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">274</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">-1.1%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="4" COLSPAN="2" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle" NOWRAP STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#ffffff"><B>&#8199;Biopharma</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>32,323</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>+5.9%</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>+8.7%</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>16,373</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#7802e6"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>6,733</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#7802e6"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="middle" NOWRAP ALIGN="right" STYLE="padding-bottom:3pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#ffffff"><B>9,217</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8199;Pharma launches (*)</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>2,790</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>43.9%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>47.2%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>1,841</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>43.7%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>521</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>42.6%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>428</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+72.6%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8199;Launches (*), (**)</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>3,905</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+40.3%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+43.9%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2,318</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+22.0%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>867</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+84.3%</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>720</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; "><B>+114.0%</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" COLSPAN="7" NOWRAP STYLE="border-bottom:1.50pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:1pt; font-family:Arial"><B>&#8195;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="3" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.50pt solid #000000">&nbsp;</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>19 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:12pt; font-family:Arial"><B>Appendix 2: Components of Business net income by segment </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="96%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt">


<TR>

<TD WIDTH="45%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8199;Q3 2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #23004c"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Biopharma</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #23004c"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Other</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00pt solid #23004c"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Total group</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&#8199;(&#128; million)</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;Q3&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;&#8195;Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;Q3&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8194;Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;Q3&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8194;Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #23004c"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Net sales</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12,157</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2.3%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12,157</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2.3%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Other revenues</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">611</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">740</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-17.4%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">125</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">80</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">56.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">736</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-10.2%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,292)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,600)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(63)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(60)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">5.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,355)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,660)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-8.3%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8199;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(26.5%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(29.6%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(27.0%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(30.1%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #23004c"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Business gross profit</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,753</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,297</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>4.9%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>62</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>20</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>210.0%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,815</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,317</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5.3%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #23004c"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8199;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>78.4%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>76.5%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>78.9%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>76.6%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,834)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,802)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,834)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,802)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.8%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8199;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14.7%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14.8%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14.7%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14.8%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Selling and general expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,242)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,219)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.0%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(49)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(13)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">276.9%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,291)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,232)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2.6%</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8199;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(18.0%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(18.3%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(18.4%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(18.4%)</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Other operating income/expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,282)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(982)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(21)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(11)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,303)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(993)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Share of profit/loss of associates and joint
ventures<SUP STYLE="font-size:75%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">47</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">62</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">38</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8199;Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1)</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #23004c"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8199;Business operating income</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>4,438</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>4,331</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2.5%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(4)</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>-275.0%</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:1pt">
<TD VALIGN="bottom" NOWRAP STYLE="border-bottom:1.00pt solid #23004c"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="10" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #23004c">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8199;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>35.7%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>35.6%</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="12"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="12"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="12"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><B>&#8194;YTD 2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #000000;"><FONT STYLE="font-family:Arial; "><B>Biopharma</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #000000;"><FONT STYLE="font-family:Arial; "><B>Other</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.00pt solid #000000;"><FONT STYLE="font-family:Arial; "><B>Total group</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #000000;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><B>&#8194;(&#128; million)</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><B>&#8201;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">3</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><B>&#8201;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; "><B>&#8201;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net sales</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>32,323</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>30,517</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5.9</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8212;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>32,323</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>30,517</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5.9</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other revenues</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,857</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,092</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-11.2</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">331</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">257</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">28.8</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,188</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,349</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-6.9</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Cost of sales</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,045</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,449</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(170</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">12.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,236</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,619</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">-4.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(28.0</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(31.0</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(28.6</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(31.5</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Business gross profit</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>25,135</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>23,160</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>8.5</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>140</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>87</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>60.9</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>25,275</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>23,247</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>8.7&#8195;&#8195;&#8195;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.00pt solid #23004c; BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>77.8</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>75.9</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>78.2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>76.2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,550</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,136</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">8.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,551</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,137</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">8.1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(17.2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(16.8</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(17.2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(16.8</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Selling and general expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6,689</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6,466</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">3.4</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(108</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(69</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">56.5</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6,797</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6,535</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">4.0</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">%&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(20.7</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(21.2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(21.0</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(21.4</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other operating income/expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,223</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,408</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(23</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,246</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,407</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Share of profit/loss of associates and joint &#8194;ventures<SUP
STYLE="font-size:75%; vertical-align:top">4</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">124</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">139</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">104</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(12</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(7</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="4" STYLE="BORDER-TOP:1.00pt solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Business
operating income</B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,785</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,247</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5.8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>23</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>18</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>27.8</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.00pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>%&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.00pt solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>&#8194;As % of net sales</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>30.3</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>30.3</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>%&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP> Figures for 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a
consistent basis to reflect the classification of Opella as a discontinued operation. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">2</SUP> Net of tax.
</I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">3 </SUP>Determined based on business income before tax, associates, and
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interests. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">4</SUP> Based on an average number of shares
outstanding of 1,218.1&nbsp;million in Q3 2025 and 1,253.0&nbsp;million in Q3 2024. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">3</SUP> Figures for 2024
comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect the classification of Opella as a discontinued operation. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">4 </SUP>Net of tax. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP
STYLE="font-size:75%; vertical-align:top">3 </SUP>Determined based on business income before tax, associates, and <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">4</SUP> Based on an average number of shares outstanding of 1,223.0&nbsp;million in YTD 2025 and 1,250.6&nbsp;million in
YTD 2024. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>20 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 3: Consolidated income statement </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="9%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>(&#128; million)</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;Q3&nbsp;
2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;YTD&nbsp;
2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Net sales</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>12,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>12,157</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>32,323</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>30,517</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other revenues</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">736</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">820</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,188</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">2,349</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Cost of sales</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,412</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,663</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,293</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">(9,629)</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Gross profit</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,758</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>9,314</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>25,218</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>23,237</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Research and development expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,834</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,802</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,551</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(5,137)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Selling and general expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,291</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,232</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(6,797</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(6,535)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating income</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">297</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">163</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">830</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">726</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other operating expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,600</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,156</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(4,076</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(3,133)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Amortization of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(461</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(401</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,238</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(1,299)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impairment of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(18</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(180</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(228</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">191</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Fair value remeasurement of contingent consideration</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(56</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(8</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(117</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(74)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Restructuring costs and similar items</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(172</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(144</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(602</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(1,204)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other gains and losses, and litigation</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">(15</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(57</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">(465)</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Operating
income</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,623</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,539</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7,382</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>6,307</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Financial expenses</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(227</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(255</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(588</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">(838)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Financial income</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">114</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">131</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">298</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">408</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Income before tax and
associates and joint ventures</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,510</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>3,415</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7,092</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,877</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Income tax expense</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(680</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(684</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,391</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,063)</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Share of profit/(loss) of associates and joint ventures</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">73</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">83</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">51</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Net income from continuing
operations</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,828</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,804</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,784</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>4,865</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net income from discontinued operations</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(20</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,861</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">242</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Net income</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,808</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>2,844</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>8,645</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-TOP:1.50pt solid #7802e6; BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,107</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Net income attributable to
<FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">6</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">29</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">46</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Net income attributable to equity holders of Sanofi</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2,802</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2,815</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>8,614</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>5,061</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Average number of shares outstanding
(million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,218.1</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,253.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,223.0</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:4pt ;"><FONT STYLE="font-family:Arial; ">1,250.6</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Basic earnings per share from continuing operations
(<FONT STYLE="font-family:Times New Roman">&#128;</FONT>)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2.32</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2.22</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>4.71</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>3.86</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>Basic earnings per share from discontinued operations (&#128;)</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>(0.02</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>0.03</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2.33</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>0.19</B></FONT></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">Basic earnings per share
(&#128;)</FONT></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2.30</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2.25</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">7.04</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">4.05</FONT></B></FONT></TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><I><SUP STYLE="font-size:75%; vertical-align:top">1</SUP>&nbsp;</I></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial; " ALIGN="justify"><I>Figures for 2024 comparative periods have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent
basis to reflect the classification of Opella as a discontinued operation. </I></P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>21 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 4: Reconciliation of net income attributable to equity holders of Sanofi (IFRS) to&nbsp;business net
income <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&#8194;(&#128; million)</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>Q3&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8194;Net income attributable to equity holders of Sanofi (IFRS)</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2,802</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>2,815</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>8,614</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>5,061</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net income from discontinued operations</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">20</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(40</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(2,861</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(242</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Amortization of intangible assets<SUP STYLE="font-size:75%; vertical-align:top">2</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">461</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">401</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,238</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,299</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Impairment of intangible assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">18</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">180</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">228</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(191</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Fair value remeasurement of contingent consideration</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">59</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">31</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">127</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">103</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Expenses arising from the impact of acquisitions on inventories</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">3</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">10</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Restructuring costs and similar items</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">172</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">144</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">602</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,204</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other gains and losses, and litigation</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">15</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">57</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">465</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Financial (income) / expense related to liabilities carried at amortized cost other than net
indebtedness</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">49</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">53</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">99</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">229</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Tax effect of the items listed above:</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(159</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(175</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(543</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(752</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>Amortization and impairment of intangible assets</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(84</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(106</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(257</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(154</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>Fair value remeasurement of contingent consideration</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(14</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(2</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(28</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(19</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>Expenses arising from the impact of acquisitions on inventories</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(15</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>&#8212;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(15</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>&#8212;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>Restructuring costs and similar items</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(34</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(34</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(147</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(377</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><I>Other items</I></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(12</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(33</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(96</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>&nbsp;</I></FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><I>(202</I></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><I>)&nbsp;</I></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other tax effects</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">5</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">14</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">16</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">21</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other items</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">63</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(30</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">65</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">63</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8194;Business net income <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT></B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>3,547</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>3,411</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>7,699</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>7,270</B></FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Business earnings per share (&#128;)</FONT><SUP
STYLE="font-size:75%; vertical-align:top">3</SUP></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2.91</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">2.72</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">6.30</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">5.81</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Basic earnings per share</FONT><SUP
STYLE="font-size:75%; vertical-align:top"> </SUP><FONT COLOR="#ffffff">(&#128;)</FONT><SUP STYLE="font-size:75%; vertical-align:top">3</SUP></B></FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8195;&#8195;&#8195;&#8195;2.30</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8195;&#8195;&#8195;&#8195;2.25</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8195;&#8195;&#8195;&#8195;7.04</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8195;&#8195;&#8195;&#8195;4.05</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> Figures for 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect the classification of Opella as a discontinued operation. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">2 </SUP>Of which related to amortization expense generated by the intangible assets measured at their acquisition-date
fair values: &#128;450&nbsp;million in Q3 2025 and &#128;387 in million in Q3 2024. </I></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">3</SUP> Based on an average
number of shares outstanding of 1,218.1&nbsp;million in Q3 2025, 1,223.0&nbsp;million in YTD 2025, 1,253.0&nbsp;million in Q3 2024 and 1,250.6&nbsp;million in YTD 2024. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>22 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"><B>Appendix 5: Summarized statements of cash flow and reconciliation of free cash flow </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) continuing operating activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">7,118</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,916</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) operating activities of the discontinued Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">187</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net cash
provided by/(used in) operating activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7,305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,270</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) continuing investing activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(10,937</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,822</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) investing activities of the discontinued Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(36</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(73</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash inflow from the Opella transaction</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">10,657</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net cash
provided by/(used in) investing activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(316</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(3,895</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) continuing financing activities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(5,589</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,780</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) financing activities of the discontinued Opella business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(48</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(35</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net cash
provided by/(used in) financing activities</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(5,637</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(1,815</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Impact of exchange rates on cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(54</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(27</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Cash and cash equivalents reported as held for sale as of December&nbsp;31, 2024</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">167</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8212;</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net change in
cash and cash equivalents</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>1,465</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(467</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Cash and cash
equivalents, beginning of period</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7,441</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>8,710</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Cash and cash
equivalents, end of period</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;&#8195;8,906</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;&#8195;8,243</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <P STYLE="font-size:32pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="2" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024<SUP STYLE="font-size:75%; vertical-align:top">1</SUP></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Net cash
provided by/(used in) operating activities (IFRS)<SUP STYLE="font-size:75%; vertical-align:top">2</SUP></B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>7,305</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>5,270</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net cash provided by/(used in) operating activities (IFRS) of the discontinued Opella
business</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(187</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(354</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Acquisition of property, plant, and equipment and software</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,288</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,280</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Acquisitions of intangibles assets, investments, and other long-term financial assets<SUP
STYLE="font-size:75%; vertical-align:top">3</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(1,415</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(670</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Proceeds from disposals of property, plant and equipment, intangible assets, and other <FONT
STYLE="white-space:nowrap">non-current</FONT> assets net of&nbsp;taxes<SUP STYLE="font-size:75%; vertical-align:top">3</SUP></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">527</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">598</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Repayment of lease liabilities</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(184</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(206</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Others</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">694</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">257</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Free cash
flow <FONT STYLE="white-space:nowrap">(non-IFRS)</FONT><SUP STYLE="font-size:75%; vertical-align:top">3</SUP></B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;&#8195;5,452</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;&#8195;3,615</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
</TABLE> <DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> Figures for 2024 comparative period have been <FONT STYLE="white-space:nowrap">re-presented</FONT> on a consistent basis to reflect the classification of Opella as a discontinued operation. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">2</SUP> Most directly comparable IFRS measure to free cash flow. </I></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">3</SUP> Non IFRS indicator (see definition in Appendix 9). </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>23 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 6: Simplified consolidated balance sheet </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="30%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Assets</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>September&nbsp;30,&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>December&nbsp;31,&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="padding-bottom:1pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8194;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>liabilities and equity</B></FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>September&nbsp;30,&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>December&nbsp;31,&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">Equity attributable to equity holders of Sanofi</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">73,263</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">77,507</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">Equity attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">270</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;" ALIGN="right"><FONT STYLE="font-family:Arial; ">350</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#ffffff"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Total equity</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>73,533</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#ffffff" STYLE=" BORDER-BOTTOM:1.50pt solid #000000;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#ffffff" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>77,857</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #000000;" BGCOLOR="#ffffff"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">Long-term debt</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,700</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; ">11,791</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Property, plant, and equipment &#8211; owned assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">9,698</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">10,091</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> lease liabilities</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial" ALIGN="right">1,566</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial" ALIGN="right">1,645</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD NOWRAP VALIGN="bottom"> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-bottom:0pt; margin-top:0pt; font-size:7pt; font-family:Arial">&nbsp;</P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-use</FONT></FONT> assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,483</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,510</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">Non-current</FONT> liabilities related to business combinations and to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">579</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">569</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Intangible assets (including goodwill)</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">68,867</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">66,013</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">Non-current</FONT> provisions and other <FONT STYLE="white-space:nowrap">non-current</FONT> liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">7,004</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">8,096</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial"><FONT STYLE="white-space:nowrap">Non-current</FONT> income tax assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">552</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">560</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">Non-current</FONT> income tax liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,660</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,512</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Other <FONT STYLE="white-space:nowrap">non-current</FONT> assets,
investments in associates and joint-ventures and deferred tax assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">15,152</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">12,036</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">Deferred tax liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,647</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,166</FONT></TD>
<TD NOWRAP VALIGN="middle" STYLE="padding-bottom:1pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B><FONT STYLE="white-space:nowrap">Non-current</FONT> assets</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>95,752</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>90,210</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B><FONT STYLE="white-space:nowrap">Non-current</FONT> liabilities</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>24,156</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>25,779</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">Accounts payable and other current liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">22,000</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">21,792</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">Current liabilities related to business combinations and to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">0</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">72</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Inventories, accounts receivable and other current assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">24,501</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">20,934</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">Current income tax liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1,614</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">697</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Current income tax assets</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">497</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">724</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">Current lease liabilities</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">287</FONT></TD>
<TD NOWRAP VALIGN="top" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" ALIGN="right"><FONT STYLE="font-family:Arial; ">261</FONT></TD>
<TD NOWRAP VALIGN="top"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">8,906</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">7,441</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"><FONT STYLE="font-family:Arial; ">Short-term debt and current portion of long-term debt</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">8,202</FONT></TD>
<TD NOWRAP VALIGN="middle" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="middle" ALIGN="right"><FONT STYLE="font-family:Arial; ">4,209</FONT></TD>
<TD NOWRAP VALIGN="middle"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial">Assets held for sale</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">138</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">13,489</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">Liabilities related to assets held for sale</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">2</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; ">2,131</FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Current assets</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>34,042</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>42,588</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Current liabilities</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>32,105</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:3pt ;" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>29,162</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:3pt ;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD>
<TD HEIGHT="5" COLSPAN="2" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#7802e6"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#7802e6"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.50em; font-size:7pt; font-family:Arial"><FONT COLOR="#FFFFFF"><B>Total assets</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>129,794</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>132,798</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>Total equity and liabilities</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>129,794</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#7802e6">&nbsp;</TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>132,798</B></FONT></TD>
<TD NOWRAP VALIGN="top" STYLE="padding-bottom:4pt ;" BGCOLOR="#7802e6"><FONT STYLE="font-family:Arial; " COLOR="#FFFFFF"><B>&nbsp;</B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>24 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 7: Other operating income net of expenses related to Regeneron </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; ">&#8194;(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1px solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Monoclonal
antibodies alliance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Income and expense related to profit/loss sharing</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,962</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(3,069</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Additional share of profit paid by Regeneron related to development costs</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">787</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">618</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Regeneron commercial operating expenses reimbursement</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">(521</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">(452</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">)&nbsp;</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Total:
monoclonal antibody alliance</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>(3,696</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>(2,903</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; "><B>)&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><B>&#8194;Other Regeneron</B></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>&#8194;Total others
related to Regeneron (mainly Libtayo<SUP STYLE="font-size:75%; vertical-align:top"> </SUP>and Zaltrap)</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>107</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial; "><B>130</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial; "><B>&nbsp;</B></FONT></TD></TR>
<TR STYLE="font-size:1pt" BGCOLOR="#7802e6">
<TD HEIGHT="5" STYLE="BORDER-TOP:1.50pt solid #7802e6;">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:1.50pt solid #7802e6;">&nbsp;</TD>
<TD HEIGHT="5" COLSPAN="4" STYLE="BORDER-TOP:1.50pt solid #7802e6;">&nbsp;</TD></TR>
<TR BGCOLOR="#7802e6" STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&#8194;Total related to
Regeneron</FONT></B></FONT></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(3,589</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">)&nbsp;</FONT></B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #7802e6;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">&nbsp;</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;" ALIGN="right"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">(2,773</FONT></B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1.50pt solid #7802e6;"><FONT STYLE="font-family:Arial" COLOR="#ffffff"><B><FONT COLOR="#ffffff">)&nbsp;</FONT></B></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>25 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 8: Currency sensitivity </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>2025 net sales currency sensitivity </I></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="12%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; "><B>&#8194;Currency</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Variation</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Net&nbsp;sales&nbsp;sensitivity</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;US&nbsp;Dollar</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.05&nbsp;USD/EUR</FONT></TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>968m</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Japanese Yen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+5 JPY/EUR</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>55m</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Chinese Yuan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.2&nbsp;CNY/EUR</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>69m</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Brazilian Real</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">+0.4 BRL/EUR</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">-<FONT STYLE="font-family:Times New Roman">&#128;</FONT>53m</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Currency exposure on Q3 2025 sales </I></FONT></P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="89%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; "><B>&#8194;Currency</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; "><B>Q3&nbsp;2025</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;US&nbsp;Dollar</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">56.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Euro</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">17.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Chinese Yuan</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">5.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Japanese Yen</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">2.7%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Canadian Dollar</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1.6%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Brazilian Real</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1.5%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;British Pound</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1.2%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;South-Korean Won</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Mexican Peso</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">1.0%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Turkish Lira</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">0.9%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Others</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&#8195;&#8195;&#8195;&#8195;&#8195;10.9%</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Currency average rates </I></FONT></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="10%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="4"></TD>
<TD HEIGHT="4" COLSPAN="4"></TD>
<TD HEIGHT="4" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="4" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2024</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:3pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Change</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;<FONT STYLE="font-family:Times New Roman">&#128;</FONT>/$</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.099</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">1.168</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.3%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;<FONT STYLE="font-family:Times New Roman">&#128;</FONT>/Yen</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">163.727</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">172.290</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+5.2%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;<FONT STYLE="font-family:Times New Roman">&#128;</FONT>/Yuan</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">7.876</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">8.365</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+6.2%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;<FONT STYLE="font-family:Times New Roman">&#128;</FONT>/Real</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><FONT STYLE="font-family:Arial; ">6.095</FONT></TD>
<TD NOWRAP VALIGN="bottom"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">6.366</FONT></TD>
<TD NOWRAP VALIGN="bottom" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT STYLE="font-family:Arial; ">+4.4%</FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="5"></TD>
<TD HEIGHT="5" COLSPAN="4"></TD>
<TD HEIGHT="5" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="5" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="top" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;<FONT
STYLE="font-family:Times New Roman">&#128;</FONT>/Ruble</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8195;&#8195;&#8195;&#8195;98.161</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; ">&#8195;&#8195;&#8195;&#8195;&#8195;94.158</FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; ">&nbsp;</FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right" STYLE="padding-bottom:6pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; "><FONT STYLE="white-space:nowrap">&#8195;&#8195;&#8195;&#8195;&#8195;-4.1%</FONT></FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>26 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Appendix 9: Definitions of <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial indicators </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Company sales at constant exchange rates (CER) </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">References to changes in net sales &#8220;at constant exchange rates&#8221; (CER) means that it excludes the effect of changes in exchange rates. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">The effect of exchange rates is eliminated by recalculating net sales for the relevant period at the exchange rates used for the previous period. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Reconciliation of net sales to company sales at constant exchange rates for Q3 and YTD 2025 </I></FONT></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="11%"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;"><FONT STYLE="font-family:Arial; ">(<FONT STYLE="font-family:Times New Roman">&#128;</FONT> million)</FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>Q3&nbsp;2025</B></FONT></TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8">&nbsp;</TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>YTD&nbsp;2025</B></FONT></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Net
sales</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>12,434</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:2pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>32,323</B></FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Effect of exchange rates</P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(578</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>)&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1.50pt solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="BORDER-BOTTOM:1.50pt solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>(864)</B></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="2"></TD>
<TD HEIGHT="2" COLSPAN="4" BGCOLOR="#e7e7e8"></TD>
<TD HEIGHT="2" COLSPAN="2" BGCOLOR="#e7e7e8"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><FONT COLOR="#23004c"><B>Company sales at
constant exchange rates</B></FONT></P></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8" ALIGN="right"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;13,012</B></FONT></TD>
<TD NOWRAP VALIGN="bottom" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&nbsp;</B></FONT></TD>
<TD VALIGN="bottom" BGCOLOR="#e7e7e8" STYLE=" BORDER-BOTTOM:1px solid #23004c;">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right" STYLE="padding-bottom:4pt ;BORDER-BOTTOM:1px solid #23004c;" BGCOLOR="#e7e7e8"><FONT STYLE="font-family:Arial; " COLOR="#23004c"><B>&#8195;&#8195;&#8195;&#8195;&#8195;33,187</B></FONT></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Business gross profit; Reconciliation from Gross profit to Business gross profit </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Business gross profit is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> indicator that fully excludes from Gross profit (IFRS) the effect of the release of the fair
value step up to inventory that is recognized upon acquisition, which constitutes a Business Combination under IFRS 3 &#8216;Business Combinations&#8217; or which is part of a group of assets as per IFRS 3&#167;2b). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Business net income </I></FONT></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Sanofi publishes a key <FONT
STYLE="white-space:nowrap">non-IFRS</FONT> indicator. Business net income is defined as net income attributable to equity holders of Sanofi excluding: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>net income from discontinued operations, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">amortization of intangible assets, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify">impairment of intangible assets, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>fair value remeasurement of contingent consideration related to business combinations or to disposals,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>expenses arising from the impact of acquisitions on inventories, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>restructuring costs and similar items<SUP STYLE="font-size:75%; vertical-align:top">16</SUP> (comprising
transaction, integration and separation costs in relation to major acquisitions and disposals), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>other gains and losses (including gains and losses on disposals of
<FONT STYLE="white-space:nowrap">non-current</FONT> assets<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>), </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>costs or provisions associated with litigation<SUP STYLE="font-size:75%; vertical-align:top">1</SUP>,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>financial (income)/expense related to liabilities carried at amortized cost other than net indebtedness,
</P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>tax effects related to the items listed above as well as effects of major tax disputes, </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>the share of profits/losses from investments accounted for using the equity method, except for joint ventures
and associates with which Sanofi has a strategic alliance, </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left"><B>


<IMG SRC="g69958dsp6a.jpg" ALT="LOGO">
</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8.5pt; font-family:Arial; " ALIGN="justify"><B></B>net income attributable to <FONT STYLE="white-space:nowrap">non-controlling</FONT> interests related to the
items listed above. </P></TD></TR></TABLE> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><FONT COLOR="#7802e6"><I>Free cash flow </I></FONT></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Free cash flow is a <FONT STYLE="white-space:nowrap">non-IFRS</FONT> financial indicator which is reviewed by management, and which management believes provides useful
information to measure the net cash generated from Sanofi&#8217;s operations that is available for strategic investments (net of divestments<SUP STYLE="font-size:75%; vertical-align:top">2</SUP>), for debt repayment, and for capital return to
shareholders. Free cash flow is determined from the Business net income adjusted for depreciation, amortization, and impairment, share of profit/loss in associates and joint ventures net of dividends received, gains and losses on disposals, net
change in provisions including pensions and other post-employment benefits, deferred taxes, share-based expense, and other <FONT STYLE="white-space:nowrap">non-cash</FONT> items. It comprises net changes in working capital, capital expenditures and
other asset acquisitions net of disposal proceeds<SUP STYLE="font-size:75%; vertical-align:top">3</SUP>, and payments related to restructuring and similar items. Free cash flow is not defined by IFRS, and it is not a substitute measure for the IFRS
aggregate net cash flow in operating activities. </P><DIV STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&nbsp;</DIV>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><I><SUP STYLE="font-size:75%; vertical-align:top">16</SUP> Reported in the line items Restructuring costs and similar items and Gains and losses on disposals, and
litigation. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>27 </B></P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Arial"><B>Forward-looking statements </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial" ALIGN="justify">This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking
statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial
results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words &#8220;expects&#8221;, &#8220;seeks&#8221;,
&#8220;targets&#8221;, &#8220;goal&#8221;, &#8220;anticipates&#8221;, &#8220;believes&#8221;, &#8220;intends&#8221;, &#8220;estimates&#8221;, &#8220;plans&#8221; and similar expressions. Although Sanofi&#8217;s management believes that the
expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally
beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among
other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug,
device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that
product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, political pressure to provide beneficial pricing in the United States including to State Medicaid programs of
&#8220;most favored nation&#8221; drug prices and elsewhere, Sanofi&#8217;s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and
any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and
the impact that global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and
uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under &#8220;Risk Factors&#8221; and &#8220;Cautionary Statement Regarding Forward-Looking
Statements&#8221; in Sanofi&#8217;s annual report on Form <FONT STYLE="white-space:nowrap">20-F</FONT> for the year ended December&nbsp;31, 2024. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise
any forward-looking information or statements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">All Sanofi trademarks mentioned in this document are protected. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial" ALIGN="right"><B>28 </B></P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>sny-20250630.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 23-October-2025 [07:35:40] {AM}-->
<schema targetNamespace="http://www.Sanofi.com/20250630" elementFormDefault="qualified" xmlns:sny="http://www.Sanofi.com/20250630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:currency="http://xbrl.sec.gov/currency/2025" xmlns:exch="http://xbrl.sec.gov/exch/2025" xmlns:naics="http://xbrl.sec.gov/naics/2025" xmlns:sic="http://xbrl.sec.gov/sic/2025" xmlns:stpr="http://xbrl.sec.gov/stpr/2025" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" xmlns:srt="http://fasb.org/srt/2025" xmlns:srt-types="http://fasb.org/srt-types/2025" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2025">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://www.Sanofi.com/role/CoverPage" id="CoverPage">
        <link:definition>1001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>1002 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedIncomeStatements" id="ConsolidatedIncomeStatements">
        <link:definition>1003 - Statement - Consolidated Income Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome" id="ConsolidatedStatementsOfComprehensiveIncome">
        <link:definition>1004 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity" id="ConsolidatedStatementsOfChangesInEquity">
        <link:definition>1005 - Statement - Consolidated Statements of Changes in Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" id="ConsolidatedStatementsOfChangesInEquityParenthetical">
        <link:definition>1006 - Statement - Consolidated Statements of Changes in Equity (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows" id="ConsolidatedStatementsOfCashFlows">
        <link:definition>1007 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" id="ConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>1008 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/Introduction" id="Introduction">
        <link:definition>1009 - Disclosure - Introduction</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies" id="BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies">
        <link:definition>1010 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements" id="PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements">
        <link:definition>1011 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipment" id="PropertyPlantAndEquipment">
        <link:definition>1012 - Disclosure - Property, Plant and Equipment</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets" id="GoodwillAndOtherIntangibleAssets">
        <link:definition>1013 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets" id="ImpairmentOfIntangibleAssets">
        <link:definition>1014 - Disclosure - Impairment of Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod" id="InvestmentsAccountedForUsingTheEquityMethod">
        <link:definition>1015 - Disclosure - Investments Accounted for Using the Equity Method</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssets" id="OtherNonCurrentAssets">
        <link:definition>1016 - Disclosure - Other Non-Current Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/AccountsReceivable" id="AccountsReceivable">
        <link:definition>1017 - Disclosure - Accounts Receivable</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquity" id="ConsolidatedShareholdersEquity">
        <link:definition>1018 - Disclosure - Consolidated Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalents" id="DebtCashAndCashEquivalents">
        <link:definition>1019 - Disclosure - Debt, Cash and Cash Equivalents</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstruments" id="DerivativeFinancialInstruments">
        <link:definition>1020 - Disclosure - Derivative Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities" id="NonCurrentProvisionsAndOtherNonCurrentLiabilities">
        <link:definition>1021 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OffBalanceSheetCommitments" id="OffBalanceSheetCommitments">
        <link:definition>1022 - Disclosure - Off Balance Sheet Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LitigationAndArbitrationProceedings" id="LitigationAndArbitrationProceedings">
        <link:definition>1023 - Disclosure - Litigation and Arbitration Proceedings</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses" id="OtherOperatingIncomeAndExpenses">
        <link:definition>1024 - Disclosure - Other Operating Income And Expenses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems" id="RestructuringCostsAndSimilarItems">
        <link:definition>1025 - Disclosure - Restructuring Costs and Similar Items</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation" id="OtherGainsAndLossesAndLitigation">
        <link:definition>1026 - Disclosure - Other Gains and Losses, and Litigation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncome" id="FinancialExpensesAndIncome">
        <link:definition>1027 - Disclosure - Financial Expenses and Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/IncomeTaxExpense" id="IncomeTaxExpense">
        <link:definition>1028 - Disclosure - Income Tax Expense</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformation" id="SegmentInformation">
        <link:definition>1029 - Disclosure - Segment Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomers" id="RevenueFromContractsWithCustomers">
        <link:definition>1030 - Disclosure - Revenue from Contracts with Customers</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations" id="InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations">
        <link:definition>1031 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" id="LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
        <link:definition>1032 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/EventsSubsequentToJune302025" id="EventsSubsequentToJune302025">
        <link:definition>1033 - Disclosure - Events Subsequent to June 30, 2025</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies" id="BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies">
        <link:definition>1034 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables" id="BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables">
        <link:definition>1035 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables" id="PropertyPlantAndEquipmentTables">
        <link:definition>1036 - Disclosure - Property, Plant and Equipment (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables" id="GoodwillAndOtherIntangibleAssetsTables">
        <link:definition>1037 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables" id="InvestmentsAccountedForUsingTheEquityMethodTables">
        <link:definition>1038 - Disclosure - Investments Accounted for Using the Equity Method (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssetsTables" id="OtherNonCurrentAssetsTables">
        <link:definition>1039 - Disclosure - Other Non-Current Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/AccountsReceivableTables" id="AccountsReceivableTables">
        <link:definition>1040 - Disclosure - Accounts Receivable (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables" id="ConsolidatedShareholdersEquityTables">
        <link:definition>1041 - Disclosure - Consolidated Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables" id="DebtCashAndCashEquivalentsTables">
        <link:definition>1042 - Disclosure - Debt, Cash and Cash Equivalents (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables" id="DerivativeFinancialInstrumentsTables">
        <link:definition>1043 - Disclosure - Derivative Financial Instruments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables" id="LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables">
        <link:definition>1044 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables" id="NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables">
        <link:definition>1045 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables" id="OtherOperatingIncomeAndExpensesTables">
        <link:definition>1046 - Disclosure - Other Operating Income And Expenses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables" id="RestructuringCostsAndSimilarItemsTables">
        <link:definition>1047 - Disclosure - Restructuring Costs and Similar Items (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables" id="FinancialExpensesAndIncomeTables">
        <link:definition>1048 - Disclosure - Financial Expenses and Income (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseTables" id="IncomeTaxExpenseTables">
        <link:definition>1049 - Disclosure - Income Tax Expense (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables" id="RevenueFromContractsWithCustomersTables">
        <link:definition>1050 - Disclosure - Revenue from Contracts with Customers (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationTables" id="SegmentInformationTables">
        <link:definition>1051 - Disclosure - Segment Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables" id="InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables">
        <link:definition>1052 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails" id="BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails">
        <link:definition>1053 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails" id="PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails">
        <link:definition>1054 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails" id="PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails">
        <link:definition>1055 - Disclosure - Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails" id="PropertyPlantAndEquipmentAdditionalInformationDetails">
        <link:definition>1056 - Disclosure - Property, Plant and Equipment - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails" id="GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails">
        <link:definition>1057 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails" id="GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails">
        <link:definition>1058 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails" id="ImpairmentOfIntangibleAssetsDetails">
        <link:definition>1059 - Disclosure - Impairment of Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails" id="InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails">
        <link:definition>1060 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails" id="InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails">
        <link:definition>1061 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails" id="InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails">
        <link:definition>1062 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails" id="OtherNonCurrentAssetsDetails">
        <link:definition>1063 - Disclosure - Other Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails" id="AccountsReceivableSummaryOfAccountsReceivableDetails">
        <link:definition>1064 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails" id="AccountsReceivableAdditionalInformationDetails">
        <link:definition>1065 - Disclosure - Accounts Receivable - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails" id="AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails">
        <link:definition>1066 - Disclosure - Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails" id="ConsolidatedShareholdersEquityAdditionalInformationDetails">
        <link:definition>1067 - Disclosure - Consolidated Shareholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails" id="ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails">
        <link:definition>1068 - Disclosure - Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails" id="ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails">
        <link:definition>1069 - Disclosure - Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails" id="ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails">
        <link:definition>1070 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails" id="ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails">
        <link:definition>1071 - Disclosure - Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails" id="ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails">
        <link:definition>1072 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" id="ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails">
        <link:definition>1073 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails" id="DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails">
        <link:definition>1074 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails" id="DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails">
        <link:definition>1075 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails" id="DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails">
        <link:definition>1076 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails" id="DebtCashAndCashEquivalentsAdditionalInformationDetails">
        <link:definition>1077 - Disclosure - Debt, Cash and Cash Equivalents - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails" id="DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails">
        <link:definition>1078 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails" id="DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails">
        <link:definition>1079 - Disclosure - Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails" id="DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails">
        <link:definition>1080 - Disclosure - Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails" id="DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails">
        <link:definition>1081 - Disclosure - Derivative Financial Instruments - Disclosure of Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails" id="LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails">
        <link:definition>1082 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails" id="LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails">
        <link:definition>1083 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails" id="LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails">
        <link:definition>1084 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails" id="NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails">
        <link:definition>1085 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails" id="NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails">
        <link:definition>1086 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails" id="NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails">
        <link:definition>1087 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails" id="OffBalanceSheetCommitmentsAdditionalInformationDetails">
        <link:definition>1088 - Disclosure - Off Balance Sheet Commitments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails" id="LitigationAndArbitrationProceedingsDetails">
        <link:definition>1089 - Disclosure - Litigation and Arbitration Proceedings (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails" id="OtherOperatingIncomeAndExpensesAdditionalInformationDetails">
        <link:definition>1090 - Disclosure - Other Operating Income And Expenses - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails" id="OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails">
        <link:definition>1091 - Disclosure - Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails" id="RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails">
        <link:definition>1092 - Disclosure - Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails" id="RestructuringCostsAndSimilarItemsAdditionalInformationDetails">
        <link:definition>1093 - Disclosure - Restructuring Costs and Similar Items - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails" id="OtherGainsAndLossesAndLitigationDetails">
        <link:definition>1094 - Disclosure - Other Gains and Losses, and Litigation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails" id="FinancialExpensesAndIncomeDetails">
        <link:definition>1095 - Disclosure - Financial Expenses and Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails" id="IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails">
        <link:definition>1096 - Disclosure - Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails" id="IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails">
        <link:definition>1097 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails" id="IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails">
        <link:definition>1098 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails" id="RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails">
        <link:definition>1099 - Disclosure - Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails" id="RevenueFromContractsWithCustomersDetails">
        <link:definition>1100 - Disclosure - Revenue from Contracts with Customers (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails" id="SegmentInformationScheduleOfSegmentResultsDetails">
        <link:definition>1101 - Disclosure - Segment Information - Schedule of Segment Results (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails" id="SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails">
        <link:definition>1102 - Disclosure - Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails" id="SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails">
        <link:definition>1103 - Disclosure - Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails" id="SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails">
        <link:definition>1104 - Disclosure - Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails" id="SegmentInformationPrincipalCustomersAndCreditRiskDetails">
        <link:definition>1105 - Disclosure - Segment Information - Principal Customers and Credit Risk (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" id="InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails">
        <link:definition>1106 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/EventsSubsequentToJune302025Details" id="EventsSubsequentToJune302025Details">
        <link:definition>1107 - Disclosure - Events Subsequent to June 30, 2025 (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1" id="ConsolidatedStatementsOfComprehensiveIncomeAlternate1">
        <link:definition>1108 - Statement - Consolidated Statements of Comprehensive Income Alternate 1</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
      <link:linkbase id="lnk" >
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#CoverPage" roleURI="http://www.Sanofi.com/role/CoverPage"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedBalanceSheets" roleURI="http://www.Sanofi.com/role/ConsolidatedBalanceSheets"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedIncomeStatements" roleURI="http://www.Sanofi.com/role/ConsolidatedIncomeStatements"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfComprehensiveIncome" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfChangesInEquity" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfChangesInEquityParenthetical" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfCashFlows" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfCashFlowsParenthetical" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#Introduction" roleURI="http://www.Sanofi.com/role/Introduction"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies" roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements" roleURI="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PropertyPlantAndEquipment" roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipment"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#GoodwillAndOtherIntangibleAssets" roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ImpairmentOfIntangibleAssets" roleURI="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InvestmentsAccountedForUsingTheEquityMethod" roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherNonCurrentAssets" roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssets"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#AccountsReceivable" roleURI="http://www.Sanofi.com/role/AccountsReceivable"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquity" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquity"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalents" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalents"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DerivativeFinancialInstruments" roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstruments"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#NonCurrentProvisionsAndOtherNonCurrentLiabilities" roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OffBalanceSheetCommitments" roleURI="http://www.Sanofi.com/role/OffBalanceSheetCommitments"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LitigationAndArbitrationProceedings" roleURI="http://www.Sanofi.com/role/LitigationAndArbitrationProceedings"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherOperatingIncomeAndExpenses" roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RestructuringCostsAndSimilarItems" roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherGainsAndLossesAndLitigation" roleURI="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#FinancialExpensesAndIncome" roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncome"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#IncomeTaxExpense" roleURI="http://www.Sanofi.com/role/IncomeTaxExpense"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformation" roleURI="http://www.Sanofi.com/role/SegmentInformation"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RevenueFromContractsWithCustomers" roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomers"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations" roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#EventsSubsequentToJune302025" roleURI="http://www.Sanofi.com/role/EventsSubsequentToJune302025"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies" roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables" roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PropertyPlantAndEquipmentTables" roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#GoodwillAndOtherIntangibleAssetsTables" roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InvestmentsAccountedForUsingTheEquityMethodTables" roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherNonCurrentAssetsTables" roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssetsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#AccountsReceivableTables" roleURI="http://www.Sanofi.com/role/AccountsReceivableTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquityTables" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsTables" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DerivativeFinancialInstrumentsTables" roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables" roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables" roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherOperatingIncomeAndExpensesTables" roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RestructuringCostsAndSimilarItemsTables" roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#FinancialExpensesAndIncomeTables" roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#IncomeTaxExpenseTables" roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RevenueFromContractsWithCustomersTables" roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationTables" roleURI="http://www.Sanofi.com/role/SegmentInformationTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables" roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails" roleURI="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails" roleURI="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails" roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#PropertyPlantAndEquipmentAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails" roleURI="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ImpairmentOfIntangibleAssetsDetails" roleURI="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails" roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails" roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails" roleURI="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherNonCurrentAssetsDetails" roleURI="http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#AccountsReceivableSummaryOfAccountsReceivableDetails" roleURI="http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#AccountsReceivableAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails" roleURI="http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquityAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" roleURI="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails" roleURI="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails" roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails" roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails" roleURI="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails" roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails" roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails" roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails" roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails" roleURI="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OffBalanceSheetCommitmentsAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#LitigationAndArbitrationProceedingsDetails" roleURI="http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherOperatingIncomeAndExpensesAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails" roleURI="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails" roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RestructuringCostsAndSimilarItemsAdditionalInformationDetails" roleURI="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#OtherGainsAndLossesAndLitigationDetails" roleURI="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#FinancialExpensesAndIncomeDetails" roleURI="http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails" roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails" roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails" roleURI="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails" roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#RevenueFromContractsWithCustomersDetails" roleURI="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationScheduleOfSegmentResultsDetails" roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails" roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails" roleURI="http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails" roleURI="http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#SegmentInformationPrincipalCustomersAndCreditRiskDetails" roleURI="http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" roleURI="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#EventsSubsequentToJune302025Details" roleURI="http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"  />
        <link:roleRef xlink:type="simple" xlink:href="sny-20250630.xsd#ConsolidatedStatementsOfComprehensiveIncomeAlternate1" roleURI="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel"  />
        <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel"  />
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/CoverPage" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract_200012" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_200013" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_200012" xlink:to="loc_dei_EntitiesTable_200013" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_200014" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntitiesTable_200013" xlink:to="loc_dei_EntityInformationLineItems_200014" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_200015" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentType_200015" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_200016" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_EntityRegistrantName_200016" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_200017" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_AmendmentFlag_200017" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_200018" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_EntityCentralIndexKey_200018" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_200019" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_CurrentFiscalYearEndDate_200019" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_200020" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentPeriodEndDate_200020" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_200021" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentFiscalYearFocus_200021" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_200022" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentFiscalPeriodFocus_200022" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedBalanceSheets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract_200064" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract_200065" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_200064" xlink:to="loc_ifrs-full_AssetsAbstract_200065" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_200067" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_200067" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets_200068" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_RightofuseAssets_200068" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_200069" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_Goodwill_200069" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_200070" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_200070" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200071" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200071" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_200072" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_200072" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent_200073" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_CurrentTaxAssetsNoncurrent_200073" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets_200074" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_DeferredTaxAssets_200074" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets_200075" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_NoncurrentAssets_200075" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories_200077" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_Inventories_200077" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_200078" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_CurrentTradeReceivables_200078" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets_200079" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_OtherCurrentAssets_200079" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent_200080" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent_200080" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200081" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_CashAndCashEquivalents_200081" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_200082" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale_200082" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets_203209" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_CurrentAssets_203209" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets_200083" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAbstract_200065" xlink:to="loc_ifrs-full_Assets_200083" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract_200064" xlink:to="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent_200084" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent_200084" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests_200085" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_NoncontrollingInterests_200085" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_200086" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_Equity_200086" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_200087" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_LongtermBorrowings_200087" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities_200088" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities_200088" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_200089" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_200089" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_200090" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_200090" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_200091" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent_200091" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities_200092" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_DeferredTaxLiabilities_200092" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities_200093" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_NoncurrentLiabilities_200093" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_200094" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers_200094" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_200095" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_200095" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_200096" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities_200096" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_200097" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent_200097" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities_200098" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities_200098" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_200099" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_200099" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_200101" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale_200101" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities_200100" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_CurrentLiabilities_200100" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities_200102" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract_200066" xlink:to="loc_ifrs-full_EquityAndLiabilities_200102" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedIncomeStatements" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract_200138" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_200140" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_200140" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_200141" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_OtherRevenue_200141" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_200142" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_CostOfSales_200142" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit_200143" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_GrossProfit_200143" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_200144" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_200144" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_200145" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_200145" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_200146" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_200146" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_200147" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_200147" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_200148" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_200148" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_200149" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_200149" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_200150" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_200150" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_200151" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_200151" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_sny_OtherGainsLossesAndLitigation_200152" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_sny_OtherGainsLossesAndLitigation_200152" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_200153" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_200153" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_200154" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_FinanceCosts_200154" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_200155" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_FinanceIncome_200155" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_200156" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_200156" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_200157" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_200157" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_200158" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_200158" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations_200159" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations_200159" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200160" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200160" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_200139" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_ProfitLoss_200139" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200161" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLoss_200139" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200161" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_200162" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLoss_200139" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_200162" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_200163" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_WeightedAverageShares_200163" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_200164" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_200164" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_200167" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations_200167" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_200168" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_200168" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:label="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_200165" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent_200165" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_200169" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_200169" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_200170" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations_200170" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:label="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_200166" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProfitLossAbstract_200138" xlink:to="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent_200166" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_200196" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ProfitLoss_200196" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_200197" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent_200197" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200198" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200198" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_200199" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset_200199" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_200200" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments_200200" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_200201" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss_200201" use="optional" order="7" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_200202" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_200202" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:label="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_200203" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax_200203" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_200204" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_200204" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_200205" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax_200205" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_200206" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss_200206" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_200207" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_200207" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromContinuedOperations" xlink:label="loc_sny_OtherComprehensiveIncomeFromContinuedOperations_200208" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_sny_OtherComprehensiveIncomeFromContinuedOperations_200208" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xlink:label="loc_sny_OtherComprehensiveIncomeFromDiscontinuedOperations_200209" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract_200195" xlink:to="loc_sny_OtherComprehensiveIncomeFromDiscontinuedOperations_200209" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_200210" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ComprehensiveIncome_200210" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_200211" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent_200211" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xlink:label="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations_200212" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations_200212" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xlink:label="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations_200213" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations_200213" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_200214" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract_200194" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests_200214" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_200250" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_200251" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_200250" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_200251" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_200252" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200251" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_200252" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200253" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200252" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200253" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_200253" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_200257" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_IssuedCapitalMember_200257" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember_200258" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_AdditionalPaidinCapitalMember_200258" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_200259" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_TreasurySharesMember_200259" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_200260" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_RetainedEarningsMember_200260" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_200261" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_200261" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_200262" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_200262" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_200263" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_200253" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_200263" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200251" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_200264" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_Equity_200264" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_200265" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_200265" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_200266" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ProfitLoss_200266" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_200267" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ComprehensiveIncome_200267" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_200268" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_200268" use="optional" order="17" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_200270" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_200270" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_200271" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_200271" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital_200272" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ReductionOfIssuedCapital_200272" use="optional" order="20" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TaxesOnShareCancellations" xlink:label="loc_sny_TaxesOnShareCancellations_203226" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_TaxesOnShareCancellations_203226" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareBasedPaymentPlansAbstract" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract_200256" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_ShareBasedPaymentPlansAbstract_200256" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_200273" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_200273" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_200274" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_200274" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_200275" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_200275" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_200276" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_200276" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_200277" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_200277" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_200278" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_200278" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_200279" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_200279" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_200281" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_Equity_200281" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract_200306" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_200307" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract_200306" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_200307" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_200310" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_200310" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200311" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200310" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200311" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xlink:to="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_200319" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" xlink:to="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_200319" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_200388" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity_200388" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xlink:label="loc_sny_AdjustmentsForLossesGainsOnTransferOfBusiness_200389" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_sny_AdjustmentsForLossesGainsOnTransferOfBusiness_200389" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200390" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_200390" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_200391" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod_200391" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:label="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_200392" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset_200392" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_200393" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets_200393" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_200394" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense_200394" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_200395" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities_200395" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments_200396" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments_200396" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:label="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_200397" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue_200397" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_200398" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss_200398" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_200399" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital_200399" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_200400" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_200400" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_200401" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_200401" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_200402" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_200402" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:label="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_200403" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities_200403" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_200404" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations_200404" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_200405" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract_200384" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations_200405" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_200406" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_200383" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities_200406" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_200407" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_200407" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200408" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200408" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_200409" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities_200409" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_200410" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets_200410" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200411" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200411" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherNonCurrentAssets" xlink:label="loc_sny_NetChangeInOtherNonCurrentAssets_200412" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_sny_NetChangeInOtherNonCurrentAssets_200412" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInContinuingInvestingActivities" xlink:label="loc_sny_NetCashProvidedByusedInContinuingInvestingActivities_200413" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_sny_NetCashProvidedByusedInContinuingInvestingActivities_200413" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xlink:label="loc_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities_200415" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities_200415" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashInflowFromDiscontinuedOperations" xlink:label="loc_sny_NetCashInflowFromDiscontinuedOperations_200417" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_sny_NetCashInflowFromDiscontinuedOperations_200417" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_200416" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_200385" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities_200416" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares_200418" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares_200418" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DividendsPaidAbstract" xlink:label="loc_sny_DividendsPaidAbstract_200387" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_sny_DividendsPaidAbstract_200387" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_200419" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DividendsPaidAbstract_200387" xlink:to="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities_200419" use="optional" order="36" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_200420" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DividendsPaidAbstract_200387" xlink:to="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities_200420" use="optional" order="37" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_200421" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings_200421" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_200422" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings_200422" use="optional" order="39" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_200423" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_200423" use="optional" order="40" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200424" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200424" use="optional" order="41" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_200425" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares_200425" use="optional" order="42" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_200426" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations_200426" use="optional" order="43" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_200427" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_200386" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations_200427" use="optional" order="44" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_200428" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities_200428" use="optional" order="45" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_200429" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_200429" use="optional" order="46" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xlink:label="loc_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale_200430" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale_200430" use="optional" order="47" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_200431" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_200431" use="optional" order="48" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200432" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashAndCashEquivalents_200432" use="optional" order="49" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200433" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200382" xlink:to="loc_ifrs-full_CashAndCashEquivalents_200433" use="optional" order="50" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract_200452" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract_200452" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_200454" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_200454" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_200455" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_200454" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_200455" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_200459" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_200455" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_200459" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_200460" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" xlink:to="loc_sny_OpellaMember_200460" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_200461" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_200461" use="optional" order="9" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_200462" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_200462" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_200463" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_200463" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xlink:label="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities_200464" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities_200464" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200465" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200465" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200466" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_CashAndCashEquivalents_200466" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/Introduction" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_sny_GeneralInformationAboutFinancialStatementsAbstract_200471" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_200472" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GeneralInformationAboutFinancialStatementsAbstract_200471" xlink:to="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory_200472" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200477" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_200478" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200477" xlink:to="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory_200478" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_200483" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_200484" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_200483" xlink:to="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock_200484" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PropertyPlantAndEquipment" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200489" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_200490" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200489" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_200490" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_200495" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_200496" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_200495" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory_200496" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract_200501" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_200502" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract_200501" xlink:to="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock_200502" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestsInOtherEntitiesAbstract" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_200507" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_200508" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_200507" xlink:to="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory_200508" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherNonCurrentAssets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200513" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_200514" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200513" xlink:to="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory_200514" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivable" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_200519" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfTradeReceivablesTextBlock" xlink:label="loc_sny_DisclosureOfTradeReceivablesTextBlock_200520" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_200519" xlink:to="loc_sny_DisclosureOfTradeReceivablesTextBlock_200520" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquity" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200526" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_200527" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200526" xlink:to="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_200527" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalents" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_200533" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_200534" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_200533" xlink:to="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock_200534" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstruments" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract_200539" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_200540" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_200539" xlink:to="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory_200540" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200545" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock_200546" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200545" xlink:to="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock_200546" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OffBalanceSheetCommitments" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OffBalanceSheetCommitmentsAbstract" xlink:label="loc_sny_OffBalanceSheetCommitmentsAbstract_200551" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_200552" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OffBalanceSheetCommitmentsAbstract_200551" xlink:to="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock_200552" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LitigationAndArbitrationProceedings" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_200557" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_200558" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_200557" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock_200558" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200563" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_200564" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200563" xlink:to="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory_200564" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200570" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRestructuringTextBlock" xlink:label="loc_sny_DisclosureOfRestructuringTextBlock_200572" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200570" xlink:to="loc_sny_DisclosureOfRestructuringTextBlock_200572" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200577" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:label="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_200578" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200577" xlink:to="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock_200578" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/FinancialExpensesAndIncome" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200583" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_200584" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200583" xlink:to="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_200584" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpense" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_200589" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_200590" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_200589" xlink:to="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory_200590" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformation" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200595" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_200596" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200595" xlink:to="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_200596" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomers" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_200607" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory_200608" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_200607" xlink:to="loc_ifrs-full_DisclosureOfRevenueExplanatory_200608" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200614" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_200615" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200614" xlink:to="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory_200615" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_203229" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_203230" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_203229" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock_203230" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/EventsSubsequentToJune302025" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_200601" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_200602" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_200601" xlink:to="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_200602" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfIFRSCompliance" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance_200628" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_ifrs-full_StatementOfIFRSCompliance_200628" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_200629" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory_200629" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xlink:label="loc_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock_200630" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock_200630" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:label="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_200631" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory_200631" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_200632" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory_200632" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_200633" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200627" xlink:to="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations_200633" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200639" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_200640" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200639" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory_200640" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200645" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_200646" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200645" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock_200646" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_200651" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_200652" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_200651" xlink:to="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock_200652" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestsInOtherEntitiesAbstract" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_200658" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:label="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_200659" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_200658" xlink:to="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock_200659" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_200660" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_200658" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory_200660" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock_203224" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_200658" xlink:to="loc_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock_203224" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherNonCurrentAssetsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200665" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xlink:label="loc_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock_200666" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200665" xlink:to="loc_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock_200666" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_200672" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:label="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_200673" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_200672" xlink:to="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock_200673" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:label="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_200674" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_200672" xlink:to="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock_200674" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_200685" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory_200685" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_200686" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock_200686" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:label="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_200687" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock_200687" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:label="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_200688" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock_200688" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:label="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_200689" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock_200689" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_200690" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_200684" xlink:to="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock_200690" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_200698" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:label="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_200699" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_200698" xlink:to="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock_200699" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_200700" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_200698" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock_200700" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_200701" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_200698" xlink:to="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock_200701" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:label="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_200702" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_200698" xlink:to="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock_200702" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract_200709" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:label="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_200710" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_200709" xlink:to="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock_200710" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_200711" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_200709" xlink:to="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock_200711" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_200712" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_200709" xlink:to="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock_200712" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_200717" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:label="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_200718" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_200717" xlink:to="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock_200718" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200725" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_200726" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200725" xlink:to="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock_200726" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTableTextBlock_200727" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200725" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsTableTextBlock_200727" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:label="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock_200728" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_200725" xlink:to="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock_200728" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200733" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingExpensesTableTextBlock" xlink:label="loc_sny_OtherOperatingExpensesTableTextBlock_200734" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200733" xlink:to="loc_sny_OtherOperatingExpensesTableTextBlock_200734" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200739" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:label="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_200740" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200739" xlink:to="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock_200740" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200745" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_200746" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_200745" xlink:to="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock_200746" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_200752" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:label="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_200753" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_200752" xlink:to="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock_200753" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_200754" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_200752" xlink:to="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock_200754" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_200774" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_200775" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_200774" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory_200775" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherRevenueTextBlock" xlink:label="loc_sny_DisclosureOfOtherRevenueTextBlock_200776" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_200774" xlink:to="loc_sny_DisclosureOfOtherRevenueTextBlock_200776" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200763" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_200765" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200763" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory_200765" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:label="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_200766" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200763" xlink:to="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock_200766" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_200767" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200763" xlink:to="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock_200767" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_200768" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_200763" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory_200768" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_203252" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_203253" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_203252" xlink:to="loc_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_203253" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200796" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract_200796" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_200798" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_ifrs-full_GeographicalAreasAxis_200798" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_200799" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_200798" xlink:to="loc_ifrs-full_GeographicalAreasDomain_200799" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR" xlink:label="loc_country_AR_200805" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_200799" xlink:to="loc_country_AR_200805" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_TR" xlink:label="loc_country_TR_200806" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_200799" xlink:to="loc_country_TR_200806" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementAxis" xlink:label="loc_sny_TypesOfAgreementAxis_200800" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_sny_TypesOfAgreementAxis_200800" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementDomain" xlink:label="loc_sny_TypesOfAgreementDomain_200801" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_TypesOfAgreementAxis_200800" xlink:to="loc_sny_TypesOfAgreementDomain_200801" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_200802" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_ifrs-full_CounterpartiesAxis_200802" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_200803" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_200802" xlink:to="loc_ifrs-full_CounterpartiesDomain_200803" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xlink:label="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears_200809" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" xlink:to="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears_200809" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_200861" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract_200861" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_200863" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_200863" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_200864" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_200863" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_200864" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_200866" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_200866" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionAxis" xlink:label="loc_sny_AssetsAcquisitionAxis_200867" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_sny_AssetsAcquisitionAxis_200867" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_200868" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionAxis_200867" xlink:to="loc_sny_AssetsAcquisitionDomain_200868" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionMember" xlink:label="loc_sny_AssetsAcquisitionMember_200875" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_AssetsAcquisitionMember_200875" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VigilNeuroscienceIncMember" xlink:label="loc_sny_VigilNeuroscienceIncMember_200876" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_VigilNeuroscienceIncMember_200876" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BlueprintMedicinesCorporationMember" xlink:label="loc_sny_BlueprintMedicinesCorporationMember_200877" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_BlueprintMedicinesCorporationMember_200877" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_200878" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OpellaMember_200878" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_200879" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OpellaBusinessMember_200879" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OPALJVCoMember" xlink:label="loc_sny_OPALJVCoMember_203218" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OPALJVCoMember_203218" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BpifranceMember" xlink:label="loc_sny_BpifranceMember_203219" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_BpifranceMember_203219" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_200884" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_200884" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_200885" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_200885" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200887" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200887" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_200892" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_200892" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200893" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200893" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PotentialFuturePayments" xlink:label="loc_sny_PotentialFuturePayments_200897" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_PotentialFuturePayments_200897" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashInflowFromDiscontinuedOperations" xlink:label="loc_sny_NetCashInflowFromDiscontinuedOperations_200898" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_NetCashInflowFromDiscontinuedOperations_200898" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_200899" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_200899" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_200900" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_200900" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInterestsOfAcquirerPerShare" xlink:label="loc_sny_EquityInterestsOfAcquirerPerShare_200901" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_EquityInterestsOfAcquirerPerShare_200901" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DeferredCashPayments" xlink:label="loc_sny_DeferredCashPayments_200902" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_DeferredCashPayments_200902" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_200903" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_200903" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashTransferredPerShare" xlink:label="loc_sny_CashTransferredPerShare_200904" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_CashTransferredPerShare_200904" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200905" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200905" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-full_NetAssetsLiabilities_200906" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_NetAssetsLiabilities_200906" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_203216" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_203216" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_203220" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_203220" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment_203225" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment_203225" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones_203227" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones_203227" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200996" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_200996" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_200998" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xlink:to="loc_ifrs-full_SegmentsAxis_200998" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_200999" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_200998" xlink:to="loc_ifrs-full_SegmentsDomain_200999" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_201003" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_200999" xlink:to="loc_sny_BiopharmaSegmentMember_201003" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_201005" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_200999" xlink:to="loc_sny_OpellaMember_201005" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ManufacturingAndSupplyMember" xlink:label="loc_sny_ManufacturingAndSupplyMember_201006" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" xlink:to="loc_sny_ManufacturingAndSupplyMember_201006" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_201008" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_201008" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised" xlink:label="loc_ifrs-full_InterestCostsCapitalised_201009" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" xlink:to="loc_ifrs-full_InterestCostsCapitalised_201009" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_201015" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:label="loc_sny_FirmOrdersOfPropertyPlantAndEquipment_201016" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract_201015" xlink:to="loc_sny_FirmOrdersOfPropertyPlantAndEquipment_201016" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_201037" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_201037" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketedProductsMember" xlink:label="loc_sny_MarketedProductsMember_201047" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" xlink:to="loc_sny_MarketedProductsMember_201047" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TechnologicalPlatformsMember" xlink:label="loc_sny_TechnologicalPlatformsMember_201048" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" xlink:to="loc_sny_TechnologicalPlatformsMember_201048" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_201041" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_sny_PrincipalAlliancesAxis_201041" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_201042" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_201041" xlink:to="loc_sny_PrincipalAlliancesDomain_201042" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201043" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_ifrs-full_CounterpartiesAxis_201043" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201044" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_201043" xlink:to="loc_ifrs-full_CounterpartiesDomain_201044" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_201051" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_Goodwill_201051" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201053" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201053" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_201054" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_201054" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_201094" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract_201094" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AcquiredResearchAndDevelopmentMember" xlink:label="loc_sny_AcquiredResearchAndDevelopmentMember_201106" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_sny_AcquiredResearchAndDevelopmentMember_201106" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductsTrademarksAndOtherRightsMember" xlink:label="loc_sny_ProductsTrademarksAndOtherRightsMember_201098" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_sny_ProductsTrademarksAndOtherRightsMember_201098" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_201108" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_ifrs-full_ComputerSoftwareMember_201108" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201100" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" xlink:to="loc_ifrs-full_CarryingAmountMember_201100" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_201113" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_201100" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_201113" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_201114" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_201100" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_201114" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_201101" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_201101" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_201102" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_201101" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_201102" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201103" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_CounterpartiesAxis_201103" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201104" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_201103" xlink:to="loc_ifrs-full_CounterpartiesDomain_201104" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201129" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201129" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_201130" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_201130" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_201119" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_201119" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_201120" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_201120" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_201121" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_201121" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_201122" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_201122" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_201123" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_201123" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_201124" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_201124" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets_201128" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_OtherIntangibleAssets_201128" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract_201136" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract_201136" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_203214" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_203214" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_201137" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_201137" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestsInOtherEntitiesAbstract" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_201175" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_201175" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis" xlink:label="loc_ifrs-full_JointVenturesAxis_201177" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_JointVenturesAxis_201177" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain" xlink:label="loc_ifrs-full_JointVenturesDomain_201178" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesAxis_201177" xlink:to="loc_ifrs-full_JointVenturesDomain_201178" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfraservGmbhAndCoHochstKGMember" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_201188" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_201188" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSPVaccineCompanyMember" xlink:label="loc_sny_MSPVaccineCompanyMember_201189" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_sny_MSPVaccineCompanyMember_201189" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_201190" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_201190" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_201179" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_dei_LegalEntityAxis_201179" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201180" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_201179" xlink:to="loc_dei_EntityDomain_201180" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EuroapiMember" xlink:label="loc_sny_EuroapiMember_201191" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_201180" xlink:to="loc_sny_EuroapiMember_201191" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSPVaccineCompanyMember" xlink:label="loc_sny_MSPVaccineCompanyMember_201192" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_201180" xlink:to="loc_sny_MSPVaccineCompanyMember_201192" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EuroapiMember" xlink:label="loc_sny_EuroapiMember_201193" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_EuroapiMember_201193" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_201194" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_OpellaMember_201194" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OPALJVCoMember" xlink:label="loc_sny_OPALJVCoMember_203217" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_OPALJVCoMember_203217" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CDRMember" xlink:label="loc_sny_CDRMember_203222" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_CDRMember_203222" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BpifranceMember" xlink:label="loc_sny_BpifranceMember_203223" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_BpifranceMember_203223" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MCMVaccineBVMember" xlink:label="loc_sny_MCMVaccineBVMember_201195" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" xlink:to="loc_sny_MCMVaccineBVMember_201195" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_201197" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_201197" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_201198" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_201198" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_201199" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_201199" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod_201200" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod_201200" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_201201" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_201201" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockPrice" xlink:label="loc_sny_StockPrice_201203" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_sny_StockPrice_201203" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_201204" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_201204" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LoansToAssociates" xlink:label="loc_sny_LoansToAssociates_201207" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_sny_LoansToAssociates_201207" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_201208" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_201208" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestsInOtherEntitiesAbstract" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract_201225" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract_201225" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssociatesAndJointVenturesMember" xlink:label="loc_sny_AssociatesAndJointVenturesMember_201230" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" xlink:to="loc_sny_AssociatesAndJointVenturesMember_201230" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_201231" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_201231" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_201232" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_201232" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_201233" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_201233" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsRelatedPartyTransactions" xlink:label="loc_sny_OtherAssetsRelatedPartyTransactions_201234" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_OtherAssetsRelatedPartyTransactions_201234" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_201235" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_201235" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_201236" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_201236" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubordinateHybridBondRelatedPartyTransactions" xlink:label="loc_sny_SubordinateHybridBondRelatedPartyTransactions_201238" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_SubordinateHybridBondRelatedPartyTransactions_201238" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_201262" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_201262" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssociatesAndJointVenturesMember" xlink:label="loc_sny_AssociatesAndJointVenturesMember_201267" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" xlink:to="loc_sny_AssociatesAndJointVenturesMember_201267" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xlink:label="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures_201282" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures_201282" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetIncomeRelatedPartyDisclosures" xlink:label="loc_sny_NetIncomeRelatedPartyDisclosures_201281" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NetIncomeRelatedPartyDisclosures_201281" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures_201269" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures_201269" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures_201270" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures_201270" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentAssetsRelatedPartyTransactions_201280" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NonCurrentAssetsRelatedPartyTransactions_201280" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_CurrentAssetsRelatedPartyTransactions_201272" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_CurrentAssetsRelatedPartyTransactions_201272" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsRelatedPartyTransactions" xlink:label="loc_sny_AssetsRelatedPartyTransactions_201273" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_AssetsRelatedPartyTransactions_201273" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions_201274" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions_201274" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions_201275" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions_201275" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRelatedPartyTransactions" xlink:label="loc_sny_EquityRelatedPartyTransactions_201276" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityRelatedPartyTransactions_201276" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions_201277" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions_201277" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_CurrentLiabilitiesRelatedPartyTransactions_201278" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_CurrentLiabilitiesRelatedPartyTransactions_201278" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_LiabilitiesRelatedPartyTransactions_201279" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_LiabilitiesRelatedPartyTransactions_201279" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAndLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions_201271" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions_201271" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_201299" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsTable" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_201299" xlink:to="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_201301" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_201301" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201302" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201301" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201302" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradingEquitySecuritiesMember" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_201304" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201302" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_201304" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="loc_ifrs-full_DebtSecuritiesMember_201305" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201302" xlink:to="loc_ifrs-full_DebtSecuritiesMember_201305" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" xlink:to="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_201306" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_201306" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss_201307" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss_201307" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PreFundedPensionObligations" xlink:label="loc_sny_PreFundedPensionObligations_201308" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_PreFundedPensionObligations_201308" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LongTermPrepaidExpenses" xlink:label="loc_sny_LongTermPrepaidExpenses_201309" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_LongTermPrepaidExpenses_201309" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLoansAndReceivables" xlink:label="loc_sny_NonCurrentLoansAndReceivables_201310" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_NonCurrentLoansAndReceivables_201310" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_201311" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_201311" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_201312" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_201312" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201323" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableTable" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable_201324" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201323" xlink:to="loc_sny_DisclosureOfAccountsReceivableTable_201324" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_201324" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201326" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" xlink:to="loc_ifrs-full_CarryingAmountMember_201326" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_201328" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_201326" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_201328" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_201329" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CarryingAmountMember_201326" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_201329" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableLineItems" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_201324" xlink:to="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_201330" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" xlink:to="loc_ifrs-full_CurrentTradeReceivables_201330" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201336" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_201337" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201336" xlink:to="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables_201337" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerecognizedReceivables" xlink:label="loc_sny_DerecognizedReceivables_201338" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201336" xlink:to="loc_sny_DerecognizedReceivables_201338" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201352" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract_201352" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_201354" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" xlink:to="loc_ifrs-full_MaturityAxis_201354" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_201355" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_201354" xlink:to="loc_ifrs-full_MaturityDomain_201355" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember_201357" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_NotLaterThanOneMonthMember_201357" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_201358" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_201358" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_201359" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_201359" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_201360" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_201360" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_201361" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanOneYearMember_201361" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OverdueReceivablesGrossValue" xlink:label="loc_sny_OverdueReceivablesGrossValue_201362" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" xlink:to="loc_sny_OverdueReceivablesGrossValue_201362" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201411" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201411" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201413" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201413" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201414" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201413" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201414" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_201426" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201414" xlink:to="loc_ifrs-full_IssuedCapitalMember_201426" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201427" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201414" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201427" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_201415" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_dei_LegalEntityAxis_201415" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201416" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_201415" xlink:to="loc_dei_EntityDomain_201416" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiMember" xlink:label="loc_sny_SanofiMember_201428" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_201416" xlink:to="loc_sny_SanofiMember_201428" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramAxis" xlink:label="loc_sny_ShareProgramAxis_201417" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_sny_ShareProgramAxis_201417" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramDomain" xlink:label="loc_sny_ShareProgramDomain_201418" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareProgramAxis_201417" xlink:to="loc_sny_ShareProgramDomain_201418" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2024ProgramMember" xlink:label="loc_sny_ShareRepurchase2024ProgramMember_201431" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareProgramDomain_201418" xlink:to="loc_sny_ShareRepurchase2024ProgramMember_201431" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2025ProgramMember" xlink:label="loc_sny_ShareRepurchase2025ProgramMember_201432" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareProgramDomain_201418" xlink:to="loc_sny_ShareRepurchase2025ProgramMember_201432" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EmployeeShareOwnershipPlanMember" xlink:label="loc_sny_EmployeeShareOwnershipPlanMember_201433" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" xlink:to="loc_sny_EmployeeShareOwnershipPlanMember_201433" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForeignCurrencyTranslationMember" xlink:label="loc_sny_ForeignCurrencyTranslationMember_201436" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" xlink:to="loc_sny_ForeignCurrencyTranslationMember_201436" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xlink:label="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember_203246" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" xlink:to="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember_203246" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsAxis" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_201423" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_201423" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201424" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201423" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201424" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201437" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201424" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201437" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_201438" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_IssuedCapital_201438" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_201439" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_NumberOfSharesIssued_201439" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_201440" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_ParValuePerShare_201440" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_201441" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_201441" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease_201442" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease_201442" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_201443" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_201443" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease_201453" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease_201453" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PeriodOfShareRepurchaseProgram" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram_201445" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_PeriodOfShareRepurchaseProgram_201445" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesRepurchased" xlink:label="loc_sny_NumberOfSharesRepurchased_201446" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesRepurchased_201446" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmountOfSharesRepurchased" xlink:label="loc_sny_AmountOfSharesRepurchased_201447" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_AmountOfSharesRepurchased_201447" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PerShareValueOfSharesRepurchased" xlink:label="loc_sny_PerShareValueOfSharesRepurchased_201456" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_PerShareValueOfSharesRepurchased_201456" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubscriptionPricePerShare" xlink:label="loc_sny_SubscriptionPricePerShare_201448" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_SubscriptionPricePerShare_201448" use="optional" order="35" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesSubscribed" xlink:label="loc_sny_NumberOfSharesSubscribed_201449" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesSubscribed_201449" use="optional" order="36" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_201450" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_201450" use="optional" order="37" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201451" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201451" use="optional" order="38" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201454" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201454" use="optional" order="39" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CancellationOfTreasuryShares" xlink:label="loc_ifrs-full_CancellationOfTreasuryShares_201455" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_CancellationOfTreasuryShares_201455" use="optional" order="40" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201462" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesHeld" xlink:label="loc_sny_NumberOfSharesHeld_201463" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201462" xlink:to="loc_sny_NumberOfSharesHeld_201463" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PercentageOfShareCapitalForThePeriod" xlink:label="loc_sny_PercentageOfShareCapitalForThePeriod_201464" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201462" xlink:to="loc_sny_PercentageOfShareCapitalForThePeriod_201464" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201489" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201489" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2024Member" xlink:label="loc_sny_RestrictedSharePlan2024Member_201500" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" xlink:to="loc_sny_RestrictedSharePlan2024Member_201500" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2025Member" xlink:label="loc_sny_RestrictedSharePlan2025Member_201502" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" xlink:to="loc_sny_RestrictedSharePlan2025Member_201502" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionAxis" xlink:label="loc_sny_MarketConditionAxis_201493" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_sny_MarketConditionAxis_201493" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionDomain" xlink:label="loc_sny_MarketConditionDomain_201494" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionAxis_201493" xlink:to="loc_sny_MarketConditionDomain_201494" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithoutMarketConditionMember" xlink:label="loc_sny_WithoutMarketConditionMember_201503" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionDomain_201494" xlink:to="loc_sny_WithoutMarketConditionMember_201503" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithMarketConditionMember" xlink:label="loc_sny_WithMarketConditionMember_201504" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_MarketConditionDomain_201494" xlink:to="loc_sny_WithMarketConditionMember_201504" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_201495" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_srt_TitleOfIndividualAxis_201495" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_201495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExcludingChiefExecutiveOfficerMember" xlink:label="loc_sny_ExcludingChiefExecutiveOfficerMember_201505" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" xlink:to="loc_sny_ExcludingChiefExecutiveOfficerMember_201505" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_201506" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" xlink:to="loc_srt_ChiefExecutiveOfficerMember_201506" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_201507" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_201507" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_201508" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_201508" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOfPlanAtDateOfGrant" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant_201509" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_FairValueOfPlanAtDateOfGrant_201509" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfYearsServicePeriod" xlink:label="loc_sny_NumberOfYearsServicePeriod_201510" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_NumberOfYearsServicePeriod_201510" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201527" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201527" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharesMember" xlink:label="loc_sny_RestrictedSharesMember_201531" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharesMember_201531" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2025Member" xlink:label="loc_sny_RestrictedSharePlan2025Member_201538" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2025Member_201538" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2023Member" xlink:label="loc_sny_RestrictedSharePlan2023Member_201533" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2023Member_201533" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2024Member" xlink:label="loc_sny_RestrictedSharePlan2024Member_201537" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2024Member_201537" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2022Member" xlink:label="loc_sny_RestrictedSharePlan2022Member_201534" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2022Member_201534" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2021Member" xlink:label="loc_sny_RestrictedSharePlan2021Member_201535" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2021Member_201535" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201539" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201539" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_201540" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" xlink:to="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_201540" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201564" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201564" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_201566" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_RangeAxis_201566" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_201567" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_201566" xlink:to="loc_ifrs-full_RangeDomain_201567" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_201573" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_201567" xlink:to="loc_ifrs-full_BottomOfRangeMember_201573" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_201574" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeDomain_201567" xlink:to="loc_ifrs-full_TopOfRangeMember_201574" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeTwoMember" xlink:label="loc_sny_ExercisePriceRangeTwoMember_201575" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeTwoMember_201575" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeThreeMember" xlink:label="loc_sny_ExercisePriceRangeThreeMember_201576" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeThreeMember_201576" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeFourMember" xlink:label="loc_sny_ExercisePriceRangeFourMember_201577" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeFourMember_201577" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201570" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201570" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201571" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201570" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201571" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockOptionPlanMember" xlink:label="loc_sny_StockOptionPlanMember_201578" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201571" xlink:to="loc_sny_StockOptionPlanMember_201578" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_201579" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_201579" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_201580" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_201580" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_201581" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_201581" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_201582" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_201582" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_201583" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_201583" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_201584" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_201584" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201592" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_201593" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201592" xlink:to="loc_ifrs-full_WeightedAverageShares_201593" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_201594" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201592" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_201594" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:label="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_201595" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201592" xlink:to="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares_201595" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_201596" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201592" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_201596" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201639" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract_201639" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201641" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201641" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201642" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201641" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201642" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201650" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201642" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201650" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsAxis" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_201643" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_201643" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201644" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201643" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201644" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_201651" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201644" xlink:to="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_201651" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201652" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201644" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201652" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInstrumentsIncludedInFinancialAssetsMember" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember_201653" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" xlink:to="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember_201653" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentsMember" xlink:label="loc_sny_DebtInstrumentsMember_201654" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" xlink:to="loc_sny_DebtInstrumentsMember_201654" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_201659" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_201659" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_201660" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_201660" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments_201661" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments_201661" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_201662" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_201662" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_201663" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_201663" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_201664" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_201664" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_201665" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_201665" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_201666" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_201666" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_201667" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_201667" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures_201668" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures_201668" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments_201669" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments_201669" use="optional" order="26" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_201670" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_201670" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_201671" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_201671" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_201672" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_201672" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_201673" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_201673" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_201674" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_201674" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_201675" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_201675" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_201676" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_201676" use="optional" order="33" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201677" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201677" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_201691" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_ifrs-full_LongtermBorrowings_201691" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201692" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201692" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201693" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201693" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201694" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_ifrs-full_Borrowings_201694" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_201695" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_ifrs-full_CashAndCashEquivalents_201695" use="optional" order="5" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201696" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201696" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_201697" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_201697" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_201698" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201690" xlink:to="loc_ifrs-full_LeaseLiabilities_201698" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_201718" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201718" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201720" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" xlink:to="loc_ifrs-full_MeasurementAxis_201720" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201721" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_201720" xlink:to="loc_ifrs-full_MeasurementDomain_201721" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizedCostNettingMember" xlink:label="loc_sny_AmortizedCostNettingMember_201723" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_AmortizedCostNettingMember_201723" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_201724" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_201724" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201725" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_ValueOnRedemptionMember_201725" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_201726" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_LongtermBorrowings_201726" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201727" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201727" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201728" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201728" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201729" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_Borrowings_201729" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_201730" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_CashAndCashEquivalents_201730" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201731" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201731" use="optional" order="13" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_201732" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_201732" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_201733" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_LeaseLiabilities_201733" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_201764" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201764" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201766" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_MeasurementAxis_201766" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201767" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_201766" xlink:to="loc_ifrs-full_MeasurementDomain_201767" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201775" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201767" xlink:to="loc_sny_ValueOnRedemptionMember_201775" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesMember" xlink:label="loc_sny_NonCurrentLiabilitiesMember_201776" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" xlink:to="loc_sny_NonCurrentLiabilitiesMember_201776" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesMember" xlink:label="loc_sny_CurrentLiabilitiesMember_201777" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" xlink:to="loc_sny_CurrentLiabilitiesMember_201777" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_201770" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_201770" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201771" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201770" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201771" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsMember" xlink:label="loc_sny_NonCurrentAssetsMember_201778" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201771" xlink:to="loc_sny_NonCurrentAssetsMember_201778" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsMember" xlink:label="loc_sny_CurrentAssetsMember_201779" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201771" xlink:to="loc_sny_CurrentAssetsMember_201779" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_201772" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_201772" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201773" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201772" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201773" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_201780" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201773" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_201780" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInFranceMember" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_201781" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201773" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_201781" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BondsIssued" xlink:label="loc_ifrs-full_BondsIssued_201782" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_BondsIssued_201782" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherBankBorrowings" xlink:label="loc_sny_OtherBankBorrowings_201783" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_OtherBankBorrowings_201783" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_201784" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_OtherBorrowings_201784" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_201785" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_201785" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201786" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201786" use="optional" order="22" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201787" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_Borrowings_201787" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_201788" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_CashAndCashEquivalents_201788" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201789" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201789" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_201790" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_201790" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_201832" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201832" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_201834" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_201834" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201835" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201834" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201835" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInFranceMember" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_201846" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_201846" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_201847" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_201847" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingDecember2027Member" xlink:label="loc_sny_FourBillionFacilityMaturingDecember2027Member_201849" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FourBillionFacilityMaturingDecember2027Member_201849" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingMarch2030Member" xlink:label="loc_sny_FourBillionFacilityMaturingMarch2030Member_201850" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FourBillionFacilityMaturingMarch2030Member_201850" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2020Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2020Member_201852" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondIssueFromApril2020Member_201852" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2022Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2022Member_201853" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondIssueFromApril2022Member_201853" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member_201854" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member_201854" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2027Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2027Member_201855" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2027Member_201855" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2031Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2031Member_201856" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2031Member_201856" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingJune2029Member" xlink:label="loc_sny_FixedRateBondMaturingJune2029Member_201857" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingJune2029Member_201857" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2032Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2032Member_201858" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2032Member_201858" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member_201859" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member_201859" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentAxis" xlink:label="loc_sny_DebtInstrumentAxis_201836" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_sny_DebtInstrumentAxis_201836" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentDomain" xlink:label="loc_sny_DebtInstrumentDomain_201837" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentAxis_201836" xlink:to="loc_sny_DebtInstrumentDomain_201837" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiEuroMediumTermNotesMember" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_201860" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DebtInstrumentDomain_201837" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_201860" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201838" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_ifrs-full_CounterpartiesAxis_201838" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201839" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_201838" xlink:to="loc_ifrs-full_CounterpartiesDomain_201839" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_201864" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_ifrs-full_NotionalAmount_201864" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfTranches" xlink:label="loc_sny_NumberOfTranches_201870" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_sny_NumberOfTranches_201870" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued_201867" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_ifrs-full_CommercialPapersIssued_201867" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BorrowingAverageDrawdown" xlink:label="loc_sny_BorrowingAverageDrawdown_201868" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_sny_BorrowingAverageDrawdown_201868" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract_201882" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract_201882" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201884" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" xlink:to="loc_ifrs-full_MeasurementAxis_201884" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201885" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_201884" xlink:to="loc_ifrs-full_MeasurementDomain_201885" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtMarketValueMember" xlink:label="loc_sny_AtMarketValueMember_201887" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201885" xlink:to="loc_sny_AtMarketValueMember_201887" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201888" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201885" xlink:to="loc_sny_ValueOnRedemptionMember_201888" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201889" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" xlink:to="loc_ifrs-full_Borrowings_201889" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RedemptionOfDebtInstrumentIssued" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued_201890" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" xlink:to="loc_sny_RedemptionOfDebtInstrumentIssued_201890" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract_201923" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_201923" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201925" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_MeasurementAxis_201925" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201926" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_201925" xlink:to="loc_ifrs-full_MeasurementDomain_201926" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_201927" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_ifrs-full_AtFairValueMember_201927" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_201935" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_sny_AtNotionalAmountMember_201935" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOfHedgeRecognizedInEquityMember" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_201936" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_201936" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesAxis" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_201928" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_201928" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_201929" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_201928" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_201929" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesMember" xlink:label="loc_ifrs-full_CashFlowHedgesMember_201937" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_201929" xlink:to="loc_ifrs-full_CashFlowHedgesMember_201937" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NotEligibleForHedgeAccountingMember" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember_201938" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_201929" xlink:to="loc_sny_NotEligibleForHedgeAccountingMember_201938" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_201930" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_201930" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201931" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201930" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201931" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesMember" xlink:label="loc_sny_ForwardCurrencySalesMember_201932" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201931" xlink:to="loc_sny_ForwardCurrencySalesMember_201932" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_201939" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_201939" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_201943" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_201943" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_201940" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_201940" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInJapaneseYenMember" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_201941" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_201941" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInPoundSterlingMember" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_203254" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_203254" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesMember" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_201933" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201931" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_201933" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_201944" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_201944" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_201945" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_201945" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember_201948" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember_201948" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember_201947" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember_201947" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInTurkishLiraMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember_201950" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember_201950" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstruments" xlink:label="loc_sny_DerivativeFinancialInstruments_201952" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" xlink:to="loc_sny_DerivativeFinancialInstruments_201952" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract_201991" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_201991" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201993" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_MeasurementAxis_201993" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201994" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_201993" xlink:to="loc_ifrs-full_MeasurementDomain_201994" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_202002" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201994" xlink:to="loc_sny_AtNotionalAmountMember_202002" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_202003" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_201994" xlink:to="loc_ifrs-full_AtFairValueMember_202003" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_201995" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_201995" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201996" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201995" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201996" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsMember" xlink:label="loc_sny_CrossCurrencySellerSwapsMember_202018" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySellerSwapsMember_202018" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesMember" xlink:label="loc_sny_ForwardCurrencySalesMember_201997" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencySalesMember_201997" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_202004" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_202004" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInPoundSterlingMember" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_202006" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_202006" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInJapaneseYenMember" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_203256" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_203256" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesMember" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_201998" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_201998" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_202008" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_202008" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_202007" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_202007" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember_202014" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember_202014" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember_202010" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember_202010" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2029Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2029Member_202015" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapExpiring2029Member_202015" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2032Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2032Member_202016" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapExpiring2032Member_202016" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapMember" xlink:label="loc_sny_CrossCurrencySwapMember_202017" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapMember_202017" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsInUSDollarMember" xlink:label="loc_sny_CrossCurrencySellerSwapsInUSDollarMember_202019" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySellerSwapsInUSDollarMember_202019" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_201999" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_MaturityAxis_201999" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202000" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_201999" xlink:to="loc_ifrs-full_MaturityDomain_202000" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_202020" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_202020" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202021" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202021" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember_203255" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember_203255" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_202022" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_202022" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_202023" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_NotionalAmount_202023" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_202024" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_202024" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_202025" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_202025" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_202026" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_202026" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract_202059" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_FinancialInstrumentsAbstract_202059" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_202061" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_202061" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_202062" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_202061" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_202062" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember_202075" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember_202075" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xlink:label="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember_202072" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember_202072" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member_202073" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member_202073" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_202063" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_MeasurementAxis_202063" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_202064" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementAxis_202063" xlink:to="loc_ifrs-full_MeasurementDomain_202064" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_202077" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_sny_AtNotionalAmountMember_202077" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_202078" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_ifrs-full_AtFairValueMember_202078" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOfHedgeRecognizedInEquityMember" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_202079" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_202079" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_202065" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_MaturityAxis_202065" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202066" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_202065" xlink:to="loc_ifrs-full_MaturityDomain_202066" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_202080" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_202080" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202081" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202081" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_202082" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_202082" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_202083" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_202083" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_202084" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_202084" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesAxis" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_202067" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_202067" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_202068" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_202067" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_202068" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FairValueHedgesMember" xlink:label="loc_ifrs-full_FairValueHedgesMember_202085" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_202068" xlink:to="loc_ifrs-full_FairValueHedgesMember_202085" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesMember" xlink:label="loc_ifrs-full_CashFlowHedgesMember_202086" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_202068" xlink:to="loc_ifrs-full_CashFlowHedgesMember_202086" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_202088" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" xlink:to="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_202088" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_202111" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_202111" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_202113" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_202113" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202114" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202113" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202114" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_202119" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_202119" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:label="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202120" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202120" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilities1Member" xlink:label="loc_sny_OtherLiabilities1Member_202122" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_OtherLiabilities1Member_202122" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xlink:label="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202123" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202123" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_202124" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_202124" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_202125" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_202125" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_202127" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_202127" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202128" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202128" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202129" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202129" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202130" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202130" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_203232" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_203233" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_203232" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_203233" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_203234" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_203232" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_203234" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_202149" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract_202149" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_202151" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_202151" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202152" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202151" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202152" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:label="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202158" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202152" xlink:to="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202158" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_202153" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xlink:to="loc_ifrs-full_RangeAxis_202153" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_202154" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_202153" xlink:to="loc_ifrs-full_RangeDomain_202154" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202163" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202163" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PercentageIncreaseInFairValueLiabilities" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities_202164" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" xlink:to="loc_sny_PercentageIncreaseInFairValueLiabilities_202164" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202183" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTable" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202183" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_202185" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_sny_PrincipalAlliancesAxis_202185" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202186" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_202185" xlink:to="loc_sny_PrincipalAlliancesDomain_202186" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesCollaborationAgreementMember" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_202192" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesDomain_202186" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_202192" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_202187" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_ifrs-full_CounterpartiesAxis_202187" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202188" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_202187" xlink:to="loc_ifrs-full_CounterpartiesDomain_202188" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SwedishOrphanBiovitrumABMember" xlink:label="loc_sny_SwedishOrphanBiovitrumABMember_202193" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesDomain_202188" xlink:to="loc_sny_SwedishOrphanBiovitrumABMember_202193" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_202189" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_ifrs-full_MaturityAxis_202189" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202190" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityAxis_202189" xlink:to="loc_ifrs-full_MaturityDomain_202190" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_202194" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202190" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_202194" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_203248" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MaturityDomain_202190" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_203248" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_202196" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_ifrs-full_NoncurrentProvisions_202196" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_202197" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_202197" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_202198" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_202198" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202227" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTable" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202227" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_202229" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_202229" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_202229" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember_202237" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember_202237" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForOtherLongTermBenefitsMember" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember_202238" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_ProvisionsForOtherLongTermBenefitsMember_202238" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentRestructuringProvisionMember" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember_202239" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_NonCurrentRestructuringProvisionMember_202239" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherProvisionsMember" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember_202240" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_ifrs-full_MiscellaneousOtherProvisionsMember_202240" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202231" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202231" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202232" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202231" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202232" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_country_GB_202241" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202232" xlink:to="loc_country_GB_202241" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsMember" xlink:label="loc_ifrs-full_PlanAssetsMember_202242" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" xlink:to="loc_ifrs-full_PlanAssetsMember_202242" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" xlink:to="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_202243" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_NoncurrentProvisions_202243" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInOtherProvisions" xlink:label="loc_ifrs-full_ChangesInOtherProvisions_202244" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_ChangesInOtherProvisions_202244" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_202245" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_202245" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_202248" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_202248" use="optional" order="19" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_202246" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_202246" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions_202247" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions_202247" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_202249" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_202249" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions_202250" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions_202250" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_202251" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_NoncurrentProvisions_202251" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_202252" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_202252" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202284" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_202284" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsMember" xlink:label="loc_ifrs-full_PlanAssetsMember_202299" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" xlink:to="loc_ifrs-full_PlanAssetsMember_202299" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_202288" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_202288" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_202289" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_202288" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_202289" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_202300" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_202289" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_202300" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202290" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202290" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202291" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202290" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202291" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UKZONEMember" xlink:label="loc_sny_UKZONEMember_202303" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202291" xlink:to="loc_sny_UKZONEMember_202303" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EUROZONEMember" xlink:label="loc_sny_EUROZONEMember_202302" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202291" xlink:to="loc_sny_EUROZONEMember_202302" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_202292" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_202292" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_202293" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_202292" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_202293" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_202304" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_202293" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_202304" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_202305" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_202293" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_202305" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_202294" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_srt_RangeAxis_202294" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_202295" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_202294" xlink:to="loc_srt_RangeMember_202295" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_202306" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_202295" xlink:to="loc_srt_MinimumMember_202306" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_202307" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_202295" xlink:to="loc_srt_MaximumMember_202307" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_202308" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" xlink:to="loc_sny_OpellaBusinessMember_202308" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_202309" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_202309" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_202310" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_202310" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_202311" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_202311" use="optional" order="26" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_202312" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_202312" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OffBalanceSheetCommitmentsAbstract" xlink:label="loc_sny_OffBalanceSheetCommitmentsAbstract_203236" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OffBalanceSheetCommitmentsAbstract_203236" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_203240" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" xlink:to="loc_ifrs-full_RelatedPartiesMember_203240" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EarendilLabsMember" xlink:label="loc_sny_EarendilLabsMember_203241" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RelatedPartiesMember_203240" xlink:to="loc_sny_EarendilLabsMember_203241" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_203244" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" xlink:to="loc_ifrs-full_Prepayments_203244" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions_203242" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" xlink:to="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions_203242" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_202391" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract_202391" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsAxis" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis_202393" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_sny_LegalAndArbitralProceedingsAxis_202393" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsDomain" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_202394" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_202393" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_202394" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_202400" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_202394" xlink:to="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_202400" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoldBondProductLitigationInTheUSMember" xlink:label="loc_sny_GoldBondProductLitigationInTheUSMember_202403" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_202394" xlink:to="loc_sny_GoldBondProductLitigationInTheUSMember_202403" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantAxis" xlink:label="loc_sny_DefendantAxis_202395" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_sny_DefendantAxis_202395" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantDomain" xlink:label="loc_sny_DefendantDomain_202396" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantAxis_202395" xlink:to="loc_sny_DefendantDomain_202396" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichWeAreDefendantMember" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember_202404" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantDomain_202396" xlink:to="loc_sny_ActionForWhichWeAreDefendantMember_202404" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichSanofiAreDefendantMember" xlink:label="loc_sny_ActionForWhichSanofiAreDefendantMember_202405" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DefendantDomain_202396" xlink:to="loc_sny_ActionForWhichSanofiAreDefendantMember_202405" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductLiabilitiesMember" xlink:label="loc_sny_ProductLiabilitiesMember_202406" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" xlink:to="loc_sny_ProductLiabilitiesMember_202406" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfClassActionLawsuits" xlink:label="loc_sny_NumberOfClassActionLawsuits_202411" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_NumberOfClassActionLawsuits_202411" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PaymentOfDamagesClaimedByCounterparty" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty_202414" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_PaymentOfDamagesClaimedByCounterparty_202414" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PenaltyFeeIncurred" xlink:label="loc_sny_PenaltyFeeIncurred_202413" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_PenaltyFeeIncurred_202413" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202432" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202432" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_202441" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_202441" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RegeneronMember" xlink:label="loc_sny_RegeneronMember_202442" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" xlink:to="loc_sny_RegeneronMember_202442" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingIncomeExpenseMember" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_202443" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_202443" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercializationRelatedExpensesMember" xlink:label="loc_sny_CommercializationRelatedExpensesMember_203247" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" xlink:to="loc_sny_CommercializationRelatedExpensesMember_203247" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202444" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202444" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202445" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202445" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsOnDivestmentOfProducts" xlink:label="loc_sny_GainsOnDivestmentOfProducts_202446" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_sny_GainsOnDivestmentOfProducts_202446" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202473" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202473" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RegeneronMember" xlink:label="loc_sny_RegeneronMember_202484" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" xlink:to="loc_sny_RegeneronMember_202484" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_202477" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_srt_CounterpartyNameAxis_202477" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_202477" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesAllianceMember" xlink:label="loc_sny_AntibodiesAllianceMember_202485" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" xlink:to="loc_sny_AntibodiesAllianceMember_202485" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OthersCounterpartyMember" xlink:label="loc_sny_OthersCounterpartyMember_202487" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" xlink:to="loc_sny_OthersCounterpartyMember_202487" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_202489" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_202489" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_202490" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_202490" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercializationRelatedExpensesMember" xlink:label="loc_sny_CommercializationRelatedExpensesMember_202491" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_CommercializationRelatedExpensesMember_202491" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingIncomeExpenseMember" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_202492" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_202492" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202493" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202493" use="optional" order="18" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202494" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202494" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202495" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202495" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_202496" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_202496" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_202507" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses_202507" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_202508" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories_202508" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_202510" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" xlink:to="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts_202510" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherRestructuringCosts" xlink:label="loc_sny_OtherRestructuringCosts_202511" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" xlink:to="loc_sny_OtherRestructuringCosts_202511" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_202512" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202506" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_202512" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202517" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xlink:label="loc_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities_202518" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202517" xlink:to="loc_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities_202518" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202524" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_sny_OtherGainsLossesAndLitigation_202525" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202524" xlink:to="loc_sny_OtherGainsLossesAndLitigation_202525" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202551" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract_202551" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsAxis" xlink:label="loc_ifrs-full_HedgedItemsAxis_202553" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" xlink:to="loc_ifrs-full_HedgedItemsAxis_202553" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsDomain" xlink:label="loc_ifrs-full_HedgedItemsDomain_202554" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgedItemsAxis_202553" xlink:to="loc_ifrs-full_HedgedItemsDomain_202554" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesMember" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember_202556" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_HedgedItemsDomain_202554" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesMember_202556" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_202557" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_202557" use="optional" order="6" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestIncome" xlink:label="loc_sny_InterestIncome_202558" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_InterestIncome_202558" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CostOfDebtNet" xlink:label="loc_sny_CostOfDebtNet_202559" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_CostOfDebtNet_202559" use="optional" order="8" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonOperatingForeignExchangeGainsLosses" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses_202560" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_NonOperatingForeignExchangeGainsLosses_202560" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_202561" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_202561" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetInterestCostRelatedToEmployeeBenefits" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits_202562" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_NetInterestCostRelatedToEmployeeBenefits_202562" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_202564" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_202564" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_202565" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_202565" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_202566" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceIncomeCost_202566" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_202567" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceCosts_202567" use="optional" order="15" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_202568" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceIncome_202568" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageDebt" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageDebt_202569" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_GainLossOnDerivativesUsedToManageDebt_202569" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents_202570" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents_202570" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilityRecognisedForEstimatedFutureRoyalties" xlink:label="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties_202572" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties_202572" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202580" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome_202581" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202580" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome_202581" use="optional" order="1" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome_202582" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202580" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome_202582" use="optional" order="2" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_202583" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202580" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations_202583" use="optional" order="3" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202584" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202580" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202584" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate_202598" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" xlink:to="loc_ifrs-full_ApplicableTaxRate_202598" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_202599" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates_202599" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:label="loc_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes_202600" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" xlink:to="loc_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes_202600" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_202603" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome_202603" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate_202604" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract_202597" xlink:to="loc_ifrs-full_AverageEffectiveTaxRate_202604" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentTaxExpenseRelatedToPillarTwo" xlink:label="loc_sny_CurrentTaxExpenseRelatedToPillarTwo_202618" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" xlink:to="loc_sny_CurrentTaxExpenseRelatedToPillarTwo_202618" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202702" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202702" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202704" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202704" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202705" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202704" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202705" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_202720" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_srt_EuropeMember_202720" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_country_US_202721" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_country_US_202721" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesMember" xlink:label="loc_sny_OtherCountriesMember_202722" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_sny_OtherCountriesMember_202722" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202706" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_SegmentsAxis_202706" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202707" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_202706" xlink:to="loc_ifrs-full_SegmentsDomain_202707" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202723" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_202707" xlink:to="loc_sny_BiopharmaSegmentMember_202723" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_202708" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_202708" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202709" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202708" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202709" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SpecialtyCareMember" xlink:label="loc_sny_SpecialtyCareMember_202710" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_SpecialtyCareMember_202710" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DupixentMember" xlink:label="loc_sny_DupixentMember_202729" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SpecialtyCareMember_202710" xlink:to="loc_sny_DupixentMember_202729" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AubagioMember" xlink:label="loc_sny_AubagioMember_202730" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_SpecialtyCareMember_202710" xlink:to="loc_sny_AubagioMember_202730" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GeneralMedicinesMember" xlink:label="loc_sny_GeneralMedicinesMember_202711" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_GeneralMedicinesMember_202711" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IndustrialSalesMember" xlink:label="loc_sny_IndustrialSalesMember_202742" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_GeneralMedicinesMember_202711" xlink:to="loc_sny_IndustrialSalesMember_202742" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VaccinesMember" xlink:label="loc_sny_VaccinesMember_202714" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_VaccinesMember_202714" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PolioPertussisHibVaccinesMember" xlink:label="loc_sny_PolioPertussisHibVaccinesMember_202743" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_VaccinesMember_202714" xlink:to="loc_sny_PolioPertussisHibVaccinesMember_202743" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfluenzaVaccinesMember" xlink:label="loc_sny_InfluenzaVaccinesMember_202744" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_VaccinesMember_202714" xlink:to="loc_sny_InfluenzaVaccinesMember_202744" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NexviazymeMember" xlink:label="loc_sny_NexviazymeMember_202748" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_NexviazymeMember_202748" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SarclisaMember" xlink:label="loc_sny_SarclisaMember_202749" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_SarclisaMember_202749" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AltuviiioMember" xlink:label="loc_sny_AltuviiioMember_202750" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_AltuviiioMember_202750" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RezurockMember" xlink:label="loc_sny_RezurockMember_202751" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_RezurockMember_202751" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CabliviMember" xlink:label="loc_sny_CabliviMember_202752" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_CabliviMember_202752" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_XenpozymeMember" xlink:label="loc_sny_XenpozymeMember_202753" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_XenpozymeMember_202753" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TzieldMember" xlink:label="loc_sny_TzieldMember_202755" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_TzieldMember_202755" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RSVVaccinesMember" xlink:label="loc_sny_RSVVaccinesMember_202756" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_RSVVaccinesMember_202756" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MeningitisTravelAndEndemicVaccinesMember" xlink:label="loc_sny_MeningitisTravelAndEndemicVaccinesMember_202757" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_MeningitisTravelAndEndemicVaccinesMember_202757" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_202715" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_srt_ProductOrServiceAxis_202715" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202716" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_202715" xlink:to="loc_srt_ProductsAndServicesDomain_202716" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202766" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202766" use="optional" order="34" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract_203085" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RevenueAbstract_203085" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_203087" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_203087" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_203098" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_203087" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_203098" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_203088" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_GeographicalAreasAxis_203088" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_203099" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_203088" xlink:to="loc_ifrs-full_GeographicalAreasDomain_203099" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersAxis" xlink:label="loc_ifrs-full_MarketsOfCustomersAxis_203089" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_MarketsOfCustomersAxis_203089" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersDomain" xlink:label="loc_ifrs-full_MarketsOfCustomersDomain_203100" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MarketsOfCustomersAxis_203089" xlink:to="loc_ifrs-full_MarketsOfCustomersDomain_203100" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_203090" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TypesOfCustomersAxis_203090" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_203101" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_203090" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_203101" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="loc_ifrs-full_TypesOfContractsAxis_203091" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TypesOfContractsAxis_203091" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-full_TypesOfContractsDomain_203102" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TypesOfContractsAxis_203091" xlink:to="loc_ifrs-full_TypesOfContractsDomain_203102" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationAxis" xlink:label="loc_ifrs-full_ContractDurationAxis_203092" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_ContractDurationAxis_203092" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationDomain" xlink:label="loc_ifrs-full_ContractDurationDomain_203103" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ContractDurationAxis_203092" xlink:to="loc_ifrs-full_ContractDurationDomain_203103" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsAxis" xlink:label="loc_ifrs-full_SalesChannelsAxis_203094" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_SalesChannelsAxis_203094" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsDomain" xlink:label="loc_ifrs-full_SalesChannelsDomain_203105" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SalesChannelsAxis_203094" xlink:to="loc_ifrs-full_SalesChannelsDomain_203105" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_203095" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_SegmentsAxis_203095" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_203096" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_203095" xlink:to="loc_ifrs-full_SegmentsDomain_203096" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_203106" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_203096" xlink:to="loc_sny_BiopharmaSegmentMember_203106" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_203107" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_203096" xlink:to="loc_sny_OpellaBusinessMember_203107" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xlink:label="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts_203108" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts_203108" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xlink:label="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations_203109" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations_203109" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_203110" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_ifrs-full_RevenueFromRoyalties_203110" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherRevenue" xlink:label="loc_sny_MiscellaneousOtherRevenue_203111" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_MiscellaneousOtherRevenue_203111" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_203112" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_ifrs-full_OtherRevenue_203112" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202798" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202798" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202800" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" xlink:to="loc_ifrs-full_SegmentsAxis_202800" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202801" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_202800" xlink:to="loc_ifrs-full_SegmentsDomain_202801" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202804" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_sny_BiopharmaSegmentMember_202804" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AllOtherSegmentsMember" xlink:label="loc_ifrs-full_AllOtherSegmentsMember_202806" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_ifrs-full_AllOtherSegmentsMember_202806" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReportableSegmentsMember" xlink:label="loc_ifrs-full_ReportableSegmentsMember_202802" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_ifrs-full_ReportableSegmentsMember_202802" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202807" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202807" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_202808" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_OtherRevenue_202808" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_202809" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_CostOfSales_202809" use="optional" order="10" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_202810" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_202810" use="optional" order="11" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_202811" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_202811" use="optional" order="12" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202812" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202812" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202813" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202813" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202814" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202814" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_sny_BusinessOperatingIncome_202815" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_sny_BusinessOperatingIncome_202815" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202869" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202869" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_202887" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" xlink:to="loc_ifrs-full_OperatingSegmentsMember_202887" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_202888" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_202888" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_202889" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_202889" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_202876" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_202876" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202877" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202876" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202877" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/label" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_202878" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_sny_PrincipalAlliancesAxis_202878" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202879" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_PrincipalAlliancesAxis_202878" xlink:to="loc_sny_PrincipalAlliancesDomain_202879" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_202880" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_CounterpartiesAxis_202880" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202881" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_202880" xlink:to="loc_ifrs-full_CounterpartiesDomain_202881" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_202882" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_srt_ProductOrServiceAxis_202882" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202883" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_202882" xlink:to="loc_srt_ProductsAndServicesDomain_202883" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202884" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_SegmentsAxis_202884" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202885" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_202884" xlink:to="loc_ifrs-full_SegmentsDomain_202885" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_sny_BusinessOperatingIncome_202899" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_BusinessOperatingIncome_202899" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202900" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202900" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202901" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202901" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_202902" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_202902" use="optional" order="23" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_202903" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_202903" use="optional" order="24" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_202904" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_202904" use="optional" order="25" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_202905" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_202905" use="optional" order="26" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_sny_OtherGainsLossesAndLitigation_202906" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_OtherGainsLossesAndLitigation_202906" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_202908" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_202908" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_202909" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_FinanceCosts_202909" use="optional" order="29" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_202910" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_FinanceIncome_202910" use="optional" order="30" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202911" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202911" use="optional" order="31" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_202913" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_202913" use="optional" order="32" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill_202918" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill_202918" use="optional" order="33" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202934" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202934" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202936" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" xlink:to="loc_ifrs-full_SegmentsAxis_202936" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202937" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsAxis_202936" xlink:to="loc_ifrs-full_SegmentsDomain_202937" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReportableSegmentsMember" xlink:label="loc_ifrs-full_ReportableSegmentsMember_202938" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SegmentsDomain_202937" xlink:to="loc_ifrs-full_ReportableSegmentsMember_202938" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202940" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_ReportableSegmentsMember_202938" xlink:to="loc_sny_BiopharmaSegmentMember_202940" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_202943" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_202943" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_202944" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_202944" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_202945" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_202945" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202965" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202965" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202967" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202967" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202968" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202967" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202968" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ReportableGeographicalZonesMember" xlink:label="loc_sny_ReportableGeographicalZonesMember_202969" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202968" xlink:to="loc_sny_ReportableGeographicalZonesMember_202969" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_202970" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_srt_EuropeMember_202970" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR" xlink:label="loc_country_FR_202973" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_FR_202973" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_country_US_202974" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_US_202974" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xlink:label="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember_202975" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember_202975" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN" xlink:label="loc_country_CN_202976" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_CN_202976" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202977" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202977" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_202972" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_202972" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_202978" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_202978" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_202979" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_Goodwill_202979" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_202980" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_202980" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202993" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract_202993" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_202995" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" xlink:to="loc_ifrs-full_MajorCustomersAxis_202995" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain" xlink:label="loc_ifrs-full_MajorCustomersDomain_202996" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersAxis_202995" xlink:to="loc_ifrs-full_MajorCustomersDomain_202996" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CertainWholesalersInTheUnitedStatesMember" xlink:label="loc_sny_CertainWholesalersInTheUnitedStatesMember_202998" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CertainWholesalersInTheUnitedStatesMember_202998" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerOneMember" xlink:label="loc_sny_CustomerOneMember_202999" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerOneMember_202999" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerTwoMember" xlink:label="loc_sny_CustomerTwoMember_203000" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerTwoMember_203000" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerThreeMember" xlink:label="loc_sny_CustomerThreeMember_203001" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerThreeMember_203001" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_203002" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_203002" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_203162" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract_203162" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_203180" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" xlink:to="loc_sny_OpellaBusinessMember_203180" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations_203184" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations_203184" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations_203185" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations_203185" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations_203186" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations_203186" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations_203187" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations_203187" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations_203188" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations_203188" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations_203189" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations_203189" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations_203190" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations_203190" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations_203191" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations_203191" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203192" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203192" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203193" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203193" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations_203194" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations_203194" use="optional" order="16" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203195" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203195" use="optional" order="17" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203196" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203196" use="optional" order="18" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations_203197" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations_203197" use="optional" order="19" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations_203198" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations_203198" use="optional" order="20" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations_203199" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations_203199" use="optional" order="21" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations_203200" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations_203200" use="optional" order="22" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations_203201" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations_203201" use="optional" order="23" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations_203202" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations_203202" use="optional" order="24" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_203203" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_203203" use="optional" order="25" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_203204" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_WeightedAverageShares_203204" use="optional" order="26" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_203205" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_203205" use="optional" order="27" preferredLabel="http://www.xbrl.org/2003/role/definitionGuidance" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_203206" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_203206" use="optional" order="28" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_203207" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_203207" use="optional" order="29" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
        </link:presentationLink>
        <link:presentationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/EventsSubsequentToJune302025Details" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_203030" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract_203030" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" use="optional" order="1" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_203032" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_CounterpartiesAxis_203032" use="optional" order="2" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_203033" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_CounterpartiesAxis_203032" xlink:to="loc_ifrs-full_CounterpartiesDomain_203033" use="optional" order="3" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" use="optional" order="4" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035" use="optional" order="5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_203036" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_RangeAxis_203036" use="optional" order="6" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_203037" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_RangeAxis_203036" xlink:to="loc_ifrs-full_RangeDomain_203037" use="optional" order="7" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_203038" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_203038" use="optional" order="8" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_203039" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_203038" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_203039" use="optional" order="9" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionAxis" xlink:label="loc_sny_AssetsAcquisitionAxis_203040" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_sny_AssetsAcquisitionAxis_203040" use="optional" order="10" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_203041" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionAxis_203040" xlink:to="loc_sny_AssetsAcquisitionDomain_203041" use="optional" order="11" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VicebioLtdMember" xlink:label="loc_sny_VicebioLtdMember_203049" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_sny_AssetsAcquisitionDomain_203041" xlink:to="loc_sny_VicebioLtdMember_203049" use="optional" order="12" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" use="optional" order="13" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UpfrontPayments" xlink:label="loc_sny_UpfrontPayments_203050" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" xlink:to="loc_sny_UpfrontPayments_203050" use="optional" order="14" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TotalMilestonePayments" xlink:label="loc_sny_TotalMilestonePayments_203054" />
          <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" xlink:to="loc_sny_TotalMilestonePayments_203054" use="optional" order="15" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
        </link:presentationLink>
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"  />
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"  />
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"  />
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"  />
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"  />
        <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll"  />
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/CoverPage" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems_200014" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable_200013" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_EntitiesTable_200013" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType_200015" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentType_200015" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName_200016" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_EntityRegistrantName_200016" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag_200017" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_AmendmentFlag_200017" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey_200018" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_EntityCentralIndexKey_200018" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate_200019" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_CurrentFiscalYearEndDate_200019" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate_200020" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentPeriodEndDate_200020" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus_200021" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentFiscalYearFocus_200021" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus_200022" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityInformationLineItems_200014" xlink:to="loc_dei_DocumentFiscalPeriodFocus_200022" use="optional" order="9" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_200251" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_200251" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_200252" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200251" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_200252" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200253" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200252" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200253" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200253_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200252" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200253_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_200253" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_200257" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_IssuedCapitalMember_200257" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember_200258" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_AdditionalPaidinCapitalMember_200258" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember_200259" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_TreasurySharesMember_200259" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember_200260" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_RetainedEarningsMember_200260" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_200261" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_ReserveOfSharebasedPaymentsMember_200261" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_200262" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember_200254" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_200262" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember_200263" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_200253" xlink:to="loc_ifrs-full_NoncontrollingInterestsMember_200263" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity_200264" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_Equity_200264" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_200265" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_200265" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss_200266" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ProfitLoss_200266" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome_200267" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ComprehensiveIncome_200267" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_200268" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent_200268" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareBasedPaymentPlansAbstract" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract_200256" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_ShareBasedPaymentPlansAbstract_200256" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_200273" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions_200273" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_200274" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares_200274" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_200275" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans_200275" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_200276" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees_200276" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_200277" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions_200277" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_200278" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract_200256" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl_200278" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_200270" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests_200270" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares_200271" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_PurchaseOfTreasuryShares_200271" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital_200272" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_ifrs-full_ReductionOfIssuedCapital_200272" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TaxesOnShareCancellations" xlink:label="loc_sny_TaxesOnShareCancellations_203226" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_TaxesOnShareCancellations_203226" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_200279" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200255" xlink:to="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity_200279" use="optional" order="29" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable_200307" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" xlink:to="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200308" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200309_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_200310" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable_200307" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_200310" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200311" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200310" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200311" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_200311_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_200310" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_200311_default" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_200319" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems_200312" xlink:to="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare_200319" use="optional" order="8" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_200454" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_200454" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_200455" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_200454" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_200455" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_200455_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_200454" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_200455_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_200459" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_200455" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_200459" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_200453" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200456" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_200460" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200457" xlink:to="loc_sny_OpellaMember_200460" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_200461" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_200461" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_200462" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities_200462" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_200463" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities_200463" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xlink:label="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities_200464" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities_200464" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200465" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments_200465" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_200466" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_200458" xlink:to="loc_ifrs-full_CashAndCashEquivalents_200466" use="optional" order="15" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" xlink:to="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_200798" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_ifrs-full_GeographicalAreasAxis_200798" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_200799" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_200798" xlink:to="loc_ifrs-full_GeographicalAreasDomain_200799" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_200799_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_200798" xlink:to="loc_ifrs-full_GeographicalAreasDomain_200799_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR" xlink:label="loc_country_AR_200805" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_200799" xlink:to="loc_country_AR_200805" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_TR" xlink:label="loc_country_TR_200806" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_200799" xlink:to="loc_country_TR_200806" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementAxis" xlink:label="loc_sny_TypesOfAgreementAxis_200800" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_sny_TypesOfAgreementAxis_200800" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementDomain" xlink:label="loc_sny_TypesOfAgreementDomain_200801" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_TypesOfAgreementAxis_200800" xlink:to="loc_sny_TypesOfAgreementDomain_200801" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementDomain" xlink:label="loc_sny_TypesOfAgreementDomain_200801_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_TypesOfAgreementAxis_200800" xlink:to="loc_sny_TypesOfAgreementDomain_200801_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_200802" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable_200797" xlink:to="loc_ifrs-full_CounterpartiesAxis_200802" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_200803" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_200802" xlink:to="loc_ifrs-full_CounterpartiesDomain_200803" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_200803_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_200802" xlink:to="loc_ifrs-full_CounterpartiesDomain_200803_default" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xlink:label="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears_200809" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems_200804" xlink:to="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears_200809" use="optional" order="13" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_200863" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_200863" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_200864" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_200863" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_200864" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_200864_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_200863" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_200864_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_200866" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_200866" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain_200866_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis_200865" xlink:to="loc_srt_EquityMethodInvesteeNameDomain_200866_default" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionAxis" xlink:label="loc_sny_AssetsAcquisitionAxis_200867" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_sny_AssetsAcquisitionAxis_200867" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_200868" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_AssetsAcquisitionAxis_200867" xlink:to="loc_sny_AssetsAcquisitionDomain_200868" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_200868_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_AssetsAcquisitionAxis_200867" xlink:to="loc_sny_AssetsAcquisitionDomain_200868_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionMember" xlink:label="loc_sny_AssetsAcquisitionMember_200875" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_AssetsAcquisitionMember_200875" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VigilNeuroscienceIncMember" xlink:label="loc_sny_VigilNeuroscienceIncMember_200876" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_VigilNeuroscienceIncMember_200876" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BlueprintMedicinesCorporationMember" xlink:label="loc_sny_BlueprintMedicinesCorporationMember_200877" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AssetsAcquisitionDomain_200868" xlink:to="loc_sny_BlueprintMedicinesCorporationMember_200877" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable_200862" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_200869" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_200878" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OpellaMember_200878" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_200879" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OpellaBusinessMember_200879" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OPALJVCoMember" xlink:label="loc_sny_OPALJVCoMember_203218" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_OPALJVCoMember_203218" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BpifranceMember" xlink:label="loc_sny_BpifranceMember_203219" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_200870" xlink:to="loc_sny_BpifranceMember_203219" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_200884" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_200884" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_200885" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_200885" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200887" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities_200887" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss_200892" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_NetForeignExchangeLoss_200892" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200893" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_200893" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PotentialFuturePayments" xlink:label="loc_sny_PotentialFuturePayments_200897" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_PotentialFuturePayments_200897" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashInflowFromDiscontinuedOperations" xlink:label="loc_sny_NetCashInflowFromDiscontinuedOperations_200898" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_NetCashInflowFromDiscontinuedOperations_200898" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome_200899" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_OtherComprehensiveIncome_200899" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer_200900" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_EquityInterestsOfAcquirer_200900" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInterestsOfAcquirerPerShare" xlink:label="loc_sny_EquityInterestsOfAcquirerPerShare_200901" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_EquityInterestsOfAcquirerPerShare_200901" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DeferredCashPayments" xlink:label="loc_sny_DeferredCashPayments_200902" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_DeferredCashPayments_200902" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_200903" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired_200903" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashTransferredPerShare" xlink:label="loc_sny_CashTransferredPerShare_200904" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_CashTransferredPerShare_200904" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200905" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_200905" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-full_NetAssetsLiabilities_200906" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_NetAssetsLiabilities_200906" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_203216" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_203216" use="optional" order="36" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_203220" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty_203220" use="optional" order="37" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment_203225" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment_203225" use="optional" order="38" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones_203227" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems_200871" xlink:to="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones_203227" use="optional" order="39" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" xlink:to="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_200998" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xlink:to="loc_ifrs-full_SegmentsAxis_200998" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_200999" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_200998" xlink:to="loc_ifrs-full_SegmentsDomain_200999" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_200999_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_200998" xlink:to="loc_ifrs-full_SegmentsDomain_200999_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_201003" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_200999" xlink:to="loc_sny_BiopharmaSegmentMember_201003" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_201005" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_200999" xlink:to="loc_sny_OpellaMember_201005" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_200997" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_201000" xlink:to="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ManufacturingAndSupplyMember" xlink:label="loc_sny_ManufacturingAndSupplyMember_201006" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain_201001" xlink:to="loc_sny_ManufacturingAndSupplyMember_201006" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_201008" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_201008" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised" xlink:label="loc_ifrs-full_InterestCostsCapitalised_201009" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems_201002" xlink:to="loc_ifrs-full_InterestCostsCapitalised_201009" use="optional" order="12" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201039" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketedProductsMember" xlink:label="loc_sny_MarketedProductsMember_201047" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" xlink:to="loc_sny_MarketedProductsMember_201047" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TechnologicalPlatformsMember" xlink:label="loc_sny_TechnologicalPlatformsMember_201048" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201040" xlink:to="loc_sny_TechnologicalPlatformsMember_201048" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_201041" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_sny_PrincipalAlliancesAxis_201041" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_201042" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_201041" xlink:to="loc_sny_PrincipalAlliancesDomain_201042" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_201042_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_201041" xlink:to="loc_sny_PrincipalAlliancesDomain_201042_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201043" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_201038" xlink:to="loc_ifrs-full_CounterpartiesAxis_201043" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201044" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_201043" xlink:to="loc_ifrs-full_CounterpartiesDomain_201044" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201044_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_201043" xlink:to="loc_ifrs-full_CounterpartiesDomain_201044_default" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_201051" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_Goodwill_201051" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201053" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201053" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_201054" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems_201045" xlink:to="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_201054" use="optional" order="15" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_201096" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AcquiredResearchAndDevelopmentMember" xlink:label="loc_sny_AcquiredResearchAndDevelopmentMember_201106" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_sny_AcquiredResearchAndDevelopmentMember_201106" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductsTrademarksAndOtherRightsMember" xlink:label="loc_sny_ProductsTrademarksAndOtherRightsMember_201098" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_sny_ProductsTrademarksAndOtherRightsMember_201098" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember_201108" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_201097" xlink:to="loc_ifrs-full_ComputerSoftwareMember_201108" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201100" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" xlink:to="loc_ifrs-full_CarryingAmountMember_201100" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201100_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201099" xlink:to="loc_ifrs-full_CarryingAmountMember_201100_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_201113" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_201100" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_201113" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_201114" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_201100" xlink:to="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember_201114" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_201101" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_201101" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_201102" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_201101" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_201102" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_201102_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_201101" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_201102_default" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201103" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_201095" xlink:to="loc_ifrs-full_CounterpartiesAxis_201103" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201104" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_201103" xlink:to="loc_ifrs-full_CounterpartiesDomain_201104" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201104_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_201103" xlink:to="loc_ifrs-full_CounterpartiesDomain_201104_default" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201129" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_201129" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_201130" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets_201130" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_201119" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_201119" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_201120" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill_201120" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_201121" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill_201121" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_201122" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill_201122" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_201123" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_201123" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_201124" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill_201124" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets_201128" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_201105" xlink:to="loc_ifrs-full_OtherIntangibleAssets_201128" use="optional" order="27" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_201137" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_201137" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems_203215" xlink:to="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable_203211" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_203212" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213_default" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_203214" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_203213" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_203214" use="optional" order="6" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis" xlink:label="loc_ifrs-full_JointVenturesAxis_201177" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_JointVenturesAxis_201177" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain" xlink:label="loc_ifrs-full_JointVenturesDomain_201178" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_JointVenturesAxis_201177" xlink:to="loc_ifrs-full_JointVenturesDomain_201178" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain" xlink:label="loc_ifrs-full_JointVenturesDomain_201178_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_JointVenturesAxis_201177" xlink:to="loc_ifrs-full_JointVenturesDomain_201178_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfraservGmbhAndCoHochstKGMember" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember_201188" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_sny_InfraservGmbhAndCoHochstKGMember_201188" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSPVaccineCompanyMember" xlink:label="loc_sny_MSPVaccineCompanyMember_201189" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_sny_MSPVaccineCompanyMember_201189" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSPVaccineCompanyMember" xlink:label="loc_sny_MSPVaccineCompanyMember_201192" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_201180" xlink:to="loc_sny_MSPVaccineCompanyMember_201192" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_201190" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_JointVenturesDomain_201178" xlink:to="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember_201190" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_201179" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_dei_LegalEntityAxis_201179" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201180" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_201179" xlink:to="loc_dei_EntityDomain_201180" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201180_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_201179" xlink:to="loc_dei_EntityDomain_201180_default" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EuroapiMember" xlink:label="loc_sny_EuroapiMember_201191" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_201180" xlink:to="loc_sny_EuroapiMember_201191" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EuroapiMember" xlink:label="loc_sny_EuroapiMember_201193" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_EuroapiMember_201193" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_201181" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember_201194" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_OpellaMember_201194" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OPALJVCoMember" xlink:label="loc_sny_OPALJVCoMember_203217" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_OPALJVCoMember_203217" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CDRMember" xlink:label="loc_sny_CDRMember_203222" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_CDRMember_203222" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BpifranceMember" xlink:label="loc_sny_BpifranceMember_203223" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_201182" xlink:to="loc_sny_BpifranceMember_203223" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201183" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184_default" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MCMVaccineBVMember" xlink:label="loc_sny_MCMVaccineBVMember_201195" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201184" xlink:to="loc_sny_MCMVaccineBVMember_201195" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201176" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201185" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201186_default" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_201197" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate_201197" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_201198" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod_201198" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_201199" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture_201199" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod_201200" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod_201200" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_201201" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_201201" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockPrice" xlink:label="loc_sny_StockPrice_201203" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_sny_StockPrice_201203" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_201204" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary_201204" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LoansToAssociates" xlink:label="loc_sny_LoansToAssociates_201207" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_sny_LoansToAssociates_201207" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_201208" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201187" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod_201208" use="optional" order="36" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201226" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201227" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssociatesAndJointVenturesMember" xlink:label="loc_sny_AssociatesAndJointVenturesMember_201230" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201228" xlink:to="loc_sny_AssociatesAndJointVenturesMember_201230" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_201231" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions_201231" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_201232" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions_201232" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_201233" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions_201233" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsRelatedPartyTransactions" xlink:label="loc_sny_OtherAssetsRelatedPartyTransactions_201234" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_OtherAssetsRelatedPartyTransactions_201234" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_201235" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions_201235" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_201236" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_ifrs-full_AmountsPayableRelatedPartyTransactions_201236" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubordinateHybridBondRelatedPartyTransactions" xlink:label="loc_sny_SubordinateHybridBondRelatedPartyTransactions_201238" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201229" xlink:to="loc_sny_SubordinateHybridBondRelatedPartyTransactions_201238" use="optional" order="12" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_201263" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_201264" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssociatesAndJointVenturesMember" xlink:label="loc_sny_AssociatesAndJointVenturesMember_201267" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_201265" xlink:to="loc_sny_AssociatesAndJointVenturesMember_201267" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xlink:label="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures_201282" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures_201282" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetIncomeRelatedPartyDisclosures" xlink:label="loc_sny_NetIncomeRelatedPartyDisclosures_201281" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NetIncomeRelatedPartyDisclosures_201281" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures_201269" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures_201269" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures_201270" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures_201270" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentAssetsRelatedPartyTransactions_201280" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NonCurrentAssetsRelatedPartyTransactions_201280" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_CurrentAssetsRelatedPartyTransactions_201272" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_CurrentAssetsRelatedPartyTransactions_201272" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsRelatedPartyTransactions" xlink:label="loc_sny_AssetsRelatedPartyTransactions_201273" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_AssetsRelatedPartyTransactions_201273" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions_201274" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions_201274" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions_201275" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions_201275" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRelatedPartyTransactions" xlink:label="loc_sny_EquityRelatedPartyTransactions_201276" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityRelatedPartyTransactions_201276" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions_201277" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions_201277" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_CurrentLiabilitiesRelatedPartyTransactions_201278" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_CurrentLiabilitiesRelatedPartyTransactions_201278" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_LiabilitiesRelatedPartyTransactions_201279" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_LiabilitiesRelatedPartyTransactions_201279" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAndLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions_201271" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_201266" xlink:to="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions_201271" use="optional" order="19" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsTable" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_201301" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsTable_201300" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_201301" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201302" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201301" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201302" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201302_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201301" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201302_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradingEquitySecuritiesMember" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember_201304" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201302" xlink:to="loc_ifrs-full_TradingEquitySecuritiesMember_201304" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="loc_ifrs-full_DebtSecuritiesMember_201305" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201302" xlink:to="loc_ifrs-full_DebtSecuritiesMember_201305" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_201306" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome_201306" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss_201307" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss_201307" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PreFundedPensionObligations" xlink:label="loc_sny_PreFundedPensionObligations_201308" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_PreFundedPensionObligations_201308" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LongTermPrepaidExpenses" xlink:label="loc_sny_LongTermPrepaidExpenses_201309" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_LongTermPrepaidExpenses_201309" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLoansAndReceivables" xlink:label="loc_sny_NonCurrentLoansAndReceivables_201310" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_sny_NonCurrentLoansAndReceivables_201310" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_201311" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets_201311" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets_201312" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems_201303" xlink:to="loc_ifrs-full_OtherNoncurrentAssets_201312" use="optional" order="13" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableLineItems" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableTable" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable_201324" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" xlink:to="loc_sny_DisclosureOfAccountsReceivableTable_201324" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable_201324" xlink:to="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201326" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" xlink:to="loc_ifrs-full_CarryingAmountMember_201326" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember_201326_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_201325" xlink:to="loc_ifrs-full_CarryingAmountMember_201326_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember_201328" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_201326" xlink:to="loc_ifrs-full_GrossCarryingAmountMember_201328" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember_201329" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CarryingAmountMember_201326" xlink:to="loc_ifrs-full_AccumulatedImpairmentMember_201329" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables_201330" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems_201327" xlink:to="loc_ifrs-full_CurrentTradeReceivables_201330" use="optional" order="7" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" xlink:to="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_201354" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_201353" xlink:to="loc_ifrs-full_MaturityAxis_201354" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_201355" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_201354" xlink:to="loc_ifrs-full_MaturityDomain_201355" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_201355_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_201354" xlink:to="loc_ifrs-full_MaturityDomain_201355_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember_201357" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_NotLaterThanOneMonthMember_201357" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_201358" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember_201358" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_201359" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_201359" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_201360" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember_201360" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember_201361" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_201355" xlink:to="loc_ifrs-full_LaterThanOneYearMember_201361" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OverdueReceivablesGrossValue" xlink:label="loc_sny_OverdueReceivablesGrossValue_201362" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems_201356" xlink:to="loc_sny_OverdueReceivablesGrossValue_201362" use="optional" order="10" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201413" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201413" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201414" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201413" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201414" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201414_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201413" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201414_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember_201426" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201414" xlink:to="loc_ifrs-full_IssuedCapitalMember_201426" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201427" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201414" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201427" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis_201415" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_dei_LegalEntityAxis_201415" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201416" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_201415" xlink:to="loc_dei_EntityDomain_201416" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain_201416_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_201415" xlink:to="loc_dei_EntityDomain_201416_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiMember" xlink:label="loc_sny_SanofiMember_201428" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_201416" xlink:to="loc_sny_SanofiMember_201428" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramAxis" xlink:label="loc_sny_ShareProgramAxis_201417" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_sny_ShareProgramAxis_201417" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramDomain" xlink:label="loc_sny_ShareProgramDomain_201418" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_ShareProgramAxis_201417" xlink:to="loc_sny_ShareProgramDomain_201418" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramDomain" xlink:label="loc_sny_ShareProgramDomain_201418_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_ShareProgramAxis_201417" xlink:to="loc_sny_ShareProgramDomain_201418_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2024ProgramMember" xlink:label="loc_sny_ShareRepurchase2024ProgramMember_201431" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareProgramDomain_201418" xlink:to="loc_sny_ShareRepurchase2024ProgramMember_201431" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2025ProgramMember" xlink:label="loc_sny_ShareRepurchase2025ProgramMember_201432" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ShareProgramDomain_201418" xlink:to="loc_sny_ShareRepurchase2025ProgramMember_201432" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201419" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420_default" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EmployeeShareOwnershipPlanMember" xlink:label="loc_sny_EmployeeShareOwnershipPlanMember_201433" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201420" xlink:to="loc_sny_EmployeeShareOwnershipPlanMember_201433" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201421" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422_default" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForeignCurrencyTranslationMember" xlink:label="loc_sny_ForeignCurrencyTranslationMember_201436" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" xlink:to="loc_sny_ForeignCurrencyTranslationMember_201436" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xlink:label="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember_203246" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201422" xlink:to="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember_203246" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsAxis" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_201423" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201412" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_201423" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201424" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201423" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201424" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201424_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201423" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201424_default" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201437" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201424" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201437" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital_201438" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_IssuedCapital_201438" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued_201439" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_NumberOfSharesIssued_201439" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare_201440" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_ParValuePerShare_201440" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_201441" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions_201441" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease_201442" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease_201442" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_201443" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease_201443" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease_201453" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease_201453" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PeriodOfShareRepurchaseProgram" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram_201445" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_PeriodOfShareRepurchaseProgram_201445" use="optional" order="36" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesRepurchased" xlink:label="loc_sny_NumberOfSharesRepurchased_201446" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesRepurchased_201446" use="optional" order="37" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmountOfSharesRepurchased" xlink:label="loc_sny_AmountOfSharesRepurchased_201447" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_AmountOfSharesRepurchased_201447" use="optional" order="38" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PerShareValueOfSharesRepurchased" xlink:label="loc_sny_PerShareValueOfSharesRepurchased_201456" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_PerShareValueOfSharesRepurchased_201456" use="optional" order="39" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubscriptionPricePerShare" xlink:label="loc_sny_SubscriptionPricePerShare_201448" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_SubscriptionPricePerShare_201448" use="optional" order="40" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesSubscribed" xlink:label="loc_sny_NumberOfSharesSubscribed_201449" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_NumberOfSharesSubscribed_201449" use="optional" order="41" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_201450" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution_201450" use="optional" order="42" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201451" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201451" use="optional" order="43" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201454" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201454" use="optional" order="44" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CancellationOfTreasuryShares" xlink:label="loc_ifrs-full_CancellationOfTreasuryShares_201455" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201425" xlink:to="loc_ifrs-full_CancellationOfTreasuryShares_201455" use="optional" order="45" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201491" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2024Member" xlink:label="loc_sny_RestrictedSharePlan2024Member_201500" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" xlink:to="loc_sny_RestrictedSharePlan2024Member_201500" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2025Member" xlink:label="loc_sny_RestrictedSharePlan2025Member_201502" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201492" xlink:to="loc_sny_RestrictedSharePlan2025Member_201502" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionAxis" xlink:label="loc_sny_MarketConditionAxis_201493" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_sny_MarketConditionAxis_201493" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionDomain" xlink:label="loc_sny_MarketConditionDomain_201494" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_MarketConditionAxis_201493" xlink:to="loc_sny_MarketConditionDomain_201494" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionDomain" xlink:label="loc_sny_MarketConditionDomain_201494_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_MarketConditionAxis_201493" xlink:to="loc_sny_MarketConditionDomain_201494_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithoutMarketConditionMember" xlink:label="loc_sny_WithoutMarketConditionMember_201503" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_MarketConditionDomain_201494" xlink:to="loc_sny_WithoutMarketConditionMember_201503" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithMarketConditionMember" xlink:label="loc_sny_WithMarketConditionMember_201504" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_MarketConditionDomain_201494" xlink:to="loc_sny_WithMarketConditionMember_201504" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis_201495" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201490" xlink:to="loc_srt_TitleOfIndividualAxis_201495" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_201495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_201495" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496_default" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExcludingChiefExecutiveOfficerMember" xlink:label="loc_sny_ExcludingChiefExecutiveOfficerMember_201505" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" xlink:to="loc_sny_ExcludingChiefExecutiveOfficerMember_201505" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember_201506" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_201496" xlink:to="loc_srt_ChiefExecutiveOfficerMember_201506" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_201507" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted_201507" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_201508" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod_201508" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOfPlanAtDateOfGrant" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant_201509" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_FairValueOfPlanAtDateOfGrant_201509" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfYearsServicePeriod" xlink:label="loc_sny_NumberOfYearsServicePeriod_201510" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201497" xlink:to="loc_sny_NumberOfYearsServicePeriod_201510" use="optional" order="20" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" xlink:to="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable_201528" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_201529" xlink:to="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharesMember" xlink:label="loc_sny_RestrictedSharesMember_201531" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharesMember_201531" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2025Member" xlink:label="loc_sny_RestrictedSharePlan2025Member_201538" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2025Member_201538" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2023Member" xlink:label="loc_sny_RestrictedSharePlan2023Member_201533" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2023Member_201533" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2024Member" xlink:label="loc_sny_RestrictedSharePlan2024Member_201537" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2024Member_201537" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2022Member" xlink:label="loc_sny_RestrictedSharePlan2022Member_201534" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2022Member_201534" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2021Member" xlink:label="loc_sny_RestrictedSharePlan2021Member_201535" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain_201530" xlink:to="loc_sny_RestrictedSharePlan2021Member_201535" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201539" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" xlink:to="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets_201539" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_201540" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems_201532" xlink:to="loc_sny_NumberOfRestrictedSharesNotYetFullyVested_201540" use="optional" order="12" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_201566" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_RangeAxis_201566" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_201567" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_201566" xlink:to="loc_ifrs-full_RangeDomain_201567" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_201567_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_201566" xlink:to="loc_ifrs-full_RangeDomain_201567_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember_201573" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_201567" xlink:to="loc_ifrs-full_BottomOfRangeMember_201573" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember_201574" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangeDomain_201567" xlink:to="loc_ifrs-full_TopOfRangeMember_201574" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis_201568" xlink:to="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeTwoMember" xlink:label="loc_sny_ExercisePriceRangeTwoMember_201575" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeTwoMember_201575" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeThreeMember" xlink:label="loc_sny_ExercisePriceRangeThreeMember_201576" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeThreeMember_201576" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeFourMember" xlink:label="loc_sny_ExercisePriceRangeFourMember_201577" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain_201569" xlink:to="loc_sny_ExercisePriceRangeFourMember_201577" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201570" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_201565" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201570" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201571" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201570" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201571" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201571_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201570" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201571_default" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockOptionPlanMember" xlink:label="loc_sny_StockOptionPlanMember_201578" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201571" xlink:to="loc_sny_StockOptionPlanMember_201578" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_201579" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019_201579" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions_201580" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_NumberOfOutstandingShareOptions_201580" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_201581" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019_201581" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_201582" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_201582" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_201583" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement_201583" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_201584" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems_201572" xlink:to="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019_201584" use="optional" order="22" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis_201641" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ComponentsOfEquityAxis_201641" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201642" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201641" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201642" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain_201642_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis_201641" xlink:to="loc_ifrs-full_ComponentsOfEquityDomain_201642_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201650" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain_201642" xlink:to="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember_201650" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsAxis" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis_201643" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ReclassifiedItemsAxis_201643" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201644" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201643" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201644" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain_201644_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis_201643" xlink:to="loc_ifrs-full_ReclassifiedItemsDomain_201644_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_201651" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201644" xlink:to="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember_201651" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201652" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain_201644" xlink:to="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember_201652" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis_201645" xlink:to="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInstrumentsIncludedInFinancialAssetsMember" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember_201653" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" xlink:to="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember_201653" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentsMember" xlink:label="loc_sny_DebtInstrumentsMember_201654" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain_201646" xlink:to="loc_sny_DebtInstrumentsMember_201654" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable_201640" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_201647" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_201648_default" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_201659" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures_201659" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_201660" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures_201660" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments_201661" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments_201661" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_201662" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures_201662" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_201663" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax_201663" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_201664" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges_201664" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_201665" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod_201665" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_201666" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax_201666" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_201667" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures_201667" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures_201668" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures_201668" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments_201669" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments_201669" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_201670" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures_201670" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_201671" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures_201671" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_201672" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome_201672" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_201673" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures_201673" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_201674" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures_201674" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_201675" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations_201675" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_201676" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_sny_ChangeInCurrencyTranslationOnTaxEffects_201676" use="optional" order="36" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201677" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems_201649" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax_201677" use="optional" order="37" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201720" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201719" xlink:to="loc_ifrs-full_MeasurementAxis_201720" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201721" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_201720" xlink:to="loc_ifrs-full_MeasurementDomain_201721" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201721_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_201720" xlink:to="loc_ifrs-full_MeasurementDomain_201721_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizedCostNettingMember" xlink:label="loc_sny_AmortizedCostNettingMember_201723" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_AmortizedCostNettingMember_201723" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_201724" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember_201724" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201725" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201721" xlink:to="loc_sny_ValueOnRedemptionMember_201725" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings_201726" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_LongtermBorrowings_201726" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201727" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings_201727" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201728" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201728" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201729" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_Borrowings_201729" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_201730" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_CashAndCashEquivalents_201730" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201731" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201731" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_201732" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_201732" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities_201733" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201722" xlink:to="loc_ifrs-full_LeaseLiabilities_201733" use="optional" order="15" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201766" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_MeasurementAxis_201766" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201767" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_201766" xlink:to="loc_ifrs-full_MeasurementDomain_201767" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201767_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_201766" xlink:to="loc_ifrs-full_MeasurementDomain_201767_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201775" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201767" xlink:to="loc_sny_ValueOnRedemptionMember_201775" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis_201768" xlink:to="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesMember" xlink:label="loc_sny_NonCurrentLiabilitiesMember_201776" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" xlink:to="loc_sny_NonCurrentLiabilitiesMember_201776" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesMember" xlink:label="loc_sny_CurrentLiabilitiesMember_201777" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain_201769" xlink:to="loc_sny_CurrentLiabilitiesMember_201777" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis_201770" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_ClassesOfAssetsAxis_201770" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201771" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201770" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201771" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain_201771_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis_201770" xlink:to="loc_ifrs-full_ClassesOfAssetsDomain_201771_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsMember" xlink:label="loc_sny_NonCurrentAssetsMember_201778" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201771" xlink:to="loc_sny_NonCurrentAssetsMember_201778" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsMember" xlink:label="loc_sny_CurrentAssetsMember_201779" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain_201771" xlink:to="loc_sny_CurrentAssetsMember_201779" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_201772" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable_201765" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_201772" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201773" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201772" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201773" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201773_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201772" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201773_default" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_201780" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201773" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_201780" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInFranceMember" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_201781" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201773" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_201781" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BondsIssued" xlink:label="loc_ifrs-full_BondsIssued_201782" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_BondsIssued_201782" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherBankBorrowings" xlink:label="loc_sny_OtherBankBorrowings_201783" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_OtherBankBorrowings_201783" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings_201784" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_OtherBorrowings_201784" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_201785" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents_201785" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201786" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt_201786" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201787" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_Borrowings_201787" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents_201788" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_ifrs-full_CashAndCashEquivalents_201788" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201789" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent_201789" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents_201790" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems_201774" xlink:to="loc_sny_DebtNetOfCashAndCashEquivalents_201790" use="optional" order="29" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis_201834" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_ifrs-full_BorrowingsByNameAxis_201834" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201835" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201834" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201835" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain_201835_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BorrowingsByNameAxis_201834" xlink:to="loc_ifrs-full_BorrowingsByNameDomain_201835_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInFranceMember" xlink:label="loc_sny_CommercialPaperProgramInFranceMember_201846" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_CommercialPaperProgramInFranceMember_201846" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember_201847" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_CommercialPaperProgramInUSAMember_201847" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingDecember2027Member" xlink:label="loc_sny_FourBillionFacilityMaturingDecember2027Member_201849" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FourBillionFacilityMaturingDecember2027Member_201849" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingMarch2030Member" xlink:label="loc_sny_FourBillionFacilityMaturingMarch2030Member_201850" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FourBillionFacilityMaturingMarch2030Member_201850" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2020Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2020Member_201852" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondIssueFromApril2020Member_201852" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2022Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2022Member_201853" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondIssueFromApril2022Member_201853" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member_201854" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member_201854" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2027Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2027Member_201855" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2027Member_201855" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2031Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2031Member_201856" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2031Member_201856" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingJune2029Member" xlink:label="loc_sny_FixedRateBondMaturingJune2029Member_201857" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingJune2029Member_201857" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2032Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2032Member_201858" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_FixedRateBondMaturingMarch2032Member_201858" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member_201859" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BorrowingsByNameDomain_201835" xlink:to="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member_201859" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentAxis" xlink:label="loc_sny_DebtInstrumentAxis_201836" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_sny_DebtInstrumentAxis_201836" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentDomain" xlink:label="loc_sny_DebtInstrumentDomain_201837" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DebtInstrumentAxis_201836" xlink:to="loc_sny_DebtInstrumentDomain_201837" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentDomain" xlink:label="loc_sny_DebtInstrumentDomain_201837_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DebtInstrumentAxis_201836" xlink:to="loc_sny_DebtInstrumentDomain_201837_default" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiEuroMediumTermNotesMember" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember_201860" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DebtInstrumentDomain_201837" xlink:to="loc_sny_SanofiEuroMediumTermNotesMember_201860" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_201838" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201833" xlink:to="loc_ifrs-full_CounterpartiesAxis_201838" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201839" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_201838" xlink:to="loc_ifrs-full_CounterpartiesDomain_201839" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_201839_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_201838" xlink:to="loc_ifrs-full_CounterpartiesDomain_201839_default" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_201864" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_ifrs-full_NotionalAmount_201864" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfTranches" xlink:label="loc_sny_NumberOfTranches_201870" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_sny_NumberOfTranches_201870" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued_201867" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_ifrs-full_CommercialPapersIssued_201867" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BorrowingAverageDrawdown" xlink:label="loc_sny_BorrowingAverageDrawdown_201868" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201840" xlink:to="loc_sny_BorrowingAverageDrawdown_201868" use="optional" order="27" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" xlink:to="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201884" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_201883" xlink:to="loc_ifrs-full_MeasurementAxis_201884" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201885" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_201884" xlink:to="loc_ifrs-full_MeasurementDomain_201885" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201885_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_201884" xlink:to="loc_ifrs-full_MeasurementDomain_201885_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtMarketValueMember" xlink:label="loc_sny_AtMarketValueMember_201887" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201885" xlink:to="loc_sny_AtMarketValueMember_201887" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember_201888" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201885" xlink:to="loc_sny_ValueOnRedemptionMember_201888" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings_201889" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" xlink:to="loc_ifrs-full_Borrowings_201889" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RedemptionOfDebtInstrumentIssued" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued_201890" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems_201886" xlink:to="loc_sny_RedemptionOfDebtInstrumentIssued_201890" use="optional" order="8" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201925" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_MeasurementAxis_201925" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201926" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_201925" xlink:to="loc_ifrs-full_MeasurementDomain_201926" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201926_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_201925" xlink:to="loc_ifrs-full_MeasurementDomain_201926_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_201927" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_ifrs-full_AtFairValueMember_201927" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_201935" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_sny_AtNotionalAmountMember_201935" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOfHedgeRecognizedInEquityMember" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_201936" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201926" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_201936" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesAxis" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_201928" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_201928" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_201929" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_201928" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_201929" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_201929_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_201928" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_201929_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesMember" xlink:label="loc_ifrs-full_CashFlowHedgesMember_201937" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_201929" xlink:to="loc_ifrs-full_CashFlowHedgesMember_201937" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NotEligibleForHedgeAccountingMember" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember_201938" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_201929" xlink:to="loc_sny_NotEligibleForHedgeAccountingMember_201938" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_201930" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable_201924" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_201930" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201931" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201930" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201931" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201931_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201930" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201931_default" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesMember" xlink:label="loc_sny_ForwardCurrencySalesMember_201932" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201931" xlink:to="loc_sny_ForwardCurrencySalesMember_201932" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_201939" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_201939" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_201943" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInSingaporeDollarMember_201943" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_201940" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember_201940" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInJapaneseYenMember" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_201941" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_201941" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInPoundSterlingMember" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_203254" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201932" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_203254" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesMember" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_201933" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201931" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_201933" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_201944" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_201944" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_201945" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_201945" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember_201948" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember_201948" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember_201947" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember_201947" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInTurkishLiraMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember_201950" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201933" xlink:to="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember_201950" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstruments" xlink:label="loc_sny_DerivativeFinancialInstruments_201952" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems_201934" xlink:to="loc_sny_DerivativeFinancialInstruments_201952" use="optional" order="28" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_201993" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_MeasurementAxis_201993" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201994" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_201993" xlink:to="loc_ifrs-full_MeasurementDomain_201994" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_201994_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_201993" xlink:to="loc_ifrs-full_MeasurementDomain_201994_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_202002" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201994" xlink:to="loc_sny_AtNotionalAmountMember_202002" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_202003" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_201994" xlink:to="loc_ifrs-full_AtFairValueMember_202003" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_201995" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_201995" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201996" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201995" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201996" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_201996_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_201995" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_201996_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsMember" xlink:label="loc_sny_CrossCurrencySellerSwapsMember_202018" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySellerSwapsMember_202018" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesMember" xlink:label="loc_sny_ForwardCurrencySalesMember_201997" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencySalesMember_201997" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember_202004" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInUSDollarMember_202004" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInPoundSterlingMember" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember_202006" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInPoundSterlingMember_202006" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInJapaneseYenMember" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember_203256" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencySalesMember_201997" xlink:to="loc_sny_ForwardCurrencySalesInJapaneseYenMember_203256" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesMember" xlink:label="loc_sny_ForwardCurrencyPurchasesMember_201998" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencyPurchasesMember_201998" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_202008" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember_202008" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_202007" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarMember_202007" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember_202014" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ForwardCurrencyPurchasesMember_201998" xlink:to="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember_202014" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember_202010" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember_202010" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2029Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2029Member_202015" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapExpiring2029Member_202015" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2032Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2032Member_202016" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapExpiring2032Member_202016" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapMember" xlink:label="loc_sny_CrossCurrencySwapMember_202017" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySwapMember_202017" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsInUSDollarMember" xlink:label="loc_sny_CrossCurrencySellerSwapsInUSDollarMember_202019" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_201996" xlink:to="loc_sny_CrossCurrencySellerSwapsInUSDollarMember_202019" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_201999" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable_201992" xlink:to="loc_ifrs-full_MaturityAxis_201999" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202000" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_201999" xlink:to="loc_ifrs-full_MaturityDomain_202000" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202000_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_201999" xlink:to="loc_ifrs-full_MaturityDomain_202000_default" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_202020" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_202020" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202021" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202021" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember_203255" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202000" xlink:to="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember_203255" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_202022" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure_202022" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount_202023" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_NotionalAmount_202023" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets_202024" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_DerivativeFinancialAssets_202024" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities_202025" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_DerivativeFinancialLiabilities_202025" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_202026" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems_202001" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax_202026" use="optional" order="34" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" xlink:to="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis_202061" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_HedgingInstrumentsAxis_202061" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_202062" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_202061" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_202062" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain_202062_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis_202061" xlink:to="loc_ifrs-full_HedgingInstrumentsDomain_202062_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember_202075" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember_202075" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xlink:label="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember_202072" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember_202072" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member_202073" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain_202062" xlink:to="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member_202073" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis_202063" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_MeasurementAxis_202063" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_202064" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MeasurementAxis_202063" xlink:to="loc_ifrs-full_MeasurementDomain_202064" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain_202064_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MeasurementAxis_202063" xlink:to="loc_ifrs-full_MeasurementDomain_202064_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember_202077" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_sny_AtNotionalAmountMember_202077" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember_202078" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_ifrs-full_AtFairValueMember_202078" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOfHedgeRecognizedInEquityMember" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember_202079" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MeasurementDomain_202064" xlink:to="loc_sny_ValueOfHedgeRecognizedInEquityMember_202079" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_202065" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_MaturityAxis_202065" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202066" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_202065" xlink:to="loc_ifrs-full_MaturityDomain_202066" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202066_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_202065" xlink:to="loc_ifrs-full_MaturityDomain_202066_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember_202080" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_NotLaterThanOneYearMember_202080" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202081" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember_202081" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_202082" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember_202082" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_202083" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember_202083" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_202084" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202066" xlink:to="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember_202084" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesAxis" xlink:label="loc_ifrs-full_TypesOfHedgesAxis_202067" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable_202060" xlink:to="loc_ifrs-full_TypesOfHedgesAxis_202067" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_202068" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_202067" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_202068" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain_202068_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfHedgesAxis_202067" xlink:to="loc_ifrs-full_TypesOfHedgesDomain_202068_default" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FairValueHedgesMember" xlink:label="loc_ifrs-full_FairValueHedgesMember_202085" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_202068" xlink:to="loc_ifrs-full_FairValueHedgesMember_202085" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesMember" xlink:label="loc_ifrs-full_CashFlowHedgesMember_202086" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_TypesOfHedgesDomain_202068" xlink:to="loc_ifrs-full_CashFlowHedgesMember_202086" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_202088" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems_202069" xlink:to="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents_202088" use="optional" order="27" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xlink:label="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202123" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202123" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_202124" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination_202124" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_202125" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities_202125" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_202127" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward_202116" xlink:to="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests_202127" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_202113" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202112" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_202113" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202114" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202113" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202114" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202114_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202113" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202114_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_202119" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember_202119" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:label="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202120" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202120" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilities1Member" xlink:label="loc_sny_OtherLiabilities1Member_202122" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202114" xlink:to="loc_sny_OtherLiabilities1Member_202122" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202129" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202129" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202130" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202115" xlink:to="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests_202130" use="optional" order="14" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" xlink:to="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_202151" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_202151" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202152" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202151" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202152" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_202152_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_202151" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_202152_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:label="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202158" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_BusinessCombinationsDomain_202152" xlink:to="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember_202158" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_202153" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable_202150" xlink:to="loc_ifrs-full_RangeAxis_202153" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_202154" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_202153" xlink:to="loc_ifrs-full_RangeDomain_202154" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_202154_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_202153" xlink:to="loc_ifrs-full_RangeDomain_202154_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202163" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" xlink:to="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination_202163" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PercentageIncreaseInFairValueLiabilities" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities_202164" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems_202155" xlink:to="loc_sny_PercentageIncreaseInFairValueLiabilities_202164" use="optional" order="10" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTable" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_202185" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_sny_PrincipalAlliancesAxis_202185" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202186" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_202185" xlink:to="loc_sny_PrincipalAlliancesDomain_202186" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202186_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_202185" xlink:to="loc_sny_PrincipalAlliancesDomain_202186_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesCollaborationAgreementMember" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember_202192" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_PrincipalAlliancesDomain_202186" xlink:to="loc_sny_AntibodiesCollaborationAgreementMember_202192" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_202187" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_ifrs-full_CounterpartiesAxis_202187" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202188" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_202187" xlink:to="loc_ifrs-full_CounterpartiesDomain_202188" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202188_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_202187" xlink:to="loc_ifrs-full_CounterpartiesDomain_202188_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SwedishOrphanBiovitrumABMember" xlink:label="loc_sny_SwedishOrphanBiovitrumABMember_202193" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CounterpartiesDomain_202188" xlink:to="loc_sny_SwedishOrphanBiovitrumABMember_202193" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis_202189" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202184" xlink:to="loc_ifrs-full_MaturityAxis_202189" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202190" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MaturityAxis_202189" xlink:to="loc_ifrs-full_MaturityDomain_202190" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain_202190_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MaturityAxis_202189" xlink:to="loc_ifrs-full_MaturityDomain_202190_default" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_202194" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202190" xlink:to="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember_202194" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember_203248" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MaturityDomain_202190" xlink:to="loc_ifrs-full_LaterThanFiveYearsMember_203248" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_202196" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_ifrs-full_NoncurrentProvisions_202196" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities_202197" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities_202197" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_202198" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202191" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities_202198" use="optional" order="17" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTable" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" xlink:to="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis_202229" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_ClassesOfProvisionsAxis_202229" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_202229" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis_202229" xlink:to="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember_202237" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember_202237" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForOtherLongTermBenefitsMember" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember_202238" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_ProvisionsForOtherLongTermBenefitsMember_202238" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentRestructuringProvisionMember" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember_202239" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_sny_NonCurrentRestructuringProvisionMember_202239" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherProvisionsMember" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember_202240" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain_202230" xlink:to="loc_ifrs-full_MiscellaneousOtherProvisionsMember_202240" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202231" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202231" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202232" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202231" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202232" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202232_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202231" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202232_default" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_country_GB_202241" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202232" xlink:to="loc_country_GB_202241" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable_202228" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202233" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234_default" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsMember" xlink:label="loc_ifrs-full_PlanAssetsMember_202242" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202234" xlink:to="loc_ifrs-full_PlanAssetsMember_202242" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" xlink:to="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions_202243" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_NoncurrentProvisions_202243" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInOtherProvisions" xlink:label="loc_ifrs-full_ChangesInOtherProvisions_202244" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_ChangesInOtherProvisions_202244" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions_202245" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_ProvisionUsedOtherProvisions_202245" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_202248" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions_202248" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_202246" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions_202246" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions_202247" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions_202247" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_202249" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions_202249" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions_202250" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract_202236" xlink:to="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions_202250" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_202252" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems_202235" xlink:to="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans_202252" use="optional" order="26" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis_202286" xlink:to="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsMember" xlink:label="loc_ifrs-full_PlanAssetsMember_202299" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain_202287" xlink:to="loc_ifrs-full_PlanAssetsMember_202299" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis_202288" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_DefinedBenefitPlansAxis_202288" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_202289" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_202288" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_202289" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain_202289_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis_202288" xlink:to="loc_ifrs-full_DefinedBenefitPlansDomain_202289_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_202300" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain_202289" xlink:to="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember_202300" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202290" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202290" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202291" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202290" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202291" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202291_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202290" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202291_default" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UKZONEMember" xlink:label="loc_sny_UKZONEMember_202303" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202291" xlink:to="loc_sny_UKZONEMember_202303" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EUROZONEMember" xlink:label="loc_sny_EUROZONEMember_202302" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202291" xlink:to="loc_sny_EUROZONEMember_202302" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis_202292" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_ActuarialAssumptionsAxis_202292" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_202293" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_202292" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_202293" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain_202293_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis_202292" xlink:to="loc_ifrs-full_ActuarialAssumptionsDomain_202293_default" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_202304" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_202293" xlink:to="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember_202304" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_202305" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain_202293" xlink:to="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember_202305" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis_202294" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_srt_RangeAxis_202294" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_202295" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_202294" xlink:to="loc_srt_RangeMember_202295" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember_202295_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_202294" xlink:to="loc_srt_RangeMember_202295_default" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember_202306" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_202295" xlink:to="loc_srt_MinimumMember_202306" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember_202307" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_202295" xlink:to="loc_srt_MaximumMember_202307" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable_202285" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202296" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297_default" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_202308" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202297" xlink:to="loc_sny_OpellaBusinessMember_202308" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_202309" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset_202309" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_202310" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset_202310" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_202311" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption_202311" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_202312" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems_202298" xlink:to="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption_202312" use="optional" order="32" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" xlink:to="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_203237" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_203238" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember_203240" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_203239" xlink:to="loc_ifrs-full_RelatedPartiesMember_203240" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EarendilLabsMember" xlink:label="loc_sny_EarendilLabsMember_203241" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_RelatedPartiesMember_203240" xlink:to="loc_sny_EarendilLabsMember_203241" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments_203244" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" xlink:to="loc_ifrs-full_Prepayments_203244" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions_203242" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems_203243" xlink:to="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions_203242" use="optional" order="8" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsAxis" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis_202393" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_sny_LegalAndArbitralProceedingsAxis_202393" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsDomain" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_202394" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_202393" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_202394" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsDomain" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain_202394_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis_202393" xlink:to="loc_sny_LegalAndArbitralProceedingsDomain_202394_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_202400" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_202394" xlink:to="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember_202400" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoldBondProductLitigationInTheUSMember" xlink:label="loc_sny_GoldBondProductLitigationInTheUSMember_202403" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain_202394" xlink:to="loc_sny_GoldBondProductLitigationInTheUSMember_202403" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantAxis" xlink:label="loc_sny_DefendantAxis_202395" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_sny_DefendantAxis_202395" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantDomain" xlink:label="loc_sny_DefendantDomain_202396" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_DefendantAxis_202395" xlink:to="loc_sny_DefendantDomain_202396" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantDomain" xlink:label="loc_sny_DefendantDomain_202396_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_DefendantAxis_202395" xlink:to="loc_sny_DefendantDomain_202396_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichWeAreDefendantMember" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember_202404" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DefendantDomain_202396" xlink:to="loc_sny_ActionForWhichWeAreDefendantMember_202404" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichSanofiAreDefendantMember" xlink:label="loc_sny_ActionForWhichSanofiAreDefendantMember_202405" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DefendantDomain_202396" xlink:to="loc_sny_ActionForWhichSanofiAreDefendantMember_202405" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable_202392" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis_202397" xlink:to="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398_default" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductLiabilitiesMember" xlink:label="loc_sny_ProductLiabilitiesMember_202406" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain_202398" xlink:to="loc_sny_ProductLiabilitiesMember_202406" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfClassActionLawsuits" xlink:label="loc_sny_NumberOfClassActionLawsuits_202411" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_NumberOfClassActionLawsuits_202411" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PaymentOfDamagesClaimedByCounterparty" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty_202414" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_PaymentOfDamagesClaimedByCounterparty_202414" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PenaltyFeeIncurred" xlink:label="loc_sny_PenaltyFeeIncurred_202413" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems_202399" xlink:to="loc_sny_PenaltyFeeIncurred_202413" use="optional" order="18" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202434" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember_202441" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202435" xlink:to="loc_ifrs-full_OtherRelatedPartiesMember_202441" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202436" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RegeneronMember" xlink:label="loc_sny_RegeneronMember_202442" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202437" xlink:to="loc_sny_RegeneronMember_202442" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202433" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202438" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439_default" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingIncomeExpenseMember" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_202443" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_202443" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercializationRelatedExpensesMember" xlink:label="loc_sny_CommercializationRelatedExpensesMember_203247" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202439" xlink:to="loc_sny_CommercializationRelatedExpensesMember_203247" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202444" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202444" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202445" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202445" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsOnDivestmentOfProducts" xlink:label="loc_sny_GainsOnDivestmentOfProducts_202446" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202440" xlink:to="loc_sny_GainsOnDivestmentOfProducts_202446" use="optional" order="17" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis_202475" xlink:to="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RegeneronMember" xlink:label="loc_sny_RegeneronMember_202484" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain_202476" xlink:to="loc_sny_RegeneronMember_202484" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis_202477" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_srt_CounterpartyNameAxis_202477" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_202477" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_202477" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478_default" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesAllianceMember" xlink:label="loc_sny_AntibodiesAllianceMember_202485" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" xlink:to="loc_sny_AntibodiesAllianceMember_202485" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OthersCounterpartyMember" xlink:label="loc_sny_OthersCounterpartyMember_202487" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_202478" xlink:to="loc_sny_OthersCounterpartyMember_202487" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis_202479" xlink:to="loc_ifrs-full_CategoriesOfRelatedPartiesDomain_202480_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable_202474" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis_202481" xlink:to="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_202489" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember_202489" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_202490" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember_202490" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercializationRelatedExpensesMember" xlink:label="loc_sny_CommercializationRelatedExpensesMember_202491" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_CommercializationRelatedExpensesMember_202491" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingIncomeExpenseMember" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember_202492" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain_202482" xlink:to="loc_sny_OtherOperatingIncomeExpenseMember_202492" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202493" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense_202493" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202494" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome_202494" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202495" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202495" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense_202496" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems_202483" xlink:to="loc_ifrs-full_OtherOperatingIncomeExpense_202496" use="optional" order="24" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsAxis" xlink:label="loc_ifrs-full_HedgedItemsAxis_202553" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable_202552" xlink:to="loc_ifrs-full_HedgedItemsAxis_202553" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsDomain" xlink:label="loc_ifrs-full_HedgedItemsDomain_202554" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_HedgedItemsAxis_202553" xlink:to="loc_ifrs-full_HedgedItemsDomain_202554" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsDomain" xlink:label="loc_ifrs-full_HedgedItemsDomain_202554_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_HedgedItemsAxis_202553" xlink:to="loc_ifrs-full_HedgedItemsDomain_202554_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesMember" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember_202556" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_HedgedItemsDomain_202554" xlink:to="loc_sny_InterestRateAndCurrencyDerivativesMember_202556" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings_202557" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings_202557" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestIncome" xlink:label="loc_sny_InterestIncome_202558" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_InterestIncome_202558" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CostOfDebtNet" xlink:label="loc_sny_CostOfDebtNet_202559" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_CostOfDebtNet_202559" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonOperatingForeignExchangeGainsLosses" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses_202560" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_NonOperatingForeignExchangeGainsLosses_202560" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_202561" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions_202561" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetInterestCostRelatedToEmployeeBenefits" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits_202562" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_NetInterestCostRelatedToEmployeeBenefits_202562" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_202564" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities_202564" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost_202565" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost_202565" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost_202566" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceIncomeCost_202566" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_202567" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceCosts_202567" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_202568" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_ifrs-full_FinanceIncome_202568" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageDebt" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageDebt_202569" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_GainLossOnDerivativesUsedToManageDebt_202569" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents_202570" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents_202570" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilityRecognisedForEstimatedFutureRoyalties" xlink:label="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties_202572" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems_202555" xlink:to="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties_202572" use="optional" order="19" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" xlink:to="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable_202614" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis_202615" xlink:to="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain_202617_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentTaxExpenseRelatedToPillarTwo" xlink:label="loc_sny_CurrentTaxExpenseRelatedToPillarTwo_202618" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems_202616" xlink:to="loc_sny_CurrentTaxExpenseRelatedToPillarTwo_202618" use="optional" order="5" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202704" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202704" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202705" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202704" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202705" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202705_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202704" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202705_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_202720" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_srt_EuropeMember_202720" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_country_US_202721" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_country_US_202721" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesMember" xlink:label="loc_sny_OtherCountriesMember_202722" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202705" xlink:to="loc_sny_OtherCountriesMember_202722" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202706" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_SegmentsAxis_202706" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202707" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_202706" xlink:to="loc_ifrs-full_SegmentsDomain_202707" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202707_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_202706" xlink:to="loc_ifrs-full_SegmentsDomain_202707_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202723" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_202707" xlink:to="loc_sny_BiopharmaSegmentMember_202723" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_202708" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_202708" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202709" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202708" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202709" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202709_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202708" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202709_default" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202716" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_202715" xlink:to="loc_srt_ProductsAndServicesDomain_202716" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202716_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_202715" xlink:to="loc_srt_ProductsAndServicesDomain_202716_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SpecialtyCareMember" xlink:label="loc_sny_SpecialtyCareMember_202710" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_SpecialtyCareMember_202710" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DupixentMember" xlink:label="loc_sny_DupixentMember_202729" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SpecialtyCareMember_202710" xlink:to="loc_sny_DupixentMember_202729" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AubagioMember" xlink:label="loc_sny_AubagioMember_202730" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_SpecialtyCareMember_202710" xlink:to="loc_sny_AubagioMember_202730" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GeneralMedicinesMember" xlink:label="loc_sny_GeneralMedicinesMember_202711" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_GeneralMedicinesMember_202711" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IndustrialSalesMember" xlink:label="loc_sny_IndustrialSalesMember_202742" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_GeneralMedicinesMember_202711" xlink:to="loc_sny_IndustrialSalesMember_202742" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VaccinesMember" xlink:label="loc_sny_VaccinesMember_202714" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_VaccinesMember_202714" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PolioPertussisHibVaccinesMember" xlink:label="loc_sny_PolioPertussisHibVaccinesMember_202743" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_VaccinesMember_202714" xlink:to="loc_sny_PolioPertussisHibVaccinesMember_202743" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfluenzaVaccinesMember" xlink:label="loc_sny_InfluenzaVaccinesMember_202744" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_VaccinesMember_202714" xlink:to="loc_sny_InfluenzaVaccinesMember_202744" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NexviazymeMember" xlink:label="loc_sny_NexviazymeMember_202748" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_NexviazymeMember_202748" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SarclisaMember" xlink:label="loc_sny_SarclisaMember_202749" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_SarclisaMember_202749" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AltuviiioMember" xlink:label="loc_sny_AltuviiioMember_202750" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_AltuviiioMember_202750" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RezurockMember" xlink:label="loc_sny_RezurockMember_202751" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_RezurockMember_202751" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CabliviMember" xlink:label="loc_sny_CabliviMember_202752" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_CabliviMember_202752" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_XenpozymeMember" xlink:label="loc_sny_XenpozymeMember_202753" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_XenpozymeMember_202753" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TzieldMember" xlink:label="loc_sny_TzieldMember_202755" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_TzieldMember_202755" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RSVVaccinesMember" xlink:label="loc_sny_RSVVaccinesMember_202756" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_RSVVaccinesMember_202756" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MeningitisTravelAndEndemicVaccinesMember" xlink:label="loc_sny_MeningitisTravelAndEndemicVaccinesMember_202757" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ProductsAndServicesDomain_202709" xlink:to="loc_sny_MeningitisTravelAndEndemicVaccinesMember_202757" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_202715" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_srt_ProductOrServiceAxis_202715" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202703" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718" use="optional" order="36" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_202717" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_202718_default" use="optional" order="37" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202766" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202719" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202766" use="optional" order="38" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_203087" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_203087" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_203098" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_203087" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_203098" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_203098_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_203087" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_203098_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_203088" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_GeographicalAreasAxis_203088" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_203099" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_203088" xlink:to="loc_ifrs-full_GeographicalAreasDomain_203099" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_203099_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_203088" xlink:to="loc_ifrs-full_GeographicalAreasDomain_203099_default" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersAxis" xlink:label="loc_ifrs-full_MarketsOfCustomersAxis_203089" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_MarketsOfCustomersAxis_203089" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersDomain" xlink:label="loc_ifrs-full_MarketsOfCustomersDomain_203100" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MarketsOfCustomersAxis_203089" xlink:to="loc_ifrs-full_MarketsOfCustomersDomain_203100" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersDomain" xlink:label="loc_ifrs-full_MarketsOfCustomersDomain_203100_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MarketsOfCustomersAxis_203089" xlink:to="loc_ifrs-full_MarketsOfCustomersDomain_203100_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis_203090" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TypesOfCustomersAxis_203090" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_203101" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_203090" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_203101" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain_203101_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfCustomersAxis_203090" xlink:to="loc_ifrs-full_TypesOfCustomersDomain_203101_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="loc_ifrs-full_TypesOfContractsAxis_203091" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TypesOfContractsAxis_203091" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-full_TypesOfContractsDomain_203102" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TypesOfContractsAxis_203091" xlink:to="loc_ifrs-full_TypesOfContractsDomain_203102" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-full_TypesOfContractsDomain_203102_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TypesOfContractsAxis_203091" xlink:to="loc_ifrs-full_TypesOfContractsDomain_203102_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationAxis" xlink:label="loc_ifrs-full_ContractDurationAxis_203092" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_ContractDurationAxis_203092" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationDomain" xlink:label="loc_ifrs-full_ContractDurationDomain_203103" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ContractDurationAxis_203092" xlink:to="loc_ifrs-full_ContractDurationDomain_203103" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationDomain" xlink:label="loc_ifrs-full_ContractDurationDomain_203103_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ContractDurationAxis_203092" xlink:to="loc_ifrs-full_ContractDurationDomain_203103_default" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis_203093" xlink:to="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain_203104_default" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsAxis" xlink:label="loc_ifrs-full_SalesChannelsAxis_203094" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_SalesChannelsAxis_203094" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsDomain" xlink:label="loc_ifrs-full_SalesChannelsDomain_203105" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SalesChannelsAxis_203094" xlink:to="loc_ifrs-full_SalesChannelsDomain_203105" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsDomain" xlink:label="loc_ifrs-full_SalesChannelsDomain_203105_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SalesChannelsAxis_203094" xlink:to="loc_ifrs-full_SalesChannelsDomain_203105_default" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_203095" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_203086" xlink:to="loc_ifrs-full_SegmentsAxis_203095" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_203096" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_203095" xlink:to="loc_ifrs-full_SegmentsDomain_203096" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_203096_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_203095" xlink:to="loc_ifrs-full_SegmentsDomain_203096_default" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_203106" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_203096" xlink:to="loc_sny_BiopharmaSegmentMember_203106" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_203107" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_203096" xlink:to="loc_sny_OpellaBusinessMember_203107" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xlink:label="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts_203108" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts_203108" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xlink:label="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations_203109" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations_203109" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties_203110" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_ifrs-full_RevenueFromRoyalties_203110" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherRevenue" xlink:label="loc_sny_MiscellaneousOtherRevenue_203111" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_sny_MiscellaneousOtherRevenue_203111" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_203112" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems_203097" xlink:to="loc_ifrs-full_OtherRevenue_203112" use="optional" order="35" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202800" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202799" xlink:to="loc_ifrs-full_SegmentsAxis_202800" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202801" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_202800" xlink:to="loc_ifrs-full_SegmentsDomain_202801" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202801_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_202800" xlink:to="loc_ifrs-full_SegmentsDomain_202801_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202804" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_sny_BiopharmaSegmentMember_202804" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AllOtherSegmentsMember" xlink:label="loc_ifrs-full_AllOtherSegmentsMember_202806" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_ifrs-full_AllOtherSegmentsMember_202806" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReportableSegmentsMember" xlink:label="loc_ifrs-full_ReportableSegmentsMember_202802" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_202801" xlink:to="loc_ifrs-full_ReportableSegmentsMember_202802" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202807" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202807" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue_202808" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_OtherRevenue_202808" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales_202809" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_CostOfSales_202809" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense_202810" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense_202810" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_202811" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense_202811" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202812" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_sny_MiscellaneousOtherOperatingIncomeExpenses_202812" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202813" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202813" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202814" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202814" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_sny_BusinessOperatingIncome_202815" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202803" xlink:to="loc_sny_BusinessOperatingIncome_202815" use="optional" order="16" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain_202872_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis_202871" xlink:to="loc_ifrs-full_SegmentConsolidationItemsDomain_202872_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember_202887" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" xlink:to="loc_ifrs-full_OperatingSegmentsMember_202887" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember_202888" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain_202872" xlink:to="loc_ifrs-full_MaterialReconcilingItemsMember_202888" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_202873" xlink:to="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874_default" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember_202889" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain_202874" xlink:to="loc_ifrs-full_OtherIntangibleAssetsMember_202889" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis_202876" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_ProductsAndServicesAxis_202876" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202877" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202876" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202877" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain_202877_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_ProductsAndServicesAxis_202876" xlink:to="loc_ifrs-full_ProductsAndServicesDomain_202877_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202883" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_202882" xlink:to="loc_srt_ProductsAndServicesDomain_202883" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain_202883_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_202882" xlink:to="loc_srt_ProductsAndServicesDomain_202883_default" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis_202878" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_sny_PrincipalAlliancesAxis_202878" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202879" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_PrincipalAlliancesAxis_202878" xlink:to="loc_sny_PrincipalAlliancesDomain_202879" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain_202879_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_PrincipalAlliancesAxis_202878" xlink:to="loc_sny_PrincipalAlliancesDomain_202879_default" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_202880" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_CounterpartiesAxis_202880" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202881" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_202880" xlink:to="loc_ifrs-full_CounterpartiesDomain_202881" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_202881_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_202880" xlink:to="loc_ifrs-full_CounterpartiesDomain_202881_default" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis_202882" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_srt_ProductOrServiceAxis_202882" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202884" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202870" xlink:to="loc_ifrs-full_SegmentsAxis_202884" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202885" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_202884" xlink:to="loc_ifrs-full_SegmentsDomain_202885" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202885_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_202884" xlink:to="loc_ifrs-full_SegmentsDomain_202885_default" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_sny_BusinessOperatingIncome_202899" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_BusinessOperatingIncome_202899" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202900" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_202900" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202901" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests_202901" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_202902" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill_202902" use="optional" order="29" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_202903" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability_202903" use="optional" order="30" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_202904" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories_202904" use="optional" order="31" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities_202905" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities_202905" use="optional" order="32" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_sny_OtherGainsLossesAndLitigation_202906" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_OtherGainsLossesAndLitigation_202906" use="optional" order="33" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities_202908" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities_202908" use="optional" order="34" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts_202909" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_FinanceCosts_202909" use="optional" order="35" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome_202910" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_FinanceIncome_202910" use="optional" order="36" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202911" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments_202911" use="optional" order="37" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_202913" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill_202913" use="optional" order="38" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill_202918" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202886" xlink:to="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill_202918" use="optional" order="39" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis_202936" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable_202935" xlink:to="loc_ifrs-full_SegmentsAxis_202936" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202937" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SegmentsAxis_202936" xlink:to="loc_ifrs-full_SegmentsDomain_202937" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain_202937_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SegmentsAxis_202936" xlink:to="loc_ifrs-full_SegmentsDomain_202937_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReportableSegmentsMember" xlink:label="loc_ifrs-full_ReportableSegmentsMember_202938" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SegmentsDomain_202937" xlink:to="loc_ifrs-full_ReportableSegmentsMember_202938" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember_202940" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_ReportableSegmentsMember_202938" xlink:to="loc_sny_BiopharmaSegmentMember_202940" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_202943" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod_202943" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_202944" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_202944" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_202945" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems_202939" xlink:to="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_202945" use="optional" order="9" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" xlink:to="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis_202967" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable_202966" xlink:to="loc_ifrs-full_GeographicalAreasAxis_202967" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202968" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202967" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202968" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain_202968_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_GeographicalAreasAxis_202967" xlink:to="loc_ifrs-full_GeographicalAreasDomain_202968_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ReportableGeographicalZonesMember" xlink:label="loc_sny_ReportableGeographicalZonesMember_202969" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_GeographicalAreasDomain_202968" xlink:to="loc_sny_ReportableGeographicalZonesMember_202969" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember_202970" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_srt_EuropeMember_202970" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR" xlink:label="loc_country_FR_202973" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_FR_202973" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_country_US_202974" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_US_202974" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xlink:label="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember_202975" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember_202975" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN" xlink:label="loc_country_CN_202976" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_ReportableGeographicalZonesMember_202969" xlink:to="loc_country_CN_202976" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods_202977" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods_202977" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract_202972" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems_202971" xlink:to="loc_ifrs-full_NoncurrentAssetsAbstract_202972" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment_202978" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment_202978" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill_202979" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_Goodwill_202979" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_202980" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract_202972" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill_202980" use="optional" order="15" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" xlink:to="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis_202995" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable_202994" xlink:to="loc_ifrs-full_MajorCustomersAxis_202995" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain" xlink:label="loc_ifrs-full_MajorCustomersDomain_202996" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_MajorCustomersAxis_202995" xlink:to="loc_ifrs-full_MajorCustomersDomain_202996" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain" xlink:label="loc_ifrs-full_MajorCustomersDomain_202996_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_MajorCustomersAxis_202995" xlink:to="loc_ifrs-full_MajorCustomersDomain_202996_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CertainWholesalersInTheUnitedStatesMember" xlink:label="loc_sny_CertainWholesalersInTheUnitedStatesMember_202998" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CertainWholesalersInTheUnitedStatesMember_202998" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerOneMember" xlink:label="loc_sny_CustomerOneMember_202999" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerOneMember_202999" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerTwoMember" xlink:label="loc_sny_CustomerTwoMember_203000" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerTwoMember_203000" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerThreeMember" xlink:label="loc_sny_CustomerThreeMember_203001" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_MajorCustomersDomain_202996" xlink:to="loc_sny_CustomerThreeMember_203001" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue_203002" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems_202997" xlink:to="loc_ifrs-full_PercentageOfEntitysRevenue_203002" use="optional" order="9" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable_203167" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis_203168" xlink:to="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember_203180" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain_203169" xlink:to="loc_sny_OpellaBusinessMember_203180" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations_203184" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations_203184" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations_203185" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations_203185" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations_203186" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations_203186" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations_203187" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations_203187" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations_203188" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations_203188" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations_203189" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations_203189" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations_203190" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations_203190" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations_203191" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations_203191" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203192" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203192" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203193" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203193" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations_203194" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations_203194" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203195" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203195" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203196" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations_203196" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations_203197" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations_203197" use="optional" order="19" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations_203198" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations_203198" use="optional" order="20" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations_203199" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations_203199" use="optional" order="21" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations_203200" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations_203200" use="optional" order="22" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations_203201" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations_203201" use="optional" order="23" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations_203202" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations_203202" use="optional" order="24" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_203203" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations_203203" use="optional" order="25" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares_203204" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_WeightedAverageShares_203204" use="optional" order="26" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares_203205" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_AdjustedWeightedAverageShares_203205" use="optional" order="27" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_203206" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations_203206" use="optional" order="28" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_203207" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems_203170" xlink:to="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations_203207" use="optional" order="29" />
        </link:definitionLink>
        <link:definitionLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/EventsSubsequentToJune302025Details" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" xlink:to="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xbrldt:contextElement="segment" xbrldt:closed="true" use="optional" order="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis_203032" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_CounterpartiesAxis_203032" use="optional" order="2" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_203033" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_CounterpartiesAxis_203032" xlink:to="loc_ifrs-full_CounterpartiesDomain_203033" use="optional" order="3" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain_203033_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_CounterpartiesAxis_203032" xlink:to="loc_ifrs-full_CounterpartiesDomain_203033_default" use="optional" order="4" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" use="optional" order="5" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035" use="optional" order="6" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis_203034" xlink:to="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain_203035_default" use="optional" order="7" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis_203036" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_RangeAxis_203036" use="optional" order="8" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_203037" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_RangeAxis_203036" xlink:to="loc_ifrs-full_RangeDomain_203037" use="optional" order="9" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain_203037_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_RangeAxis_203036" xlink:to="loc_ifrs-full_RangeDomain_203037_default" use="optional" order="10" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis_203038" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_ifrs-full_BusinessCombinationsAxis_203038" use="optional" order="11" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_203039" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_203038" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_203039" use="optional" order="12" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain_203039_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ifrs-full_BusinessCombinationsAxis_203038" xlink:to="loc_ifrs-full_BusinessCombinationsDomain_203039_default" use="optional" order="13" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionAxis" xlink:label="loc_sny_AssetsAcquisitionAxis_203040" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable_203031" xlink:to="loc_sny_AssetsAcquisitionAxis_203040" use="optional" order="14" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_203041" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_sny_AssetsAcquisitionAxis_203040" xlink:to="loc_sny_AssetsAcquisitionDomain_203041" use="optional" order="15" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain_203041_default" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_sny_AssetsAcquisitionAxis_203040" xlink:to="loc_sny_AssetsAcquisitionDomain_203041_default" use="optional" order="16" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VicebioLtdMember" xlink:label="loc_sny_VicebioLtdMember_203049" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_sny_AssetsAcquisitionDomain_203041" xlink:to="loc_sny_VicebioLtdMember_203049" use="optional" order="17" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UpfrontPayments" xlink:label="loc_sny_UpfrontPayments_203050" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" xlink:to="loc_sny_UpfrontPayments_203050" use="optional" order="18" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TotalMilestonePayments" xlink:label="loc_sny_TotalMilestonePayments_203054" />
          <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems_203042" xlink:to="loc_sny_TotalMilestonePayments_203054" use="optional" order="19" />
        </link:definitionLink>
        <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"  />
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedBalanceSheets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_NoncurrentAssets" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_PropertyPlantAndEquipment" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_RightofuseAssets" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_Goodwill" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_OtherNoncurrentAssets" use="optional" order="7" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_CurrentTaxAssetsNoncurrent" use="optional" order="8" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="loc_ifrs-full_DeferredTaxAssets" use="optional" order="9" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Assets" xlink:to="loc_ifrs-full_CurrentAssets" use="optional" order="10" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_Inventories" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentTradeReceivables" use="optional" order="12" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_OtherCurrentAssets" use="optional" order="13" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CurrentTaxAssetsCurrent" use="optional" order="14" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="15" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" use="optional" order="16" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedBalanceSheets" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_Equity" use="optional" order="17" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ifrs-full_EquityAttributableToOwnersOfParent" use="optional" order="18" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Equity" xlink:to="loc_ifrs-full_NoncontrollingInterests" use="optional" order="19" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_NoncurrentLiabilities" use="optional" order="20" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_LongtermBorrowings" use="optional" order="21" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_NoncurrentLeaseLiabilities" use="optional" order="22" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_SNY_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_SNY_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" use="optional" order="23" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilities" use="optional" order="24" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" use="optional" order="25" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="loc_ifrs-full_DeferredTaxLiabilities" use="optional" order="26" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="loc_ifrs-full_CurrentLiabilities" use="optional" order="27" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" use="optional" order="28" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_SNY_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_SNY_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" use="optional" order="29" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:label="loc_SNY_CurrentProvisionsAndOtherCurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_SNY_CurrentProvisionsAndOtherCurrentLiabilities" use="optional" order="30" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" use="optional" order="31" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentLeaseLiabilities" use="optional" order="32" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" use="optional" order="33" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" use="optional" order="34" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedIncomeStatements" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossFromContinuingOperations" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:to="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_GrossProfit" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="loc_ifrs-full_OtherRevenue" use="optional" order="7" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="loc_ifrs-full_CostOfSales" use="optional" order="8" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense" use="optional" order="9" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" use="optional" order="10" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingIncome" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_MiscellaneousOtherOperatingExpense" use="optional" order="12" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" use="optional" order="13" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" use="optional" order="14" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" use="optional" order="15" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_ifrs-full_ExpenseOfRestructuringActivities" use="optional" order="16" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_SNY_OtherGainsLossesAndLitigation" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="loc_SNY_OtherGainsLossesAndLitigation" use="optional" order="17" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_FinanceCosts" use="optional" order="18" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_FinanceIncome" use="optional" order="19" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:to="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" use="optional" order="20" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" use="optional" order="21" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:label="loc_SNY_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_SNY_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xlink:label="loc_SNY_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" use="optional" order="3" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:label="loc_SNY_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:label="loc_SNY_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:label="loc_SNY_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" use="optional" order="7" weight="-1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" use="optional" order="8" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" use="optional" order="9" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xlink:label="loc_SNY_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" use="optional" order="10" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" use="optional" order="12" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" use="optional" order="13" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" use="optional" order="14" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_SNY_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" use="optional" order="15" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_SNY_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" use="optional" order="16" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:label="loc_SNY_ChangeInCurrencyTranslationOnTaxEffects" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_ChangeInCurrencyTranslationOnTaxEffects" use="optional" order="17" weight="-1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="loc_ifrs-full_WeightedAverageShares" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:label="loc_SNY_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="loc_SNY_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" use="optional" order="3" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xlink:label="loc_SNY_AdjustmentsForLossesGainsOnTransferOfBusiness" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_SNY_AdjustmentsForLossesGainsOnTransferOfBusiness" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" use="optional" order="7" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:label="loc_SNY_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_SNY_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" use="optional" order="8" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" use="optional" order="9" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" use="optional" order="10" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_SNY_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_SNY_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_AdjustmentsForSharebasedPayments" use="optional" order="12" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:label="loc_SNY_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_SNY_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" use="optional" order="13" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" use="optional" order="14" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" use="optional" order="15" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" use="optional" order="16" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" use="optional" order="17" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:label="loc_SNY_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_SNY_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" use="optional" order="18" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" use="optional" order="19" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" use="optional" order="20" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInContinuingInvestingActivities" xlink:label="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" use="optional" order="21" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" use="optional" order="22" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" use="optional" order="23" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" use="optional" order="24" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" use="optional" order="25" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" use="optional" order="26" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherNonCurrentAssets" xlink:label="loc_SNY_NetChangeInOtherNonCurrentAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="loc_SNY_NetChangeInOtherNonCurrentAssets" use="optional" order="27" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xlink:label="loc_SNY_NetCashProvidedByusedInDiscontinuingInvestingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_SNY_NetCashProvidedByusedInDiscontinuingInvestingActivities" use="optional" order="28" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashInflowFromDiscontinuedOperations" xlink:label="loc_SNY_NetCashInflowFromDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="loc_SNY_NetCashInflowFromDiscontinuedOperations" use="optional" order="29" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" use="optional" order="30" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" use="optional" order="31" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_ProceedsFromIssuingShares" use="optional" order="32" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" use="optional" order="33" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" use="optional" order="34" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" use="optional" order="35" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" use="optional" order="36" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" use="optional" order="37" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:label="loc_SNY_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_SNY_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" use="optional" order="38" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" use="optional" order="39" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" use="optional" order="40" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" use="optional" order="41" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xlink:label="loc_SNY_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_SNY_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" use="optional" order="42" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_OtherComprehensiveIncome" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ProfitLoss" use="optional" order="2" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xlink:label="loc_SNY_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="loc_SNY_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xlink:label="loc_SNY_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="loc_SNY_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" use="optional" order="4" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_ifrs-full_ProfitLoss" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" use="optional" order="7" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromContinuedOperations" xlink:label="loc_SNY_OtherComprehensiveIncomeFromContinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_SNY_OtherComprehensiveIncomeFromContinuedOperations" use="optional" order="8" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_OtherComprehensiveIncomeFromContinuedOperations" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" use="optional" order="9" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" use="optional" order="10" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" use="optional" order="12" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_OtherComprehensiveIncomeFromContinuedOperations" xlink:to="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" use="optional" order="13" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:label="loc_SNY_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_SNY_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" use="optional" order="14" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" use="optional" order="15" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" use="optional" order="16" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" use="optional" order="17" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xlink:label="loc_SNY_OtherComprehensiveIncomeFromDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="loc_SNY_OtherComprehensiveIncomeFromDiscontinuedOperations" use="optional" order="18" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_SNY_DebtNetOfCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_Borrowings" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_LongtermBorrowings" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" use="optional" order="4" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="5" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" use="optional" order="6" weight="-1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_SNY_DebtNetOfCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_Borrowings" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BondsIssued" xlink:label="loc_ifrs-full_BondsIssued" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_BondsIssued" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherBankBorrowings" xlink:label="loc_SNY_OtherBankBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_SNY_OtherBankBorrowings" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_OtherBorrowings" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" use="optional" order="6" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="7" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" use="optional" order="8" weight="-1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_SNY_DebtNetOfCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_Borrowings" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_LongtermBorrowings" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_Borrowings" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageDebt" use="optional" order="4" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_ifrs-full_CashAndCashEquivalents" use="optional" order="5" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_DebtNetOfCashAndCashEquivalents" xlink:to="loc_SNY_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" use="optional" order="6" weight="-1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CostOfDebtNet" xlink:label="loc_SNY_CostOfDebtNet" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_SNY_CostOfDebtNet" use="optional" order="1" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_CostOfDebtNet" xlink:to="loc_ifrs-full_InterestExpenseOnBorrowings" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestIncome" xlink:label="loc_SNY_InterestIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_CostOfDebtNet" xlink:to="loc_SNY_InterestIncome" use="optional" order="3" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonOperatingForeignExchangeGainsLosses" xlink:label="loc_SNY_NonOperatingForeignExchangeGainsLosses" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_SNY_NonOperatingForeignExchangeGainsLosses" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" use="optional" order="5" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetInterestCostRelatedToEmployeeBenefits" xlink:label="loc_SNY_NetInterestCostRelatedToEmployeeBenefits" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_SNY_NetInterestCostRelatedToEmployeeBenefits" use="optional" order="6" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" use="optional" order="7" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="loc_ifrs-full_OtherFinanceIncomeCost" use="optional" order="8" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="loc_ifrs-full_CurrentTaxExpenseIncome" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="loc_ifrs-full_DeferredTaxExpenseIncome" use="optional" order="2" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="loc_ifrs-full_ApplicableTaxRate" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:label="loc_SNY_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="loc_SNY_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" use="optional" order="4" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_GoodwillDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_GoodwillDisposalGroupIncludingDiscontinuedOperations" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_InventoriesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_InventoriesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" use="optional" order="7" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="8" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="9" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" use="optional" order="10" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="11" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_SNY_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="loc_SNY_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" use="optional" order="12" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:to="loc_ifrs-full_NoncurrentProvisions" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:to="loc_ifrs-full_OtherNoncurrentLiabilities" use="optional" order="2" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_SNY_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_SNY_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PreFundedPensionObligations" xlink:label="loc_SNY_PreFundedPensionObligations" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_SNY_PreFundedPensionObligations" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LongTermPrepaidExpenses" xlink:label="loc_SNY_LongTermPrepaidExpenses" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_SNY_LongTermPrepaidExpenses" use="optional" order="4" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLoansAndReceivables" xlink:label="loc_SNY_NonCurrentLoansAndReceivables" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_SNY_NonCurrentLoansAndReceivables" use="optional" order="5" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" use="optional" order="6" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:label="loc_SNY_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="loc_SNY_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:label="loc_SNY_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="loc_SNY_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:label="loc_SNY_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="loc_SNY_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" use="optional" order="3" weight="1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherRestructuringCosts" xlink:label="loc_SNY_OtherRestructuringCosts" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="loc_SNY_OtherRestructuringCosts" use="optional" order="4" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_ProfitLossFromOperatingActivities" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_FinanceCosts" use="optional" order="2" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="loc_ifrs-full_FinanceIncome" use="optional" order="3" weight="1" />
        </link:calculationLink>
        <link:calculationLink xlink:type="extended" xlink:role="http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails" >
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_SNY_BusinessOperatingIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_RevenueFromSaleOfGoods" use="optional" order="1" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_OtherRevenue" use="optional" order="2" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_CostOfSales" use="optional" order="3" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_ResearchAndDevelopmentExpense" use="optional" order="4" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" use="optional" order="5" weight="-1" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_SNY_MiscellaneousOtherOperatingIncomeExpenses" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_SNY_MiscellaneousOtherOperatingIncomeExpenses" use="optional" order="6" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" use="optional" order="7" weight="1" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
          <link:calculationArc xlink:type="arc" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_SNY_BusinessOperatingIncome" xlink:to="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" use="optional" order="8" weight="1" />
        </link:calculationLink>
        <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link" >
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CoverAbstract" xlink:label="loc_dei_CoverAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CoverAbstract" xml:lang="en-US">Cover [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntitiesTable" xlink:label="loc_dei_EntitiesTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntitiesTable" xml:lang="en-US">Entities [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntitiesTable" xml:lang="en-US">Entities [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitiesTable" xlink:to="lab_dei_EntitiesTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityInformationLineItems" xlink:label="loc_dei_EntityInformationLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityInformationLineItems" xml:lang="en-US">Entity Information [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityInformationLineItems" xml:lang="en-US">Entity Information [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInformationLineItems" xlink:to="lab_dei_EntityInformationLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentType" xlink:label="loc_dei_DocumentType" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentType" xml:lang="en-US">Document Type</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityRegistrantName" xlink:label="loc_dei_EntityRegistrantName" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityRegistrantName" xml:lang="en-US">Entity Registrant Name</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_AmendmentFlag" xlink:label="loc_dei_AmendmentFlag" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_AmendmentFlag" xml:lang="en-US">Amendment Flag</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityCentralIndexKey" xlink:label="loc_dei_EntityCentralIndexKey" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityCentralIndexKey" xml:lang="en-US">Entity Central Index Key</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_dei_CurrentFiscalYearEndDate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_CurrentFiscalYearEndDate" xml:lang="en-US">Current Fiscal Year End Date</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_dei_DocumentPeriodEndDate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentPeriodEndDate" xml:lang="en-US">Document Period End Date</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_dei_DocumentFiscalYearFocus" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentFiscalYearFocus" xml:lang="en-US">Document Fiscal Year Focus</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_dei_DocumentFiscalPeriodFocus" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xml:lang="en-US">Document Fiscal Period Focus</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-full_StatementOfFinancialPositionAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfFinancialPositionAbstract" xml:lang="en-US">Statement of financial position [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="lab_ifrs-full_StatementOfFinancialPositionAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-full_AssetsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAbstract" xml:lang="en-US">Assets [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAbstract" xml:lang="en-US">Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAbstract" xlink:to="lab_ifrs-full_AssetsAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-full_PropertyPlantAndEquipment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xml:lang="en-US">Property, plant and equipment</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xml:lang="en-US">Property, plant and equipment owned</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_PropertyPlantAndEquipment" xml:lang="en-US">Property, plant and equipment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipment" xlink:to="lab_ifrs-full_PropertyPlantAndEquipment" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-full_RightofuseAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RightofuseAssets" xml:lang="en-US">Right-of-use assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RightofuseAssets" xml:lang="en-US">Right-of-use assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RightofuseAssets" xlink:to="lab_ifrs-full_RightofuseAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-full_Goodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Goodwill" xml:lang="en-US">Goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Goodwill" xml:lang="en-US">Goodwill</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Goodwill" xlink:to="lab_ifrs-full_Goodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Other intangible assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Carrying amount of intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xml:lang="en-US">Investments accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" xml:lang="en-US">Investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-full_OtherNoncurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xml:lang="en-US">Other non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xml:lang="en-US">Other non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherNoncurrentAssets" xml:lang="en-US">Total</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentAssets" xlink:to="lab_ifrs-full_OtherNoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsNoncurrent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxAssetsNoncurrent" xml:lang="en-US">Current tax assets, non-current</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxAssetsNoncurrent" xml:lang="en-US">Non-current income tax assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssetsNoncurrent" xlink:to="lab_ifrs-full_CurrentTaxAssetsNoncurrent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxAssets" xlink:label="loc_ifrs-full_DeferredTaxAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxAssets" xml:lang="en-US">Deferred tax assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxAssets" xml:lang="en-US">Deferred tax assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxAssets" xlink:to="lab_ifrs-full_DeferredTaxAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-full_NoncurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssets" xml:lang="en-US">Non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentAssets" xml:lang="en-US">Non-current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssets" xlink:to="lab_ifrs-full_NoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-full_Inventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Inventories" xml:lang="en-US">Current inventories</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Inventories" xml:lang="en-US">Inventories</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Inventories" xlink:to="lab_ifrs-full_Inventories" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-full_CurrentTradeReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xml:lang="en-US">Current trade receivables</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTradeReceivables" xml:lang="en-US">Accounts receivable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTradeReceivables" xlink:to="lab_ifrs-full_CurrentTradeReceivables" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-full_OtherCurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherCurrentAssets" xml:lang="en-US">Other current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherCurrentAssets" xml:lang="en-US">Other current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherCurrentAssets" xlink:to="lab_ifrs-full_OtherCurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="loc_ifrs-full_CurrentTaxAssetsCurrent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxAssetsCurrent" xml:lang="en-US">Current tax assets, current</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxAssetsCurrent" xml:lang="en-US">Current income tax assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxAssetsCurrent" xlink:to="lab_ifrs-full_CurrentTaxAssetsCurrent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-full_CashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CashAndCashEquivalents" xml:lang="en-US">Cash and cash equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalents" xlink:to="lab_ifrs-full_CashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xml:lang="en-US">Non-current assets or disposal groups classified as held for sale</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xml:lang="en-US">Assets held for sale</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-full_Assets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Assets" xml:lang="en-US">Assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Assets" xml:lang="en-US">Total assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Assets" xlink:to="lab_ifrs-full_Assets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-full_CurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentAssets" xml:lang="en-US">Current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentAssets" xml:lang="en-US">Current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentAssets" xlink:to="lab_ifrs-full_CurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="loc_ifrs-full_EquityAndLiabilitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xml:lang="en-US">Equity and liabilities [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAndLiabilitiesAbstract" xml:lang="en-US">Equity and liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilitiesAbstract" xlink:to="lab_ifrs-full_EquityAndLiabilitiesAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xml:lang="en-US">Equity attributable to owners of parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParent" xml:lang="en-US">Equity attributable to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-full_NoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterests" xml:lang="en-US">Non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NoncontrollingInterests" xml:lang="en-US">Equity attributable to non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterests" xlink:to="lab_ifrs-full_NoncontrollingInterests" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-full_Equity" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Equity</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Total equity</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Beginning balance</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_Equity" xml:lang="en-US">Ending balance</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Equity" xlink:to="lab_ifrs-full_Equity" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-full_LongtermBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LongtermBorrowings" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LongtermBorrowings" xml:lang="en-US">Long-term debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LongtermBorrowings" xlink:to="lab_ifrs-full_LongtermBorrowings" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-full_NoncurrentLeaseLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xml:lang="en-US">Non-current lease liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentLeaseLiabilities" xml:lang="en-US">Non-current lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLeaseLiabilities" xlink:to="lab_ifrs-full_NoncurrentLeaseLiabilities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Non-Current Liabilities Related To Business Combinations And To Non-Controlling Interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Non-current liabilities related to business combinations and to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Non-current portion</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:to="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Non-Current Provisions And Other Non-Current Liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Non-current provisions and other non-current liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Non-current provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:to="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xml:lang="en-US">Current tax liabilities, non-current</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xml:lang="en-US">Non-current income tax liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesNoncurrent" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesNoncurrent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxLiabilities" xlink:label="loc_ifrs-full_DeferredTaxLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xml:lang="en-US">Deferred tax liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DeferredTaxLiabilities" xml:lang="en-US">Deferred tax liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxLiabilities" xlink:to="lab_ifrs-full_DeferredTaxLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-full_NoncurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xml:lang="en-US">Non-current liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_NoncurrentLiabilities" xml:lang="en-US">Non-current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentLiabilities" xlink:to="lab_ifrs-full_NoncurrentLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:label="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xml:lang="en-US">Current trade payables</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xml:lang="en-US">Accounts payable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:to="lab_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:label="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Current Liabilities Related To Business Combinations And To Non-Controlling Interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Current liabilities related to business combinations and to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">Current portion</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xlink:to="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" xml:lang="en-US">This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xml:lang="en-US">Current Provisions And Other Current Liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xml:lang="en-US">Current provisions and other current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilities" xlink:to="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilities" xml:lang="en-US">The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xml:lang="en-US">Current tax liabilities, current</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" xml:lang="en-US">Current income tax liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="lab_ifrs-full_CurrentTaxLiabilitiesCurrent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-full_CurrentLeaseLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xml:lang="en-US">Current lease liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CurrentLeaseLiabilities" xml:lang="en-US">Current lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLeaseLiabilities" xlink:to="lab_ifrs-full_CurrentLeaseLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xml:lang="en-US">Current borrowings and current portion of non-current borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xml:lang="en-US">Short-term debt and current portion of long-term debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-full_CurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentLiabilities" xml:lang="en-US">Current liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CurrentLiabilities" xml:lang="en-US">Current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentLiabilities" xlink:to="lab_ifrs-full_CurrentLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:label="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xml:lang="en-US">Liabilities included in disposal groups classified as held for sale</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xml:lang="en-US">Liabilities related to assets held for sale</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" xlink:to="lab_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-full_EquityAndLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAndLiabilities" xml:lang="en-US">Equity and liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_EquityAndLiabilities" xml:lang="en-US">Total equity and liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAndLiabilities" xlink:to="lab_ifrs-full_EquityAndLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAbstract" xlink:label="loc_ifrs-full_ProfitLossAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAbstract" xml:lang="en-US">Profit (loss) [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAbstract" xlink:to="lab_ifrs-full_ProfitLossAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-full_ProfitLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Profit (loss)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Net income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLoss" xml:lang="en-US">Net income for the period</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLoss" xlink:to="lab_ifrs-full_ProfitLoss" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xml:lang="en-US">Profit (loss), attributable to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xml:lang="en-US">Net income attributable to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xml:lang="en-US">Attributable to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xml:lang="en-US">Non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xml:lang="en-US">Profit (loss), attributable to owners of parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xml:lang="en-US">Net income attributable to equity holders of Sanofi</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ProfitLossAttributableToOwnersOfParent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoods" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoods" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xml:lang="en-US">Revenue from sale of goods</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoods" xml:lang="en-US">Net sales</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoods" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoods" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-full_OtherRevenue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherRevenue" xml:lang="en-US">Other revenue</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherRevenue" xml:lang="en-US">Other revenues</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRevenue" xlink:to="lab_ifrs-full_OtherRevenue" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-full_CostOfSales" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CostOfSales" xml:lang="en-US">Cost of sales</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CostOfSales" xml:lang="en-US">Cost of sales</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CostOfSales" xlink:to="lab_ifrs-full_CostOfSales" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-full_GrossProfit" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossProfit" xml:lang="en-US">Gross profit</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_GrossProfit" xml:lang="en-US">Gross profit</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossProfit" xlink:to="lab_ifrs-full_GrossProfit" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ResearchAndDevelopmentExpense" xlink:label="loc_ifrs-full_ResearchAndDevelopmentExpense" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ResearchAndDevelopmentExpense" xml:lang="en-US">Research and development expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ResearchAndDevelopmentExpense" xlink:to="lab_ifrs-full_ResearchAndDevelopmentExpense" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:label="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling, general and administrative expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" xml:lang="en-US">Selling and general expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SellingGeneralAndAdministrativeExpense" xlink:to="lab_ifrs-full_SellingGeneralAndAdministrativeExpense" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingIncome" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xml:lang="en-US">Miscellaneous other operating income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingIncome" xml:lang="en-US">Other operating income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingIncome" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherOperatingExpense" xlink:label="loc_ifrs-full_MiscellaneousOtherOperatingExpense" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xml:lang="en-US">Miscellaneous other operating expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xml:lang="en-US">Other operating expenses</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MiscellaneousOtherOperatingExpense" xml:lang="en-US">Other operating expense</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherOperatingExpense" xlink:to="lab_ifrs-full_MiscellaneousOtherOperatingExpense" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortisation, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortization of intangible assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortization expense</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Impairment loss recognised in profit or loss, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Impairment of intangible assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Impairment loss on other intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:label="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xml:lang="en-US">Increase (decrease) in contingent consideration asset (liability)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xml:lang="en-US">Fair value remeasurement of contingent consideration</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" xlink:to="lab_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseOfRestructuringActivities" xlink:label="loc_ifrs-full_ExpenseOfRestructuringActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xml:lang="en-US">Expense of restructuring activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xml:lang="en-US">Restructuring costs and similar items</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ExpenseOfRestructuringActivities" xml:lang="en-US">Total</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseOfRestructuringActivities" xlink:to="lab_ifrs-full_ExpenseOfRestructuringActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherGainsLossesAndLitigation" xlink:label="loc_sny_OtherGainsLossesAndLitigation" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xml:lang="en-US">Other Gains, (Losses) And Litigation</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xml:lang="en-US">Other gains and losses, and litigation</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xml:lang="en-US">Other gains and litigation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherGainsLossesAndLitigation" xlink:to="lab_sny_OtherGainsLossesAndLitigation" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherGainsLossesAndLitigation" xml:lang="en-US">The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-full_ProfitLossFromOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xml:lang="en-US">Profit (loss) from operating activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xml:lang="en-US">Operating income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromOperatingActivities" xml:lang="en-US">Operating income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromOperatingActivities" xlink:to="lab_ifrs-full_ProfitLossFromOperatingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-full_FinanceCosts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceCosts" xml:lang="en-US">Finance costs</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_FinanceCosts" xml:lang="en-US">comprising: Financial expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceCosts" xlink:to="lab_ifrs-full_FinanceCosts" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-full_FinanceIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Finance income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Financial income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FinanceIncome" xml:lang="en-US">Financial income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncome" xlink:to="lab_ifrs-full_FinanceIncome" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xml:lang="en-US">Income Before Tax And Investments Accounted For Equity Method Investments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xml:lang="en-US">Income before tax and investments accounted for using the equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xml:lang="en-US">Income before tax and investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xlink:to="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" xml:lang="en-US">Income before tax and investments accounted for equity method investments.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Tax expense (income)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Income tax expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" xml:lang="en-US">Total</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="lab_ifrs-full_IncomeTaxExpenseContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit (loss) of associates accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the&#160;equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="loc_ifrs-full_ProfitLossFromContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations" xml:lang="en-US">Profit (loss) from continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ProfitLossFromContinuingOperations" xml:lang="en-US">Net income from continuing operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromContinuingOperations" xlink:to="lab_ifrs-full_ProfitLossFromContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:label="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xml:lang="en-US">Profit (loss) from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xml:lang="en-US">Net (income)/loss of the exchanged/held-for-exchange Animal Health business</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" xml:lang="en-US">Net income from discontinued operations (Opella)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossFromDiscontinuedOperations" xlink:to="lab_ifrs-full_ProfitLossFromDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-full_WeightedAverageShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageShares" xml:lang="en-US">Weighted average number of ordinary shares used in calculating basic earnings per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares" xml:lang="en-US">Average number of shares outstanding</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_WeightedAverageShares" xml:lang="en-US">Average number of shares outstanding</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageShares" xlink:to="lab_ifrs-full_WeightedAverageShares" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-full_AdjustedWeightedAverageShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xml:lang="en-US">Weighted average number of ordinary shares used in calculating diluted earnings per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xml:lang="en-US">Average number of shares after dilution (in shares)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xml:lang="en-US">Average number of shares used to compute diluted earnings per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_ifrs-full_AdjustedWeightedAverageShares" xml:lang="en-US">Average number of shares after dilution</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustedWeightedAverageShares" xlink:to="lab_ifrs-full_AdjustedWeightedAverageShares" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:label="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Basic earnings per share (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xlink:to="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:label="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Diluted earnings per share (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xlink:to="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" xml:lang="en-US">Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xml:lang="en-US">Basic earnings (loss) per share from continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xml:lang="en-US">Basic earnings per share from continuing operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Basic earnings (loss) per share from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Basic earnings per share from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Basic earnings per share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" xlink:to="lab_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Diluted earnings (loss) per share from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Diluted earnings per share from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xml:lang="en-US">Diluted earnings per share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:label="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xml:lang="en-US">Diluted earnings (loss) per share from continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xml:lang="en-US">Diluted earnings per share from continuing operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" xlink:to="lab_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" xml:lang="en-US">Statement of comprehensive income [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_StatementOfComprehensiveIncomeAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xml:lang="en-US">Other comprehensive income [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeAbstract" xml:lang="en-US">Other comprehensive income:</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeAbstract" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Actuarial gains/(losses)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:label="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xml:lang="en-US">Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, entity's own equity instruments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xml:lang="en-US">Change in fair value of equity instruments included in financial assets and financial liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" xlink:to="lab_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xml:lang="en-US">Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" xlink:to="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income that will not be reclassified to profit or loss, net of tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss from continuing operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:label="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xml:lang="en-US">Gains (Losses) On Remeasuring Debt Instruments, Before Tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xml:lang="en-US">Change in fair value of debt instruments included in financial assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xlink:to="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" xml:lang="en-US">Gains (Losses) On Remeasuring Debt Instruments, Before Tax</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xml:lang="en-US">Gains (losses) on cash flow hedges, before tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xml:lang="en-US">Change in fair value of cash flow hedges</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" xlink:to="lab_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:label="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xml:lang="en-US">Gains (losses) on exchange differences on translation of foreign operations, before tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xml:lang="en-US">Change in currency translation differences</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" xlink:to="lab_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:label="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xml:lang="en-US">Income tax relating to components of other comprehensive income that will be reclassified to profit or loss</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" xlink:to="lab_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:label="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Items subsequently reclassifiable to profit or loss</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xml:lang="en-US">Other comprehensive income that will be reclassified to profit or loss, net of tax</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" xlink:to="lab_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromContinuedOperations" xlink:label="loc_sny_OtherComprehensiveIncomeFromContinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherComprehensiveIncomeFromContinuedOperations" xml:lang="en-US">Other comprehensive income from continued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_OtherComprehensiveIncomeFromContinuedOperations" xml:lang="en-US">&#8201;Other comprehensive income/(loss) from continuing operations for the period, net of taxes (A+B)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherComprehensiveIncomeFromContinuedOperations" xlink:to="lab_sny_OtherComprehensiveIncomeFromContinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherComprehensiveIncomeFromContinuedOperations" xml:lang="en-US">Other comprehensive income from continued operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xlink:label="loc_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xml:lang="en-US">Other comprehensive income from discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xml:lang="en-US">&#8201;Other comprehensive income/(loss) for the period from discontinued operations, net of taxes (C)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xlink:to="lab_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherComprehensiveIncomeFromDiscontinuedOperations" xml:lang="en-US">Other comprehensive income from discontinued operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-full_ComprehensiveIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncome" xml:lang="en-US">Comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncome" xml:lang="en-US">Comprehensive income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncome" xlink:to="lab_ifrs-full_ComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xml:lang="en-US">Comprehensive income, attributable to owners of parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xlink:label="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, continuing operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xlink:to="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, continuing operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xlink:label="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, discontinued operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xlink:to="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" xml:lang="en-US">Comprehensive income, attributable to owners of parent, discontinued operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xml:lang="en-US">Comprehensive income, attributable to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xml:lang="en-US">Attributable to non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" xlink:to="lab_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-full_StatementOfChangesInEquityAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityAbstract" xml:lang="en-US">Statement of changes in equity [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityAbstract" xlink:to="lab_ifrs-full_StatementOfChangesInEquityAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-full_StatementOfChangesInEquityTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xml:lang="en-US">Statement of changes in equity [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_StatementOfChangesInEquityTable" xml:lang="en-US">Statement of changes in equity [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityTable" xlink:to="lab_ifrs-full_StatementOfChangesInEquityTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-full_ComponentsOfEquityAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xml:lang="en-US">Components of equity [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityAxis" xml:lang="en-US">Components of equity [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityAxis" xlink:to="lab_ifrs-full_ComponentsOfEquityAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComponentsOfEquityDomain" xlink:label="loc_ifrs-full_ComponentsOfEquityDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xml:lang="en-US">Components of equity [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComponentsOfEquityDomain" xml:lang="en-US">Components of equity [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComponentsOfEquityDomain" xlink:to="lab_ifrs-full_ComponentsOfEquityDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" xml:lang="en-US">Attributable to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="lab_ifrs-full_EquityAttributableToOwnersOfParentMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-full_IssuedCapitalMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapitalMember" xml:lang="en-US">Issued capital [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapitalMember" xml:lang="en-US">Share capital</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapitalMember" xlink:to="lab_ifrs-full_IssuedCapitalMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-full_AdditionalPaidinCapitalMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionalPaidinCapitalMember" xml:lang="en-US">Additional paid-in capital [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdditionalPaidinCapitalMember" xml:lang="en-US">Additional paid-in capital</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionalPaidinCapitalMember" xlink:to="lab_ifrs-full_AdditionalPaidinCapitalMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-full_TreasurySharesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TreasurySharesMember" xml:lang="en-US">Treasury shares [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TreasurySharesMember" xml:lang="en-US">Treasury shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TreasurySharesMember" xlink:to="lab_ifrs-full_TreasurySharesMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-full_RetainedEarningsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RetainedEarningsMember" xml:lang="en-US">Retained earnings [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RetainedEarningsMember" xml:lang="en-US">Reserves and retained earnings</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RetainedEarningsMember" xlink:to="lab_ifrs-full_RetainedEarningsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" xml:lang="en-US">Stock options and other share-based payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="lab_ifrs-full_ReserveOfSharebasedPaymentsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:label="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Accumulated other comprehensive income [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Other comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xml:lang="en-US">Accumulated other comprehensive income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_ifrs-full_AccumulatedOtherComprehensiveIncomeMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-full_NoncontrollingInterestsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xml:lang="en-US">Non-controlling interests [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncontrollingInterestsMember" xml:lang="en-US">Attributable to&#160;non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncontrollingInterestsMember" xlink:to="lab_ifrs-full_NoncontrollingInterestsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="loc_ifrs-full_StatementOfChangesInEquityLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_StatementOfChangesInEquityLineItems" xml:lang="en-US">Statement of changes in equity [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfChangesInEquityLineItems" xlink:to="lab_ifrs-full_StatementOfChangesInEquityLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareBasedPaymentPlansAbstract" xlink:label="loc_sny_ShareBasedPaymentPlansAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xml:lang="en-US">Share Based Payment Plans [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xml:lang="en-US">Share-based payment plans:</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareBasedPaymentPlansAbstract" xlink:to="lab_sny_ShareBasedPaymentPlansAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareBasedPaymentPlansAbstract" xml:lang="en-US">Share based payment plans.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xml:lang="en-US">Increase (decrease) through exercise of options, equity</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xml:lang="en-US">Exercise of stock options</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Issuance Of Restricted Shares And Vesting Of Existing Restricted Shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xml:lang="en-US">Issuance of restricted shares and vesting of existing restricted shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" xml:lang="en-US">Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Employee Share Ownership Plans</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xml:lang="en-US">Employee share ownership plan</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" xml:lang="en-US">Employee share ownership plans.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Value Of Services Obtained From Employees</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xml:lang="en-US">Value of services obtained from employees</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" xml:lang="en-US">Value of services obtained from employees.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:label="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xml:lang="en-US">Increase (Decrease) Through Share-Based Payment Plans Tax Effects Of The Exercise Of Stock Options</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xml:lang="en-US">Tax effects of share-based payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xlink:to="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" xml:lang="en-US">Tax effects of the exercise of stock options.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xml:lang="en-US">Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xml:lang="en-US">Change in non-controlling interests without loss of control</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-full_OtherComprehensiveIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xml:lang="en-US">Other comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherComprehensiveIncome" xml:lang="en-US">Other comprehensive income for the period</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherComprehensiveIncome" xlink:to="lab_ifrs-full_OtherComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xml:lang="en-US">Dividends recognised as distributions to owners of parent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xml:lang="en-US">Dividend paid out of earnings</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:label="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xml:lang="en-US">Dividends recognised as distributions to non-controlling interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xml:lang="en-US">Payment of dividends to non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" xlink:to="lab_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfTreasuryShares" xlink:label="loc_ifrs-full_PurchaseOfTreasuryShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares" xml:lang="en-US">Purchase of treasury shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PurchaseOfTreasuryShares" xml:lang="en-US">Share repurchase program</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfTreasuryShares" xlink:to="lab_ifrs-full_PurchaseOfTreasuryShares" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReductionOfIssuedCapital" xlink:label="loc_ifrs-full_ReductionOfIssuedCapital" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReductionOfIssuedCapital" xml:lang="en-US">Reduction of issued capital</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ReductionOfIssuedCapital" xml:lang="en-US">Reduction in share capital</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReductionOfIssuedCapital" xlink:to="lab_ifrs-full_ReductionOfIssuedCapital" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:label="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xml:lang="en-US">Increase (Decrease) Through Issuance Of Restricted Shares, Equity</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xml:lang="en-US">Other changes arising from issuance of restricted shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xlink:to="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" xml:lang="en-US">Increase (decrease) through issuance of restricted shares, equity.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TaxesOnShareCancellations" xlink:label="loc_sny_TaxesOnShareCancellations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TaxesOnShareCancellations" xml:lang="en-US">Taxes on Share Cancellations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TaxesOnShareCancellations" xlink:to="lab_sny_TaxesOnShareCancellations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TaxesOnShareCancellations" xml:lang="en-US">Taxes on Share Cancellations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xml:lang="en-US">Subsidiaries [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xml:lang="en-US">Subsidiaries [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xml:lang="en-US">Subsidiaries [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xml:lang="en-US">Subsidiaries [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInSubsidiariesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:label="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xml:lang="en-US">Dividends paid, ordinary shares per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" xml:lang="en-US">Dividend paid per share (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidOrdinarySharesPerShare" xlink:to="lab_ifrs-full_DividendsPaidOrdinarySharesPerShare" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-full_StatementOfCashFlowsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfCashFlowsAbstract" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfCashFlowsAbstract" xlink:to="lab_ifrs-full_StatementOfCashFlowsAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) operating activities [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xml:lang="en-US">Adjustments to reconcile profit (loss) [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="lab_ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xml:lang="en-US">(Increase)/decrease in inventories</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xml:lang="en-US">(Increase)/decrease in accounts receivable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="lab_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xml:lang="en-US">Increase/(decrease) in accounts payable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="lab_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:label="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xml:lang="en-US">Net Change In Other Current Assets And Other Current Liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xml:lang="en-US">Net change in other current assets and other current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xlink:to="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" xml:lang="en-US">Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">Cash flows from (used in) operating activities, continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xml:lang="en-US">&#8201;Net cash provided by/(used in) continuing operating activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xml:lang="en-US">Cash flows from (used in) operating activities, discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xml:lang="en-US">&#8201;Net cash provided by/(used in) operating activities of the discontinued Opella business</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:label="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xml:lang="en-US">Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xml:lang="en-US">Net income attributable to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" xlink:to="lab_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xlink:label="loc_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xml:lang="en-US">Adjustments for losses (gains) on transfer of business</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xml:lang="en-US">&#8201;Net (income)/loss from the discontinued Opella business</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xlink:to="lab_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AdjustmentsForLossesGainsOnTransferOfBusiness" xml:lang="en-US">Adjustments for losses (gains) on transfer of business</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xml:lang="en-US">Adjustments for undistributed profits of investments accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xml:lang="en-US">Share of undistributed earnings from investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:label="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xml:lang="en-US">Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Of Property Plant And Equipment Right-Of Use Assets And Intangible Asset</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xml:lang="en-US">Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xlink:to="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" xml:lang="en-US">Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:label="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xml:lang="en-US">Adjustments for losses (gains) on disposal of non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xml:lang="en-US">Gains and losses on disposals of non-current assets, net of tax</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" xlink:to="lab_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:label="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" xml:lang="en-US">Adjustments for deferred tax expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" xml:lang="en-US">Net change in deferred taxes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForDeferredTaxExpense" xlink:to="lab_ifrs-full_AdjustmentsForDeferredTaxExpense" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:label="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Adjustments For Non-Current Provisions And Other Non-Current Liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Net change in non-current provisions and other non-current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xlink:to="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" xml:lang="en-US">Adjustments for noncurrent provisions and other noncurrent liabilities.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-full_AdjustmentsForSharebasedPayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xml:lang="en-US">Adjustments for share-based payments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdjustmentsForSharebasedPayments" xml:lang="en-US">Cost of employee benefits (stock options and other share-based payments)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="lab_ifrs-full_AdjustmentsForSharebasedPayments" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:label="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xml:lang="en-US">Impact Of The Workdown Of Acquired Inventories Remeasured At Fair Value</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xml:lang="en-US">Impact of the workdown of acquired inventories remeasured at fair value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xlink:to="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" xml:lang="en-US">Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:label="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xml:lang="en-US">Other adjustments to reconcile profit (loss)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xml:lang="en-US">Other profit or loss items with no cash effect on cash flows generated by operating activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" xlink:to="lab_ifrs-full_OtherAdjustmentsToReconcileProfitLoss" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xml:lang="en-US">Cash flows from (used in) operations before changes in working capital</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xml:lang="en-US">Operating cash flow before changes in working capital</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" xml:lang="en-US">Net cash provided by/(used in) operating activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInOperatingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) investing activities [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xml:lang="en-US">Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xml:lang="en-US">Acquisitions of property, plant and equipment and intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xml:lang="en-US">Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xml:lang="en-US">Acquisitions of consolidated undertakings and investments accounted for using the equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xml:lang="en-US">Net cash flow on acquisition</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xml:lang="en-US">Purchase of financial instruments, classified as investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xml:lang="en-US">Acquisitions of other equity investments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:label="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xml:lang="en-US">Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xml:lang="en-US">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" xlink:to="lab_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xml:lang="en-US">Cash flows from losing control of subsidiaries or other businesses, classified as investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xml:lang="en-US">Disposals of consolidated undertakings and investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetChangeInOtherNonCurrentAssets" xlink:label="loc_sny_NetChangeInOtherNonCurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xml:lang="en-US">Net Change In Other Non-Current Assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xml:lang="en-US">Net change in other non-current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetChangeInOtherNonCurrentAssets" xlink:to="lab_sny_NetChangeInOtherNonCurrentAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetChangeInOtherNonCurrentAssets" xml:lang="en-US">Net change in other non-current assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInContinuingInvestingActivities" xlink:label="loc_sny_NetCashProvidedByusedInContinuingInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetCashProvidedByusedInContinuingInvestingActivities" xml:lang="en-US">Net Cash Provided by/(used in) Continuing Investing Activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_NetCashProvidedByusedInContinuingInvestingActivities" xml:lang="en-US">Net Cash Provided by/(used in) Continuing Investing Activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetCashProvidedByusedInContinuingInvestingActivities" xlink:to="lab_sny_NetCashProvidedByusedInContinuingInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetCashProvidedByusedInContinuingInvestingActivities" xml:lang="en-US">Net Cash Provided by/(used in) Continuing Investing Activities</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xlink:label="loc_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xml:lang="en-US">Net Cash Provided by/(used in) Discontinuing Investing Activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xml:lang="en-US">&#8201;Net cash provided by/(used in) investing activities of the discontinued Opella business</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xlink:to="lab_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" xml:lang="en-US">Net Cash Provided by/(used in) Discontinuing Investing Activities</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" xml:lang="en-US">Net cash provided by/(used in) investing activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetCashInflowFromDiscontinuedOperations" xlink:label="loc_sny_NetCashInflowFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetCashInflowFromDiscontinuedOperations" xml:lang="en-US">Net Cash Inflow from Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_NetCashInflowFromDiscontinuedOperations" xml:lang="en-US">Net cash inflow from the Opella transaction</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetCashInflowFromDiscontinuedOperations" xml:lang="en-US">Net Cash Inflow from Discontinued Operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetCashInflowFromDiscontinuedOperations" xlink:to="lab_sny_NetCashInflowFromDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetCashInflowFromDiscontinuedOperations" xml:lang="en-US">Net Cash Inflow from Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xml:lang="en-US">Cash flows from (used in) financing activities [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DividendsPaidAbstract" xlink:label="loc_sny_DividendsPaidAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DividendsPaidAbstract" xml:lang="en-US">Dividends Paid [Abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DividendsPaidAbstract" xml:lang="en-US">Dividends paid:</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DividendsPaidAbstract" xlink:to="lab_sny_DividendsPaidAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DividendsPaidAbstract" xml:lang="en-US">Dividends Paid</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xml:lang="en-US">Dividends paid to equity holders of parent, classified as financing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xml:lang="en-US">Dividends paid to equity holders of Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xml:lang="en-US">Dividends paid to non-controlling interests, classified as financing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromIssuingShares" xlink:label="loc_ifrs-full_ProceedsFromIssuingShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xml:lang="en-US">Proceeds from issuing shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromIssuingShares" xml:lang="en-US">Issuance of Sanofi shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromIssuingShares" xlink:to="lab_ifrs-full_ProceedsFromIssuingShares" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:label="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xml:lang="en-US">Proceeds from non-current borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" xml:lang="en-US">Additional long-term debt contracted</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromNoncurrentBorrowings" xlink:to="lab_ifrs-full_ProceedsFromNoncurrentBorrowings" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:label="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xml:lang="en-US">Repayments of non-current borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" xml:lang="en-US">Repayments of long-term debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RepaymentsOfNoncurrentBorrowings" xlink:to="lab_ifrs-full_RepaymentsOfNoncurrentBorrowings" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xml:lang="en-US">Repayment of lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="lab_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:label="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xml:lang="en-US">Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xml:lang="en-US">Net change in short-term debt and other financial instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xlink:to="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" xml:lang="en-US">Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:label="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xml:lang="en-US">Payments to acquire or redeem entity's shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xml:lang="en-US">Acquisitions of treasury shares and related tax effect</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" xlink:to="lab_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">Cash flows from (used in) financing activities, continuing operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xml:lang="en-US">&#8201;Net cash provided by/(used in) continuing financing activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xml:lang="en-US">Cash flows from (used in) financing activities, discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xml:lang="en-US">&#8201;Net cash provided by/(used in) financing activities of the discontinued Opella business</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" xml:lang="en-US">Net cash provided by/(used in) financing activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="lab_ifrs-full_CashFlowsFromUsedInFinancingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xml:lang="en-US">Impact of exchange rates on cash and cash equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="lab_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xlink:label="loc_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xml:lang="en-US">Cash and Cash Equivalents Reclassified to Assets Held for Sale</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xml:lang="en-US">Cash and Cash Equivalents Reclassified to Assets Held for Sale</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xlink:to="lab_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" xml:lang="en-US">Cash and Cash Equivalents Reclassified to Assets Held for Sale</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xml:lang="en-US">Net change in cash and cash equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="lab_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xml:lang="en-US">Disclosure of detailed information about borrowings [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-full_BorrowingsByNameAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xml:lang="en-US">Borrowings by name [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsByNameAxis" xml:lang="en-US">Borrowings by name [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameAxis" xlink:to="lab_ifrs-full_BorrowingsByNameAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BorrowingsByNameDomain" xlink:label="loc_ifrs-full_BorrowingsByNameDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xml:lang="en-US">Borrowings by name [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BorrowingsByNameDomain" xml:lang="en-US">Borrowings by name [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BorrowingsByNameDomain" xlink:to="lab_ifrs-full_BorrowingsByNameDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInUSAMember" xlink:label="loc_sny_CommercialPaperProgramInUSAMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xml:lang="en-US">Commercial Paper Program In USA [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xml:lang="en-US">Commercial paper program in USA</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercialPaperProgramInUSAMember" xlink:to="lab_sny_CommercialPaperProgramInUSAMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CommercialPaperProgramInUSAMember" xml:lang="en-US">Commercial paper program in USA.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaMember" xlink:label="loc_sny_OpellaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OpellaMember" xml:lang="en-US">Opella [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OpellaMember" xml:lang="en-US">Opella</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaMember" xlink:to="lab_sny_OpellaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OpellaMember" xml:lang="en-US">Opella</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xml:lang="en-US">Disclosure of detailed information about borrowings [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xml:lang="en-US">Disclosure of detailed information about borrowings [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xml:lang="en-US">Income tax paid</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xml:lang="en-US">Interest paid, classified as operating activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xml:lang="en-US">Interest paid</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestPaidClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestPaidClassifiedAsOperatingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:label="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xml:lang="en-US">Interest received, classified as operating activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xml:lang="en-US">Interest received</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" xlink:to="lab_ifrs-full_InterestReceivedClassifiedAsOperatingActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xlink:label="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xml:lang="en-US">Dividends Received From Nonconsolidated Entities Classified As Operating Activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xml:lang="en-US">Dividends received from non-consolidated entities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xlink:to="lab_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" xml:lang="en-US">Dividends received from non-consolidated entities.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:label="loc_sny_GeneralInformationAboutFinancialStatementsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xml:lang="en-US">General Information About Financial Statements [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GeneralInformationAboutFinancialStatementsAbstract" xlink:to="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GeneralInformationAboutFinancialStatementsAbstract" xml:lang="en-US">General Information About Financial Statements [Abstract]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xml:lang="en-US">Disclosure of general information about financial statements [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xml:lang="en-US">Introduction</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:label="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xml:lang="en-US">Corporate information and statement of IFRS compliance [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" xlink:to="lab_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xml:lang="en-US">Disclosure of basis of preparation of financial statements [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xml:lang="en-US">Basis of Preparation of the Half-Year Financial Statements and Accounting Policies</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xml:lang="en-US">Disclosure of detailed information about business combination [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsAbstract" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Impact Of Changes In The Scope Of Consolidation Due To Acquisitions And Divestments Explanatory [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xml:lang="en-US">Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" xml:lang="en-US">The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:label="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" xml:lang="en-US">Property, plant and equipment [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PropertyPlantAndEquipmentAbstract" xlink:to="lab_ifrs-full_PropertyPlantAndEquipmentAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xml:lang="en-US">Property, Plant and Equipment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:label="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xml:lang="en-US">Intangible assets and goodwill [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IntangibleAssetsAndGoodwillAbstract" xlink:to="lab_ifrs-full_IntangibleAssetsAndGoodwillAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xml:lang="en-US">Disclosure of intangible assets and goodwill [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" xlink:label="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" xml:lang="en-US">Disclosure of impairment loss and reversal of impairment loss [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" xlink:to="lab_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Impairment Of Intangible Assets And Property Plant And Equipment Explanatory [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xml:lang="en-US">Impairment of Intangible Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" xml:lang="en-US">The entire disclosure for impairment of intangible assets and property, plant and equipment.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestsInOtherEntitiesAbstract" xlink:label="loc_sny_InterestsInOtherEntitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestsInOtherEntitiesAbstract" xml:lang="en-US">Interests In Other Entities [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestsInOtherEntitiesAbstract" xlink:to="lab_sny_InterestsInOtherEntitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestsInOtherEntitiesAbstract" xml:lang="en-US">Interests In Other Entities [Abstract]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xml:lang="en-US">Disclosure of investments accounted for using equity method [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xml:lang="en-US">Investments Accounted for Using the Equity Method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:label="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xml:lang="en-US">Subclassifications of assets, liabilities and equities [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" xlink:to="lab_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xml:lang="en-US">Disclosure of other non-current assets [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xml:lang="en-US">Other Non-Current Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradeAndOtherReceivablesAbstract" xlink:label="loc_ifrs-full_TradeAndOtherReceivablesAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradeAndOtherReceivablesAbstract" xml:lang="en-US">Trade and other receivables [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradeAndOtherReceivablesAbstract" xlink:to="lab_ifrs-full_TradeAndOtherReceivablesAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfTradeReceivablesTextBlock" xlink:label="loc_sny_DisclosureOfTradeReceivablesTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xml:lang="en-US">Disclosure Of Trade Receivables [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xml:lang="en-US">Accounts Receivable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfTradeReceivablesTextBlock" xlink:to="lab_sny_DisclosureOfTradeReceivablesTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfTradeReceivablesTextBlock" xml:lang="en-US">The disclosure of trade receivables.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:label="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xml:lang="en-US">Share Capital, Reserves And Other Equity Interest [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xlink:to="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareCapitalReservesAndOtherEquityInterestAbstract" xml:lang="en-US">Share Capital, Reserves And Other Equity Interest [Abstract]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xml:lang="en-US">Consolidated Shareholders' Equity</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="lab_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashAndCashEquivalentsAbstract" xlink:label="loc_ifrs-full_CashAndCashEquivalentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashAndCashEquivalentsAbstract" xml:lang="en-US">Cash and cash equivalents [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashAndCashEquivalentsAbstract" xlink:to="lab_ifrs-full_CashAndCashEquivalentsAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Debt Instruments Issued Explanatory [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xml:lang="en-US">Debt, Cash and Cash Equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" xml:lang="en-US">Disclosure of debt instruments issued explanatory.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FinancialInstrumentsAbstract" xlink:label="loc_sny_FinancialInstrumentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FinancialInstrumentsAbstract" xml:lang="en-US">Financial Instruments [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FinancialInstrumentsAbstract" xlink:to="lab_sny_FinancialInstrumentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FinancialInstrumentsAbstract" xml:lang="en-US">Financial Instruments [Abstract]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xml:lang="en-US">Disclosure of derivative financial instruments [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xml:lang="en-US">Derivative Financial Instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xml:lang="en-US">Disclosure Of Provisions And Other Non-Current Liabilities [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xml:lang="en-US">Non-Current Provisions And Other Non-Current Liabilities.</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xlink:to="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" xml:lang="en-US">Disclosure Of Provisions And Other Non-Current Liabilities</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OffBalanceSheetCommitmentsAbstract" xlink:label="loc_sny_OffBalanceSheetCommitmentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OffBalanceSheetCommitmentsAbstract" xml:lang="en-US">Off-Balance Sheet Commitments [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OffBalanceSheetCommitmentsAbstract" xlink:to="lab_sny_OffBalanceSheetCommitmentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OffBalanceSheetCommitmentsAbstract" xml:lang="en-US">Off-Balance Sheet Commitments</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Off-Balance Sheet Commitments Explanatory [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xml:lang="en-US">Off Balance Sheet Commitments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" xml:lang="en-US">Disclosure of off-balance sheet commitments.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:label="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xml:lang="en-US">Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xlink:to="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" xml:lang="en-US">Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xml:lang="en-US">Litigation and Arbitration Proceedings</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:label="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xml:lang="en-US">Analysis of income and expense [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" xlink:to="lab_ifrs-full_AnalysisOfIncomeAndExpenseAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xml:lang="en-US">Disclosure of other operating income (expense) [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xml:lang="en-US">Other Operating Income and Expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRestructuringTextBlock" xlink:label="loc_sny_DisclosureOfRestructuringTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfRestructuringTextBlock" xml:lang="en-US">Disclosure Of Restructuring [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfRestructuringTextBlock" xml:lang="en-US">Restructuring costs and similar items</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringTextBlock" xlink:to="lab_sny_DisclosureOfRestructuringTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfRestructuringTextBlock" xml:lang="en-US">Disclosure Of Restructuring [Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:label="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xml:lang="en-US">Disclosure Of Other Gains And Losses, And Litigation [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xml:lang="en-US">Other Gains and Losses, and Litigation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xlink:to="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" xml:lang="en-US">The entire disclosure of other gains and losses, and litigation.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xml:lang="en-US">Disclosure of finance income (cost) [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xml:lang="en-US">Financial Expenses and Income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="lab_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:label="loc_ifrs-full_IncomeTaxesPaidRefundAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxesPaidRefundAbstract" xml:lang="en-US">Income taxes paid (refund) [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxesPaidRefundAbstract" xlink:to="lab_ifrs-full_IncomeTaxesPaidRefundAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xml:lang="en-US">Disclosure of income tax [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" xml:lang="en-US">Income Tax Expense</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="lab_ifrs-full_DisclosureOfIncomeTaxExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xml:lang="en-US">Disclosure of operating segments [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsAbstract" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xml:lang="en-US">Disclosure of entity's operating segments [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xml:lang="en-US">Segment Information</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueAbstract" xlink:label="loc_ifrs-full_RevenueAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueAbstract" xml:lang="en-US">Revenue [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueAbstract" xlink:to="lab_ifrs-full_RevenueAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-full_DisclosureOfRevenueExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory" xml:lang="en-US">Disclosure of revenue [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfRevenueExplanatory" xml:lang="en-US">Revenue from Contracts with Customers</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="lab_ifrs-full_DisclosureOfRevenueExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xml:lang="en-US">Disclosure of non-current assets held for sale and discontinued operations [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xml:lang="en-US">Information related to Opella, presented within assets held for sale and discontinued operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:label="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xml:lang="en-US">Disclosure of contingent liabilities in business combination [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" xlink:to="lab_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Explanatory [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xml:lang="en-US">Liabilities Related to Business Combinations and to Non-Controlling Interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" xml:lang="en-US">The entire disclosure for liabilities related to business combination and to non-controlling interests.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xml:lang="en-US">Disclosure of events after reporting period [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xml:lang="en-US">Events Subsequent to June 30, 2023</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="lab_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_StatementOfIFRSCompliance" xlink:label="loc_ifrs-full_StatementOfIFRSCompliance" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xml:lang="en-US">Statement of IFRS compliance [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_StatementOfIFRSCompliance" xml:lang="en-US">International Financial Reporting Standards (IFRS)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_StatementOfIFRSCompliance" xlink:to="lab_ifrs-full_StatementOfIFRSCompliance" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xml:lang="en-US">Disclosure of accounting judgements and estimates [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xml:lang="en-US">Use of Estimates</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xlink:label="loc_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xml:lang="en-US">Seasonality Or Cyclicality Of Interim Operations [Policy Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xml:lang="en-US">Seasonal Trends</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xlink:to="lab_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" xml:lang="en-US">Seasonality Or Cyclicality Of Interim Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:label="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xml:lang="en-US">Disclosure of information about hyperinflationary reporting [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xml:lang="en-US">Consolidation and Foreign Currency Translation of the Financial Statements of Subsidiaries in Hyperinflationary Economies</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" xlink:to="lab_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xml:lang="en-US">Description of accounting policy for financial instruments [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:label="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xml:lang="en-US">Disclosure of expected impact of initial application of new standards or interpretations [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xml:lang="en-US">New Pronouncements Issued by the IASB and Applicable from 2024</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" xlink:to="lab_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xml:lang="en-US">Disclosure of detailed information about financial instruments [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xml:lang="en-US">Disclosure of Measurement Principles Applied to Financial Instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xml:lang="en-US">Summary of Acquisitions and Capitalized Interest by Operating Segment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xml:lang="en-US">Disclosure Of Reconciliation Of Changes In Other Intangible Assets [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xml:lang="en-US">Schedule of Movements in Other Intangible Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" xml:lang="en-US">Disclosure of reconciliation of changes in other intangible assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:label="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xml:lang="en-US">Disclosure Of Investments In Associates And Joint Ventures [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xml:lang="en-US">Summary of Investments in Associates and Joint Ventures</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xlink:to="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" xml:lang="en-US">The entire disclosure of investments in associates and joint ventures explanatory.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xml:lang="en-US">Disclosure of transactions between related parties [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xml:lang="en-US">Summary of Principal Transactions and Balances with Related Parties</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Unaudited Financial Statements Of Subsidiaries Explanatory [Table Text Block]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of unaudited financial statements of subsidiaries explanatory.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xlink:label="loc_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xml:lang="en-US">Disclosure Of Components Of Other Non-Current Assets [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xml:lang="en-US">Summary of Other Non-Current Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xlink:to="lab_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" xml:lang="en-US">The disclosure of components of other noncurrent assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:label="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xml:lang="en-US">Disclosure Of Current Trade Receivables [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xml:lang="en-US">Summary of Accounts Receivable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xlink:to="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" xml:lang="en-US">The disclosure of current trade receivables.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:label="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xml:lang="en-US">Disclosure Of Overdue Receivables Gross Value [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xml:lang="en-US">Summary of Gross Value of Overdue Receivables</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xlink:to="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" xml:lang="en-US">The disclosure of overdue receivables gross value.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xml:lang="en-US">Disclosure of classes of share capital [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xml:lang="en-US">Summary of Treasury Shares Held</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Employee Stock Ownership Plan Awarded In Capital Increase Reserved Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xml:lang="en-US">Summary of Principal Characteristics of Restricted Share Plans</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:label="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xml:lang="en-US">Disclosure Of Number Of Restricted Share Plans Not Yet Fully Vested [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xml:lang="en-US">Summary of Number of Restricted Shares Not Yet Fully Vested</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xlink:to="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" xml:lang="en-US">Disclosure of number of restricted share plans Not yet fully vested.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:label="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xml:lang="en-US">Disclosure Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xml:lang="en-US">Summary of Options Outstanding and Exercisable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xlink:to="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" xml:lang="en-US">The disclosure of share based compensation shares authorized under stock option plans by exercise price range.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:label="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xml:lang="en-US">Disclosure Of Shares Used To Compute Diluted Earnings Per Share [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xml:lang="en-US">Summary of Number of Shares Used to Compute Diluted Earnings Per Share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xlink:to="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" xml:lang="en-US">The disclosure of shares used to compute diluted earnings per share.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Accumulated Other Comprehensive Income Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xml:lang="en-US">Summary of Movements within Other Comprehensive Income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of detailed information of accumulated other comprehensive income.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:label="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xml:lang="en-US">Disclosure Of Changes In Financial Position [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xml:lang="en-US">Summary of Changes in Financial Position</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfChangesInFinancialPositionTableTextBlock" xml:lang="en-US">Disclosure of changes in financial position [text block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xml:lang="en-US">Summary of Reconciliation of Carrying Amount to Value on Redemption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [text block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Debt Net Of Cash And Cash Equivalents By Type At Value On Redemption Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xml:lang="en-US">Summary of Net Debt by Type Valuation of Redemption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" xml:lang="en-US">The disclosure of debt net of cash and cash equivalents by type at value on redemption.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:label="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xml:lang="en-US">Disclosure Of Market Value Of Net Debt [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xml:lang="en-US">Summary of Market Value of Net Debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xlink:to="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" xml:lang="en-US">Disclosure of market value of net debt [Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:label="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xml:lang="en-US">Disclosure Of Operating Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xml:lang="en-US">Summary of Operating Currency Hedging Instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xlink:to="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" xml:lang="en-US">The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Financial Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" xml:lang="en-US">The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Interest Rates Hedging Instruments With Notional Amount By Expiry Date Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of Instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" xml:lang="en-US">The disclosure of interest rates hedging instruments with notional amount by expiry date.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:label="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xml:lang="en-US">Disclosure Of Changes In Liabilities Related To Business Combinations And To Noncontrolling Interests [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xml:lang="en-US">Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xlink:to="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" xml:lang="en-US">The disclosure of changes in liabilities related to business combinations and to non-controlling interests.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Provisions And Other Non Current Liabilities Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xml:lang="en-US">Summary of Non-current provisions and other non-current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Provisions And Other Non Current Liabilities Explanatory</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xml:lang="en-US">Disclosure Of Non-Current Provisions [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xml:lang="en-US">Summary of Movements in Non-Current Provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xlink:to="lab_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTableTextBlock" xml:lang="en-US">Disclosure of noncurrent provisions explanatory.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:label="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xml:lang="en-US">Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xml:lang="en-US">Disclosure of Remeasurement of Net Defined Benefit Liability Asset</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xlink:to="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" xml:lang="en-US">Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingExpensesTableTextBlock" xlink:label="loc_sny_OtherOperatingExpensesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xml:lang="en-US">Other Operating Expenses [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xml:lang="en-US">Schedule of Other Operating Expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherOperatingExpensesTableTextBlock" xlink:to="lab_sny_OtherOperatingExpensesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherOperatingExpensesTableTextBlock" xml:lang="en-US">Other Operating Expenses [Table Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:label="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xml:lang="en-US">Disclosure Of Restructuring Costs Details [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xml:lang="en-US">Summary of Restructuring Costs and Similar Items</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xlink:to="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" xml:lang="en-US">The disclosure of restructuring costs details.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Financial Income And Expenses Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xml:lang="en-US">Summary of Analysis of Financial Income and Expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" xml:lang="en-US">The entire disclosure for financial income and expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:label="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xml:lang="en-US">Disclosure Of Allocation Of Income Tax Between Current And Deferred Taxes [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xml:lang="en-US">Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xlink:to="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" xml:lang="en-US">The disclosure of allocation of income tax between current and deferred taxes.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:label="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure Of Reconciliation Of Average Effective Tax Rate And Applicable Tax Rate Explanatory [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xml:lang="en-US">Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xlink:to="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" xml:lang="en-US">Disclosure of reconciliation of average effective tax rate and applicable tax rate.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xml:lang="en-US">Summary of Net Sales by Segment and Geographical Area</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherRevenueTextBlock" xlink:label="loc_sny_DisclosureOfOtherRevenueTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherRevenueTextBlock" xml:lang="en-US">Disclosure of other revenue [Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherRevenueTextBlock" xml:lang="en-US">Disclosure of Other Revenue</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherRevenueTextBlock" xlink:to="lab_sny_DisclosureOfOtherRevenueTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherRevenueTextBlock" xml:lang="en-US">Disclosure of other revenue [Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xml:lang="en-US">Disclosure of operating segments [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xml:lang="en-US">Schedule of Segment Results</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:label="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xml:lang="en-US">Disclosure Of Operating Segments Reconciling Items [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xml:lang="en-US">Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xlink:to="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" xml:lang="en-US">The disclosure of operating segments reconciling items.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:label="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xml:lang="en-US">Disclosure Of Acquisitions Of Property Plant And Equipment And Other Intangible Assets And Carrying Amount Of Investments In Associates And Joint Ventures By Operating Segment [Table Text Block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xml:lang="en-US">Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xlink:to="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" xml:lang="en-US">The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xml:lang="en-US">Disclosure of geographical areas [text block]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xml:lang="en-US">Summary of Geographical Information on Net Sales and Non-Current Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasExplanatory" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasExplanatory" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:label="loc_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xml:lang="en-US">Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xlink:to="lab_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" xml:lang="en-US">Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Table Text Block]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xml:lang="en-US">Disclosure of initial application of standards or interpretations [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xml:lang="en-US">Disclosure of initial application of standards or interpretations [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" xlink:to="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasAxis" xlink:label="loc_ifrs-full_GeographicalAreasAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xml:lang="en-US">Geographical areas [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeographicalAreasAxis" xml:lang="en-US">Geographical areas [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasAxis" xlink:to="lab_ifrs-full_GeographicalAreasAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GeographicalAreasDomain" xlink:label="loc_ifrs-full_GeographicalAreasDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xml:lang="en-US">Geographical areas [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GeographicalAreasDomain" xml:lang="en-US">Geographical areas [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GeographicalAreasDomain" xlink:to="lab_ifrs-full_GeographicalAreasDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_AR" xlink:label="loc_country_AR" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_AR" xml:lang="en-US">ARKANSAS</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_AR" xml:lang="en-US">Argentina</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_AR" xlink:to="lab_country_AR" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_TR" xlink:label="loc_country_TR" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_TR" xml:lang="en-US">T&#220;RKIYE</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_TR" xml:lang="en-US">Turkey</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_TR" xlink:to="lab_country_TR" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementAxis" xlink:label="loc_sny_TypesOfAgreementAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TypesOfAgreementAxis" xml:lang="en-US">Types Of Agreement [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_TypesOfAgreementAxis" xml:lang="en-US">Types Of Agreement [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TypesOfAgreementAxis" xlink:to="lab_sny_TypesOfAgreementAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TypesOfAgreementAxis" xml:lang="en-US">Types Of Agreement</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TypesOfAgreementDomain" xlink:label="loc_sny_TypesOfAgreementDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TypesOfAgreementDomain" xml:lang="en-US">Types Of Agreement [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_TypesOfAgreementDomain" xml:lang="en-US">Types Of Agreement [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TypesOfAgreementDomain" xlink:to="lab_sny_TypesOfAgreementDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TypesOfAgreementDomain" xml:lang="en-US">Types Of Agreement [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesAxis" xlink:label="loc_ifrs-full_CounterpartiesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesAxis" xml:lang="en-US">Counterparties [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CounterpartiesAxis" xml:lang="en-US">Counterparties [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesAxis" xlink:to="lab_ifrs-full_CounterpartiesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CounterpartiesDomain" xlink:label="loc_ifrs-full_CounterpartiesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CounterpartiesDomain" xml:lang="en-US">Counterparties [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CounterpartiesDomain" xml:lang="en-US">Counterparties [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CounterpartiesDomain" xlink:to="lab_ifrs-full_CounterpartiesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xml:lang="en-US">Disclosure of initial application of standards or interpretations [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xml:lang="en-US">Disclosure of initial application of standards or interpretations [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xlink:label="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xml:lang="en-US">Cumulative Consumer Price Inflation Rate Over The Last Three Years</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xml:lang="en-US">Cumulative consumer price inflation rate</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xlink:to="lab_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" xml:lang="en-US">Cumulative Consumer Price Inflation Rate Over The Last Three Years</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-full_BusinessCombinationsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xml:lang="en-US">Business combinations [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BusinessCombinationsAxis" xml:lang="en-US">Business Combinations [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsAxis" xlink:to="lab_ifrs-full_BusinessCombinationsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BusinessCombinationsDomain" xlink:label="loc_ifrs-full_BusinessCombinationsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BusinessCombinationsDomain" xml:lang="en-US">Business combinations [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BusinessCombinationsDomain" xml:lang="en-US">Entity's total for business combinations [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BusinessCombinationsDomain" xlink:to="lab_ifrs-full_BusinessCombinationsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:label="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xml:lang="en-US">Investment, Name [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xml:lang="en-US">Investment, Name [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" xlink:to="lab_srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EquityMethodInvesteeNameDomain" xlink:label="loc_srt_EquityMethodInvesteeNameDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xml:lang="en-US">Investment, Name [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_EquityMethodInvesteeNameDomain" xml:lang="en-US">Investment, Name [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EquityMethodInvesteeNameDomain" xlink:to="lab_srt_EquityMethodInvesteeNameDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionAxis" xlink:label="loc_sny_AssetsAcquisitionAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssetsAcquisitionAxis" xml:lang="en-US">Assets Acquisition [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AssetsAcquisitionAxis" xml:lang="en-US">Assets Acquisition [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssetsAcquisitionAxis" xlink:to="lab_sny_AssetsAcquisitionAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssetsAcquisitionAxis" xml:lang="en-US">Assets Acquisition</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionDomain" xlink:label="loc_sny_AssetsAcquisitionDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssetsAcquisitionDomain" xml:lang="en-US">Assets Acquisition [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AssetsAcquisitionDomain" xml:lang="en-US">Assets Acquisition [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssetsAcquisitionDomain" xlink:to="lab_sny_AssetsAcquisitionDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssetsAcquisitionDomain" xml:lang="en-US">Assets Acquisition [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsAcquisitionMember" xlink:label="loc_sny_AssetsAcquisitionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssetsAcquisitionMember" xml:lang="en-US">Assets Acquisition [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AssetsAcquisitionMember" xml:lang="en-US">Assets Acquisition</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssetsAcquisitionMember" xlink:to="lab_sny_AssetsAcquisitionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssetsAcquisitionMember" xml:lang="en-US">Assets Acquisition</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VigilNeuroscienceIncMember" xlink:label="loc_sny_VigilNeuroscienceIncMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_VigilNeuroscienceIncMember" xml:lang="en-US">Vigil Neuroscience, Inc [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_VigilNeuroscienceIncMember" xml:lang="en-US">Vigil Neuroscience, Inc</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VigilNeuroscienceIncMember" xlink:to="lab_sny_VigilNeuroscienceIncMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_VigilNeuroscienceIncMember" xml:lang="en-US">Vigil Neuroscience, Inc [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BlueprintMedicinesCorporationMember" xlink:label="loc_sny_BlueprintMedicinesCorporationMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BlueprintMedicinesCorporationMember" xml:lang="en-US">Blueprint Medicines Corporation [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_BlueprintMedicinesCorporationMember" xml:lang="en-US">Blueprint Medicines Corporation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BlueprintMedicinesCorporationMember" xlink:to="lab_sny_BlueprintMedicinesCorporationMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BlueprintMedicinesCorporationMember" xml:lang="en-US">Blueprint Medicines Corporation [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OpellaBusinessMember" xlink:label="loc_sny_OpellaBusinessMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OpellaBusinessMember" xml:lang="en-US">Opella Business [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OpellaBusinessMember" xml:lang="en-US">Opella Business</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OpellaBusinessMember" xlink:to="lab_sny_OpellaBusinessMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OpellaBusinessMember" xml:lang="en-US">Opella Business [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OPALJVCoMember" xlink:label="loc_sny_OPALJVCoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OPALJVCoMember" xml:lang="en-US">OPAL JV Co [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OPALJVCoMember" xlink:to="lab_sny_OPALJVCoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OPALJVCoMember" xml:lang="en-US">OPAL JV Co.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BpifranceMember" xlink:label="loc_sny_BpifranceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BpifranceMember" xml:lang="en-US">Bpifrance [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BpifranceMember" xlink:to="lab_sny_BpifranceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BpifranceMember" xml:lang="en-US">Bpifrance.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xml:lang="en-US">Disclosure of detailed information about business combination [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfBusinessCombinationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfBusinessCombinationsLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="lab_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="lab_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-full_NetForeignExchangeLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xml:lang="en-US">Net foreign exchange loss</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetForeignExchangeLoss" xml:lang="en-US">Net foreign exchange loss</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetForeignExchangeLoss" xlink:to="lab_ifrs-full_NetForeignExchangeLoss" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PotentialFuturePayments" xlink:label="loc_sny_PotentialFuturePayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PotentialFuturePayments" xml:lang="en-US">Potential Future Payments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PotentialFuturePayments" xml:lang="en-US">Potential Future Payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PotentialFuturePayments" xlink:to="lab_sny_PotentialFuturePayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PotentialFuturePayments" xml:lang="en-US">Potential Future Payments</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_EquityInterestsOfAcquirer" xlink:label="loc_ifrs-full_EquityInterestsOfAcquirer" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xml:lang="en-US">Equity interests of acquirer</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_EquityInterestsOfAcquirer" xml:lang="en-US">Equity interests of acquirer</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_EquityInterestsOfAcquirer" xlink:to="lab_ifrs-full_EquityInterestsOfAcquirer" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInterestsOfAcquirerPerShare" xlink:label="loc_sny_EquityInterestsOfAcquirerPerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityInterestsOfAcquirerPerShare" xml:lang="en-US">Equity Interests Of Acquirer, Per Share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityInterestsOfAcquirerPerShare" xml:lang="en-US">Equity Interests Of Acquirer, Per Share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInterestsOfAcquirerPerShare" xlink:to="lab_sny_EquityInterestsOfAcquirerPerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityInterestsOfAcquirerPerShare" xml:lang="en-US">Equity Interests Of Acquirer, Per Share</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DeferredCashPayments" xlink:label="loc_sny_DeferredCashPayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DeferredCashPayments" xml:lang="en-US">Deferred Cash Payments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DeferredCashPayments" xml:lang="en-US">Deferred Cash Payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DeferredCashPayments" xlink:to="lab_sny_DeferredCashPayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DeferredCashPayments" xml:lang="en-US">Deferred Cash Payments</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="lab_ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CashTransferredPerShare" xlink:label="loc_sny_CashTransferredPerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CashTransferredPerShare" xml:lang="en-US">Cash Transferred, Per Share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CashTransferredPerShare" xml:lang="en-US">Cash Transferred, Per Share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CashTransferredPerShare" xlink:to="lab_sny_CashTransferredPerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CashTransferredPerShare" xml:lang="en-US">Cash Transferred, Per Share</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetAssetsLiabilities" xlink:label="loc_ifrs-full_NetAssetsLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetAssetsLiabilities" xml:lang="en-US">Assets (liabilities)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetAssetsLiabilities" xml:lang="en-US">Assets (liabilities)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetAssetsLiabilities" xlink:to="lab_ifrs-full_NetAssetsLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" xml:lang="en-US">Proportion of ownership interest in associate</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInAssociate" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInAssociate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:label="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty" xml:lang="en-US">Proceeds from sales of investment property</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty" xml:lang="en-US">Proceeds from sales of investment property</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProceedsFromSalesOfInvestmentProperty" xlink:to="lab_ifrs-full_ProceedsFromSalesOfInvestmentProperty" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xml:lang="en-US">MileStone Payment Per CVR Recognised In Business Combination attainment of future development</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xml:lang="en-US">MileStone Payment Per CVR Recognised In Business Combination attainment of future development</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xlink:to="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" xml:lang="en-US">Milestone payment per CVR recognised in business combination attainment of future development.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xlink:label="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xml:lang="en-US">MileStone Payment Per CVR Recognised In Business Combination attainment of regulatory milestones</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xml:lang="en-US">MileStone Payment Per CVR Recognised In Business Combination attainment of regulatory milestones</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xlink:to="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" xml:lang="en-US">Milestone payment per CVR recognised in business combination attainment of regulatory milestones.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-full_SegmentsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentsAxis" xml:lang="en-US">Segments [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SegmentsAxis" xml:lang="en-US">Segments [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsAxis" xlink:to="lab_ifrs-full_SegmentsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentsDomain" xlink:label="loc_ifrs-full_SegmentsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentsDomain" xml:lang="en-US">Segments [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SegmentsDomain" xml:lang="en-US">Segments [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentsDomain" xlink:to="lab_ifrs-full_SegmentsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BiopharmaSegmentMember" xlink:label="loc_sny_BiopharmaSegmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BiopharmaSegmentMember" xml:lang="en-US">Biopharma Segment [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_BiopharmaSegmentMember" xml:lang="en-US">Biopharma Segment [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BiopharmaSegmentMember" xlink:to="lab_sny_BiopharmaSegmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BiopharmaSegmentMember" xml:lang="en-US">Pharmaceuticals segment.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xml:lang="en-US">Classes of property, plant and equipment [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:label="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xml:lang="en-US">Classes of property, plant and equipment [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" xlink:to="lab_ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ManufacturingAndSupplyMember" xlink:label="loc_sny_ManufacturingAndSupplyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ManufacturingAndSupplyMember" xml:lang="en-US">Manufacturing And Supply [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ManufacturingAndSupplyMember" xml:lang="en-US">Manufacturing &amp; Supply</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ManufacturingAndSupplyMember" xlink:to="lab_sny_ManufacturingAndSupplyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ManufacturingAndSupplyMember" xml:lang="en-US">Manufacturing and supply</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:label="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" xlink:to="lab_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestCostsCapitalised" xlink:label="loc_ifrs-full_InterestCostsCapitalised" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestCostsCapitalised" xml:lang="en-US">Interest costs capitalised</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InterestCostsCapitalised" xml:lang="en-US">Interest costs capitalised</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestCostsCapitalised" xlink:to="lab_ifrs-full_InterestCostsCapitalised" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:label="loc_sny_FirmOrdersOfPropertyPlantAndEquipment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xml:lang="en-US">Firm Orders Of Property Plant And Equipment</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xml:lang="en-US">Firm orders of property, plant and equipment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FirmOrdersOfPropertyPlantAndEquipment" xlink:to="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FirmOrdersOfPropertyPlantAndEquipment" xml:lang="en-US">Firm orders of property plant and equipment.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:label="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xml:lang="en-US">Classes of intangible assets other than goodwill [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" xlink:to="lab_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketedProductsMember" xlink:label="loc_sny_MarketedProductsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MarketedProductsMember" xml:lang="en-US">Marketed Products [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MarketedProductsMember" xml:lang="en-US">Marketed products</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketedProductsMember" xlink:to="lab_sny_MarketedProductsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MarketedProductsMember" xml:lang="en-US">Marketed products.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TechnologicalPlatformsMember" xlink:label="loc_sny_TechnologicalPlatformsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TechnologicalPlatformsMember" xml:lang="en-US">Technological Platforms [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_TechnologicalPlatformsMember" xml:lang="en-US">Technological platforms</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TechnologicalPlatformsMember" xlink:to="lab_sny_TechnologicalPlatformsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TechnologicalPlatformsMember" xml:lang="en-US">Technological Platforms</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesAxis" xlink:label="loc_sny_PrincipalAlliancesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PrincipalAlliancesAxis" xml:lang="en-US">Principal Alliances [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PrincipalAlliancesAxis" xml:lang="en-US">Principal Alliances [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalAlliancesAxis" xlink:to="lab_sny_PrincipalAlliancesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PrincipalAlliancesAxis" xml:lang="en-US">Principal Alliances</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PrincipalAlliancesDomain" xlink:label="loc_sny_PrincipalAlliancesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PrincipalAlliancesDomain" xml:lang="en-US">Principal Alliances [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PrincipalAlliancesDomain" xml:lang="en-US">Principal Alliances [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PrincipalAlliancesDomain" xlink:to="lab_sny_PrincipalAlliancesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PrincipalAlliancesDomain" xml:lang="en-US">Principal Alliances [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:label="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" xlink:to="lab_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Useful life measured as period of time, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Weighted average amortization period</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsTable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductsTrademarksAndOtherRightsMember" xlink:label="loc_sny_ProductsTrademarksAndOtherRightsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ProductsTrademarksAndOtherRightsMember" xml:lang="en-US">Products, Trademarks And Other Rights [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ProductsTrademarksAndOtherRightsMember" xml:lang="en-US">Products, trademarks and other rights</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProductsTrademarksAndOtherRightsMember" xlink:to="lab_sny_ProductsTrademarksAndOtherRightsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ProductsTrademarksAndOtherRightsMember" xml:lang="en-US">Products, trademarks and other rights</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AcquiredResearchAndDevelopmentMember" xlink:label="loc_sny_AcquiredResearchAndDevelopmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AcquiredResearchAndDevelopmentMember" xml:lang="en-US">Acquired Research And Development [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AcquiredResearchAndDevelopmentMember" xml:lang="en-US">Acquired R&amp;D</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AcquiredResearchAndDevelopmentMember" xlink:to="lab_sny_AcquiredResearchAndDevelopmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AcquiredResearchAndDevelopmentMember" xml:lang="en-US">Acquired Research And Development</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-full_ComputerSoftwareMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xml:lang="en-US">Computer software [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ComputerSoftwareMember" xml:lang="en-US">Software</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ComputerSoftwareMember" xlink:to="lab_ifrs-full_ComputerSoftwareMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="lab_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-full_CarryingAmountMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CarryingAmountMember" xml:lang="en-US">Carrying amount [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CarryingAmountMember" xml:lang="en-US">Carrying amount [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CarryingAmountMember" xlink:to="lab_ifrs-full_CarryingAmountMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-full_GrossCarryingAmountMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xml:lang="en-US">Gross carrying amount [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GrossCarryingAmountMember" xml:lang="en-US">Gross value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GrossCarryingAmountMember" xlink:to="lab_ifrs-full_GrossCarryingAmountMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xml:lang="en-US">Accumulated depreciation, amortisation and impairment [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xml:lang="en-US">Accumulated amortization and impairment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:label="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xml:lang="en-US">Disclosure of detailed information about intangible assets [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfIntangibleAssetsLineItems" xlink:to="lab_ifrs-full_DisclosureOfIntangibleAssetsLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Acquisitions and other increases</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Disposals and retirements, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Disposals and other decreases</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Increase (decrease) through net exchange differences, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Currency translation differences</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Increase (decrease) through transfers, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Transfers</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Impairment loss recognised in other comprehensive income, intangible assets other than goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Impairment losses, net of reversals</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" xlink:to="lab_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssets" xlink:label="loc_ifrs-full_OtherIntangibleAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIntangibleAssets" xml:lang="en-US">Other intangible assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssets" xml:lang="en-US">Other intangible assets, ending balance</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssets" xlink:to="lab_ifrs-full_OtherIntangibleAssets" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:label="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combination, Intangible Assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xml:lang="en-US">Changes in scope of consolidation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xlink:to="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" xml:lang="en-US">Change In Scope Of Consolidation Through Business Combination, Intangible Assets</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherIntangibleAssetsMember" xlink:label="loc_ifrs-full_OtherIntangibleAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xml:lang="en-US">Other intangible assets [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherIntangibleAssetsMember" xml:lang="en-US">Other intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherIntangibleAssetsMember" xlink:to="lab_ifrs-full_OtherIntangibleAssetsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesAxis" xlink:label="loc_ifrs-full_JointVenturesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_JointVenturesAxis" xml:lang="en-US">Joint ventures [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_JointVenturesAxis" xml:lang="en-US">Joint ventures [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesAxis" xlink:to="lab_ifrs-full_JointVenturesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_JointVenturesDomain" xlink:label="loc_ifrs-full_JointVenturesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_JointVenturesDomain" xml:lang="en-US">Joint ventures [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_JointVenturesDomain" xlink:to="lab_ifrs-full_JointVenturesDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfraservGmbhAndCoHochstKGMember" xlink:label="loc_sny_InfraservGmbhAndCoHochstKGMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xml:lang="en-US">Infraserv Gmbh And Co Hochst KG [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xml:lang="en-US">Infraserv GmbH &amp; Co. H&#246;chst KG</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InfraservGmbhAndCoHochstKGMember" xlink:to="lab_sny_InfraservGmbhAndCoHochstKGMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InfraservGmbhAndCoHochstKGMember" xml:lang="en-US">Infraserv GmbH and Co. Hochst KG.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSPVaccineCompanyMember" xlink:label="loc_sny_MSPVaccineCompanyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MSPVaccineCompanyMember" xml:lang="en-US">MSP Vaccine Company [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MSPVaccineCompanyMember" xml:lang="en-US">MSP Vaccine Company</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MSPVaccineCompanyMember" xlink:to="lab_sny_MSPVaccineCompanyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MSPVaccineCompanyMember" xml:lang="en-US">MSP Vaccine Company</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:label="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xml:lang="en-US">Aggregated individually immaterial associates [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xml:lang="en-US">Other investments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" xlink:to="lab_ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_LegalEntityAxis" xlink:label="loc_dei_LegalEntityAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_LegalEntityAxis" xml:lang="en-US">Legal Entity [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2025/dei-2025.xsd#dei_EntityDomain" xlink:label="loc_dei_EntityDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_dei_EntityDomain" xml:lang="en-US">Entity [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EuroapiMember" xlink:label="loc_sny_EuroapiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EuroapiMember" xml:lang="en-US">Euroapi [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EuroapiMember" xml:lang="en-US">Euroapi</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_EuroapiMember" xml:lang="en-US">EUROAPI</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EuroapiMember" xlink:to="lab_sny_EuroapiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EuroapiMember" xml:lang="en-US">Euroapi</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xml:lang="en-US">Associates [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" xml:lang="en-US">Associates [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesAxis" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:label="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" xml:lang="en-US">Associates [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" xml:lang="en-US">Entity's total for associates [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SignificantInvestmentsInAssociatesDomain" xlink:to="lab_ifrs-full_SignificantInvestmentsInAssociatesDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CDRMember" xlink:label="loc_sny_CDRMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CDRMember" xml:lang="en-US">CD&amp;R [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CDRMember" xlink:to="lab_sny_CDRMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CDRMember" xml:lang="en-US">CD&amp;R.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MCMVaccineBVMember" xlink:label="loc_sny_MCMVaccineBVMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MCMVaccineBVMember" xml:lang="en-US">MCM Vaccine BV [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MCMVaccineBVMember" xml:lang="en-US">MCM Vaccine BV</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MCMVaccineBVMember" xlink:to="lab_sny_MCMVaccineBVMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MCMVaccineBVMember" xml:lang="en-US">MCM Vaccine BV</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xml:lang="en-US">Categories of related parties [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" xml:lang="en-US">Categories of related parties [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:label="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xml:lang="en-US">Categories of related parties [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" xml:lang="en-US">Entity's total for related parties [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CategoriesOfRelatedPartiesDomain" xlink:to="lab_ifrs-full_CategoriesOfRelatedPartiesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:label="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xml:lang="en-US">Disclosure of transactions between related parties [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" xlink:to="lab_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Investments in associates accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xml:lang="en-US">Investments in associates</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xml:lang="en-US">Proportion of ownership interest in joint venture</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xml:lang="en-US">Proportion of ownership interest in joint venture</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInJointVenture" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInJointVenture" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xml:lang="en-US">Investments in joint ventures accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xml:lang="en-US">Investments in joint ventures</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockPrice" xlink:label="loc_sny_StockPrice" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_StockPrice" xml:lang="en-US">Stock Price</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_StockPrice" xml:lang="en-US">Stock price (in euro per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockPrice" xlink:to="lab_sny_StockPrice" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_StockPrice" xml:lang="en-US">Stock Price</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="lab_ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LoansToAssociates" xlink:label="loc_sny_LoansToAssociates" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LoansToAssociates" xml:lang="en-US">Loans to Associates</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LoansToAssociates" xml:lang="en-US">Loans to Associates</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LoansToAssociates" xlink:to="lab_sny_LoansToAssociates" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LoansToAssociates" xml:lang="en-US">Loans to Associates</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssociatesAndJointVenturesMember" xlink:label="loc_sny_AssociatesAndJointVenturesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xml:lang="en-US">Associates And Joint Ventures [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xml:lang="en-US">Associates and joint ventures</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssociatesAndJointVenturesMember" xlink:to="lab_sny_AssociatesAndJointVenturesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssociatesAndJointVenturesMember" xml:lang="en-US">Associates and Joint Ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xml:lang="en-US">Revenue from sale of goods, related party transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xml:lang="en-US">Sales</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" xlink:to="lab_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:label="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xml:lang="en-US">Royalties And Other Income, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xml:lang="en-US">Royalties and other income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xlink:to="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" xml:lang="en-US">Royalties and other income, related party transactions.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" xml:lang="en-US">Amounts receivable, related party transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" xml:lang="en-US">Accounts receivable and other receivables</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="lab_ifrs-full_AmountsReceivableRelatedPartyTransactions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsRelatedPartyTransactions" xlink:label="loc_sny_OtherAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherAssetsRelatedPartyTransactions" xml:lang="en-US">Other Assets, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherAssetsRelatedPartyTransactions" xml:lang="en-US">Other Assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherAssetsRelatedPartyTransactions" xlink:to="lab_sny_OtherAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherAssetsRelatedPartyTransactions" xml:lang="en-US">Other Assets, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:label="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xml:lang="en-US">Purchases of goods, related party transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xml:lang="en-US">Purchases of goods and services (including research expenses)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" xlink:to="lab_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-full_AmountsPayableRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" xml:lang="en-US">Amounts payable, related party transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" xml:lang="en-US">Amounts payable, related party transactions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="lab_ifrs-full_AmountsPayableRelatedPartyTransactions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubordinateHybridBondRelatedPartyTransactions" xlink:label="loc_sny_SubordinateHybridBondRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SubordinateHybridBondRelatedPartyTransactions" xml:lang="en-US">Subordinate Hybrid Bond, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SubordinateHybridBondRelatedPartyTransactions" xml:lang="en-US">Subordinate Hybrid Bond, Related Party Transactions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SubordinateHybridBondRelatedPartyTransactions" xlink:to="lab_sny_SubordinateHybridBondRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SubordinateHybridBondRelatedPartyTransactions" xml:lang="en-US">Subordinate Hybrid Bond, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Other Comprehensive Income, Related Party Disclosures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Other Comprehensive Income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xlink:to="lab_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Other Comprehensive Income, Related Party Disclosures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ComprehensiveIncomeRelatedPartyDisclosures" xlink:label="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Comprehensive Income, Related Party Disclosures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Comprehensive Income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ComprehensiveIncomeRelatedPartyDisclosures" xlink:to="lab_sny_ComprehensiveIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ComprehensiveIncomeRelatedPartyDisclosures" xml:lang="en-US">Comprehensive Income, Related Party Disclosures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAndLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityAndLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Equity and Liabilities, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityAndLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Total equity and liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityAndLiabilitiesRelatedPartyTransactions" xlink:to="lab_sny_EquityAndLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityAndLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Equity and Liabilities, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_CurrentAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentAssetsRelatedPartyTransactions" xml:lang="en-US">Current assets, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentAssetsRelatedPartyTransactions" xml:lang="en-US">Current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentAssetsRelatedPartyTransactions" xlink:to="lab_sny_CurrentAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentAssetsRelatedPartyTransactions" xml:lang="en-US">Current assets, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsRelatedPartyTransactions" xlink:label="loc_sny_AssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssetsRelatedPartyTransactions" xml:lang="en-US">Assets, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AssetsRelatedPartyTransactions" xml:lang="en-US">Total assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssetsRelatedPartyTransactions" xlink:to="lab_sny_AssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssetsRelatedPartyTransactions" xml:lang="en-US">Assets, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xml:lang="en-US">Equity Attributable to Equity Holders, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xml:lang="en-US">&#8194;Equity attributable to equity holders of OPAL JV Co</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xlink:to="lab_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" xml:lang="en-US">Equity Attributable to Equity Holders, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xlink:label="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xml:lang="en-US">Equity Attributable to Non Controlling Interest, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xml:lang="en-US">&#8194;Equity attributable to non-controlling interests</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xlink:to="lab_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" xml:lang="en-US">Equity Attributable to Non Controlling Interest, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRelatedPartyTransactions" xlink:label="loc_sny_EquityRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityRelatedPartyTransactions" xml:lang="en-US">Equity, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityRelatedPartyTransactions" xml:lang="en-US">Total equity</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityRelatedPartyTransactions" xlink:to="lab_sny_EquityRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityRelatedPartyTransactions" xml:lang="en-US">Equity, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Non Current Liabilities, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Non Current Liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentLiabilitiesRelatedPartyTransactions" xlink:to="lab_sny_NonCurrentLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Non Current Liabilities, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_CurrentLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Current Liabilities, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Current Liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentLiabilitiesRelatedPartyTransactions" xlink:to="lab_sny_CurrentLiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentLiabilitiesRelatedPartyTransactions" xml:lang="en-US">Current Liabilities, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesRelatedPartyTransactions" xlink:label="loc_sny_LiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LiabilitiesRelatedPartyTransactions" xml:lang="en-US">Liabilities, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LiabilitiesRelatedPartyTransactions" xml:lang="en-US">Total liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LiabilitiesRelatedPartyTransactions" xlink:to="lab_sny_LiabilitiesRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LiabilitiesRelatedPartyTransactions" xml:lang="en-US">Liabilities, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsRelatedPartyTransactions" xlink:label="loc_sny_NonCurrentAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentAssetsRelatedPartyTransactions" xml:lang="en-US">Non Current assets, Related Party Transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentAssetsRelatedPartyTransactions" xml:lang="en-US">&#8194;Non-current assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentAssetsRelatedPartyTransactions" xlink:to="lab_sny_NonCurrentAssetsRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentAssetsRelatedPartyTransactions" xml:lang="en-US">Non Current assets, Related Party Transactions</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetIncomeRelatedPartyDisclosures" xlink:label="loc_sny_NetIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetIncomeRelatedPartyDisclosures" xml:lang="en-US">Net Income, Related Party Disclosures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetIncomeRelatedPartyDisclosures" xml:lang="en-US">Net Income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetIncomeRelatedPartyDisclosures" xlink:to="lab_sny_NetIncomeRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetIncomeRelatedPartyDisclosures" xml:lang="en-US">Net Income, Related Party Disclosures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xlink:label="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xml:lang="en-US">Net Sales and Other Revenues, Related Party Disclosures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xml:lang="en-US">Net Sales and Other Revenues</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xlink:to="lab_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" xml:lang="en-US">Net Sales and Other Revenues, Related Party Disclosures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsTable" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsTable" xml:lang="en-US">Disclosure Of Other Non-Current Assets [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsTable" xml:lang="en-US">Disclosure Of Other Non-current Assets [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsTable" xlink:to="lab_sny_DisclosureOfOtherNonCurrentAssetsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsTable" xml:lang="en-US">Schedule disclosing information related to other non-current assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfAssetsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xml:lang="en-US">Classes of assets [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfAssetsAxis" xml:lang="en-US">Classes of assets [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfAssetsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfAssetsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xml:lang="en-US">Classes of assets [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfAssetsDomain" xml:lang="en-US">Assets [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfAssetsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TradingEquitySecuritiesMember" xlink:label="loc_ifrs-full_TradingEquitySecuritiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TradingEquitySecuritiesMember" xml:lang="en-US">Trading equity securities [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TradingEquitySecuritiesMember" xml:lang="en-US">Trading equity securities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TradingEquitySecuritiesMember" xlink:to="lab_ifrs-full_TradingEquitySecuritiesMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DebtSecuritiesMember" xlink:label="loc_ifrs-full_DebtSecuritiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DebtSecuritiesMember" xml:lang="en-US">Debt securities [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DebtSecuritiesMember" xml:lang="en-US">Debt securities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DebtSecuritiesMember" xlink:to="lab_ifrs-full_DebtSecuritiesMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:label="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xml:lang="en-US">Disclosure Of Other Non-Current Assets [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xml:lang="en-US">Disclosure Of Other Non Current Assets [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xlink:to="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherNonCurrentAssetsLineItems" xml:lang="en-US">Disclosure of other non-current assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:label="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xml:lang="en-US">Non-current financial assets at fair value through other comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xml:lang="en-US">Instruments at fair value through other comprehensive income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" xlink:to="lab_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:label="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xml:lang="en-US">Other Financial Assets At Fair Value Through Profit Or Loss</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xml:lang="en-US">Other financial assets at fair value through profit or loss</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xlink:to="lab_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" xml:lang="en-US">Other Financial Assets At Fair Value Through Profit Or Loss</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PreFundedPensionObligations" xlink:label="loc_sny_PreFundedPensionObligations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PreFundedPensionObligations" xml:lang="en-US">Pre-Funded Pension Obligations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PreFundedPensionObligations" xml:lang="en-US">Pre-funded pension obligations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PreFundedPensionObligations" xlink:to="lab_sny_PreFundedPensionObligations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PreFundedPensionObligations" xml:lang="en-US">Pre-funded pension obligations.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LongTermPrepaidExpenses" xlink:label="loc_sny_LongTermPrepaidExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LongTermPrepaidExpenses" xml:lang="en-US">Long Term Prepaid Expenses</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LongTermPrepaidExpenses" xml:lang="en-US">Long-term prepaid expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LongTermPrepaidExpenses" xlink:to="lab_sny_LongTermPrepaidExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LongTermPrepaidExpenses" xml:lang="en-US">Long term prepaid expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLoansAndReceivables" xlink:label="loc_sny_NonCurrentLoansAndReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentLoansAndReceivables" xml:lang="en-US">Non current loans and receivables</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentLoansAndReceivables" xml:lang="en-US">Long-term loans and advances and other non-current receivables</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentLoansAndReceivables" xlink:to="lab_sny_NonCurrentLoansAndReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentLoansAndReceivables" xml:lang="en-US">Non current loans and receivables</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:label="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xml:lang="en-US">Non-current derivative financial assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" xml:lang="en-US">Derivative financial instruments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentDerivativeFinancialAssets" xlink:to="lab_ifrs-full_NoncurrentDerivativeFinancialAssets" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableTable" xlink:label="loc_sny_DisclosureOfAccountsReceivableTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xml:lang="en-US">Disclosure Of Accounts Receivable [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xml:lang="en-US">Disclosure of Accounts Receivable [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccountsReceivableTable" xlink:to="lab_sny_DisclosureOfAccountsReceivableTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAccountsReceivableTable" xml:lang="en-US">Disclosure of Accounts receivable Table.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AccumulatedImpairmentMember" xlink:label="loc_ifrs-full_AccumulatedImpairmentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xml:lang="en-US">Accumulated impairment [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AccumulatedImpairmentMember" xml:lang="en-US">Allowances</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AccumulatedImpairmentMember" xlink:to="lab_ifrs-full_AccumulatedImpairmentMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfAccountsReceivableLineItems" xlink:label="loc_sny_DisclosureOfAccountsReceivableLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xml:lang="en-US">Disclosure Of Accounts Receivable [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xml:lang="en-US">Disclosure of Accounts Receivable [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfAccountsReceivableLineItems" xlink:to="lab_sny_DisclosureOfAccountsReceivableLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfAccountsReceivableLineItems" xml:lang="en-US">Disclosure Of Accounts Receivable [line items]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:label="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xml:lang="en-US">Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" xlink:to="lab_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerecognizedReceivables" xlink:label="loc_sny_DerecognizedReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DerecognizedReceivables" xml:lang="en-US">Derecognized Receivables</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DerecognizedReceivables" xml:lang="en-US">Derecognized receivables</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerecognizedReceivables" xlink:to="lab_sny_DerecognizedReceivables" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DerecognizedReceivables" xml:lang="en-US">Derecognized receivables.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xml:lang="en-US">Disclosure of Financial Assets that are Either Past Due or Impaired [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-full_MaturityAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityAxis" xml:lang="en-US">Maturity [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaturityAxis" xml:lang="en-US">Maturity [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityAxis" xlink:to="lab_ifrs-full_MaturityAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaturityDomain" xlink:label="loc_ifrs-full_MaturityDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaturityDomain" xml:lang="en-US">Maturity [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaturityDomain" xml:lang="en-US">Aggregated time bands [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaturityDomain" xlink:to="lab_ifrs-full_MaturityDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneMonthMember" xlink:label="loc_ifrs-full_NotLaterThanOneMonthMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneMonthMember" xml:lang="en-US">Not later than one month [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneMonthMember" xml:lang="en-US">Overdue by less than 1 month</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneMonthMember" xlink:to="lab_ifrs-full_NotLaterThanOneMonthMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:label="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xml:lang="en-US">Later than one month and not later than three months [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xml:lang="en-US">Overdue by 1-3 months</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" xlink:to="lab_ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xml:lang="en-US">Overdue by 3-6 months</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:to="lab_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xml:lang="en-US">Later than six months and not later than one year [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xml:lang="en-US">Overdue by 6-12 months</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-full_LaterThanOneYearMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xml:lang="en-US">Later than one year [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearMember" xml:lang="en-US">Overdue by &gt; 12 months</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearMember" xlink:to="lab_ifrs-full_LaterThanOneYearMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xml:lang="en-US">Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OverdueReceivablesGrossValue" xlink:label="loc_sny_OverdueReceivablesGrossValue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OverdueReceivablesGrossValue" xml:lang="en-US">Overdue Receivables Gross Value</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OverdueReceivablesGrossValue" xml:lang="en-US">Overdue receivables gross value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OverdueReceivablesGrossValue" xlink:to="lab_sny_OverdueReceivablesGrossValue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OverdueReceivablesGrossValue" xml:lang="en-US">Overdue receivables gross value.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xml:lang="en-US">Disclosure of classes of share capital [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalTable" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalTable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiMember" xlink:label="loc_sny_SanofiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SanofiMember" xml:lang="en-US">Sanofi [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SanofiMember" xml:lang="en-US">Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiMember" xlink:to="lab_sny_SanofiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SanofiMember" xml:lang="en-US">Sanofi.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramAxis" xlink:label="loc_sny_ShareProgramAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareProgramAxis" xml:lang="en-US">Share Program [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareProgramAxis" xml:lang="en-US">Share Program [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareProgramAxis" xlink:to="lab_sny_ShareProgramAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareProgramAxis" xml:lang="en-US">Share Program [Axis]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareProgramDomain" xlink:label="loc_sny_ShareProgramDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareProgramDomain" xml:lang="en-US">Share Program [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareProgramDomain" xml:lang="en-US">Share Program [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareProgramDomain" xlink:to="lab_sny_ShareProgramDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareProgramDomain" xml:lang="en-US">Share Program [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2024ProgramMember" xlink:label="loc_sny_ShareRepurchase2024ProgramMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareRepurchase2024ProgramMember" xml:lang="en-US">Share Repurchase 2024 Program [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareRepurchase2024ProgramMember" xml:lang="en-US">Share Repurchase 2024 Program</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2024ProgramMember" xlink:to="lab_sny_ShareRepurchase2024ProgramMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareRepurchase2024ProgramMember" xml:lang="en-US">Share Repurchase 2024 Program</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareRepurchase2025ProgramMember" xlink:label="loc_sny_ShareRepurchase2025ProgramMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareRepurchase2025ProgramMember" xml:lang="en-US">Share Repurchase 2025 Program [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareRepurchase2025ProgramMember" xml:lang="en-US">Share Repurchase 2025 Program</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareRepurchase2025ProgramMember" xlink:to="lab_sny_ShareRepurchase2025ProgramMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareRepurchase2025ProgramMember" xml:lang="en-US">Share Repurchase 2025 Program [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xml:lang="en-US">Types of share-based payment arrangements [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:label="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xml:lang="en-US">Types of share-based payment arrangements [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xml:lang="en-US">Stock options and other share-based payment [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" xlink:to="lab_ifrs-full_TypesOfSharebasedPaymentArrangementsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EmployeeShareOwnershipPlanMember" xlink:label="loc_sny_EmployeeShareOwnershipPlanMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EmployeeShareOwnershipPlanMember" xml:lang="en-US">Employee Share Ownership Plan [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EmployeeShareOwnershipPlanMember" xml:lang="en-US">Employees share ownership plan</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EmployeeShareOwnershipPlanMember" xlink:to="lab_sny_EmployeeShareOwnershipPlanMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EmployeeShareOwnershipPlanMember" xml:lang="en-US">Employees share ownership plan.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xml:lang="en-US">Classes of financial assets [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsAxis" xml:lang="en-US">Classes of financial assets [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfFinancialAssetsDomain" xlink:label="loc_ifrs-full_ClassesOfFinancialAssetsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xml:lang="en-US">Classes of financial assets [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfFinancialAssetsDomain" xml:lang="en-US">Financial assets, class [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfFinancialAssetsDomain" xlink:to="lab_ifrs-full_ClassesOfFinancialAssetsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForeignCurrencyTranslationMember" xlink:label="loc_sny_ForeignCurrencyTranslationMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xml:lang="en-US">Foreign Currency Translation [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xml:lang="en-US">Foreign Currency Translation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForeignCurrencyTranslationMember" xlink:to="lab_sny_ForeignCurrencyTranslationMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForeignCurrencyTranslationMember" xml:lang="en-US">Foreign Currency Translation</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xlink:label="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xml:lang="en-US">Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xlink:to="lab_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" xml:lang="en-US">Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsAxis" xlink:label="loc_ifrs-full_ReclassifiedItemsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReclassifiedItemsAxis" xml:lang="en-US">Reclassified items [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReclassifiedItemsAxis" xml:lang="en-US">Reclassified items [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassifiedItemsAxis" xlink:to="lab_ifrs-full_ReclassifiedItemsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReclassifiedItemsDomain" xlink:label="loc_ifrs-full_ReclassifiedItemsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReclassifiedItemsDomain" xml:lang="en-US">Reclassified items [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReclassifiedItemsDomain" xml:lang="en-US">Reclassified items [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReclassifiedItemsDomain" xlink:to="lab_ifrs-full_ReclassifiedItemsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items Subsequently Reclassifiable To Profit Or Loss [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items subsequently reclassifiable to profit or loss</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xlink:to="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items subsequently reclassifiable to profit or loss.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:label="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xml:lang="en-US">Disclosure of classes of share capital [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xml:lang="en-US">Disclosure of classes of share capital [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" xlink:to="lab_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-full_IssuedCapital" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IssuedCapital" xml:lang="en-US">Issued capital</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IssuedCapital" xml:lang="en-US">Share capital</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IssuedCapital" xlink:to="lab_ifrs-full_IssuedCapital" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-full_NumberOfSharesIssued" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xml:lang="en-US">Number of shares issued</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfSharesIssued" xml:lang="en-US">Number of shares (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfSharesIssued" xlink:to="lab_ifrs-full_NumberOfSharesIssued" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-full_ParValuePerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ParValuePerShare" xml:lang="en-US">Par value per share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ParValuePerShare" xml:lang="en-US">Par value per share (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ParValuePerShare" xlink:to="lab_ifrs-full_ParValuePerShare" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:label="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xml:lang="en-US">Number Of Shares Issued In Regards Of Capital Increase By Exercise Of Stock Subscription Options</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xml:lang="en-US">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xlink:to="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" xml:lang="en-US">Number of shares issued in regards of capital increase by exercise of stock subscription options.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xml:lang="en-US">Number Of Restricted Shares Vested In Regards Of Capital Increase</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xml:lang="en-US">Number of restricted shares vested (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xlink:to="lab_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" xml:lang="en-US">Number Of Restricted Shares Vested In Regards Of Capital Increase</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xml:lang="en-US">Number Of Restricted Shares Issued In Regards Of Capital Increase</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xml:lang="en-US">Capital increase by issuance of restricted shares (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xlink:to="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" xml:lang="en-US">Number of restricted shares issued in regards of capital increase.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PeriodOfShareRepurchaseProgram" xlink:label="loc_sny_PeriodOfShareRepurchaseProgram" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xml:lang="en-US">Period Of Share Repurchase Program</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xml:lang="en-US">Period of share repurchase program</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PeriodOfShareRepurchaseProgram" xlink:to="lab_sny_PeriodOfShareRepurchaseProgram" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PeriodOfShareRepurchaseProgram" xml:lang="en-US">Period of share repurchase program.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesRepurchased" xlink:label="loc_sny_NumberOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfSharesRepurchased" xml:lang="en-US">Number Of Shares Repurchased</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfSharesRepurchased" xml:lang="en-US">Number of shares repurchased (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesRepurchased" xlink:to="lab_sny_NumberOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfSharesRepurchased" xml:lang="en-US">Number of shares repurchased.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmountOfSharesRepurchased" xlink:label="loc_sny_AmountOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AmountOfSharesRepurchased" xml:lang="en-US">Amount Of Shares Repurchased</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AmountOfSharesRepurchased" xml:lang="en-US">Amount of shares repurchased</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmountOfSharesRepurchased" xlink:to="lab_sny_AmountOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AmountOfSharesRepurchased" xml:lang="en-US">Amount of shares repurchased.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SubscriptionPricePerShare" xlink:label="loc_sny_SubscriptionPricePerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SubscriptionPricePerShare" xml:lang="en-US">Subscription Price Per Share</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SubscriptionPricePerShare" xml:lang="en-US">Subscription price (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SubscriptionPricePerShare" xlink:to="lab_sny_SubscriptionPricePerShare" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SubscriptionPricePerShare" xml:lang="en-US">Subscription price per share.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesSubscribed" xlink:label="loc_sny_NumberOfSharesSubscribed" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfSharesSubscribed" xml:lang="en-US">Number Of Shares Subscribed</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfSharesSubscribed" xml:lang="en-US">Number of shares subscribed (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesSubscribed" xlink:to="lab_sny_NumberOfSharesSubscribed" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfSharesSubscribed" xml:lang="en-US">Number of shares subscribed.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:label="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xml:lang="en-US">Issuance Of Further Shares As An Employers Contribution</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xml:lang="en-US">Number of shares issued immediately for employer's contribution (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xlink:to="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IssuanceOfFurtherSharesAsAnEmployersContribution" xml:lang="en-US">Further shares as an employers contribution.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:label="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xml:lang="en-US">Expense from equity-settled share-based payment transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xml:lang="en-US">Expense recognized</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xml:lang="en-US">Total expense for restricted share plans</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" xlink:to="lab_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xlink:label="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xml:lang="en-US">Number of restricted shares alloted in regards of capital increase</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xml:lang="en-US">Number of restricted shares alloted in regards of capital increase</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xlink:to="lab_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" xml:lang="en-US">Number of restricted shares alloted in regards of capital increase</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CancellationOfTreasuryShares" xlink:label="loc_ifrs-full_CancellationOfTreasuryShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CancellationOfTreasuryShares" xml:lang="en-US">Cancellation of treasury shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CancellationOfTreasuryShares" xml:lang="en-US">Cancellation of treasury shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CancellationOfTreasuryShares" xlink:to="lab_ifrs-full_CancellationOfTreasuryShares" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PerShareValueOfSharesRepurchased" xlink:label="loc_sny_PerShareValueOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PerShareValueOfSharesRepurchased" xml:lang="en-US">Per Share Value of Shares Repurchased</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PerShareValueOfSharesRepurchased" xml:lang="en-US">Per Share Value of Shares Repurchased</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PerShareValueOfSharesRepurchased" xlink:to="lab_sny_PerShareValueOfSharesRepurchased" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PerShareValueOfSharesRepurchased" xml:lang="en-US">Per Share Value of Shares Repurchased</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfSharesHeld" xlink:label="loc_sny_NumberOfSharesHeld" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfSharesHeld" xml:lang="en-US">Number Of Shares Held</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfSharesHeld" xml:lang="en-US">Number of shares (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfSharesHeld" xlink:to="lab_sny_NumberOfSharesHeld" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfSharesHeld" xml:lang="en-US">Number of shares held.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PercentageOfShareCapitalForThePeriod" xlink:label="loc_sny_PercentageOfShareCapitalForThePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xml:lang="en-US">Percentage Of Share Capital For The Period</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xml:lang="en-US">% of share capital for the period</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageOfShareCapitalForThePeriod" xlink:to="lab_sny_PercentageOfShareCapitalForThePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PercentageOfShareCapitalForThePeriod" xml:lang="en-US">Percentage of share capital for the period.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2024Member" xlink:label="loc_sny_RestrictedSharePlan2024Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharePlan2024Member" xml:lang="en-US">Restricted Share Plan 2024 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharePlan2024Member" xml:lang="en-US">Restricted Share Plan 2024</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2024Member" xlink:to="lab_sny_RestrictedSharePlan2024Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharePlan2024Member" xml:lang="en-US">Restricted Share Plan 2024</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2025Member" xlink:label="loc_sny_RestrictedSharePlan2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharePlan2025Member" xml:lang="en-US">Restricted Share Plan 2025 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharePlan2025Member" xml:lang="en-US">Restricted Share Plan 2025</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2025Member" xlink:to="lab_sny_RestrictedSharePlan2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharePlan2025Member" xml:lang="en-US">Restricted Share Plan 2025 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionAxis" xlink:label="loc_sny_MarketConditionAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MarketConditionAxis" xml:lang="en-US">Market Condition [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MarketConditionAxis" xml:lang="en-US">Market Condition [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketConditionAxis" xlink:to="lab_sny_MarketConditionAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MarketConditionAxis" xml:lang="en-US">Market Condition</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MarketConditionDomain" xlink:label="loc_sny_MarketConditionDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MarketConditionDomain" xml:lang="en-US">Market Condition [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MarketConditionDomain" xml:lang="en-US">Market Condition [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MarketConditionDomain" xlink:to="lab_sny_MarketConditionDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MarketConditionDomain" xml:lang="en-US">Market Condition [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithoutMarketConditionMember" xlink:label="loc_sny_WithoutMarketConditionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_WithoutMarketConditionMember" xml:lang="en-US">Without Market Condition [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_WithoutMarketConditionMember" xml:lang="en-US">Without market condition</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WithoutMarketConditionMember" xlink:to="lab_sny_WithoutMarketConditionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_WithoutMarketConditionMember" xml:lang="en-US">Without Market Condition</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_WithMarketConditionMember" xlink:label="loc_sny_WithMarketConditionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_WithMarketConditionMember" xml:lang="en-US">With Market Condition [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_WithMarketConditionMember" xml:lang="en-US">With market condition</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_WithMarketConditionMember" xlink:to="lab_sny_WithMarketConditionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_WithMarketConditionMember" xml:lang="en-US">With Market Condition</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualAxis" xlink:label="loc_srt_TitleOfIndividualAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualAxis" xml:lang="en-US">Title and Position [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_TitleOfIndividualAxis" xml:lang="en-US">Title and Position [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title and Position [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xml:lang="en-US">Title and Position [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExcludingChiefExecutiveOfficerMember" xlink:label="loc_sny_ExcludingChiefExecutiveOfficerMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExcludingChiefExecutiveOfficerMember" xml:lang="en-US">Excluding Chief Executive Officer [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExcludingChiefExecutiveOfficerMember" xml:lang="en-US">Excluding General Director</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExcludingChiefExecutiveOfficerMember" xlink:to="lab_sny_ExcludingChiefExecutiveOfficerMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExcludingChiefExecutiveOfficerMember" xml:lang="en-US">Excluding Chief Executive Officer</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ChiefExecutiveOfficerMember" xlink:label="loc_srt_ChiefExecutiveOfficerMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xml:lang="en-US">Chief Executive Officer</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:label="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xml:lang="en-US">Number of other equity instruments granted in share-based payment arrangement</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xml:lang="en-US">Total number of shares awarded (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" xlink:to="lab_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:label="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xml:lang="en-US">Fair Value Per Share Awarded For Three Year Service Period</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xml:lang="en-US">Fair value per share awarded (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xlink:to="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FairValuePerShareAwardedForThreeYearServicePeriod" xml:lang="en-US">Fair value per share awarded to a three year service period.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FairValueOfPlanAtDateOfGrant" xlink:label="loc_sny_FairValueOfPlanAtDateOfGrant" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xml:lang="en-US">Fair Value Of Plan At Date Of Grant</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xml:lang="en-US">Fair value of plan at the date of grant</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FairValueOfPlanAtDateOfGrant" xlink:to="lab_sny_FairValueOfPlanAtDateOfGrant" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FairValueOfPlanAtDateOfGrant" xml:lang="en-US">Fair value of plan at the date of grant.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfYearsServicePeriod" xlink:label="loc_sny_NumberOfYearsServicePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfYearsServicePeriod" xml:lang="en-US">Number Of Years, Service Period</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfYearsServicePeriod" xml:lang="en-US">Service period</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfYearsServicePeriod" xlink:to="lab_sny_NumberOfYearsServicePeriod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfYearsServicePeriod" xml:lang="en-US">Number Of Years, Service Period</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharesMember" xlink:label="loc_sny_RestrictedSharesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharesMember" xml:lang="en-US">Restricted Shares [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharesMember" xml:lang="en-US">Restricted shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharesMember" xlink:to="lab_sny_RestrictedSharesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharesMember" xml:lang="en-US">Restricted shares.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2023Member" xlink:label="loc_sny_RestrictedSharePlan2023Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharePlan2023Member" xml:lang="en-US">Restricted Share Plan 2023 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharePlan2023Member" xml:lang="en-US">Restricted share plan 2023</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2023Member" xlink:to="lab_sny_RestrictedSharePlan2023Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharePlan2023Member" xml:lang="en-US">Restricted Share Plan 2023</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2022Member" xlink:label="loc_sny_RestrictedSharePlan2022Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharePlan2022Member" xml:lang="en-US">Restricted Share Plan 2022 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharePlan2022Member" xml:lang="en-US">Restricted share plan 2022</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2022Member" xlink:to="lab_sny_RestrictedSharePlan2022Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharePlan2022Member" xml:lang="en-US">Restricted Share Plan 2022</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RestrictedSharePlan2021Member" xlink:label="loc_sny_RestrictedSharePlan2021Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RestrictedSharePlan2021Member" xml:lang="en-US">Restricted Share Plan 2021 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RestrictedSharePlan2021Member" xml:lang="en-US">Restricted share plan 2021</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RestrictedSharePlan2021Member" xlink:to="lab_sny_RestrictedSharePlan2021Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RestrictedSharePlan2021Member" xml:lang="en-US">Restricted Share Plan 2021</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:label="loc_sny_NumberOfRestrictedSharesNotYetFullyVested" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xml:lang="en-US">Number Of Restricted Shares Not Yet Fully Vested</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xml:lang="en-US">Number of shares not yet fully vested</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfRestrictedSharesNotYetFullyVested" xlink:to="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfRestrictedSharesNotYetFullyVested" xml:lang="en-US">Number of restricted shares not yet fully vested.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-full_RangeAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeAxis" xml:lang="en-US">Range [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangeAxis" xml:lang="en-US">Range [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeAxis" xlink:to="lab_ifrs-full_RangeAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangeDomain" xlink:label="loc_ifrs-full_RangeDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangeDomain" xml:lang="en-US">Range [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangeDomain" xml:lang="en-US">Ranges [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangeDomain" xlink:to="lab_ifrs-full_RangeDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-full_BottomOfRangeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BottomOfRangeMember" xml:lang="en-US">Bottom of range [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BottomOfRangeMember" xml:lang="en-US">Bottom of range</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BottomOfRangeMember" xlink:to="lab_ifrs-full_BottomOfRangeMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-full_TopOfRangeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TopOfRangeMember" xml:lang="en-US">Top of range [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TopOfRangeMember" xml:lang="en-US">Top of range</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TopOfRangeMember" xlink:to="lab_ifrs-full_TopOfRangeMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xml:lang="en-US">Ranges of exercise prices for outstanding share options [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:label="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xml:lang="en-US">Ranges of exercise prices for outstanding share options [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xml:lang="en-US">Ranges of exercise prices for outstanding share options [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" xlink:to="lab_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeTwoMember" xlink:label="loc_sny_ExercisePriceRangeTwoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xml:lang="en-US">From &#8364;60.00 to &#8364;70.00 per share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeTwoMember" xlink:to="lab_sny_ExercisePriceRangeTwoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExercisePriceRangeTwoMember" xml:lang="en-US">Exercise Price Range Two [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeThreeMember" xlink:label="loc_sny_ExercisePriceRangeThreeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xml:lang="en-US">From &#8364;70.00 to &#8364;80.00 per share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeThreeMember" xlink:to="lab_sny_ExercisePriceRangeThreeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExercisePriceRangeThreeMember" xml:lang="en-US">Exercise Price Range Three [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExercisePriceRangeFourMember" xlink:label="loc_sny_ExercisePriceRangeFourMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExercisePriceRangeFourMember" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExercisePriceRangeFourMember" xml:lang="en-US">From &#8364;80.00 to &#8364;90.00 per share</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExercisePriceRangeFourMember" xlink:to="lab_sny_ExercisePriceRangeFourMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExercisePriceRangeFourMember" xml:lang="en-US">Exercise Price Range Four [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_StockOptionPlanMember" xlink:label="loc_sny_StockOptionPlanMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_StockOptionPlanMember" xml:lang="en-US">Stock Option Plan [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_StockOptionPlanMember" xml:lang="en-US">Stock Option Plan</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_StockOptionPlanMember" xlink:to="lab_sny_StockOptionPlanMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_StockOptionPlanMember" xml:lang="en-US">Stock Option Plan [member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:label="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" xlink:to="lab_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xml:lang="en-US">Exercise price of outstanding share options</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xml:lang="en-US">Exercise price of outstanding options (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_ExercisePriceOfOutstandingShareOptions2019" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-full_NumberOfOutstandingShareOptions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_NumberOfOutstandingShareOptions" xml:lang="en-US">Outstanding, number&#160;of options (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfOutstandingShareOptions" xlink:to="lab_ifrs-full_NumberOfOutstandingShareOptions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:label="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xml:lang="en-US">Weighted average remaining contractual life of outstanding share options</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xml:lang="en-US">Weighted average residual life (years)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" xlink:to="lab_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:label="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xml:lang="en-US">Number of share options exercisable in share-based payment arrangement</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xml:lang="en-US">Exercisable, number of options (in shares)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" xlink:to="lab_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise price of share options exercisable in share-based payment arrangement</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xml:lang="en-US">Weighted average exercise&#160;price per share, options exercisable (in euros per share)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" xlink:to="lab_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xml:lang="en-US">Dilutive effect of share options on weighted average number of ordinary shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xml:lang="en-US">Adjustment for stock options with dilutive effect</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="lab_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:label="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xml:lang="en-US">Dilutive Effect Of Share Options On Number Of Restricted Shares</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xml:lang="en-US">Adjustment for restricted shares</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xlink:to="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" xml:lang="en-US">Dilutive effect of share options on number of restricted shares.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:label="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items Not Subsequently Reclassifiable To Profit Or Loss [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xlink:to="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" xml:lang="en-US">Items not subsequently reclassifiable to profit or loss.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityInstrumentsIncludedInFinancialAssetsMember" xlink:label="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetsMember" xml:lang="en-US">Equity Instruments Included In Financial Assets [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetsMember" xml:lang="en-US">Equity instruments included in financial assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityInstrumentsIncludedInFinancialAssetsMember" xlink:to="lab_sny_EquityInstrumentsIncludedInFinancialAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityInstrumentsIncludedInFinancialAssetsMember" xml:lang="en-US">Equity Instruments Included In Financial Assets[member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentsMember" xlink:label="loc_sny_DebtInstrumentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DebtInstrumentsMember" xml:lang="en-US">Debt Instruments [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DebtInstrumentsMember" xml:lang="en-US">Debt instruments included in financial assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentsMember" xlink:to="lab_sny_DebtInstrumentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DebtInstrumentsMember" xml:lang="en-US">Debt Instruments.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xml:lang="en-US">Disclosure of analysis of other comprehensive income by item [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xml:lang="en-US">Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xml:lang="en-US">Actuarial gains/(losses) excluding investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xml:lang="en-US">Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Equity Investments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xlink:to="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" xml:lang="en-US">Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Equity Investments</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:label="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xml:lang="en-US">Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xml:lang="en-US">Change in fair value (investments accounted for using the equity method, net of taxes)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xlink:to="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" xml:lang="en-US">Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:label="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xml:lang="en-US">Equity Risk Hedging Instruments Designated At Fair Value Hedges</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xml:lang="en-US">Equity risk hedging instruments designated as fair value hedges</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xlink:to="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" xml:lang="en-US">Equity Risk Hedging Instruments Designated At Fair Value Hedges</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xlink:to="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Debt Instrument Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xml:lang="en-US">Change in fair value (investments accounted for using the equity method, net of taxes)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Debt Instrument Associates And Joint Ventures</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xlink:label="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Equity Investments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xlink:to="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" xml:lang="en-US">Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Equity Investments</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xml:lang="en-US">Change in fair value (excluding investments accounted for using the equity method)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" xml:lang="en-US">Change in fair value on cash flow hedges excluding associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Change In Fair Value On Cash Flow Hedges Net Of Tax On Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Change in fair value (investments accounted for using the equity method, net of taxes)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Change in fair value on cash flow hedges net of tax on associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:label="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xml:lang="en-US">Income tax relating to cash flow hedges included in other comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" xlink:to="lab_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xml:lang="en-US">Change In Currency Translation Before Tax Excluding Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xml:lang="en-US">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" xml:lang="en-US">Change in currency translation before tax excluding associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:label="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Change In Currency Translation Net Of Tax On Associates And Joint Ventures</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Currency translation differences (investments accounted for using the equity method)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xlink:to="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" xml:lang="en-US">Change in currency translation net of tax on associates and joint ventures.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:label="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xml:lang="en-US">Change In Currency Translation On Hedges Of Net Investments In Foreign Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xml:lang="en-US">Hedges of net investments in foreign operations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xlink:to="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" xml:lang="en-US">Change in currency translation on hedges of net investments in foreign operations.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:label="loc_sny_ChangeInCurrencyTranslationOnTaxEffects" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xml:lang="en-US">Change In Currency Translation On Tax Effects</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xml:lang="en-US">Tax effects</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangeInCurrencyTranslationOnTaxEffects" xlink:to="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangeInCurrencyTranslationOnTaxEffects" xml:lang="en-US">Change in currency translation on tax effects.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xml:lang="en-US">Interest Rate And Currency Derivatives Used To Manage Debt</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xml:lang="en-US">Interest rate and currency derivatives used to manage debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" xml:lang="en-US">Interest rate and currency derivatives used to manage debt.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Borrowings" xlink:label="loc_ifrs-full_Borrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Borrowings" xml:lang="en-US">Borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_Borrowings" xml:lang="en-US">Total debt</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_Borrowings" xml:lang="en-US">Market value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Borrowings" xlink:to="lab_ifrs-full_Borrowings" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xml:lang="en-US">Interest Rate And Currency Derivatives Used To Manage Cash And Cash Equivalent</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xml:lang="en-US">Interest rate and currency derivatives used to manage cash and cash equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" xml:lang="en-US">Interest rate and currency derivatives used to manage cash and cash equivalent.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_DebtNetOfCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xml:lang="en-US">Debt Net Of Cash And Cash Equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xml:lang="en-US">Net debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtNetOfCashAndCashEquivalents" xlink:to="lab_sny_DebtNetOfCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DebtNetOfCashAndCashEquivalents" xml:lang="en-US">Debt net of cash and cash equivalents.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-full_LeaseLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LeaseLiabilities" xml:lang="en-US">Lease liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LeaseLiabilities" xml:lang="en-US">Lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LeaseLiabilities" xlink:to="lab_ifrs-full_LeaseLiabilities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [table]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-full_MeasurementAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MeasurementAxis" xml:lang="en-US">Measurement [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MeasurementAxis" xml:lang="en-US">Measurement [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementAxis" xlink:to="lab_ifrs-full_MeasurementAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MeasurementDomain" xlink:label="loc_ifrs-full_MeasurementDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MeasurementDomain" xml:lang="en-US">Measurement [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MeasurementDomain" xml:lang="en-US">Aggregated measurement [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MeasurementDomain" xlink:to="lab_ifrs-full_MeasurementDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizedCostNettingMember" xlink:label="loc_sny_AmortizedCostNettingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AmortizedCostNettingMember" xml:lang="en-US">Amortized Cost, Netting [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AmortizedCostNettingMember" xml:lang="en-US">Amortized cost</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmortizedCostNettingMember" xlink:to="lab_sny_AmortizedCostNettingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AmortizedCostNettingMember" xml:lang="en-US">Amortized cost.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:label="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xml:lang="en-US">Adjustment To Debt Measured At Fair Value [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xml:lang="en-US">Adjustment to debt measured at fair value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AdjustmentToDebtMeasuredAtFairValueMember" xlink:to="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AdjustmentToDebtMeasuredAtFairValueMember" xml:lang="en-US">Adjustment to debt measured at fair value.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOnRedemptionMember" xlink:label="loc_sny_ValueOnRedemptionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ValueOnRedemptionMember" xml:lang="en-US">Value On Redemption [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ValueOnRedemptionMember" xml:lang="en-US">Value on redemption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOnRedemptionMember" xlink:to="lab_sny_ValueOnRedemptionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ValueOnRedemptionMember" xml:lang="en-US">Value on redemption.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:label="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xml:lang="en-US">Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xlink:to="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" xml:lang="en-US">Disclosure of reconciliation of carrying amount to value on redemption.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesAxis" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis" xml:lang="en-US">Assets and liabilities [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesAxis" xml:lang="en-US">Assets and liabilities [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesAxis" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AssetsAndLiabilitiesDomain" xlink:label="loc_ifrs-full_AssetsAndLiabilitiesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesDomain" xml:lang="en-US">Assets and liabilities [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AssetsAndLiabilitiesDomain" xml:lang="en-US">Assets and liabilities [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AssetsAndLiabilitiesDomain" xlink:to="lab_ifrs-full_AssetsAndLiabilitiesDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentLiabilitiesMember" xlink:label="loc_sny_NonCurrentLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentLiabilitiesMember" xml:lang="en-US">Non-Current Liabilities [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentLiabilitiesMember" xml:lang="en-US">non-current</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentLiabilitiesMember" xlink:to="lab_sny_NonCurrentLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentLiabilitiesMember" xml:lang="en-US">Non-current liabilities.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentLiabilitiesMember" xlink:label="loc_sny_CurrentLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentLiabilitiesMember" xml:lang="en-US">Current Liabilities [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentLiabilitiesMember" xml:lang="en-US">current</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentLiabilitiesMember" xlink:to="lab_sny_CurrentLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentLiabilitiesMember" xml:lang="en-US">Current liabilities.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentAssetsMember" xlink:label="loc_sny_NonCurrentAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentAssetsMember" xml:lang="en-US">Non-Current Assets [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentAssetsMember" xml:lang="en-US">non-current</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentAssetsMember" xlink:to="lab_sny_NonCurrentAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentAssetsMember" xml:lang="en-US">Non-current assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentAssetsMember" xlink:label="loc_sny_CurrentAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentAssetsMember" xml:lang="en-US">Current Assets [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentAssetsMember" xml:lang="en-US">current</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentAssetsMember" xlink:to="lab_sny_CurrentAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentAssetsMember" xml:lang="en-US">Current assets.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercialPaperProgramInFranceMember" xlink:label="loc_sny_CommercialPaperProgramInFranceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xml:lang="en-US">Commercial Paper Program In France [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xml:lang="en-US">Commercial paper program in France</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercialPaperProgramInFranceMember" xlink:to="lab_sny_CommercialPaperProgramInFranceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CommercialPaperProgramInFranceMember" xml:lang="en-US">Commercial paper program In France.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BondsIssued" xlink:label="loc_ifrs-full_BondsIssued" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BondsIssued" xml:lang="en-US">Bonds issued</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BondsIssued" xml:lang="en-US">Bond issues</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BondsIssued" xlink:to="lab_ifrs-full_BondsIssued" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherBankBorrowings" xlink:label="loc_sny_OtherBankBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherBankBorrowings" xml:lang="en-US">Other Bank Borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherBankBorrowings" xml:lang="en-US">Other bank borrowings</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherBankBorrowings" xlink:to="lab_sny_OtherBankBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherBankBorrowings" xml:lang="en-US">Other bank borrowings.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherBorrowings" xlink:label="loc_ifrs-full_OtherBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherBorrowings" xml:lang="en-US">Other borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherBorrowings" xml:lang="en-US">Other borrowings</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherBorrowings" xlink:to="lab_ifrs-full_OtherBorrowings" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:label="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xml:lang="en-US">Bank overdrafts</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xml:lang="en-US">Bank credit balances</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" xlink:to="lab_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingDecember2027Member" xlink:label="loc_sny_FourBillionFacilityMaturingDecember2027Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FourBillionFacilityMaturingDecember2027Member" xml:lang="en-US">Four Billion Facility Maturing December 2027 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FourBillionFacilityMaturingDecember2027Member" xml:lang="en-US">Four Billion Facility Maturing December 2027</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FourBillionFacilityMaturingDecember2027Member" xlink:to="lab_sny_FourBillionFacilityMaturingDecember2027Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FourBillionFacilityMaturingDecember2027Member" xml:lang="en-US">Four Billion Facility Maturing December 2027 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FourBillionFacilityMaturingMarch2030Member" xlink:label="loc_sny_FourBillionFacilityMaturingMarch2030Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FourBillionFacilityMaturingMarch2030Member" xml:lang="en-US">Four Billion Facility Maturing March 2030 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FourBillionFacilityMaturingMarch2030Member" xml:lang="en-US">Four Billion Facility Maturing March 2030</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FourBillionFacilityMaturingMarch2030Member" xlink:to="lab_sny_FourBillionFacilityMaturingMarch2030Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FourBillionFacilityMaturingMarch2030Member" xml:lang="en-US">Four Billion Facility Maturing March 2030 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2020Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2020Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondIssueFromApril2020Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2020 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondIssueFromApril2020Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2020</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondIssueFromApril2020Member" xlink:to="lab_sny_FixedRateBondIssueFromApril2020Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondIssueFromApril2020Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2020 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondIssueFromApril2022Member" xlink:label="loc_sny_FixedRateBondIssueFromApril2022Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondIssueFromApril2022Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2022 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondIssueFromApril2022Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2022</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondIssueFromApril2022Member" xlink:to="lab_sny_FixedRateBondIssueFromApril2022Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondIssueFromApril2022Member" xml:lang="en-US">Fixed Rate Bond Issue from April 2022 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In March 2025 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In March 2025</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xlink:to="lab_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In March 2025 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2027Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2027Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondMaturingMarch2027Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2027 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondMaturingMarch2027Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2027</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondMaturingMarch2027Member" xlink:to="lab_sny_FixedRateBondMaturingMarch2027Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondMaturingMarch2027Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2027 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2031Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2031Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondMaturingMarch2031Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2031 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondMaturingMarch2031Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2031</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondMaturingMarch2031Member" xlink:to="lab_sny_FixedRateBondMaturingMarch2031Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondMaturingMarch2031Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2031 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingJune2029Member" xlink:label="loc_sny_FixedRateBondMaturingJune2029Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondMaturingJune2029Member" xml:lang="en-US">Fixed Rate Bond Maturing June 2029 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondMaturingJune2029Member" xml:lang="en-US">Fixed Rate Bond Maturing June 2029</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondMaturingJune2029Member" xlink:to="lab_sny_FixedRateBondMaturingJune2029Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondMaturingJune2029Member" xml:lang="en-US">Fixed Rate Bond Maturing June 2029 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_FixedRateBondMaturingMarch2032Member" xlink:label="loc_sny_FixedRateBondMaturingMarch2032Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_FixedRateBondMaturingMarch2032Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2032 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_FixedRateBondMaturingMarch2032Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2032</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_FixedRateBondMaturingMarch2032Member" xlink:to="lab_sny_FixedRateBondMaturingMarch2032Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_FixedRateBondMaturingMarch2032Member" xml:lang="en-US">Fixed Rate Bond Maturing March 2032 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xlink:label="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In June 2025 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In June 2025</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xlink:to="lab_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" xml:lang="en-US">One Billion Five Hundred Million Bonds, Issued In June 2025 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentAxis" xlink:label="loc_sny_DebtInstrumentAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentAxis" xlink:to="lab_sny_DebtInstrumentAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DebtInstrumentAxis" xml:lang="en-US">Debt Instrument</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DebtInstrumentDomain" xlink:label="loc_sny_DebtInstrumentDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DebtInstrumentDomain" xml:lang="en-US">Debt Instrument [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DebtInstrumentDomain" xml:lang="en-US">Debt Instrument [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DebtInstrumentDomain" xlink:to="lab_sny_DebtInstrumentDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DebtInstrumentDomain" xml:lang="en-US">Debt Instrument [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SanofiEuroMediumTermNotesMember" xlink:label="loc_sny_SanofiEuroMediumTermNotesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xml:lang="en-US">Sanofi Euro Medium Term Notes [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xml:lang="en-US">Sanofi Euro Medium Term Notes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SanofiEuroMediumTermNotesMember" xlink:to="lab_sny_SanofiEuroMediumTermNotesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SanofiEuroMediumTermNotesMember" xml:lang="en-US">Sanofi Euro Medium Term Notes</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-full_NotionalAmount" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotionalAmount" xml:lang="en-US">Notional amount</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotionalAmount" xml:lang="en-US">Notional amount</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotionalAmount" xlink:to="lab_ifrs-full_NotionalAmount" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommercialPapersIssued" xlink:label="loc_ifrs-full_CommercialPapersIssued" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CommercialPapersIssued" xml:lang="en-US">Commercial papers issued</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CommercialPapersIssued" xml:lang="en-US">Commercial paper programs</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommercialPapersIssued" xlink:to="lab_ifrs-full_CommercialPapersIssued" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BorrowingAverageDrawdown" xlink:label="loc_sny_BorrowingAverageDrawdown" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BorrowingAverageDrawdown" xml:lang="en-US">Borrowing, Average Drawdown</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_BorrowingAverageDrawdown" xml:lang="en-US">Borrowing, average drawdown</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BorrowingAverageDrawdown" xlink:to="lab_sny_BorrowingAverageDrawdown" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BorrowingAverageDrawdown" xml:lang="en-US">Borrowing, Average Drawdown</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfTranches" xlink:label="loc_sny_NumberOfTranches" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfTranches" xml:lang="en-US">Number Of Tranches</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfTranches" xml:lang="en-US">Number Of Tranches</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfTranches" xlink:to="lab_sny_NumberOfTranches" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfTranches" xml:lang="en-US">Number Of Tranches</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtMarketValueMember" xlink:label="loc_sny_AtMarketValueMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AtMarketValueMember" xml:lang="en-US">At Market Value [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AtMarketValueMember" xml:lang="en-US">Market value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AtMarketValueMember" xlink:to="lab_sny_AtMarketValueMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AtMarketValueMember" xml:lang="en-US">At market value.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RedemptionOfDebtInstrumentIssued" xlink:label="loc_sny_RedemptionOfDebtInstrumentIssued" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xml:lang="en-US">Redemption Of Debt Instrument Issued</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xml:lang="en-US">Value on redemption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RedemptionOfDebtInstrumentIssued" xlink:to="lab_sny_RedemptionOfDebtInstrumentIssued" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RedemptionOfDebtInstrumentIssued" xml:lang="en-US">Redemption of debt instrument issued.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xml:lang="en-US">Disclosure of information about credit exposures designated as measured at fair value through profit or loss [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xml:lang="en-US">Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AtFairValueMember" xlink:label="loc_ifrs-full_AtFairValueMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AtFairValueMember" xml:lang="en-US">At fair value [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AtFairValueMember" xml:lang="en-US">Fair value</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AtFairValueMember" xlink:to="lab_ifrs-full_AtFairValueMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AtNotionalAmountMember" xlink:label="loc_sny_AtNotionalAmountMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AtNotionalAmountMember" xml:lang="en-US">At Notional Amount [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AtNotionalAmountMember" xml:lang="en-US">Notional amount</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AtNotionalAmountMember" xlink:to="lab_sny_AtNotionalAmountMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AtNotionalAmountMember" xml:lang="en-US">At notional amount.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ValueOfHedgeRecognizedInEquityMember" xlink:label="loc_sny_ValueOfHedgeRecognizedInEquityMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xml:lang="en-US">Value Of Hedge Recognized In Equity [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xml:lang="en-US">Value of hedge recognized in equity</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ValueOfHedgeRecognizedInEquityMember" xlink:to="lab_sny_ValueOfHedgeRecognizedInEquityMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ValueOfHedgeRecognizedInEquityMember" xml:lang="en-US">Value Of Hedge Recognized In Equity [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesAxis" xlink:label="loc_ifrs-full_TypesOfHedgesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xml:lang="en-US">Types of hedges [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfHedgesAxis" xml:lang="en-US">Types of Hedges [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesAxis" xlink:to="lab_ifrs-full_TypesOfHedgesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfHedgesDomain" xlink:label="loc_ifrs-full_TypesOfHedgesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfHedgesDomain" xml:lang="en-US">Types of hedges [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfHedgesDomain" xml:lang="en-US">Hedges [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfHedgesDomain" xlink:to="lab_ifrs-full_TypesOfHedgesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CashFlowHedgesMember" xlink:label="loc_ifrs-full_CashFlowHedgesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CashFlowHedgesMember" xml:lang="en-US">Cash flow hedges [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CashFlowHedgesMember" xml:lang="en-US">Cash flow hedges</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CashFlowHedgesMember" xlink:to="lab_ifrs-full_CashFlowHedgesMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NotEligibleForHedgeAccountingMember" xlink:label="loc_sny_NotEligibleForHedgeAccountingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xml:lang="en-US">Not Eligible For Hedge Accounting [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xml:lang="en-US">Not eligible for hedge accounting</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NotEligibleForHedgeAccountingMember" xlink:to="lab_sny_NotEligibleForHedgeAccountingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NotEligibleForHedgeAccountingMember" xml:lang="en-US">Not eligible for hedge accounting.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsAxis" xlink:label="loc_ifrs-full_HedgingInstrumentsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xml:lang="en-US">Hedging instruments [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_HedgingInstrumentsAxis" xml:lang="en-US">Hedging Instruments [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsAxis" xlink:to="lab_ifrs-full_HedgingInstrumentsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgingInstrumentsDomain" xlink:label="loc_ifrs-full_HedgingInstrumentsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_HedgingInstrumentsDomain" xml:lang="en-US">Hedging instruments [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_HedgingInstrumentsDomain" xml:lang="en-US">Hedging instruments [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgingInstrumentsDomain" xlink:to="lab_ifrs-full_HedgingInstrumentsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesMember" xlink:label="loc_sny_ForwardCurrencySalesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesMember" xml:lang="en-US">Forward Currency Sales [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesMember" xml:lang="en-US">Forward currency sales</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesMember" xlink:to="lab_sny_ForwardCurrencySalesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesMember" xml:lang="en-US">Forward currency sales.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xml:lang="en-US">Forward Currency Sales In US Dollar [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xml:lang="en-US">Forward currency sales in US dollar</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInUSDollarMember" xlink:to="lab_sny_ForwardCurrencySalesInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesInUSDollarMember" xml:lang="en-US">Forward currency sales in USD.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xml:lang="en-US">Forward Currency Sales In Chinese Yuan Renminbi [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xml:lang="en-US">Forward currency sales in Chinese yuan renminbi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xlink:to="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesInChineseYuanRenminbiMember" xml:lang="en-US">Forward currency sales in Chinese Yuan Renminbi.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInJapaneseYenMember" xlink:label="loc_sny_ForwardCurrencySalesInJapaneseYenMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xml:lang="en-US">Forward Currency Sales In Japanese Yen [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xml:lang="en-US">Forward currency sales in Japanese yen</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInJapaneseYenMember" xlink:to="lab_sny_ForwardCurrencySalesInJapaneseYenMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesInJapaneseYenMember" xml:lang="en-US">Forward currency sales in Japanese Yen.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencySalesInSingaporeDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xml:lang="en-US">Forward Currency Sales In Singapore Dollar [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xml:lang="en-US">Forward currency sales in Singapore dollar</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInSingaporeDollarMember" xlink:to="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesInSingaporeDollarMember" xml:lang="en-US">Forward currency sales in Singapore Dollar.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencySalesInPoundSterlingMember" xlink:label="loc_sny_ForwardCurrencySalesInPoundSterlingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xml:lang="en-US">Forward Currency Sales In Pound Sterling [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xml:lang="en-US">Forward currency sales in Pound sterling</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencySalesInPoundSterlingMember" xlink:to="lab_sny_ForwardCurrencySalesInPoundSterlingMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencySalesInPoundSterlingMember" xml:lang="en-US">Forward Currency Sales In Pound Sterling</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesMember" xlink:label="loc_sny_ForwardCurrencyPurchasesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xml:lang="en-US">Forward Currency Purchases [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xml:lang="en-US">Forward currency purchases</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesMember" xlink:to="lab_sny_ForwardCurrencyPurchasesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesMember" xml:lang="en-US">Forward currency purchases.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarMember" xml:lang="en-US">Forward Currency Purchases In US Dollar [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarMember" xml:lang="en-US">Forward currency purchases in US dollar</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInUSDollarMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarMember" xml:lang="en-US">Forward currency purchases in USD.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xml:lang="en-US">Forward Currency Purchases In Singapore Dollar [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xml:lang="en-US">Forward currency purchases in Singapore dollar</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInSingaporeDollarMember" xml:lang="en-US">Forward currency purchases in Singapore Dollar.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xml:lang="en-US">Forward Currency Purchases In United Arab Emirates Dirham [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xml:lang="en-US">Forward Currency Purchases In United Arab Emirates Dirham</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xml:lang="en-US">Forward Currency Purchases In Chinese Yuan Renminbi [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xml:lang="en-US">Forward currency purchases in Chinese yuan renminbi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" xml:lang="en-US">Forward Currency Purchases In Chinese Yuan Renminbi</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInTurkishLiraMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInTurkishLiraMember" xml:lang="en-US">Forward Currency Purchases In Turkish lira [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInTurkishLiraMember" xml:lang="en-US">Forward Currency Purchases In Turkish lira</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInTurkishLiraMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInTurkishLiraMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInTurkishLiraMember" xml:lang="en-US">Forward Currency Purchases In Turkish lira</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xml:lang="en-US">Disclosure of information about credit exposures designated as measured at fair value through profit or loss [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xml:lang="en-US">Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstruments" xlink:label="loc_sny_DerivativeFinancialInstruments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DerivativeFinancialInstruments" xml:lang="en-US">Derivative Financial Instruments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DerivativeFinancialInstruments" xml:lang="en-US">Operating currency hedging instruments in place</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialInstruments" xlink:to="lab_sny_DerivativeFinancialInstruments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DerivativeFinancialInstruments" xml:lang="en-US">Derivative financial instrument</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xml:lang="en-US">Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xml:lang="en-US">Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xml:lang="en-US">Forward Currency Purchases In Hungarian florint [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xml:lang="en-US">Forward Currency Purchases In Hungarian florint</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInHungarianFlorintMember" xml:lang="en-US">Forward Currency Purchases In Hungarian florint</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xlink:label="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xml:lang="en-US">Forward Currency Purchases In US Dollar, US Bond [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xml:lang="en-US">Forward currency purchases in US dollar, US bond</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xlink:to="lab_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" xml:lang="en-US">Forward Currency Purchases In US Dollar, US Bond</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2029Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2029Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CrossCurrencySwapExpiring2029Member" xml:lang="en-US">Cross Currency Swap, Expiring 2029 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CrossCurrencySwapExpiring2029Member" xml:lang="en-US">Cross Currency Swap, Expiring 2029</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CrossCurrencySwapExpiring2029Member" xlink:to="lab_sny_CrossCurrencySwapExpiring2029Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CrossCurrencySwapExpiring2029Member" xml:lang="en-US">Cross Currency Swap, Expiring 2029 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapExpiring2032Member" xlink:label="loc_sny_CrossCurrencySwapExpiring2032Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CrossCurrencySwapExpiring2032Member" xml:lang="en-US">Cross Currency Swap, Expiring 2032 [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CrossCurrencySwapExpiring2032Member" xml:lang="en-US">Cross Currency Swap, Expiring 2032</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CrossCurrencySwapExpiring2032Member" xlink:to="lab_sny_CrossCurrencySwapExpiring2032Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CrossCurrencySwapExpiring2032Member" xml:lang="en-US">Cross Currency Swap, Expiring 2032 [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySwapMember" xlink:label="loc_sny_CrossCurrencySwapMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CrossCurrencySwapMember" xml:lang="en-US">Cross Currency Swap [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CrossCurrencySwapMember" xml:lang="en-US">Cross Currency Swap</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CrossCurrencySwapMember" xlink:to="lab_sny_CrossCurrencySwapMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CrossCurrencySwapMember" xml:lang="en-US">Cross Currency Swap [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsMember" xlink:label="loc_sny_CrossCurrencySellerSwapsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CrossCurrencySellerSwapsMember" xml:lang="en-US">Cross Currency Seller Swaps [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CrossCurrencySellerSwapsMember" xml:lang="en-US">Cross Currency Seller Swaps</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CrossCurrencySellerSwapsMember" xlink:to="lab_sny_CrossCurrencySellerSwapsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CrossCurrencySellerSwapsMember" xml:lang="en-US">Cross Currency Seller Swaps [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CrossCurrencySellerSwapsInUSDollarMember" xlink:label="loc_sny_CrossCurrencySellerSwapsInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CrossCurrencySellerSwapsInUSDollarMember" xml:lang="en-US">Cross Currency Seller Swaps In US Dollar [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CrossCurrencySellerSwapsInUSDollarMember" xml:lang="en-US">Cross Currency Seller Swaps In US Dollar</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CrossCurrencySellerSwapsInUSDollarMember" xlink:to="lab_sny_CrossCurrencySellerSwapsInUSDollarMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CrossCurrencySellerSwapsInUSDollarMember" xml:lang="en-US">Cross Currency Seller Swaps In US Dollar [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NotLaterThanOneYearMember" xlink:label="loc_ifrs-full_NotLaterThanOneYearMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xml:lang="en-US">Not later than one year [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NotLaterThanOneYearMember" xml:lang="en-US">2025</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NotLaterThanOneYearMember" xlink:to="lab_ifrs-full_NotLaterThanOneYearMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xml:lang="en-US">Later than one year and not later than two years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xml:lang="en-US">2026</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xml:lang="en-US">Later than five years and not later than seven years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xml:lang="en-US">2032</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:label="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xml:lang="en-US">Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xml:lang="en-US">Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" xlink:to="lab_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:label="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xml:lang="en-US">Derivative Financial Instruments To Manage Financial Exposure</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/definitionGuidance" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xml:lang="en-US">Derivative Financial Instruments To Manage Financial Exposure</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xlink:to="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DerivativeFinancialInstrumentsToManageFinancialExposure" xml:lang="en-US">Derivative financial instruments to manage financial exposure.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialAssets" xlink:label="loc_ifrs-full_DerivativeFinancialAssets" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xml:lang="en-US">Derivative financial assets</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DerivativeFinancialAssets" xml:lang="en-US">Derivative financial assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialAssets" xlink:to="lab_ifrs-full_DerivativeFinancialAssets" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DerivativeFinancialLiabilities" xlink:label="loc_ifrs-full_DerivativeFinancialLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xml:lang="en-US">Derivative financial liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DerivativeFinancialLiabilities" xml:lang="en-US">Derivative financial liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DerivativeFinancialLiabilities" xlink:to="lab_ifrs-full_DerivativeFinancialLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" xml:lang="en-US">Disclosure of detailed information about financial instruments [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsTable" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsTable" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xlink:label="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xml:lang="en-US">Interest Rate Swaps Pay Two Point Zero Eight Percent Receive Euribor Three M [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xml:lang="en-US">pay 2.08% / receive Euribor 3m</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" xlink:to="lab_sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Ester / Receive 0.92% [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xml:lang="en-US">pay capitalized Ester / receive 0.92%</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" xml:lang="en-US">Interest Rate Swaps Pay Capitalized Ester / Receive 0.92%</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xlink:label="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xml:lang="en-US">Interest Rate Swaps Pay Capitalized SOFR USD Receive 1 Point 17 Percent [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xml:lang="en-US">pay capitalized SOFR USD / receive 1.17%</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" xlink:to="lab_sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xml:lang="en-US">Later than two years and not later than three years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xml:lang="en-US">2027</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" xlink:to="lab_ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:label="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xml:lang="en-US">Later than three years and not later than four years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xml:lang="en-US">2028</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" xlink:to="lab_ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xml:lang="en-US">Later than four years and not later than five years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xml:lang="en-US">2029 and beyond</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FairValueHedgesMember" xlink:label="loc_ifrs-full_FairValueHedgesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FairValueHedgesMember" xml:lang="en-US">Fair value hedges [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_FairValueHedgesMember" xml:lang="en-US">Fair value hedges</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FairValueHedgesMember" xlink:to="lab_ifrs-full_FairValueHedgesMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xml:lang="en-US">Disclosure of detailed information about financial instruments [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfFinancialInstrumentsLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:label="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xml:lang="en-US">Currency And Interest Rate Derivatives Used To Manage Debt Net Of Cash And Cash Equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xml:lang="en-US">Currency and interest rate derivatives</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xlink:to="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" xml:lang="en-US">Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Table</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:label="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xml:lang="en-US">MSD Contingent Consideration European Vaccines Business [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xml:lang="en-US">MSD contingent consideration (European Vaccines business)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xlink:to="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" xml:lang="en-US">MSD contingent consideration European vaccines business.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:label="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xml:lang="en-US">Shire Contingent Consideration Arising From Acquisition Of Translate Bio [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xml:lang="en-US">Shire contingent consideration arising from acquisition of Translate Bio</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xlink:to="lab_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" xml:lang="en-US">Shire Contingent Consideration Arising From Acquisition Of Translate Bio</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilities1Member" xlink:label="loc_sny_OtherLiabilities1Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherLiabilities1Member" xml:lang="en-US">Other Liabilities1 [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherLiabilities1Member" xml:lang="en-US">Other</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherLiabilities1Member" xlink:to="lab_sny_OtherLiabilities1Member" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherLiabilities1Member" xml:lang="en-US">Other liabilities.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:label="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xlink:to="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" xml:lang="en-US">Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xlink:label="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xml:lang="en-US">Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xml:lang="en-US">Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xlink:to="lab_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" xml:lang="en-US">Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Contingent liabilities recognised in business combination</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Beginning balance</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Ending balance</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Fair value of contingent consideration payable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:label="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Settled liabilities, contingent liabilities recognised in business combination</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xml:lang="en-US">Payments made</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" xlink:to="lab_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:label="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xml:lang="en-US">Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xml:lang="en-US">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" xlink:to="lab_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:label="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xml:lang="en-US">Increase (Decrease) Through Net Exchange Differences Business Combinations And Noncontrolling Interests</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xml:lang="en-US">Currency translation differences</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xlink:to="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" xml:lang="en-US">Increase decrease through net exchange differences business combinations and noncontrolling interests.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PercentageIncreaseInFairValueLiabilities" xlink:label="loc_sny_PercentageIncreaseInFairValueLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xml:lang="en-US">Percentage Increase In Fair Value Liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xml:lang="en-US">Increase in fair value of liability</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PercentageIncreaseInFairValueLiabilities" xlink:to="lab_sny_PercentageIncreaseInFairValueLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PercentageIncreaseInFairValueLiabilities" xml:lang="en-US">Percentage increase in fair value liabilities.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsTable" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTable" xml:lang="en-US">Disclosure Of Non-Current Provisions [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTable" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsTable" xlink:to="lab_sny_DisclosureOfNonCurrentProvisionsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsTable" xml:lang="en-US">Disclosure Of Noncurrent Provisions [Table]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesCollaborationAgreementMember" xlink:label="loc_sny_AntibodiesCollaborationAgreementMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xml:lang="en-US">Antibodies Collaboration Agreement [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xml:lang="en-US">Antibodies Collaboration Agreement</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntibodiesCollaborationAgreementMember" xlink:to="lab_sny_AntibodiesCollaborationAgreementMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AntibodiesCollaborationAgreementMember" xml:lang="en-US">Antibodies Collaboration Agreement</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SwedishOrphanBiovitrumABMember" xlink:label="loc_sny_SwedishOrphanBiovitrumABMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SwedishOrphanBiovitrumABMember" xml:lang="en-US">Swedish Orphan Biovitrum AB [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SwedishOrphanBiovitrumABMember" xml:lang="en-US">Swedish Orphan Biovitrum AB</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SwedishOrphanBiovitrumABMember" xlink:to="lab_sny_SwedishOrphanBiovitrumABMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SwedishOrphanBiovitrumABMember" xml:lang="en-US">Swedish Orphan Biovitrum AB</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xml:lang="en-US">Later than one year and not later than five years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xml:lang="en-US">Later than one year and not later than five years [member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-full_LaterThanFiveYearsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xml:lang="en-US">Later than five years [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LaterThanFiveYearsMember" xml:lang="en-US">Total</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LaterThanFiveYearsMember" xlink:to="lab_ifrs-full_LaterThanFiveYearsMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:label="loc_sny_DisclosureOfNonCurrentProvisionsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsLineItems" xml:lang="en-US">Disclosure Of Non-Current Provisions [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsLineItems" xml:lang="en-US">Disclosure Of Non-current Provisions [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfNonCurrentProvisionsLineItems" xlink:to="lab_sny_DisclosureOfNonCurrentProvisionsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfNonCurrentProvisionsLineItems" xml:lang="en-US">Disclosure Of Non-current Provisions [line items]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentProvisions" xlink:label="loc_ifrs-full_NoncurrentProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentProvisions" xml:lang="en-US">Non-current provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentProvisions" xml:lang="en-US">Provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="lab_ifrs-full_NoncurrentProvisions" xml:lang="en-US">Beginning balance</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="lab_ifrs-full_NoncurrentProvisions" xml:lang="en-US">Ending balance</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentProvisions" xlink:to="lab_ifrs-full_NoncurrentProvisions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-full_OtherNoncurrentLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xml:lang="en-US">Other non-current liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherNoncurrentLiabilities" xml:lang="en-US">Other non-current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherNoncurrentLiabilities" xlink:to="lab_ifrs-full_OtherNoncurrentLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-full_ClassesOfProvisionsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xml:lang="en-US">Classes of other provisions [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfProvisionsAxis" xml:lang="en-US">Classes of other provisions [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfProvisionsAxis" xlink:to="lab_ifrs-full_ClassesOfProvisionsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfOtherProvisionsDomain" xlink:label="loc_ifrs-full_ClassesOfOtherProvisionsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfOtherProvisionsDomain" xml:lang="en-US">Classes of other provisions [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfOtherProvisionsDomain" xml:lang="en-US">Other provisions [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfOtherProvisionsDomain" xlink:to="lab_ifrs-full_ClassesOfOtherProvisionsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xlink:label="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xml:lang="en-US">Provisions For Pensions And Other Postemployment Benefits [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xml:lang="en-US">Provisions for pensions &amp; other post-employment benefits</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xlink:to="lab_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" xml:lang="en-US">Provisions for pensions and other post-employment benefits.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProvisionsForOtherLongTermBenefitsMember" xlink:label="loc_sny_ProvisionsForOtherLongTermBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xml:lang="en-US">Provisions For Other Long Term Benefits [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xml:lang="en-US">Provisions for other long-term benefits</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProvisionsForOtherLongTermBenefitsMember" xlink:to="lab_sny_ProvisionsForOtherLongTermBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ProvisionsForOtherLongTermBenefitsMember" xml:lang="en-US">Provisions for other long term benefits.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentRestructuringProvisionMember" xlink:label="loc_sny_NonCurrentRestructuringProvisionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xml:lang="en-US">Non-Current Restructuring Provision [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xml:lang="en-US">Restructuring provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentRestructuringProvisionMember" xlink:to="lab_sny_NonCurrentRestructuringProvisionMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentRestructuringProvisionMember" xml:lang="en-US">Restructuring provisions.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MiscellaneousOtherProvisionsMember" xlink:label="loc_ifrs-full_MiscellaneousOtherProvisionsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xml:lang="en-US">Miscellaneous other provisions [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MiscellaneousOtherProvisionsMember" xml:lang="en-US">Other provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MiscellaneousOtherProvisionsMember" xlink:to="lab_ifrs-full_MiscellaneousOtherProvisionsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_GB" xlink:label="loc_country_GB" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_GB" xml:lang="en-US">UNITED KINGDOM</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_GB" xml:lang="en-US">United Kingdom</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xml:lang="en-US">Net defined benefit liability (asset) [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xml:lang="en-US">Net defined benefit liability (asset) [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:label="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xml:lang="en-US">Net defined benefit liability (asset) [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xml:lang="en-US">Net defined benefit liability (asset) [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" xlink:to="lab_ifrs-full_NetDefinedBenefitLiabilityAssetDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PlanAssetsMember" xlink:label="loc_ifrs-full_PlanAssetsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PlanAssetsMember" xml:lang="en-US">Plan assets [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PlanAssetsMember" xml:lang="en-US">Plan assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PlanAssetsMember" xlink:to="lab_ifrs-full_PlanAssetsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:label="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xml:lang="en-US">Reconciliation of changes in other provisions [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xml:lang="en-US">Reconciliation of changes in other provisions [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" xlink:to="lab_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ChangesInOtherProvisions" xlink:label="loc_ifrs-full_ChangesInOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ChangesInOtherProvisions" xml:lang="en-US">Increase (decrease) in other provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ChangesInOtherProvisions" xml:lang="en-US">Increases in provisions and other liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ChangesInOtherProvisions" xlink:to="lab_ifrs-full_ChangesInOtherProvisions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProvisionUsedOtherProvisions" xlink:label="loc_ifrs-full_ProvisionUsedOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions" xml:lang="en-US">Provision used, other provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ProvisionUsedOtherProvisions" xml:lang="en-US">Provisions utilized</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProvisionUsedOtherProvisions" xlink:to="lab_ifrs-full_ProvisionUsedOtherProvisions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xml:lang="en-US">Increase (decrease) through transfers and other changes, other provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xml:lang="en-US">Transfers</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xml:lang="en-US">Increase (Decrease) Through Net Interest Related To Employees Benefits And Unwinding Of Discount, Other Provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xml:lang="en-US">Net interest related to employee benefits, and unwinding of discount</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xlink:to="lab_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" xml:lang="en-US">Net interest related to employees benefits and unwinding of discount.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xml:lang="en-US">Increase Decrease Of Unused Provision Reversed, Other Provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xml:lang="en-US">Reversals of unutilized provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xlink:to="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" xml:lang="en-US">Increase Decrease Of Unused Provision Reversed, Other Provisions</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:label="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xml:lang="en-US">Increase (decrease) through net exchange differences, other provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xml:lang="en-US">Currency translation differences</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" xlink:to="lab_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xlink:label="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xml:lang="en-US">Increase (Decrease) Through Actuarial Gains And Losses On Defined Benefit Plans, Other Provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xml:lang="en-US">Actuarial gains and losses on defined-benefit plans (B.12.1.)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xlink:to="lab_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" xml:lang="en-US">Actuarial gains and losses on defined-benefit plans.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:label="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xml:lang="en-US">Net defined benefit liability (asset)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" xlink:to="lab_ifrs-full_LiabilityAssetOfDefinedBenefitPlans" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-full_DefinedBenefitPlansAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xml:lang="en-US">Defined benefit plans [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DefinedBenefitPlansAxis" xml:lang="en-US">Defined benefit plans [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansAxis" xlink:to="lab_ifrs-full_DefinedBenefitPlansAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DefinedBenefitPlansDomain" xlink:label="loc_ifrs-full_DefinedBenefitPlansDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xml:lang="en-US">Defined benefit plans [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DefinedBenefitPlansDomain" xml:lang="en-US">Defined benefit plans [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DefinedBenefitPlansDomain" xlink:to="lab_ifrs-full_DefinedBenefitPlansDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:label="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xml:lang="en-US">Pensions And Other Post-Employment Benefits [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xml:lang="en-US">Pensions and other post-employment benefits</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PensionsAndOtherPostEmploymentBenefitsMember" xlink:to="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PensionsAndOtherPostEmploymentBenefitsMember" xml:lang="en-US">Pensions and other post-employment benefits.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EUROZONEMember" xlink:label="loc_sny_EUROZONEMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EUROZONEMember" xml:lang="en-US">EUROZONE [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_EUROZONEMember" xml:lang="en-US">Eurozone</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EUROZONEMember" xlink:to="lab_sny_EUROZONEMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_EUROZONEMember" xml:lang="en-US">EUROZONE</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UKZONEMember" xlink:label="loc_sny_UKZONEMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_UKZONEMember" xml:lang="en-US">UKZONE [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_UKZONEMember" xml:lang="en-US">UKZONE</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UKZONEMember" xlink:to="lab_sny_UKZONEMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_UKZONEMember" xml:lang="en-US">UKZONE</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsAxis" xlink:label="loc_ifrs-full_ActuarialAssumptionsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionsAxis" xml:lang="en-US">Actuarial assumptions [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsAxis" xlink:to="lab_ifrs-full_ActuarialAssumptionsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionsDomain" xlink:label="loc_ifrs-full_ActuarialAssumptionsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xml:lang="en-US">Actuarial assumptions [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionsDomain" xml:lang="en-US">Actuarial assumptions [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionsDomain" xlink:to="lab_ifrs-full_ActuarialAssumptionsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xml:lang="en-US">Actuarial assumption of discount rates [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xml:lang="en-US">Actuarial assumption of discount rates</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfDiscountRatesMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:label="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xml:lang="en-US">Actuarial assumption of expected rates of inflation [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xml:lang="en-US">Actuarial assumption of expected rates of inflation</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" xlink:to="lab_ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeAxis" xlink:label="loc_srt_RangeAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeAxis" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RangeMember" xlink:label="loc_srt_RangeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RangeMember" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MinimumMember" xlink:label="loc_srt_MinimumMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MinimumMember" xml:lang="en-US">Minimum</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_MaximumMember" xlink:label="loc_srt_MaximumMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_MaximumMember" xml:lang="en-US">Maximum</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:label="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xml:lang="en-US">Disclosure of net defined benefit liability (asset) [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" xlink:to="lab_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Actuarial gains/(losses) on plan assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xml:lang="en-US">Actuarial gains/(losses) on benefit obligations</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" xlink:to="lab_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xml:lang="en-US">Percentage of reasonably possible decrease in actuarial assumption</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xml:lang="en-US">Decrease in actuarial assumption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:label="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xml:lang="en-US">Percentage of reasonably possible increase in actuarial assumption</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xml:lang="en-US">Increase in actuarial assumption</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" xlink:to="lab_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RelatedPartiesMember" xlink:label="loc_ifrs-full_RelatedPartiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RelatedPartiesMember" xml:lang="en-US">Total for all related parties [member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RelatedPartiesMember" xlink:to="lab_ifrs-full_RelatedPartiesMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_EarendilLabsMember" xlink:label="loc_sny_EarendilLabsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_EarendilLabsMember" xml:lang="en-US">Earendil Labs [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_EarendilLabsMember" xlink:to="lab_sny_EarendilLabsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xlink:label="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xml:lang="en-US">Commitments made by entity, related party transactions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xml:lang="en-US">Commitments made by entity, related party transactions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" xlink:to="lab_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_Prepayments" xlink:label="loc_ifrs-full_Prepayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_Prepayments" xml:lang="en-US">Prepayments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_Prepayments" xml:lang="en-US">Prepayments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_Prepayments" xlink:to="lab_ifrs-full_Prepayments" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xml:lang="en-US">Disclosure of Legal and Arbitral Proceedings [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsTable" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsTable" xml:lang="en-US">Disclosure of legal and arbitral proceedings.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsAxis" xlink:label="loc_sny_LegalAndArbitralProceedingsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LegalAndArbitralProceedingsAxis" xlink:to="lab_sny_LegalAndArbitralProceedingsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LegalAndArbitralProceedingsAxis" xml:lang="en-US">Legal And Arbitral Proceedings [Axis]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LegalAndArbitralProceedingsDomain" xlink:label="loc_sny_LegalAndArbitralProceedingsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xml:lang="en-US">Legal And Arbitral Proceedings [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xml:lang="en-US">Legal And Arbitral Proceedings [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LegalAndArbitralProceedingsDomain" xlink:to="lab_sny_LegalAndArbitralProceedingsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LegalAndArbitralProceedingsDomain" xml:lang="en-US">[Domain] for Legal And Arbitral Proceedings [Axis]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:label="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xml:lang="en-US">Plavix Attorney General Action In Hawaii [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xml:lang="en-US">Plavix Attorney General action in Hawaii</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PlavixAttorneyGeneralActionInHawaiiMember" xlink:to="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PlavixAttorneyGeneralActionInHawaiiMember" xml:lang="en-US">Plavix Attorney General Action In Hawaii</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoldBondProductLitigationInTheUSMember" xlink:label="loc_sny_GoldBondProductLitigationInTheUSMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GoldBondProductLitigationInTheUSMember" xml:lang="en-US">Gold Bond Product Litigation In The US [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GoldBondProductLitigationInTheUSMember" xml:lang="en-US">Gold Bond Product Litigation In The US</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GoldBondProductLitigationInTheUSMember" xlink:to="lab_sny_GoldBondProductLitigationInTheUSMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GoldBondProductLitigationInTheUSMember" xml:lang="en-US">Gold Bond Product Litigation In The US</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantAxis" xlink:label="loc_sny_DefendantAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DefendantAxis" xml:lang="en-US">Defendant [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DefendantAxis" xml:lang="en-US">Defendant [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefendantAxis" xlink:to="lab_sny_DefendantAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DefendantAxis" xml:lang="en-US">Defendant [Axis]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DefendantDomain" xlink:label="loc_sny_DefendantDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DefendantDomain" xml:lang="en-US">Defendant [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DefendantDomain" xml:lang="en-US">Defendant [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DefendantDomain" xlink:to="lab_sny_DefendantDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DefendantDomain" xml:lang="en-US">Defendant [Domain]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichWeAreDefendantMember" xlink:label="loc_sny_ActionForWhichWeAreDefendantMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xml:lang="en-US">Action For Which We Are Defendant [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xml:lang="en-US">Action for which we are defendant</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActionForWhichWeAreDefendantMember" xlink:to="lab_sny_ActionForWhichWeAreDefendantMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ActionForWhichWeAreDefendantMember" xml:lang="en-US">Action for which we are defendant.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ActionForWhichSanofiAreDefendantMember" xlink:label="loc_sny_ActionForWhichSanofiAreDefendantMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ActionForWhichSanofiAreDefendantMember" xml:lang="en-US">Action For Which Sanofi Are Defendant [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ActionForWhichSanofiAreDefendantMember" xml:lang="en-US">Action For Which Sanofi Are Defendant</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ActionForWhichSanofiAreDefendantMember" xlink:to="lab_sny_ActionForWhichSanofiAreDefendantMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ActionForWhichSanofiAreDefendantMember" xml:lang="en-US">Action For Which Sanofi Are Defendant [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" xml:lang="en-US">Classes of contingent liabilities [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" xml:lang="en-US">Classes of Contingent Liabilities [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="lab_ifrs-full_ClassesOfContingentLiabilitiesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:label="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesDomain" xml:lang="en-US">Classes of contingent liabilities [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ClassesOfContingentLiabilitiesDomain" xml:lang="en-US">Classes of contingent liabilities [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ClassesOfContingentLiabilitiesDomain" xlink:to="lab_ifrs-full_ClassesOfContingentLiabilitiesDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ProductLiabilitiesMember" xlink:label="loc_sny_ProductLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ProductLiabilitiesMember" xml:lang="en-US">Product Liabilities [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ProductLiabilitiesMember" xml:lang="en-US">Product Liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ProductLiabilitiesMember" xlink:to="lab_sny_ProductLiabilitiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ProductLiabilitiesMember" xml:lang="en-US">Product Liabilities</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:label="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xml:lang="en-US">Disclosure Of Legal And Arbitral Proceedings [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xml:lang="en-US">Disclosure of Legal and Arbitral Proceedings [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xlink:to="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfLegalAndArbitralProceedingsLineItems" xml:lang="en-US">Disclosure of legal and arbitral proceedings.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NumberOfClassActionLawsuits" xlink:label="loc_sny_NumberOfClassActionLawsuits" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NumberOfClassActionLawsuits" xml:lang="en-US">Number Of Class Action Lawsuits</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NumberOfClassActionLawsuits" xml:lang="en-US">Number Of Class Action Lawsuits</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NumberOfClassActionLawsuits" xlink:to="lab_sny_NumberOfClassActionLawsuits" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NumberOfClassActionLawsuits" xml:lang="en-US">Number Of Class Action Lawsuits</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PenaltyFeeIncurred" xlink:label="loc_sny_PenaltyFeeIncurred" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PenaltyFeeIncurred" xml:lang="en-US">Penalty Fee Incurred</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PenaltyFeeIncurred" xml:lang="en-US">Penalty Fee Incurred</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PenaltyFeeIncurred" xlink:to="lab_sny_PenaltyFeeIncurred" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PenaltyFeeIncurred" xml:lang="en-US">Penalty Fee Incurred</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PaymentOfDamagesClaimedByCounterparty" xlink:label="loc_sny_PaymentOfDamagesClaimedByCounterparty" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xml:lang="en-US">Payment Of Damages Claimed By Counterparty</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xml:lang="en-US">Payment Of Damages Claimed By Counterparty</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PaymentOfDamagesClaimedByCounterparty" xlink:to="lab_sny_PaymentOfDamagesClaimedByCounterparty" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PaymentOfDamagesClaimedByCounterparty" xml:lang="en-US">Payment Of Damages Claimed By Counterparty</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xml:lang="en-US">Disclosure of Other Operating Income Expenses [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesTable" xml:lang="en-US">Disclosure of other operating income expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherRelatedPartiesMember" xlink:label="loc_ifrs-full_OtherRelatedPartiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember" xml:lang="en-US">Other related parties [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherRelatedPartiesMember" xml:lang="en-US">Other related parties</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherRelatedPartiesMember" xlink:to="lab_ifrs-full_OtherRelatedPartiesMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RegeneronMember" xlink:label="loc_sny_RegeneronMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RegeneronMember" xml:lang="en-US">Regeneron [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RegeneronMember" xml:lang="en-US">Regeneron</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RegeneronMember" xlink:to="lab_sny_RegeneronMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RegeneronMember" xml:lang="en-US">Regeneron</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xml:lang="en-US">Attribution of expenses by nature to their function [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:label="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xml:lang="en-US">Attribution of expenses by nature to their function [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" xlink:to="lab_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherOperatingIncomeExpenseMember" xlink:label="loc_sny_OtherOperatingIncomeExpenseMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xml:lang="en-US">Other Operating Income (Expense) [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xml:lang="en-US">Other operating income (expense)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherOperatingIncomeExpenseMember" xlink:to="lab_sny_OtherOperatingIncomeExpenseMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherOperatingIncomeExpenseMember" xml:lang="en-US">Other Operating Income (Expense)</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CommercializationRelatedExpensesMember" xlink:label="loc_sny_CommercializationRelatedExpensesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xml:lang="en-US">Commercialization Related Expenses [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xml:lang="en-US">Reimbursement to Regeneron of selling expenses incurred</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CommercializationRelatedExpensesMember" xlink:to="lab_sny_CommercializationRelatedExpensesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CommercializationRelatedExpensesMember" xml:lang="en-US">Commercialization related expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:label="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xml:lang="en-US">Disclosure Of Other Operating Income Expenses [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xlink:to="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" xml:lang="en-US">Disclosure of other operating income (expenses).</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainsOnDivestmentOfProducts" xlink:label="loc_sny_GainsOnDivestmentOfProducts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xml:lang="en-US">Gains On Divestment Of Products</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xml:lang="en-US">Gains on divestment of some mature products</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainsOnDivestmentOfProducts" xlink:to="lab_sny_GainsOnDivestmentOfProducts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GainsOnDivestmentOfProducts" xml:lang="en-US">Gains on divestment of products.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_CounterpartyNameAxis" xlink:label="loc_srt_CounterpartyNameAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_CounterpartyNameAxis" xml:lang="en-US">Counterparty Name [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_CounterpartyNameAxis" xml:lang="en-US">Counterparty Name [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_RepurchaseAgreementCounterpartyNameDomain" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US">Counterparty Name [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xml:lang="en-US">Counterparty Name [Domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AntibodiesAllianceMember" xlink:label="loc_sny_AntibodiesAllianceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AntibodiesAllianceMember" xml:lang="en-US">Antibodies Alliance [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AntibodiesAllianceMember" xml:lang="en-US">Monoclonal Antibodies Alliance</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AntibodiesAllianceMember" xlink:to="lab_sny_AntibodiesAllianceMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AntibodiesAllianceMember" xml:lang="en-US">Antibodies Alliance [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OthersCounterpartyMember" xlink:label="loc_sny_OthersCounterpartyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OthersCounterpartyMember" xml:lang="en-US">Others Counterparty [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OthersCounterpartyMember" xml:lang="en-US">Other (mainly Zaltrap and Libtayo)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OthersCounterpartyMember" xlink:to="lab_sny_OthersCounterpartyMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OthersCounterpartyMember" xml:lang="en-US">Others Counterparty [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xml:lang="en-US">Share Of Profit Or Loss From Commercialization Of Monoclonal Antibodies [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xml:lang="en-US">Income &amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xlink:to="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" xml:lang="en-US">Share of profit or loss from commercialization of monoclonal antibodies member.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:label="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xml:lang="en-US">Share Of Profit Or Loss From Commercialization Of Zaltrap [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xml:lang="en-US">Additional share of profit paid by Regeneron towards development costs</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xlink:to="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" xml:lang="en-US">Share of profit or loss from commercialization of Zaltrap.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:label="loc_sny_MiscellaneousOtherOperatingIncomeExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xml:lang="en-US">Miscellaneous Other Operating Income (Expenses)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xml:lang="en-US">Other operating income and expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MiscellaneousOtherOperatingIncomeExpenses" xlink:to="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MiscellaneousOtherOperatingIncomeExpenses" xml:lang="en-US">Other operating income and expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherOperatingIncomeExpense" xlink:label="loc_ifrs-full_OtherOperatingIncomeExpense" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xml:lang="en-US">Other operating income (expense)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherOperatingIncomeExpense" xml:lang="en-US">Other operating income/(expenses), net related to Regeneron</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherOperatingIncomeExpense" xlink:to="lab_ifrs-full_OtherOperatingIncomeExpense" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xml:lang="en-US">Expense Of Restructuring Activities Employee Related Expenses</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xml:lang="en-US">Employee-related expenses</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" xml:lang="en-US">Employee related expenses.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xml:lang="en-US">Expense Of Restructuring Activities Related To Property Plant And Equipment And To Inventories</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xml:lang="en-US">Charges, gains or losses on assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" xml:lang="en-US">Expense of restructuring activities related to property plant and equipment to inventories.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:label="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xml:lang="en-US">Expense Of Restructuring Activities, Transformation Programs Costs</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xml:lang="en-US">Costs of transformation programs</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xlink:to="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" xml:lang="en-US">Expense Of Restructuring Activities, Transformation Programs Costs</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherRestructuringCosts" xlink:label="loc_sny_OtherRestructuringCosts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherRestructuringCosts" xml:lang="en-US">Other Restructuring Costs</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherRestructuringCosts" xml:lang="en-US">Other restructuring costs</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherRestructuringCosts" xlink:to="lab_sny_OtherRestructuringCosts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherRestructuringCosts" xml:lang="en-US">Other restructuring costs.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xlink:label="loc_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xml:lang="en-US">Increase (Decrease) In Total Expense Of Restructuring Activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xml:lang="en-US">Decrease in total expense of restructuring activities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xlink:to="lab_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" xml:lang="en-US">Increase (Decrease) In Total Expense Of Restructuring Activities</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" xml:lang="en-US">Schedule disclosing information related to details of finance income (expense).</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsAxis" xlink:label="loc_ifrs-full_HedgedItemsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_HedgedItemsAxis" xml:lang="en-US">Hedged items [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_HedgedItemsAxis" xml:lang="en-US">Hedged items [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsAxis" xlink:to="lab_ifrs-full_HedgedItemsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_HedgedItemsDomain" xlink:label="loc_ifrs-full_HedgedItemsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_HedgedItemsDomain" xml:lang="en-US">Hedged items [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_HedgedItemsDomain" xml:lang="en-US">Hedged items [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_HedgedItemsDomain" xlink:to="lab_ifrs-full_HedgedItemsDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestRateAndCurrencyDerivativesMember" xlink:label="loc_sny_InterestRateAndCurrencyDerivativesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xml:lang="en-US">Interest Rate And Currency Derivatives [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xml:lang="en-US">Interest rate and currency derivatives used to hedge debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestRateAndCurrencyDerivativesMember" xlink:to="lab_sny_InterestRateAndCurrencyDerivativesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestRateAndCurrencyDerivativesMember" xml:lang="en-US">Interest rate and currency derivatives used to hedge debt.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:label="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xml:lang="en-US">Disclosure Of Detailed Information About Finance Income Expense [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xml:lang="en-US">Disclosure of detailed information about finance income expense [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xlink:to="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" xml:lang="en-US">Line items represent detailed information about finance income expense.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnBorrowings" xlink:label="loc_ifrs-full_InterestExpenseOnBorrowings" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xml:lang="en-US">Interest expense on borrowings</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_InterestExpenseOnBorrowings" xml:lang="en-US">Cost of debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnBorrowings" xlink:to="lab_ifrs-full_InterestExpenseOnBorrowings" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InterestIncome" xlink:label="loc_sny_InterestIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InterestIncome" xml:lang="en-US">Interest Income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InterestIncome" xml:lang="en-US">Interest income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InterestIncome" xlink:to="lab_sny_InterestIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InterestIncome" xml:lang="en-US">Interest Income</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CostOfDebtNet" xlink:label="loc_sny_CostOfDebtNet" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CostOfDebtNet" xml:lang="en-US">Cost Of Debt Net</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:label="lab_sny_CostOfDebtNet" xml:lang="en-US">Cost of net debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CostOfDebtNet" xlink:to="lab_sny_CostOfDebtNet" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CostOfDebtNet" xml:lang="en-US">Cost of debt net.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonOperatingForeignExchangeGainsLosses" xlink:label="loc_sny_NonOperatingForeignExchangeGainsLosses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xml:lang="en-US">Non-Operating Foreign Exchange Gains/(Losses)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xml:lang="en-US">Non-operating foreign exchange gains/(losses)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonOperatingForeignExchangeGainsLosses" xlink:to="lab_sny_NonOperatingForeignExchangeGainsLosses" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonOperatingForeignExchangeGainsLosses" xml:lang="en-US">Non-operating foreign exchange gains/(losses).</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:label="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xml:lang="en-US">Expense arising from passage of time on other provisions</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xml:lang="en-US">Unwinding of discounting of provisions</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" xlink:to="lab_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NetInterestCostRelatedToEmployeeBenefits" xlink:label="loc_sny_NetInterestCostRelatedToEmployeeBenefits" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xml:lang="en-US">Net Interest Cost Related To Employee Benefits</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xml:lang="en-US">Net interest cost related to employee benefits</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NetInterestCostRelatedToEmployeeBenefits" xlink:to="lab_sny_NetInterestCostRelatedToEmployeeBenefits" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NetInterestCostRelatedToEmployeeBenefits" xml:lang="en-US">Net interest cost related to employee benefits.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xml:lang="en-US">Interest expense on lease liabilities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" xml:lang="en-US">Net interest expense on lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="lab_ifrs-full_InterestExpenseOnLeaseLiabilities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherFinanceIncomeCost" xlink:label="loc_ifrs-full_OtherFinanceIncomeCost" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xml:lang="en-US">Other finance income (cost)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherFinanceIncomeCost" xml:lang="en-US">Other</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherFinanceIncomeCost" xlink:to="lab_ifrs-full_OtherFinanceIncomeCost" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-full_FinanceIncomeCost" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_FinanceIncomeCost" xml:lang="en-US">Finance income (cost)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_FinanceIncomeCost" xml:lang="en-US">Net financial income/(expenses)</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_FinanceIncomeCost" xlink:to="lab_ifrs-full_FinanceIncomeCost" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageDebt" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageDebt" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageDebt" xml:lang="en-US">Gain (Loss) On Derivatives Used To Manage Debt</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageDebt" xml:lang="en-US">Gain on derivatives used to manage debt</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnDerivativesUsedToManageDebt" xlink:to="lab_sny_GainLossOnDerivativesUsedToManageDebt" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageDebt" xml:lang="en-US">Gain (loss) on derivatives used to manage debt.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xlink:label="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xml:lang="en-US">Gain (Loss) On Derivatives Used To Manage Cash And Cash Equivalents</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xml:lang="en-US">Gain on derivatives used to manage cash and cash equivalents</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xlink:to="lab_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" xml:lang="en-US">Gain (loss) on derivatives used to manage cash and cash equivalents.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilityRecognisedForEstimatedFutureRoyalties" xlink:label="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LiabilityRecognisedForEstimatedFutureRoyalties" xml:lang="en-US">Liability Recognised For Estimated Future Royalties</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_LiabilityRecognisedForEstimatedFutureRoyalties" xml:lang="en-US">Liability Recognised For Estimated Future Royalties</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LiabilityRecognisedForEstimatedFutureRoyalties" xlink:to="lab_sny_LiabilityRecognisedForEstimatedFutureRoyalties" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LiabilityRecognisedForEstimatedFutureRoyalties" xml:lang="en-US">Liability Recognised For Estimated Future Royalties</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-full_CurrentTaxExpenseIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xml:lang="en-US">Current tax expense (income)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_CurrentTaxExpenseIncome" xml:lang="en-US">Current taxes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_CurrentTaxExpenseIncome" xlink:to="lab_ifrs-full_CurrentTaxExpenseIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-full_DeferredTaxExpenseIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xml:lang="en-US">Deferred tax expense (income)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_ifrs-full_DeferredTaxExpenseIncome" xml:lang="en-US">Deferred taxes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DeferredTaxExpenseIncome" xlink:to="lab_ifrs-full_DeferredTaxExpenseIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-full_ApplicableTaxRate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ApplicableTaxRate" xml:lang="en-US">Applicable tax rate</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ApplicableTaxRate" xml:lang="en-US">Standard tax rate applicable in France</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ApplicableTaxRate" xlink:to="lab_ifrs-full_ApplicableTaxRate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:label="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" xml:lang="en-US">Tax rate effect of foreign tax rates</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" xml:lang="en-US">Difference between the standard French tax rate and the rates applicable to Sanofi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TaxRateEffectOfForeignTaxRates" xlink:to="lab_ifrs-full_TaxRateEffectOfForeignTaxRates" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:label="loc_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xml:lang="en-US">Revisions To Tax Exposures And Settlements Of Tax Disputes</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xml:lang="en-US">Revisions to tax exposures and settlements of tax disputes</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xlink:to="lab_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" xml:lang="en-US">Revisions to tax exposures and settlements of tax disputes.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:label="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xml:lang="en-US">Other tax rate effects for reconciliation between accounting profit and tax expense (income)</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xml:lang="en-US">Other</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" xlink:to="lab_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AverageEffectiveTaxRate" xlink:label="loc_ifrs-full_AverageEffectiveTaxRate" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xml:lang="en-US">Average effective tax rate</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_ifrs-full_AverageEffectiveTaxRate" xml:lang="en-US">Effective tax rate</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AverageEffectiveTaxRate" xlink:to="lab_ifrs-full_AverageEffectiveTaxRate" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:label="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xml:lang="en-US">Temporary difference, unused tax losses and unused tax credits [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" xlink:to="lab_ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:label="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xml:lang="en-US">Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" xlink:to="lab_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentTaxExpenseRelatedToPillarTwo" xlink:label="loc_sny_CurrentTaxExpenseRelatedToPillarTwo" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentTaxExpenseRelatedToPillarTwo" xml:lang="en-US">Current Tax Expense Related to Pillar Two</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CurrentTaxExpenseRelatedToPillarTwo" xml:lang="en-US">Current Tax Expense Related to Pillar Two</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentTaxExpenseRelatedToPillarTwo" xlink:to="lab_sny_CurrentTaxExpenseRelatedToPillarTwo" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentTaxExpenseRelatedToPillarTwo" xml:lang="en-US">Current Tax Expense Related to Pillar Two</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasTable" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasTable" xml:lang="en-US">Disclosure of geographical areas [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasTable" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_EuropeMember" xlink:label="loc_srt_EuropeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_EuropeMember" xml:lang="en-US">Europe [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_EuropeMember" xml:lang="en-US">Europe</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_US" xlink:label="loc_country_US" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_US" xml:lang="en-US">UNITED STATES</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_US" xml:lang="en-US">UNITED STATES</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_country_US" xml:lang="en-US">United States</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesMember" xlink:label="loc_sny_OtherCountriesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherCountriesMember" xml:lang="en-US">Other Countries [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherCountriesMember" xml:lang="en-US">Other Countries</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCountriesMember" xlink:to="lab_sny_OtherCountriesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherCountriesMember" xml:lang="en-US">Other countries.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-full_ProductsAndServicesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xml:lang="en-US">Products and services [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xml:lang="en-US">Products and services [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProductsAndServicesAxis" xml:lang="en-US">Products and services [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesAxis" xlink:to="lab_ifrs-full_ProductsAndServicesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ProductsAndServicesDomain" xlink:label="loc_ifrs-full_ProductsAndServicesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ProductsAndServicesDomain" xml:lang="en-US">Products and services [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ProductsAndServicesDomain" xlink:to="lab_ifrs-full_ProductsAndServicesDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SpecialtyCareMember" xlink:label="loc_sny_SpecialtyCareMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SpecialtyCareMember" xml:lang="en-US">Specialty Care [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SpecialtyCareMember" xml:lang="en-US">Specialty Care [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SpecialtyCareMember" xlink:to="lab_sny_SpecialtyCareMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SpecialtyCareMember" xml:lang="en-US">Specialty Care.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DupixentMember" xlink:label="loc_sny_DupixentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DupixentMember" xml:lang="en-US">Dupixent [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DupixentMember" xml:lang="en-US">Dupixent</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DupixentMember" xlink:to="lab_sny_DupixentMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DupixentMember" xml:lang="en-US">Dupixent [member]</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AubagioMember" xlink:label="loc_sny_AubagioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AubagioMember" xml:lang="en-US">Aubagio [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AubagioMember" xml:lang="en-US">Aubagio</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AubagioMember" xlink:to="lab_sny_AubagioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AubagioMember" xml:lang="en-US">Aubagio.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GeneralMedicinesMember" xlink:label="loc_sny_GeneralMedicinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GeneralMedicinesMember" xml:lang="en-US">General Medicines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_GeneralMedicinesMember" xml:lang="en-US">General Medicines [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GeneralMedicinesMember" xlink:to="lab_sny_GeneralMedicinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GeneralMedicinesMember" xml:lang="en-US">General Medicines</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IndustrialSalesMember" xlink:label="loc_sny_IndustrialSalesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IndustrialSalesMember" xml:lang="en-US">Industrial Sales [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_IndustrialSalesMember" xml:lang="en-US">Industrial Sales [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IndustrialSalesMember" xlink:to="lab_sny_IndustrialSalesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IndustrialSalesMember" xml:lang="en-US">Industrial Sales</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VaccinesMember" xlink:label="loc_sny_VaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_VaccinesMember" xml:lang="en-US">Vaccines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_VaccinesMember" xml:lang="en-US">Vaccines [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VaccinesMember" xlink:to="lab_sny_VaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_VaccinesMember" xml:lang="en-US">Vaccines.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PolioPertussisHibVaccinesMember" xlink:label="loc_sny_PolioPertussisHibVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xml:lang="en-US">Polio Pertussis Hib Vaccines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xml:lang="en-US">Polio Pertussis Hib Vaccines [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PolioPertussisHibVaccinesMember" xlink:to="lab_sny_PolioPertussisHibVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PolioPertussisHibVaccinesMember" xml:lang="en-US">Polio Pertussis Hib Vaccines.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InfluenzaVaccinesMember" xlink:label="loc_sny_InfluenzaVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InfluenzaVaccinesMember" xml:lang="en-US">Influenza Vaccines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_InfluenzaVaccinesMember" xml:lang="en-US">Influenza Vaccines [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InfluenzaVaccinesMember" xlink:to="lab_sny_InfluenzaVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InfluenzaVaccinesMember" xml:lang="en-US">Influenza Vaccines.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NexviazymeMember" xlink:label="loc_sny_NexviazymeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NexviazymeMember" xml:lang="en-US">Nexviazyme [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_NexviazymeMember" xml:lang="en-US">Nexviazyme</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NexviazymeMember" xlink:to="lab_sny_NexviazymeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NexviazymeMember" xml:lang="en-US">Nexviazyme</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_SarclisaMember" xlink:label="loc_sny_SarclisaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_SarclisaMember" xml:lang="en-US">Sarclisa [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_SarclisaMember" xml:lang="en-US">Sarclisa</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_SarclisaMember" xlink:to="lab_sny_SarclisaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_SarclisaMember" xml:lang="en-US">Sarclisa</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AltuviiioMember" xlink:label="loc_sny_AltuviiioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AltuviiioMember" xml:lang="en-US">Altuviiio [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_AltuviiioMember" xml:lang="en-US">Altuviiio</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AltuviiioMember" xlink:to="lab_sny_AltuviiioMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AltuviiioMember" xml:lang="en-US">Altuviiio</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RezurockMember" xlink:label="loc_sny_RezurockMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RezurockMember" xml:lang="en-US">Rezurock [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RezurockMember" xml:lang="en-US">Rezurock</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RezurockMember" xlink:to="lab_sny_RezurockMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RezurockMember" xml:lang="en-US">Rezurock</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CabliviMember" xlink:label="loc_sny_CabliviMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CabliviMember" xml:lang="en-US">Cablivi [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CabliviMember" xml:lang="en-US">Cablivi</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CabliviMember" xlink:to="lab_sny_CabliviMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CabliviMember" xml:lang="en-US">Cablivi</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_XenpozymeMember" xlink:label="loc_sny_XenpozymeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_XenpozymeMember" xml:lang="en-US">Xenpozyme [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_XenpozymeMember" xml:lang="en-US">Xenpozyme</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_XenpozymeMember" xlink:to="lab_sny_XenpozymeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_XenpozymeMember" xml:lang="en-US">Xenpozyme</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TzieldMember" xlink:label="loc_sny_TzieldMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TzieldMember" xml:lang="en-US">Tzield [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_TzieldMember" xml:lang="en-US">Tzield</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TzieldMember" xlink:to="lab_sny_TzieldMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TzieldMember" xml:lang="en-US">Tzield</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RSVVaccinesMember" xlink:label="loc_sny_RSVVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RSVVaccinesMember" xml:lang="en-US">RSV Vaccines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RSVVaccinesMember" xml:lang="en-US">RSV Vaccines</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RSVVaccinesMember" xlink:to="lab_sny_RSVVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RSVVaccinesMember" xml:lang="en-US">RSV Vaccines</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MeningitisTravelAndEndemicVaccinesMember" xlink:label="loc_sny_MeningitisTravelAndEndemicVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MeningitisTravelAndEndemicVaccinesMember" xml:lang="en-US">Meningitis Travel And Endemic Vaccines [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MeningitisTravelAndEndemicVaccinesMember" xml:lang="en-US">Meningitis Travel And Endemic Vaccines</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MeningitisTravelAndEndemicVaccinesMember" xlink:to="lab_sny_MeningitisTravelAndEndemicVaccinesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MeningitisTravelAndEndemicVaccinesMember" xml:lang="en-US">Meningitis Travel And Endemic Vaccines</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductOrServiceAxis" xlink:label="loc_srt_ProductOrServiceAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductOrServiceAxis" xml:lang="en-US">Product and Service [Axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_ProductOrServiceAxis" xml:lang="en-US">Product and service [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_srt_ProductOrServiceAxis" xml:lang="en-US">Product and service [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd#srt_ProductsAndServicesDomain" xlink:label="loc_srt_ProductsAndServicesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_srt_ProductsAndServicesDomain" xml:lang="en-US">Product and Service [Domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_srt_ProductsAndServicesDomain" xml:lang="en-US">Product and service [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ProductsAndServicesDomain" xml:lang="en-US">Products and services [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:label="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" xml:lang="en-US">Disclosure of geographical areas [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfGeographicalAreasLineItems" xlink:to="lab_ifrs-full_DisclosureOfGeographicalAreasLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersAxis" xlink:label="loc_ifrs-full_MarketsOfCustomersAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MarketsOfCustomersAxis" xml:lang="en-US">Markets of customers [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MarketsOfCustomersAxis" xml:lang="en-US">Markets of customers [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketsOfCustomersAxis" xlink:to="lab_ifrs-full_MarketsOfCustomersAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MarketsOfCustomersDomain" xlink:label="loc_ifrs-full_MarketsOfCustomersDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MarketsOfCustomersDomain" xml:lang="en-US">Markets of customers [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MarketsOfCustomersDomain" xml:lang="en-US">Markets of customers [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MarketsOfCustomersDomain" xlink:to="lab_ifrs-full_MarketsOfCustomersDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersAxis" xlink:label="loc_ifrs-full_TypesOfCustomersAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfCustomersAxis" xml:lang="en-US">Types of customers [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfCustomersAxis" xml:lang="en-US">Types of customers [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfCustomersAxis" xlink:to="lab_ifrs-full_TypesOfCustomersAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfCustomersDomain" xlink:label="loc_ifrs-full_TypesOfCustomersDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfCustomersDomain" xml:lang="en-US">Types of customers [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfCustomersDomain" xml:lang="en-US">Types of customers [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfCustomersDomain" xlink:to="lab_ifrs-full_TypesOfCustomersDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsAxis" xlink:label="loc_ifrs-full_TypesOfContractsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfContractsAxis" xml:lang="en-US">Types of contracts [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfContractsAxis" xml:lang="en-US">Types of contracts [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfContractsAxis" xlink:to="lab_ifrs-full_TypesOfContractsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TypesOfContractsDomain" xlink:label="loc_ifrs-full_TypesOfContractsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TypesOfContractsDomain" xml:lang="en-US">Types of contracts [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TypesOfContractsDomain" xml:lang="en-US">Types of contracts [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TypesOfContractsDomain" xlink:to="lab_ifrs-full_TypesOfContractsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationAxis" xlink:label="loc_ifrs-full_ContractDurationAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContractDurationAxis" xml:lang="en-US">Contract duration [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContractDurationAxis" xml:lang="en-US">Contract duration [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractDurationAxis" xlink:to="lab_ifrs-full_ContractDurationAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ContractDurationDomain" xlink:label="loc_ifrs-full_ContractDurationDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ContractDurationDomain" xml:lang="en-US">Contract duration [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ContractDurationDomain" xml:lang="en-US">Contract duration [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ContractDurationDomain" xlink:to="lab_ifrs-full_ContractDurationDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xml:lang="en-US">Timing of transfer of goods or services [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xml:lang="en-US">Timing of transfer of goods or services [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" xlink:to="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:label="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xml:lang="en-US">Timing of transfer of goods or services [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xml:lang="en-US">Timing of transfer of goods or services [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" xlink:to="lab_ifrs-full_TimingOfTransferOfGoodsOrServicesDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsAxis" xlink:label="loc_ifrs-full_SalesChannelsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesChannelsAxis" xml:lang="en-US">Sales channels [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SalesChannelsAxis" xml:lang="en-US">Sales channels [axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesChannelsAxis" xlink:to="lab_ifrs-full_SalesChannelsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SalesChannelsDomain" xlink:label="loc_ifrs-full_SalesChannelsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SalesChannelsDomain" xml:lang="en-US">Sales channels [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SalesChannelsDomain" xml:lang="en-US">Sales channels [domain]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SalesChannelsDomain" xlink:to="lab_ifrs-full_SalesChannelsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:label="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" xlink:to="lab_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xlink:label="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xml:lang="en-US">Revenue from VaxServe sales of non-Sanofi products</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xml:lang="en-US">&#8199;VaxServe sales of non-Sanofi products</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xlink:to="lab_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RevenueFromVaxServeSalesOfNonSanofiProducts" xml:lang="en-US">Revenue from VaxServe sales of non-Sanofi products</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xlink:label="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xml:lang="en-US">Revenue from intragroup sales from continuing to discontinued operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xml:lang="en-US">Sales to Opella</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xlink:to="lab_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" xml:lang="en-US">Revenue from intragroup sales from continuing to discontinued operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_RevenueFromRoyalties" xlink:label="loc_ifrs-full_RevenueFromRoyalties" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_RevenueFromRoyalties" xml:lang="en-US">Royalty income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_RevenueFromRoyalties" xml:lang="en-US">&#8199;Royalties</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_RevenueFromRoyalties" xlink:to="lab_ifrs-full_RevenueFromRoyalties" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_MiscellaneousOtherRevenue" xlink:label="loc_sny_MiscellaneousOtherRevenue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_MiscellaneousOtherRevenue" xml:lang="en-US">Miscellaneous other revenue</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_MiscellaneousOtherRevenue" xml:lang="en-US">Other</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_MiscellaneousOtherRevenue" xlink:to="lab_sny_MiscellaneousOtherRevenue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_MiscellaneousOtherRevenue" xml:lang="en-US">Miscellaneous other revenue</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" xml:lang="en-US">Disclosure of operating segments [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ReportableSegmentsMember" xlink:label="loc_ifrs-full_ReportableSegmentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ReportableSegmentsMember" xml:lang="en-US">Reportable segments [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ReportableSegmentsMember" xml:lang="en-US">Reportable segments [member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ReportableSegmentsMember" xlink:to="lab_ifrs-full_ReportableSegmentsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_AllOtherSegmentsMember" xlink:label="loc_ifrs-full_AllOtherSegmentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_AllOtherSegmentsMember" xml:lang="en-US">All other segments [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_AllOtherSegmentsMember" xml:lang="en-US">Other</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_AllOtherSegmentsMember" xlink:to="lab_ifrs-full_AllOtherSegmentsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:label="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xml:lang="en-US">Disclosure of operating segments [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xml:lang="en-US">Disclosure of operating segments [Line Items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfOperatingSegmentsLineItems" xlink:to="lab_ifrs-full_DisclosureOfOperatingSegmentsLineItems" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit (loss) of associates and joint ventures accounted for using equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the equity method</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xml:lang="en-US">Share of profit/(loss) from investments accounted for using the equity method</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="lab_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_BusinessOperatingIncome" xlink:label="loc_sny_BusinessOperatingIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_BusinessOperatingIncome" xml:lang="en-US">Business Operating Income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_BusinessOperatingIncome" xml:lang="en-US">Business Operating Income</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_BusinessOperatingIncome" xml:lang="en-US">Business operating income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_BusinessOperatingIncome" xlink:to="lab_sny_BusinessOperatingIncome" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_BusinessOperatingIncome" xml:lang="en-US">Business operating income.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-full_SegmentConsolidationItemsAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentConsolidationItemsAxis" xml:lang="en-US">Segment consolidation items [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SegmentConsolidationItemsAxis" xml:lang="en-US">Segment consolidation items [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentConsolidationItemsAxis" xlink:to="lab_ifrs-full_SegmentConsolidationItemsAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_SegmentConsolidationItemsDomain" xlink:label="loc_ifrs-full_SegmentConsolidationItemsDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_SegmentConsolidationItemsDomain" xml:lang="en-US">Segment consolidation items [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_SegmentConsolidationItemsDomain" xml:lang="en-US">Entity's total for segment consolidation items [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_SegmentConsolidationItemsDomain" xlink:to="lab_ifrs-full_SegmentConsolidationItemsDomain" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-full_OperatingSegmentsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xml:lang="en-US">Operating segments [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_OperatingSegmentsMember" xml:lang="en-US">Operating segments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_OperatingSegmentsMember" xlink:to="lab_ifrs-full_OperatingSegmentsMember" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MaterialReconcilingItemsMember" xlink:label="loc_ifrs-full_MaterialReconcilingItemsMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xml:lang="en-US">Material reconciling items [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MaterialReconcilingItemsMember" xml:lang="en-US">Material reconciling items</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MaterialReconcilingItemsMember" xlink:to="lab_ifrs-full_MaterialReconcilingItemsMember" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:label="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortization And Impairment Of Intangible Assets Other Than Goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortization and impairment of intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xlink:to="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" xml:lang="en-US">Amortization and impairment of intangible assets other than goodwill.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:label="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xml:lang="en-US">Expense Arising From The Impact Of Acquisitions On Inventories</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xml:lang="en-US">Expense arising from the impact of acquisitions on inventories</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xlink:to="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" xml:lang="en-US">Expenses arising from the impact of acquisitions on inventories.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xlink:label="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xml:lang="en-US">Impairment Loss on Intangible Asset Other Than Goodwill</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xml:lang="en-US">Impairment Loss on Intangible Asset Other Than Goodwill</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xlink:to="lab_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" xml:lang="en-US">Impairment Loss on Intangible Asset Other Than Goodwill</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xml:lang="en-US">Acquisitions of property, plant and equipment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xml:lang="en-US">Acquisitions of other intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="lab_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_ReportableGeographicalZonesMember" xlink:label="loc_sny_ReportableGeographicalZonesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_ReportableGeographicalZonesMember" xml:lang="en-US">Reportable Geographical Zones [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_ReportableGeographicalZonesMember" xml:lang="en-US">Reportable Geographical Zones [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_ReportableGeographicalZonesMember" xlink:to="lab_sny_ReportableGeographicalZonesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_ReportableGeographicalZonesMember" xml:lang="en-US">Reportable geographical zones.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_FR" xlink:label="loc_country_FR" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_FR" xml:lang="en-US">FRANCE</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_FR" xml:lang="en-US">France</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_FR" xlink:to="lab_country_FR" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xlink:label="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xml:lang="en-US">Other Countries, Excluding Europe And North America [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xml:lang="en-US">Rest of the World</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xlink:to="lab_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" xml:lang="en-US">Other Countries, Excluding Europe And North America</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/country/2025/country-2025.xsd#country_CN" xlink:label="loc_country_CN" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_country_CN" xml:lang="en-US">CHINA</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_country_CN" xml:lang="en-US">China</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CN" xlink:to="lab_country_CN" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-full_NoncurrentAssetsAbstract" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xml:lang="en-US">Non-current assets [abstract]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NoncurrentAssetsAbstract" xml:lang="en-US">Non-current assets [abstract]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NoncurrentAssetsAbstract" xlink:to="lab_ifrs-full_NoncurrentAssetsAbstract" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xml:lang="en-US">Disclosure Of Information About Major Customers And Credit Risk [Table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xml:lang="en-US">Disclosure of Information About Major Customers and Credit Risk [Table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xlink:to="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" xml:lang="en-US">Disclosure of information about major customers and credit risk.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersAxis" xlink:label="loc_ifrs-full_MajorCustomersAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersAxis" xml:lang="en-US">Major customers [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MajorCustomersAxis" xml:lang="en-US">Major customers [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersAxis" xlink:to="lab_ifrs-full_MajorCustomersAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_MajorCustomersDomain" xlink:label="loc_ifrs-full_MajorCustomersDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_MajorCustomersDomain" xml:lang="en-US">Major customers [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_MajorCustomersDomain" xml:lang="en-US">Customers [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_MajorCustomersDomain" xlink:to="lab_ifrs-full_MajorCustomersDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CertainWholesalersInTheUnitedStatesMember" xlink:label="loc_sny_CertainWholesalersInTheUnitedStatesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CertainWholesalersInTheUnitedStatesMember" xml:lang="en-US">Certain Wholesalers, In The United States [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CertainWholesalersInTheUnitedStatesMember" xml:lang="en-US">Certain wholesalers in the United States</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CertainWholesalersInTheUnitedStatesMember" xlink:to="lab_sny_CertainWholesalersInTheUnitedStatesMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CertainWholesalersInTheUnitedStatesMember" xml:lang="en-US">Certain Wholesalers, In The United States</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerOneMember" xlink:label="loc_sny_CustomerOneMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CustomerOneMember" xml:lang="en-US">Customer One [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CustomerOneMember" xml:lang="en-US">Customer one</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerOneMember" xlink:to="lab_sny_CustomerOneMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CustomerOneMember" xml:lang="en-US">Customer one.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerTwoMember" xlink:label="loc_sny_CustomerTwoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CustomerTwoMember" xml:lang="en-US">Customer Two [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CustomerTwoMember" xml:lang="en-US">Customer two</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerTwoMember" xlink:to="lab_sny_CustomerTwoMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CustomerTwoMember" xml:lang="en-US">Customer two.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CustomerThreeMember" xlink:label="loc_sny_CustomerThreeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CustomerThreeMember" xml:lang="en-US">Customer Three [member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_CustomerThreeMember" xml:lang="en-US">Customer three</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CustomerThreeMember" xlink:to="lab_sny_CustomerThreeMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CustomerThreeMember" xml:lang="en-US">Customer three.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:label="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xml:lang="en-US">Disclosure Of Information About Major Customers And Credit Risk [Line Items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xml:lang="en-US">Disclosure of information about major customers and credit risk [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xlink:to="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" xml:lang="en-US">Disclosure of information about major customers and credit risk.</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-full_PercentageOfEntitysRevenue" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue" xml:lang="en-US">Percentage of entity's revenue</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_PercentageOfEntitysRevenue" xml:lang="en-US">Percentage of entity's revenue</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_PercentageOfEntitysRevenue" xlink:to="lab_ifrs-full_PercentageOfEntitysRevenue" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:label="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xml:lang="en-US">Disclosure of analysis of single amount of discontinued operations [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" xlink:to="lab_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Property, Plant And Equipmenet, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Property, plant and equipment owned</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Property, Plant And Equipmenet, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Right Of Use Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Right-of-use assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Right Of Use Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Goodwill, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Goodwill</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Goodwill, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Intangible Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Other intangible assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Intangible Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Inventories, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Inventories</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Inventories, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts Receivables, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts receivable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts Receivables, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other assets</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Assets, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Assets Of Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Total assets held for sale</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Assets Of Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Lease Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Lease liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Lease Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Non-Current Provisions And Other Non-Current Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">&#8194;Non-current provisions and other non-current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Non-Current Provisions And Other Non-Current Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts Payable, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts payable</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Accounts Payable, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Current Provisions And Other Current Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Current provisions and other current liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Current Provisions And Other Current Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other liabilities</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Other Liabilities, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Liabilities Of Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="lab_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Total liabilities related to assets held for sale</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Liabilities Of Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Revenue From Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Net sales and other revenues</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Revenue From Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Operating Revenue, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Operating income</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Operating Revenue, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Gain on Disposal of Opella, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Gain on disposal of Opella before tax</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Gain on Disposal of Opella, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income Before Tax And Investments Accounted For Using The Equity Method, Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income Before Tax And Investments Accounted For Using The Equity Method, Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xlink:label="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income Tax Expense (Benefit), Disposal Group Including Discontinued Operations</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="lab_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income tax expense</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xlink:to="lab_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" xml:lang="en-US">Income Tax Expense (Benefit), Disposal Group Including Discontinued Operations</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [table]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xml:lang="en-US">Non-adjusting events after reporting period [axis]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xml:lang="en-US">Non-adjusting events after reporting period [Axis]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodAxis" />
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:label="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xml:lang="en-US">Non-adjusting events after reporting period [domain]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xml:lang="en-US">Non-adjusting events after reporting period [Member]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" xlink:to="lab_ifrs-full_NonadjustingEventsAfterReportingPeriodDomain" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_VicebioLtdMember" xlink:label="loc_sny_VicebioLtdMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_VicebioLtdMember" xml:lang="en-US">Vicebio Ltd [Member]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_VicebioLtdMember" xml:lang="en-US">Vicebio Ltd</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_VicebioLtdMember" xlink:to="lab_sny_VicebioLtdMember" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_VicebioLtdMember" xml:lang="en-US">Vicebio Ltd [Member]</link:label>
          <link:loc xlink:type="locator" xlink:href="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd#ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:label="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xml:lang="en-US">Disclosure of non-adjusting events after reporting period [line items]</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" xlink:to="lab_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems" />
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_UpfrontPayments" xlink:label="loc_sny_UpfrontPayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_UpfrontPayments" xml:lang="en-US">Upfront Payments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_UpfrontPayments" xml:lang="en-US">Upfront payment</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_UpfrontPayments" xlink:to="lab_sny_UpfrontPayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_UpfrontPayments" xml:lang="en-US">Upfront payments.</link:label>
          <link:loc xlink:type="locator" xlink:href="sny-20250630.xsd#sny_TotalMilestonePayments" xlink:label="loc_sny_TotalMilestonePayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lab_sny_TotalMilestonePayments" xml:lang="en-US">Total Milestone Payments</link:label>
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="lab_sny_TotalMilestonePayments" xml:lang="en-US">Total Milestone Payments</link:label>
          <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sny_TotalMilestonePayments" xlink:to="lab_sny_TotalMilestonePayments" />
          <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="lab_sny_TotalMilestonePayments" xml:lang="en-US">Total Milestone Payments</link:label>
        </link:labelLink>
      </link:linkbase>
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" />
  <import namespace="http://xbrl.org/2020/extensible-enumerations-2.0" schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2025" schemaLocation="https://xbrl.sec.gov/country/2025/country-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2025" schemaLocation="https://xbrl.sec.gov/currency/2025/currency-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2025" schemaLocation="https://xbrl.sec.gov/exch/2025/exch-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2025" schemaLocation="https://xbrl.sec.gov/naics/2025/naics-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2025" schemaLocation="https://xbrl.sec.gov/sic/2025/sic-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2025" schemaLocation="https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2025" schemaLocation="https://xbrl.sec.gov/dei/2025/dei-2025.xsd" />
  <import namespace="http://fasb.org/srt-types/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd" />
  <import namespace="http://fasb.org/srt/2025" schemaLocation="https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd" />
  <import namespace="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full" schemaLocation="https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd" />
  <element name="NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NonCurrentProvisionsAndOtherNonCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CurrentProvisionsAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrentProvisionsAndOtherCurrentLiabilities" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherGainsLossesAndLitigation" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherGainsLossesAndLitigation" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="BasicEarningsLossPerShareAttributableToOwnersOfParent" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_BasicEarningsLossPerShareAttributableToOwnersOfParent" substitutionGroup="xbrli:item" />
  <element name="DilutedEarningsLossPerShareAttributableToOwnersOfParent" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent" substitutionGroup="xbrli:item" />
  <element name="GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherComprehensiveIncomeFromContinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherComprehensiveIncomeFromContinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherComprehensiveIncomeFromDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherComprehensiveIncomeFromDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ShareBasedPaymentPlansAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareBasedPaymentPlansAbstract" substitutionGroup="xbrli:item" />
  <element name="IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="TaxesOnShareCancellations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_TaxesOnShareCancellations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AdjustmentsForLossesGainsOnTransferOfBusiness" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_AdjustmentsForLossesGainsOnTransferOfBusiness" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetChangeInOtherNonCurrentAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetChangeInOtherNonCurrentAssets" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetCashProvidedByusedInContinuingInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetCashProvidedByusedInContinuingInvestingActivities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetCashProvidedByusedInDiscontinuingInvestingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetCashProvidedByusedInDiscontinuingInvestingActivities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetCashInflowFromDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetCashInflowFromDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="DividendsPaidAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DividendsPaidAbstract" substitutionGroup="xbrli:item" />
  <element name="CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="CommercialPaperProgramInUSAMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CommercialPaperProgramInUSAMember" substitutionGroup="xbrli:item" />
  <element name="OpellaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OpellaMember" substitutionGroup="xbrli:item" />
  <element name="DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="GeneralInformationAboutFinancialStatementsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_GeneralInformationAboutFinancialStatementsAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock" substitutionGroup="xbrli:item" />
  <element name="InterestsInOtherEntitiesAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InterestsInOtherEntitiesAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfTradeReceivablesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfTradeReceivablesTextBlock" substitutionGroup="xbrli:item" />
  <element name="ShareCapitalReservesAndOtherEquityInterestAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareCapitalReservesAndOtherEquityInterestAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock" substitutionGroup="xbrli:item" />
  <element name="FinancialInstrumentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FinancialInstrumentsAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock" substitutionGroup="xbrli:item" />
  <element name="OffBalanceSheetCommitmentsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OffBalanceSheetCommitmentsAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock" substitutionGroup="xbrli:item" />
  <element name="OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLegalAndArbitralProceedingsTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLegalAndArbitralProceedingsTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfRestructuringTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfRestructuringTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock" substitutionGroup="xbrli:item" />
  <element name="SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfCurrentTradeReceivablesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfCurrentTradeReceivablesTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOverdueReceivablesGrossValueTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfChangesInFinancialPositionTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfChangesInFinancialPositionTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfMarketValueOfNetDebtTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfMarketValueOfNetDebtTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfNonCurrentProvisionsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfNonCurrentProvisionsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="OtherOperatingExpensesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherOperatingExpensesTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfRestructuringCostsDetailsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfRestructuringCostsDetailsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOtherRevenueTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherRevenueTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock" substitutionGroup="xbrli:item" />
  <element name="TypesOfAgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_TypesOfAgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="TypesOfAgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_TypesOfAgreementDomain" substitutionGroup="xbrli:item" />
  <element name="CumulativeConsumerPriceInflationRateOverTheLastThreeYears" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears" substitutionGroup="xbrli:item" />
  <element name="AssetsAcquisitionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AssetsAcquisitionAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="AssetsAcquisitionDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AssetsAcquisitionDomain" substitutionGroup="xbrli:item" />
  <element name="AssetsAcquisitionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AssetsAcquisitionMember" substitutionGroup="xbrli:item" />
  <element name="VigilNeuroscienceIncMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_VigilNeuroscienceIncMember" substitutionGroup="xbrli:item" />
  <element name="BlueprintMedicinesCorporationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_BlueprintMedicinesCorporationMember" substitutionGroup="xbrli:item" />
  <element name="OpellaBusinessMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OpellaBusinessMember" substitutionGroup="xbrli:item" />
  <element name="OPALJVCoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OPALJVCoMember" substitutionGroup="xbrli:item" />
  <element name="BpifranceMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_BpifranceMember" substitutionGroup="xbrli:item" />
  <element name="PotentialFuturePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_PotentialFuturePayments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="EquityInterestsOfAcquirerPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_EquityInterestsOfAcquirerPerShare" substitutionGroup="xbrli:item" />
  <element name="DeferredCashPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DeferredCashPayments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="CashTransferredPerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CashTransferredPerShare" substitutionGroup="xbrli:item" />
  <element name="MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment" substitutionGroup="xbrli:item" />
  <element name="MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones" substitutionGroup="xbrli:item" />
  <element name="BiopharmaSegmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_BiopharmaSegmentMember" substitutionGroup="xbrli:item" />
  <element name="ManufacturingAndSupplyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ManufacturingAndSupplyMember" substitutionGroup="xbrli:item" />
  <element name="FirmOrdersOfPropertyPlantAndEquipment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_FirmOrdersOfPropertyPlantAndEquipment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="MarketedProductsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MarketedProductsMember" substitutionGroup="xbrli:item" />
  <element name="TechnologicalPlatformsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_TechnologicalPlatformsMember" substitutionGroup="xbrli:item" />
  <element name="PrincipalAlliancesAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_PrincipalAlliancesAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="PrincipalAlliancesDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_PrincipalAlliancesDomain" substitutionGroup="xbrli:item" />
  <element name="ProductsTrademarksAndOtherRightsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ProductsTrademarksAndOtherRightsMember" substitutionGroup="xbrli:item" />
  <element name="AcquiredResearchAndDevelopmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AcquiredResearchAndDevelopmentMember" substitutionGroup="xbrli:item" />
  <element name="ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="InfraservGmbhAndCoHochstKGMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InfraservGmbhAndCoHochstKGMember" substitutionGroup="xbrli:item" />
  <element name="MSPVaccineCompanyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MSPVaccineCompanyMember" substitutionGroup="xbrli:item" />
  <element name="EuroapiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_EuroapiMember" substitutionGroup="xbrli:item" />
  <element name="CDRMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CDRMember" substitutionGroup="xbrli:item" />
  <element name="MCMVaccineBVMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MCMVaccineBVMember" substitutionGroup="xbrli:item" />
  <element name="StockPrice" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_StockPrice" substitutionGroup="xbrli:item" />
  <element name="LoansToAssociates" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_LoansToAssociates" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="AssociatesAndJointVenturesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AssociatesAndJointVenturesMember" substitutionGroup="xbrli:item" />
  <element name="RoyaltiesAndOtherIncomeRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherAssetsRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherAssetsRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="SubordinateHybridBondRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_SubordinateHybridBondRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherComprehensiveIncomeRelatedPartyDisclosures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherComprehensiveIncomeRelatedPartyDisclosures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ComprehensiveIncomeRelatedPartyDisclosures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ComprehensiveIncomeRelatedPartyDisclosures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="EquityAndLiabilitiesRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_EquityAndLiabilitiesRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CurrentAssetsRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrentAssetsRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AssetsRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_AssetsRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="EquityAttributableToEquityHoldersRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_EquityAttributableToEquityHoldersRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="EquityAttributableToNonControllingInterestRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="EquityRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_EquityRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NonCurrentLiabilitiesRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentLiabilitiesRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CurrentLiabilitiesRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrentLiabilitiesRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="LiabilitiesRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_LiabilitiesRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NonCurrentAssetsRelatedPartyTransactions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentAssetsRelatedPartyTransactions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NetIncomeRelatedPartyDisclosures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetIncomeRelatedPartyDisclosures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NetSalesAndOtherRevenuesRelatedPartyDisclosures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="DisclosureOfOtherNonCurrentAssetsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherNonCurrentAssetsTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="DisclosureOfOtherNonCurrentAssetsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherNonCurrentAssetsLineItems" substitutionGroup="xbrli:item" />
  <element name="OtherFinancialAssetsAtFairValueThroughProfitOrLoss" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="PreFundedPensionObligations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_PreFundedPensionObligations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="LongTermPrepaidExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_LongTermPrepaidExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NonCurrentLoansAndReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentLoansAndReceivables" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="DisclosureOfAccountsReceivableTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAccountsReceivableTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="DisclosureOfAccountsReceivableLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfAccountsReceivableLineItems" substitutionGroup="xbrli:item" />
  <element name="DerecognizedReceivables" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_DerecognizedReceivables" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="OverdueReceivablesGrossValue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OverdueReceivablesGrossValue" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="SanofiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_SanofiMember" substitutionGroup="xbrli:item" />
  <element name="ShareProgramAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareProgramAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="ShareProgramDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareProgramDomain" substitutionGroup="xbrli:item" />
  <element name="ShareRepurchase2024ProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareRepurchase2024ProgramMember" substitutionGroup="xbrli:item" />
  <element name="ShareRepurchase2025ProgramMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareRepurchase2025ProgramMember" substitutionGroup="xbrli:item" />
  <element name="EmployeeShareOwnershipPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_EmployeeShareOwnershipPlanMember" substitutionGroup="xbrli:item" />
  <element name="ForeignCurrencyTranslationMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForeignCurrencyTranslationMember" substitutionGroup="xbrli:item" />
  <element name="FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember" substitutionGroup="xbrli:item" />
  <element name="ItemsSubsequentlyReclassifiableToProfitOrLossMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember" substitutionGroup="xbrli:item" />
  <element name="NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions" substitutionGroup="xbrli:item" />
  <element name="NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease" substitutionGroup="xbrli:item" />
  <element name="NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease" substitutionGroup="xbrli:item" />
  <element name="PeriodOfShareRepurchaseProgram" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_PeriodOfShareRepurchaseProgram" substitutionGroup="xbrli:item" />
  <element name="NumberOfSharesRepurchased" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NumberOfSharesRepurchased" substitutionGroup="xbrli:item" />
  <element name="AmountOfSharesRepurchased" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_AmountOfSharesRepurchased" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="SubscriptionPricePerShare" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_SubscriptionPricePerShare" substitutionGroup="xbrli:item" />
  <element name="NumberOfSharesSubscribed" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfSharesSubscribed" substitutionGroup="xbrli:item" />
  <element name="IssuanceOfFurtherSharesAsAnEmployersContribution" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_IssuanceOfFurtherSharesAsAnEmployersContribution" substitutionGroup="xbrli:item" />
  <element name="NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease" substitutionGroup="xbrli:item" />
  <element name="PerShareValueOfSharesRepurchased" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_PerShareValueOfSharesRepurchased" substitutionGroup="xbrli:item" />
  <element name="NumberOfSharesHeld" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfSharesHeld" substitutionGroup="xbrli:item" />
  <element name="PercentageOfShareCapitalForThePeriod" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_PercentageOfShareCapitalForThePeriod" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharePlan2024Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharePlan2024Member" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharePlan2025Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharePlan2025Member" substitutionGroup="xbrli:item" />
  <element name="MarketConditionAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MarketConditionAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="MarketConditionDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MarketConditionDomain" substitutionGroup="xbrli:item" />
  <element name="WithoutMarketConditionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_WithoutMarketConditionMember" substitutionGroup="xbrli:item" />
  <element name="WithMarketConditionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_WithMarketConditionMember" substitutionGroup="xbrli:item" />
  <element name="ExcludingChiefExecutiveOfficerMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ExcludingChiefExecutiveOfficerMember" substitutionGroup="xbrli:item" />
  <element name="FairValuePerShareAwardedForThreeYearServicePeriod" type="dtr-types:perShareItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_FairValuePerShareAwardedForThreeYearServicePeriod" substitutionGroup="xbrli:item" />
  <element name="FairValueOfPlanAtDateOfGrant" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_FairValueOfPlanAtDateOfGrant" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NumberOfYearsServicePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NumberOfYearsServicePeriod" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharesMember" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharePlan2023Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharePlan2023Member" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharePlan2022Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharePlan2022Member" substitutionGroup="xbrli:item" />
  <element name="RestrictedSharePlan2021Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RestrictedSharePlan2021Member" substitutionGroup="xbrli:item" />
  <element name="NumberOfRestrictedSharesNotYetFullyVested" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfRestrictedSharesNotYetFullyVested" substitutionGroup="xbrli:item" />
  <element name="ExercisePriceRangeTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ExercisePriceRangeTwoMember" substitutionGroup="xbrli:item" />
  <element name="ExercisePriceRangeThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ExercisePriceRangeThreeMember" substitutionGroup="xbrli:item" />
  <element name="ExercisePriceRangeFourMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ExercisePriceRangeFourMember" substitutionGroup="xbrli:item" />
  <element name="StockOptionPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_StockOptionPlanMember" substitutionGroup="xbrli:item" />
  <element name="DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares" substitutionGroup="xbrli:item" />
  <element name="ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember" substitutionGroup="xbrli:item" />
  <element name="EquityInstrumentsIncludedInFinancialAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_EquityInstrumentsIncludedInFinancialAssetsMember" substitutionGroup="xbrli:item" />
  <element name="DebtInstrumentsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DebtInstrumentsMember" substitutionGroup="xbrli:item" />
  <element name="ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ChangeInCurrencyTranslationOnTaxEffects" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ChangeInCurrencyTranslationOnTaxEffects" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="InterestRateAndCurrencyDerivativesUsedToManageDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_InterestRateAndCurrencyDerivativesUsedToManageDebt" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="DebtNetOfCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_DebtNetOfCashAndCashEquivalents" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="AmortizedCostNettingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AmortizedCostNettingMember" substitutionGroup="xbrli:item" />
  <element name="AdjustmentToDebtMeasuredAtFairValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AdjustmentToDebtMeasuredAtFairValueMember" substitutionGroup="xbrli:item" />
  <element name="ValueOnRedemptionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ValueOnRedemptionMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems" substitutionGroup="xbrli:item" />
  <element name="NonCurrentLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_NonCurrentLiabilitiesMember" substitutionGroup="xbrli:item" />
  <element name="CurrentLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CurrentLiabilitiesMember" substitutionGroup="xbrli:item" />
  <element name="NonCurrentAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_NonCurrentAssetsMember" substitutionGroup="xbrli:item" />
  <element name="CurrentAssetsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CurrentAssetsMember" substitutionGroup="xbrli:item" />
  <element name="CommercialPaperProgramInFranceMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CommercialPaperProgramInFranceMember" substitutionGroup="xbrli:item" />
  <element name="OtherBankBorrowings" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherBankBorrowings" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="FourBillionFacilityMaturingDecember2027Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FourBillionFacilityMaturingDecember2027Member" substitutionGroup="xbrli:item" />
  <element name="FourBillionFacilityMaturingMarch2030Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FourBillionFacilityMaturingMarch2030Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondIssueFromApril2020Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondIssueFromApril2020Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondIssueFromApril2022Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondIssueFromApril2022Member" substitutionGroup="xbrli:item" />
  <element name="OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondMaturingMarch2027Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondMaturingMarch2027Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondMaturingMarch2031Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondMaturingMarch2031Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondMaturingJune2029Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondMaturingJune2029Member" substitutionGroup="xbrli:item" />
  <element name="FixedRateBondMaturingMarch2032Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_FixedRateBondMaturingMarch2032Member" substitutionGroup="xbrli:item" />
  <element name="OneBillionFiveHundredMillionBondsIssuedInJune2025Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member" substitutionGroup="xbrli:item" />
  <element name="DebtInstrumentAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DebtInstrumentAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="DebtInstrumentDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DebtInstrumentDomain" substitutionGroup="xbrli:item" />
  <element name="SanofiEuroMediumTermNotesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_SanofiEuroMediumTermNotesMember" substitutionGroup="xbrli:item" />
  <element name="BorrowingAverageDrawdown" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_BorrowingAverageDrawdown" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NumberOfTranches" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfTranches" substitutionGroup="xbrli:item" />
  <element name="AtMarketValueMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AtMarketValueMember" substitutionGroup="xbrli:item" />
  <element name="RedemptionOfDebtInstrumentIssued" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RedemptionOfDebtInstrumentIssued" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="AtNotionalAmountMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AtNotionalAmountMember" substitutionGroup="xbrli:item" />
  <element name="ValueOfHedgeRecognizedInEquityMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ValueOfHedgeRecognizedInEquityMember" substitutionGroup="xbrli:item" />
  <element name="NotEligibleForHedgeAccountingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_NotEligibleForHedgeAccountingMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesInUSDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesInUSDollarMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesInChineseYuanRenminbiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesInChineseYuanRenminbiMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesInJapaneseYenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesInJapaneseYenMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesInSingaporeDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesInSingaporeDollarMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencySalesInPoundSterlingMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencySalesInPoundSterlingMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInUSDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInUSDollarMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInSingaporeDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInSingaporeDollarMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInChineseYuanRenminbiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInTurkishLiraMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInTurkishLiraMember" substitutionGroup="xbrli:item" />
  <element name="DerivativeFinancialInstruments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_DerivativeFinancialInstruments" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ForwardCurrencyPurchasesInHungarianFlorintMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInHungarianFlorintMember" substitutionGroup="xbrli:item" />
  <element name="ForwardCurrencyPurchasesInUSDollarUSBondMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ForwardCurrencyPurchasesInUSDollarUSBondMember" substitutionGroup="xbrli:item" />
  <element name="CrossCurrencySwapExpiring2029Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CrossCurrencySwapExpiring2029Member" substitutionGroup="xbrli:item" />
  <element name="CrossCurrencySwapExpiring2032Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CrossCurrencySwapExpiring2032Member" substitutionGroup="xbrli:item" />
  <element name="CrossCurrencySwapMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CrossCurrencySwapMember" substitutionGroup="xbrli:item" />
  <element name="CrossCurrencySellerSwapsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CrossCurrencySellerSwapsMember" substitutionGroup="xbrli:item" />
  <element name="CrossCurrencySellerSwapsInUSDollarMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CrossCurrencySellerSwapsInUSDollarMember" substitutionGroup="xbrli:item" />
  <element name="DerivativeFinancialInstrumentsToManageFinancialExposure" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_DerivativeFinancialInstrumentsToManageFinancialExposure" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember" substitutionGroup="xbrli:item" />
  <element name="InterestRateSwapsPayCapitalizedEsterReceive092Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InterestRateSwapsPayCapitalizedEsterReceive092Member" substitutionGroup="xbrli:item" />
  <element name="InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember" substitutionGroup="xbrli:item" />
  <element name="CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="MSDContingentConsiderationEuropeanVaccinesBusinessMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember" substitutionGroup="xbrli:item" />
  <element name="ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember" substitutionGroup="xbrli:item" />
  <element name="OtherLiabilities1Member" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OtherLiabilities1Member" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems" substitutionGroup="xbrli:item" />
  <element name="ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward" substitutionGroup="xbrli:item" />
  <element name="IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="PercentageIncreaseInFairValueLiabilities" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_PercentageIncreaseInFairValueLiabilities" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfNonCurrentProvisionsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfNonCurrentProvisionsTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="AntibodiesCollaborationAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AntibodiesCollaborationAgreementMember" substitutionGroup="xbrli:item" />
  <element name="SwedishOrphanBiovitrumABMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_SwedishOrphanBiovitrumABMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfNonCurrentProvisionsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfNonCurrentProvisionsLineItems" substitutionGroup="xbrli:item" />
  <element name="ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember" substitutionGroup="xbrli:item" />
  <element name="ProvisionsForOtherLongTermBenefitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ProvisionsForOtherLongTermBenefitsMember" substitutionGroup="xbrli:item" />
  <element name="NonCurrentRestructuringProvisionMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_NonCurrentRestructuringProvisionMember" substitutionGroup="xbrli:item" />
  <element name="IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="PensionsAndOtherPostEmploymentBenefitsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_PensionsAndOtherPostEmploymentBenefitsMember" substitutionGroup="xbrli:item" />
  <element name="EUROZONEMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_EUROZONEMember" substitutionGroup="xbrli:item" />
  <element name="UKZONEMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_UKZONEMember" substitutionGroup="xbrli:item" />
  <element name="EarendilLabsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_EarendilLabsMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLegalAndArbitralProceedingsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLegalAndArbitralProceedingsTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="LegalAndArbitralProceedingsAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_LegalAndArbitralProceedingsAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="LegalAndArbitralProceedingsDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_LegalAndArbitralProceedingsDomain" substitutionGroup="xbrli:item" />
  <element name="PlavixAttorneyGeneralActionInHawaiiMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_PlavixAttorneyGeneralActionInHawaiiMember" substitutionGroup="xbrli:item" />
  <element name="GoldBondProductLitigationInTheUSMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_GoldBondProductLitigationInTheUSMember" substitutionGroup="xbrli:item" />
  <element name="DefendantAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DefendantAxis" substitutionGroup="xbrldt:dimensionItem" />
  <element name="DefendantDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DefendantDomain" substitutionGroup="xbrli:item" />
  <element name="ActionForWhichWeAreDefendantMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ActionForWhichWeAreDefendantMember" substitutionGroup="xbrli:item" />
  <element name="ActionForWhichSanofiAreDefendantMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ActionForWhichSanofiAreDefendantMember" substitutionGroup="xbrli:item" />
  <element name="ProductLiabilitiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ProductLiabilitiesMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfLegalAndArbitralProceedingsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfLegalAndArbitralProceedingsLineItems" substitutionGroup="xbrli:item" />
  <element name="NumberOfClassActionLawsuits" type="xbrli:integerItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NumberOfClassActionLawsuits" substitutionGroup="xbrli:item" />
  <element name="PenaltyFeeIncurred" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_PenaltyFeeIncurred" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="PaymentOfDamagesClaimedByCounterparty" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_PaymentOfDamagesClaimedByCounterparty" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="DisclosureOfOtherOperatingIncomeExpensesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherOperatingIncomeExpensesTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="RegeneronMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RegeneronMember" substitutionGroup="xbrli:item" />
  <element name="OtherOperatingIncomeExpenseMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OtherOperatingIncomeExpenseMember" substitutionGroup="xbrli:item" />
  <element name="CommercializationRelatedExpensesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CommercializationRelatedExpensesMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfOtherOperatingIncomeExpensesLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfOtherOperatingIncomeExpensesLineItems" substitutionGroup="xbrli:item" />
  <element name="GainsOnDivestmentOfProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_GainsOnDivestmentOfProducts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="AntibodiesAllianceMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AntibodiesAllianceMember" substitutionGroup="xbrli:item" />
  <element name="OthersCounterpartyMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OthersCounterpartyMember" substitutionGroup="xbrli:item" />
  <element name="ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember" substitutionGroup="xbrli:item" />
  <element name="ShareOfProfitOrLossFromCommercializationOfZaltrapMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember" substitutionGroup="xbrli:item" />
  <element name="MiscellaneousOtherOperatingIncomeExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_MiscellaneousOtherOperatingIncomeExpenses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ExpenseOfRestructuringActivitiesTransformationProgramsCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="OtherRestructuringCosts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OtherRestructuringCosts" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="IncreaseDecreaseInTotalExpenseOfRestructuringActivities" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="InterestRateAndCurrencyDerivativesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InterestRateAndCurrencyDerivativesMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems" substitutionGroup="xbrli:item" />
  <element name="InterestIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_InterestIncome" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CostOfDebtNet" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_CostOfDebtNet" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="NonOperatingForeignExchangeGainsLosses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NonOperatingForeignExchangeGainsLosses" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NetInterestCostRelatedToEmployeeBenefits" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_NetInterestCostRelatedToEmployeeBenefits" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="GainLossOnDerivativesUsedToManageDebt" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_GainLossOnDerivativesUsedToManageDebt" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="GainLossOnDerivativesUsedToManageCashAndCashEquivalents" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="LiabilityRecognisedForEstimatedFutureRoyalties" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_LiabilityRecognisedForEstimatedFutureRoyalties" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes" substitutionGroup="xbrli:item" />
  <element name="CurrentTaxExpenseRelatedToPillarTwo" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_CurrentTaxExpenseRelatedToPillarTwo" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="OtherCountriesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OtherCountriesMember" substitutionGroup="xbrli:item" />
  <element name="SpecialtyCareMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_SpecialtyCareMember" substitutionGroup="xbrli:item" />
  <element name="DupixentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DupixentMember" substitutionGroup="xbrli:item" />
  <element name="AubagioMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AubagioMember" substitutionGroup="xbrli:item" />
  <element name="GeneralMedicinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_GeneralMedicinesMember" substitutionGroup="xbrli:item" />
  <element name="IndustrialSalesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_IndustrialSalesMember" substitutionGroup="xbrli:item" />
  <element name="VaccinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_VaccinesMember" substitutionGroup="xbrli:item" />
  <element name="PolioPertussisHibVaccinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_PolioPertussisHibVaccinesMember" substitutionGroup="xbrli:item" />
  <element name="InfluenzaVaccinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_InfluenzaVaccinesMember" substitutionGroup="xbrli:item" />
  <element name="NexviazymeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_NexviazymeMember" substitutionGroup="xbrli:item" />
  <element name="SarclisaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_SarclisaMember" substitutionGroup="xbrli:item" />
  <element name="AltuviiioMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_AltuviiioMember" substitutionGroup="xbrli:item" />
  <element name="RezurockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RezurockMember" substitutionGroup="xbrli:item" />
  <element name="CabliviMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CabliviMember" substitutionGroup="xbrli:item" />
  <element name="XenpozymeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_XenpozymeMember" substitutionGroup="xbrli:item" />
  <element name="TzieldMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_TzieldMember" substitutionGroup="xbrli:item" />
  <element name="RSVVaccinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_RSVVaccinesMember" substitutionGroup="xbrli:item" />
  <element name="MeningitisTravelAndEndemicVaccinesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_MeningitisTravelAndEndemicVaccinesMember" substitutionGroup="xbrli:item" />
  <element name="RevenueFromVaxServeSalesOfNonSanofiProducts" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RevenueFromVaxServeSalesOfNonSanofiProducts" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="MiscellaneousOtherRevenue" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_MiscellaneousOtherRevenue" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="BusinessOperatingIncome" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_BusinessOperatingIncome" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ImpairmentLossOnIntangibleAssetOtherThanGoodwill" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="ReportableGeographicalZonesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_ReportableGeographicalZonesMember" substitutionGroup="xbrli:item" />
  <element name="OtherCountriesExcludingEuropeAndNorthAmericaMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_OtherCountriesExcludingEuropeAndNorthAmericaMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable" substitutionGroup="xbrldt:hypercubeItem" />
  <element name="CertainWholesalersInTheUnitedStatesMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CertainWholesalersInTheUnitedStatesMember" substitutionGroup="xbrli:item" />
  <element name="CustomerOneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CustomerOneMember" substitutionGroup="xbrli:item" />
  <element name="CustomerTwoMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CustomerTwoMember" substitutionGroup="xbrli:item" />
  <element name="CustomerThreeMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_CustomerThreeMember" substitutionGroup="xbrli:item" />
  <element name="DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems" substitutionGroup="xbrli:item" />
  <element name="PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="GoodwillDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_GoodwillDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="InventoriesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_InventoriesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="OtherAssetsDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="AssetsOfDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="AccountsPayableDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="RevenueFromDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations" substitutionGroup="xbrli:item" xbrli:balance="debit" />
  <element name="VicebioLtdMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="sny_VicebioLtdMember" substitutionGroup="xbrli:item" />
  <element name="UpfrontPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_UpfrontPayments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
  <element name="TotalMilestonePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="sny_TotalMilestonePayments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g69958dsp6a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69958dsp6a.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  /  X# 1$  A$! Q$!_\0
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CJ*A35HKY]$EVV226FR76[>23<G.;NW\NKE^+DW\]+*R7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g69958dsp6b.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69958dsp6b.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  /  X# 1$  A$! Q$!_\0
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CJ*A35HKY]$EVV226FR76[>23<G.;NW\NKE^+DW\]+*R7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g69958dsp6c.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g69958dsp6c.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  - !$# 1$  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[;_:;_:AL
M?@*FE:3%9WLWB/6=PL9I-#U"\L5(CE?!>WB822$Q$>2K!P&#-M3YCE-SLU3W
M2;^[_A]6[)+=WLGK"*;3EM=+[W;_ (9:MO1+MSG[,'[7$_Q;U.W\*^)M/O5\
M5M;&9[O3_"NJ6&GAUW&6-C<(XCV84!WD <N  K$*>N:IWE[.]D[:]=6K^5W&
M6G2V[:DEQTYR:CSVNU?3II%_/22U7Y.+E]-UB;G'?$_X4Z#\6M$@T_6XY$DM
M9OM-E?VVT7%G-M9/,B9E8 [68<@@@G(-93IJ:>MKIK3LU9KYK_/=(TA4</2Z
M=O1IK[FDS,^#_P #]%^#6EBVL;_4M=OO(2V?5M9>)[J2)22JL8HXT/+$EMNY
MCRQ8\UUU*CJ-RLE=W=NK[_F[*RNVTE=G-3IJFE%/1:+R6B_)):ZV26R1Z)6)
#J?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">6-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SANOFI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001121404<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 30,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 9,574<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 10,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,510<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">40,283<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">43,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,431<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,109<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsNoncurrent', window );">Non-current income tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">541<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">560<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxAssets', window );">Deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,967<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">87,942<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">90,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,618<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,431<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,677<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,595<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,826<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssetsCurrent', window );">Current income tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">397<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">724<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,441<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale', window );">Assets held for sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">238<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,489<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">37,017<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,588<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">124,959<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">132,798<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilitiesAbstract', window );"><strong>Equity and liabilities</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">70,008<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,507<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Equity attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">271<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">70,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,857<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">13,200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,791<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Non-current lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,524<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,645<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Non-current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">564<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">569<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities', window );">Non-current provisions and other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,096<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent', window );">Non-current income tax liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,502<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxLiabilities', window );">Deferred tax liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,715<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,166<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25,621<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,779<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,075<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,551<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Current liabilities related to business combinations and to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentProvisionsAndOtherCurrentLiabilities', window );">Current provisions and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">13,697<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Current income tax liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">724<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">697<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Current lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">261<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,309<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,209<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale', window );">Liabilities related to assets held for sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,131<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">29,059<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,162<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total equity and liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 124,959<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 132,798<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">As of January 1, 2025, this comprised a non-current portion of &#8364;569 million and a current portion of &#8364;72 million.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax assets. [Refer: Current tax assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph o<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_o&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 56<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_56&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 164<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_164_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 38<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph p<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_p&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Paragraph 22<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 38<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_38&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 69<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_70&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentProvisionsAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentProvisionsAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Income Statements - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[3]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAbstract', window );"><strong>Profit (loss) [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 19,889<span></span>
</td>
<td class="nump">&#8364; 18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,452<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,881)<span></span>
</td>
<td class="num">(5,966)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,460<span></span>
</td>
<td class="nump">13,923<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,717)<span></span>
</td>
<td class="num">(3,335)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,506)<span></span>
</td>
<td class="num">(4,303)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">533<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,476)<span></span>
</td>
<td class="num">(1,977)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(777)<span></span>
</td>
<td class="num">(898)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(210)<span></span>
</td>
<td class="nump">371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,759<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">comprising: Financial expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(361)<span></span>
</td>
<td class="num">(583)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">184<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">2,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(711)<span></span>
</td>
<td class="num">(379)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the&#160;equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">85<span></span>
</td>
<td class="num">(22)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromContinuingOperations', window );">Net income from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,956<span></span>
</td>
<td class="nump">2,061<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net (income)/loss of the exchanged/held-for-exchange Animal Health business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,881<span></span>
</td>
<td class="nump">202<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,837<span></span>
</td>
<td class="nump">2,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Net income attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 5,812<span></span>
</td>
<td class="nump">&#8364; 2,246<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Average number of shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,225,500,000<span></span>
</td>
<td class="nump">1,249,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Average number of shares after dilution (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,230,700,000<span></span>
</td>
<td class="nump">1,253,800,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations', window );">Basic earnings per share from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 2.4<span></span>
</td>
<td class="nump">&#8364; 1.64<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic earnings per share from discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.34<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent', window );">Basic earnings per share (in euros per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4.74<span></span>
</td>
<td class="nump">1.8<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted earnings per share from discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.33<span></span>
</td>
<td class="nump">0.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations', window );">Diluted earnings per share from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.39<span></span>
</td>
<td class="nump">1.63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent', window );">Diluted earnings per share (in euros per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 4.72<span></span>
</td>
<td class="nump">&#8364; 1.79<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 66<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a contingent consideration asset (liability) relating to a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_vi&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BasicEarningsLossPerShareAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BasicEarningsLossPerShareAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfComprehensiveIncomeAbstract', window );"><strong>Statement of comprehensive income [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 5,837<span></span>
</td>
<td colspan="2" class="nump">&#8364; 2,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,812<span></span>
</td>
<td colspan="2" class="nump">2,246<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25<span></span>
</td>
<td colspan="2" class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">111<span></span>
</td>
<td colspan="2" class="nump">235<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments', window );">Change in fair value of equity instruments included in financial assets and financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">222<span></span>
</td>
<td colspan="2" class="num">(10)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(92)<span></span>
</td>
<td colspan="2" class="num">(59)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">241<span></span>
</td>
<td colspan="2" class="nump">166<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax', window );">Change in fair value of debt instruments included in financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3<span></span>
</td>
<td colspan="2" class="num">(5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(23)<span></span>
</td>
<td colspan="2" class="num">(3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax', window );">Change in currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,203)<span></span>
</td>
<td colspan="2" class="nump">1,040<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(95)<span></span>
</td>
<td colspan="2" class="nump">35<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,318)<span></span>
</td>
<td colspan="2" class="nump">1,067<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherComprehensiveIncomeFromContinuedOperations', window );">&#8201;Other comprehensive income/(loss) from continuing operations for the period, net of taxes (A+B)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,077)<span></span>
</td>
<td colspan="2" class="nump">1,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherComprehensiveIncomeFromDiscontinuedOperations', window );">&#8201;Other comprehensive income/(loss) for the period from discontinued operations, net of taxes (C)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">303<span></span>
</td>
<td colspan="2" class="num">(23)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,063<span></span>
</td>
<td colspan="2" class="nump">3,496<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent', window );">Attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,076<span></span>
</td>
<td colspan="2" class="nump">3,471<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations', window );">Comprehensive income, attributable to owners of parent, continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,097)<span></span>
</td>
<td colspan="2" class="nump">3,264<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations', window );">Comprehensive income, attributable to owners of parent, discontinued operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,173<span></span>
</td>
<td colspan="2" class="nump">207<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests', window );">Attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (13)<span></span>
</td>
<td colspan="2" class="nump">&#8364; 25<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_c_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph b<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_b_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) including exchange differences recognised in other comprehensive income on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income that will not be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive income, attributable to owners of parent, continuing operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive income, attributable to owners of parent, discontinued operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains (Losses) On Remeasuring Debt Instruments, Before Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherComprehensiveIncomeFromContinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other comprehensive income from continued operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherComprehensiveIncomeFromContinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherComprehensiveIncomeFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other comprehensive income from discontinued operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherComprehensiveIncomeFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2"><div>Total</div></th>
<th class="th"><div>Attributable to equity holders of Sanofi</div></th>
<th class="th"><div>Share capital</div></th>
<th class="th"><div>Additional paid-in capital</div></th>
<th class="th"><div>Treasury shares</div></th>
<th class="th"><div>Reserves and retained earnings</div></th>
<th class="th"><div>Stock options and other share-based payments</div></th>
<th class="th"><div>Other comprehensive income</div></th>
<th class="th"><div>Attributable to&#160;non-controlling interests</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance at Dec. 31, 2023</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 74,353<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 74,040<span></span>
</td>
<td class="nump">&#8364; 2,530<span></span>
</td>
<td class="nump">&#8364; 313<span></span>
</td>
<td class="num">&#8364; (1,184)<span></span>
</td>
<td class="nump">&#8364; 67,499<span></span>
</td>
<td class="nump">&#8364; 4,944<span></span>
</td>
<td class="num">&#8364; (62)<span></span>
</td>
<td class="nump">&#8364; 313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,263<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,246<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,496<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">3,471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,412<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,059<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent', window );">Dividend paid out of earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,704)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,704)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(31)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="num">(302)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(302)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">173<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">173<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of share-based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity', window );">Other changes arising from issuance of restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Jun. 30, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">72,997<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">72,690<span></span>
</td>
<td class="nump">2,533<span></span>
</td>
<td class="nump">317<span></span>
</td>
<td class="num">(1,371)<span></span>
</td>
<td class="nump">65,093<span></span>
</td>
<td class="nump">5,121<span></span>
</td>
<td class="nump">997<span></span>
</td>
<td class="nump">307<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,199<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(194)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,554<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,499<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,120<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,379<span></span>
</td>
<td class="nump">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(13)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction in share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12)<span></span>
</td>
<td class="num">(492)<span></span>
</td>
<td class="nump">530<span></span>
</td>
<td class="num">(26)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">26<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans', window );">Employee share ownership plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">154<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">154<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">132<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of share-based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Change in non-controlling interests without loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Dec. 31, 2024</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">77,857<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">77,507<span></span>
</td>
<td class="nump">2,526<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(840)<span></span>
</td>
<td class="nump">68,185<span></span>
</td>
<td class="nump">5,260<span></span>
</td>
<td class="nump">2,376<span></span>
</td>
<td class="nump">350<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,774)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,736)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,979)<span></span>
</td>
<td class="num">(38)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">5,837<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,063<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,076<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,979)<span></span>
</td>
<td class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent', window );">Dividend paid out of earnings</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,772)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,772)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests', window );">Payment of dividends to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(32)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfTreasuryShares', window );">Share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="num">(3,988)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,988)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReductionOfIssuedCapital', window );">Reduction in share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(74)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,868<span></span>
</td>
<td class="num">(3,794)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TaxesOnShareCancellations', window );">Taxes on Share Cancellations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[5]</sup></td>
<td class="num">(15)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareBasedPaymentPlansAbstract', window );"><strong>Share-based payment plans:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions', window );">Exercise of stock options</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares', window );">Issuance of restricted shares and vesting of existing restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees', window );">Value of services obtained from employees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions', window );">Tax effects of share-based payments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl', window );">Change in non-controlling interests without loss of control</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[6]</sup></td>
<td class="num">(34)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity', window );">Other changes arising from issuance of restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[7]</sup></td>
<td class="nump">15<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance at Jun. 30, 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 70,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 70,008<span></span>
</td>
<td class="nump">&#8364; 2,456<span></span>
</td>
<td class="nump">&#8364; 11<span></span>
</td>
<td class="num">&#8364; (975)<span></span>
</td>
<td class="nump">&#8364; 65,689<span></span>
</td>
<td class="nump">&#8364; 5,430<span></span>
</td>
<td class="num">&#8364; (2,603)<span></span>
</td>
<td class="nump">&#8364; 271<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">See Note B.8.2. (for amounts relating to 2024, see Note D.15.4. to the consolidated financial statements for the year ended December 31, 2024).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">For 2024, this line comprises the impact of the issuance of restricted shares to former employees of EUROAPI subsequent to the date on which Sanofi lost control of EUROAPI.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Reflects new regulations implemented on the taxation of share cancellations in Article 95 of the French Finance Bill for 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">This line comprises the impact of the derecognition of the non-controlling interests in Opella (see Note B.1.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">For 2025, this line comprises the impact of the issuance of restricted shares to former employees of Opella subsequent to the date on which Sanofi lost control of Opella.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from the exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 17<br> -IssueDate 2025-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_a_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReductionOfIssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReductionOfIssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through issuance of restricted shares, equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee share ownership plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax effects of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of services obtained from employees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareBasedPaymentPlansAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share based payment plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareBasedPaymentPlansAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TaxesOnShareCancellations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Taxes on Share Cancellations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TaxesOnShareCancellations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Changes in Equity (Parenthetical) - &#8364; / shares<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidOrdinarySharesPerShare', window );">Dividend paid per share (in euros per share)</a></td>
<td class="nump">&#8364; 3.92<span></span>
</td>
<td class="nump">&#8364; 3.76<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidOrdinarySharesPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid per ordinary share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 34<br> -IssueDate 2025-01-01<br> -Paragraph 16A<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=34&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16A_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 246<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_246_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 246<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_246_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidOrdinarySharesPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from (used in) operating activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity', window );">Net income attributable to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 5,812<span></span>
</td>
<td colspan="2" class="nump">&#8364; 2,246<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForLossesGainsOnTransferOfBusiness', window );">&#8201;Net (income)/loss from the discontinued Opella business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(2,881)<span></span>
</td>
<td colspan="2" class="num">(202)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25<span></span>
</td>
<td colspan="2" class="nump">17<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod', window );">Share of undistributed earnings from investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(15)<span></span>
</td>
<td colspan="2" class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset', window );">Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,779<span></span>
</td>
<td colspan="2" class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets', window );">Gains and losses on disposals of non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="num">(266)<span></span>
</td>
<td colspan="2" class="num">(229)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDeferredTaxExpense', window );">Net change in deferred taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(539)<span></span>
</td>
<td colspan="2" class="num">(749)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities', window );">Net change in non-current provisions and other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="num">(212)<span></span>
</td>
<td colspan="2" class="nump">1,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Cost of employee benefits (stock options and other share-based payments)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">171<span></span>
</td>
<td colspan="2" class="nump">157<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue', window );">Impact of the workdown of acquired inventories remeasured at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss', window );">Other profit or loss items with no cash effect on cash flows generated by operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[5]</sup></td>
<td class="nump">106<span></span>
</td>
<td colspan="2" class="nump">21<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital', window );">Operating cash flow before changes in working capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,980<span></span>
</td>
<td colspan="2" class="nump">3,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile profit (loss) [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">(Increase)/decrease in inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(635)<span></span>
</td>
<td colspan="2" class="num">(917)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">(Increase)/decrease in accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(785)<span></span>
</td>
<td colspan="2" class="nump">81<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Increase/(decrease) in accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">187<span></span>
</td>
<td colspan="2" class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities', window );">Net change in other current assets and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">620<span></span>
</td>
<td colspan="2" class="num">(1,612)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations', window );">&#8201;Net cash provided by/(used in) continuing operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,367<span></span>
</td>
<td colspan="2" class="nump">1,238<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations', window );">&#8201;Net cash provided by/(used in) operating activities of the discontinued Opella business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">188<span></span>
</td>
<td colspan="2" class="nump">184<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash provided by/(used in) operating activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[6]</sup></td>
<td class="nump">3,555<span></span>
</td>
<td colspan="2" class="nump">1,422<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from (used in) investing activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Acquisitions of property, plant and equipment and intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,420)<span></span>
</td>
<td colspan="2" class="num">(1,804)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Acquisitions of consolidated undertakings and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[7]</sup></td>
<td class="num">(538)<span></span>
</td>
<td colspan="2" class="num">(1,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities', window );">Acquisitions of other equity investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(423)<span></span>
</td>
<td colspan="2" class="num">(208)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets', window );">Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[8]</sup></td>
<td class="nump">434<span></span>
</td>
<td colspan="2" class="nump">516<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Disposals of consolidated undertakings and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="nump">42<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetChangeInOtherNonCurrentAssets', window );">Net change in other non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(32)<span></span>
</td>
<td colspan="2" class="num">(16)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetCashProvidedByusedInContinuingInvestingActivities', window );">Net Cash Provided by/(used in) Continuing Investing Activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,979)<span></span>
</td>
<td colspan="2" class="num">(3,355)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities', window );">&#8201;Net cash provided by/(used in) investing activities of the discontinued Opella business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(36)<span></span>
</td>
<td colspan="2" class="num">(58)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetCashInflowFromDiscontinuedOperations', window );">Net cash inflow from the Opella transaction</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[9]</sup></td>
<td class="nump">10,742<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash provided by/(used in) investing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">8,727<span></span>
</td>
<td colspan="2" class="num">(3,413)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from (used in) financing activities [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssuingShares', window );">Issuance of Sanofi shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">29<span></span>
</td>
<td colspan="2" class="nump">21<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DividendsPaidAbstract', window );"><strong>Dividends paid:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities', window );">Dividends paid to equity holders of Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,772)<span></span>
</td>
<td colspan="2" class="num">(4,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities', window );">Dividends paid to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(27)<span></span>
</td>
<td colspan="2" class="num">(25)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromNoncurrentBorrowings', window );">Additional long-term debt contracted</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,993<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RepaymentsOfNoncurrentBorrowings', window );">Repayments of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(1,859)<span></span>
</td>
<td colspan="2" class="num">(638)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Repayment of lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(124)<span></span>
</td>
<td colspan="2" class="num">(136)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments', window );">Net change in short-term debt and other financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[10]</sup></td>
<td class="nump">3,322<span></span>
</td>
<td colspan="2" class="nump">5,876<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares', window );">Acquisitions of treasury shares and related tax effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,003)<span></span>
</td>
<td colspan="2" class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations', window );">&#8201;Net cash provided by/(used in) continuing financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,441)<span></span>
</td>
<td colspan="2" class="nump">92<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations', window );">&#8201;Net cash provided by/(used in) financing activities of the discontinued Opella business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(48)<span></span>
</td>
<td colspan="2" class="num">(3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash provided by/(used in) financing activities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,489)<span></span>
</td>
<td colspan="2" class="nump">89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Impact of exchange rates on cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(42)<span></span>
</td>
<td colspan="2" class="num">(13)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale', window );">Cash and Cash Equivalents Reclassified to Assets Held for Sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">167<span></span>
</td>
<td colspan="2" class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net change in cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,918<span></span>
</td>
<td colspan="2" class="num">(1,915)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,441<span></span>
</td>
<td colspan="2" class="nump">8,710<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 15,359<span></span>
</td>
<td colspan="2" class="nump">&#8364; 6,795<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes non-current financial assets.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">This line item includes contributions paid to pension funds (see Note B.12.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Of which: June 30, 2025 (6 months) June 30, 2024 (6 months) (a) &#8226;Income tax paid (1,355) (1,434) &#8226;Interest paid (206) (320) &#8226;Interest received 170 261 &#8226;Dividends received from non-consolidated entities 5 &#8212;</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For the six months ended June 30, 2025, this line item includes the net cash outflow arising from the acquisition of Dren-0201 (see Note B.1.2.). For the six months ended June 30, 2024 it includes the net cash outflow arising from the acquisition of Inhibrx, Inc.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June 30, 2025 and June 30, 2024, this line item mainly comprises proceeds from disposals of (i) assets and businesses due to portfolio rationalization, and (ii) equity and debt instruments.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June 30, 2025, this amount includes &#8364;(667) million in respect of cash and cash equivalents held by Opella as of April 30, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[10]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June 30, 2025, this line item mainly comprises a commercial paper program in the United States for &#8364;3,353 million, compared with &#8364;6,060 million in the six months ended June 30, 2024. This line item also includes realized foreign exchange gains and losses on cash and cash equivalents in non-functional currencies, mainly the US dollar, and on derivatives used to manage them.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDeferredTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDeferredTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow (outflow) from the entity's operations before changes in working capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A_TI<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to equity holders of the parent, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 25<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsToReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsToReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToAcquireOrRedeemEntitysShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire or redeem entity's shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToAcquireOrRedeemEntitysShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssuingShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuing shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssuingShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from non-current borrowings obtained. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForLossesGainsOnTransferOfBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for losses (gains) on transfer of business</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForLossesGainsOnTransferOfBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for noncurrent provisions and other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash and Cash Equivalents Reclassified to Assets Held for Sale</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DividendsPaidAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DividendsPaidAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetCashInflowFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Inflow from Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetCashInflowFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetCashProvidedByusedInContinuingInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by/(used in) Continuing Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetCashProvidedByusedInContinuingInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetCashProvidedByusedInDiscontinuingInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Provided by/(used in) Discontinuing Investing Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetCashProvidedByusedInDiscontinuingInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetChangeInOtherNonCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net change in other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetChangeInOtherNonCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows (Parenthetical) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income tax paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (1,355)<span></span>
</td>
<td class="num">&#8364; (1,434)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities', window );">Interest paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(206)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities', window );">Interest received</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">170<span></span>
</td>
<td class="nump">261<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities', window );">Dividends received from non-consolidated entities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments', window );">Net change in short-term debt and other financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="nump">3,322<span></span>
</td>
<td class="nump">5,876<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">15,359<span></span>
</td>
<td class="nump">6,795<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember', window );">Opella</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember', window );">Commercial paper program in USA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments', window );">Net change in short-term debt and other financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 3,353<span></span>
</td>
<td class="nump">&#8364; 6,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June 30, 2025, this line item mainly comprises a commercial paper program in the United States for &#8364;3,353 million, compared with &#8364;6,060 million in the six months ended June 30, 2024. This line item also includes realized foreign exchange gains and losses on cash and cash equivalents in non-functional currencies, mainly the US dollar, and on derivatives used to manage them.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestPaidClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for interest paid, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestPaidClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestReceivedClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from interest received, classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestReceivedClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dividends received from non-consolidated entities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Introduction<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GeneralInformationAboutFinancialStatementsAbstract', window );"><strong>General Information About Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory', window );">Introduction</a></td>
<td class="text"><div id="ex99_169958_9" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">Introduction </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi, together with its subsidiaries (collectively &#8220;Sanofi&#8221;, &#8220;the Group&#8221; or &#8220;the Company&#8221;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The condensed consolidated financial statements for the six months ended June&#160;30, 2025 were reviewed by the Sanofi Board of Directors at the Board meeting on July&#160;30, 2025. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for general information about financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 128<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_128&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_51&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GeneralInformationAboutFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>General Information About Financial Statements [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GeneralInformationAboutFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory', window );">Basis of Preparation of the Half-Year Financial Statements and Accounting Policies</a></td>
<td class="text"><div id="ex99_169958_10" style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">A/ Basis of preparation of the half-year financial statements and accounting policies </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.1. International financial reporting standards (IFRS) </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The half-year consolidated financial statements have been prepared and presented in condensed format in accordance with IAS&#160;34 (Interim Financial Reporting). The accompanying notes therefore relate to significant events and transactions of the period, and should be read in conjunction with the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies used in the preparation of the consolidated financial statements as of June&#160;30,&#160;2025 comply with international financial reporting standards (IFRS) as endorsed by the European Union and as issued by the International Accounting Standards Board (IASB). IFRS as endorsed by the European Union as of June&#160;30, 2025 are available via the following web link: </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">https://www.efrag.org/Endorsement </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies applied effective January&#160;1, 2025 are identical to those presented in the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On August&#160;15, 2023, the IASB issued &#8220;Lack of Exchangeability&#8221;, an amendment to IAS 21 (The Effects of Changes in Foreign Exchange Rates), relating to how to determine the exchange rate when a currency is not exchangeable. The amendment became applicable on January&#160;1, 2025, and does not have a material impact on the Sanofi financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In its 2025 half-year financial statements, Sanofi has used an average effective tax rate that takes into account the Pillar Two <div style="white-space:nowrap;display:inline;">top-up</div> tax applicable from January&#160;1, 2024. The effective tax rate also includes a <div style="white-space:nowrap;display:inline;">one-off</div> impact from the 2024 component of the exceptional contribution in respect of French corporate income taxes (see Note B.19.). </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.2. Use of estimates and judgments </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date the financial statements are finalized. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">impairment of property, plant and equipment and intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the valuation of goodwill and the valuation and useful life of acquired intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of contingent consideration receivable in connection with asset divestments and of contingent consideration payable; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of financial assets and financial liabilities at amortized cost; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of post-employment benefit obligations; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences. </div></td></tr></table><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actual results could differ from these estimates. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For half-year financial reporting purposes, and as allowed under IAS 34, Sanofi has determined income tax expense on the basis of an estimate of the effective tax rate for the full financial year. That rate is applied to business operating income plus financial income and minus financial expenses, and before (i)&#160;the share of profit/loss of investments accounted for using the equity method and (ii)&#160;net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. The estimated full-year effective tax rate is based on the tax rates that will be applicable to projected <div style="white-space:nowrap;display:inline;">pre-tax</div> profits or losses arising in the various tax jurisdictions in which Sanofi operates. </div><div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(1)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"> </div><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.3. Seasonal trends </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi&#8217;s activities are not subject to significant seasonal fluctuations. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.4. Consolidation and foreign currency translation of the financial statements of subsidiaries in hyperinflationary economies </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In 2025, Sanofi continues to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that<div style="display:inline;"> the </div>criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. The contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since July&#160;1, 2018) treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Turkey, the cumulative rate of <div style="display:inline;">inflation </div>over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since January&#160;1, 2022) treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.5. Fair value of financial instruments </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under IFRS 13 (Fair Value Measurement) and IFRS 7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>Level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging); </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;2: quoted prices in active markets for similar assets or liabilities, or valuation techniques in which all important inputs are derived from observable market data; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;3: valuation techniques in which not all important inputs are derived from observable market data. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:13%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:9%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:6%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:7%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:10%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:14%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:11%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td rowspan="3" style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Type&#160;of&#160;financial</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">instrument</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Measurement</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">principle</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;in<br/>fair&#160;value<br/>hierarchy</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>technique</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Method used to determine fair value</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Market data</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>model</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exchange</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">rate</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Interest&#160;rate</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Volatilities</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets<br/>measured at fair value (quoted equity instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value (quoted debt instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost/ Peer comparison (primarily)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(contingent consideration receivable)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">Long-term&#160;loans</div> and&#160;advances&#160;and <div style="white-space:nowrap;display:inline;">other&#160;non-current</div> receivables</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The amortized cost of long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables at the end of the reporting period is not materially different from their fair value.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under <div style="white-space:nowrap;display:inline;">post-employment</div> benefit plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Investments in mutual funds</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Net asset value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div><br/> <div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial">B.12.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial&#160;liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Lease liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Future lease payments are discounted using the incremental borrowing rate.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Forward&#160;currency contracts</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Present value of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Market Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Interest&#160;rate&#160;swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Cross-currency</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Liabilities&#160;related&#160;to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.</div></td></tr></table><div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">A.6. New pronouncements issued by the IASB and applicable from 2026 </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;9, 2024, the IASB issued IFRS 18 (Presentation and Disclosure in Financial Statements), applicable from January&#160;1, 2027 (subject to endorsement by the European Union). An impact assessment is currently under way. Sanofi will not early adopt this new standard. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;30, 2024, the IASB issued amendments to IFRS 9 and IFRS 7 relating to the classification and measurement of financial instruments, applicable no earlier than January&#160;1, 2026. Sanofi does not expect any material impact, and will not early adopt these amendments. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;18, 2024, the IASB issued Volume 11 of &#8220;Annual Improvements to IFRS&#8221;, applicable from January&#160;1, 2026. Sanofi does not expect any material impact from those improvements to various standards, which are essentially in the nature of clarifications, and will not early adopt them. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On December&#160;18, 2024, the IASB issued &#8220;Contracts referencing nature-dependent electricity&#8221;, amendments to IFRS 9 and IFRS&#160;7, applicable from January&#160;1, 2026. The amendments clarify the application of the &#8216;own use&#8217; exemption to Power Purchase Agreements (PPAs) with physical delivery of renewable electricity, and modify the hedge accounting requirements for contracts without physical delivery (VPPAs). Sanofi does not expect any material impact and will not early adopt these amendments. Renewable energy purchase contracts entered into by Sanofi as of December&#160;31, 2024 are described in Note D.21. to the consolidated financial statements included in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F</div> for the year ended December&#160;31, 2024 (the &#8220;2024 <div style="white-space:nowrap;display:inline;">20-F&#8221;).</div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract', window );"><strong>Disclosure of detailed information about business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock', window );">Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.1. Significant transactions for the first half of 2025 </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.1. Opella - Loss of control and equity interest in OPAL JV Co </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2025, Sanofi and CD&amp;R closed the Opella transaction following the signature of the share purchase agreement (SPA) on February&#160;18, 2025. Sanofi retains a significant shareholding in Opella, through a 48.2% equity interest in OPAL JV Co (formed in Luxembourg), which indirectly holds 100% of Opella. Bpifrance owns a 1.8% equity interest, and is represented on Opella&#8217;s Board. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Completion of the deal resulted in the loss of control of Opella by Sanofi and the derecognition of Opella&#8217;s assets and liabilities. This resulted in a net gain of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2.7&#160;billion, reported within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations </div></div>in the consolidated income statement. The proceeds from the divestment of Opella, determined on the basis of a <div style="font-family:Times New Roman;display:inline;">&#8364;</div>16&#160;billion enterprise value, reflected the estimated share price. That price is subject to adjustments following finalization of the Opella completion accounts, expected at the earliest in the fourth quarter of 2025. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of the closing date of the transaction, the carrying amount of Opella&#8217;s assets and liabilities in the Sanofi consolidated balance sheet was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>11.3&#160;billion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The gain took into account the following components: (i)&#160;a reclassification of unrealized foreign exchange losses amounting to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>0.5&#160;billion associated with Opella operations, in accordance with IAS 21 (&#8220;The Effects of Changes in Foreign Exchange Rates&#8221;); (ii) recognition of the retained 48.2% equity interest in OPAL JV Co (over which Sanofi exercises significant influence as defined in IAS 28 &#8220;Investments in Associates and Joint Ventures&#8221;), reported within the balance sheet line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Investments accounted for using the equity method</div></div> at an amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>3.2&#160;billion (representing the fair value of the equity interest at the date of initial recognition in accordance with IFRS 10 and included in the estimated share price, plus capitalized transaction costs); and (iii)&#160;other items, mainly comprising compensation as agreed under the separation agreements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The Opella transaction generated a net cash inflow of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>10.7&#160;billion, presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net cash inflow from the Opella transaction</div></div> in the statement of cash flows. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As a reminder, on October&#160;21, 2024, Sanofi and CD&amp;R entered into exclusive negotiations for the transfer of a controlling interest in Opella. As of December&#160;31, 2024, completion of the transaction was considered highly probable. In accordance with the classification and presentation requirements of IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), all assets of Opella and all liabilities directly related to those assets were classified from October&#160;21, 2024 in the line items <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Assets held for sale </div></div><div style="font-weight:bold;display:inline;"></div>and<div style="font-weight:bold;display:inline;"></div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"> Liabilities related to assets held for sale</div></div>, respectively, in the consolidated balance sheet (see Notes D.8. and D.36. to the consolidated financial statements for the year ended December&#160;31, 2024). Opella (formerly known as Consumer Healthcare) constituted an operating segment of Sanofi until October&#160;21, 2024 (see Note D.35., &#8220;Segment Information&#8221; to the consolidated financial statements for the year ended December&#160;31, 2024). Consequently, Opella met the definition of a discontinued operation under IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), as a result of which the net income from that business was presented separately within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations</div></div> in the consolidated income statement. This presentation in a separate income statement line item applied to operations for the year ended December&#160;31, 2024, and on a consistent basis for the comparative periods presented. The cash flows arising from operating, investing and financing activities of the Opella business were also presented in separate line items in the consolidated statements of cash flows for the year ended December&#160;31, 2024 and for the comparative periods presented. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.2. Acquisition of Dren-0201, Inc. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;27, 2025, Sanofi announced the completion of the acquisition of 100% of Dren-0201, Inc., adding SAR448501 (formerly <div style="white-space:nowrap;display:inline;">DR-0201)</div> to Sanofi&#8217;s immunology pipeline. <div style="white-space:nowrap;display:inline;">DR-0201,</div> now named SAR448501, has shown robust <div style="white-space:nowrap;display:inline;">B-cell</div> depletion in <div style="white-space:nowrap;display:inline;">pre-clinical</div> and early clinical studies. This potential <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">first-in-class</div></div> targeted bispecific myeloid cell engager targets and engages specific tissue-resident and trafficking myeloid cells to induce deep <div style="white-space:nowrap;display:inline;">B-cell</div> depletion via targeted phagocytosis. Recent <div style="white-space:nowrap;display:inline;">pre-clinical</div> and early clinical study data in autoimmune diseases suggest that deep <div style="white-space:nowrap;display:inline;">B-cell</div> depletion has the potential to reset the adaptive immune system, leading to sustained treatment-free remission in patients with refractory <div style="white-space:nowrap;display:inline;">B-cell</div> mediated autoimmune diseases such as lupus, where significant unmet medical needs remain. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The transaction did not meet the criteria for a business combination under IFRS 3, and consequently was accounted for as an acquisition of a group of assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition price was $600&#160;million. Of that amount (plus acquisition-related costs), $562&#160;million was allocated to <div style="white-space:nowrap;display:inline;">in-process</div> development in respect of SAR448501, and recognized within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other intangible assets</div></div> in accordance with IAS 38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed in the transaction. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, potential future payments totalling $1.3&#160;billion contingent on attainment of certain development and launch milestones have been recognized as off balance sheet commitments. These milestones will be added to the value of the SAR448501 intangible asset if and when attained. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of this acquisition, as reflected within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Acquisitions of consolidated undertakings and investments accounted for using the equity method</div></div> in the consolidated statement of cash flows, is a net cash outflow of $602&#160;million. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.1.3. Agreed transactions expected to be finalized in the second half of 2025 </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Acquisition of Vigil Neuroscience, Inc. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vigil Neuroscience, Inc. (&#8220;Vigil&#8221;), a publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. This acquisition in neurology, one of Sanofi&#8217;s four strategic disease areas, enhances Sanofi&#8217;s early-stage pipeline and includes <div style="white-space:nowrap;display:inline;">VG-3927,</div> which will be evaluated in a phase 2 clinical study in Alzheimer&#8217;s disease. <div style="white-space:nowrap;display:inline;">VG-3927</div> is an oral small molecule TREM2 agonist. Activating TREM2 is expected to enhance the neuroprotective function of microglia in Alzheimer&#8217;s disease. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under the terms of a share purchase agreement (including the exclusive right of first negotiation for an exclusive license to <div style="white-space:nowrap;display:inline;">VG-3927</div> or for transfer of the rights to research, develop, manufacture, and commercialize <div style="white-space:nowrap;display:inline;">VG-3927)</div> entered into by Sanofi and Vigil in June 2024 for an amount of $40&#160;million, Sanofi already held an equity interest in Vigil Neuroscience, Inc., representing approximately 12% of Vigil&#8217;s share capital. That equity interest was remeasured at market value as at June&#160;30, 2025 through <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div>. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">VGL101, Vigil&#8217;s second molecule program, is not being acquired by Sanofi. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi will acquire all outstanding common shares of Vigil for $8.00 per share in cash at closing. Based on $8.00 per share, the total equity value of Vigil represents approximately $470&#160;million (on a fully diluted basis). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, Vigil&#8217;s shareholders will receive one <div style="white-space:nowrap;display:inline;">non-transferable</div> and <div style="white-space:nowrap;display:inline;">non-tradeable</div> contractual contingent value right (CVR) per Vigil share entitling the holder to receive a deferred cash payment of $2.00, contingent upon the first commercial sales of <div style="white-space:nowrap;display:inline;">VG-3927.</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition is expected to close in the third quarter of 2025 subject to closing conditions. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Acquisition of Blueprint Medicines Corporation </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On June&#160;2, 2025, Sanofi and Blueprint Medicines Corporation (Blueprint), a <div style="white-space:nowrap;display:inline;">US-based,</div> publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other <div style="white-space:nowrap;display:inline;">KIT-driven</div> diseases, entered into an agreement under which Sanofi agreed to acquire Blueprint. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The acquisition included a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Blueprint&#8217;s established presence among allergists, dermatologists, and immunologists is expected to enhance Sanofi&#8217;s growing immunology pipeline. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under the terms of the acquisition, Sanofi agreed to pay $129.00 per share in cash at closing, representing an equity value of approximately $9.1&#160;billion for 100% of the shares. Blueprint shareholders also received one <div style="white-space:nowrap;display:inline;">non-tradable</div> contractual contingent value right (CVR) per share which entitles the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR on the attainment of future development and regulatory milestones within the applicable milestone period, respectively, for <div style="white-space:nowrap;display:inline;">BLU-808.</div> The total equity value of the transaction, including potential CVR payments, represents approximately $9.5&#160;billion on a fully diluted basis. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In July 2025, Sanofi obtained control of Blueprint after all tender offer and merger conditions had been met. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property, Plant and Equipment</a></td>
<td class="text"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.2. Property, plant and equipment </div></div></div>  <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below sets forth acquisitions and capitalized interest by operating segment for the first half of 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquisitions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">702</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">591</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Biopharma</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">663</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">535</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">Of which Manufacturing&#160;&amp; Supply</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">453</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">366</div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Opella (discontinued operation, see Note B.1.)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">39</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">56</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Of which capitalized interest</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">22</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">22</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td></tr></table>  <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Firm orders for property, plant and equipment stood at <div style="font-family:Times New Roman;display:inline;">&#8364;</div>732&#160;million as of June&#160;30, 2025. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text"> <div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.3. Goodwill and other intangible assets </div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Goodwill amounted to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>40,283&#160;million as of <div style="display:inline;">June&#160;</div>30, 2025, versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>43,384&#160;million as of December&#160;31, 2024. The movement during the period was mainly due to the impact of changes in exchange rates. </div>  <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in other intangible assets during the first half of 2025 were as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:65%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">&#8199;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquired&#160;R&amp;D</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Products,<br/> trademarks&#160;and<br/> other rights</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Software</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;other<br/> intangible&#160;assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,866</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">66,348</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,852</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">81,066</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Changes in scope of consolidation<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"> (b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">500</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">500</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Acquisitions and other increases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">332</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">302</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">42</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">676</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(199</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(228</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(1,339</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(5,159</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(49</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(6,547</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(244</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(292</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,297</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">61,048</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,830</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">75,175</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at January&#160;1, 2025</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(4,497</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(52,507</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,433</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(58,437</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Amortization expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(800</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(52</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(852</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impairment losses, net of reversals <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(201</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(9</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(210</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">199</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">229</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">427</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">3,772</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">4,239</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">281</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">287</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(4,249</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(49,064</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,431</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(54,744</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">8,369</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">13,841</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">419</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">22,629</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,048</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,984</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">399</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">20,431</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Transfers&#8221; line mainly comprises (i)&#160;acquired R&amp;D that came into commercial use during the period and (ii)&#160;reclassifications of assets to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Assets held for sale</div></div><div style="font-style:italic;display:inline;">. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Changes in scope of consolidation&#8221; line mainly comprises the intangible asset recognized as part of the Dren-0201, Inc. acquisition (see Note B.1.) </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.4. </div></div></td></tr></table>  <div style="margin-top:16pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Products, trademarks and other products&#8221; mainly comprise: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">marketed products, with a carrying amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>11.0&#160;billion as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>12.7&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately 10 years; and </div></td></tr></table> <div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">technological platforms brought into service, with a carrying amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1.0&#160;billion as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1.1&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately 18 years. </div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Impairment of Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract', window );"><strong>Disclosure of impairment loss and reversal of impairment loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock', window );">Impairment of Intangible Assets</a></td>
<td class="text"> <div style="margin-top:22pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.4. Impairment of intangible assets </div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>210&#160;million in the first half of 2025 linked to research and development projects. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for impairment of intangible assets and property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments Accounted for Using the Equity Method<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory', window );">Investments Accounted for Using the Equity Method</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.5. Investments accounted for using the equity method </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Investments accounted for using the equity method consist of associates and joint ventures (see Note B.1. to the consolidated financial statements for the year ended December&#160;31, 2024), and comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:71%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;interest</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">OPAL JV Co <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">48.2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,239</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">EUROAPI <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">29.6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">82</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">82</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">31.2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">93</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">102</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">MSP Vaccine Company <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">50.0</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">79</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">81</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other investments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">70</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">51</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">3,563</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">316</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June&#160;30, 2025, the investment includes a &#8364;241&#160;million loan to OPAL JV Co being in substance part of the investment. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#8364;2.89 as of June&#160;30, 2025, and &#8364;2.88 as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Share of profit/(loss) from investments accounted for using the equity method</div></div> showed net income of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>85&#160;million for the first half of 2025 (versus a net loss of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>22&#160;million for the first half of 2024), including <div style="font-family:Times New Roman;display:inline;">&#8364;</div>11&#160;million for Sanofi&#8217;s share of profits from OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The financial statements include commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Sales <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c) (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">29</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">59</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Royalties and other income <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">63</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Purchases of goods and services (including research expenses) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">371</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">333</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts receivable and other receivables <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">299</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">184</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other assets <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">189</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">189</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts payable and other payables</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">637</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">160</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes loans to joint ventures and associates. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In October 2024, Sanofi raised its investment in EUROAPI by &#8364;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#8364;189&#160;million (and was also &#8364;189&#160;million as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative periods have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Key items from the OPAL JV Co 2025 unaudited half-year consolidated financial statements, as provided in accordance with Sanofi&#8217;s consolidation timelines, are presented below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated income statement</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net sales and other revenues <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">887</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net income <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">24</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated statement of comprehensive income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated balance sheet</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> assets</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">16,179</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current assets</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">2,937</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,116</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top">&#8194;Equity attributable to equity holders of OPAL JV Co</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">5,754</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Equity attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">541</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,295</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> liabilities</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">11,039</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current liabilities</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">1,782</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,821</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity and liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,116</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Assets<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory', window );">Other Non-Current Assets</a></td>
<td class="text"><div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.6. Other <div style="white-space:nowrap;display:inline;">non-current</div> assets </div></div></div><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Other <div style="white-space:nowrap;display:inline;">non-current</div> assets comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Equity instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,105</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,559</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Debt instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">362</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">357</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Other financial assets at fair value through profit or loss</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">965</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,027</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Pre-funded</div> pension obligations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">146</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">156</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Long-term prepaid expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">143</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">152</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;Long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">382</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">502</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Derivative financial instruments</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,109</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">3,753</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other non-current assets. [Refer: Other non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfTradeReceivablesTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.7. Accounts receivable </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Accounts receivable break down as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Gross value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">7,896</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">7,777</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Allowances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(100</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Carrying amount</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">7,810</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">7,677</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of allowances against accounts receivable in the first half of 2025 was a net expense of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>4&#160;million (versus a net expense of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>3&#160;million for the first half of 2024). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the ageing profile of overdue accounts receivable, based on gross value: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:49%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;accounts<br/>gross value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&lt;1&#160;month</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">1-3</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">3-6</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">6-12&#160;months</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&gt;&#160;12&#160;months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;As of June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">386</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">122</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">103</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">73</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">48</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">40</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;As of December&#160;31, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">316</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">194</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">87</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">9</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">44</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Amounts overdue by more than one month relate mainly to public-sector customers. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables that met the conditions described in Note B.8.6. to the consolidated financial statements for the year ended December&#160;31, 2024 and hence were derecognized was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>12&#160;million as of June&#160;30, 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>14&#160;million as of December&#160;31, 2024). The residual guarantees relating to those transfers were immaterial as of June&#160;30, 2025. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfTradeReceivablesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfTradeReceivablesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Consolidated Shareholders' Equity</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.8. Consolidated shareholders&#8217; equity </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.1. Share capital </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, the share capital was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2,455,512,548 and consisted of 1,227,756,274 shares (the total number of shares outstanding) with a par value of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Treasury shares held by Sanofi are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:73%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;shares</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;of&#160;share&#160;capital</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">for the period</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">10.66</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">0.868</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">December&#160;31, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">9.53</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.755</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">June&#160;30, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">15.33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1.211</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">January&#160;1, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">13.45</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1.063</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A total of 171,150 shares were issued in the first half of 2025 as a result of the exercise of Sanofi stock subscription options. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, 2,682,051 shares vested under Sanofi restricted share plans during the first half of 2025, of which 1,156,205&#160;were fulfilled by issuance of new shares and 1,525,846 by allotment of existing shares free of charge. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.2. Repurchase of Sanofi shares </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2024, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of 18&#160;months. Under that program, Sanofi repurchased 39,344,633 of its own shares during the first half of 2025 for a total amount of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>3,988&#160;million. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the meeting of the Board of Directors on January&#160;29, 2025, the Board authorized Sanofi to repurchase the Company&#8217;s shares, for an amount not exceeding <div style="font-family:Times New Roman;display:inline;">&#8364;</div>5&#160;billion, under the terms and conditions set by the General Meeting of April&#160;30, 2024 in its 19th resolution. As part of this authorization, Sanofi entered into a share buyback agreement with its historical shareholder L&#8217;Or&#233;al on February&#160;2, 2025 for the acquisition of <div style="display:inline;">2.34</div>% of Sanofi&#8217;s share capital, equivalent to 29,556,650 shares, for a total amount of approximately <div style="font-family:Times New Roman;display:inline;">&#8364;</div>3&#160;billion, representing a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>101.50 per share. The conclusion of that agreement was approved by the Board of Directors on the same day prior to the signing of the agreement, and in accordance with the procedure set forth in Articles L. <div style="white-space:nowrap;display:inline;">225-38</div> et seq. of the French Commercial Code. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30, 2025, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of 18 months. Sanofi did not use that authorization during the first half of 2025. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.3. Reduction in share capital </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025, treasury shares amounting to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>3,868&#160;million were cancelled further to decisions taken by the Sanofi Board of Directors on March&#160;13, 2025 and April&#160;23, 2025. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Those reductions have no impact on shareholders&#8217; equity, except for the impact of the tax on share cancellations. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.4. Restricted share plans </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. to the consolidated financial statements for the year ended December&#160;31, 2024. The principal features of the plans awarded in 2025 are set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Type of plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">Performance&#160;share&#160;plan</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Date of Board meeting approving the plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">30&#160;April, 2025</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total number of shares subject to a <div style="white-space:nowrap;display:inline;">3-year</div> service period</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,021,370</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with no market condition</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,599,478</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>83.94</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with market conditions</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,421,892</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded other than to the Chief Executive Officer (1,331,892 shares in total) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>79.25</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded to the Chief Executive Officer (90,000 shares) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>75.10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair value of plan at the date of grant (&#8364; million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">331</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div></div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total expense for restricted share plans (<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">146</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">128</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Number of shares not yet fully vested</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">11,550,347</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">11,192,984</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2025 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,020,451</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2024 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,110,089</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,498,109</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2023 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,313,588</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,652,352</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2022 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">106,219</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,031,060</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2021 plans</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">11,463</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.5. Capital increases </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On January&#160;29, 2025, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>72.97 per share. The subscription period was open from June&#160;10 through June&#160;30, 2025. Sanofi employees subscribed for a total of 2,260,776 shares, and this capital increase was supplemented by the immediate issuance of a further 116,794 shares for the employer&#8217;s contribution. The total expense recognized for this capital increase in the first half of 2025 was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>31&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On January&#160;31, 2024, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>72.87 per share. The subscription period was open from June&#160;4 through June&#160;24, 2024. Sanofi employees subscribed for a total of 2,124,445 shares, and this capital increase was supplemented by the immediate issuance of a further 119,951 shares for the employer&#8217;s contribution. The total expense recognized for this capital increase in the first half of 2024 was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>45&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.6. Stock subscription option plans </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">No stock subscription option plans were awarded in the first half of 2025 or in 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">No further stock option plan expenses were recognized through equity in either the first half of 2025 or 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below provides summary information about options outstanding and exercisable as of June&#160;30, 2025: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Range of exercise prices per share</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exercisable</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average</div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">residual life</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(years)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>60.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>70.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">168,784</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">2.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">65.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">168,784</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">65.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>70.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>80.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">299,250</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">2.98</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">76.48</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">299,250</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">76.48</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>80.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>90.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">257,010</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">1.86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">88.97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">257,010</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">88.97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">725,044</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">725,044</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td></tr></table><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.7. Number of shares used to compute diluted earnings per share </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Average number of shares outstanding</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,225.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,249.4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for stock options with dilutive effect</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">0.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for restricted shares</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">4.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Average number of shares used to compute diluted earnings per share</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,230.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,253.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, December&#160;31, 2024 and June&#160;30, 2024, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.8. Other comprehensive income </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements within other comprehensive income are shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8199;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;&#8194;&#8194;&#8194;June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses):</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) excluding investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">105</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">235</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(25</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(57</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Equity instruments included in financial assets and financial liabilities:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">222</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Equity risk hedging instruments designated as fair value hedges</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(60</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items not subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">243</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">166</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Debt instruments included in financial assets:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash flow hedges and fair value hedges:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Change in currency translation differences:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin: 0pt 0.63em 0pt 1.13em; text-indent: -0.63em; font-size: 8pt; font-family: Arial; text-align: justify; line-height: normal;">&#8226;&#8201;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(5,266</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Currency translation differences (investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(26</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Hedges of net investments in foreign operations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">390</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(126</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(101</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(5,017</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,067</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: immaterial over all periods. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: &#8364;2&#160;million in the first half of 2025, immaterial in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">&#8194;</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: a &#8364;459&#160;million loss in the first half of 2025 relating to the deconsolidation of Opella (see Note B.1.)., a &#8364;5&#160;million profit in 2024, and immaterial in the first half of 2024. </div></div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock', window );">Debt, Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.9. Debt, cash and cash equivalents </div></div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Changes in financial position during the period were as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8198;&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,791</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,309</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">137</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,519</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,137</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,102</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,772</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Net debt&#8221; is a <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-IFRS</div> financial measure used by management and investors to measure Sanofi&#8217;s overall net indebtedness. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family: Arial; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="background: none; text-decoration: none;display:inline;"><div style="font-weight:bolder;display:inline;"> </div></div></div></div><div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;"></div></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.9.1. Net debt at value on redemption </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A reconciliation of the carrying amount of net debt in the balance sheet to value on redemption as of June&#160;30, 2025 is shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Value on redemption</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Carrying&#160;amount&#160;at</div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Amortized&#160;cost</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Adjustment&#160;to&#160;debt<br/>measured at fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">39</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">78</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,317</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,940</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,309</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,311</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,218</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(78</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,519</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">41</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,560</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,171</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,102</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">41</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,143</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,806</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table><div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows an analysis of net debt by type, at value on redemption: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bond issues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,259</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,322</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">15,581</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,876</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,716</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">14,592</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other bank borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,847</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,905</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">64</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,290</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,354</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bank credit balances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">141</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">141</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">13,317</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">7,243</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,560</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">11,940</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">4,231</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,171</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">13,317</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(8,174</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,143</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">11,940</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(3,134</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,806</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of June 30, 2025, current other bank borrowings include &#8364;4,535&#160;million related to the US commercial paper program and &#8364;230&#160;million related to the Negotiable European Commercial Paper program in France. </div></div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial">Principal financing and debt reduction transactions during the period </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi carried out the following bond issues during the period: </div><div style="margin-top:6pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify">i. March 2025: a bond issue of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1.5&#160;billion in two tranches: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>850&#160;million of floating-rate bonds maturing March 2027, with quarterly coupons and bearing interest at an annual rate of <div style="white-space:nowrap;display:inline;">3-month</div> Euribor plus 30 basis points; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>650&#160;million of fixed-rate bonds maturing March 2031, with annual coupons and bearing interest at an annual rate of 2.750%. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify">ii. June 2025: a bond issue of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1.5&#160;billion in two tranches: </div><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>750&#160;million of fixed-rate bonds maturing June 2029, with annual coupons and bearing interest at an annual rate of 2.625%; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>750&#160;million of fixed-rate bonds maturing June 2032, with annual coupons and bearing interest at an annual rate of 3.000%. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Two bond issues were redeemed in 2025: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1&#160;billion fixed-rate bond issue from April 2020, which was redeemed at maturity on April&#160;1, 2025; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the <div style="font-family:Times New Roman;display:inline;">&#8364;</div>850&#160;million fixed-rate bond issue from April 2022, which was redeemed at maturity on April&#160;6, 2025. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi had two syndicated credit facilities linked to social and environmental criteria in place to manage its liquidity in connection with current operations: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a syndicated credit facility of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>4&#160;billion, drawable in euros and US dollars and expiring on December&#160;6, 2027, for which no further extension options are available; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a syndicated credit facility of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>4&#160;billion, drawable in euros and US dollars and expiring on March&#160;6, 2030, for which no further extension options are available. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, neither facility was drawn down. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi also has two short-term debt programs: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a <div style="font-family:Times New Roman;display:inline;">&#8364;</div>6&#160;billion Negotiable European Commercial Paper program in France; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">a $10&#160;billion Commercial Paper program in the United States. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">i.&#8198;</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the average drawdown under the US Commercial Paper program was $2.63&#160;billion; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:right">ii.</td>
<td style="font-size:8pt;width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify">the average drawdown under the Negotiable European Commercial Paper program in France was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>0.02&#160;billion. </div></td></tr></table><div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The financing in place as of June&#160;30, 2025 at the level of the holding company (which manages most of Sanofi&#8217;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking credit spreads or fees to the credit rating. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.9.2. Market value of net debt </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Market value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,589</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">8,165</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Value on redemption</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,143</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">8,806</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of debt instruments issued explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.10. Derivative financial instruments </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.10.1 Currency derivatives used to manage operating risk exposures </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows operating currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:46%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which derivatives designated<br/>as&#160;cash&#160;flow hedges</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge<br/>accounting</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which<br/>recognized<br/>in&#160;equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,619</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">133</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,619</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">133</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,351</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">100</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,351</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">100</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">539</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">10</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">539</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">10</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">480</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">480</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">253</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">253</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which pound sterling</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">173</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">173</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,418</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(84</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,418</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(84</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,540</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(55</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,540</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(55</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">610</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(15</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">610</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(15</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Turkish lira</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">159</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">159</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which United Arab Emirates dirham</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">120</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">120</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,037</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">49</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,037</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">49</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The above positions mainly hedge material foreign currency cash flows arising after the end of the reporting period in relation to transactions carried out during the six months ended June&#160;<div style="display:inline;">30,</div> 2025 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange difference on those items (hedging instruments and hedged transactions) will be immaterial in the second half of 2025. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.10.2. Currency and interest rate derivatives used to manage financial exposure </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The cash pooling arrangements for foreign subsidiaries outside the eurozone, and some of Sanofi&#8217;s financing activities, expose certain Sanofi entities to financial foreign exchange risk (i.e.&#160;the risk of changes in the value of loans and borrowings denominated in a currency other than the functional currency of the lender or borrower). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">That foreign exchange exposure is hedged using derivative instruments (currency swaps or forward contracts) that alter the currency split of Sanofi&#8217;s debt once those instruments are taken into account. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows financial currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional&#160;amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Maximum<br/>&#8195;&#8195;expiry&#160;date</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Cross currency seller swaps</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,476</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,476</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">5</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2032</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">7,723</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">176</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">6,007</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(b)</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">148</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Pound sterling</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">601</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">303</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,609</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(44</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,289</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,094</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(c)&#160;</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(33</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2026</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Hungarian forint</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">639</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">12,808</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">137</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#8364;5&#160;million, with &#8364;18&#160;million debited to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div><div style="font-style:italic;display:inline;"> under the cost of hedging accounting treatment. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div></div><div><div style="line-height:normal;display: inline;"></div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward sales with a notional amount of $3,615&#160;million expiring in 2025, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of June&#160;30, 2025, the fair value of these forward contracts represented an asset of &#8364;77&#160;million; the opposite entry was recognized in </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">, with the impact on financial income and expense being immaterial. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward purchases with a notional amount of $1,000&#160;million expiring in 2025, designated as a fair value hedge of the exposure of $1,000&#160;million of bond issues to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of these contracts represented a liability of &#8364;25&#160;million, with &#8364;0&#160;million credited to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;"> to recognize the hedging cost. </div></div></div></td></tr></table>  <div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">To optimize the cost of debt or reduce the volatility of debt, Sanofi uses derivative instruments (interest rate swaps and cross currency swaps) to alter the fixed/floating rate split of its net debt. </div>  <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows instruments of this type in place as of June&#160;30, 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:36%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>designated&#160;as&#160;fair<br/>value&#160;hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which designated<br/>as&#160;cash&#160;flow hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2026</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2027</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2028</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2029<br/>and<br/>beyond</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>recognized<br/>in equity</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Interest rate swaps</div></div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized SOFR USD / receive 1.17%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(54</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"></div><div style="display:inline;">(54</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay 2.08% / receive Euribor 3m</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized Ester / receive 0.92%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">850</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">848</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">650</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2,348</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(88</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,498</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(81</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">850</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(7</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(3</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of derivative financial instruments. [Refer: Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-Current Provisions And Other Non-Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock', window );">Non-Current Provisions And Other Non-Current Liabilities.</a></td>
<td class="text"> <div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.12. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> provisions and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities </div></div></div></div>  <div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The line item <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> provisions and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities</div></div></div> comprises the following: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Provisions</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">5,003</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">5,762</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,113</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,334</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; background-color: rgb(120, 2, 230); width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;Total</div></div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">7,116</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,096</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes &#8364;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#8364;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#8364;2,293&#160;million. </div></div></div></td></tr></table>  <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows movements in provisions: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/>pensions&#160;&amp;&#160;other<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">post-employment</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">other&#160;long-term</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Restructuring<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,992</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">821</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">799</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2,150</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,762</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Increases in provisions and other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">69</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">78</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">175</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">293</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">615</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Provisions utilized</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(378</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(616</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Reversals of unutilized provisions</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(17</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(178</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(197</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(158</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(93</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Net interest related to employee benefits, and unwinding of discount</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(94</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(74</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(83</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains and losses on defined-benefit plans&#160;(B.12.1.)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(111</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(111</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,705</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">765</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">802</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,731</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,003</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Mainly transfers to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Current provisions and other current liabilities</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">. </div></div></div></td></tr></table>  <div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold">Provisions for pensions and other post-employment benefits </div> <div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For an analysis of the sensitivity of obligations in respect of pensions and other employee benefits as of December&#160;31, 2024, and of the assumptions used as of that date, see Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The principal assumptions used (in particular, discount and inflation rates) and the market value of plan assets for the eurozone, the United States and the United Kingdom were reviewed as of June&#160;30, 2025 to take into account changes during the first half of the year. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">During the first half of 2025, Sanofi completed a further <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">buy-in</div> (amounting to <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div>101&#160;million) to cover the remaining uninsured liabilities arising under the main defined benefit pension scheme in the United Kingdom. Consequently, all scheme members are now fully insured as a result of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">buy-in</div> transactions, except for liabilities rising from guaranteed minimum pension equalization (as described in Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024). </div>  <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actuarial gains and losses arising on pensions and other post-employment benefits and recognized in equity are as follows (amounts reported before tax): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2024<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on plan assets</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(45</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on benefit obligations</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">152</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">373</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(b)</div>&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the <div style="white-space:nowrap;display:inline;">-0.30%</div> change in the inflation rate in the United Kingdom in the first half of 2025. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes actuarial gains/ (losses) related to Opella of &#8364;(4)&#160;million for the first half of 2025 and &#8364;(6)&#160;million for the first half of 2024 . </div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Provisions And Other Non-Current Liabilities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off Balance Sheet Commitments<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OffBalanceSheetCommitmentsAbstract', window );"><strong>Off-Balance Sheet Commitments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock', window );">Off Balance Sheet Commitments</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.13. Off balance sheet commitments </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Off balance sheet commitments to third parties as of December&#160;31, 2024 are presented in Note D.21.1. to the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The principal commitments entered into, amended or discontinued during the period are described below: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>In April 2025, Sanofi entered into a license and collaboration agreement with Earendil Labs for two bispecific antibodies in the field of autoimmune and inflammatory bowel diseases: <div style="white-space:nowrap;display:inline;">HXN-1002</div> (targeting <div style="font-family:Times New Roman;display:inline;"><div style="FONT-FAMILY:SYMBOL;display:inline;">a</div></div>4&#223;7 and TL1A for potential treatment of moderate to severe ulcerative colitis and Crohn&#8217;s disease) and <div style="white-space:nowrap;display:inline;">HXN-1003</div> (targeting TL1A and IL23 for potential treatment of colitis and skin inflammation). Under the terms of the agreement, Earendil Labs received an upfront payment of $125&#160;million, is eligible to receive up to a total of $1.7&#160;billion in development and commercial milestone payments, and is eligible to receive tiered royalties on product sales. </div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi has not entered into any material new long-term renewable energy contract agreements as part of its sustainability strategy. The main existing agreements are presented in Note D.21.1. to the consolidated financial statements in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F.</div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of off-balance sheet commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OffBalanceSheetCommitmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Off-Balance Sheet Commitments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OffBalanceSheetCommitmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation and Arbitration Proceedings<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract', window );"><strong>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock', window );">Litigation and Arbitration Proceedings</a></td>
<td class="text"><div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.14. Litigation and arbitration proceedings </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The matters discussed below constitute the most significant developments since publication of the financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.1. Products </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Zantac product litigation in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As regards the ongoing Zantac product litigation in the US, the Separation Agreement (see Notes D.1 and D.22 to the consolidated financial statements in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F)</div> entered into between Sanofi and Opella specifies that Sanofi will indemnify the Opella group in respect of liabilities relating to (i)&#160;the commercialization of any Zantac branded products (i.e. products containing ranitidine as their active pharmaceutical ingredient) prior to closing, and (ii)&#160;all personal injury claims resulting from the manufacturing or handling of Zantac prior to closing. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In April 2025, Sanofi reached several settlement deals that in total resolve a majority of the Delaware State Court consolidated litigation. In addition, in May 2025, Sanofi reached settlements with the City of Baltimore and the New Mexico Attorney General, amicably resolving both those matters. Other cases are pending in various state courts. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;10, 2025, the Delaware Supreme Court unanimously reversed the Superior Court&#8217;s denial of Defendants&#8217; <div style="font-style:italic;display:inline;">Daubert </div>motion based on the lack of reliability of plaintiff&#8217;s experts on causation and remanded its findings back to the Superior Court for proceedings consistent with the rulings in the opinion. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Talc product litigation in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, Sanofi was named as a defendant in approximately 900 ongoing product liability actions. To date, no cases have proceeded to trial. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.2. Patents </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Praluent (alirocumab)-related Amgen patent litigation in Europe </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Regarding Amgen&#8217;s EP 3 666 797, in April 2025, the Opposition Division of the European Patent Office ruled in Amgen&#8217;s favor and decided to maintain the patent as granted. Sanofi has appealed this decision to the Technical Board of Appeals of the European Patent Office, and the appeal hearing is scheduled for April 2026. <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div> </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel) Litigation (Commonwealth) Litigation in Australia </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">This matter has been finalized with no possibility of appeal. The matter is closed. </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.14.3. Other litigation </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel) - Attorney General action in Hawaii </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In May 2025, the parties agreed to settle the Hawaii action, with Sanofi US to pay $350&#160;million pursuant to its settlement agreement and Bristol-Myers Squibb to pay $350&#160;million pursuant to its separate settlement agreement. The appeal and the underlying case were dismissed pursuant to the settlement. This matter is closed. </div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">Plavix (clopidogrel)-related litigation in France </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In the claim filed by the <div style="font-style:italic;display:inline;">Caisse Nationale d&#8217;Assurance Maladie</div> <div style="font-style:italic;display:inline;">&#8211; CNAM</div> (French Social Security), hearings were held in June 2025. </div><div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">340B drug pricing program in the US </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In the action filed by Sanofi against the Department of Health and Human Services (HHS), the Health Resources and Services Administration (HRSA) and their respective administrators, following a joint hearing held on April&#160;29, 2025 in Sanofi&#8217;s case and the similar cases filed by Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos, the district court held on May&#160;15, 2025 that, although Section&#160;340B does not categorically prohibit the use of manufacturer rebates, it does not allow HRSA to require preapproval of a manufacturer rebate program. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The district court also held that HRSA&#8217;s letter determining that Sanofi would violate Section&#160;340B if it launched its Credit (rebate) Model was arbitrary and capricious and remanded the Sanofi matter back to HRSA for further consideration. Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos appealed the district court&#8217;s decision to the Circuit Court. Those appeals, along with a similar appeal by Johnson&#160;&amp; Johnson, have been expedited and consolidated. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"><div style="text-decoration:underline;display:inline;">ADR Proceedings in the US</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In June 2025, Sanofi received notice that Hudson Headwaters Health Network (Hudson Headwaters) had filed a petition for monetary relief against Sanofi before the HRSA ADR (Administrative Dispute Resolution) Panel. Hudson Headwaters alleges that Sanofi has violated Section&#160;340B by allowing only one contract pharmacy to be selected and utilized per covered entity, if the covered entity does not have an <div style="white-space:nowrap;display:inline;">in-house</div> pharmacy capable of dispensing its drug. Hudson Headwaters alleges that this Sanofi policy is an &#8220;overcharge&#8221; under Section&#160;340B. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"><div style="text-decoration:underline;display:inline;">State Litigation in the US</div> </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In lawsuits filed by PhRMA and certain other manufacturers challenging a contract pharmacy law passed by the State of Mississippi, the court denied for each of the plaintiffs their preliminary injunctions in their respective lawsuits. The plaintiffs appealed the denials of the preliminary injunction motions. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Various other challenges to similar state laws have been filed by PhRMA and/or certain manufacturers in a number of other states, including in Colorado, Kansas, Louisiana, Maryland, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, Tennessee, Utah, South Dakota, and Vermont. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLegalAndArbitralProceedingsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Legal And Arbitral Proceedings [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLegalAndArbitralProceedingsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Income And Expenses<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory', window );">Other Operating Income and Expenses</a></td>
<td class="text"><div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.15. Other operating income and expenses </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating income</div></div> amounted to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>533&#160;million in the first half of 2025 (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>563&#160;million in the first half of 2024), and <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating expenses</div></div> to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2,476&#160;million (<div style="font-style:italic;display:inline;">versus</div> <div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;1,977&#160;million in the first half of 2024). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The main items included in <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating income</div></div> were: in the first half of 2025, (i) income from pharmaceutical partners of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>87&#160;million (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>121&#160;million in the first half of 2024), of which <div style="font-family:Times New Roman;display:inline;">&#8364;</div>70&#160;million came from Regeneron (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>96&#160;million in the first half of 2024, see table below) and (ii)&#160;gains on disposals of assets and operations of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>344&#160;million, primarily on divestments of non strategic products (versus <div style="font-family:Times New Roman;display:inline;">&#8364;</div>319&#160;million in the first half of 2024). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating expenses</div></div> for the first half of 2025 included <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2,331&#160;million of expenses related to Regeneron (compared with <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1,841&#160;million in the first half of 2024), as shown in the table below. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Income&#160;&amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(2,475</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,934</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Additional share of profit paid by Regeneron towards development costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">494</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">389</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Reimbursement to Regeneron of selling expenses incurred</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(346)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(292)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total: Monoclonal Antibody Alliance</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(2,327</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,837</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other (mainly Zaltrap and Libtayo)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">66</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">92</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Other operating income/(expenses), net related to Regeneron</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(2,261</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(1,745</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.75em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which amount presented in &#8220;Other operating income&#8221;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">70</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">96</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs and Similar Items<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringTextBlock', window );">Restructuring costs and similar items</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.16. Restructuring costs and similar items </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Restructuring costs and similar items </div></div>comprise the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Employee-related expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">201</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">810</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Charges, gains or losses on assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">109</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Costs of transformation programs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">80</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">114</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other restructuring costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">163</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">430</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,060</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Restructuring and similar costs decreased by <div style="font-family:Times New Roman;display:inline;">&#8364;</div>630&#160;million between June&#160;30, 2024 and June&#160;30, 2025. In the first half of 2024, restructuring and similar costs mainly comprised the impacts of (i)&#160;the renewal of the Job Management and Career Paths (GEPP) program in France to cover the 2024-2026 period, including scope extensions in the job profiles affected by transformations and (ii)&#160;a voluntary redundancy <div style="display:inline;">program</div> <div style="display:inline;">announced</div> in 2024 in connection with the reorganization of R&amp;D operations to make Sanofi a leader in <div style="display:inline;">immunology</div>. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Restructuring [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Gains and Losses, and Litigation<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock', window );">Other Gains and Losses, and Litigation</a></td>
<td class="text"><div style="margin-top:20pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.17. Other gains and losses, and litigation </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For the first half of 2025, <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div> is a charge of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>57&#160;million, mainly related to major litigation. That compares with a charge of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>450&#160;million in the first half of 2024, mainly comprising a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US state of Hawaii. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of other gains and losses, and litigation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Expenses and Income<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Financial Expenses and Income</a></td>
<td class="text"><div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.18. Financial expenses and income </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">An analysis of financial expenses and income is set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(219</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(306</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Interest income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">162</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">239</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Cost of net debt</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(57</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(67</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">Non-operating</div> foreign exchange gains/(losses)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Unwinding of discounting of provisions <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(19</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest cost related to employee benefits</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(39</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest expense on lease liabilities</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">(161</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Net financial income/(expenses)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(177</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(306</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">comprising: Financial expenses</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(361</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(583</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8196;Financial income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">184</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#8364;(25)&#160;million in the first half of 2025 and &#8364;(24)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;(4)&#160;million in the first half of 2025 and &#8364;(18)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes a financial expense of &#8364;50&#160;million for the six months ended June&#160;30, 2025 and &#8364;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The impact of the ineffective portion of hedging relationships was not material in either 2025 or 2024. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax Expense<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income Tax Expense</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.19. Income tax expense </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the allocation of income tax expense between current and deferred taxes: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Current taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,202</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(1,108</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Deferred taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8199;&#8194;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;491</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;729</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(711</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(379</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,582</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,462</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The difference between the effective tax rate (on income before tax and investments accounted for using the equity method) and the standard corporate income tax rate applicable in France is explained as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(as a percentage)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Standard tax rate applicable in France</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">25.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">25.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Difference between the standard French tax rate and the rates applicable to Sanofi<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(7.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(15.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Revisions to tax exposures and settlements of tax disputes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1.0</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Effective tax rate</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">15.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">&#8194;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The 2024 component of the temporary exceptional corporate income tax contribution, introduced under the 2025 French Finance Bill, is included in the tax charge but excluded from the calculation of the annual average effective tax rate in accordance with IAS 34. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#8364;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#8217;s current understanding of Pillar Two rules, and &#8364;52&#160;million for the six months ended June&#160;30, 2024. </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment Information</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.21. Segment information </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The segment information presented by Sanofi consists of a single operating segment: Biopharma. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Specialty Care, General Medicines and Vaccines franchises plus support and corporate functions, for all geographical territories. It also includes revenues generated from the manufacture of Consumer Healthcare products invoiced to Opella, which constitutes a related party with effect from the deconsolidation date (April 30, 2025). Those revenues, which before that date represented intragroup transactions classified within continuing operations, are presented within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other Revenues</div></div> in the income statement. The Biopharma operating segment also includes the purchase price of Biopharma products manufactured by Opella. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The &#8220;Other&#8221; category comprises primarily, but not exclusively, Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </div><div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.1. Segment results </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial">Sanofi reports segment results on the basis of &#8220;Business operating income&#8221;. This indicator is used internally by Sanofi&#8217;s chief operating decision maker to measure the performance of the operating segment and to allocate resources. </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">&#8220;Business operating income&#8221; is derived from <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Operating income</div></div>, adjusted as follows: </div><div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature), are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>fair value remeasurements of contingent consideration relating to business combinations (IFRS 3) or business divestments, and presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Fair value remeasurement of contingent consideration</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>expenses arising from the remeasurement of inventories following business combinations (IFRS 3) or acquisitions of groups of assets that do not constitute a business within the meaning of paragraph 2b of IFRS 3, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>amounts reported within the line items <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Restructuring costs and similar items </div></div>are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>other gains and losses (including gains and losses on major divestments), presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>other costs and provisions related to litigation, presented within the line item <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other gains and losses, and litigation</div></div>, are eliminated; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to joint ventures and associates with which Sanofi has a strategic alliance; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>the portion attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests related to continuing operations and excluding the effects of the above reconciliation items, is deducted. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Segment results are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="36" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="34" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025 (6 months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">19,889</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,246</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-7.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-6.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">206</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+15.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,452</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-5.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-3.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(5,753</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-0.1</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(128</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+14.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(5,881</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+0.2</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(3,716</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(3,717</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(4,447</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(59</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(4,506</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,941</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,943</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,347</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+11.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">16</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,363</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+10.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;As % of net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">26.9</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;&#8199;27.0%</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2024 (6 months) (a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Other</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Total</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,352</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">177</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,529</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(5,849</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(110</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(5,959</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(3,334</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(3,335</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(4,247</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(56</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(4,303</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,426</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">12</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,414</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,916</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">22</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,938</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below, presented in compliance with IFRS 8, shows a reconciliation between &#8220;Business operating income&#8221; and <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Income before tax and investments accounted for using the equity method</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">5,363</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,938</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Amortization and impairment of intangible assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(987</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(527</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Fair value remeasurement of contingent consideration</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Expense arising from the impact of acquisitions on inventories<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Restructuring costs and similar items<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(f)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(430</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(1,060</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other gains and losses, and litigation<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(g)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(57</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(450</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,759</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,768</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(361</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(583</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial income</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">184</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">277</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,582</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,462</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint ventures and associates with which Sanofi has entered into a strategic alliance. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#8364;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#8364;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(f)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.16. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(g)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.17. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.2. Other segment information </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The tables below show the split by operating segment of (i)&#160;the carrying amount of investments in joint ventures and associates accounted for using the equity method with which Sanofi has entered into a collaboration agreement; (ii)&#160;acquisitions of property, plant and equipment; and (iii)&#160;acquisitions of intangible assets. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Investments accounted for using the equity method mainly comprise MSP Vaccine Company and Infraserv GmbH&#160;&amp; Co. H&#246;chst&#160;KG (see Note B.5.). </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Investments accounted for using the equity method <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">483</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">229</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of property, plant and equipment</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">845</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">882</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of other intangible assets</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">575</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">922</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Carrying amount at the end of the reporting period. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.3. Information by geographical region </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The geographical information on net sales provided below is based on the geographical location of the customer. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,144</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">4,072</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">835</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">855</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">9,535</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">8,292</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">6,210</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">5,996</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,388</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,406</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 8, the <div style="white-space:nowrap;display:inline;">non-current</div> assets reported below exclude financial instruments, deferred tax assets, <div style="white-space:nowrap;display:inline;">pre-funded</div> pension obligations, and <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">right-of-use</div></div> assets as determined under IFRS 16. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:47%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,438</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">5,550</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">3,307</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,953</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,112</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,080</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">16,725</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2,411</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">18,711</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,056</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">539</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2,130</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">611</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">83</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">96</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,574</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">40,283</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">20,431</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">10,091</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">43,384</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">22,629</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As stated in Note D.5. to the consolidated financial statements for the year ended December&#160;31, 2024, goodwill is not allocated by geographical region. </div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.21.4. Disclosures about major customers </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented 35% of net sales in the first half of 2025. Sanofi&#8217;s three largest customers respectively accounted for approximately 18%, 12% and 5% of consolidated net sales in the first half of 2025 (versus approximately 13%, 9% and 7% in the first half of 2024). </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Revenue from Contracts with Customers</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.20. Revenue from contracts with customers </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.20.1. Analysis of net sales </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below sets forth net sales for the six months ended June&#160;30, 2025 and June&#160;30, 2024: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:8%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:33%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United<br/>States</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">States</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2024 <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#23004c"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total Group</div></div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,144</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,535</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">6,210</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,072</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,292</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,996</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Immunology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Dupixent</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">944</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,283</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,085</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">7,312</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">770</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">4,437</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">931</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">6,138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Rare diseases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">ALTUVIIIO</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">456</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">542</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">259</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">21</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">280</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Nexviazyme/Nexviadyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">132</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">195</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">387</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">174</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">51</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">320</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Cablivi</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">55</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">71</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">136</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">43</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">113</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Xenpozyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">44</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">47</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">19</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">110</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">24</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">11</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Neurology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Aubagio</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">96</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">18</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Oncology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Sarclisa</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">83</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">119</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">74</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">276</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">64</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">100</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">63</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">227</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other medicines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Rezurock</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">220</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">263</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">12</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">188</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">207</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Tzield</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">27</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">29</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">21</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Industrial sales</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">241</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">9</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">251</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">273</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">274</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Vaccines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial">Polio/Pertussis/</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial">Hib Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">223</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">320</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">818</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,361</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">248</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">311</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">789</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,348</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Meningitis, travel and endemics vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">96</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">319</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">194</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">609</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">301</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">185</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">583</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">RSV vaccine (Beyfortus)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">85</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">68</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">203</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">356</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">116</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Influenza Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">52</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">54</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">108</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">214</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">30</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">16</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">142</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">188</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total net sales</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,144</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,535</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">6,210</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,072</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,292</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,996</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.20.2. Other revenues </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;VaxServe sales of <div style="white-space:nowrap;display:inline;">non-Sanofi</div> products</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">842</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">854</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales to Opella <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Royalties</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">68</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">62</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">275</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">341</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Biopharma Other revenues</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,246</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,352</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales / Revenues from Opella products<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">206</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">177</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Other revenues</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,452</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,529</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information related to Opella, presented within assets held for sale and discontinued operations<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory', window );">Information related to Opella, presented within assets held for sale and discontinued operations</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;">B.22. Information related to Opella, presented within assets held for sale and discontinued operations </div></div></div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;30 2025, the Opella transaction was closed (see Note B.1.) triggering loss of control, and resulting in the derecognition of all assets and liabilities of Opella subsidiaries. As of December&#160;31, 2024, all Opella assets and associated liabilities were classified as held for sale, in accordance with IFRS 5. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:86%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Assets</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Property, plant and equipment owned</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">760</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Right-of-use</div></div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">116</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Goodwill</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7,255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">2,928</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">600</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">989</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">841</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#661de8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">13,489</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Liabilities</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">112</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> provisions and other <div style="white-space:nowrap;display:inline;">non-current</div> liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">204</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">797</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Current provisions and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">570</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">448</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#661de8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities related to assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">2,131</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 5, the Opella held for sale asset group, and the related liabilities, were measured at the lower of carrying amount and fair value less costs to sell. This valuation did not result in the recognition of any impairment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the main items presented within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net sales and other revenues <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,736</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,645</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Operating income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">266</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">277</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,781</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:Arial">Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,039</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">278</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Income tax expense <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(158</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(85</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,881</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">202</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In 2025, this line includes an expense of &#8364;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below presents basic and diluted earnings per share from discontinued operations (Opella), in accordance with IAS 33 (Earnings per Share): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,881</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">202</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares outstanding (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,225.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,249.4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares after dilution (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,230.7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,253.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Basic earnings per share (in euros)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.34</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.16</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Diluted earnings per share (in euros)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.33</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">0.16</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for non-current assets held for sale and discontinued operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Section Presentation and disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IFRS05_g30-42_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Business Combinations and to Non-Controlling Interests<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract', window );"><strong>Disclosure of contingent liabilities in business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock', window );">Liabilities Related to Business Combinations and to Non-Controlling Interests</a></td>
<td class="text"> <div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"><div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style: normal;display:inline;"><div style="font-style:italic;display:inline;">B.11. Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests </div></div></div></div> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For a description of the nature of the liabilities reported in the line item <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests</div></div></div>, refer to Note B.8.4. to the consolidated financial statements for the year ended December&#160;31, 2024. </div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests shown in the table below are level&#160;3 instruments under the IFRS 13 and IFRS 7 fair value hierarchy (see Note A.5.). </div>  <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests in the first half of 2025 are shown below: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">MSD&#160;contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Shire&#160;contingent<br/>consideration<br/>arising from<br/>acquisition&#160;of<br/>Translate&#160;Bio</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">72</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">568</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">641</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Payments made</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">71</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">563</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">564</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Of which:</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Current portion</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> portion</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">564</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of January&#160;1, 2025, this comprised a <div style="white-space:nowrap;display:inline;">non-current</div> portion of &#8364;569&#160;million and a current portion of &#8364;72&#160;million. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Amounts mainly reported within the income statement line item &#8220;Fair value remeasurement of contingent consideration&#8221;. </div></div></div></td></tr></table>  <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests</div></div></div> mainly comprised the contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi&#8217;s acquisition of Translate Bio in September 2021. The fair value of the Shire liability is determined by applying the contractual terms to development and sales projections that are weighted to reflect the probability of success, and discounted. The liability was measured at <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div>563&#160;million as of June&#160;30, 2025, compared with <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;display:inline;">&#8364;</div>568&#160;million as of December&#160;31, 2024. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately 10%. </div> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture was extinguished during 2024 in accordance with the contractual terms. Sanofi has no further liability in respect of this contingent consideration following settlement of the milestone linked to 2024 sales. </div> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for liabilities related to business combination and to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Events Subsequent to June 30, 2025<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract', window );"><strong>Disclosure of non-adjusting events after reporting period [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Events Subsequent to June 30, 2023</a></td>
<td class="text"><div id="ex99_169958_12" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold">C/ Events subsequent to June&#160;30, 2025 </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vicebio Ltd (&#8220;Vicebio&#8221;), a privately held biotechnology company headquartered in London, UK. The acquisition brings to Sanofi an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands Sanofi&#8217;s capabilities in vaccine design and development with Vicebio&#8217;s &#8216;Molecular Clamp&#8217; technology. Under the terms of the agreement, Sanofi would acquire all of Vicebio&#8217;s share capital for a total upfront payment of $1.15&#160;billion, with potential milestone payments of up to $450&#160;million based on development and regulatory achievements. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including receipt of regulatory approvals. </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2025-01-01<br> -Section Disclosure<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_StatementOfIFRSCompliance', window );">International Financial Reporting Standards (IFRS)</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The half-year consolidated financial statements have been prepared and presented in condensed format in accordance with IAS&#160;34 (Interim Financial Reporting). The accompanying notes therefore relate to significant events and transactions of the period, and should be read in conjunction with the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies used in the preparation of the consolidated financial statements as of June&#160;30,&#160;2025 comply with international financial reporting standards (IFRS) as endorsed by the European Union and as issued by the International Accounting Standards Board (IASB). IFRS as endorsed by the European Union as of June&#160;30, 2025 are available via the following web link: </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">https://www.efrag.org/Endorsement </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The accounting policies applied effective January&#160;1, 2025 are identical to those presented in the consolidated financial statements for the year ended December&#160;31, 2024. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On August&#160;15, 2023, the IASB issued &#8220;Lack of Exchangeability&#8221;, an amendment to IAS 21 (The Effects of Changes in Foreign Exchange Rates), relating to how to determine the exchange rate when a currency is not exchangeable. The amendment became applicable on January&#160;1, 2025, and does not have a material impact on the Sanofi financial statements. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In its 2025 half-year financial statements, Sanofi has used an average effective tax rate that takes into account the Pillar Two <div style="white-space:nowrap;display:inline;">top-up</div> tax applicable from January&#160;1, 2024. The effective tax rate also includes a <div style="white-space:nowrap;display:inline;">one-off</div> impact from the 2024 component of the exceptional contribution in respect of French corporate income taxes (see Note B.19.). </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date the financial statements are finalized. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">impairment of property, plant and equipment and intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the valuation of goodwill and the valuation and useful life of acquired intangible assets; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of contingent consideration receivable in connection with asset divestments and of contingent consideration payable; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the measurement of financial assets and financial liabilities at amortized cost; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of post-employment benefit obligations; </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences. </div></td></tr></table><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actual results could differ from these estimates. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">For half-year financial reporting purposes, and as allowed under IAS 34, Sanofi has determined income tax expense on the basis of an estimate of the effective tax rate for the full financial year. That rate is applied to business operating income plus financial income and minus financial expenses, and before (i)&#160;the share of profit/loss of investments accounted for using the equity method and (ii)&#160;net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. The estimated full-year effective tax rate is based on the tax rates that will be applicable to projected <div style="white-space:nowrap;display:inline;">pre-tax</div> profits or losses arising in the various tax jurisdictions in which Sanofi operates. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock', window );">Seasonal Trends</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Sanofi&#8217;s activities are not subject to significant seasonal fluctuations. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory', window );">Consolidation and Foreign Currency Translation of the Financial Statements of Subsidiaries in Hyperinflationary Economies</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In 2025, Sanofi continues to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that<div style="display:inline;"> the </div>criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. The contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since July&#160;1, 2018) treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In Turkey, the cumulative rate of <div style="display:inline;">inflation </div>over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since January&#160;1, 2022) treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. </div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Under IFRS 13 (Fair Value Measurement) and IFRS 7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"><div style="font-weight:bold;display:inline;"></div>Level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging); </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;2: quoted prices in active markets for similar assets or liabilities, or valuation techniques in which all important inputs are derived from observable market data; and </div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:1%;vertical-align:top;text-align:left">&#8226;</td>
<td style="width:1%;vertical-align:top">&#160;</td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify">Level&#160;3: valuation techniques in which not all important inputs are derived from observable market data. </div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:13%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:9%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:6%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:7%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:10%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:14%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:11%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td rowspan="3" style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Type&#160;of&#160;financial</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">instrument</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Measurement</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">principle</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;in<br/>fair&#160;value<br/>hierarchy</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>technique</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Method used to determine fair value</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Market data</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>model</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exchange</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">rate</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Interest&#160;rate</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Volatilities</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets<br/>measured at fair value (quoted equity instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value (quoted debt instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost/ Peer comparison (primarily)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(contingent consideration receivable)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">Long-term&#160;loans</div> and&#160;advances&#160;and <div style="white-space:nowrap;display:inline;">other&#160;non-current</div> receivables</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The amortized cost of long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables at the end of the reporting period is not materially different from their fair value.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under <div style="white-space:nowrap;display:inline;">post-employment</div> benefit plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Investments in mutual funds</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Net asset value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div><br/> <div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial">B.12.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial&#160;liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Lease liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Future lease payments are discounted using the incremental borrowing rate.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Forward&#160;currency contracts</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Present value of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Market Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Interest&#160;rate&#160;swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Cross-currency</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Liabilities&#160;related&#160;to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.</div></td></tr></table><div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations', window );">New Pronouncements Issued by the IASB and Applicable from 2024</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On April&#160;9, 2024, the IASB issued IFRS 18 (Presentation and Disclosure in Financial Statements), applicable from January&#160;1, 2027 (subject to endorsement by the European Union). An impact assessment is currently under way. Sanofi will not early adopt this new standard. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On May&#160;30, 2024, the IASB issued amendments to IFRS 9 and IFRS 7 relating to the classification and measurement of financial instruments, applicable no earlier than January&#160;1, 2026. Sanofi does not expect any material impact, and will not early adopt these amendments. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On July&#160;18, 2024, the IASB issued Volume 11 of &#8220;Annual Improvements to IFRS&#8221;, applicable from January&#160;1, 2026. Sanofi does not expect any material impact from those improvements to various standards, which are essentially in the nature of clarifications, and will not early adopt them. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">On December&#160;18, 2024, the IASB issued &#8220;Contracts referencing nature-dependent electricity&#8221;, amendments to IFRS 9 and IFRS&#160;7, applicable from January&#160;1, 2026. The amendments clarify the application of the &#8216;own use&#8217; exemption to Power Purchase Agreements (PPAs) with physical delivery of renewable electricity, and modify the hedge accounting requirements for contracts without physical delivery (VPPAs). Sanofi does not expect any material impact and will not early adopt these amendments. Renewable energy purchase contracts entered into by Sanofi as of December&#160;31, 2024 are described in Note D.21. to the consolidated financial statements included in the 2024 Form <div style="white-space:nowrap;display:inline;">20-F</div> for the year ended December&#160;31, 2024 (the &#8220;2024 <div style="white-space:nowrap;display:inline;">20-F&#8221;).</div> </div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 117<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 30<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_30_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 180<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_180_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 180<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_180_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of information about financial reporting in hyperinflationary economies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 29<br> -IssueDate 2025-01-01<br> -Section Disclosures<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=29&amp;code=ifrs-tx-2025-en-r&amp;doctype=Standard&amp;dita_xref=IAS29_g39-40_TI<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_StatementOfIFRSCompliance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_StatementOfIFRSCompliance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Seasonality Or Cyclicality Of Interim Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract', window );"><strong>Corporate information and statement of IFRS compliance [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory', window );">Disclosure of Measurement Principles Applied to Financial Instruments</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:13%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:9%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:6%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td style="width:7%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:10%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:14%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:12%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:11%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td rowspan="3" style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Note</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Type&#160;of&#160;financial</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">instrument</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Measurement</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">principle</div></div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Level&#160;in<br/>fair&#160;value<br/>hierarchy</div></div></td>
<td rowspan="3" style="vertical-align:bottom">&#160;&#160;</td>
<td rowspan="3" style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>technique</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Method used to determine fair value</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Market data</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Valuation<br/>model</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exchange</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">rate</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Interest&#160;rate</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Volatilities</div></div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets<br/>measured at fair value (quoted equity instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value (quoted debt instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost/ Peer comparison (primarily)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;(contingent consideration receivable)</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">Long-term&#160;loans</div> and&#160;advances&#160;and <div style="white-space:nowrap;display:inline;">other&#160;non-current</div> receivables</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">The amortized cost of long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables at the end of the reporting period is not materially different from their fair value.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under <div style="white-space:nowrap;display:inline;">post-employment</div> benefit plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market&#160;value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.6.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Quoted market price</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Investments in mutual funds</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">1</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Market value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Net asset value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div><br/> <div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial">B.12.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Financial&#160;liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Amortized cost&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.9.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Lease liabilities</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Amortized</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">cost</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Future lease payments are discounted using the incremental borrowing rate.</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Forward&#160;currency contracts</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Revenue-based approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Present value of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Market Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Interest&#160;rate&#160;swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.10.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial">Cross-currency</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial">swaps</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">2</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Present value&#160;of future&#160;cash flows</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Mid</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Spot</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&lt;&#160;1&#160;year:&#160;Mid&#160;Money</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Market&#160;and&#160;Euronext</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">interest&#160;rate&#160;futures</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">&gt;&#160;1&#160;year:&#160;Mid&#160;Zero</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">Coupon</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"><div style="font-family:Arial;display:inline;">N/A</div></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">B.11.</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Liabilities&#160;related&#160;to business combinations and to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">Fair value</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;display:inline;">3</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">Revenue-</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center">based</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center">approach</div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.</div></td></tr></table><div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 7<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 35K<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35K&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 43<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_43&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock', window );">Summary of Acquisitions and Capitalized Interest by Operating Segment</a></td>
<td class="text"> <div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below sets forth acquisitions and capitalized interest by operating segment for the first half of 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt">&#160;</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquisitions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">702</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">591</div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Biopharma</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">663</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">535</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="font-style:italic;display:inline;">Of which Manufacturing&#160;&amp; Supply</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">453</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">366</div></div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial">Opella (discontinued operation, see Note B.1.)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">39</div></td>
<td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">56</div></td>
<td style="white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Of which capitalized interest</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">22</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">22</div></div></div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract', window );"><strong>Intangible assets and goodwill [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock', window );">Schedule of Movements in Other Intangible Assets</a></td>
<td class="text"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in other intangible assets during the first half of 2025 were as follows: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:65%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">&#8199;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Acquired&#160;R&amp;D</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Products,<br/> trademarks&#160;and<br/> other rights</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Software</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total&#160;other<br/> intangible&#160;assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,866</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">66,348</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,852</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">81,066</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Changes in scope of consolidation<div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"> (b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">500</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">500</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Acquisitions and other increases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">332</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">302</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">42</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">676</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(199</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(228</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(1,339</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(5,159</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(49</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(6,547</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(244</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(292</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Gross value at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,297</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">61,048</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,830</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">75,175</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at January&#160;1, 2025</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(4,497</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(52,507</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,433</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(58,437</div></div></td>
<td style="white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Amortization expense</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(800</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(52</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(852</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Impairment losses, net of reversals <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(201</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(9</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">(210</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Disposals and other decreases</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">199</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">229</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">427</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">3,772</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">4,239</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">281</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;display:inline;">287</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Accumulated amortization and impairment at June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(4,249</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(49,064</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,431</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(54,744</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at January&#160;1, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">8,369</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">13,841</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">419</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">22,629</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Carrying amount at June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,048</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,984</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">399</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">20,431</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Transfers&#8221; line mainly comprises (i)&#160;acquired R&amp;D that came into commercial use during the period and (ii)&#160;reclassifications of assets to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Assets held for sale</div></div><div style="font-style:italic;display:inline;">. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The &#8220;Changes in scope of consolidation&#8221; line mainly comprises the intangible asset recognized as part of the Dren-0201, Inc. acquisition (see Note B.1.) </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.4. </div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of changes in other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments Accounted for Using the Equity Method (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestsInOtherEntitiesAbstract', window );"><strong>Interests In Other Entities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock', window );">Summary of Investments in Associates and Joint Ventures</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Investments accounted for using the equity method consist of associates and joint ventures (see Note B.1. to the consolidated financial statements for the year ended December&#160;31, 2024), and comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:71%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8201;&#8201;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;interest</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">OPAL JV Co <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">48.2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,239</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">EUROAPI <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">29.6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">82</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">82</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Infraserv GmbH&#160;&amp; Co. H&#246;chst KG <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">31.2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">93</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">102</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">MSP Vaccine Company <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">50.0</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">79</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">81</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial">Other investments</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">70</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">51</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">3,563</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">316</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June&#160;30, 2025, the investment includes a &#8364;241&#160;million loan to OPAL JV Co being in substance part of the investment. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#8364;2.89 as of June&#160;30, 2025, and &#8364;2.88 as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory', window );">Summary of Principal Transactions and Balances with Related Parties</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The financial statements include commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Sales <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c) (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">29</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">59</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Royalties and other income <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">63</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Purchases of goods and services (including research expenses) <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(c)</div> <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(d)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">371</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">333</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts receivable and other receivables <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">299</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">184</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other assets <div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">189</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">189</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Accounts payable and other payables</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">637</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">160</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes loans to joint ventures and associates. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In October 2024, Sanofi raised its investment in EUROAPI by &#8364;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#8364;189&#160;million (and was also &#8364;189&#160;million as of December&#160;31, 2024). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative periods have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock', window );">Disclosure Of Unaudited Financial Statements Of Subsidiaries Explanatory [Table Text Block]</a></td>
<td class="text"><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Key items from the OPAL JV Co 2025 unaudited half-year consolidated financial statements, as provided in accordance with Sanofi&#8217;s consolidation timelines, are presented below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated income statement</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net sales and other revenues <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">887</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Net income <div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">24</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated statement of comprehensive income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial">&#8194;Comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:2%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"><div style="font-family:Arial;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#7802e6;display:inline;"><div style="font-style:italic;display:inline;"></div> </div></div><div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"> </div><div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"></div><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:91%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Consolidated balance sheet</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> assets</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">16,179</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current assets</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">2,937</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,116</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top">&#8194;Equity attributable to equity holders of OPAL JV Co</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">5,754</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Equity attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">541</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,295</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:top"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> liabilities</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">11,039</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top">&#8194;Current liabilities</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right">1,782</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">12,821</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total equity and liabilities</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,116</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of investments in associates and joint ventures explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of unaudited financial statements of subsidiaries explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestsInOtherEntitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interests In Other Entities [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestsInOtherEntitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Non-Current Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock', window );">Summary of Other Non-Current Assets</a></td>
<td class="text"><div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Other <div style="white-space:nowrap;display:inline;">non-current</div> assets comprise: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Equity instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,105</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,559</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Debt instruments at fair value through other comprehensive income</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">362</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">357</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Other financial assets at fair value through profit or loss</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">965</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,027</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Pre-funded</div> pension obligations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">146</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">156</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Long-term prepaid expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">143</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">152</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;Long-term loans and advances and other <div style="white-space:nowrap;display:inline;">non-current</div> receivables</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">382</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">502</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Derivative financial instruments</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,109</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">3,753</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of components of other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock', window );">Summary of Accounts Receivable</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Accounts receivable break down as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Gross value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">7,896</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">7,777</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;Allowances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(100</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Carrying amount</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">7,810</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">7,677</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock', window );">Summary of Gross Value of Overdue Receivables</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the ageing profile of overdue accounts receivable, based on gross value: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:49%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;accounts<br/>gross value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&lt;1&#160;month</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">1-3</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">3-6</div> months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="white-space:nowrap;display:inline;">6-12&#160;months</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Overdue&#160;by</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&gt;&#160;12&#160;months</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;As of June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">386</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">122</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">103</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">73</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">48</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">40</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#8194;As of December&#160;31, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">316</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">194</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">87</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">9</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">44</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfCurrentTradeReceivablesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of current trade receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfCurrentTradeReceivablesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of overdue receivables gross value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory', window );">Summary of Treasury Shares Held</a></td>
<td class="text"><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold">B.8.1. Share capital </div><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">As of June&#160;30, 2025, the share capital was <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2,455,512,548 and consisted of 1,227,756,274 shares (the total number of shares outstanding) with a par value of <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Treasury shares held by Sanofi are as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:73%"></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:10%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;shares</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;of&#160;share&#160;capital</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">for the period</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">10.66</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">0.868</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">December&#160;31, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">9.53</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.755</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">June&#160;30, 2024</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">15.33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1.211</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">January&#160;1, 2024</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">13.45</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1.063</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">%&#160;</div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A total of 171,150 shares were issued in the first half of 2025 as a result of the exercise of Sanofi stock subscription options. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In addition, 2,682,051 shares vested under Sanofi restricted share plans during the first half of 2025, of which 1,156,205&#160;were fulfilled by issuance of new shares and 1,525,846 by allotment of existing shares free of charge. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock', window );">Summary of Principal Characteristics of Restricted Share Plans</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. to the consolidated financial statements for the year ended December&#160;31, 2024. The principal features of the plans awarded in 2025 are set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:83%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Type of plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">Performance&#160;share&#160;plan</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Date of Board meeting approving the plan</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">30&#160;April, 2025</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total number of shares subject to a <div style="white-space:nowrap;display:inline;">3-year</div> service period</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,021,370</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with no market condition</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,599,478</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>83.94</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Of which with market conditions</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,421,892</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded other than to the Chief Executive Officer (1,331,892 shares in total) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>79.25</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Fair value per share awarded to the Chief Executive Officer (90,000 shares) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-family:Times New Roman;display:inline;">&#8364;</div>75.10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair value of plan at the date of grant (&#8364; million)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">331</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock', window );">Summary of Number of Restricted Shares Not Yet Fully Vested</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Total expense for restricted share plans (<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">146</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">128</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Number of shares not yet fully vested</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">11,550,347</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">11,192,984</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2025 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,020,451</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2024 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,110,089</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">4,498,109</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2023 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,313,588</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,652,352</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2022 plans</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">106,219</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,031,060</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;Under 2021 plans</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">11,463</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock', window );">Summary of Options Outstanding and Exercisable</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below provides summary information about options outstanding and exercisable as of June&#160;30, 2025: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Range of exercise prices per share</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Outstanding</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Exercisable</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average</div></div></div><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">residual life</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(years)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Number&#160;of&#160;options</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Weighted&#160;average<br/>exercise price<br/>per&#160;share</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>)</div><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"></div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>60.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>70.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">168,784</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">2.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">65.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">168,784</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">65.84</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>70.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>80.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">299,250</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">2.98</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">76.48</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">299,250</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">76.48</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">From <div style="font-family:Times New Roman;display:inline;">&#8364;</div>80.00 to <div style="font-family:Times New Roman;display:inline;">&#8364;</div>90.00 per share</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">257,010</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">1.86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">88.97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">257,010</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">88.97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">725,044</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">725,044</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock', window );">Summary of Number of Shares Used to Compute Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Average number of shares outstanding</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,225.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,249.4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for stock options with dilutive effect</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">0.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Adjustment for restricted shares</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5.1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">4.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Average number of shares used to compute diluted earnings per share</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,230.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,253.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock', window );">Summary of Movements within Other Comprehensive Income</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements within other comprehensive income are shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8199;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;&#8194;&#8194;&#8194;June&#160;30,&#160;2024<br/>(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses):</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) excluding investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">105</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">235</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(25</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(57</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Equity instruments included in financial assets and financial liabilities:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">222</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Equity risk hedging instruments designated as fair value hedges</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(60</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items not subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">243</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">166</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Debt instruments included in financial assets:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash flow hedges and fair value hedges:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (excluding investments accounted for using the equity method)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Change in fair value (investments accounted for using the equity method, net of taxes)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Change in currency translation differences:</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:middle;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin: 0pt 0.63em 0pt 1.13em; text-indent: -0.63em; font-size: 8pt; font-family: Arial; text-align: justify; line-height: normal;">&#8226;&#8201;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(5,266</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Currency translation differences (investments accounted for using the equity method)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(26</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Hedges of net investments in foreign operations</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">390</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(126</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Tax effects</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(101</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">33</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Items subsequently reclassifiable to profit or loss</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(5,017</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,067</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: immaterial over all periods. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: &#8364;2&#160;million in the first half of 2025, immaterial in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; background: none; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">&#8194;</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes reclassifications to profit or loss: a &#8364;459&#160;million loss in the first half of 2025 relating to the deconsolidation of Opella (see Note B.1.)., a &#8364;5&#160;million profit in 2024, and immaterial in the first half of 2024. </div></div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of detailed information of accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of number of restricted share plans Not yet fully vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of share based compensation shares authorized under stock option plans by exercise price range.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of shares used to compute diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInFinancialPositionTableTextBlock', window );">Summary of Changes in Financial Position</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Changes in financial position during the period were as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:82%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8198;&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,791</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,309</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">137</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,519</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,137</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,102</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,772</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock', window );">Summary of Reconciliation of Carrying Amount to Value on Redemption</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">A reconciliation of the carrying amount of net debt in the balance sheet to value on redemption as of June&#160;30, 2025 is shown below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:43%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Value on redemption</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Carrying&#160;amount&#160;at</div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Amortized&#160;cost</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Adjustment&#160;to&#160;debt<br/>measured at fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">39</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">78</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,317</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,940</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Short-term debt and current portion of long-term debt</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,309</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">7,311</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,218</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(78</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,519</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">41</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,560</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,171</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,102</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">41</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,143</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,806</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024. </div></div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock', window );">Summary of Net Debt by Type Valuation of Redemption</a></td>
<td class="text"><div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows an analysis of net debt by type, at value on redemption: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:26%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30, 2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31, 2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div></div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">current</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bond issues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13,259</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,322</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">15,581</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">11,876</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,716</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">14,592</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other bank borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,847</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">4,905</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">64</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,290</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1,354</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Other borrowings</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Bank credit balances</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">141</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">141</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage debt</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(68</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: middle; padding-bottom: 0.375pt;"></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">13</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total debt</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">13,317</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">7,243</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">20,560</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;"></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">11,940</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">4,231</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">16,171</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(15,359</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7,441</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Interest rate and currency derivatives used to manage cash and cash equivalents</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(58</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Net debt</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">13,317</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(8,174</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,143</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">11,940</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(3,134</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,806</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of June 30, 2025, current other bank borrowings include &#8364;4,535&#160;million related to the US commercial paper program and &#8364;230&#160;million related to the Negotiable European Commercial Paper program in France. </div></div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock', window );">Summary of Market Value of Net Debt</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The market value of Sanofi&#8217;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows: </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Market value</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,589</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">8,165</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial">Value on redemption</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,143</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">8,806</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInFinancialPositionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of changes in financial position [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInFinancialPositionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of debt net of cash and cash equivalents by type at value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfMarketValueOfNetDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of market value of net debt [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfMarketValueOfNetDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption [text block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FinancialInstrumentsAbstract', window );"><strong>Financial Instruments [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock', window );">Summary of Operating Currency Hedging Instruments</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows operating currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:46%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;June&#160;30, 2025</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which derivatives designated<br/>as&#160;cash&#160;flow hedges</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of&#160;which&#160;derivatives&#160;not<br/>eligible&#160;for&#160;hedge<br/>accounting</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Of which<br/>recognized<br/>in&#160;equity</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional<br/>amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,619</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">133</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">6,619</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">133</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,351</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">100</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,351</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">100</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">539</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">10</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">539</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">10</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">480</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">480</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">253</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">253</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which pound sterling</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">173</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">173</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,418</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(84</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,418</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(84</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,540</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(55</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,540</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(55</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">610</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(15</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">610</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(15</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Chinese yuan renminbi</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Turkish lira</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">159</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">159</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which United Arab Emirates dirham</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">120</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">120</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,037</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">49</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">11,037</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">49</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The above positions mainly hedge material foreign currency cash flows arising after the end of the reporting period in relation to transactions carried out during the six months ended June&#160;<div style="display:inline;">30,</div> 2025 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange difference on those items (hedging instruments and hedged transactions) will be immaterial in the second half of 2025. </div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock', window );">Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows financial currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. </div><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:top">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Notional&#160;amount</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Fair&#160;value</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Maximum<br/>&#8195;&#8195;expiry&#160;date</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Cross currency seller swaps</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,476</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,476</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(a)</div>&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">5</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2032</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">7,723</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">176</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">6,007</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(b)</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">148</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Pound sterling</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">601</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Japanese yen</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">303</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">9</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Forward currency purchases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,609</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(44</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Singapore dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,289</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(14</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which US dollar</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,094</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;(c)&#160;</div>&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">(33</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2026</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which Hungarian forint</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">639</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2025</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">12,808</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">137</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td>
<td style="vertical-align:middle;background-color:#7802e6"></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#8364;5&#160;million, with &#8364;18&#160;million debited to </div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div><div style="font-style:italic;display:inline;"> under the cost of hedging accounting treatment. </div></div></td></tr></table><div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div><div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"></div><div></div><div><div style="line-height:normal;display: inline;"></div></div> <div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward sales with a notional amount of $3,615&#160;million expiring in 2025, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of June&#160;30, 2025, the fair value of these forward contracts represented an asset of &#8364;77&#160;million; the opposite entry was recognized in </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">, with the impact on financial income and expense being immaterial. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes forward purchases with a notional amount of $1,000&#160;million expiring in 2025, designated as a fair value hedge of the exposure of $1,000&#160;million of bond issues to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of these contracts represented a liability of &#8364;25&#160;million, with &#8364;0&#160;million credited to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Other comprehensive income</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;"> to recognize the hedging cost. </div></div></div></td></tr></table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock', window );">Disclosure of Instruments</a></td>
<td class="text"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows instruments of this type in place as of June&#160;30, 2025: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:36%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;&#160;</td>
<td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style="vertical-align: bottom; padding-bottom: 0.375pt;">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>designated&#160;as&#160;fair<br/>value&#160;hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which designated<br/>as&#160;cash&#160;flow hedges</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2026</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2027</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2028</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2029<br/>and<br/>beyond</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Notional<br/>amount</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Fair<br/>value</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Of which<br/>recognized<br/>in equity</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Interest rate swaps</div></div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized SOFR USD / receive 1.17%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(54</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">848</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"></div><div style="display:inline;">(54</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay 2.08% / receive Euribor 3m</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">850</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">pay capitalized Ester / receive 0.92%</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">650</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">850</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">848</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">650</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2,348</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(88</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,498</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(81</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">850</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(7</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(3</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">)&#160;</div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of interest rates hedging instruments with notional amount by expiry date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FinancialInstrumentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Financial Instruments [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FinancialInstrumentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract', window );"><strong>Disclosure of contingent liabilities in business combination [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock', window );">Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests</a></td>
<td class="text"> <div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Movements in liabilities related to business combinations and to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-controlling</div> interests in the first half of 2025 are shown below: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:66%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">MSD&#160;contingent<br/>consideration<br/>(European<br/>Vaccines<br/>business)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Shire&#160;contingent<br/>consideration<br/>arising from<br/>acquisition&#160;of<br/>Translate&#160;Bio</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">72</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">568</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">641</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Payments made</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">71</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">563</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">564</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">Of which:</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; Current portion</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:middle;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8226; <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> portion</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"><div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">564</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">As of January&#160;1, 2025, this comprised a <div style="white-space:nowrap;display:inline;">non-current</div> portion of &#8364;569&#160;million and a current portion of &#8364;72&#160;million. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Amounts mainly reported within the income statement line item &#8220;Fair value remeasurement of contingent consideration&#8221;. </div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of changes in liabilities related to business combinations and to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-Current Provisions And Other Non-Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock', window );">Summary of Non-current provisions and other non-current liabilities</a></td>
<td class="text"> <div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The line item <div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">Non-current</div> provisions and other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities</div></div></div> comprises the following: </div> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">December&#160;31,&#160;2024</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Provisions</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">5,003</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">5,762</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;">&#8194;Other <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">non-current</div> liabilities<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#160;(a)</div></div></td>
<td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,113</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align: bottom; width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2,334</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom: 3pt; vertical-align: bottom; background-color: rgb(120, 2, 230); width: 76%;"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#8194;Total</div></div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">7,116</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">8,096</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes &#8364;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#8364;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#8364;2,293&#160;million. </div></div></div></td></tr></table> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNonCurrentProvisionsTableTextBlock', window );">Summary of Movements in Non-Current Provisions</a></td>
<td class="text"> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows movements in provisions: </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/>pensions&#160;&amp;&#160;other<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">post-employment</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Provisions&#160;for<br/><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;">other&#160;long-term</div><br/>benefits</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Restructuring<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Other<br/>provisions</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Total</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at January&#160;1, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,992</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">821</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">799</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">2,150</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,762</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Increases in provisions and other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">69</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8199;&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">78</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">175</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">293</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">615</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Provisions utilized</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(378</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(616</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Reversals of unutilized provisions</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(17</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(178</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(197</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Transfers <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(158</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(93</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Net interest related to employee benefits, and unwinding of discount</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Currency translation differences</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(94</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(74</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(83</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains and losses on defined-benefit plans&#160;(B.12.1.)</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(111</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(111</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"><div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">Balance at June&#160;30, 2025</div></div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,705</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">765</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">802</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">1,731</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">5,003</div></div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">&#160;</div></div></div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Mainly transfers to </div></div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bolder;display:inline;"><div style="font-style:italic;display:inline;">Current provisions and other current liabilities</div></div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">. </div></div></div></td></tr></table> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock', window );">Disclosure of Remeasurement of Net Defined Benefit Liability Asset</a></td>
<td class="text"> <div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Actuarial gains and losses arising on pensions and other post-employment benefits and recognized in equity are as follows (amounts reported before tax): </div> <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:76%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2025<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">June&#160;30,&#160;2024<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;</div></div></div></div><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)<div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"><div style="display:inline;"></div></div></div><div style="font-size:5pt;color:#23004c;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></div><div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"><div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"><div style="display:inline;"><div style="font-weight:bolder;display:inline;">(6&#160;months)&#8195;&#8196;</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on plan assets</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(45</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">(138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;">Actuarial gains/(losses) on benefit obligations</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">152</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(a)</div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;">373</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">&#8194;(b)</div>&#160;</div></td></tr></table> <div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the <div style="white-space:nowrap;display:inline;">-0.30%</div> change in the inflation rate in the United Kingdom in the first half of 2025. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(b)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024. </div></div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">(c)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-style:italic;display:inline;">Includes actuarial gains/ (losses) related to Opella of &#8364;(4)&#160;million for the first half of 2025 and &#8364;(6)&#160;million for the first half of 2024 . </div></div></div></td></tr></table> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNonCurrentProvisionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of noncurrent provisions explanatory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNonCurrentProvisionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Provisions And Other Non Current Liabilities Explanatory</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Operating Income And Expenses (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherOperatingExpensesTableTextBlock', window );">Schedule of Other Operating Expenses</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Other operating expenses</div></div> for the first half of 2025 included <div style="font-family:Times New Roman;display:inline;">&#8364;</div>2,331&#160;million of expenses related to Regeneron (compared with <div style="font-family:Times New Roman;display:inline;">&#8364;</div>1,841&#160;million in the first half of 2024), as shown in the table below. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Income&#160;&amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(2,475</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,934</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Additional share of profit paid by Regeneron towards development costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">494</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">389</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Reimbursement to Regeneron of selling expenses incurred</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(346)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(292)</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total: Monoclonal Antibody Alliance</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(2,327</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(1,837</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other (mainly Zaltrap and Libtayo)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">66</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">92</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Other operating income/(expenses), net related to Regeneron</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(2,261</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(1,745</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.75em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which amount presented in &#8220;Other operating income&#8221;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">70</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">96</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherOperatingExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Operating Expenses [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherOperatingExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs and Similar Items (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock', window );">Summary of Restructuring Costs and Similar Items</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Restructuring costs and similar items </div></div>comprise the following: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6&#160;months)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Employee-related expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">201</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">810</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Charges, gains or losses on assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">109</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(27</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Costs of transformation programs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">80</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">114</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other restructuring costs</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">163</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">430</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,060</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi. </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfRestructuringCostsDetailsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of restructuring costs details.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfRestructuringCostsDetailsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial Expenses and Income (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock', window );">Summary of Analysis of Financial Income and Expenses</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">An analysis of financial expenses and income is set forth below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of debt <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(219</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(306</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Interest income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">162</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">239</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Cost of net debt</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(57</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(67</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">Non-operating</div> foreign exchange gains/(losses)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Unwinding of discounting of provisions <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(19</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest cost related to employee benefits</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(39</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net interest expense on lease liabilities</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"><div style="font-family:Arial;display:inline;">(161</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Net financial income/(expenses)</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(177</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(306</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">comprising: Financial expenses</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(361</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(583</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8196;Financial income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">184</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">277</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#8364;(25)&#160;million in the first half of 2025 and &#8364;(24)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;(4)&#160;million in the first half of 2025 and &#8364;(18)&#160;million in the first half of 2024. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Includes a financial expense of &#8364;50&#160;million for the six months ended June&#160;30, 2025 and &#8364;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US. </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax Expense (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock', window );">Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the allocation of income tax expense between current and deferred taxes: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:69%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8198;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div>&#160;million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">(6 months)&#160;<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Current taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,202</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(1,108</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Deferred taxes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8199;&#8194;&#8194;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;491</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;&#8195;729</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(711</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">(379</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">)&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,582</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,462</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock', window );">Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate</a></td>
<td class="text"><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The difference between the effective tax rate (on income before tax and investments accounted for using the equity method) and the standard corporate income tax rate applicable in France is explained as follows: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:7%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">(as a percentage)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)(b)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Standard tax rate applicable in France</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">25.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">25.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Difference between the standard French tax rate and the rates applicable to Sanofi<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(7.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(15.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Revisions to tax exposures and settlements of tax disputes</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2.3</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"> (d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1.0</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Effective tax rate</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">15.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">&#8194;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The 2024 component of the temporary exceptional corporate income tax contribution, introduced under the 2025 French Finance Bill, is included in the tax charge but excluded from the calculation of the annual average effective tax rate in accordance with IAS 34. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#8364;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#8217;s current understanding of Pillar Two rules, and &#8364;52&#160;million for the six months ended June&#160;30, 2024. </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of allocation of income tax between current and deferred taxes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of average effective tax rate and applicable tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueAbstract', window );"><strong>Revenue [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory', window );">Summary of Net Sales by Segment and Geographical Area</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below sets forth net sales for the six months ended June&#160;30, 2025 and June&#160;30, 2024: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:8%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:33%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United<br/>States</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Europe</div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">United</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">States</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">countries</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2024 <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td>
<td colspan="4" style="height:3pt;background-color:#23004c"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#23004c"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total Group</div></div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,144</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,535</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">6,210</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,072</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,292</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,996</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#23004c">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Immunology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Dupixent</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">944</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,283</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,085</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">7,312</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">770</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">4,437</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">931</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">6,138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Rare diseases</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">ALTUVIIIO</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">456</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">86</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">542</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">259</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">21</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">280</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Nexviazyme/Nexviadyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">132</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">195</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">387</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">174</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">51</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">320</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Cablivi</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">55</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">71</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">136</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">43</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">60</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">10</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">113</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Xenpozyme</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">44</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">47</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">19</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">110</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">24</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">37</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">11</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">72</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Neurology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Aubagio</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">40</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">76</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">22</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">138</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">96</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">18</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">209</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Oncology</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Sarclisa</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">83</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">119</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">74</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">276</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">64</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">100</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">63</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">227</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other medicines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Rezurock</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">23</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">220</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">263</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">12</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">188</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">207</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Tzield</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">27</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">29</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">20</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">21</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Industrial sales</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">241</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">9</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">251</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">273</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">274</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Vaccines</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">of which</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial">Polio/Pertussis/</div><div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial">Hib Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">223</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">320</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">818</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,361</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">248</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">311</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">789</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,348</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:middle"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Meningitis, travel and endemics vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">96</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">319</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">194</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">609</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">97</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">301</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">185</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">583</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">RSV vaccine (Beyfortus)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">85</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">68</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">203</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">356</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">116</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">200</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="2" style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"><div style="font-family:Arial;display:inline;">Influenza Vaccines</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">52</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">54</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">108</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">214</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">30</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">16</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">142</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">188</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td colspan="3" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Total net sales</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,144</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,535</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">6,210</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,072</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">8,292</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,996</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherRevenueTextBlock', window );">Disclosure of Other Revenue</a></td>
<td class="text">
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;VaxServe sales of <div style="white-space:nowrap;display:inline;">non-Sanofi</div> products</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">842</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">854</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales to Opella <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">95</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Royalties</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">68</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">62</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Other<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">275</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">341</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Biopharma Other revenues</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,246</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,352</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8199;Sales / Revenues from Opella products<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">206</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">177</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8199;Total Other revenues</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,452</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">1,529</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). </div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2025-01-01<br> -Paragraph 114<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherRevenueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other revenue [Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherRevenueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract', window );"><strong>Disclosure of operating segments [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of Segment Results</a></td>
<td class="text"><div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Segment results are shown in the table below: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:44%"></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:2%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="36" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="34" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025 (6 months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Total</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div><div style="font-weight:bold;display:inline;">June&#160;30,<br/>2025</div><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 on a<br/>reported<br/>basis&#160;(IFRS)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Change&#160;vs.<br/>June&#160;30,<br/>2024 at<br/>constant<br/>exchange<br/>rates<br/><div style="white-space:nowrap;display:inline;">(non-IFRS)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">19,889</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+8.3</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;"></div></div>&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">+9.9</div></div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">%</div></div>&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,246</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-7.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-6.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">206</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+15.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,452</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-5.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-3.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(5,753</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-0.1</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(128</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+16.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+14.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(5,881</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">-1.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+0.2</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(3,716</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(3,717</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+11.5</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+12.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(4,447</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(59</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.4</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(4,506</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+4.7</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">+5.9</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,941</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(2</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(1,943</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td>
<td style="vertical-align:bottom;background-color:#e7e7e8"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,347</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+11.0</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">16</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">-27.3</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">5,363</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+8.6</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">+10.8</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">%&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8195;As % of net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">26.9</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">%&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8199;&#8199;27.0%</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"><div style="font-size:x-small;display:inline;">&#160;</div></td></tr></table><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:75%"></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:4%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2024 (6 months) (a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Other</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8195;&#8195;Total</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-size:x-small;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other revenues</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,352</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">177</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">1,529</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Cost of sales</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(5,849</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(110</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(5,959</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Research and development expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(3,334</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(3,335</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Selling and general expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(4,247</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(56</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(4,303</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other operating income and expenses</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,426</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">12</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(1,414</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,916</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">22</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">4,938</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock', window );">Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method</a></td>
<td class="text"><div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial">The table below, presented in compliance with IFRS 8, shows a reconciliation between &#8220;Business operating income&#8221; and <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Income before tax and investments accounted for using the equity method</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:79%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025<br/>(6&#160;months)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024<br/>(6&#160;months)&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Business operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">5,363</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">4,938</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Share of profit/(loss) from investments accounted for using the equity method<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(77</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Net income attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(c)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">6</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Amortization and impairment of intangible assets<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(d)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(987</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(527</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Fair value remeasurement of contingent consideration</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(61</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(66</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Expense arising from the impact of acquisitions on inventories<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(e)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Restructuring costs and similar items<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(f)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(430</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(1,060</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#ffffff"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Other gains and losses, and litigation<div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(g)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(57</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(450</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Operating income</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,759</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,768</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial expenses</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(361</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">(583</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial">Financial income</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">184</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">277</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Income before tax and investments accounted for using the equity method</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">3,582</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,462</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for the 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(b)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Joint ventures and associates with which Sanofi has entered into a strategic alliance. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(c)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to <div style="white-space:nowrap;display:inline;">non-controlling</div> interests. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(d)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#8364;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#8364;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(e)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(f)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.16. </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(g)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">See Note B.17. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock', window );">Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment</a></td>
<td class="text"><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:8%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Biopharma</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Investments accounted for using the equity method <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">483</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">229</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of property, plant and equipment</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">845</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">882</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Acquisitions of other intangible assets</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">575</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">922</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Carrying amount at the end of the reporting period. </div></div></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory', window );">Summary of Geographical Information on Net Sales and Non-Current Assets</a></td>
<td class="text"><div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The geographical information on net sales provided below is based on the geographical location of the customer. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:78%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="8" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="vertical-align:bottom">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Net sales</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024&#160;(a)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">4,144</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">4,072</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">835</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">855</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">9,535</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">8,292</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">6,210</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">5,996</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,388</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">1,406</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">19,889</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">18,360</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;">(a)</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">Figures for 2024 comparative period have been <div style="white-space:nowrap;display:inline;">re-presented</div> on a consistent basis to reflect the classification of Opella as a discontinued operation. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 8, the <div style="white-space:nowrap;display:inline;">non-current</div> assets reported below exclude financial instruments, deferred tax assets, <div style="white-space:nowrap;display:inline;">pre-funded</div> pension obligations, and <div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">right-of-use</div></div> assets as determined under IFRS 16. </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:47%"></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:3%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="12" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="12" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td rowspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30, 2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31, 2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Property,&#160;plant<br/>and&#160;equipment</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Goodwill</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">Other<br/>intangible<br/>assets</div></div></td>
<td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Europe</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">5,438</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,167</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">5,550</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">3,307</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which France</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">2,953</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">3,112</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;United States</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,080</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">16,725</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2,411</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">18,711</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Rest of the World</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,056</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">539</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">2,130</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">611</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="font-style:italic;display:inline;">&#8194;of which China</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">83</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">96</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8212;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#7802e6"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total</div></div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">9,574</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">40,283</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">20,431</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">10,091</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">43,384</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="vertical-align:bottom;background-color:#7802e6">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">22,629</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of geographical information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments reconciling items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Information related to Opella, presented within assets held for sale and discontinued operations (Tables)<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th"><div>Jun. 30, 2025</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract', window );"><strong>Subclassifications of assets, liabilities and equities [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock', window );">Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block]</a></td>
<td class="text">As of December&#160;31, 2024, all Opella assets and associated liabilities were classified as held for sale, in accordance with IFRS 5. <div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:86%"></td>
<td style="vertical-align:bottom;width:9%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;(<div style="font-family:Times New Roman;display:inline;">&#8364;</div> million)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">December&#160;31,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#ffffff"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Assets</div></div></div></td>
<td style="vertical-align:bottom;background-color:#ffffff">&#160;&#160;</td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td>
<td style="vertical-align:bottom;background-color:#ffffff"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Property, plant and equipment owned</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">760</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;"><div style="white-space:nowrap;display:inline;">&#8194;Right-of-use</div></div> assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">116</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Goodwill</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">7,255</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other intangible assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">2,928</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Inventories</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">600</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts receivable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">989</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other assets</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">841</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#661de8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">13,489</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Liabilities</div></div></div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom"></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Lease liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">112</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="white-space:nowrap;display:inline;">&#8194;Non-current</div> provisions and other <div style="white-space:nowrap;display:inline;">non-current</div> liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">204</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Accounts payable</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">797</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Current provisions and other current liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">570</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Other liabilities</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">448</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt;background-color:#7802e6"></td>
<td colspan="4" style="height:3pt;background-color:#661de8"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Total liabilities related to assets held for sale</div></div></div></td>
<td style="vertical-align:bottom;background-color:#661de8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">2,131</div></div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"><div style="font-family:Arial;color:#FFFFFF;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">In accordance with IFRS 5, the Opella held for sale asset group, and the related liabilities, were measured at the lower of carrying amount and fair value less costs to sell. This valuation did not result in the recognition of any impairment. </div><div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below shows the main items presented within <div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;">Net income from discontinued operations</div></div>: </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:6%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net sales and other revenues <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">1,736</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,645</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Operating income <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(a)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">266</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">277</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2,781</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">&#8212;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:Arial">Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">3,039</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">278</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#8194;Income tax expense <div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px">(b)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">(158</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">)&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">(85</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">)&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,881</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">202</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr></table><div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(a)</div></div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.). </div></div></td></tr></table>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%">
<tr style="page-break-inside:avoid">
<td style="width:3%;vertical-align:top;text-align:left"><div style="font-style:italic;display:inline;"><div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px">(b)</div>&#160;</div></td>
<td style="vertical-align:top;text-align:left"><div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"><div style="font-style:italic;display:inline;">In 2025, this line includes an expense of &#8364;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella. </div></div></td></tr></table><div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify">The table below presents basic and diluted earnings per share from discontinued operations (Opella), in accordance with IAS 33 (Earnings per Share): </div><div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</div>
<table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto">
<tr>
<td style="width:80%"></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td>
<td style="vertical-align:bottom;width:5%"></td>
<td></td>
<td></td>
<td></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style="font-family:Arial;display:inline;"><div style="font-style:italic;display:inline;">&#8194;(&#8364; million)</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2025</div></div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">June&#160;30,&#160;2024</div></div></td>
<td style="vertical-align:bottom">&#160;</td></tr>
<tr style="font-size:1pt">
<td style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8">&#160;</td>
<td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt">&#160;</td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"><div style="color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#8194;Net income from discontinued operations (Opella)</div></div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">2,881</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">202</div></div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;color:#23004c;display:inline;"><div style="font-weight:bold;display:inline;">&#160;</div></div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares outstanding (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,225.5</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,249.4</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Average number of shares after dilution (million)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">1,230.7</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">1,253.8</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Basic earnings per share (in euros)</div></td>
<td style="vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.34</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"><div style="font-family:Arial;display:inline;">0.16</div></td>
<td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr>
<tr style="font-size:1pt">
<td style="height:3pt"></td>
<td colspan="4" style="height:3pt;background-color:#e7e7e8"></td>
<td colspan="4" style="height:3pt"></td></tr>
<tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt">
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"><div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial">&#8194;Diluted earnings per share (in euros)</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"><div style="font-family:Arial;display:inline;">2.33</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom">&#160;&#160;</td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"><div style="font-family:Arial;display:inline;">0.16</div></td>
<td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"><div style="font-family:Arial;display:inline;">&#160;</div></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)<br></strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_AR', window );">Argentina</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears', window );">Cumulative consumer price inflation rate</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_TR', window );">Turkey</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems', window );"><strong>Disclosure of initial application of standards or interpretations [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears', window );">Cumulative consumer price inflation rate</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cumulative Consumer Price Inflation Rate Over The Last Three Years</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_AR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_AR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_TR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_TR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)<br> $ / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 27, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>May 22, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Apr. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th" colspan="2">
<div>Jun. 30, 2024 </div>
<div>EUR (&#8364;)</div>
</th>
<th class="th">
<div>Jun. 02, 2025 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,885<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,563<span></span>
</td>
<td class="nump">&#8364; 316<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetCashInflowFromDiscontinuedOperations', window );">Net Cash Inflow from Discontinued Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,742<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,774)<span></span>
</td>
<td class="nump">&#8364; 1,199<span></span>
</td>
<td class="nump">1,233<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net (income)/loss of the exchanged/held-for-exchange Animal Health business</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 202<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember', window );">Opella</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetCashInflowFromDiscontinuedOperations', window );">Net Cash Inflow from Discontinued Operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 10,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProceedsFromSalesOfInvestmentProperty', window );">Proceeds from sales of investment property</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 16,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember', window );">Opella Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Net foreign exchange loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net (income)/loss of the exchanged/held-for-exchange Animal Health business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetAssetsLiabilities', window );">Assets (liabilities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 11,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OPALJVCoMember', window );">OPAL JV Co [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.20%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BpifranceMember', window );">Bpifrance [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AssetsAcquisitionAxis=sny_AssetsAcquisitionMember', window );">Assets Acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 600,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">562,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities', window );">Net cash flow on acquisition | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">602,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PotentialFuturePayments', window );">Potential Future Payments | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 1,300,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AssetsAcquisitionAxis=sny_VigilNeuroscienceIncMember', window );">Vigil Neuroscience, Inc</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income for the period | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 40,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Equity interests of acquirer | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 470,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityInterestsOfAcquirerPerShare', window );">Equity Interests Of Acquirer, Per Share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DeferredCashPayments', window );">Deferred Cash Payments | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AssetsAcquisitionAxis=sny_BlueprintMedicinesCorporationMember', window );">Blueprint Medicines Corporation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems', window );"><strong>Disclosure of detailed information about business combination [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,100,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_EquityInterestsOfAcquirer', window );">Equity interests of acquirer | $</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 9,500,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CashTransferredPerShare', window );">Cash Transferred, Per Share | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 129<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment', window );">MileStone Payment Per CVR Recognised In Business Combination attainment of future development | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones', window );">MileStone Payment Per CVR Recognised In Business Combination attainment of regulatory milestones | $ / shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">$ 4<span></span>
</td>
</tr>
<tr><td colspan="9"></td></tr>
<tr><td colspan="9"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For the six months ended June 30, 2025, this line item includes the net cash outflow arising from the acquisition of Dren-0201 (see Note B.1.2.). For the six months ended June 30, 2024 it includes the net cash outflow arising from the acquisition of Inhibrx, Inc.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June 30, 2025, this amount includes &#8364;(667) million in respect of cash and cash equivalents held by Opella as of April 30, 2025.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 39<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_39&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityInterestsOfAcquirer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_f_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityInterestsOfAcquirer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph IE72<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetAssetsLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets less the amount of liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG63<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IG63&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetAssetsLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2025-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromSalesOfInvestmentProperty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from sales of investment property. [Refer: Investment property]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromSalesOfInvestmentProperty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CashTransferredPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Transferred, Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CashTransferredPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DeferredCashPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Cash Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DeferredCashPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityInterestsOfAcquirerPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Interests Of Acquirer, Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityInterestsOfAcquirerPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payment per CVR recognised in business combination attainment of future development.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Milestone payment per CVR recognised in business combination attainment of regulatory milestones.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetCashInflowFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Cash Inflow from Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetCashInflowFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PotentialFuturePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Future Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PotentialFuturePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OPALJVCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OPALJVCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BpifranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_BpifranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsAcquisitionAxis=sny_AssetsAcquisitionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsAcquisitionAxis=sny_AssetsAcquisitionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsAcquisitionAxis=sny_VigilNeuroscienceIncMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsAcquisitionAxis=sny_VigilNeuroscienceIncMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsAcquisitionAxis=sny_BlueprintMedicinesCorporationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsAcquisitionAxis=sny_BlueprintMedicinesCorporationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions other than through business combinations, property, plant and equipment</a></td>
<td class="nump">&#8364; 702<span></span>
</td>
<td class="nump">&#8364; 591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestCostsCapitalised', window );">Interest costs capitalised</a></td>
<td class="nump">22<span></span>
</td>
<td class="nump">22<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions other than through business combinations, property, plant and equipment</a></td>
<td class="nump">663<span></span>
</td>
<td class="nump">535<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Manufacturing &amp; Supply</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions other than through business combinations, property, plant and equipment</a></td>
<td class="nump">453<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_OpellaMember', window );">Opella</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems', window );"><strong>Disclosure of detailed information about property, plant and equipment [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions other than through business combinations, property, plant and equipment</a></td>
<td class="nump">&#8364; 39<span></span>
</td>
<td class="nump">&#8364; 56<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestCostsCapitalised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestCostsCapitalised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_ManufacturingAndSupplyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=sny_ManufacturingAndSupplyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_OpellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_OpellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment - Additional Information (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, plant and equipment [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FirmOrdersOfPropertyPlantAndEquipment', window );">Firm orders of property, plant and equipment</a></td>
<td class="nump">&#8364; 732<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FirmOrdersOfPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Firm orders of property plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FirmOrdersOfPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 40,283<span></span>
</td>
<td class="nump">&#8364; 43,384<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,431<span></span>
</td>
<td class="nump">22,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember', window );">Marketed products</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 11,000<span></span>
</td>
<td class="nump">12,700<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Weighted average amortization period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember', window );">Technological platforms</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems', window );"><strong>Disclosure of reconciliation of changes in goodwill [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 1,000<span></span>
</td>
<td class="nump">&#8364; 1,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Weighted average amortization period</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">18 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_MarketedProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_TechnologicalPlatformsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 20,431<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 22,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(777)<span></span>
</td>
<td colspan="2" class="num">&#8364; (898)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,431<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,175<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">81,066<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes in scope of consolidation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">676<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(228)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,547)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(292)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember', window );">Accumulated amortization and impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(54,744)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(58,437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">229<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,239<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">287<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(852)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(210)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredResearchAndDevelopmentMember', window );">Acquired R&amp;D</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">8,369<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,048<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredResearchAndDevelopmentMember', window );">Acquired R&amp;D | Gross value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,297<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">12,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes in scope of consolidation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">500<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">332<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,339)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(40)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredResearchAndDevelopmentMember', window );">Acquired R&amp;D | Accumulated amortization and impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,249)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(4,497)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">427<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(201)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_ProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">13,841<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,984<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_ProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights | Gross value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61,048<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">66,348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes in scope of consolidation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">302<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(199)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,159)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(244)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_ProductsTrademarksAndOtherRightsMember', window );">Products, trademarks and other rights | Accumulated amortization and impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49,064)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">(52,507)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">199<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,772<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">281<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(800)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(9)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherIntangibleAssets', window );">Other intangible assets, ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">399<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software | Gross value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,830<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">1,852<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets', window );">Changes in scope of consolidation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Acquisitions and other increases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Software | Accumulated amortization and impairment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Carrying amount of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,431)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (1,433)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill', window );">Disposals and other decreases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill', window );">Transfers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(52)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill', window );">Impairment losses, net of reversals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets other than goodwill resulting from disposals and retirements. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 119<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_119&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Scope Of Consolidation Through Business Combination, Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_AcquiredResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_ProductsTrademarksAndOtherRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=sny_ProductsTrademarksAndOtherRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Impairment of Intangible Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss on other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 210<span></span>
</td>
<td colspan="2" class="num">&#8364; (371)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems', window );"><strong>Disclosure of detailed information about intangible assets [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss on other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 210<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details) - EUR (&#8364;)<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="4">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[1],[2]</sup></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 3,563<span></span>
</td>
<td class="nump">&#8364; 3,563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 316<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the&#160;equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11<span></span>
</td>
<td class="nump">&#8364; 85<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td colspan="2" class="num">&#8364; (22)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29.60%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod', window );">Investments in associates</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">82<span></span>
</td>
<td class="nump">&#8364; 82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OpellaMember', window );">Opella</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod', window );">Investments in associates</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">&#8364; 3,239<span></span>
</td>
<td class="nump">&#8364; 3,239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LoansToAssociates', window );">Loans to Associates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 241<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OPALJVCoMember', window );">OPAL JV Co [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_CDRMember', window );">CD&amp;R [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_BpifranceMember', window );">Bpifrance [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInAssociate', window );">Proportion of ownership interest in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=sny_EuroapiMember', window );">EUROAPI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_StockPrice', window );">Stock price (in euro per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 2.89<span></span>
</td>
<td class="nump">&#8364; 2.89<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.88<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=sny_MSPVaccineCompanyMember', window );">MSP Vaccine Company | MCM Vaccine BV</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember', window );">Infraserv GmbH &amp; Co. H&#246;chst KG</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31.20%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod', window );">Investments in joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">&#8364; 93<span></span>
</td>
<td class="nump">&#8364; 93<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 102<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember', window );">MSP Vaccine Company</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod', window );">Investments in joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">79<span></span>
</td>
<td class="nump">&#8364; 79<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">81<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember', window );">Other investments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture', window );">Proportion of ownership interest in joint venture</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod', window );">Investments in joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 51<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#8364;2.89 as of June&#160;30, 2025, and &#8364;2.88 as of December&#160;31, 2024).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June 30, 2025, the investment includes a &#8364;241 million loan to OPAL JV Co being in substance part of the investment.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Joint venture.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in joint ventures accounted for using the equity method. [Refer: Total for all joint ventures [member]; Investments accounted for using equity method]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LoansToAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Loans to Associates</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LoansToAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_StockPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_StockPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OpellaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OpellaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OPALJVCoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_OPALJVCoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_CDRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_CDRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_BpifranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_BpifranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_EuroapiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_EuroapiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_MSPVaccineCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_MSPVaccineCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_MCMVaccineBVMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_MCMVaccineBVMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=sny_InfraservGmbhAndCoHochstKGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=sny_MSPVaccineCompanyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_JointVenturesAxis=ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Oct. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsRelatedPartyTransactions', window );">Other Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SubordinateHybridBondRelatedPartyTransactions', window );">Subordinate Hybrid Bond, Related Party Transactions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember', window );">Associates and joint ventures</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions', window );">Sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">29<span></span>
</td>
<td class="nump">&#8364; 59<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions', window );">Royalties and other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">63<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">Accounts receivable and other receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">299<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">184<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsRelatedPartyTransactions', window );">Other Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions', window );">Purchases of goods and services (including research expenses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">371<span></span>
</td>
<td class="nump">&#8364; 333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">Amounts payable, related party transactions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 637<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 160<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative periods have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes loans to joint ventures and associates.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">In October 2024, Sanofi raised its investment in EUROAPI by &#8364;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#8364;189&#160;million (and was also &#8364;189&#160;million as of December&#160;31, 2024).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 20<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 230<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_230_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchasesOfGoodsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of goods purchased by the entity in related party transactions. [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 234<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_234_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 234<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_234_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchasesOfGoodsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 234<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_234_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 234<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_234_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Assets, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Royalties and other income, related party transactions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SubordinateHybridBondRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subordinate Hybrid Bond, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SubordinateHybridBondRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details) - Associates and joint ventures<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures', window );">Net Sales and Other Revenues</a></td>
<td class="nump">&#8364; 887<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetIncomeRelatedPartyDisclosures', window );">Net Income</a></td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherComprehensiveIncomeRelatedPartyDisclosures', window );">Other Comprehensive Income</a></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ComprehensiveIncomeRelatedPartyDisclosures', window );">Comprehensive Income</a></td>
<td class="nump">23<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentAssetsRelatedPartyTransactions', window );">&#8194;Non-current assets</a></td>
<td class="nump">16,179<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentAssetsRelatedPartyTransactions', window );">Current assets</a></td>
<td class="nump">2,937<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AssetsRelatedPartyTransactions', window );">Total assets</a></td>
<td class="nump">19,116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions', window );">&#8194;Equity attributable to equity holders of OPAL JV Co</a></td>
<td class="nump">5,754<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions', window );">&#8194;Equity attributable to non-controlling interests</a></td>
<td class="nump">541<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityRelatedPartyTransactions', window );">Total equity</a></td>
<td class="nump">6,295<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedPartyTransactions', window );">Non Current Liabilities</a></td>
<td class="nump">11,039<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedPartyTransactions', window );">Current Liabilities</a></td>
<td class="nump">1,782<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LiabilitiesRelatedPartyTransactions', window );">Total liabilities</a></td>
<td class="nump">12,821<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityAndLiabilitiesRelatedPartyTransactions', window );">Total equity and liabilities</a></td>
<td class="nump">&#8364; 19,116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ComprehensiveIncomeRelatedPartyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Comprehensive Income, Related Party Disclosures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ComprehensiveIncomeRelatedPartyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current assets, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Liabilities, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityAndLiabilitiesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity and Liabilities, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityAndLiabilitiesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityAttributableToEquityHoldersRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Attributable to Equity Holders, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityAttributableToEquityHoldersRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Attributable to Non Controlling Interest, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LiabilitiesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LiabilitiesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetIncomeRelatedPartyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Income, Related Party Disclosures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetIncomeRelatedPartyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net Sales and Other Revenues, Related Party Disclosures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentAssetsRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Current assets, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentAssetsRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non Current Liabilities, Related Party Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherComprehensiveIncomeRelatedPartyDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income, Related Party Disclosures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherComprehensiveIncomeRelatedPartyDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_AssociatesAndJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Other Non-Current Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss', window );">Other financial assets at fair value through profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 965<span></span>
</td>
<td class="nump">&#8364; 1,027<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PreFundedPensionObligations', window );">Pre-funded pension obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">146<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LongTermPrepaidExpenses', window );">Long-term prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">143<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLoansAndReceivables', window );">Long-term loans and advances and other non-current receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">382<span></span>
</td>
<td class="nump">502<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentDerivativeFinancialAssets', window );">Derivative financial instruments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,109<span></span>
</td>
<td class="nump">3,753<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember', window );">Trading equity securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Instruments at fair value through other comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,105<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember', window );">Debt securities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems', window );"><strong>Disclosure Of Other Non Current Assets [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome', window );">Instruments at fair value through other comprehensive income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 362<span></span>
</td>
<td class="nump">&#8364; 357<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentDerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current derivative financial assets. [Refer: Derivative financial assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentDerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 8<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_8_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 44<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_44_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherNonCurrentAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other non-current assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherNonCurrentAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LongTermPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LongTermPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLoansAndReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non current loans and receivables</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLoansAndReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Financial Assets At Fair Value Through Profit Or Loss</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PreFundedPensionObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pre-funded pension obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PreFundedPensionObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_TradingEquitySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=ifrs-full_DebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable - Summary of Accounts Receivable (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of Accounts Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 7,810<span></span>
</td>
<td class="nump">&#8364; 7,677<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of Accounts Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,896<span></span>
</td>
<td class="nump">7,777<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember', window );">Allowances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfAccountsReceivableLineItems', window );"><strong>Disclosure of Accounts Receivable [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (86)<span></span>
</td>
<td class="num">&#8364; (100)<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfAccountsReceivableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Accounts Receivable [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfAccountsReceivableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedImpairmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accounts Receivable - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TradeAndOtherReceivablesAbstract', window );"><strong>Trade and other receivables [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables', window );">Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables</a></td>
<td class="nump">&#8364; 4<span></span>
</td>
<td class="nump">&#8364; 3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerecognizedReceivables', window );">Derecognized receivables</a></td>
<td class="nump">&#8364; 12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 14<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerecognizedReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derecognized receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerecognizedReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">&#8364; 386<span></span>
</td>
<td class="nump">&#8364; 650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember', window );">Overdue by less than 1 month</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">122<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember', window );">Overdue by 1-3 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">103<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember', window );">Overdue by 3-6 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">73<span></span>
</td>
<td class="nump">87<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember', window );">Overdue by 6-12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">48<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember', window );">Overdue by &gt; 12 months</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems', window );"><strong>Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OverdueReceivablesGrossValue', window );">Overdue receivables gross value</a></td>
<td class="nump">&#8364; 40<span></span>
</td>
<td class="nump">&#8364; 44<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OverdueReceivablesGrossValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Overdue receivables gross value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OverdueReceivablesGrossValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneMonthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Additional Information (Details) - EUR (&#8364;)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th"><div>Feb. 02, 2025</div></th>
<th class="th"><div>Jan. 29, 2025</div></th>
<th class="th"><div>Apr. 30, 2024</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jan. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,455,512,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,227,756,274<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share (in euros per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease', window );">Number of restricted shares vested (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,682,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease', window );">Number of restricted shares alloted in regards of capital increase</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,525,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income that will be reclassified to profit or loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (5,318,000,000)<span></span>
</td>
<td class="nump">&#8364; 1,067,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CancellationOfTreasuryShares', window );">Cancellation of treasury shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,868,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeeShareOwnershipPlanMember', window );">Employees share ownership plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_SubscriptionPricePerShare', window );">Subscription price (in euros per share)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 72.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 72.87<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesSubscribed', window );">Number of shares subscribed (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,260,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,124,445<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IssuanceOfFurtherSharesAsAnEmployersContribution', window );">Number of shares issued immediately for employer's contribution (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">116,794<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,951<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Expense recognized</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 31,000,000<span></span>
</td>
<td class="nump">45,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareProgramAxis=sny_ShareRepurchase2024ProgramMember', window );">Share Repurchase 2024 Program</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PeriodOfShareRepurchaseProgram', window );">Period of share repurchase program</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares repurchased (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,344,633<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Amount of shares repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,988,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareProgramAxis=sny_ShareRepurchase2025ProgramMember', window );">Share Repurchase 2025 Program</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesRepurchased', window );">Number of shares repurchased (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,556,650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmountOfSharesRepurchased', window );">Amount of shares repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 3,000,000,000<span></span>
</td>
<td class="nump">&#8364; 5,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PerShareValueOfSharesRepurchased', window );">Per Share Value of Shares Repurchased</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 101.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember', window );">Share capital | Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions', window );">Capital&#160;increase&#160;by&#160;exercise&#160;of stock subscription options (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease', window );">Capital increase by issuance of restricted shares (in shares)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,156,205<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Other comprehensive income | Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income that will be reclassified to profit or loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">&#8364; (5,017,000,000)<span></span>
</td>
<td class="nump">&#8364; 1,067,000,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Other comprehensive income | Foreign Currency Translation | Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income that will be reclassified to profit or loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">459,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Other comprehensive income | Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures [Member] | Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Other comprehensive income that will be reclassified to profit or loss, net of tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="10"></td></tr>
<tr><td colspan="10"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CancellationOfTreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of treasury stock cancelled during the period. [Refer: Treasury shares]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CancellationOfTreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph f<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B10_a_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 160<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_160_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmountOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmountOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IssuanceOfFurtherSharesAsAnEmployersContribution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Further shares as an employers contribution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IssuanceOfFurtherSharesAsAnEmployersContribution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted shares alloted in regards of capital increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted shares issued in regards of capital increase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Restricted Shares Vested In Regards Of Capital Increase</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in regards of capital increase by exercise of stock subscription options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesSubscribed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares subscribed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesSubscribed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PerShareValueOfSharesRepurchased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per Share Value of Shares Repurchased</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PerShareValueOfSharesRepurchased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PeriodOfShareRepurchaseProgram">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of share repurchase program.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PeriodOfShareRepurchaseProgram</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_SubscriptionPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Subscription price per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_SubscriptionPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeeShareOwnershipPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_EmployeeShareOwnershipPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareProgramAxis=sny_ShareRepurchase2024ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareProgramAxis=sny_ShareRepurchase2024ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareProgramAxis=sny_ShareRepurchase2025ProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareProgramAxis=sny_ShareRepurchase2025ProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_IssuedCapitalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=sny_SanofiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=sny_SanofiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_ForeignCurrencyTranslationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_ForeignCurrencyTranslationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details) - shares<br> shares in Thousands</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfSharesHeld', window );">Number of shares (in shares)</a></td>
<td class="nump">10,660<span></span>
</td>
<td class="nump">9,530<span></span>
</td>
<td class="nump">15,330<span></span>
</td>
<td class="nump">13,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageOfShareCapitalForThePeriod', window );">% of share capital for the period</a></td>
<td class="nump">0.868%<span></span>
</td>
<td class="nump">0.755%<span></span>
</td>
<td class="nump">1.211%<span></span>
</td>
<td class="nump">1.063%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfSharesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares held.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfSharesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageOfShareCapitalForThePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of share capital for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageOfShareCapitalForThePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;) </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member', window );">Restricted Share Plan 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfYearsServicePeriod', window );">Service period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Total number of shares awarded (in shares)</a></td>
<td class="nump">4,021,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValueOfPlanAtDateOfGrant', window );">Fair value of plan at the date of grant | &#8364;</a></td>
<td class="nump">&#8364; 331<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025 | Without market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Total number of shares awarded (in shares)</a></td>
<td class="nump">2,599,478<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 83.94<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025 | With market condition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Total number of shares awarded (in shares)</a></td>
<td class="nump">1,421,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025 | With market condition | Excluding General Director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Total number of shares awarded (in shares)</a></td>
<td class="nump">1,331,892<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 79.25<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025 | With market condition | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted', window );">Total number of shares awarded (in shares)</a></td>
<td class="nump">90,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod', window );">Fair value per share awarded (in euros per share) | &#8364; / shares</a></td>
<td class="nump">&#8364; 75.1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValueOfPlanAtDateOfGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of plan at the date of grant.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValueOfPlanAtDateOfGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_FairValuePerShareAwardedForThreeYearServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value per share awarded to a three year service period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_FairValuePerShareAwardedForThreeYearServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfYearsServicePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Years, Service Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfYearsServicePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MarketConditionAxis=sny_WithoutMarketConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MarketConditionAxis=sny_WithoutMarketConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MarketConditionAxis=sny_WithMarketConditionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MarketConditionAxis=sny_WithMarketConditionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=sny_ExcludingChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=sny_ExcludingChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember', window );">Restricted shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets', window );">Total expense for restricted share plans</a></td>
<td class="nump">&#8364; 146<span></span>
</td>
<td class="nump">&#8364; 128<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">11,550,347<span></span>
</td>
<td class="nump">11,192,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member', window );">Restricted Share Plan 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">4,020,451<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2023Member', window );">Restricted share plan 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">3,313,588<span></span>
</td>
<td class="nump">3,652,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member', window );">Restricted Share Plan 2024</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">4,110,089<span></span>
</td>
<td class="nump">4,498,109<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member', window );">Restricted share plan 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">106,219<span></span>
</td>
<td class="nump">3,031,060<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member', window );">Restricted share plan 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems', window );"><strong>Disclosure of classes of share capital [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfRestrictedSharesNotYetFullyVested', window );">Number of shares not yet fully vested</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">11,463<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfClassesOfShareCapitalLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfClassesOfShareCapitalLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 51<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_51_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfRestrictedSharesNotYetFullyVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of restricted shares not yet fully vested.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfRestrictedSharesNotYetFullyVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2024Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=sny_RestrictedSharePlan2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details) - Stock Option Plan<br></strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
</tr>
<tr><th class="th">
<div>Jun. 30, 2025 </div>
<div>shares </div>
<div>&#8364; / shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, number&#160;of options (in shares) | shares</a></td>
<td class="nump">725,044<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">725,044<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember', window );">From &#8364;60.00 to &#8364;70.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, number&#160;of options (in shares) | shares</a></td>
<td class="nump">168,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual life (years)</a></td>
<td class="text">2 years 10 months 2 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 65.84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">168,784<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 65.84<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember', window );">From &#8364;70.00 to &#8364;80.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, number&#160;of options (in shares) | shares</a></td>
<td class="nump">299,250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual life (years)</a></td>
<td class="text">2 years 11 months 23 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 76.48<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">299,250<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 76.48<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember', window );">From &#8364;80.00 to &#8364;90.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding, number&#160;of options (in shares) | shares</a></td>
<td class="nump">257,010<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019', window );">Weighted average residual life (years)</a></td>
<td class="text">1 year 10 months 9 days<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)</a></td>
<td class="nump">&#8364; 88.97<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement', window );">Exercisable, number of options (in shares) | shares</a></td>
<td class="nump">257,010<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019', window );">Weighted average exercise&#160;price per share, options exercisable (in euros per share)</a></td>
<td class="nump">&#8364; 88.97<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | From &#8364;60.00 to &#8364;70.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">60<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | From &#8364;70.00 to &#8364;80.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range | From &#8364;80.00 to &#8364;90.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | From &#8364;60.00 to &#8364;70.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | From &#8364;70.00 to &#8364;80.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range | From &#8364;80.00 to &#8364;90.00 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems', window );"><strong>Disclosure of terms and conditions of share-based payment arrangement [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019', window );">Exercise price of outstanding options (in euros per share)</a></td>
<td class="nump">&#8364; 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExercisePriceOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exercise price of outstanding share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExercisePriceOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercisable in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 31<br> -Subparagraph b<br> -Clause vi<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_31_b_vi&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=sny_StockOptionPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=sny_StockOptionPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis=sny_ExercisePriceRangeFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract', window );"><strong>Share Capital, Reserves And Other Equity Interest [Abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Average number of shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,225,500,000<span></span>
</td>
<td class="nump">1,249,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Adjustment for stock options with dilutive effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">100,000<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares', window );">Adjustment for restricted shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,100,000<span></span>
</td>
<td class="nump">4,300,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Average number of shares used to compute diluted earnings per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,230,700,000<span></span>
</td>
<td class="nump">1,253,800,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Dilutive effect of share options on number of restricted shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ShareCapitalReservesAndOtherEquityInterestAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Capital, Reserves And Other Equity Interest [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ShareCapitalReservesAndOtherEquityInterestAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 241<span></span>
</td>
<td class="nump">&#8364; 166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,318)<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items not subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures', window );">Actuarial gains/(losses) excluding investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105<span></span>
</td>
<td class="nump">235<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures', window );">Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(57)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax', window );">Items not subsequently reclassifiable to profit or loss from continuing operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">243<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items not subsequently reclassifiable to profit or loss | Equity instruments included in financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">222<span></span>
</td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax', window );">Change in fair value (investments accounted for using the equity method, net of taxes)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges', window );">Equity risk hedging instruments designated as fair value hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(60)<span></span>
</td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="num">(23)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures', window );">Change in fair value (investments accounted for using the equity method, net of taxes)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures', window );">Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(5,266)<span></span>
</td>
<td class="nump">1,167<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures', window );">Currency translation differences (investments accounted for using the equity method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(26)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations', window );">Hedges of net investments in foreign operations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">390<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInCurrencyTranslationOnTaxEffects', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(101)<span></span>
</td>
<td class="nump">33<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax', window );">Items subsequently reclassifiable to profit or loss</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,017)<span></span>
</td>
<td class="nump">1,067<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember', window );">Accumulated other comprehensive income | Items subsequently reclassifiable to profit or loss | Debt instruments included in financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems', window );"><strong>Disclosure of analysis of other comprehensive income by item [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures', window );">Change in fair value (excluding investments accounted for using the equity method)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">3<span></span>
</td>
<td class="num">(5)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures', window );">Change in fair value (investments accounted for using the equity method, net of taxes)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments', window );">Tax effects</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes reclassifications to profit or loss: &#8364;2&#160;million in the first half of 2025, immaterial in the first half of 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Includes reclassifications to profit or loss: immaterial over all periods.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph ab<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_ab&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 90<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_90&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph IG6<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82A<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82A&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation before tax excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation on hedges of net investments in foreign operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInCurrencyTranslationOnTaxEffects">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in currency translation on tax effects.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInCurrencyTranslationOnTaxEffects</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value on cash flow hedges excluding associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change in fair value on cash flow hedges net of tax on associates and joint ventures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Debt Instrument Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity Risk Hedging Instruments Designated At Fair Value Hedges</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Equity Investments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComponentsOfEquityAxis=ifrs-full_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassifiedItemsAxis=sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassifiedItemsAxis=sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_EquityInstrumentsIncludedInFinancialAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_EquityInstrumentsIncludedInFinancialAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReclassifiedItemsAxis=sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=sny_DebtInstrumentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=sny_DebtInstrumentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsAbstract', window );"><strong>Cash and cash equivalents [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 13,200<span></span>
</td>
<td class="nump">&#8364; 11,791<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,309<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,519<span></span>
</td>
<td class="nump">16,137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="num">&#8364; (6,795)<span></span>
</td>
<td colspan="2" class="num">&#8364; (8,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">5,102<span></span>
</td>
<td class="nump">8,772<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 1,776<span></span>
</td>
<td class="nump">&#8364; 1,906<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 13,200<span></span>
</td>
<td class="nump">&#8364; 11,791<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">7,309<span></span>
</td>
<td class="nump">4,209<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,519<span></span>
</td>
<td class="nump">16,137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="num">&#8364; (6,795)<span></span>
</td>
<td colspan="2" class="num">&#8364; (8,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">5,102<span></span>
</td>
<td class="nump">8,772<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,776<span></span>
</td>
<td class="nump">1,906<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AmortizedCostNettingMember', window );">Amortized cost</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember', window );">Adjustment to debt measured at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(78)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,317<span></span>
</td>
<td class="nump">11,940<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings', window );">Short-term debt and current portion of long-term debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,311<span></span>
</td>
<td class="nump">4,218<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68)<span></span>
</td>
<td class="nump">13<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,560<span></span>
</td>
<td class="nump">16,171<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">&#8364; 5,143<span></span>
</td>
<td class="nump">&#8364; 8,806<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="7"></td></tr>
<tr><td colspan="7"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AmortizedCostNettingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AmortizedCostNettingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AdjustmentToDebtMeasuredAtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,519<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="num">&#8364; (6,795)<span></span>
</td>
<td colspan="2" class="num">&#8364; (8,710)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">5,102<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,772<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,581<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">14,592<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,905<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,354<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">209<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,560<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,171<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">5,143<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,806<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,940<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(15,359)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,441)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent', window );">Interest rate and currency derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(58)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DebtNetOfCashAndCashEquivalents', window );">Net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,174)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,134)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,876<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">64<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,317<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">11,940<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BondsIssued', window );">Bond issues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,322<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,716<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1,290<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherBorrowings', window );">Other borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents', window );">Bank credit balances</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">141<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">209<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt', window );">Interest rate and currency derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Total debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,243<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 4,231<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | current | Commercial paper program in USA</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,535<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption | current | Commercial paper program in France</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems', window );"><strong>Disclosure of reconciliation of carrying amount to value on redemption [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherBankBorrowings', window );">Other bank borrowings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="8"></td></tr>
<tr><td colspan="8"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Net debt does not include lease liabilities, which amounted to &#8364;1,776&#160;million as of June&#160;30, 2025 and &#8364;1,906&#160;million as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">As of June 30, 2025, current other bank borrowings include &#8364;4,535&#160;million related to the US commercial paper program and &#8364;230&#160;million related to the Negotiable European Commercial Paper program in France.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankOverdraftsClassifiedAsCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankOverdraftsClassifiedAsCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BondsIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of bonds issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BondsIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 45<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 169<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_169&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of reconciliation of carrying amount to value on redemption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage cash and cash equivalent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestRateAndCurrencyDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest rate and currency derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestRateAndCurrencyDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherBankBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other bank borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherBankBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_NonCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=sny_CurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=sny_CurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=sny_NonCurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=sny_NonCurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AssetsAndLiabilitiesAxis=sny_CurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AssetsAndLiabilitiesAxis=sny_CurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents - Additional Information (Details) - 6 months ended Jun. 30, 2025<br> &#8364; in Millions, $ in Millions</strong></div></th>
<th class="th">
<div>EUR (&#8364;) </div>
<div>&#8364; / shares</div>
</th>
<th class="th"><div>USD ($)</div></th>
<th class="th">
<div>USD ($) </div>
<div>&#8364; / shares</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember', window );">Commercial paper program in France | Sanofi Euro Medium Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommercialPapersIssued', window );">Commercial paper programs</a></td>
<td class="nump">&#8364; 6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BorrowingAverageDrawdown', window );">Borrowing, average drawdown</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember', window );">Commercial paper program in USA | Sanofi Euro Medium Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommercialPapersIssued', window );">Commercial paper programs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BorrowingAverageDrawdown', window );">Borrowing, average drawdown | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingDecember2027Member', window );">Four Billion Facility Maturing December 2027 | Sanofi Euro Medium Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingMarch2030Member', window );">Four Billion Facility Maturing March 2030 | Sanofi Euro Medium Term Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2020Member', window );">Fixed Rate Bond Issue from April 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2022Member', window );">Fixed Rate Bond Issue from April 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member', window );">One Billion Five Hundred Million Bonds, Issued In March 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">&#8364; 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfTranches', window );">Number Of Tranches | &#8364; / shares</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2027Member', window );">Fixed Rate Bond Maturing March 2027</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">&#8364; 850<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2031Member', window );">Fixed Rate Bond Maturing March 2031</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">650<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingJune2029Member', window );">Fixed Rate Bond Maturing June 2029</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2032Member', window );">Fixed Rate Bond Maturing March 2032</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member', window );">One Billion Five Hundred Million Bonds, Issued In June 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="nump">&#8364; 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfTranches', window );">Number Of Tranches | &#8364; / shares</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CommercialPapersIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of commercial paper issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CommercialPapersIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BorrowingAverageDrawdown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Borrowing, Average Drawdown</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BorrowingAverageDrawdown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfTranches">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Tranches</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfTranches</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInFranceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DebtInstrumentAxis=sny_SanofiEuroMediumTermNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_CommercialPaperProgramInUSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingDecember2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingDecember2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingMarch2030Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FourBillionFacilityMaturingMarch2030Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondIssueFromApril2022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2027Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2027Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2031Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2031Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingJune2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingJune2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_FixedRateBondMaturingMarch2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Market value</a></td>
<td class="nump">&#8364; 20,519<span></span>
</td>
<td class="nump">&#8364; 16,137<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtMarketValueMember', window );">Market value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Market value</a></td>
<td class="nump">4,589<span></span>
</td>
<td class="nump">8,165<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember', window );">Value on redemption</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems', window );"><strong>Disclosure of detailed information about borrowings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Borrowings', window );">Market value</a></td>
<td class="nump">20,560<span></span>
</td>
<td class="nump">16,171<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RedemptionOfDebtInstrumentIssued', window );">Value on redemption</a></td>
<td class="nump">&#8364; 5,143<span></span>
</td>
<td class="nump">&#8364; 8,806<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Borrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of outstanding funds that the entity is obligated to repay.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Borrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RedemptionOfDebtInstrumentIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Redemption of debt instrument issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RedemptionOfDebtInstrumentIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtMarketValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtMarketValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOnRedemptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">&#8364; 49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">49<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">133<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">14<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(84)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(55)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(5)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Not eligible for hedge accounting | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">11,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">6,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">3,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">4,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">11,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">6,619<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">3,351<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">539<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">480<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">253<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">173<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">4,418<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">2,540<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">610<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Not eligible for hedge accounting | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">159<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency sales</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency sales in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency sales in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency sales in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency sales in Japanese yen</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward Currency Sales In Pound Sterling [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency purchases</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency purchases in US dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency purchases in Singapore dollar</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward currency purchases in Chinese yuan renminbi</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward Currency Purchases In United Arab Emirates Dirham</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges | Forward Currency Purchases In Turkish lira</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems', window );"><strong>Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstruments', window );">Operating currency hedging instruments in place</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial instrument</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanRenminbiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInChineseYuanRenminbiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInTurkishLiraMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInTurkishLiraMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=sny_NotEligibleForHedgeAccountingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=sny_NotEligibleForHedgeAccountingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (23)<span></span>
</td>
<td colspan="2" class="num">&#8364; (3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember', window );">Forward currency sales in US dollar</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,615<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarUSBondMember', window );">Forward currency purchases in US dollar, US bond</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,000<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialLiabilities', window );">Derivative financial liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2029Member', window );">Cross Currency Swap, Expiring 2029</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">870<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2032Member', window );">Cross Currency Swap, Expiring 2032</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Notional amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">870<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapMember', window );">Cross Currency Swap</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DerivativeFinancialAssets', window );">Derivative financial assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax', window );">Change in fair value of cash flow hedges</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,808<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cross Currency Seller Swaps</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,476<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,723<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in US dollar | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">6,007<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Pound sterling | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">601<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency sales in Japanese yen | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">303<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,609<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in Singapore dollar | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,289<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward currency purchases in US dollar | 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">1,094<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Forward Currency Purchases In Hungarian florint | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">639<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cross Currency Seller Swaps In US Dollar | 2032</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">1,476<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">137<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cross Currency Seller Swaps</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">176<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in US dollar | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">148<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Pound sterling | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency sales in Japanese yen | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in Singapore dollar | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward currency purchases in US dollar | 2026</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(33)<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Forward Currency Purchases In Hungarian florint | 2025</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cross Currency Seller Swaps In US Dollar | 2032</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems', window );"><strong>Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure', window );">Derivative Financial Instruments To Manage Financial Exposure</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 5<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes forward sales with a notional amount of $3,615 million expiring in 2025, designated as a hedge of Sanofi&#8217;s net investment in Bioverativ. As of June 30, 2025, the fair value of these forward contracts represented an asset of &#8364;77 million; the opposite entry was recognized in Other comprehensive income, with the impact on financial income and expense being immaterial.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Includes forward purchases with a notional amount of $1,000 million expiring in 2025, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of June 30, 2025, the fair value of these contracts represented a liability of &#8364;25 million, with &#8364;0 million credited to Other comprehensive income to recognize the hedging cost.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#8364;5&#160;million, with &#8364;18&#160;million debited to Other comprehensive income under the cost of hedging accounting treatment.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DerivativeFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DerivativeFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 91<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_91_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DerivativeFinancialInstrumentsToManageFinancialExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Derivative financial instruments to manage financial exposure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DerivativeFinancialInstrumentsToManageFinancialExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarUSBondMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarUSBondMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2029Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2029Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2032Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapExpiring2032Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySellerSwapsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySellerSwapsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInPoundSterlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencySalesInJapaneseYenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInSingaporeDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInSingaporeDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInHungarianFlorintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_ForwardCurrencyPurchasesInHungarianFlorintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySellerSwapsInUSDollarMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_CrossCurrencySellerSwapsInUSDollarMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Financial Instruments - Disclosure of Instruments (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 2,348<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">1,498<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2028</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember', window );">Notional amount | 2029 and beyond</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(88)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(81)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember', window );">Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember', window );">Value of hedge recognized in equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount | 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Notional amount | 2028</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">848<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Fair value | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(54)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember', window );">pay capitalized SOFR USD / receive 1.17% | Value of hedge recognized in equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount | 2028</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Notional amount | 2029 and beyond</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(7)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember', window );">pay 2.08% / receive Euribor 3m | Value of hedge recognized in equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | 2025</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | 2026</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | 2027</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | 2028</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Notional amount | 2029 and beyond</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Fair value</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Fair value | Fair value hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Fair value | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member', window );">pay capitalized Ester / receive 0.92% | Value of hedge recognized in equity | Cash flow hedges</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems', window );"><strong>Disclosure of detailed information about financial instruments [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents', window );">Currency and interest rate derivatives</a></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_AtNotionalAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_FairValueHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_FairValueHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfHedgesAxis=ifrs-full_CashFlowHedgesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_NotLaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_AtFairValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=sny_ValueOfHedgeRecognizedInEquityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgingInstrumentsAxis=sny_InterestRateSwapsPayCapitalizedEsterReceive092Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><sup>[3]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward', window );"><strong>Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 641<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(72)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2]</sup></td>
<td class="nump">72<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(77)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">564<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">&#8364; 72<span></span>
</td>
<td colspan="2" class="nump">&#8364; 72<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Non-current portion</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">564<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="nump">&#8364; 569<span></span>
</td>
<td colspan="2" class="nump">&#8364; 569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember', window );">MSD contingent consideration (European Vaccines business)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward', window );"><strong>Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(72)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember', window );">Shire contingent consideration arising from acquisition of Translate Bio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward', window );"><strong>Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">568<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">71<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(76)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilities1Member', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward', window );"><strong>Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Beginning balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination', window );">Payments made</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities', window );">Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests', window );">Currency translation differences</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Ending balance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of January 1, 2025, this comprised a non-current portion of &#8364;569 million and a current portion of &#8364;72 million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts mainly reported within the income statement line item &#8220;Fair value remeasurement of contingent consideration&#8221;.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2025-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_93_e_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 95<br> -Subparagraph d<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_95_d_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase decrease through net exchange differences business combinations and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilities1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_OtherLiabilities1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><sup>[1],[2]</sup></th>
<th class="th"><div>Jan. 01, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract', window );"><strong>Disclosure of contingent liabilities in business combination [abstract]</strong></a></td>
<td colspan="2" class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Non-current portion</a></td>
<td colspan="2" class="nump">&#8364; 564<span></span>
</td>
<td class="nump">&#8364; 569<span></span>
</td>
<td colspan="2" class="nump">&#8364; 569<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests', window );">Current portion</a></td>
<td colspan="2" class="nump">&#8364; 0<span></span>
</td>
<td class="nump">&#8364; 72<span></span>
</td>
<td colspan="2" class="nump">&#8364; 72<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of January 1, 2025, this comprised a non-current portion of &#8364;569 million and a current portion of &#8364;72 million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Fair value of contingent consideration payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 564<span></span>
</td>
<td class="nump">&#8364; 641<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember', window );">Shire contingent consideration arising from acquisition of Translate Bio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems', window );"><strong>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination', window );">Fair value of contingent consideration payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 563<span></span>
</td>
<td class="nump">&#8364; 568<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PercentageIncreaseInFairValueLiabilities', window );">Increase in fair value of liability</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As of January 1, 2025, this comprised a non-current portion of &#8364;569 million and a current portion of &#8364;72 million.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of contingent liabilities recognised in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PercentageIncreaseInFairValueLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage increase in fair value liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PercentageIncreaseInFairValueLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNonCurrentProvisionsLineItems', window );"><strong>Disclosure Of Non-current Provisions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Provisions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 5,003<span></span>
</td>
<td class="nump">&#8364; 5,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,113<span></span>
</td>
<td class="nump">2,334<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities', window );">Non-current provisions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">7,116<span></span>
</td>
<td class="nump">&#8364; 8,096<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember', window );">Antibodies Collaboration Agreement | Swedish Orphan Biovitrum AB</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNonCurrentProvisionsLineItems', window );"><strong>Disclosure Of Non-current Provisions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,756<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember', window );">Antibodies Collaboration Agreement | Swedish Orphan Biovitrum AB | Later than one year and not later than five years [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNonCurrentProvisionsLineItems', window );"><strong>Disclosure Of Non-current Provisions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember', window );">Antibodies Collaboration Agreement | Swedish Orphan Biovitrum AB | Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfNonCurrentProvisionsLineItems', window );"><strong>Disclosure Of Non-current Provisions [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 2,293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes &#8364;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#8364;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#8364;2,293&#160;million.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 55<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfNonCurrentProvisionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure Of Non-current Provisions [line items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfNonCurrentProvisionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PrincipalAlliancesAxis=sny_AntibodiesCollaborationAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CounterpartiesAxis=sny_SwedishOrphanBiovitrumABMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CounterpartiesAxis=sny_SwedishOrphanBiovitrumABMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr><th class="th" colspan="2">
<div>Jun. 30, 2025 </div>
<div>EUR (&#8364;)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">&#8364; 5,762<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions and other liabilities</a></td>
<td class="nump">615<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(616)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(197)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(255)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions', window );">Actuarial gains and losses on defined-benefit plans (B.12.1.)</a></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">5,003<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_GB', window );">United Kingdom | Plan assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans', window );">Net defined benefit liability (asset)</a></td>
<td class="nump">101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember', window );">Provisions for pensions &amp; other post-employment benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">1,992<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions and other liabilities</a></td>
<td class="nump">69<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(167)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(17)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(94)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions', window );">Actuarial gains and losses on defined-benefit plans (B.12.1.)</a></td>
<td class="num">(111)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">1,705<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember', window );">Provisions for other long-term benefits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">821<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions and other liabilities</a></td>
<td class="nump">78<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(61)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(74)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions', window );">Actuarial gains and losses on defined-benefit plans (B.12.1.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">765<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember', window );">Restructuring provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">799<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions and other liabilities</a></td>
<td class="nump">175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(10)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(2)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(158)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">2<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions', window );">Actuarial gains and losses on defined-benefit plans (B.12.1.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">802<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember', window );">Other provisions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract', window );"><strong>Reconciliation of changes in other provisions [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Beginning balance</a></td>
<td class="nump">2,150<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ChangesInOtherProvisions', window );">Increases in provisions and other liabilities</a></td>
<td class="nump">293<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProvisionUsedOtherProvisions', window );">Provisions utilized</a></td>
<td class="num">(378)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions', window );">Reversals of unutilized provisions</a></td>
<td class="num">(178)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions', window );">Transfers</a></td>
<td class="num">(93)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions', window );">Net interest related to employee benefits, and unwinding of discount</a></td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions', window );">Currency translation differences</a></td>
<td class="num">(83)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions', window );">Actuarial gains and losses on defined-benefit plans (B.12.1.)</a></td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentProvisions', window );">Ending balance</a></td>
<td class="nump">&#8364; 1,731<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Mainly transfers to Current provisions and other current liabilities.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">In the case of &#8220;Provisions for pensions and other post-employment benefits&#8221;, the &#8220;Increases in provisions&#8221; line corresponds to rights vesting in employees during the period, and past service cost; the &#8220;Provisions utilized&#8221; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#8220;Reversals of unutilized provisions&#8221; line corresponds to plan curtailments, settlements and amendments.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ChangesInOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ChangesInOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilityAssetOfDefinedBenefitPlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 140<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_140_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 206<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_206_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 206<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_206_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilityAssetOfDefinedBenefitPlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProvisionUsedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2025-01-01<br> -Paragraph 84<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_84_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 257<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_257_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProvisionUsedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase Decrease Of Unused Provision Reversed, Other Provisions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Actuarial gains and losses on defined-benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net interest related to employees benefits and unwinding of discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_ProvisionsForOtherLongTermBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=sny_NonCurrentRestructuringProvisionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=ifrs-full_MiscellaneousOtherProvisionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="4">6 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Actuarial assumption of discount rates | Minimum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease in actuarial assumption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.00%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase in actuarial assumption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.40%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember', window );">Actuarial assumption of discount rates | Maximum</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase in actuarial assumption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0.30%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.65%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_UKZONEMember', window );">UKZONE | Actuarial assumption of expected rates of inflation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption', window );">Decrease in actuarial assumption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_EUROZONEMember', window );">Eurozone | Actuarial assumption of expected rates of inflation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption', window );">Increase in actuarial assumption</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0.10%<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) on benefit obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 152<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">&#8364; 373<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember', window );">Pensions and other post-employment benefits | Opella Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) on benefit obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember', window );">Plan assets | Pensions and other post-employment benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems', window );"><strong>Disclosure of net defined benefit liability (asset) [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset', window );">Actuarial gains/(losses) on plan assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (45)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">&#8364; (138)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes actuarial gains/ (losses) related to Opella of &#8364;(4)&#160;million for the first half of 2025 and &#8364;(6)&#160;million for the first half of 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the -0.30% change in the inflation rate in the United Kingdom in the first half of 2025.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 145<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_145_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [domain]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 141<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_141_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 207<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_207_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfDiscountRatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_UKZONEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_UKZONEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ActuarialAssumptionsAxis=ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_EUROZONEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_EUROZONEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=sny_PensionsAndOtherPostEmploymentBenefitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDefinedBenefitLiabilityAssetAxis=ifrs-full_PlanAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Off Balance Sheet Commitments - Additional Information (Details) - Earendil Labs [Member] - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th"><div>Apr. 01, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems', window );"><strong>Disclosure of transactions between related parties [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Prepayments', window );">Prepayments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions', window );">Commitments made by entity, related party transactions</a></td>
<td class="nump">&#8364; 1,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of related-party commitments made by the entity to do something if a particular event occurs or does not occur in the future, including executory contracts (recognised and unrecognised). [Refer: Total for all related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2025-01-01<br> -Paragraph 21<br> -Subparagraph i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_21_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Prepayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Receivables that represent amounts paid for goods and services before they have been delivered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph B9<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B9_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Prepayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=sny_EarendilLabsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=sny_EarendilLabsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Litigation and Arbitration Proceedings (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>May 31, 2025 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2025 </div>
<div>Proceeding</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember', window );">Plavix Attorney General action in Hawaii | Action For Which Sanofi Are Defendant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PaymentOfDamagesClaimedByCounterparty', window );">Payment Of Damages Claimed By Counterparty</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PenaltyFeeIncurred', window );">Penalty Fee Incurred</a></td>
<td class="nump">$ 350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LegalAndArbitralProceedingsAxis=sny_GoldBondProductLitigationInTheUSMember', window );">Gold Bond Product Litigation In The US | Action for which we are defendant | Product Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems', window );"><strong>Disclosure of Legal and Arbitral Proceedings [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NumberOfClassActionLawsuits', window );">Number Of Class Action Lawsuits | Proceeding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfLegalAndArbitralProceedingsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of legal and arbitral proceedings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfLegalAndArbitralProceedingsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NumberOfClassActionLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Class Action Lawsuits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NumberOfClassActionLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PaymentOfDamagesClaimedByCounterparty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment Of Damages Claimed By Counterparty</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PaymentOfDamagesClaimedByCounterparty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PenaltyFeeIncurred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Penalty Fee Incurred</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PenaltyFeeIncurred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_PlavixAttorneyGeneralActionInHawaiiMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DefendantAxis=sny_ActionForWhichSanofiAreDefendantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DefendantAxis=sny_ActionForWhichSanofiAreDefendantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LegalAndArbitralProceedingsAxis=sny_GoldBondProductLitigationInTheUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LegalAndArbitralProceedingsAxis=sny_GoldBondProductLitigationInTheUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DefendantAxis=sny_ActionForWhichWeAreDefendantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_ProductLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=sny_ProductLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Operating Income And Expenses - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 533<span></span>
</td>
<td class="nump">&#8364; 563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,476<span></span>
</td>
<td class="nump">1,977<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Other operating income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember', window );">Other related parties | Other operating income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">87<span></span>
</td>
<td class="nump">121<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainsOnDivestmentOfProducts', window );">Gains on divestment of some mature products</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">344<span></span>
</td>
<td class="nump">319<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember', window );">Other related parties | Regeneron | Commercialization Related Expenses [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 2,331<span></span>
</td>
<td class="nump">&#8364; 1,841<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other operating income (expenses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherOperatingIncomeExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainsOnDivestmentOfProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gains on divestment of products.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainsOnDivestmentOfProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_OtherRelatedPartiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_CommercializationRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_CommercializationRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (2,476)<span></span>
</td>
<td class="num">&#8364; (1,977)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">533<span></span>
</td>
<td class="nump">563<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherOperatingIncomeExpense', window );">Other operating income/(expenses), net related to Regeneron</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,261)<span></span>
</td>
<td class="num">(1,745)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibodies Alliance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,327)<span></span>
</td>
<td class="num">(1,837)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibodies Alliance | Income &amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,475)<span></span>
</td>
<td class="num">(1,934)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibodies Alliance | Additional share of profit paid by Regeneron towards development costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">494<span></span>
</td>
<td class="nump">389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember', window );">Monoclonal Antibodies Alliance | Reimbursement to Regeneron of selling expenses incurred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingExpense', window );">Other operating expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(346)<span></span>
</td>
<td class="num">(292)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=sny_OthersCounterpartyMember', window );">Other (mainly Zaltrap and Libtayo)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">66<span></span>
</td>
<td class="nump">92<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember', window );">Regeneron | Other operating income (expense)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems', window );"><strong>Disclosure Of Other Operating Income Expenses [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MiscellaneousOtherOperatingIncome', window );">Other operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 70<span></span>
</td>
<td class="nump">&#8364; 96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MiscellaneousOtherOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MiscellaneousOtherOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherOperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherOperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfOtherOperatingIncomeExpensesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of other operating income (expenses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfOtherOperatingIncomeExpensesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MiscellaneousOtherOperatingIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MiscellaneousOtherOperatingIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_AntibodiesAllianceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_CommercializationRelatedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_CommercializationRelatedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=sny_OthersCounterpartyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=sny_OthersCounterpartyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInAssociatesAxis=sny_RegeneronMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_OtherOperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis=sny_OtherOperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses', window );">Employee-related expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 201<span></span>
</td>
<td class="nump">&#8364; 810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories', window );">Charges, gains or losses on assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">109<span></span>
</td>
<td class="num">(27)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts', window );">Costs of transformation programs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">80<span></span>
</td>
<td class="nump">114<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherRestructuringCosts', window );">Other restructuring costs</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40<span></span>
</td>
<td class="nump">163<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">&#8364; 430<span></span>
</td>
<td class="nump">&#8364; 1,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee related expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense of restructuring activities related to property plant and equipment to inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expense Of Restructuring Activities, Transformation Programs Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherRestructuringCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other restructuring costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherRestructuringCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring Costs and Similar Items - Additional Information (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities', window );">Decrease in total expense of restructuring activities</a></td>
<td class="nump">&#8364; 630<span></span>
</td>
<td class="nump">&#8364; 630<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Total Expense Of Restructuring Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Other Gains and Losses, and Litigation (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract', window );"><strong>Analysis of income and expense [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 57<span></span>
</td>
<td class="nump">&#8364; 450<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AnalysisOfIncomeAndExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AnalysisOfIncomeAndExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Financial Expenses and Income (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems', window );"><strong>Disclosure of detailed information about finance income expense [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnBorrowings', window );">Cost of debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">&#8364; (219)<span></span>
</td>
<td class="num">&#8364; (306)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InterestIncome', window );">Interest income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">162<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CostOfDebtNet', window );">Cost of net debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(67)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonOperatingForeignExchangeGainsLosses', window );">Non-operating foreign exchange gains/(losses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions', window );">Unwinding of discounting of provisions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(19)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NetInterestCostRelatedToEmployeeBenefits', window );">Net interest cost related to employee benefits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(37)<span></span>
</td>
<td class="num">(39)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Net interest expense on lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(22)<span></span>
</td>
<td class="num">(20)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncomeCost', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="num">(40)<span></span>
</td>
<td class="num">(161)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Net financial income/(expenses)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(177)<span></span>
</td>
<td class="num">(306)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">comprising: Financial expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">(361)<span></span>
</td>
<td class="num">(583)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="nump">184<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[7]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LiabilityRecognisedForEstimatedFutureRoyalties', window );">Liability Recognised For Estimated Future Royalties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember', window );">Interest rate and currency derivatives used to hedge debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems', window );"><strong>Disclosure of detailed information about finance income expense [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnDerivativesUsedToManageDebt', window );">Gain on derivatives used to manage debt</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents', window );">Gain on derivatives used to manage cash and cash equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (4)<span></span>
</td>
<td class="num">&#8364; (18)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#8364;(25)&#160;million in the first half of 2025 and &#8364;(24)&#160;million in the first half of 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#8364;(4)&#160;million in the first half of 2025 and &#8364;(18)&#160;million in the first half of 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Includes a financial expense of &#8364;50&#160;million for the six months ended June&#160;30, 2025 and &#8364;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 115<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_115_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CostOfDebtNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of debt net.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CostOfDebtNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent detailed information about finance income expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on derivatives used to manage cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainLossOnDerivativesUsedToManageDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain (loss) on derivatives used to manage debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainLossOnDerivativesUsedToManageDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InterestIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest Income</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InterestIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LiabilityRecognisedForEstimatedFutureRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liability Recognised For Estimated Future Royalties</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LiabilityRecognisedForEstimatedFutureRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NetInterestCostRelatedToEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net interest cost related to employee benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NetInterestCostRelatedToEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonOperatingForeignExchangeGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-operating foreign exchange gains/(losses).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonOperatingForeignExchangeGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_HedgedItemsAxis=sny_InterestRateAndCurrencyDerivativesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[1]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Current taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">&#8364; (1,202)<span></span>
</td>
<td colspan="2" class="num">&#8364; (1,108)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Deferred taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">491<span></span>
</td>
<td colspan="2" class="nump">729<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(711)<span></span>
</td>
<td colspan="2" class="num">(379)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">&#8364; 3,582<span></span>
</td>
<td colspan="2" class="nump">&#8364; 2,462<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 193<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_193_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph f<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_f_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2025-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 79<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 192<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_192&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundAbstract', window );"><strong>Income taxes paid (refund) [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Standard tax rate applicable in France</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25.80%<span></span>
</td>
<td colspan="2" class="nump">25.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_TaxRateEffectOfForeignTaxRates', window );">Difference between the standard French tax rate and the rates applicable to Sanofi</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[3]</sup></td>
<td class="num">(7.30%)<span></span>
</td>
<td colspan="2" class="num">(15.50%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes', window );">Revisions to tax exposures and settlements of tax disputes</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2.30%<span></span>
</td>
<td colspan="2" class="nump">2.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[4]</sup></td>
<td class="num">(1.00%)<span></span>
</td>
<td colspan="2" class="nump">2.80%<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AverageEffectiveTaxRate', window );">Effective tax rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">19.80%<span></span>
</td>
<td colspan="2" class="nump">15.40%<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#8364;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#8217;s current understanding of Pillar Two rules, and &#8364;52&#160;million for the six months ended June&#160;30, 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AverageEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AverageEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectOfForeignTaxRates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 194<br> -Subparagraph c<br> -Clause ii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_194_c_ii&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectOfForeignTaxRates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revisions to tax exposures and settlements of tax disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems', window );"><strong>Disclosure of temporary difference, unused tax losses and unused tax credits [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentTaxExpenseRelatedToPillarTwo', window );">Current Tax Expense Related to Pillar Two</a></td>
<td class="nump">&#8364; 17<span></span>
</td>
<td class="nump">&#8364; 52<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentTaxExpenseRelatedToPillarTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Tax Expense Related to Pillar Two</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentTaxExpenseRelatedToPillarTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 19,889<span></span>
</td>
<td class="nump">&#8364; 18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,889<span></span>
</td>
<td class="nump">18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Dupixent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,312<span></span>
</td>
<td class="nump">6,138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Aubagio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">138<span></span>
</td>
<td class="nump">209<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Industrial Sales [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">251<span></span>
</td>
<td class="nump">274<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Polio Pertussis Hib Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,361<span></span>
</td>
<td class="nump">1,348<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Influenza Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">214<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Nexviazyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">387<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Sarclisa</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">276<span></span>
</td>
<td class="nump">227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Altuviiio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">542<span></span>
</td>
<td class="nump">280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Rezurock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">263<span></span>
</td>
<td class="nump">207<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Cablivi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">136<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Xenpozyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110<span></span>
</td>
<td class="nump">72<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Tzield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | RSV Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">356<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member] | Meningitis Travel And Endemic Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">609<span></span>
</td>
<td class="nump">583<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,144<span></span>
</td>
<td class="nump">4,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,144<span></span>
</td>
<td class="nump">4,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Dupixent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">944<span></span>
</td>
<td class="nump">770<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Aubagio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">40<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Industrial Sales [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">241<span></span>
</td>
<td class="nump">273<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Polio Pertussis Hib Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">223<span></span>
</td>
<td class="nump">248<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Influenza Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Nexviazyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">132<span></span>
</td>
<td class="nump">95<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Sarclisa</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83<span></span>
</td>
<td class="nump">64<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Altuviiio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Rezurock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Cablivi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">55<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Xenpozyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">44<span></span>
</td>
<td class="nump">24<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Tzield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | RSV Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">85<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe | Biopharma Segment [Member] | Meningitis Travel And Endemic Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">96<span></span>
</td>
<td class="nump">97<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Dupixent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,283<span></span>
</td>
<td class="nump">4,437<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Aubagio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76<span></span>
</td>
<td class="nump">96<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Industrial Sales [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Polio Pertussis Hib Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">320<span></span>
</td>
<td class="nump">311<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Influenza Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54<span></span>
</td>
<td class="nump">16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Nexviazyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">195<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Sarclisa</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">119<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Altuviiio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">456<span></span>
</td>
<td class="nump">259<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Rezurock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">220<span></span>
</td>
<td class="nump">188<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Cablivi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Xenpozyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47<span></span>
</td>
<td class="nump">37<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Tzield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | RSV Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68<span></span>
</td>
<td class="nump">116<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">UNITED STATES | Biopharma Segment [Member] | Meningitis Travel And Endemic Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">319<span></span>
</td>
<td class="nump">301<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,210<span></span>
</td>
<td class="nump">5,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,210<span></span>
</td>
<td class="nump">5,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Dupixent</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,085<span></span>
</td>
<td class="nump">931<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Aubagio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">22<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Industrial Sales [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Polio Pertussis Hib Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">818<span></span>
</td>
<td class="nump">789<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Influenza Vaccines [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Nexviazyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60<span></span>
</td>
<td class="nump">51<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Sarclisa</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">74<span></span>
</td>
<td class="nump">63<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Altuviiio</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">86<span></span>
</td>
<td class="nump">21<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Rezurock</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20<span></span>
</td>
<td class="nump">7<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Cablivi</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Xenpozyme</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19<span></span>
</td>
<td class="nump">11<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Tzield</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | RSV Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">203<span></span>
</td>
<td class="nump">77<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember', window );">Other Countries | Biopharma Segment [Member] | Meningitis Travel And Endemic Vaccines</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 194<span></span>
</td>
<td class="nump">&#8364; 185<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_DupixentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_DupixentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_AubagioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_AubagioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_IndustrialSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_IndustrialSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_PolioPertussisHibVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_PolioPertussisHibVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_InfluenzaVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_InfluenzaVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_NexviazymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_NexviazymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_SarclisaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_SarclisaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_AltuviiioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_AltuviiioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_RezurockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_RezurockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_CabliviMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_CabliviMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_XenpozymeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_XenpozymeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_TzieldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_TzieldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_RSVVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_RSVVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=sny_MeningitisTravelAndEndemicVaccinesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=sny_MeningitisTravelAndEndemicVaccinesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Revenue from Contracts with Customers (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 1,452<span></span>
</td>
<td colspan="2" class="nump">&#8364; 1,529<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RevenueFromVaxServeSalesOfNonSanofiProducts', window );">&#8199;VaxServe sales of non-Sanofi products</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">842<span></span>
</td>
<td colspan="2" class="nump">854<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations', window );">Sales to Opella</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">61<span></span>
</td>
<td colspan="2" class="nump">95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromRoyalties', window );">&#8199;Royalties</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68<span></span>
</td>
<td colspan="2" class="nump">62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="nump">275<span></span>
</td>
<td colspan="2" class="nump">341<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,246<span></span>
</td>
<td colspan="2" class="nump">1,352<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_OpellaBusinessMember', window );">Opella Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems', window );"><strong>Disclosure of disaggregation of revenue from contracts with customers [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td colspan="2" class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">&#8364; 206<span></span>
</td>
<td colspan="2" class="nump">&#8364; 177<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights).</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromRoyalties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromRoyalties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MiscellaneousOtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Miscellaneous other revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MiscellaneousOtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from intragroup sales from continuing to discontinued operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RevenueFromVaxServeSalesOfNonSanofiProducts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue from VaxServe sales of non-Sanofi products</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RevenueFromVaxServeSalesOfNonSanofiProducts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_OpellaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_OpellaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Segment Results (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[3]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 19,889<span></span>
</td>
<td class="nump">&#8364; 18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">1,452<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(5,881)<span></span>
</td>
<td class="num">(5,966)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(3,717)<span></span>
</td>
<td class="num">(3,335)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,506)<span></span>
</td>
<td class="num">(4,303)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25<span></span>
</td>
<td class="nump">17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,889<span></span>
</td>
<td class="nump">18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,246<span></span>
</td>
<td class="nump">1,352<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,753)<span></span>
</td>
<td class="num">(5,849)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,716)<span></span>
</td>
<td class="num">(3,334)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,447)<span></span>
</td>
<td class="num">(4,247)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,941)<span></span>
</td>
<td class="num">(1,426)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business Operating Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,347<span></span>
</td>
<td class="nump">4,916<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">206<span></span>
</td>
<td class="nump">177<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(128)<span></span>
</td>
<td class="num">(110)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(1)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(56)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2)<span></span>
</td>
<td class="nump">12<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business Operating Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16<span></span>
</td>
<td class="nump">22<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember', window );">Reportable segments [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,889<span></span>
</td>
<td class="nump">18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,452<span></span>
</td>
<td class="nump">1,529<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,881)<span></span>
</td>
<td class="num">(5,959)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ResearchAndDevelopmentExpense', window );">Research and development expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,717)<span></span>
</td>
<td class="num">(3,335)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SellingGeneralAndAdministrativeExpense', window );">Selling and general expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,506)<span></span>
</td>
<td class="num">(4,303)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_MiscellaneousOtherOperatingIncomeExpenses', window );">Other operating income and expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,943)<span></span>
</td>
<td class="num">(1,414)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77<span></span>
</td>
<td class="nump">66<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8)<span></span>
</td>
<td class="num">(6)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business Operating Income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 5,363<span></span>
</td>
<td class="nump">&#8364; 4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 99<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 103<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 126<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_126&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 266<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_266&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_MiscellaneousOtherOperatingIncomeExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other operating income and expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_MiscellaneousOtherOperatingIncomeExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_AllOtherSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_ReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[2]</sup></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 25<span></span>
</td>
<td class="nump">&#8364; 17<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(57)<span></span>
</td>
<td class="num">(450)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,759<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">comprising: Financial expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(361)<span></span>
</td>
<td class="num">(583)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Financial income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">184<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments', window );">Income before tax and investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">3,582<span></span>
</td>
<td class="nump">2,462<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss on other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">210<span></span>
</td>
<td class="num">(371)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill', window );">Impairment loss on other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill', window );">Impairment Loss on Intangible Asset Other Than Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_BusinessOperatingIncome', window );">Business operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,363<span></span>
</td>
<td class="nump">4,938<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember', window );">Material reconciling items</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of profit/(loss) from investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(77)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">Net income attributable to non-controlling interests</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="nump">8<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill', window );">Amortization and impairment of intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="num">(987)<span></span>
</td>
<td class="num">(527)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability', window );">Fair value remeasurement of contingent consideration</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(61)<span></span>
</td>
<td class="num">(66)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories', window );">Expense arising from the impact of acquisitions on inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[7]</sup></td>
<td class="nump">0<span></span>
</td>
<td class="num">(7)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ExpenseOfRestructuringActivities', window );">Restructuring costs and similar items</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[8]</sup></td>
<td class="num">(430)<span></span>
</td>
<td class="num">(1,060)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherGainsLossesAndLitigation', window );">Other gains and losses, and litigation</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[9]</sup></td>
<td class="num">&#8364; (57)<span></span>
</td>
<td class="num">&#8364; (450)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Joint ventures and associates with which Sanofi has entered into a strategic alliance.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#8364;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#8364;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[7]</td>
<td style="vertical-align: top;" valign="top">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[8]</td>
<td style="vertical-align: top;" valign="top">See Note B.16.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[9]</td>
<td style="vertical-align: top;" valign="top">See Note B.17.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseOfRestructuringActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseOfRestructuringActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -Clause iv<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e_iv&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in a contingent consideration asset (liability) relating to a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph b<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2025-01-01<br> -Paragraph IE33<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 85<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization and impairment of intangible assets other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_BusinessOperatingIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business operating income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_BusinessOperatingIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses arising from the impact of acquisitions on inventories.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impairment Loss on Intangible Asset Other Than Goodwill</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income before tax and investments accounted for equity method investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherGainsLossesAndLitigation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherGainsLossesAndLitigation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_MaterialReconcilingItemsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 3,563<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 316<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember', window );">Biopharma Segment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems', window );"><strong>Disclosure of operating segments [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_InvestmentAccountedForUsingEquityMethod', window );">Investments accounted for using the equity method</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">483<span></span>
</td>
<td class="nump">&#8364; 229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisitions of property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">845<span></span>
</td>
<td class="nump">882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisitions of other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 575<span></span>
</td>
<td class="nump">&#8364; 922<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Carrying amount at the end of the reporting period.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B16<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B16&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 89<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_89&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2025-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=sny_BiopharmaSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details) - EUR (&#8364;)<br> &#8364; in Millions</strong></div></th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
<th class="th"><sup>[3]</sup></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">&#8364; 19,889<span></span>
</td>
<td class="nump">&#8364; 18,360<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">9,574<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 10,091<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">40,283<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">43,384<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">20,431<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,144<span></span>
</td>
<td class="nump">4,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,167<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_FR', window );">France</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">835<span></span>
</td>
<td class="nump">855<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,953<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_US', window );">United States</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,535<span></span>
</td>
<td class="nump">8,292<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,080<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,411<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,725<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesExcludingEuropeAndNorthAmericaMember', window );">Rest of the World</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,210<span></span>
</td>
<td class="nump">5,996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,056<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,130<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_GeographicalAreasAxis=country_CN', window );">China</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfGeographicalAreasLineItems', window );"><strong>Disclosure of geographical areas [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_RevenueFromSaleOfGoods', window );">Net sales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,388<span></span>
</td>
<td class="nump">&#8364; 1,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets [abstract]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property, plant and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">83<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 0<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfGeographicalAreasLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfGeographicalAreasLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2025-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2025-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 254<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_254_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 255<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_255_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 37<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_37&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2025-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 263<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_263_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2025-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2027-01-01<br> -Name IFRS<br> -Number 19<br> -IssueDate 2025-01-01<br> -Paragraph 200<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=19&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_200_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromSaleOfGoods">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromSaleOfGoods</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_FR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_FR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=sny_OtherCountriesExcludingEuropeAndNorthAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=sny_OtherCountriesExcludingEuropeAndNorthAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeographicalAreasAxis=country_CN">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeographicalAreasAxis=country_CN</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment Information - Principal Customers and Credit Risk (Details)<br></strong></div></th>
<th class="th" colspan="2">6 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2024</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CertainWholesalersInTheUnitedStatesMember', window );">Certain wholesalers in the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerOneMember', window );">Customer one</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember', window );">Customer two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">12.00%<span></span>
</td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember', window );">Customer three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems', window );"><strong>Disclosure of information about major customers and credit risk [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of entity's revenue</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">7.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2025-01-01<br> -Paragraph 34<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of information about major customers and credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CertainWholesalersInTheUnitedStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CertainWholesalersInTheUnitedStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MajorCustomersAxis=sny_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Information related to Opella, presented within assets held for sale and discontinued operations (Details) - EUR (&#8364;)<br> &#8364; / shares in Units, &#8364; in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">6 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2025</div></th>
<th class="th"><div>Jun. 30, 2025</div></th>
<th class="th" colspan="2"><div>Jun. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Property, plant and equipment owned</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">116<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,255<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Other intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,928<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations', window );">Accounts receivable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">989<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">841<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations', window );">Total assets held for sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,489<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations', window );">&#8194;Non-current provisions and other non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations', window );">Accounts payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations', window );">Current provisions and other current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">570<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">448<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations', window );">Total liabilities related to assets held for sale</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">&#8364; 2,131<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations', window );">Net sales and other revenues</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 1,736<span></span>
</td>
<td class="nump">&#8364; 2,645<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations', window );">Operating income</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">266<span></span>
</td>
<td class="nump">277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations', window );">Gain on disposal of Opella before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,781<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations', window );">Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,039<span></span>
</td>
<td class="nump">278<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(158)<span></span>
</td>
<td class="num">(85)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income from discontinued operations (Opella)</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2,881<span></span>
</td>
<td class="nump">&#8364; 202<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Average number of shares outstanding</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,225,500,000<span></span>
</td>
<td class="nump">1,249,400,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Average number of shares after dilution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,230,700,000<span></span>
</td>
<td class="nump">1,253,800,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations', window );">Basic earnings per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.34<span></span>
</td>
<td class="nump">&#8364; 0.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations', window );">Diluted earnings per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 2.33<span></span>
</td>
<td class="nump">&#8364; 0.16<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember', window );">Opella Business</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems', window );"><strong>Disclosure of analysis of single amount of discontinued operations [line items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations', window );">Income tax expense</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">&#8364; 88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_ProfitLossFromDiscontinuedOperations', window );">Net income from discontinued operations (Opella)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">&#8364; 2,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.).</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">In 2025, this line includes an expense of &#8364;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#8217;s audited consolidated financial statements as of December&#160;31, 2024.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 68<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 67<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-2022:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2025-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2025-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause vii<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_B12_b_vii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2025-03-27<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 98<br> -Subparagraph e<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_98_e&amp;doctype=Standard<br> -URIDate 2025-03-27<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2027-01-01<br> -Name IAS<br> -Number 1<br> -IssueDate 2025-01-01<br> -Paragraph 82<br> -Subparagraph ea<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2025-en-b&amp;anchor=para_82_ea&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2025-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2025-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2025-03-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Payable, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivables, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Assets Of Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Current Provisions And Other Current Liabilities, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gain on Disposal of Opella, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_GoodwillDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Goodwill, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_GoodwillDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Before Tax And Investments Accounted For Using The Equity Method, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Income Tax Expense (Benefit), Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_InventoriesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Inventories, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_InventoriesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Liabilities, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Liabilities Of Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Current Provisions And Other Non-Current Liabilities, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Revenue, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Assets, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Intangible Assets, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Liabilities, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Property, Plant And Equipmenet, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue From Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Right Of Use Assets, Disposal Group Including Discontinued Operations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=sny_OpellaBusinessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Events Subsequent to June 30, 2025 (Details) - Vicebio Ltd<br> $ in Millions</strong></div></th>
<th class="th">
<div>Jul. 22, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems', window );"><strong>Disclosure of non-adjusting events after reporting period [line items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_UpfrontPayments', window );">Upfront payment</a></td>
<td class="nump">$ 1,150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_sny_TotalMilestonePayments', window );">Total Milestone Payments</a></td>
<td class="nump">$ 450<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_TotalMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total Milestone Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_TotalMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_UpfrontPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Upfront payments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_UpfrontPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>sny_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_sny_AssetsAcquisitionAxis=sny_VicebioLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">sny_AssetsAcquisitionAxis=sny_VicebioLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>624</ContextCount>
  <ElementCount>435</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>194</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>9</UnitCount>
  <MyReports>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>1001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1002 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1003 - Statement - Consolidated Income Statements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedIncomeStatements</Role>
      <ShortName>Consolidated Income Statements</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1004 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1005 - Statement - Consolidated Statements of Changes in Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity</Role>
      <ShortName>Consolidated Statements of Changes in Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1006 - Statement - Consolidated Statements of Changes in Equity (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical</Role>
      <ShortName>Consolidated Statements of Changes in Equity (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1007 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>1008 - Statement - Consolidated Statements of Cash Flows (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>Consolidated Statements of Cash Flows (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>1009 - Disclosure - Introduction</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/Introduction</Role>
      <ShortName>Introduction</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>1010 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies</Role>
      <ShortName>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>1011 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements</Role>
      <ShortName>Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>1012 - Disclosure - Property, Plant and Equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PropertyPlantAndEquipment</Role>
      <ShortName>Property, Plant and Equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>1013 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>1014 - Disclosure - Impairment of Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets</Role>
      <ShortName>Impairment of Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>1015 - Disclosure - Investments Accounted for Using the Equity Method</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod</Role>
      <ShortName>Investments Accounted for Using the Equity Method</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>1016 - Disclosure - Other Non-Current Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherNonCurrentAssets</Role>
      <ShortName>Other Non-Current Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>1017 - Disclosure - Accounts Receivable</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/AccountsReceivable</Role>
      <ShortName>Accounts Receivable</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>1018 - Disclosure - Consolidated Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquity</Role>
      <ShortName>Consolidated Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>1019 - Disclosure - Debt, Cash and Cash Equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalents</Role>
      <ShortName>Debt, Cash and Cash Equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>1020 - Disclosure - Derivative Financial Instruments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DerivativeFinancialInstruments</Role>
      <ShortName>Derivative Financial Instruments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>1021 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities</Role>
      <ShortName>Non-Current Provisions And Other Non-Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>1022 - Disclosure - Off Balance Sheet Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OffBalanceSheetCommitments</Role>
      <ShortName>Off Balance Sheet Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>1023 - Disclosure - Litigation and Arbitration Proceedings</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LitigationAndArbitrationProceedings</Role>
      <ShortName>Litigation and Arbitration Proceedings</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>1024 - Disclosure - Other Operating Income And Expenses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses</Role>
      <ShortName>Other Operating Income And Expenses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>1025 - Disclosure - Restructuring Costs and Similar Items</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems</Role>
      <ShortName>Restructuring Costs and Similar Items</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>1026 - Disclosure - Other Gains and Losses, and Litigation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation</Role>
      <ShortName>Other Gains and Losses, and Litigation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>1027 - Disclosure - Financial Expenses and Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/FinancialExpensesAndIncome</Role>
      <ShortName>Financial Expenses and Income</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>1028 - Disclosure - Income Tax Expense</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/IncomeTaxExpense</Role>
      <ShortName>Income Tax Expense</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>1029 - Disclosure - Segment Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformation</Role>
      <ShortName>Segment Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>1030 - Disclosure - Revenue from Contracts with Customers</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RevenueFromContractsWithCustomers</Role>
      <ShortName>Revenue from Contracts with Customers</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>1031 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations</Role>
      <ShortName>Information related to Opella, presented within assets held for sale and discontinued operations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>1032 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</Role>
      <ShortName>Liabilities Related to Business Combinations and to Non-Controlling Interests</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>1033 - Disclosure - Events Subsequent to June 30, 2025</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/EventsSubsequentToJune302025</Role>
      <ShortName>Events Subsequent to June 30, 2025</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>1034 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies</Role>
      <ShortName>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>1035 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables</Role>
      <ShortName>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>1036 - Disclosure - Property, Plant and Equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables</Role>
      <ShortName>Property, Plant and Equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/PropertyPlantAndEquipment</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>1037 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>1038 - Disclosure - Investments Accounted for Using the Equity Method (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables</Role>
      <ShortName>Investments Accounted for Using the Equity Method (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>1039 - Disclosure - Other Non-Current Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherNonCurrentAssetsTables</Role>
      <ShortName>Other Non-Current Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/OtherNonCurrentAssets</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>1040 - Disclosure - Accounts Receivable (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/AccountsReceivableTables</Role>
      <ShortName>Accounts Receivable (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/AccountsReceivable</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>1041 - Disclosure - Consolidated Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables</Role>
      <ShortName>Consolidated Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/ConsolidatedShareholdersEquity</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>1042 - Disclosure - Debt, Cash and Cash Equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables</Role>
      <ShortName>Debt, Cash and Cash Equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/DebtCashAndCashEquivalents</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>1043 - Disclosure - Derivative Financial Instruments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables</Role>
      <ShortName>Derivative Financial Instruments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/DerivativeFinancialInstruments</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>1044 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables</Role>
      <ShortName>Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>1045 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables</Role>
      <ShortName>Non-Current Provisions And Other Non-Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>1046 - Disclosure - Other Operating Income And Expenses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables</Role>
      <ShortName>Other Operating Income And Expenses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>1047 - Disclosure - Restructuring Costs and Similar Items (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables</Role>
      <ShortName>Restructuring Costs and Similar Items (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>1048 - Disclosure - Financial Expenses and Income (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables</Role>
      <ShortName>Financial Expenses and Income (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/FinancialExpensesAndIncome</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>1049 - Disclosure - Income Tax Expense (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/IncomeTaxExpenseTables</Role>
      <ShortName>Income Tax Expense (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/IncomeTaxExpense</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>1050 - Disclosure - Revenue from Contracts with Customers (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables</Role>
      <ShortName>Revenue from Contracts with Customers (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/RevenueFromContractsWithCustomers</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>1051 - Disclosure - Segment Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationTables</Role>
      <ShortName>Segment Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/SegmentInformation</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>1052 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables</Role>
      <ShortName>Information related to Opella, presented within assets held for sale and discontinued operations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>1053 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails</Role>
      <ShortName>Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>1054 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails</Role>
      <ShortName>Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>1055 - Disclosure - Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails</Role>
      <ShortName>Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>1056 - Disclosure - Property, Plant and Equipment - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails</Role>
      <ShortName>Property, Plant and Equipment - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>1057 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>1058 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>1059 - Disclosure - Impairment of Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails</Role>
      <ShortName>Impairment of Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>1060 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails</Role>
      <ShortName>Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>1061 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails</Role>
      <ShortName>Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>1062 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails</Role>
      <ShortName>Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>1063 - Disclosure - Other Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails</Role>
      <ShortName>Other Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/OtherNonCurrentAssetsTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>1064 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails</Role>
      <ShortName>Accounts Receivable - Summary of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>1065 - Disclosure - Accounts Receivable - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails</Role>
      <ShortName>Accounts Receivable - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>1066 - Disclosure - Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails</Role>
      <ShortName>Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>1067 - Disclosure - Consolidated Shareholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>1068 - Disclosure - Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>1069 - Disclosure - Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>1070 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>1071 - Disclosure - Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>1072 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>1073 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails</Role>
      <ShortName>Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>1074 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails</Role>
      <ShortName>Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>1075 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails</Role>
      <ShortName>Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>1076 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails</Role>
      <ShortName>Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>1077 - Disclosure - Debt, Cash and Cash Equivalents - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails</Role>
      <ShortName>Debt, Cash and Cash Equivalents - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>1078 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails</Role>
      <ShortName>Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>1079 - Disclosure - Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>1080 - Disclosure - Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails</Role>
      <ShortName>Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>1081 - Disclosure - Derivative Financial Instruments - Disclosure of Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails</Role>
      <ShortName>Derivative Financial Instruments - Disclosure of Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>1082 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails</Role>
      <ShortName>Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>1083 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails</Role>
      <ShortName>Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>1084 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails</Role>
      <ShortName>Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>1085 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails</Role>
      <ShortName>Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>1086 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails</Role>
      <ShortName>Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>1087 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails</Role>
      <ShortName>Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>87</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>1088 - Disclosure - Off Balance Sheet Commitments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails</Role>
      <ShortName>Off Balance Sheet Commitments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>1089 - Disclosure - Litigation and Arbitration Proceedings (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails</Role>
      <ShortName>Litigation and Arbitration Proceedings (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/LitigationAndArbitrationProceedings</ParentRole>
      <Position>89</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>1090 - Disclosure - Other Operating Income And Expenses - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails</Role>
      <ShortName>Other Operating Income And Expenses - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>1091 - Disclosure - Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails</Role>
      <ShortName>Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>1092 - Disclosure - Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails</Role>
      <ShortName>Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>1093 - Disclosure - Restructuring Costs and Similar Items - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails</Role>
      <ShortName>Restructuring Costs and Similar Items - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>1094 - Disclosure - Other Gains and Losses, and Litigation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails</Role>
      <ShortName>Other Gains and Losses, and Litigation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation</ParentRole>
      <Position>94</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>1095 - Disclosure - Financial Expenses and Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails</Role>
      <ShortName>Financial Expenses and Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables</ParentRole>
      <Position>95</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>1096 - Disclosure - Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails</Role>
      <ShortName>Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>96</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>1097 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails</Role>
      <ShortName>Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>1098 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails</Role>
      <ShortName>Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>1099 - Disclosure - Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails</Role>
      <ShortName>Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>1100 - Disclosure - Revenue from Contracts with Customers (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails</Role>
      <ShortName>Revenue from Contracts with Customers (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables</ParentRole>
      <Position>100</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>1101 - Disclosure - Segment Information - Schedule of Segment Results (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails</Role>
      <ShortName>Segment Information - Schedule of Segment Results (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>101</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>1102 - Disclosure - Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails</Role>
      <ShortName>Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>1103 - Disclosure - Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails</Role>
      <ShortName>Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>1104 - Disclosure - Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails</Role>
      <ShortName>Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>1105 - Disclosure - Segment Information - Principal Customers and Credit Risk (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails</Role>
      <ShortName>Segment Information - Principal Customers and Credit Risk (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>1106 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails</Role>
      <ShortName>Information related to Opella, presented within assets held for sale and discontinued operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables</ParentRole>
      <Position>106</Position>
    </Report>
    <Report instance="d69958d6k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>1107 - Disclosure - Events Subsequent to June 30, 2025 (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.Sanofi.com/role/EventsSubsequentToJune302025Details</Role>
      <ShortName>Events Subsequent to June 30, 2025 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.Sanofi.com/role/EventsSubsequentToJune302025</ParentRole>
      <Position>107</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="6-K" isDefinitelyFs="true" isIfrs="true" original="d69958d6k.htm">d69958d6k.htm</File>
    <File doctype="6-K" isDefinitelyFs="true" isIfrs="true" original="d69958dex991.htm">d69958dex991.htm</File>
    <File>sny-20250630.xsd</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="8">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="1046">https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>123
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d69958d6k.htm d69958dex991.htm": {
   "nsprefix": "sny",
   "nsuri": "http://www.Sanofi.com/20250630",
   "dts": {
    "inline": {
     "local": [
      "d69958d6k.htm",
      "d69958dex991.htm"
     ]
    },
    "schema": {
     "local": [
      "sny-20250630.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/2023/calculation-1.1.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-roles-2025.xsd",
      "https://xbrl.fasb.org/srt/2025/elts/srt-types-2025.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/rol_ifrs_ea-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/rol_full_ifrs-dim_2025-03-27.xsd",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/full_ifrs-cor_2025-03-27.xsd",
      "https://xbrl.sec.gov/country/2025/country-2025.xsd",
      "https://xbrl.sec.gov/currency/2025/currency-2025.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/exch/2025/exch-2025.xsd",
      "https://xbrl.sec.gov/naics/2025/naics-2025.xsd",
      "https://xbrl.sec.gov/sic/2025/sic-2025.xsd",
      "https://xbrl.sec.gov/stpr/2025/stpr-2025.xsd"
     ]
    },
    "definitionLink": {
     "remote": [
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions-ea/dim_ifrs_ea_2025-03-27_role-995000.xml",
      "https://xbrl.ifrs.org/taxonomy/2025-03-27/full_ifrs/dimensions/dim_full_ifrs_2025-03-27_role-995000.xml"
     ]
    }
   },
   "keyStandard": 231,
   "keyCustom": 204,
   "axisStandard": 38,
   "axisCustom": 7,
   "memberStandard": 53,
   "memberCustom": 134,
   "hidden": {
    "total": 5,
    "http://xbrl.sec.gov/dei/2025": 5
   },
   "contextCount": 624,
   "entityCount": 1,
   "segmentCount": 194,
   "elementCount": 841,
   "unitCount": 9,
   "baseTaxonomies": {
    "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full": 1046,
    "http://xbrl.sec.gov/dei/2025": 8
   },
   "report": {
    "R1": {
     "role": "http://www.Sanofi.com/role/CoverPage",
     "longName": "1001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958d6k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958d6k.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
     "longName": "1002 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "2",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:RightofuseAssets",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
     "longName": "1003 - Statement - Consolidated Income Statements",
     "shortName": "Consolidated Income Statements",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:GrossProfit",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome",
     "longName": "1004 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ProfitLoss",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
     "longName": "1005 - Statement - Consolidated Statements of Changes in Equity",
     "shortName": "Consolidated Statements of Changes in Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2023",
      "name": "ifrs-full:Equity",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2023",
      "name": "ifrs-full:Equity",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical",
     "longName": "1006 - Statement - Consolidated Statements of Changes in Equity (Parenthetical)",
     "shortName": "Consolidated Statements of Changes in Equity (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "unitRef": "Unit_EUR_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DividendsPaidOrdinarySharesPerShare",
      "unitRef": "Unit_EUR_per_Share",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
     "longName": "1007 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
     "longName": "1008 - Statement - Consolidated Statements of Cash Flows (Parenthetical)",
     "shortName": "Consolidated Statements of Cash Flows (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.Sanofi.com/role/Introduction",
     "longName": "1009 - Disclosure - Introduction",
     "shortName": "Introduction",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies",
     "longName": "1010 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies",
     "shortName": "Basis of Preparation of the Half-Year Financial Statements and Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements",
     "longName": "1011 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements",
     "shortName": "Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.Sanofi.com/role/PropertyPlantAndEquipment",
     "longName": "1012 - Disclosure - Property, Plant and Equipment",
     "shortName": "Property, Plant and Equipment",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets",
     "longName": "1013 - Disclosure - Goodwill and Other Intangible Assets",
     "shortName": "Goodwill and Other Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets",
     "longName": "1014 - Disclosure - Impairment of Intangible Assets",
     "shortName": "Impairment of Intangible Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod",
     "longName": "1015 - Disclosure - Investments Accounted for Using the Equity Method",
     "shortName": "Investments Accounted for Using the Equity Method",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.Sanofi.com/role/OtherNonCurrentAssets",
     "longName": "1016 - Disclosure - Other Non-Current Assets",
     "shortName": "Other Non-Current Assets",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.Sanofi.com/role/AccountsReceivable",
     "longName": "1017 - Disclosure - Accounts Receivable",
     "shortName": "Accounts Receivable",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfTradeReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfTradeReceivablesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquity",
     "longName": "1018 - Disclosure - Consolidated Shareholders' Equity",
     "shortName": "Consolidated Shareholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalents",
     "longName": "1019 - Disclosure - Debt, Cash and Cash Equivalents",
     "shortName": "Debt, Cash and Cash Equivalents",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://www.Sanofi.com/role/DerivativeFinancialInstruments",
     "longName": "1020 - Disclosure - Derivative Financial Instruments",
     "shortName": "Derivative Financial Instruments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities",
     "longName": "1021 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities",
     "shortName": "Non-Current Provisions And Other Non-Current Liabilities",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://www.Sanofi.com/role/OffBalanceSheetCommitments",
     "longName": "1022 - Disclosure - Off Balance Sheet Commitments",
     "shortName": "Off Balance Sheet Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://www.Sanofi.com/role/LitigationAndArbitrationProceedings",
     "longName": "1023 - Disclosure - Litigation and Arbitration Proceedings",
     "shortName": "Litigation and Arbitration Proceedings",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses",
     "longName": "1024 - Disclosure - Other Operating Income And Expenses",
     "shortName": "Other Operating Income And Expenses",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems",
     "longName": "1025 - Disclosure - Restructuring Costs and Similar Items",
     "shortName": "Restructuring Costs and Similar Items",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "25",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfRestructuringTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfRestructuringTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation",
     "longName": "1026 - Disclosure - Other Gains and Losses, and Litigation",
     "shortName": "Other Gains and Losses, and Litigation",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "26",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.Sanofi.com/role/FinancialExpensesAndIncome",
     "longName": "1027 - Disclosure - Financial Expenses and Income",
     "shortName": "Financial Expenses and Income",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "27",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.Sanofi.com/role/IncomeTaxExpense",
     "longName": "1028 - Disclosure - Income Tax Expense",
     "shortName": "Income Tax Expense",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "28",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.Sanofi.com/role/SegmentInformation",
     "longName": "1029 - Disclosure - Segment Information",
     "shortName": "Segment Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "29",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.Sanofi.com/role/RevenueFromContractsWithCustomers",
     "longName": "1030 - Disclosure - Revenue from Contracts with Customers",
     "shortName": "Revenue from Contracts with Customers",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "30",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations",
     "longName": "1031 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations",
     "shortName": "Information related to Opella, presented within assets held for sale and discontinued operations",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "31",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
     "longName": "1032 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests",
     "shortName": "Liabilities Related to Business Combinations and to Non-Controlling Interests",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "32",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.Sanofi.com/role/EventsSubsequentToJune302025",
     "longName": "1033 - Disclosure - Events Subsequent to June 30, 2025",
     "shortName": "Events Subsequent to June 30, 2025",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "33",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies",
     "longName": "1034 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)",
     "shortName": "Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "34",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:StatementOfIFRSCompliance",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:StatementOfIFRSCompliance",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables",
     "longName": "1035 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)",
     "shortName": "Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables",
     "longName": "1036 - Disclosure - Property, Plant and Equipment (Tables)",
     "shortName": "Property, Plant and Equipment (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables",
     "longName": "1037 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "37",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables",
     "longName": "1038 - Disclosure - Investments Accounted for Using the Equity Method (Tables)",
     "shortName": "Investments Accounted for Using the Equity Method (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "38",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.Sanofi.com/role/OtherNonCurrentAssetsTables",
     "longName": "1039 - Disclosure - Other Non-Current Assets (Tables)",
     "shortName": "Other Non-Current Assets (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "39",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.Sanofi.com/role/AccountsReceivableTables",
     "longName": "1040 - Disclosure - Accounts Receivable (Tables)",
     "shortName": "Accounts Receivable (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "40",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables",
     "longName": "1041 - Disclosure - Consolidated Shareholders' Equity (Tables)",
     "shortName": "Consolidated Shareholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "41",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables",
     "longName": "1042 - Disclosure - Debt, Cash and Cash Equivalents (Tables)",
     "shortName": "Debt, Cash and Cash Equivalents (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "42",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables",
     "longName": "1043 - Disclosure - Derivative Financial Instruments (Tables)",
     "shortName": "Derivative Financial Instruments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "43",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables",
     "longName": "1044 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)",
     "shortName": "Liabilities Related to Business Combinations and to Non-Controlling Interests (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "44",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables",
     "longName": "1045 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities (Tables)",
     "shortName": "Non-Current Provisions And Other Non-Current Liabilities (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "45",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables",
     "longName": "1046 - Disclosure - Other Operating Income And Expenses (Tables)",
     "shortName": "Other Operating Income And Expenses (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "46",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:OtherOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:OtherOperatingExpensesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables",
     "longName": "1047 - Disclosure - Restructuring Costs and Similar Items (Tables)",
     "shortName": "Restructuring Costs and Similar Items (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "47",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables",
     "longName": "1048 - Disclosure - Financial Expenses and Income (Tables)",
     "shortName": "Financial Expenses and Income (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "48",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.Sanofi.com/role/IncomeTaxExpenseTables",
     "longName": "1049 - Disclosure - Income Tax Expense (Tables)",
     "shortName": "Income Tax Expense (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "49",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables",
     "longName": "1050 - Disclosure - Revenue from Contracts with Customers (Tables)",
     "shortName": "Revenue from Contracts with Customers (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "50",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.Sanofi.com/role/SegmentInformationTables",
     "longName": "1051 - Disclosure - Segment Information (Tables)",
     "shortName": "Segment Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "51",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables",
     "longName": "1052 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Tables)",
     "shortName": "Information related to Opella, presented within assets held for sale and discontinued operations (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "52",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails",
     "longName": "1053 - Disclosure - Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)",
     "shortName": "Basis of Preparation of the Half-Year Financial Statements and Accounting Policies (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis",
      "name": "sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis",
      "name": "sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
     "longName": "1054 - Disclosure - Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)",
     "shortName": "Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements - Principal Changes in Scope of Consolidation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis",
      "name": "sny:NetCashInflowFromDiscontinuedOperations",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-8",
      "ancestors": [
       "div",
       "sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails",
     "longName": "1055 - Disclosure - Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)",
     "shortName": "Property, Plant and Equipment - Summary of Acquisitions and Capitalized Interest by Operating Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails",
     "longName": "1056 - Disclosure - Property, Plant and Equipment - Additional Information (Details)",
     "shortName": "Property, Plant and Equipment - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:FirmOrdersOfPropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:FirmOrdersOfPropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
     "longName": "1057 - Disclosure - Goodwill and Other Intangible Assets - Additional Information (Details)",
     "shortName": "Goodwill and Other Intangible Assets - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:Goodwill",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-8",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
     "longName": "1058 - Disclosure - Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details)",
     "shortName": "Goodwill and Other Intangible Assets - Schedule of Movements in Other Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:IntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:OtherIntangibleAssets",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails",
     "longName": "1059 - Disclosure - Impairment of Intangible Assets (Details)",
     "shortName": "Impairment of Intangible Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R60": {
     "role": "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
     "longName": "1060 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details)",
     "shortName": "Investments Accounted for Using the Equity Method - Summary of Investments in Associates and Joint Ventures (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P05_01_2025To06_30_2025",
      "name": "ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails",
     "longName": "1061 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details)",
     "shortName": "Investments Accounted for Using the Equity Method - Summary of Principal Transactions and Balances with Related Parties (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OtherAssetsRelatedPartyTransactions",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OtherAssetsRelatedPartyTransactions",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
     "longName": "1062 - Disclosure - Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details)",
     "shortName": "Investments Accounted for Using the Equity Method - Summary of Key Items Which Have Not Been Audited (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "name": "sny:NetSalesAndOtherRevenuesRelatedPartyDisclosures",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "name": "sny:NetSalesAndOtherRevenuesRelatedPartyDisclosures",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails",
     "longName": "1063 - Disclosure - Other Non-Current Assets (Details)",
     "shortName": "Other Non-Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails",
     "longName": "1064 - Disclosure - Accounts Receivable - Summary of Accounts Receivable (Details)",
     "shortName": "Accounts Receivable - Summary of Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
      "name": "ifrs-full:CurrentTradeReceivables",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfCurrentTradeReceivablesTableTextBlock",
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails",
     "longName": "1065 - Disclosure - Accounts Receivable - Additional Information (Details)",
     "shortName": "Accounts Receivable - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails",
     "longName": "1066 - Disclosure - Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details)",
     "shortName": "Accounts Receivable - Summary of Gross Value of Overdue Receivables (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OverdueReceivablesGrossValue",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:OverdueReceivablesGrossValue",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
       "sny:DisclosureOfTradeReceivablesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
     "longName": "1067 - Disclosure - Consolidated Shareholders' Equity - Additional Information (Details)",
     "shortName": "Consolidated Shareholders' Equity - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:IssuedCapital",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "0",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails",
     "longName": "1068 - Disclosure - Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Treasury Shares Held (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:NumberOfSharesHeld",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:NumberOfSharesHeld",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-4",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails",
     "longName": "1069 - Disclosure - Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Principal Characteristics of Restricted Share Plans (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "name": "sny:NumberOfYearsServicePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "name": "sny:NumberOfYearsServicePeriod",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
     "longName": "1070 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Number of Restricted Shares Not Yet Fully Vested (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis",
      "name": "ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails",
     "longName": "1071 - Disclosure - Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Options Outstanding and Exercisable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis",
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails",
     "longName": "1072 - Disclosure - Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Number of Shares Used to Compute Diluted Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:WeightedAverageShares",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "INF",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
      "unitRef": "Unit_shares",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-5",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
     "longName": "1073 - Disclosure - Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details)",
     "shortName": "Consolidated Shareholders' Equity - Summary of Movements within Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis",
      "name": "sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
     "longName": "1074 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details)",
     "shortName": "Debt, Cash and Cash Equivalents - Summary of Changes in Financial Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:LongtermBorrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R75": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails",
     "longName": "1075 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)",
     "shortName": "Debt, Cash and Cash Equivalents - Summary of Reconciliation of Carrying Amount to Value on Redemption (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:LongtermBorrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis",
      "name": "ifrs-full:LongtermBorrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
     "longName": "1076 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details)",
     "shortName": "Debt, Cash and Cash Equivalents - Summary of Net Debt by Type Valuation of Redemption (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:InterestRateAndCurrencyDerivativesUsedToManageDebt",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
       "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis",
      "name": "ifrs-full:BondsIssued",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
     "longName": "1077 - Disclosure - Debt, Cash and Cash Equivalents - Additional Information (Details)",
     "shortName": "Debt, Cash and Cash Equivalents - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis",
      "name": "ifrs-full:CommercialPapersIssued",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-9",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis",
      "name": "ifrs-full:CommercialPapersIssued",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-9",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails",
     "longName": "1078 - Disclosure - Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details)",
     "shortName": "Debt, Cash and Cash Equivalents - Summary of Market Value of Net Debt (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:Borrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfChangesInFinancialPositionTableTextBlock",
       "sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_AtMarketValueMemberifrsfullMeasurementAxis",
      "name": "ifrs-full:Borrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfMarketValueOfNetDebtTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails",
     "longName": "1079 - Disclosure - Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)",
     "shortName": "Derivative Financial Instruments - Summary of Operating Currency Hedging Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis",
      "name": "sny:DerivativeFinancialInstruments",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis",
      "name": "sny:DerivativeFinancialInstruments",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
       "ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
     "longName": "1080 - Disclosure - Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)",
     "shortName": "Derivative Financial Instruments - Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis",
      "name": "ifrs-full:NotionalAmount",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
     "longName": "1081 - Disclosure - Derivative Financial Instruments - Disclosure of Instruments (Details)",
     "shortName": "Derivative Financial Instruments - Disclosure of Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis",
      "name": "sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis",
      "name": "sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails",
     "longName": "1082 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)",
     "shortName": "Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2024",
      "name": "ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails",
     "longName": "1083 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details)",
     "shortName": "Liabilities Related to Business Combinations and to Non-Controlling Interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Paranthetical) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R84": {
     "role": "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
     "longName": "1084 - Disclosure - Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details)",
     "shortName": "Liabilities Related to Business Combinations and to Non-Controlling Interests - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis",
      "name": "sny:PercentageIncreaseInFairValueLiabilities",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails",
     "longName": "1085 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details)",
     "shortName": "Non-Current Provisions And Other Non-Current Liabilities - Summary of Non-Current Provisions and Other Non-Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:NoncurrentProvisions",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:OtherNoncurrentLiabilities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
     "longName": "1086 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)",
     "shortName": "Non-Current Provisions And Other Non-Current Liabilities - Summary of Movements in Non-Current Provisions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2024",
      "name": "ifrs-full:NoncurrentProvisions",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ChangesInOtherProvisions",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfNonCurrentProvisionsTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
     "longName": "1087 - Disclosure - Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details)",
     "shortName": "Non-Current Provisions And Other Non-Current Liabilities - Disclosure of Remeasurement of Net Defined Benefit Liability Asset (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis",
      "name": "ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis",
      "name": "ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "4",
      "ancestors": [
       "div",
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock",
       "sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R88": {
     "role": "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails",
     "longName": "1088 - Disclosure - Off Balance Sheet Commitments - Additional Information (Details)",
     "shortName": "Off Balance Sheet Commitments - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "88",
     "firstAnchor": {
      "contextRef": "PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "name": "ifrs-full:Prepayments",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "name": "ifrs-full:Prepayments",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R89": {
     "role": "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails",
     "longName": "1089 - Disclosure - Litigation and Arbitration Proceedings (Details)",
     "shortName": "Litigation and Arbitration Proceedings (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "89",
     "firstAnchor": {
      "contextRef": "P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis",
      "name": "sny:PaymentOfDamagesClaimedByCounterparty",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis",
      "name": "sny:PaymentOfDamagesClaimedByCounterparty",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfLegalAndArbitralProceedingsTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R90": {
     "role": "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
     "longName": "1090 - Disclosure - Other Operating Income And Expenses - Additional Information (Details)",
     "shortName": "Other Operating Income And Expenses - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "90",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:MiscellaneousOtherOperatingIncome",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis",
      "name": "ifrs-full:MiscellaneousOtherOperatingIncome",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R91": {
     "role": "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails",
     "longName": "1091 - Disclosure - Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details)",
     "shortName": "Other Operating Income And Expenses - Schedule of Other Operating Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "91",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:MiscellaneousOtherOperatingExpense",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:OtherOperatingIncomeExpense",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:OtherOperatingExpensesTableTextBlock",
       "ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R92": {
     "role": "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails",
     "longName": "1092 - Disclosure - Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details)",
     "shortName": "Restructuring Costs and Similar Items - Summary of Restructuring Costs and Similar Items (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "92",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfRestructuringCostsDetailsTableTextBlock",
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R93": {
     "role": "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails",
     "longName": "1093 - Disclosure - Restructuring Costs and Similar Items - Additional Information (Details)",
     "shortName": "Restructuring Costs and Similar Items - Additional Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "93",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "sny:DisclosureOfRestructuringTextBlock",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R94": {
     "role": "http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails",
     "longName": "1094 - Disclosure - Other Gains and Losses, and Litigation (Details)",
     "shortName": "Other Gains and Losses, and Litigation (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "94",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:OtherGainsLossesAndLitigation",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R95": {
     "role": "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails",
     "longName": "1095 - Disclosure - Financial Expenses and Income (Details)",
     "shortName": "Financial Expenses and Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "95",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:InterestExpenseOnBorrowings",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R96": {
     "role": "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails",
     "longName": "1096 - Disclosure - Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)",
     "shortName": "Income Tax Expense - Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "96",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:CurrentTaxExpenseIncome",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R97": {
     "role": "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails",
     "longName": "1097 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)",
     "shortName": "Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "97",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ApplicableTaxRate",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "3",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R98": {
     "role": "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails",
     "longName": "1098 - Disclosure - Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details)",
     "shortName": "Income Tax Expense - Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate (Parenthetical) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "parenthetical",
     "menuCat": "Details",
     "order": "98",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:CurrentTaxExpenseRelatedToPillarTwo",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "sny:CurrentTaxExpenseRelatedToPillarTwo",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R99": {
     "role": "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
     "longName": "1099 - Disclosure - Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details)",
     "shortName": "Revenue from Contracts with Customers - Summary of Net Sales by Segment and Geographical Area (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "99",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R100": {
     "role": "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
     "longName": "1100 - Disclosure - Revenue from Contracts with Customers (Details)",
     "shortName": "Revenue from Contracts with Customers (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "100",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:OtherRevenue",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis",
      "name": "sny:RevenueFromVaxServeSalesOfNonSanofiProducts",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOtherRevenueTextBlock",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R101": {
     "role": "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails",
     "longName": "1101 - Disclosure - Segment Information - Schedule of Segment Results (Details)",
     "shortName": "Segment Information - Schedule of Segment Results (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "101",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis",
      "name": "ifrs-full:CostOfSales",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R102": {
     "role": "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
     "longName": "1102 - Disclosure - Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)",
     "shortName": "Segment Information - Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "102",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:ProfitLossAttributableToNoncontrollingInterests",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis",
      "name": "sny:ImpairmentLossOnIntangibleAssetOtherThanGoodwill",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R103": {
     "role": "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
     "longName": "1103 - Disclosure - Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)",
     "shortName": "Segment Information - Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "103",
     "firstAnchor": {
      "contextRef": "PAsOn06_30_2025",
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis",
      "name": "ifrs-full:InvestmentAccountedForUsingEquityMethod",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R104": {
     "role": "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails",
     "longName": "1104 - Disclosure - Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)",
     "shortName": "Segment Information - Summary of Geographical Information on Net Sales and Non-Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "104",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025",
      "name": "ifrs-full:RevenueFromSaleOfGoods",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis",
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfGeographicalAreasExplanatory",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "unique": true
     }
    },
    "R105": {
     "role": "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails",
     "longName": "1105 - Disclosure - Segment Information - Principal Customers and Credit Risk (Details)",
     "shortName": "Segment Information - Principal Customers and Credit Risk (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "105",
     "firstAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis",
      "name": "ifrs-full:PercentageOfEntitysRevenue",
      "unitRef": "Unit_pure",
      "xsiNil": "false",
      "lang": null,
      "decimals": "2",
      "ancestors": [
       "div",
       "ix:continuation",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R106": {
     "role": "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails",
     "longName": "1106 - Disclosure - Information related to Opella, presented within assets held for sale and discontinued operations (Details)",
     "shortName": "Information related to Opella, presented within assets held for sale and discontinued operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "106",
     "firstAnchor": {
      "contextRef": "PAsOn12_31_2024",
      "name": "sny:PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "PAsOn12_31_2024",
      "name": "sny:PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations",
      "unitRef": "Unit_EUR",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-6",
      "ancestors": [
       "div",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    },
    "R107": {
     "role": "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
     "longName": "1107 - Disclosure - Events Subsequent to June 30, 2025 (Details)",
     "shortName": "Events Subsequent to June 30, 2025 (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "107",
     "firstAnchor": {
      "contextRef": "P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis",
      "name": "sny:UpfrontPayments",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-7",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis",
      "name": "sny:UpfrontPayments",
      "unitRef": "Unit_USD",
      "xsiNil": "false",
      "lang": null,
      "decimals": "-7",
      "ancestors": [
       "div",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d69958dex991.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "country_AR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "AR",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ARKANSAS",
        "terseLabel": "Argentina"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AccountsPayableDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AccountsPayableDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Payable, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Accounts payable",
        "documentation": "Accounts Payable, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivables, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Accounts receivable",
        "documentation": "Accounts Receivables, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AccumulatedDepreciationAmortisationAndImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedDepreciationAmortisationAndImpairmentMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated depreciation, amortisation and impairment [member]",
        "terseLabel": "Accumulated amortization and impairment"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r14",
      "r52",
      "r65",
      "r68",
      "r213",
      "r236",
      "r245",
      "r248"
     ]
    },
    "ifrs-full_AccumulatedImpairmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedImpairmentMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated impairment [member]",
        "terseLabel": "Allowances"
       }
      }
     },
     "auth_ref": [
      "r141",
      "r155",
      "r267",
      "r372",
      "r405",
      "r410",
      "r413",
      "r414"
     ]
    },
    "ifrs-full_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accumulated other comprehensive income [member]",
        "terseLabel": "Other comprehensive income",
        "verboseLabel": "Accumulated other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for accumulated other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "sny_AcquiredResearchAndDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AcquiredResearchAndDevelopmentMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquired Research And Development [Member]",
        "terseLabel": "Acquired R&amp;D",
        "documentation": "Acquired Research And Development"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "terseLabel": "Consideration transferred, acquisition-date fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r137",
      "r257"
     ]
    },
    "sny_ActionForWhichSanofiAreDefendantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ActionForWhichSanofiAreDefendantMember",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Action For Which Sanofi Are Defendant [Member]",
        "terseLabel": "Action For Which Sanofi Are Defendant",
        "documentation": "Action For Which Sanofi Are Defendant [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ActionForWhichWeAreDefendantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ActionForWhichWeAreDefendantMember",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Action For Which We Are Defendant [member]",
        "terseLabel": "Action for which we are defendant",
        "documentation": "Action for which we are defendant."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ActuarialAssumptionOfDiscountRatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfDiscountRatesMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of discount rates [member]",
        "terseLabel": "Actuarial assumption of discount rates"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the discount rates used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "ifrs-full_ActuarialAssumptionOfExpectedRatesOfInflationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionOfExpectedRatesOfInflationMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumption of expected rates of inflation [member]",
        "terseLabel": "Actuarial assumption of expected rates of inflation"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the expected rates of inflation used as actuarial assumptions. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r406"
     ]
    },
    "ifrs-full_ActuarialAssumptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [axis]",
        "terseLabel": "Actuarial assumptions [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_ActuarialAssumptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialAssumptionsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial assumptions [domain]",
        "terseLabel": "Actuarial assumptions [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all actuarial assumptions. Actuarial assumptions are the entity\u2019s unbiased and mutually compatible best estimates of the demographic and financial variables that will determine the ultimate cost of providing post-employment benefits. It also represents the standard value for the 'Actuarial assumptions' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "ifrs-full_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions",
        "negatedLabel": "Actuarial gains/(losses)"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from actuarial gains (losses) arising from changes in financial assumptions that result in remeasurements of the net defined benefit liability (asset). Financial assumptions deal with items such as: (a) the discount rate; (b) benefit levels, excluding any cost of the benefits to be met by employees, and future salary; (c) in the case of medical benefits, future medical costs, including claim handling costs (ie the costs that will be incurred in processing and resolving claims, including legal and adjuster's fees); and (d) taxes payable by the plan on contributions relating to service before the reporting date or on benefits resulting from that service. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r20"
     ]
    },
    "sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Associates And Joint Ventures",
        "terseLabel": "Actuarial gains/(losses) excluding investments accounted for using the equity method",
        "documentation": "Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset excluding associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes",
        "documentation": "Actuarial gains (losses) arising from changes in financial assumptions net defined benefit liability asset net of tax on associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdditionalPaidinCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionalPaidinCapitalMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [member]",
        "terseLabel": "Additional paid-in capital"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r428"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "terseLabel": "Acquisitions and other increases"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r53",
      "r237"
     ]
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "verboseLabel": "Additions other than through business combinations, property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Total for all business combinations [member]; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r11",
      "r214"
     ]
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustedWeightedAverageShares",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating diluted earnings per share",
        "verboseLabel": "Average number of shares after dilution (in shares)",
        "totalLabel": "Average number of shares used to compute diluted earnings per share",
        "definitionGuidance": "Average number of shares after dilution"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "sny_AdjustmentToDebtMeasuredAtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AdjustmentToDebtMeasuredAtFairValueMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To Debt Measured At Fair Value [Member]",
        "terseLabel": "Adjustment to debt measured at fair value",
        "documentation": "Adjustment to debt measured at fair value."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "terseLabel": "(Increase)/decrease in inventories"
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "terseLabel": "(Increase)/decrease in accounts receivable"
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ifrs-full_AdjustmentsForDeferredTaxExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForDeferredTaxExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for deferred tax expense",
        "terseLabel": "Net change in deferred taxes"
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "sny_AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments For Depreciation And Amortisation Expense And Impairment Loss Reversal Of Impairment Loss Of Property Plant And Equipment Right-Of Use Assets And Intangible Asset",
        "terseLabel": "Depreciation, amortization and impairment of property, plant and equipment, right-of-use assets and intangible assets",
        "documentation": "Depreciation, amortization and impairment of property, plant and equipment, right-of use assets and intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "terseLabel": "Increase/(decrease) in accounts payable"
       }
      }
     },
     "auth_ref": [
      "r418"
     ]
    },
    "ifrs-full_AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for losses (gains) on disposal of non-current assets",
        "terseLabel": "Gains and losses on disposals of non-current assets, net of tax"
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "sny_AdjustmentsForLossesGainsOnTransferOfBusiness": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AdjustmentsForLossesGainsOnTransferOfBusiness",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for losses (gains) on transfer of business",
        "terseLabel": "Net (income)/loss from the discontinued Opella business",
        "documentation": "Adjustments for losses (gains) on transfer of business"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments For Non-Current Provisions And Other Non-Current Liabilities",
        "terseLabel": "Net change in non-current provisions and other non-current liabilities",
        "documentation": "Adjustments for noncurrent provisions and other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss) [abstract]",
        "terseLabel": "Adjustments to reconcile profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForSharebasedPayments",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for share-based payments",
        "terseLabel": "Cost of employee benefits (stock options and other share-based payments)"
       }
      }
     },
     "auth_ref": [
      "r419"
     ]
    },
    "ifrs-full_AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments for undistributed profits of investments accounted for using equity method",
        "negatedLabel": "Share of undistributed earnings from investments accounted for using the equity method"
       }
      }
     },
     "auth_ref": [
      "r420"
     ]
    },
    "ifrs-full_AggregatedIndividuallyImmaterialAssociatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AggregatedIndividuallyImmaterialAssociatesMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregated individually immaterial associates [member]",
        "terseLabel": "Other investments"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the aggregation of associates that are individually immaterial. [Refer: Total for all associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "ifrs-full_AllOtherSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AllOtherSegmentsMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All other segments [member]",
        "verboseLabel": "Other"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for business activities and operating segments that are not reportable."
       }
      }
     },
     "auth_ref": [
      "r114",
      "r165",
      "r182"
     ]
    },
    "sny_AltuviiioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AltuviiioMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Altuviiio [Member]",
        "terseLabel": "Altuviiio",
        "documentation": "Altuviiio"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortisation, intangible assets other than goodwill",
        "negatedLabel": "Amortization of intangible assets",
        "negatedTerseLabel": "Amortization expense"
       }
      }
     },
     "auth_ref": [
      "r56",
      "r240"
     ]
    },
    "sny_AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortization And Impairment Of Intangible Assets Other Than Goodwill",
        "negatedLabel": "Amortization and impairment of intangible assets",
        "documentation": "Amortization and impairment of intangible assets other than goodwill."
       }
      }
     },
     "auth_ref": []
    },
    "sny_AmortizedCostNettingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AmortizedCostNettingMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amortized Cost, Netting [Member]",
        "terseLabel": "Amortized cost",
        "documentation": "Amortized cost."
       }
      }
     },
     "auth_ref": []
    },
    "sny_AmountOfSharesRepurchased": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AmountOfSharesRepurchased",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount Of Shares Repurchased",
        "terseLabel": "Amount of shares repurchased",
        "documentation": "Amount of shares repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmountsPayableRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "terseLabel": "Amounts payable, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r26",
      "r30",
      "r222"
     ]
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amounts receivable, related party transactions",
        "terseLabel": "Accounts receivable and other receivables"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r26",
      "r30",
      "r222"
     ]
    },
    "ifrs-full_AnalysisOfIncomeAndExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AnalysisOfIncomeAndExpenseAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Analysis of income and expense [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AntibodiesAllianceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AntibodiesAllianceMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antibodies Alliance [Member]",
        "terseLabel": "Monoclonal Antibodies Alliance",
        "documentation": "Antibodies Alliance [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AntibodiesCollaborationAgreementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AntibodiesCollaborationAgreementMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Antibodies Collaboration Agreement [Member]",
        "terseLabel": "Antibodies Collaboration Agreement",
        "documentation": "Antibodies Collaboration Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ApplicableTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ApplicableTaxRate",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails": {
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Applicable tax rate",
        "terseLabel": "Standard tax rate applicable in France"
       }
      },
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r209"
     ]
    },
    "ifrs-full_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      }
     },
     "auth_ref": [
      "r106",
      "r107",
      "r110",
      "r168",
      "r171",
      "r275",
      "r276",
      "r310"
     ]
    },
    "ifrs-full_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AssetsAcquisitionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssetsAcquisitionAxis",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Acquisition [Axis]",
        "terseLabel": "Assets Acquisition [Axis]",
        "documentation": "Assets Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AssetsAcquisitionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssetsAcquisitionDomain",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Acquisition [Domain]",
        "terseLabel": "Assets Acquisition [Domain]",
        "documentation": "Assets Acquisition [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AssetsAcquisitionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssetsAcquisitionMember",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Acquisition [Member]",
        "terseLabel": "Assets Acquisition",
        "documentation": "Assets Acquisition"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AssetsAndLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities [axis]",
        "terseLabel": "Assets and liabilities [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r205",
      "r221",
      "r283",
      "r295"
     ]
    },
    "ifrs-full_AssetsAndLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AssetsAndLiabilitiesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets and liabilities [domain]",
        "terseLabel": "Assets and liabilities [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for assets and liabilities. It also represents the standard value for the 'Assets and liabilities' axis if no other member is used. [Refer: Assets; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r25",
      "r205",
      "r221",
      "r283",
      "r295"
     ]
    },
    "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets Of Disposal Group Including Discontinued Operations",
        "totalLabel": "Total assets held for sale",
        "documentation": "Assets Of Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Related Party Transactions",
        "terseLabel": "Total assets",
        "documentation": "Assets, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_AssociatesAndJointVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AssociatesAndJointVenturesMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Associates And Joint Ventures [Member]",
        "terseLabel": "Associates and joint ventures",
        "documentation": "Associates and Joint Ventures."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AtFairValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AtFairValueMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At fair value [member]",
        "terseLabel": "Fair value"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for measurement based on fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r67",
      "r90",
      "r106",
      "r247",
      "r273",
      "r275"
     ]
    },
    "sny_AtMarketValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AtMarketValueMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At Market Value [member]",
        "terseLabel": "Market value",
        "documentation": "At market value."
       }
      }
     },
     "auth_ref": []
    },
    "sny_AtNotionalAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AtNotionalAmountMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "At Notional Amount [member]",
        "terseLabel": "Notional amount",
        "documentation": "At notional amount."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionAxis",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [axis]",
        "terseLabel": "Attribution of expenses by nature to their function [axis]"
       }
      }
     },
     "auth_ref": [
      "r426",
      "r429"
     ]
    },
    "ifrs-full_AttributionOfExpensesByNatureToTheirFunctionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AttributionOfExpensesByNatureToTheirFunctionDomain",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Attribution of expenses by nature to their function [domain]",
        "terseLabel": "Attribution of expenses by nature to their function [domain]"
       }
      }
     },
     "auth_ref": [
      "r426",
      "r429"
     ]
    },
    "sny_AubagioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "AubagioMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aubagio [Member]",
        "terseLabel": "Aubagio",
        "documentation": "Aubagio."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_AverageEffectiveTaxRate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "AverageEffectiveTaxRate",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Average effective tax rate",
        "totalLabel": "Effective tax rate"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax expense (income) divided by the accounting profit. [Refer: Accounting profit]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r209"
     ]
    },
    "ifrs-full_BankOverdraftsClassifiedAsCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BankOverdraftsClassifiedAsCashEquivalents",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank overdrafts",
        "terseLabel": "Bank credit balances"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount that has been withdrawn from an account in excess of existing cash balances. This is considered a short-term extension of credit by the bank. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r421"
     ]
    },
    "sny_BasicEarningsLossPerShareAttributableToOwnersOfParent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BasicEarningsLossPerShareAttributableToOwnersOfParent",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "verboseLabel": "Basic earnings per share (in euros per share)",
        "documentation": "Basic Earnings (Loss) Per Share, Attributable To Owners Of Parent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BasicEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share from continuing operations",
        "terseLabel": "Basic earnings per share from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from continuing operations. [Refer: Basic earnings (loss) per share; Continuing operations, unless line item indicates otherwise [member]]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38"
     ]
    },
    "ifrs-full_BasicEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BasicEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings (loss) per share from discontinued operations",
        "definitionGuidance": "Basic earnings per share from discontinued operations",
        "verboseLabel": "Basic earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "Basic earnings (loss) per share from discontinued operations. [Refer: Basic earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39"
     ]
    },
    "sny_BiopharmaSegmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BiopharmaSegmentMember",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Biopharma Segment [Member]",
        "terseLabel": "Biopharma Segment [Member]",
        "documentation": "Pharmaceuticals segment."
       }
      }
     },
     "auth_ref": []
    },
    "sny_BlueprintMedicinesCorporationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BlueprintMedicinesCorporationMember",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Blueprint Medicines Corporation [Member]",
        "terseLabel": "Blueprint Medicines Corporation",
        "documentation": "Blueprint Medicines Corporation [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BondsIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BondsIssued",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bonds issued",
        "terseLabel": "Bond issues"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of bonds issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "sny_BorrowingAverageDrawdown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BorrowingAverageDrawdown",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowing, Average Drawdown",
        "terseLabel": "Borrowing, average drawdown",
        "documentation": "Borrowing, Average Drawdown"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Borrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Borrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings",
        "totalLabel": "Total debt",
        "verboseLabel": "Market value"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of outstanding funds that the entity is obligated to repay."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]",
        "terseLabel": "Borrowings by name [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ifrs-full_BorrowingsByNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BorrowingsByNameDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Borrowings by name [domain]",
        "terseLabel": "Borrowings by name [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "ifrs-full_BottomOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BottomOfRangeMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bottom of range [member]",
        "terseLabel": "Bottom of range"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r125",
      "r131",
      "r201",
      "r356",
      "r358",
      "r423"
     ]
    },
    "sny_BpifranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BpifranceMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bpifrance [Member]",
        "documentation": "Bpifrance."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [axis]",
        "terseLabel": "Business Combinations [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r258"
     ]
    },
    "ifrs-full_BusinessCombinationsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "BusinessCombinationsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business combinations [domain]",
        "terseLabel": "Entity's total for business combinations [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r142",
      "r258"
     ]
    },
    "sny_BusinessOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "BusinessOperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Operating Income",
        "totalLabel": "Business Operating Income",
        "terseLabel": "Business operating income",
        "documentation": "Business operating income."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CDRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CDRMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CD&amp;R [Member]",
        "documentation": "CD&amp;R."
       }
      }
     },
     "auth_ref": []
    },
    "country_CN": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "CN",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "CHINA",
        "terseLabel": "China"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CabliviMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CabliviMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cablivi [Member]",
        "terseLabel": "Cablivi",
        "documentation": "Cablivi"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CancellationOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CancellationOfTreasuryShares",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of treasury shares",
        "terseLabel": "Cancellation of treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of treasury stock cancelled during the period. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]",
        "terseLabel": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r12",
      "r52",
      "r58",
      "r64",
      "r65",
      "r66",
      "r67",
      "r68",
      "r141",
      "r155",
      "r156",
      "r213",
      "r215",
      "r236",
      "r241",
      "r244",
      "r245",
      "r246",
      "r247",
      "r248",
      "r260",
      "r267",
      "r268"
     ]
    },
    "ifrs-full_CarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CarryingAmountMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount [member]",
        "terseLabel": "Carrying amount [Member]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r58",
      "r64",
      "r66",
      "r67",
      "r141",
      "r155",
      "r156",
      "r215",
      "r241",
      "r244",
      "r246",
      "r247",
      "r260",
      "r267",
      "r268"
     ]
    },
    "ifrs-full_CashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 7.0
      },
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "terseLabel": "Cash and cash equivalents",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "negatedLabel": "Cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r100",
      "r202",
      "r303"
     ]
    },
    "ifrs-full_CashAndCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashAndCashEquivalentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CashAndCashEquivalentsReclassifiedToAssetsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CashAndCashEquivalentsReclassifiedToAssetsHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 42.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash and Cash Equivalents Reclassified to Assets Held for Sale",
        "terseLabel": "Cash and Cash Equivalents Reclassified to Assets Held for Sale",
        "documentation": "Cash and Cash Equivalents Reclassified to Assets Held for Sale"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowHedgesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowHedgesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flow hedges [member]",
        "terseLabel": "Cash flow hedges"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for hedges of the exposure to variability in cash flows that (a) are attributable to a particular risk associated with a recognised asset or liability (such as all or some future interest payments on variable rate debt) or a highly probable forecast transaction; and (b) could affect profit or loss. [Refer: Types of hedges [domain]]"
       }
      }
     },
     "auth_ref": [
      "r62",
      "r150",
      "r151",
      "r152",
      "r263",
      "r264",
      "r265"
     ]
    },
    "ifrs-full_CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from losing control of subsidiaries or other businesses, classified as investing activities",
        "terseLabel": "Disposals of consolidated undertakings and investments accounted for using the equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate cash flows arising from losing control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash provided by/(used in) financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r78"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities [abstract]",
        "terseLabel": "Cash flows from (used in) financing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities, continuing operations",
        "totalLabel": "Net cash provided by/(used in) continuing financing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's financing activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) financing activities]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0,
       "order": 40.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities, discontinued operations",
        "terseLabel": "Net cash provided by/(used in) financing activities of the discontinued Opella business"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's financing activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) financing activities]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "sny_CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 38.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments",
        "terseLabel": "Net change in short-term debt and other financial instruments",
        "documentation": "Cash Flows From (Used In) Increase (Decrease) In Current Borrowings And Other Financial Instruments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash provided by/(used in) investing activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents, from continuing and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r78"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities [abstract]",
        "terseLabel": "Cash flows from (used in) investing activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash provided by/(used in) operating activities"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r78"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities [abstract]",
        "terseLabel": "Cash flows from (used in) operating activities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities, continuing operations",
        "totalLabel": "Net cash provided by/(used in) continuing operating activities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's operating activities, related to continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Cash flows from (used in) operating activities]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities, discontinued operations",
        "terseLabel": "Net cash provided by/(used in) operating activities of the discontinued Opella business"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) the entity's operating activities, related to discontinued operations. [Refer: Discontinued operations [member]; Cash flows from (used in) operating activities]"
       }
      }
     },
     "auth_ref": [
      "r145"
     ]
    },
    "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operations before changes in working capital",
        "totalLabel": "Operating cash flow before changes in working capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow (outflow) from the entity's operations before changes in working capital."
       }
      }
     },
     "auth_ref": [
      "r352",
      "r420"
     ]
    },
    "ifrs-full_CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": -1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities",
        "negatedTerseLabel": "Acquisitions of consolidated undertakings and investments accounted for using the equity method",
        "terseLabel": "Net cash flow on acquisition"
       }
      },
      "en": {
       "role": {
        "documentation": "The aggregate cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "sny_CashTransferredPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CashTransferredPerShare",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Transferred, Per Share",
        "terseLabel": "Cash Transferred, Per Share",
        "documentation": "Cash Transferred, Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails",
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]",
        "terseLabel": "Categories of related parties [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r225"
     ]
    },
    "ifrs-full_CategoriesOfRelatedPartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CategoriesOfRelatedPartiesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails",
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Categories of related parties [domain]",
        "terseLabel": "Entity's total for related parties [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r225"
     ]
    },
    "sny_CertainWholesalersInTheUnitedStatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CertainWholesalersInTheUnitedStatesMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Certain Wholesalers, In The United States [Member]",
        "terseLabel": "Certain wholesalers in the United States",
        "documentation": "Certain Wholesalers, In The United States"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Currency Translation Before Tax Excluding Associates And Joint Ventures",
        "terseLabel": "Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method)",
        "documentation": "Change in currency translation before tax excluding associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Currency Translation Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Currency translation differences (investments accounted for using the equity method)",
        "documentation": "Change in currency translation net of tax on associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Currency Translation On Hedges Of Net Investments In Foreign Operations",
        "terseLabel": "Hedges of net investments in foreign operations",
        "documentation": "Change in currency translation on hedges of net investments in foreign operations."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInCurrencyTranslationOnTaxEffects": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInCurrencyTranslationOnTaxEffects",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Currency Translation On Tax Effects",
        "negatedTerseLabel": "Tax effects",
        "documentation": "Change in currency translation on tax effects."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)",
        "documentation": "Change in fair value on cash flow hedges excluding associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Cash Flow Hedges Net Of Tax On Associates And Joint Ventures",
        "terseLabel": "Change in fair value (investments accounted for using the equity method, net of taxes)",
        "documentation": "Change in fair value on cash flow hedges net of tax on associates and joint ventures."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Debt Instrument Associates And Joint Ventures",
        "terseLabel": "Change in fair value (investments accounted for using the equity method, net of taxes)",
        "documentation": "Change In Fair Value On Debt Instrument Associates And Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)",
        "documentation": "Change In Fair Value On Debt Instrument Excluding Associates And Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures",
        "terseLabel": "Change in fair value (excluding investments accounted for using the equity method)",
        "documentation": "Change In Fair Value On Equity Instruments Excluding Associates And Joint Ventures"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax",
        "terseLabel": "Change in fair value (investments accounted for using the equity method, net of taxes)",
        "documentation": "Change In Fair Value On Equity Instruments For Investments Accounted For Using The Equity Method Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Scope Of Consolidation Through Business Combination, Intangible Assets",
        "terseLabel": "Changes in scope of consolidation",
        "documentation": "Change In Scope Of Consolidation Through Business Combination, Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ChangesInLiabilitiesRelatedToBusinessCombinationsAndNonControllingInterestsRollForward",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]",
        "terseLabel": "Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]",
        "documentation": "Changes In Liabilities Related To Business Combinations And Non-Controlling Interests [Roll Forward]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ChangesInOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ChangesInOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in other provisions",
        "terseLabel": "Increases in provisions and other liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r233"
     ]
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Chief Executive Officer [Member]",
        "terseLabel": "Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]",
        "terseLabel": "Classes of assets [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r44",
      "r111",
      "r120",
      "r186",
      "r229",
      "r279"
     ]
    },
    "ifrs-full_ClassesOfAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfAssetsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of assets [domain]",
        "terseLabel": "Assets [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r43",
      "r111",
      "r120",
      "r186",
      "r229",
      "r279"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]",
        "terseLabel": "Classes of Contingent Liabilities [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r49",
      "r140",
      "r234"
     ]
    },
    "ifrs-full_ClassesOfContingentLiabilitiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfContingentLiabilitiesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [domain]",
        "terseLabel": "Classes of contingent liabilities [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r140"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]",
        "terseLabel": "Classes of financial assets [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r127",
      "r160",
      "r161",
      "r178",
      "r179",
      "r287"
     ]
    },
    "ifrs-full_ClassesOfFinancialAssetsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfFinancialAssetsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of financial assets [domain]",
        "terseLabel": "Financial assets, class [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "auth_ref": [
      "r127",
      "r160",
      "r161",
      "r178",
      "r179",
      "r287"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]",
        "terseLabel": "Classes of intangible assets other than goodwill [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r242"
     ]
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillDomain",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [domain]",
        "terseLabel": "Classes of intangible assets other than goodwill [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r242"
     ]
    },
    "ifrs-full_ClassesOfOtherProvisionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfOtherProvisionsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [domain]",
        "terseLabel": "Other provisions [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r233"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]",
        "terseLabel": "Classes of property, plant and equipment [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r216"
     ]
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfPropertyPlantAndEquipmentDomain",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Classes of property, plant and equipment' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r216"
     ]
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ClassesOfProvisionsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]",
        "terseLabel": "Classes of other provisions [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r233"
     ]
    },
    "sny_CommercialPaperProgramInFranceMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CommercialPaperProgramInFranceMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper Program In France [Member]",
        "terseLabel": "Commercial paper program in France",
        "documentation": "Commercial paper program In France."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CommercialPaperProgramInUSAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CommercialPaperProgramInUSAMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial Paper Program In USA [Member]",
        "terseLabel": "Commercial paper program in USA",
        "documentation": "Commercial paper program in USA."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CommercialPapersIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CommercialPapersIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercial papers issued",
        "terseLabel": "Commercial paper programs"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of commercial paper issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "sny_CommercializationRelatedExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CommercializationRelatedExpensesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commercialization Related Expenses [Member]",
        "terseLabel": "Reimbursement to Regeneron of selling expenses incurred",
        "documentation": "Commercialization related expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CommitmentsMadeByEntityRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CommitmentsMadeByEntityRelatedPartyTransactions",
     "presentation": [
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments made by entity, related party transactions",
        "terseLabel": "Commitments made by entity, related party transactions"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of related-party commitments made by the entity to do something if a particular event occurs or does not occur in the future, including executory contracts (recognised and unrecognised). [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r344"
     ]
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [axis]",
        "terseLabel": "Components of equity [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_ComponentsOfEquityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComponentsOfEquityDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of equity [domain]",
        "terseLabel": "Components of equity [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_ComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income",
        "totalLabel": "Comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r84",
      "r96",
      "r227",
      "r250",
      "r289",
      "r323",
      "r354"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to non-controlling interests",
        "terseLabel": "Attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to non-controlling interests. [Refer: Comprehensive income; Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r289",
      "r326"
     ]
    },
    "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent",
        "totalLabel": "Attributable to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of comprehensive income attributable to owners of the parent. [Refer: Comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r289",
      "r327"
     ]
    },
    "sny_ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1": {
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent, continuing operations",
        "terseLabel": "Comprehensive income, attributable to owners of parent, continuing operations",
        "documentation": "Comprehensive income, attributable to owners of parent, continuing operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncomeAlternate1": {
       "parentTag": "ifrs-full_ComprehensiveIncomeAttributableToOwnersOfParent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive income, attributable to owners of parent, discontinued operations",
        "terseLabel": "Comprehensive income, attributable to owners of parent, discontinued operations",
        "documentation": "Comprehensive income, attributable to owners of parent, discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ComprehensiveIncomeRelatedPartyDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ComprehensiveIncomeRelatedPartyDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Comprehensive Income, Related Party Disclosures",
        "terseLabel": "Comprehensive Income",
        "documentation": "Comprehensive Income, Related Party Disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ComputerSoftwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ComputerSoftwareMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Computer software [member]",
        "terseLabel": "Software"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r346"
     ]
    },
    "ifrs-full_ContingentLiabilitiesRecognisedInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContingentLiabilitiesRecognisedInBusinessCombination",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent liabilities recognised in business combination",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "terseLabel": "Fair value of contingent consideration payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised in a business combination. [Refer: Classes of contingent liabilities [domain]; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "ifrs-full_ContractDurationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractDurationAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract duration [axis]",
        "terseLabel": "Contract duration [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r388"
     ]
    },
    "ifrs-full_ContractDurationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ContractDurationDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contract duration [domain]",
        "terseLabel": "Contract duration [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all durations of contracts with customers. It also represents the standard value for the 'Contract duration' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r363",
      "r388"
     ]
    },
    "ifrs-full_CorporateInformationAndStatementOfIFRSComplianceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CorporateInformationAndStatementOfIFRSComplianceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate information and statement of IFRS compliance [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CostOfDebtNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CostOfDebtNet",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost Of Debt Net",
        "negatedTotalLabel": "Cost of net debt",
        "documentation": "Cost of debt net."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0,
       "order": 3.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of sales",
        "negatedLabel": "Cost of sales"
       }
      }
     },
     "auth_ref": [
      "r288",
      "r338"
     ]
    },
    "ifrs-full_CounterpartiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CounterpartiesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [axis]",
        "terseLabel": "Counterparties [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "ifrs-full_CounterpartiesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CounterpartiesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparties [domain]",
        "terseLabel": "Counterparties [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the parties to the transaction other than the entity. It also represents the standard value for the 'Counterparties' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CrossCurrencySellerSwapsInUSDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CrossCurrencySellerSwapsInUSDollarMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cross Currency Seller Swaps In US Dollar [Member]",
        "terseLabel": "Cross Currency Seller Swaps In US Dollar",
        "documentation": "Cross Currency Seller Swaps In US Dollar [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CrossCurrencySellerSwapsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CrossCurrencySellerSwapsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cross Currency Seller Swaps [Member]",
        "terseLabel": "Cross Currency Seller Swaps",
        "documentation": "Cross Currency Seller Swaps [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CrossCurrencySwapExpiring2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CrossCurrencySwapExpiring2029Member",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cross Currency Swap, Expiring 2029 [Member]",
        "terseLabel": "Cross Currency Swap, Expiring 2029",
        "documentation": "Cross Currency Swap, Expiring 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CrossCurrencySwapExpiring2032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CrossCurrencySwapExpiring2032Member",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cross Currency Swap, Expiring 2032 [Member]",
        "terseLabel": "Cross Currency Swap, Expiring 2032",
        "documentation": "Cross Currency Swap, Expiring 2032 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CrossCurrencySwapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CrossCurrencySwapMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cross Currency Swap [Member]",
        "terseLabel": "Cross Currency Swap",
        "documentation": "Cross Currency Swap [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CumulativeConsumerPriceInflationRateOverTheLastThreeYears": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CumulativeConsumerPriceInflationRateOverTheLastThreeYears",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Consumer Price Inflation Rate Over The Last Three Years",
        "terseLabel": "Cumulative consumer price inflation rate",
        "documentation": "Cumulative Consumer Price Inflation Rate Over The Last Three Years"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency And Interest Rate Derivatives Used To Manage Debt Net Of Cash And Cash Equivalents",
        "terseLabel": "Currency and interest rate derivatives",
        "documentation": "Currency and interest rate derivatives used to manage debt, net of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets",
        "totalLabel": "Current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      }
     },
     "auth_ref": [
      "r92",
      "r315",
      "r354"
     ]
    },
    "sny_CurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentAssetsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Assets [Member]",
        "terseLabel": "current",
        "documentation": "Current assets."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrentAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets, Related Party Transactions",
        "terseLabel": "Current assets",
        "documentation": "Current assets, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 33.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current borrowings and current portion of non-current borrowings",
        "verboseLabel": "Short-term debt and current portion of long-term debt"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current borrowings and current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 32.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current lease liabilities",
        "terseLabel": "Current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ifrs-full_CurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities",
        "totalLabel": "Current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r94",
      "r316",
      "r354"
     ]
    },
    "sny_CurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentLiabilitiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities [Member]",
        "terseLabel": "current",
        "documentation": "Current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrentLiabilitiesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentLiabilitiesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities, Related Party Transactions",
        "terseLabel": "Current Liabilities",
        "documentation": "Current Liabilities, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Liabilities Related To Business Combinations And To Non-Controlling Interests",
        "terseLabel": "Current liabilities related to business combinations and to non-controlling interests",
        "verboseLabel": "Current portion",
        "documentation": "This account includes current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes current portion of liabilities related to non-controlling interests."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrentProvisionsAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentProvisionsAndOtherCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 30.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Provisions And Other Current Liabilities",
        "terseLabel": "Current provisions and other current liabilities",
        "documentation": "The amount of current provisions and current other liabilities that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Provisions And Other Current Liabilities, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Current provisions and other current liabilities",
        "documentation": "Current Provisions And Other Current Liabilities, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTaxAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax assets, current",
        "terseLabel": "Current income tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax assets. [Refer: Current tax assets]"
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_CurrentTaxAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax assets, non-current",
        "terseLabel": "Non-current income tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax assets. [Refer: Current tax assets]"
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax expense (income)",
        "negatedLabel": "Current taxes"
       }
      }
     },
     "auth_ref": [
      "r339",
      "r391"
     ]
    },
    "sny_CurrentTaxExpenseRelatedToPillarTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CurrentTaxExpenseRelatedToPillarTwo",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Tax Expense Related to Pillar Two",
        "terseLabel": "Current Tax Expense Related to Pillar Two",
        "documentation": "Current Tax Expense Related to Pillar Two"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 31.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax liabilities, current",
        "terseLabel": "Current income tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_CurrentTaxLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTaxLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current tax liabilities, non-current",
        "terseLabel": "Non-current income tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r305"
     ]
    },
    "ifrs-full_CurrentTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "CurrentTradeReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails",
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current trade receivables",
        "terseLabel": "Accounts receivable"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      }
     },
     "auth_ref": [
      "r394",
      "r398",
      "r400"
     ]
    },
    "sny_CustomerOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CustomerOneMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer One [member]",
        "terseLabel": "Customer one",
        "documentation": "Customer one."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CustomerThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CustomerThreeMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Three [member]",
        "terseLabel": "Customer three",
        "documentation": "Customer three."
       }
      }
     },
     "auth_ref": []
    },
    "sny_CustomerTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "CustomerTwoMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Two [member]",
        "terseLabel": "Customer two",
        "documentation": "Customer two."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]",
        "documentation": "Debt Instrument"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DebtInstrumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DebtInstrumentDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instrument [Domain]",
        "terseLabel": "Debt Instrument [Domain]",
        "documentation": "Debt Instrument [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DebtInstrumentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DebtInstrumentsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Instruments [Member]",
        "terseLabel": "Debt instruments included in financial assets",
        "documentation": "Debt Instruments."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DebtNetOfCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DebtNetOfCashAndCashEquivalents",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Net Of Cash And Cash Equivalents",
        "totalLabel": "Net debt",
        "documentation": "Debt net of cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DebtSecuritiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt securities [member]",
        "terseLabel": "Debt securities"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for instruments held by the entity that represent indebtedness."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r357"
     ]
    },
    "sny_DefendantAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DefendantAxis",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defendant [Axis]",
        "terseLabel": "Defendant [Axis]",
        "documentation": "Defendant [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DefendantDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DefendantDomain",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defendant [Domain]",
        "terseLabel": "Defendant [Domain]",
        "documentation": "Defendant [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DeferredCashPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DeferredCashPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Cash Payments",
        "terseLabel": "Deferred Cash Payments",
        "documentation": "Deferred Cash Payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DeferredTaxAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax assets",
        "terseLabel": "Deferred tax assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes recoverable in future periods in respect of: (a) deductible temporary differences; (b) the carryforward of unused tax losses; and (c) the carryforward of unused tax credits. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r210",
      "r306",
      "r311"
     ]
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxExpenseIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails": {
       "parentTag": "ifrs-full_IncomeTaxExpenseContinuingOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax expense (income)",
        "negatedLabel": "Deferred taxes"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      }
     },
     "auth_ref": [
      "r7",
      "r211"
     ]
    },
    "ifrs-full_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 26.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred tax liabilities",
        "terseLabel": "Deferred tax liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amounts of income taxes payable in future periods in respect of taxable temporary differences. [Refer: Temporary differences [member]]"
       }
      }
     },
     "auth_ref": [
      "r6",
      "r210",
      "r306",
      "r311"
     ]
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansAxis",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]",
        "terseLabel": "Defined benefit plans [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r217"
     ]
    },
    "ifrs-full_DefinedBenefitPlansDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DefinedBenefitPlansDomain",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Defined benefit plans [domain]",
        "terseLabel": "Defined benefit plans [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r217"
     ]
    },
    "sny_DerecognizedReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DerecognizedReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derecognized Receivables",
        "terseLabel": "Derecognized receivables",
        "documentation": "Derecognized receivables."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DerivativeFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DerivativeFinancialAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial assets",
        "terseLabel": "Derivative financial assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial assets classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "sny_DerivativeFinancialInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DerivativeFinancialInstruments",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Financial Instruments",
        "terseLabel": "Operating currency hedging instruments in place",
        "documentation": "Derivative financial instrument"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DerivativeFinancialInstrumentsToManageFinancialExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DerivativeFinancialInstrumentsToManageFinancialExposure",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Financial Instruments To Manage Financial Exposure",
        "definitionGuidance": "Derivative Financial Instruments To Manage Financial Exposure",
        "documentation": "Derivative financial instruments to manage financial exposure."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DerivativeFinancialLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DerivativeFinancialLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative financial liabilities",
        "terseLabel": "Derivative financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of financial liabilities classified as derivative instruments. [Refer: Financial assets; Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of accounting policy for financial instruments [text block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The description of the entity's material accounting policy information for financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r430"
     ]
    },
    "ifrs-full_DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of expected impact of initial application of new standards or interpretations [text block]",
        "terseLabel": "New Pronouncements Issued by the IASB and Applicable from 2024"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r204"
     ]
    },
    "sny_DilutedEarningsLossPerShareAttributableToOwnersOfParent": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DilutedEarningsLossPerShareAttributableToOwnersOfParent",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent",
        "terseLabel": "Diluted earnings per share (in euros per share)",
        "documentation": "Diluted Earnings (Loss) Per Share, Attributable To Owners Of Parent"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DilutedEarningsLossPerShareFromContinuingOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromContinuingOperations",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share from continuing operations",
        "terseLabel": "Diluted earnings per share from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Diluted earnings (loss) per share]"
       }
      }
     },
     "auth_ref": [
      "r37",
      "r38"
     ]
    },
    "ifrs-full_DilutedEarningsLossPerShareFromDiscontinuedOperations": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutedEarningsLossPerShareFromDiscontinuedOperations",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings (loss) per share from discontinued operations",
        "terseLabel": "Diluted earnings per share from discontinued operations",
        "verboseLabel": "Diluted earnings per share"
       }
      },
      "en": {
       "role": {
        "documentation": "Diluted earnings (loss) per share from discontinued operations. [Refer: Diluted earnings (loss) per share; Discontinued operations [member]]"
       }
      }
     },
     "auth_ref": [
      "r38",
      "r39"
     ]
    },
    "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails": {
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive effect of share options on weighted average number of ordinary shares",
        "terseLabel": "Adjustment for stock options with dilutive effect"
       }
      },
      "en": {
       "role": {
        "documentation": "The potential dilutive effect on the weighted average number of ordinary shares that relate to the assumed exercise of the entity's share options."
       }
      }
     },
     "auth_ref": [
      "r408"
     ]
    },
    "sny_DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails": {
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dilutive Effect Of Share Options On Number Of Restricted Shares",
        "terseLabel": "Adjustment for restricted shares",
        "documentation": "Dilutive effect of share options on number of restricted shares."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAccountingJudgementsAndEstimatesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAccountingJudgementsAndEstimatesExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of accounting judgements and estimates [text block]",
        "terseLabel": "Use of Estimates"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of judgements that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognised in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year. [Refer: Carrying amount [member]]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "sny_DisclosureOfAccountsReceivableLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAccountsReceivableLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Accounts Receivable [line items]",
        "terseLabel": "Disclosure of Accounts Receivable [Line Items]",
        "documentation": "Disclosure Of Accounts Receivable [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfAccountsReceivableTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAccountsReceivableTable",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Accounts Receivable [Table]",
        "terseLabel": "Disclosure of Accounts Receivable [Table]",
        "documentation": "Disclosure of Accounts receivable Table."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Accumulated Other Comprehensive Income Explanatory [Table Text Block]",
        "terseLabel": "Summary of Movements within Other Comprehensive Income",
        "documentation": "Disclosure of detailed information of accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment And Other Intangible Assets And Carrying Amount Of Investments In Associates And Joint Ventures By Operating Segment [Table Text Block]",
        "terseLabel": "Schedule of Acquisition of Intangible Assets, Property, Plant and Equipment and Investments Accounted for Using the Equity Method by Segment",
        "documentation": "The disclosure of acquisitions of property plant and equipment and other intangible assets and carrying amount of investments in associates and joint ventures by operating segment."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Acquisitions Of Property Plant And Equipment By Operating Segments Explanatory [Table Text Block]",
        "terseLabel": "Summary of Acquisitions and Capitalized Interest by Operating Segment",
        "documentation": "Disclosure of acquisitions of property plant and equipment by operating segments explanatory [text block]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Allocation Of Income Tax Between Current And Deferred Taxes [Table Text Block]",
        "terseLabel": "Summary of Allocation of Income Tax Expense Between Current and Deferred Taxes",
        "documentation": "The disclosure of allocation of income tax between current and deferred taxes."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of other comprehensive income by item [line items]",
        "terseLabel": "Disclosure of analysis of other comprehensive income by item [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfOtherComprehensiveIncomeByItemTable",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of other comprehensive income by item [table]",
        "terseLabel": "Disclosure of analysis of other comprehensive income by item [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of other comprehensive income by item."
       }
      }
     },
     "auth_ref": [
      "r294"
     ]
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [line items]",
        "terseLabel": "Disclosure of analysis of single amount of discontinued operations [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfAnalysisOfSingleAmountOfDiscontinuedOperationsTable",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of analysis of single amount of discontinued operations [table]",
        "terseLabel": "Disclosure of analysis of single amount of discontinued operations [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the analysis of the single amount of discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of basis of preparation of financial statements [text block]",
        "terseLabel": "Basis of Preparation of the Half-Year Financial Statements and Accounting Policies"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_DisclosureOfBusinessCombinationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [line items]",
        "terseLabel": "Disclosure of detailed information about business combination [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfBusinessCombinationsTable",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]",
        "terseLabel": "Disclosure of detailed information about business combination [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      }
     },
     "auth_ref": [
      "r138",
      "r258"
     ]
    },
    "sny_DisclosureOfChangesInFinancialPositionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfChangesInFinancialPositionTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Changes In Financial Position [Table Text Block]",
        "terseLabel": "Summary of Changes in Financial Position",
        "documentation": "Disclosure of changes in financial position [text block]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Changes In Liabilities Related To Business Combinations And To Noncontrolling Interests [Table Text Block]",
        "verboseLabel": "Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests",
        "documentation": "The disclosure of changes in liabilities related to business combinations and to non-controlling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [text block]",
        "terseLabel": "Summary of Treasury Shares Held"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of classes of share capital. [Refer: Classes of share capital [domain]]"
       }
      }
     },
     "auth_ref": [
      "r198",
      "r281",
      "r319"
     ]
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [line items]",
        "terseLabel": "Disclosure of classes of share capital [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfClassesOfShareCapitalTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfClassesOfShareCapitalTable",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of classes of share capital [table]",
        "terseLabel": "Disclosure of classes of share capital [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to classes of share capital."
       }
      }
     },
     "auth_ref": [
      "r198",
      "r281",
      "r319"
     ]
    },
    "sny_DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Components Of Other Non-Current Assets [Table Text Block]",
        "terseLabel": "Summary of Other Non-Current Assets",
        "documentation": "The disclosure of components of other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities in business combination [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfCurrentTradeReceivablesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfCurrentTradeReceivablesTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Current Trade Receivables [Table Text Block]",
        "terseLabel": "Summary of Accounts Receivable",
        "documentation": "The disclosure of current trade receivables."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Debt Instruments Issued Explanatory [Text Block]",
        "terseLabel": "Debt, Cash and Cash Equivalents",
        "documentation": "Disclosure of debt instruments issued explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Debt Net Of Cash And Cash Equivalents By Type At Value On Redemption Explanatory [Table Text Block]",
        "terseLabel": "Summary of Net Debt by Type Valuation of Redemption",
        "documentation": "The disclosure of debt net of cash and cash equivalents by type at value on redemption."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDerivativeFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDerivativeFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstruments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of derivative financial instruments [text block]",
        "terseLabel": "Derivative Financial Instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of derivative financial instruments. [Refer: Derivatives [member]]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [line items]",
        "terseLabel": "Disclosure of detailed information about borrowings [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]",
        "terseLabel": "Disclosure of detailed information about borrowings [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      }
     },
     "auth_ref": [
      "r423"
     ]
    },
    "sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeExpenseLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Detailed Information About Finance Income Expense [Line Items]",
        "terseLabel": "Disclosure of detailed information about finance income expense [Line Items]",
        "documentation": "Line items represent detailed information about finance income expense."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfDetailedInformationAboutFinanceIncomeExpenseTable",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Detailed Information About Finance Income Expense [table]",
        "terseLabel": "Disclosure Of Detailed Information About Finance Income Expense [table]",
        "documentation": "Schedule disclosing information related to details of finance income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [text block]",
        "terseLabel": "Disclosure of Measurement Principles Applied to Financial Instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r154",
      "r157",
      "r162",
      "r261"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [text block]",
        "terseLabel": "Summary of Net Sales by Segment and Geographical Area"
       }
      }
     },
     "auth_ref": [
      "r113",
      "r181"
     ]
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [line items]",
        "terseLabel": "Disclosure of disaggregation of revenue from contracts with customers [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]",
        "terseLabel": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      }
     },
     "auth_ref": [
      "r113",
      "r181"
     ]
    },
    "sny_DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block]",
        "documentation": "Disclosure Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Employee Stock Ownership Plan Awarded In Capital Increase Reserved Explanatory [Table Text Block]",
        "terseLabel": "Summary of Principal Characteristics of Restricted Share Plans",
        "documentation": "Disclosure of employee stock ownership plan awarded in capital increase reserved explanatory [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of entity's operating segments [text block]",
        "terseLabel": "Segment Information"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of events after reporting period [text block]",
        "terseLabel": "Events Subsequent to June 30, 2023"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of finance income (cost) [text block]",
        "terseLabel": "Financial Expenses and Income"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [line items]",
        "terseLabel": "Disclosure of Financial Assets that are Either Past Due or Impaired [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [table]",
        "terseLabel": "Disclosure of Financial Assets that are Either Past Due or Impaired [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired."
       }
      }
     },
     "auth_ref": [
      "r286"
     ]
    },
    "sny_DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Financial Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Financial Currency Hedging Instruments in Place with Notional Amount Translated",
        "documentation": "The disclosure of financial currency hedging instruments with notional amount translated in to euros at closing exchange rate."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Financial Income And Expenses Explanatory [Table Text Block]",
        "terseLabel": "Summary of Analysis of Financial Income and Expenses",
        "documentation": "The entire disclosure for financial income and expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [line items]",
        "terseLabel": "Disclosure of detailed information about financial instruments [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfFinancialInstrumentsTable",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about financial instruments [table]",
        "terseLabel": "Disclosure of detailed information about financial instruments [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of financial instruments."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r157",
      "r162",
      "r261"
     ]
    },
    "ifrs-full_DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/Introduction"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of general information about financial statements [text block]",
        "terseLabel": "Introduction"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for general information about financial statements."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r298"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [text block]",
        "terseLabel": "Summary of Geographical Information on Net Sales and Non-Current Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of geographical information."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_DisclosureOfGeographicalAreasLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [line items]",
        "terseLabel": "Disclosure of geographical areas [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfGeographicalAreasTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfGeographicalAreasTable",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of geographical areas [table]",
        "terseLabel": "Disclosure of geographical areas [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to geographical areas."
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "ifrs-full_DisclosureOfHyperinflationaryReportingExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfHyperinflationaryReportingExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about hyperinflationary reporting [text block]",
        "terseLabel": "Consolidation and Foreign Currency Translation of the Financial Statements of Subsidiaries in Hyperinflationary Economies"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of information about financial reporting in hyperinflationary economies."
       }
      }
     },
     "auth_ref": [
      "r36"
     ]
    },
    "sny_DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Impact Of Changes In The Scope Of Consolidation Due To Acquisitions And Divestments Explanatory [Text Block]",
        "terseLabel": "Principal Changes in Scope of Consolidation in the Period and Amendments to Principal Agreements",
        "documentation": "The entire disclosure for impact of changes in the scope of consolidation due to acquisitions and divestments."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfImpairmentLossAndReversalOfImpairmentLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of impairment loss and reversal of impairment loss [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Impairment Of Intangible Assets And Property Plant And Equipment Explanatory [Text Block]",
        "terseLabel": "Impairment of Intangible Assets",
        "documentation": "The entire disclosure for impairment of intangible assets and property, plant and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpense"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of income tax [text block]",
        "terseLabel": "Income Tax Expense"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about credit exposures designated as measured at fair value through profit or loss [line items]",
        "terseLabel": "Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutCreditExposuresDesignatedAsMeasuredAtFairValueThroughProfitOrLossTable",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about credit exposures designated as measured at fair value through profit or loss [table]",
        "terseLabel": "Disclosure of Information about Credit Exposures Designated as Measured at Fair Value Through Profit or Loss [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to credit exposures designated as measured at fair value through profit or loss."
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfInformationAboutMajorCustomersAndCreditRiskLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Information About Major Customers And Credit Risk [Line Items]",
        "terseLabel": "Disclosure of information about major customers and credit risk [line items]",
        "documentation": "Disclosure of information about major customers and credit risk."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfInformationAboutMajorCustomersAndCreditRiskTable",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Information About Major Customers And Credit Risk [Table]",
        "terseLabel": "Disclosure of Information About Major Customers and Credit Risk [Table]",
        "documentation": "Disclosure of information about major customers and credit risk."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [line items]",
        "terseLabel": "Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInformationAboutTermsAndConditionsOfHedgingInstrumentsAndHowTheyAffectFutureCashFlowsTable",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of information about terms and conditions of hedging instruments and how they affect future cash flows [table]",
        "terseLabel": "Disclosure of Information about Terms and Conditions of Hedging Instruments and How They Affect Future Cash Flows [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the terms and conditions of hedging instruments and how they affect future cash flows."
       }
      }
     },
     "auth_ref": [
      "r148"
     ]
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [line items]",
        "terseLabel": "Disclosure of initial application of standards or interpretations [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInitialApplicationOfStandardsOrInterpretationsTable",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of initial application of standards or interpretations [table]",
        "terseLabel": "Disclosure of initial application of standards or interpretations [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the initial application of standards or interpretations."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r203"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsAndGoodwillExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsAndGoodwillExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of intangible assets and goodwill [text block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of intangible assets and goodwill. [Refer: Intangible assets and goodwill]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_DisclosureOfIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [line items]",
        "terseLabel": "Disclosure of detailed information about intangible assets [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfIntangibleAssetsTable",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]",
        "terseLabel": "Disclosure of detailed information about intangible assets [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      }
     },
     "auth_ref": [
      "r59",
      "r242"
     ]
    },
    "sny_DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Interest Rates Hedging Instruments With Notional Amount By Expiry Date Explanatory [Table Text Block]",
        "terseLabel": "Disclosure of Instruments",
        "documentation": "The disclosure of interest rates hedging instruments with notional amount by expiry date."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethod"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of investments accounted for using equity method [text block]",
        "terseLabel": "Investments Accounted for Using the Equity Method"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of investments accounted for using the equity method. [Refer: Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "sny_DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Investments In Associates And Joint Ventures [Table Text Block]",
        "terseLabel": "Summary of Investments in Associates and Joint Ventures",
        "documentation": "The entire disclosure of investments in associates and joint ventures explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLegalAndArbitralProceedingsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Legal And Arbitral Proceedings [Line Items]",
        "terseLabel": "Disclosure of Legal and Arbitral Proceedings [Line Items]",
        "documentation": "Disclosure of legal and arbitral proceedings."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLegalAndArbitralProceedingsTable",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Legal And Arbitral Proceedings [Table]",
        "terseLabel": "Disclosure of Legal and Arbitral Proceedings [Table]",
        "documentation": "Disclosure of legal and arbitral proceedings."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLegalAndArbitralProceedingsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLegalAndArbitralProceedingsTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedings"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Legal And Arbitral Proceedings [Text Block]",
        "terseLabel": "Litigation and Arbitration Proceedings",
        "documentation": "Disclosure Of Legal And Arbitral Proceedings [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Explanatory [Text Block]",
        "terseLabel": "Liabilities Related to Business Combinations and to Non-Controlling Interests",
        "documentation": "The entire disclosure for liabilities related to business combination and to non-controlling interests."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]",
        "terseLabel": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Line Items]",
        "documentation": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTable",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]",
        "terseLabel": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [Table]",
        "documentation": "Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests Table"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfMarketValueOfNetDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfMarketValueOfNetDebtTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Market Value Of Net Debt [Table Text Block]",
        "terseLabel": "Summary of Market Value of Net Debt",
        "documentation": "Disclosure of market value of net debt [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [line items]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNetDefinedBenefitLiabilityAssetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNetDefinedBenefitLiabilityAssetTable",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of net defined benefit liability (asset) [table]",
        "terseLabel": "Disclosure of net defined benefit liability (asset) [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the net defined benefit liability (asset)."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r219"
     ]
    },
    "sny_DisclosureOfNonCurrentProvisionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfNonCurrentProvisionsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Non-Current Provisions [Line Items]",
        "terseLabel": "Disclosure Of Non-current Provisions [Line Items]",
        "documentation": "Disclosure Of Non-current Provisions [line items]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfNonCurrentProvisionsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfNonCurrentProvisionsTable",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Non-Current Provisions [Table]",
        "terseLabel": "Disclosure Of Noncurrent Provisions [Table]",
        "documentation": "Disclosure Of Noncurrent Provisions [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfNonCurrentProvisionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfNonCurrentProvisionsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Non-Current Provisions [Table Text Block]",
        "terseLabel": "Summary of Movements in Non-Current Provisions",
        "documentation": "Disclosure of noncurrent provisions explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [line items]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfNonadjustingEventsAfterReportingPeriodTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNonadjustingEventsAfterReportingPeriodTable",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-adjusting events after reporting period [table]",
        "terseLabel": "Disclosure of non-adjusting events after reporting period [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to non-adjusting events after the reporting period."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r206"
     ]
    },
    "ifrs-full_DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of non-current assets held for sale and discontinued operations [text block]",
        "terseLabel": "Information related to Opella, presented within assets held for sale and discontinued operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for non-current assets held for sale and discontinued operations."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "sny_DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Number Of Restricted Share Plans Not Yet Fully Vested [Table Text Block]",
        "terseLabel": "Summary of Number of Restricted Shares Not Yet Fully Vested",
        "documentation": "Disclosure of number of restricted share plans Not yet fully vested."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/OffBalanceSheetCommitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Off-Balance Sheet Commitments Explanatory [Text Block]",
        "terseLabel": "Off Balance Sheet Commitments",
        "documentation": "Disclosure of off-balance sheet commitments."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Operating Currency Hedging Instruments With Notional Amount Translated In To Euros At Closing Exchange Rate [Table Text Block]",
        "terseLabel": "Summary of Operating Currency Hedging Instruments",
        "documentation": "The disclosure of operating currency hedging instruments with notional amount translated in to euros at closing exchange rate."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [text block]",
        "terseLabel": "Schedule of Segment Results"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ifrs-full_DisclosureOfOperatingSegmentsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [line items]",
        "terseLabel": "Disclosure of operating segments [Line Items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Operating Segments Reconciling Items [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation Between Business Operating Income for the Segments and Income Before Tax and Investments Accounted for Using the Equity Method",
        "documentation": "The disclosure of operating segments reconciling items."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOperatingSegmentsTable",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]",
        "terseLabel": "Disclosure of operating segments [Table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "sny_DisclosureOfOtherGainsAndLossesAndLitigationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherGainsAndLossesAndLitigationTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Gains And Losses, And Litigation [Text Block]",
        "terseLabel": "Other Gains and Losses, and Litigation",
        "documentation": "The entire disclosure of other gains and losses, and litigation."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOtherNonCurrentAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherNonCurrentAssetsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Non-Current Assets [Line Items]",
        "terseLabel": "Disclosure Of Other Non Current Assets [Line Items]",
        "documentation": "Disclosure of other non-current assets."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOtherNonCurrentAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherNonCurrentAssetsTable",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Non-Current Assets [Table]",
        "terseLabel": "Disclosure Of Other Non-current Assets [Table]",
        "documentation": "Schedule disclosing information related to other non-current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfOtherNoncurrentAssetsExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherNoncurrentAssetsExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other non-current assets [text block]",
        "terseLabel": "Other Non-Current Assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of other non-current assets. [Refer: Other non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "ifrs-full_DisclosureOfOtherOperatingIncomeExpenseExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfOtherOperatingIncomeExpenseExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpenses"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other operating income (expense) [text block]",
        "terseLabel": "Other Operating Income and Expenses"
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "sny_DisclosureOfOtherOperatingIncomeExpensesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherOperatingIncomeExpensesLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Operating Income Expenses [Line Items]",
        "terseLabel": "Disclosure Of Other Operating Income Expenses [Line Items]",
        "documentation": "Disclosure of other operating income (expenses)."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOtherOperatingIncomeExpensesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherOperatingIncomeExpensesTable",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Other Operating Income Expenses [Table]",
        "terseLabel": "Disclosure of Other Operating Income Expenses [Table]",
        "documentation": "Disclosure of other operating income expenses."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOtherRevenueTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOtherRevenueTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of other revenue [Text Block]",
        "terseLabel": "Disclosure of Other Revenue",
        "documentation": "Disclosure of other revenue [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfOverdueReceivablesGrossValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfOverdueReceivablesGrossValueTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Overdue Receivables Gross Value [Table Text Block]",
        "terseLabel": "Summary of Gross Value of Overdue Receivables",
        "documentation": "The disclosure of overdue receivables gross value."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipment"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [line items]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]",
        "terseLabel": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r216"
     ]
    },
    "sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Provisions And Other Non Current Liabilities Explanatory [Table Text Block]",
        "terseLabel": "Summary of Non-current provisions and other non-current liabilities",
        "documentation": "Disclosure Of Provisions And Other Non Current Liabilities Explanatory"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilities"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Provisions And Other Non-Current Liabilities [Text Block]",
        "terseLabel": "Non-Current Provisions And Other Non-Current Liabilities.",
        "documentation": "Disclosure Of Provisions And Other Non-Current Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reconciliation Of Average Effective Tax Rate And Applicable Tax Rate Explanatory [Table Text Block]",
        "terseLabel": "Summary of Difference Between Effective Tax Rate and Standard Corporate Income Tax Rate",
        "documentation": "Disclosure of reconciliation of average effective tax rate and applicable tax rate."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Line Items]",
        "terseLabel": "Disclosure of reconciliation of carrying amount to value on redemption [line items]",
        "documentation": "Disclosure of reconciliation of carrying amount to value on redemption."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTable",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table]",
        "terseLabel": "Disclosure of reconciliation of carrying amount to value on redemption [Table]",
        "documentation": "Disclosure of reconciliation of carrying amount to value on redemption [table]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reconciliation Of Carrying Amount To Value On Redemption [Table Text Block]",
        "terseLabel": "Summary of Reconciliation of Carrying Amount to Value on Redemption",
        "documentation": "Disclosure of reconciliation of carrying amount to value on redemption [text block]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [line items]",
        "terseLabel": "Disclosure of reconciliation of changes in goodwill [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]",
        "terseLabel": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r260"
     ]
    },
    "sny_DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Reconciliation Of Changes In Other Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Movements in Other Intangible Assets",
        "documentation": "Disclosure of reconciliation of changes in other intangible assets."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset [Table Text Block]",
        "terseLabel": "Disclosure of Remeasurement of Net Defined Benefit Liability Asset",
        "documentation": "Disclosure Of Remeasurement Of Net Defined Benefit Liability Asset"
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfRestructuringCostsDetailsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfRestructuringCostsDetailsTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Restructuring Costs Details [Table Text Block]",
        "terseLabel": "Summary of Restructuring Costs and Similar Items",
        "documentation": "The disclosure of restructuring costs details."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DisclosureOfRestructuringTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfRestructuringTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItems"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Restructuring [Text Block]",
        "terseLabel": "Restructuring costs and similar items",
        "documentation": "Disclosure Of Restructuring [Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfRevenueExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomers"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of revenue [text block]",
        "terseLabel": "Revenue from Contracts with Customers"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      }
     },
     "auth_ref": [
      "r425"
     ]
    },
    "sny_DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Share Based Compensation Shares Authorized Under Stock Option Plans By Exercise Price Range [Table Text Block]",
        "terseLabel": "Summary of Options Outstanding and Exercisable",
        "documentation": "The disclosure of share based compensation shares authorized under stock option plans by exercise price range."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "terseLabel": "Consolidated Shareholders' Equity"
       }
      },
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      }
     },
     "auth_ref": [
      "r199",
      "r282",
      "r320"
     ]
    },
    "sny_DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Shares Used To Compute Diluted Earnings Per Share [Table Text Block]",
        "terseLabel": "Summary of Number of Shares Used to Compute Diluted Earnings Per Share",
        "documentation": "The disclosure of shares used to compute diluted earnings per share."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]",
        "terseLabel": "Disclosure of temporary difference, unused tax losses and unused tax credits [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsTable",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of temporary difference, unused tax losses and unused tax credits [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to temporary differences, unused tax losses and unused tax credits."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r212"
     ]
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [line items]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]",
        "terseLabel": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r254"
     ]
    },
    "sny_DisclosureOfTradeReceivablesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfTradeReceivablesTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Trade Receivables [Text Block]",
        "terseLabel": "Accounts Receivable",
        "documentation": "The disclosure of trade receivables."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesExplanatory",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [text block]",
        "terseLabel": "Summary of Principal Transactions and Balances with Related Parties"
       }
      },
      "en": {
       "role": {
        "documentation": "The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r27",
      "r223"
     ]
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails",
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [line items]",
        "terseLabel": "Disclosure of transactions between related parties [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails",
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]",
        "terseLabel": "Disclosure of transactions between related parties [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      }
     },
     "auth_ref": [
      "r29",
      "r225"
     ]
    },
    "sny_DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disclosure Of Unaudited Financial Statements Of Subsidiaries Explanatory [Table Text Block]",
        "documentation": "Disclosure of unaudited financial statements of subsidiaries explanatory."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposals and retirements, intangible assets other than goodwill",
        "negatedTerseLabel": "Disposals and other decreases"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets other than goodwill resulting from disposals and retirements. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "sny_DividendsPaidAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DividendsPaidAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Paid [Abstract]",
        "terseLabel": "Dividends paid:",
        "documentation": "Dividends Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsPaidOrdinarySharesPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaidOrdinarySharesPerShare",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid, ordinary shares per share",
        "terseLabel": "Dividend paid per share (in euros per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends paid per ordinary share."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r228"
     ]
    },
    "ifrs-full_DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 33.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid to equity holders of parent, classified as financing activities",
        "negatedLabel": "Dividends paid to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to equity holders of the parent, classified as financing activities."
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 34.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests, classified as financing activities",
        "negatedLabel": "Dividends paid to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid to non-controlling interests, classified as financing activities. [Refer: Non-controlling interests; Dividends paid to non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "sny_DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends Received From Nonconsolidated Entities Classified As Operating Activities",
        "terseLabel": "Dividends received from non-consolidated entities",
        "documentation": "Dividends received from non-consolidated entities."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsRecognisedAsDistributionsToNoncontrollingInterests",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to non-controlling interests",
        "negatedLabel": "Payment of dividends to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to non-controlling interests. [Refer: Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "DividendsRecognisedAsDistributionsToOwnersOfParent",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends recognised as distributions to owners of parent",
        "negatedLabel": "Dividend paid out of earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners of the parent. [Refer: Parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "DocumentType",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "sny_DupixentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "DupixentMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dupixent [Member]",
        "terseLabel": "Dupixent",
        "documentation": "Dupixent [member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EUROZONEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EUROZONEMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "EUROZONE [Member]",
        "terseLabel": "Eurozone",
        "documentation": "EUROZONE"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EarendilLabsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EarendilLabsMember",
     "presentation": [
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earendil Labs [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0,
       "order": 41.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "terseLabel": "Impact of exchange rates on cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r72"
     ]
    },
    "sny_EmployeeShareOwnershipPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EmployeeShareOwnershipPlanMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Share Ownership Plan [Member]",
        "terseLabel": "Employees share ownership plan",
        "documentation": "Employees share ownership plan."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntitiesTable",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "terseLabel": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "terseLabel": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.Sanofi.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r404"
     ]
    },
    "ifrs-full_Equity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Equity",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity",
        "totalLabel": "Total equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      }
     },
     "auth_ref": [
      "r81",
      "r83",
      "r106",
      "r107",
      "r110",
      "r226",
      "r249",
      "r275",
      "r276",
      "r285",
      "r310",
      "r317"
     ]
    },
    "ifrs-full_EquityAndLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAndLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities",
        "totalLabel": "Total equity and liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      }
     },
     "auth_ref": [
      "r310"
     ]
    },
    "ifrs-full_EquityAndLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAndLiabilitiesAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and liabilities [abstract]",
        "terseLabel": "Equity and liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EquityAndLiabilitiesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityAndLiabilitiesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity and Liabilities, Related Party Transactions",
        "terseLabel": "Total equity and liabilities",
        "documentation": "Equity and Liabilities, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EquityAttributableToEquityHoldersRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityAttributableToEquityHoldersRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Attributable to Equity Holders, Related Party Transactions",
        "terseLabel": "Equity attributable to equity holders of OPAL JV Co",
        "documentation": "Equity Attributable to Equity Holders, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EquityAttributableToNonControllingInterestRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityAttributableToNonControllingInterestRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Attributable to Non Controlling Interest, Related Party Transactions",
        "terseLabel": "Equity attributable to non-controlling interests",
        "documentation": "Equity Attributable to Non Controlling Interest, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "verboseLabel": "Equity attributable to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      }
     },
     "auth_ref": [
      "r309"
     ]
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityAttributableToOwnersOfParentMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]",
        "terseLabel": "Attributable to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "sny_EquityInstrumentsIncludedInFinancialAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityInstrumentsIncludedInFinancialAssetsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Instruments Included In Financial Assets [Member]",
        "terseLabel": "Equity instruments included in financial assets",
        "documentation": "Equity Instruments Included In Financial Assets[member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_EquityInterestsOfAcquirer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "EquityInterestsOfAcquirer",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity interests of acquirer",
        "terseLabel": "Equity interests of acquirer"
       }
      },
      "en": {
       "role": {
        "documentation": "The fair value, at the acquisition date, of equity interests of the acquirer transferred as consideration in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r136",
      "r256"
     ]
    },
    "sny_EquityInterestsOfAcquirerPerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityInterestsOfAcquirerPerShare",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Interests Of Acquirer, Per Share",
        "terseLabel": "Equity Interests Of Acquirer, Per Share",
        "documentation": "Equity Interests Of Acquirer, Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EquityMethodInvesteeNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EquityMethodInvesteeNameDomain",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Domain]",
        "terseLabel": "Investment, Name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EquityRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity, Related Party Transactions",
        "terseLabel": "Total equity",
        "documentation": "Equity, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Risk Hedging Instruments Designated At Fair Value Hedges",
        "terseLabel": "Equity risk hedging instruments designated as fair value hedges",
        "documentation": "Equity Risk Hedging Instruments Designated At Fair Value Hedges"
       }
      }
     },
     "auth_ref": []
    },
    "sny_EuroapiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "EuroapiMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euroapi [Member]",
        "terseLabel": "Euroapi",
        "verboseLabel": "EUROAPI",
        "documentation": "Euroapi"
       }
      }
     },
     "auth_ref": []
    },
    "srt_EuropeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "EuropeMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExcludingChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExcludingChiefExecutiveOfficerMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Excluding Chief Executive Officer [Member]",
        "terseLabel": "Excluding General Director",
        "documentation": "Excluding Chief Executive Officer"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExercisePriceOfOutstandingShareOptions2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExercisePriceOfOutstandingShareOptions2019",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise price of outstanding share options",
        "terseLabel": "Exercise price of outstanding options (in euros per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The exercise price of outstanding share options."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "sny_ExercisePriceRangeFourMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExercisePriceRangeFourMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Four [Member]",
        "terseLabel": "From \u20ac80.00 to \u20ac90.00 per share",
        "documentation": "Exercise Price Range Four [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExercisePriceRangeThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExercisePriceRangeThreeMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Three [Member]",
        "terseLabel": "From \u20ac70.00 to \u20ac80.00 per share",
        "documentation": "Exercise Price Range Three [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExercisePriceRangeTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExercisePriceRangeTwoMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price Range Two [Member]",
        "terseLabel": "From \u20ac60.00 to \u20ac70.00 per share",
        "documentation": "Exercise Price Range Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExpenseArisingFromTheImpactOfAcquisitionsOnInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExpenseArisingFromTheImpactOfAcquisitionsOnInventories",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Arising From The Impact Of Acquisitions On Inventories",
        "negatedLabel": "Expense arising from the impact of acquisitions on inventories",
        "documentation": "Expenses arising from the impact of acquisitions on inventories."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ExpenseDueToUnwindingOfDiscountOnProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseDueToUnwindingOfDiscountOnProvisions",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense arising from passage of time on other provisions",
        "negatedLabel": "Unwinding of discounting of provisions"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense from equity-settled share-based payment transactions",
        "terseLabel": "Expense recognized",
        "verboseLabel": "Total expense for restricted share plans"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "ifrs-full_ExpenseOfRestructuringActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ExpenseOfRestructuringActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 16.0
      },
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense of restructuring activities",
        "negatedLabel": "Restructuring costs and similar items",
        "totalLabel": "Total"
       }
      }
     },
     "auth_ref": [
      "r336"
     ]
    },
    "sny_ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails": {
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Of Restructuring Activities Employee Related Expenses",
        "terseLabel": "Employee-related expenses",
        "documentation": "Employee related expenses."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails": {
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Of Restructuring Activities Related To Property Plant And Equipment And To Inventories",
        "terseLabel": "Charges, gains or losses on assets",
        "documentation": "Expense of restructuring activities related to property plant and equipment to inventories."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ExpenseOfRestructuringActivitiesTransformationProgramsCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ExpenseOfRestructuringActivitiesTransformationProgramsCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails": {
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expense Of Restructuring Activities, Transformation Programs Costs",
        "terseLabel": "Costs of transformation programs",
        "documentation": "Expense Of Restructuring Activities, Transformation Programs Costs"
       }
      }
     },
     "auth_ref": []
    },
    "country_FR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "FR",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "FRANCE",
        "terseLabel": "France"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FairValueHedgesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FairValueHedgesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value hedges [member]",
        "terseLabel": "Fair value hedges"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for hedges of the exposure to changes in fair value of a recognised asset or liability or an unrecognised firm commitment, or an identified portion of such an asset, liability or firm commitment, that is attributable to a particular risk and could affect profit or loss. [Refer: Types of hedges [domain]]"
       }
      }
     },
     "auth_ref": [
      "r61",
      "r150",
      "r151",
      "r152",
      "r263",
      "r264",
      "r265"
     ]
    },
    "sny_FairValueOfPlanAtDateOfGrant": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FairValueOfPlanAtDateOfGrant",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Of Plan At Date Of Grant",
        "terseLabel": "Fair value of plan at the date of grant",
        "documentation": "Fair value of plan at the date of grant."
       }
      }
     },
     "auth_ref": []
    },
    "sny_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures [Member]",
        "documentation": "Fair Value On Cash Flow Hedges Excluding Associates And Joint Ventures [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FairValuePerShareAwardedForThreeYearServicePeriod": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FairValuePerShareAwardedForThreeYearServicePeriod",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Per Share Awarded For Three Year Service Period",
        "terseLabel": "Fair value per share awarded (in euros per share)",
        "documentation": "Fair value per share awarded to a three year service period."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_FinanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": -1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedTerseLabel": "comprising: Financial expenses"
       }
      }
     },
     "auth_ref": [
      "r328"
     ]
    },
    "ifrs-full_FinanceIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income",
        "verboseLabel": "Financial income",
        "terseLabel": "Financial income"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_FinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "FinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Net financial income/(expenses)"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "sny_FinancialInstrumentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FinancialInstrumentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial Instruments [Abstract]",
        "documentation": "Financial Instruments [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FirmOrdersOfPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FirmOrdersOfPropertyPlantAndEquipment",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Firm Orders Of Property Plant And Equipment",
        "terseLabel": "Firm orders of property, plant and equipment",
        "documentation": "Firm orders of property plant and equipment."
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondIssueFromApril2020Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondIssueFromApril2020Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Issue from April 2020 [Member]",
        "terseLabel": "Fixed Rate Bond Issue from April 2020",
        "documentation": "Fixed Rate Bond Issue from April 2020 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondIssueFromApril2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondIssueFromApril2022Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Issue from April 2022 [Member]",
        "terseLabel": "Fixed Rate Bond Issue from April 2022",
        "documentation": "Fixed Rate Bond Issue from April 2022 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondMaturingJune2029Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondMaturingJune2029Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Maturing June 2029 [Member]",
        "terseLabel": "Fixed Rate Bond Maturing June 2029",
        "documentation": "Fixed Rate Bond Maturing June 2029 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondMaturingMarch2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondMaturingMarch2027Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Maturing March 2027 [Member]",
        "terseLabel": "Fixed Rate Bond Maturing March 2027",
        "documentation": "Fixed Rate Bond Maturing March 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondMaturingMarch2031Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondMaturingMarch2031Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Maturing March 2031 [Member]",
        "terseLabel": "Fixed Rate Bond Maturing March 2031",
        "documentation": "Fixed Rate Bond Maturing March 2031 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FixedRateBondMaturingMarch2032Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FixedRateBondMaturingMarch2032Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fixed Rate Bond Maturing March 2032 [Member]",
        "terseLabel": "Fixed Rate Bond Maturing March 2032",
        "documentation": "Fixed Rate Bond Maturing March 2032 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForeignCurrencyTranslationMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForeignCurrencyTranslationMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Foreign Currency Translation [Member]",
        "terseLabel": "Foreign Currency Translation",
        "documentation": "Foreign Currency Translation"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInChineseYuanRenminbiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInChineseYuanRenminbiMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In Chinese Yuan Renminbi [Member]",
        "terseLabel": "Forward currency purchases in Chinese yuan renminbi",
        "documentation": "Forward Currency Purchases In Chinese Yuan Renminbi"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInHungarianFlorintMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInHungarianFlorintMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In Hungarian florint [Member]",
        "terseLabel": "Forward Currency Purchases In Hungarian florint",
        "documentation": "Forward Currency Purchases In Hungarian florint"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInSingaporeDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInSingaporeDollarMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In Singapore Dollar [Member]",
        "terseLabel": "Forward currency purchases in Singapore dollar",
        "documentation": "Forward currency purchases in Singapore Dollar."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInTurkishLiraMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInTurkishLiraMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In Turkish lira [Member]",
        "terseLabel": "Forward Currency Purchases In Turkish lira",
        "documentation": "Forward Currency Purchases In Turkish lira"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInUSDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInUSDollarMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In US Dollar [Member]",
        "terseLabel": "Forward currency purchases in US dollar",
        "documentation": "Forward currency purchases in USD."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInUSDollarUSBondMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInUSDollarUSBondMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In US Dollar, US Bond [Member]",
        "terseLabel": "Forward currency purchases in US dollar, US bond",
        "documentation": "Forward Currency Purchases In US Dollar, US Bond"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases In United Arab Emirates Dirham [Member]",
        "terseLabel": "Forward Currency Purchases In United Arab Emirates Dirham"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencyPurchasesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencyPurchasesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Purchases [Member]",
        "terseLabel": "Forward currency purchases",
        "documentation": "Forward currency purchases."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesInChineseYuanRenminbiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesInChineseYuanRenminbiMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales In Chinese Yuan Renminbi [member]",
        "terseLabel": "Forward currency sales in Chinese yuan renminbi",
        "documentation": "Forward currency sales in Chinese Yuan Renminbi."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesInJapaneseYenMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesInJapaneseYenMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales In Japanese Yen [Member]",
        "terseLabel": "Forward currency sales in Japanese yen",
        "documentation": "Forward currency sales in Japanese Yen."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesInPoundSterlingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesInPoundSterlingMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales In Pound Sterling [Member]",
        "terseLabel": "Forward currency sales in Pound sterling",
        "documentation": "Forward Currency Sales In Pound Sterling"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesInSingaporeDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesInSingaporeDollarMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales In Singapore Dollar [member]",
        "terseLabel": "Forward currency sales in Singapore dollar",
        "documentation": "Forward currency sales in Singapore Dollar."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesInUSDollarMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesInUSDollarMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales In US Dollar [Member]",
        "terseLabel": "Forward currency sales in US dollar",
        "documentation": "Forward currency sales in USD."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ForwardCurrencySalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ForwardCurrencySalesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forward Currency Sales [Member]",
        "terseLabel": "Forward currency sales",
        "documentation": "Forward currency sales."
       }
      }
     },
     "auth_ref": []
    },
    "sny_FourBillionFacilityMaturingDecember2027Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FourBillionFacilityMaturingDecember2027Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Billion Facility Maturing December 2027 [Member]",
        "terseLabel": "Four Billion Facility Maturing December 2027",
        "documentation": "Four Billion Facility Maturing December 2027 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_FourBillionFacilityMaturingMarch2030Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "FourBillionFacilityMaturingMarch2030Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Four Billion Facility Maturing March 2030 [Member]",
        "terseLabel": "Four Billion Facility Maturing March 2030",
        "documentation": "Four Billion Facility Maturing March 2030 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "GB",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED KINGDOM",
        "terseLabel": "United Kingdom"
       }
      }
     },
     "auth_ref": []
    },
    "sny_GainLossOnDerivativesUsedToManageCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GainLossOnDerivativesUsedToManageCashAndCashEquivalents",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) On Derivatives Used To Manage Cash And Cash Equivalents",
        "terseLabel": "Gain on derivatives used to manage cash and cash equivalents",
        "documentation": "Gain (loss) on derivatives used to manage cash and cash equivalents."
       }
      }
     },
     "auth_ref": []
    },
    "sny_GainLossOnDerivativesUsedToManageDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GainLossOnDerivativesUsedToManageDebt",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain (Loss) On Derivatives Used To Manage Debt",
        "terseLabel": "Gain on derivatives used to manage debt",
        "documentation": "Gain (loss) on derivatives used to manage debt."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from gain (loss) on remeasurement in other comprehensive income",
        "terseLabel": "Actuarial gains/(losses) on benefit obligations"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in a net defined benefit liability (asset) resulting from the remeasurement of that net defined benefit liability (asset). [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r21",
      "r220"
     ]
    },
    "sny_GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gain on Disposal of Opella, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Gain on disposal of Opella before tax",
        "documentation": "Gain on Disposal of Opella, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesOnCashFlowHedgesBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnCashFlowHedgesBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains (losses) on cash flow hedges, before tax",
        "terseLabel": "Change in fair value of cash flow hedges"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on cash flow hedges, before tax, before reclassification adjustments. [Refer: Cash flow hedges [member]]"
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "ifrs-full_GainsLossesOnExchangeDifferencesOnTranslationBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesOnExchangeDifferencesOnTranslationBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains (losses) on exchange differences on translation of foreign operations, before tax",
        "terseLabel": "Change in currency translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) recognised in other comprehensive income on exchange differences on the translation of financial statements of foreign operations, before tax, before reclassification adjustments. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r334"
     ]
    },
    "sny_GainsLossesOnRemeasuringDebtInstrumentsBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GainsLossesOnRemeasuringDebtInstrumentsBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains (Losses) On Remeasuring Debt Instruments, Before Tax",
        "terseLabel": "Change in fair value of debt instruments included in financial assets",
        "documentation": "Gains (Losses) On Remeasuring Debt Instruments, Before Tax"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains (losses) recognised in other comprehensive income including exchange differences, fair value measurement, entity's own equity instruments",
        "terseLabel": "Change in fair value of equity instruments included in financial assets and financial liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) including exchange differences recognised in other comprehensive income on the fair value measurement of the entity's own equity instruments. [Refer: At fair value [member]; Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r109",
      "r278"
     ]
    },
    "ifrs-full_GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains (losses) recognised in profit or loss including exchange differences, fair value measurement, liabilities",
        "terseLabel": "Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount)"
       }
      },
      "en": {
       "role": {
        "documentation": "The gains (losses) including exchange differences recognised in profit or loss on the fair value measurement of liabilities. [Refer: At fair value [member]]"
       }
      }
     },
     "auth_ref": [
      "r108",
      "r277"
     ]
    },
    "sny_GainsOnDivestmentOfProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GainsOnDivestmentOfProducts",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gains On Divestment Of Products",
        "terseLabel": "Gains on divestment of some mature products",
        "documentation": "Gains on divestment of products."
       }
      }
     },
     "auth_ref": []
    },
    "sny_GeneralInformationAboutFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GeneralInformationAboutFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "General Information About Financial Statements [Abstract]",
        "documentation": "General Information About Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_GeneralMedicinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GeneralMedicinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Medicines [Member]",
        "terseLabel": "General Medicines [Member]",
        "documentation": "General Medicines"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GeographicalAreasAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasAxis",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [axis]",
        "terseLabel": "Geographical areas [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r340",
      "r360",
      "r368",
      "r385"
     ]
    },
    "ifrs-full_GeographicalAreasDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GeographicalAreasDomain",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical areas [domain]",
        "terseLabel": "Geographical areas [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated geographical areas. It also represents the standard value for the 'Geographical areas' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r175",
      "r340",
      "r360",
      "r368",
      "r385"
     ]
    },
    "sny_GoldBondProductLitigationInTheUSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GoldBondProductLitigationInTheUSMember",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gold Bond Product Litigation In The US [Member]",
        "terseLabel": "Gold Bond Product Litigation In The US",
        "documentation": "Gold Bond Product Litigation In The US"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r141",
      "r230",
      "r231",
      "r260",
      "r300"
     ]
    },
    "sny_GoodwillDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "GoodwillDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Goodwill",
        "documentation": "Goodwill, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossCarryingAmountMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfAccountsReceivableDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]",
        "terseLabel": "Gross value"
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r65",
      "r68",
      "r141",
      "r156",
      "r158",
      "r213",
      "r236",
      "r245",
      "r248",
      "r268",
      "r269",
      "r372"
     ]
    },
    "ifrs-full_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "auth_ref": [
      "r396"
     ]
    },
    "ifrs-full_HedgedItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "HedgedItemsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedged items [axis]",
        "terseLabel": "Hedged items [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r264"
     ]
    },
    "ifrs-full_HedgedItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "HedgedItemsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedged items [domain]",
        "terseLabel": "Hedged items [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for hedged items. A hedged item can be a recognised asset or liability, an unrecognised firm commitment, a forecast transaction or a net investment in a foreign operation. The hedged item can be: (a) a single item; or (b) a group of items (subject to paragraphs 6.6.1\u20136.6.6 and B6.6.1\u2013B6.6.16 of IFRS 9). A hedged item can also be a component of such an item or group of items (see paragraphs 6.3.7 and B6.3.7\u2013B6.3.25 of IFRS 9). This member also represents the standard value for the 'Hedged items' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r151",
      "r264"
     ]
    },
    "ifrs-full_HedgingInstrumentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "HedgingInstrumentsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedging instruments [axis]",
        "terseLabel": "Hedging Instruments [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r150",
      "r263"
     ]
    },
    "ifrs-full_HedgingInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "HedgingInstrumentsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hedging instruments [domain]",
        "terseLabel": "Hedging instruments [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for hedging instruments. A hedging instrument can be a designated: (a) derivative measured at fair value through profit or loss, except for some written options (see paragraph B6.2.4 of IFRS 9); (b) non-derivative financial asset or non-derivative financial liability measured at fair value through profit or loss, unless it is a financial liability designated as at fair value through profit or loss for which the amount of its change in fair value that is attributable to changes in the credit risk of that liability is presented in other comprehensive income in accordance with paragraph 5.7.7 of IFRS 9. For a hedge of foreign currency risk, the foreign currency risk component of a non-derivative financial asset or a non-derivative financial liability may be designated as a hedging instrument provided that it is not an investment in an equity instrument for which an entity has elected to present changes in fair value in other comprehensive income in accordance with paragraph 5.7.5 of IFRS 9. This member also represents the standard value for the 'Hedging instruments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r150",
      "r263"
     ]
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Identifiable intangible assets recognised as of acquisition date",
        "terseLabel": "Identifiable intangible assets recognised as of acquisition date"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r370",
      "r371",
      "r393"
     ]
    },
    "sny_ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impact Of The Workdown Of Acquired Inventories Remeasured At Fair Value",
        "terseLabel": "Impact of the workdown of acquired inventories remeasured at fair value",
        "documentation": "Impact of the workdown of acquired inventories remeasured at fair value arising from business combination in accordance with IFRS 3."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ImpairmentLossOnIntangibleAssetOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ImpairmentLossOnIntangibleAssetOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment Loss on Intangible Asset Other Than Goodwill",
        "terseLabel": "Impairment Loss on Intangible Asset Other Than Goodwill",
        "documentation": "Impairment Loss on Intangible Asset Other Than Goodwill"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in other comprehensive income, intangible assets other than goodwill",
        "negatedTerseLabel": "Impairment losses, net of reversals"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of impairment loss recognised in other comprehensive income for intangible assets other than goodwill. [Refer: Impairment loss recognised in other comprehensive income; Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r54",
      "r238"
     ]
    },
    "ifrs-full_ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss recognised in profit or loss, intangible assets other than goodwill",
        "negatedLabel": "Impairment of intangible assets",
        "terseLabel": "Impairment loss on other intangible assets"
       }
      }
     },
     "auth_ref": [
      "r55",
      "r239"
     ]
    },
    "ifrs-full_ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables",
        "negatedLabel": "Impairment loss (reversal of impairment loss) recognised in profit or loss, trade receivables"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromContinuingOperations",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Before Tax And Investments Accounted For Equity Method Investments",
        "totalLabel": "Income before tax and investments accounted for using the equity method",
        "terseLabel": "Income before tax and investments accounted for using the equity method",
        "documentation": "Income before tax and investments accounted for equity method investments."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Before Tax And Investments Accounted For Using The Equity Method, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax",
        "documentation": "Income Before Tax And Investments Accounted For Using The Equity Method, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Expense (Benefit), Disposal Group Including Discontinued Operations",
        "verboseLabel": "Income tax expense",
        "documentation": "Income Tax Expense (Benefit), Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxExpenseContinuingOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromContinuingOperations",
       "weight": -1.0,
       "order": 20.0
      },
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfAllocationOfIncomeTaxExpenseBetweenCurrentAndDeferredTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax expense (income)",
        "negatedLabel": "Income tax expense",
        "negatedTotalLabel": "Total"
       }
      }
     },
     "auth_ref": [
      "r2",
      "r4",
      "r5",
      "r31",
      "r101",
      "r167",
      "r207",
      "r208",
      "r209",
      "r330"
     ]
    },
    "sny_IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Equity Investments",
        "negatedTerseLabel": "Tax effects",
        "documentation": "Income Tax Relating To Actuarial Gains (Losses) Arising From Changes In Financial Assumptions Net Defined Benefit Liability Asset Excluding Equity Investments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax relating to cash flow hedges included in other comprehensive income",
        "negatedTerseLabel": "Tax effects"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income in relation to cash flow hedges. [Refer: Cash flow hedges [member]; Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r3",
      "r332"
     ]
    },
    "sny_IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Equity Investments",
        "negatedTerseLabel": "Tax effects",
        "documentation": "Income Tax Relating To Change In Fair Value Of Debt Instrument Excluding Equity Investments"
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method",
        "negatedTerseLabel": "Tax effects",
        "documentation": "Income Tax Relating To Change In Fair Value Of Equity Instruments Excluding Equity Method"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income that will be reclassified to profit or loss",
        "negatedLabel": "Tax effects"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "ifrs-full_IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income tax relating to components of other comprehensive income that will not be reclassified to profit or loss",
        "negatedLabel": "Tax effects"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of income tax relating to amounts recognised in other comprehensive income that will not be reclassified to profit or loss. [Refer: Income tax relating to components of other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r335"
     ]
    },
    "ifrs-full_IncomeTaxesPaidRefundAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedLabel": "Income tax paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r347"
     ]
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Net change in cash and cash equivalents"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r202"
     ]
    },
    "ifrs-full_IncreaseDecreaseInContingentConsiderationAssetLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseInContingentConsiderationAssetLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) in contingent consideration asset (liability)",
        "negatedLabel": "Fair value remeasurement of contingent consideration"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in a contingent consideration asset (liability) relating to a business combination."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r259"
     ]
    },
    "sny_IncreaseDecreaseInTotalExpenseOfRestructuringActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseInTotalExpenseOfRestructuringActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) In Total Expense Of Restructuring Activities",
        "negatedLabel": "Decrease in total expense of restructuring activities",
        "documentation": "Increase (Decrease) In Total Expense Of Restructuring Activities"
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase Decrease Of Unused Provision Reversed, Other Provisions",
        "negatedTerseLabel": "Reversals of unutilized provisions",
        "documentation": "Increase Decrease Of Unused Provision Reversed, Other Provisions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Actuarial Gains And Losses On Defined Benefit Plans, Other Provisions",
        "terseLabel": "Actuarial gains and losses on defined-benefit plans (B.12.1.)",
        "documentation": "Actuarial gains and losses on defined-benefit plans."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through changes in ownership interests in subsidiaries that do not result in loss of control, equity",
        "terseLabel": "Change in non-controlling interests without loss of control"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity through changes in ownership interests in subsidiaries that do not result in loss of control. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r292"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughExerciseOfOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughExerciseOfOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through exercise of options, equity",
        "terseLabel": "Exercise of stock options"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from the exercise of options."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "sny_IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Issuance Of Restricted Shares, Equity",
        "terseLabel": "Other changes arising from issuance of restricted shares",
        "documentation": "Increase (decrease) through issuance of restricted shares, equity."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Net Exchange Differences Business Combinations And Noncontrolling Interests",
        "terseLabel": "Currency translation differences",
        "documentation": "Increase decrease through net exchange differences business combinations and noncontrolling interests."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, intangible assets other than goodwill",
        "terseLabel": "Currency translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from net exchange differences arising on the translation of the financial statements from the functional currency into a different presentation currency, including the translation of a foreign operation into the presentation currency of the reporting entity. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through net exchange differences, other provisions",
        "terseLabel": "Currency translation differences"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from foreign currency exchange rate changes on provisions measured in a currency different from the entity's presentation currency. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "sny_IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Net Interest Related To Employees Benefits And Unwinding Of Discount, Other Provisions",
        "terseLabel": "Net interest related to employee benefits, and unwinding of discount",
        "documentation": "Net interest related to employees benefits and unwinding of discount."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Share-Based Payment Plans Employee Share Ownership Plans",
        "terseLabel": "Employee share ownership plan",
        "documentation": "Employee share ownership plans."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Share-Based Payment Plans Issuance Of Restricted Shares And Vesting Of Existing Restricted Shares",
        "terseLabel": "Issuance of restricted shares and vesting of existing restricted shares",
        "documentation": "Increase (decrease) through share-based payment plans issuance of restricted shares and vesting of existing restricted shares."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Share-Based Payment Plans Tax Effects Of The Exercise Of Stock Options",
        "terseLabel": "Tax effects of share-based payments",
        "documentation": "Tax effects of the exercise of stock options."
       }
      }
     },
     "auth_ref": []
    },
    "sny_IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) Through Share-Based Payment Plans Value Of Services Obtained From Employees",
        "terseLabel": "Value of services obtained from employees",
        "documentation": "Value of services obtained from employees."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers and other changes, other provisions",
        "terseLabel": "Transfers"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in other provisions resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r409"
     ]
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (decrease) through transfers, intangible assets other than goodwill",
        "terseLabel": "Transfers"
       }
      },
      "en": {
       "role": {
        "documentation": "The increase (decrease) in intangible assets other than goodwill resulting from transfers. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r411"
     ]
    },
    "sny_IndustrialSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IndustrialSalesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Industrial Sales [Member]",
        "terseLabel": "Industrial Sales [Member]",
        "documentation": "Industrial Sales"
       }
      }
     },
     "auth_ref": []
    },
    "sny_InfluenzaVaccinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InfluenzaVaccinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Influenza Vaccines [Member]",
        "terseLabel": "Influenza Vaccines [Member]",
        "documentation": "Influenza Vaccines."
       }
      }
     },
     "auth_ref": []
    },
    "sny_InfraservGmbhAndCoHochstKGMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InfraservGmbhAndCoHochstKGMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Infraserv Gmbh And Co Hochst KG [member]",
        "terseLabel": "Infraserv GmbH &amp; Co. H\u00f6chst KG",
        "documentation": "Infraserv GmbH and Co. Hochst KG."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsAndGoodwillAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsAndGoodwillAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible assets other than goodwill",
        "verboseLabel": "Other intangible assets",
        "terseLabel": "Carrying amount of intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      }
     },
     "auth_ref": [
      "r58",
      "r241",
      "r300"
     ]
    },
    "ifrs-full_InterestCostsCapitalised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestCostsCapitalised",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest costs capitalised",
        "terseLabel": "Interest costs capitalised"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of interest costs that an entity incurs in connection with the borrowing of funds that are directly attributable to the acquisition, construction or production of a qualifying asset and which form part of the cost of that asset."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_InterestExpenseOnBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "sny_CostOfDebtNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on borrowings",
        "negatedLabel": "Cost of debt"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestExpenseOnLeaseLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities",
        "negatedTerseLabel": "Net interest expense on lease liabilities"
       }
      }
     },
     "auth_ref": [
      "r118",
      "r184"
     ]
    },
    "sny_InterestIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "sny_CostOfDebtNet",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Income",
        "terseLabel": "Interest income",
        "documentation": "Interest Income"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestPaidClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestPaidClassifiedAsOperatingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest paid, classified as operating activities",
        "negatedLabel": "Interest paid"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for interest paid, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "sny_InterestRateAndCurrencyDerivativesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateAndCurrencyDerivativesMember",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate And Currency Derivatives [Member]",
        "terseLabel": "Interest rate and currency derivatives used to hedge debt",
        "documentation": "Interest rate and currency derivatives used to hedge debt."
       }
      }
     },
     "auth_ref": []
    },
    "sny_InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 6.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "sny_DebtNetOfCashAndCashEquivalents",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate And Currency Derivatives Used To Manage Cash And Cash Equivalent",
        "negatedLabel": "Interest rate and currency derivatives used to manage cash and cash equivalents",
        "documentation": "Interest rate and currency derivatives used to manage cash and cash equivalent."
       }
      }
     },
     "auth_ref": []
    },
    "sny_InterestRateAndCurrencyDerivativesUsedToManageDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateAndCurrencyDerivativesUsedToManageDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate And Currency Derivatives Used To Manage Debt",
        "negatedLabel": "Interest rate and currency derivatives used to manage debt",
        "documentation": "Interest rate and currency derivatives used to manage debt."
       }
      }
     },
     "auth_ref": []
    },
    "sny_InterestRateSwapsPayCapitalizedEsterReceive092Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateSwapsPayCapitalizedEsterReceive092Member",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Swaps Pay Capitalized Ester / Receive 0.92% [Member]",
        "terseLabel": "pay capitalized Ester / receive 0.92%",
        "documentation": "Interest Rate Swaps Pay Capitalized Ester / Receive 0.92%"
       }
      }
     },
     "auth_ref": []
    },
    "sny_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Swaps Pay Capitalized SOFR USD Receive 1 Point 17 Percent [Member]",
        "terseLabel": "pay capitalized SOFR USD / receive 1.17%"
       }
      }
     },
     "auth_ref": []
    },
    "sny_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest Rate Swaps Pay Two Point Zero Eight Percent Receive Euribor Three M [Member]",
        "terseLabel": "pay 2.08% / receive Euribor 3m"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InterestReceivedClassifiedAsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InterestReceivedClassifiedAsOperatingActivities",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest received, classified as operating activities",
        "terseLabel": "Interest received"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from interest received, classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "sny_InterestsInOtherEntitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InterestsInOtherEntitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interests In Other Entities [Abstract]",
        "documentation": "Interests In Other Entities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Inventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Inventories",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current inventories",
        "terseLabel": "Inventories"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      }
     },
     "auth_ref": [
      "r24",
      "r200",
      "r302",
      "r398"
     ]
    },
    "sny_InventoriesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "InventoriesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventories, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Inventories",
        "documentation": "Inventories, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_InvestmentAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentAccountedForUsingEquityMethod",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments accounted for using equity method",
        "terseLabel": "Investments accounted for using the equity method"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments accounted for using the equity method. The equity method is a method of accounting whereby the investment is initially recognised at cost and adjusted thereafter for the post-acquisition change in the investor's share of net assets of the investee. The investor's profit or loss includes its share of the profit or loss of the investee. The investor's other comprehensive income includes its share of the other comprehensive income of the investee. [Refer: At cost [member]]"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r169",
      "r274",
      "r301"
     ]
    },
    "ifrs-full_InvestmentsInAssociatesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentsInAssociatesAccountedForUsingEquityMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in associates accounted for using equity method",
        "terseLabel": "Investments in associates"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in associates accounted for using the equity method. [Refer: Total for all associates [member]; Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_InvestmentsInJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "InvestmentsInJointVenturesAccountedForUsingEquityMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments in joint ventures accounted for using equity method",
        "terseLabel": "Investments in joint ventures"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of investments in joint ventures accounted for using the equity method. [Refer: Total for all joint ventures [member]; Investments accounted for using equity method]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "sny_IssuanceOfFurtherSharesAsAnEmployersContribution": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "IssuanceOfFurtherSharesAsAnEmployersContribution",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance Of Further Shares As An Employers Contribution",
        "terseLabel": "Number of shares issued immediately for employer's contribution (in shares)",
        "documentation": "Further shares as an employers contribution."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_IssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapital",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital",
        "terseLabel": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r401"
     ]
    },
    "ifrs-full_IssuedCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "IssuedCapitalMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issued capital [member]",
        "terseLabel": "Share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "sny_ItemsNotSubsequentlyReclassifiableToProfitOrLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ItemsNotSubsequentlyReclassifiableToProfitOrLossMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items Not Subsequently Reclassifiable To Profit Or Loss [Member]",
        "terseLabel": "Items not subsequently reclassifiable to profit or loss",
        "documentation": "Items not subsequently reclassifiable to profit or loss."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ItemsSubsequentlyReclassifiableToProfitOrLossMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ItemsSubsequentlyReclassifiableToProfitOrLossMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Items Subsequently Reclassifiable To Profit Or Loss [Member]",
        "terseLabel": "Items subsequently reclassifiable to profit or loss",
        "documentation": "Items subsequently reclassifiable to profit or loss."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_JointVenturesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "JointVenturesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint ventures [axis]",
        "terseLabel": "Joint ventures [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r104",
      "r271"
     ]
    },
    "ifrs-full_JointVenturesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "JointVenturesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Joint ventures [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Joint ventures' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r104",
      "r271"
     ]
    },
    "ifrs-full_LaterThanFiveYearsAndNotLaterThanSevenYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsAndNotLaterThanSevenYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than five years and not later than seven years [member]",
        "terseLabel": "2032"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years and not later than seven years."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r383"
     ]
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFiveYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than five years [member]",
        "terseLabel": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r189",
      "r193",
      "r376",
      "r381",
      "r383"
     ]
    },
    "ifrs-full_LaterThanFourYearsAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanFourYearsAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than four years and not later than five years [member]",
        "terseLabel": "2029 and beyond"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than four years and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r376",
      "r383",
      "r429"
     ]
    },
    "ifrs-full_LaterThanOneMonthAndNotLaterThanThreeMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneMonthAndNotLaterThanThreeMonthsMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one month and not later than three months [member]",
        "terseLabel": "Overdue by 1-3 months"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one month and not later than three months."
       }
      }
     },
     "auth_ref": [
      "r374",
      "r378",
      "r383"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanFiveYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanFiveYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than five years [member]",
        "terseLabel": "Later than one year and not later than five years [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than five years."
       }
      }
     },
     "auth_ref": [
      "r188",
      "r192",
      "r375",
      "r383"
     ]
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanTwoYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearAndNotLaterThanTwoYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year and not later than two years [member]",
        "terseLabel": "2026"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than two years."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r376",
      "r383",
      "r429"
     ]
    },
    "ifrs-full_LaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanOneYearMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than one year [member]",
        "verboseLabel": "Overdue by > 12 months"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      }
     },
     "auth_ref": [
      "r313"
     ]
    },
    "ifrs-full_LaterThanSixMonthsAndNotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanSixMonthsAndNotLaterThanOneYearMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than six months and not later than one year [member]",
        "terseLabel": "Overdue by 6-12 months"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than six months and not later than one year."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r380",
      "r383"
     ]
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three months and not later than six months [member]",
        "terseLabel": "Overdue by 3-6 months"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than six months."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r379",
      "r383"
     ]
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFourYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanThreeYearsAndNotLaterThanFourYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than three years and not later than four years [member]",
        "terseLabel": "2028"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than four years."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r376",
      "r383",
      "r429"
     ]
    },
    "ifrs-full_LaterThanTwoYearsAndNotLaterThanThreeYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LaterThanTwoYearsAndNotLaterThanThreeYearsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later than two years and not later than three years [member]",
        "terseLabel": "2027"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than two years and not later than three years."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r376",
      "r383",
      "r429"
     ]
    },
    "ifrs-full_LeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LeaseLiabilities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "terseLabel": "Lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "sny_LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Liabilities, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Lease liabilities",
        "documentation": "Lease Liabilities, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_LegalAndArbitralProceedingsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LegalAndArbitralProceedingsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal And Arbitral Proceedings [Axis]",
        "terseLabel": "Legal And Arbitral Proceedings [Axis]",
        "documentation": "Legal And Arbitral Proceedings [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_LegalAndArbitralProceedingsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LegalAndArbitralProceedingsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal And Arbitral Proceedings [Domain]",
        "terseLabel": "Legal And Arbitral Proceedings [Domain]",
        "documentation": "[Domain] for Legal And Arbitral Proceedings [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 34.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities included in disposal groups classified as held for sale",
        "terseLabel": "Liabilities related to assets held for sale"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities included in disposal groups classified as held for sale. [Refer: Liabilities; Disposal groups classified as held for sale [member]]"
       }
      }
     },
     "auth_ref": [
      "r146",
      "r307"
     ]
    },
    "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities Of Disposal Group Including Discontinued Operations",
        "totalLabel": "Total liabilities related to assets held for sale",
        "documentation": "Liabilities Of Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_LiabilitiesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LiabilitiesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Related Party Transactions",
        "terseLabel": "Total liabilities",
        "documentation": "Liabilities, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LiabilityAssetOfDefinedBenefitPlans": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LiabilityAssetOfDefinedBenefitPlans",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset)",
        "terseLabel": "Net defined benefit liability (asset)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of deficit or surplus in a defined benefit plan, adjusted for any effect of limiting a net defined benefit asset to the asset ceiling. [Refer: Defined benefit plans [domain]]"
       }
      }
     },
     "auth_ref": [
      "r18",
      "r219"
     ]
    },
    "sny_LiabilityRecognisedForEstimatedFutureRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LiabilityRecognisedForEstimatedFutureRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liability Recognised For Estimated Future Royalties",
        "terseLabel": "Liability Recognised For Estimated Future Royalties",
        "documentation": "Liability Recognised For Estimated Future Royalties"
       }
      }
     },
     "auth_ref": []
    },
    "sny_LoansToAssociates": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LoansToAssociates",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Loans to Associates",
        "terseLabel": "Loans to Associates",
        "documentation": "Loans to Associates"
       }
      }
     },
     "auth_ref": []
    },
    "sny_LongTermPrepaidExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "LongTermPrepaidExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Long Term Prepaid Expenses",
        "terseLabel": "Long-term prepaid expenses",
        "documentation": "Long term prepaid expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_LongtermBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "LongtermBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfChangesInFinancialPositionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "terseLabel": "Long-term debt"
       }
      },
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "sny_MCMVaccineBVMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MCMVaccineBVMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MCM Vaccine BV [Member]",
        "terseLabel": "MCM Vaccine BV",
        "documentation": "MCM Vaccine BV"
       }
      }
     },
     "auth_ref": []
    },
    "sny_MSDContingentConsiderationEuropeanVaccinesBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MSDContingentConsiderationEuropeanVaccinesBusinessMember",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MSD Contingent Consideration European Vaccines Business [Member]",
        "terseLabel": "MSD contingent consideration (European Vaccines business)",
        "documentation": "MSD contingent consideration European vaccines business."
       }
      }
     },
     "auth_ref": []
    },
    "sny_MSPVaccineCompanyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MSPVaccineCompanyMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MSP Vaccine Company [Member]",
        "terseLabel": "MSP Vaccine Company",
        "documentation": "MSP Vaccine Company"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [axis]",
        "terseLabel": "Major customers [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "ifrs-full_MajorCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MajorCustomersDomain",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Major customers [domain]",
        "terseLabel": "Customers [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for customers. It also represents the standard value for the 'Major customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "sny_ManufacturingAndSupplyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ManufacturingAndSupplyMember",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Manufacturing And Supply [Member]",
        "terseLabel": "Manufacturing &amp; Supply",
        "documentation": "Manufacturing and supply"
       }
      }
     },
     "auth_ref": []
    },
    "sny_MarketConditionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MarketConditionAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Condition [Axis]",
        "terseLabel": "Market Condition [Axis]",
        "documentation": "Market Condition"
       }
      }
     },
     "auth_ref": []
    },
    "sny_MarketConditionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MarketConditionDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Market Condition [Domain]",
        "terseLabel": "Market Condition [Domain]",
        "documentation": "Market Condition [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_MarketedProductsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MarketedProductsMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Marketed Products [Member]",
        "terseLabel": "Marketed products",
        "documentation": "Marketed products."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MarketsOfCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MarketsOfCustomersAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Markets of customers [axis]",
        "terseLabel": "Markets of customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r386"
     ]
    },
    "ifrs-full_MarketsOfCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MarketsOfCustomersDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Markets of customers [domain]",
        "terseLabel": "Markets of customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all markets of customers. It also represents the standard value for the 'Markets of customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r386"
     ]
    },
    "ifrs-full_MaterialReconcilingItemsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaterialReconcilingItemsMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material reconciling items [member]",
        "terseLabel": "Material reconciling items"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for material adjustments used to reconcile items in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_MaturityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityAxis",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [axis]",
        "terseLabel": "Maturity [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r149",
      "r159",
      "r180",
      "r183",
      "r190",
      "r194",
      "r266",
      "r314",
      "r342",
      "r376"
     ]
    },
    "ifrs-full_MaturityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MaturityDomain",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maturity [domain]",
        "terseLabel": "Aggregated time bands [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r115",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r126",
      "r149",
      "r180",
      "r183",
      "r190",
      "r194",
      "r266",
      "r314",
      "r342",
      "r376",
      "r382"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MeasurementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [axis]",
        "terseLabel": "Measurement [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r67",
      "r106",
      "r247",
      "r275"
     ]
    },
    "ifrs-full_MeasurementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MeasurementDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measurement [domain]",
        "terseLabel": "Aggregated measurement [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r63",
      "r67",
      "r106",
      "r247",
      "r275"
     ]
    },
    "sny_MeningitisTravelAndEndemicVaccinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MeningitisTravelAndEndemicVaccinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Meningitis Travel And Endemic Vaccines [Member]",
        "terseLabel": "Meningitis Travel And Endemic Vaccines",
        "documentation": "Meningitis Travel And Endemic Vaccines"
       }
      }
     },
     "auth_ref": []
    },
    "sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MileStone Payment Per CVR Recognised In Business Combination attainment of future development",
        "terseLabel": "MileStone Payment Per CVR Recognised In Business Combination attainment of future development",
        "documentation": "Milestone payment per CVR recognised in business combination attainment of future development."
       }
      }
     },
     "auth_ref": []
    },
    "sny_MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MileStone Payment Per CVR Recognised In Business Combination attainment of regulatory milestones",
        "terseLabel": "MileStone Payment Per CVR Recognised In Business Combination attainment of regulatory milestones",
        "documentation": "Milestone payment per CVR recognised in business combination attainment of regulatory milestones."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MiscellaneousOtherOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating expense",
        "negatedLabel": "Other operating expenses",
        "terseLabel": "Other operating expense"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_MiscellaneousOtherOperatingIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MiscellaneousOtherOperatingIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous other operating income",
        "terseLabel": "Other operating income"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "sny_MiscellaneousOtherOperatingIncomeExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MiscellaneousOtherOperatingIncomeExpenses",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous Other Operating Income (Expenses)",
        "terseLabel": "Other operating income and expenses",
        "documentation": "Other operating income and expenses."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_MiscellaneousOtherProvisionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "MiscellaneousOtherProvisionsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous other provisions [member]",
        "terseLabel": "Other provisions"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for miscellaneous other provisions. [Refer: Classes of other provisions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r48",
      "r233"
     ]
    },
    "sny_MiscellaneousOtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "MiscellaneousOtherRevenue",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Miscellaneous other revenue",
        "terseLabel": "Other",
        "documentation": "Miscellaneous other revenue"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetAssetsLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetAssetsLiabilities",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets (liabilities)",
        "terseLabel": "Assets (liabilities)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets less the amount of liabilities."
       }
      }
     },
     "auth_ref": [
      "r353",
      "r429"
     ]
    },
    "sny_NetCashInflowFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetCashInflowFromDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 29.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Inflow from Discontinued Operations",
        "verboseLabel": "Net cash inflow from the Opella transaction",
        "terseLabel": "Net Cash Inflow from Discontinued Operations",
        "documentation": "Net Cash Inflow from Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetCashProvidedByusedInContinuingInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetCashProvidedByusedInContinuingInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by/(used in) Continuing Investing Activities",
        "totalLabel": "Net Cash Provided by/(used in) Continuing Investing Activities",
        "documentation": "Net Cash Provided by/(used in) Continuing Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetCashProvidedByusedInDiscontinuingInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetCashProvidedByusedInDiscontinuingInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by/(used in) Discontinuing Investing Activities",
        "terseLabel": "Net cash provided by/(used in) investing activities of the discontinued Opella business",
        "documentation": "Net Cash Provided by/(used in) Discontinuing Investing Activities"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Change In Other Current Assets And Other Current Liabilities",
        "terseLabel": "Net change in other current assets and other current liabilities",
        "documentation": "Adjustments for decrease (increase) in other current assets and increase (decrease) in other current liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetChangeInOtherNonCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetChangeInOtherNonCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": 1.0,
       "order": 27.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Change In Other Non-Current Assets",
        "terseLabel": "Net change in other non-current assets",
        "documentation": "Net change in other non-current assets."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetAxis",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [axis]",
        "terseLabel": "Net defined benefit liability (asset) [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r219"
     ]
    },
    "ifrs-full_NetDefinedBenefitLiabilityAssetDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetDefinedBenefitLiabilityAssetDomain",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net defined benefit liability (asset) [domain]",
        "terseLabel": "Net defined benefit liability (asset) [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the net defined benefit liability (asset). It also represents the standard value for the 'Net defined benefit liability (asset)' axis if no other member is used. [Refer: Net defined benefit liability (asset)]"
       }
      }
     },
     "auth_ref": [
      "r18",
      "r219"
     ]
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NetForeignExchangeLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "terseLabel": "Net foreign exchange loss"
       }
      }
     },
     "auth_ref": [
      "r407",
      "r431"
     ]
    },
    "sny_NetIncomeRelatedPartyDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetIncomeRelatedPartyDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income, Related Party Disclosures",
        "terseLabel": "Net Income",
        "documentation": "Net Income, Related Party Disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetInterestCostRelatedToEmployeeBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetInterestCostRelatedToEmployeeBenefits",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Interest Cost Related To Employee Benefits",
        "negatedLabel": "Net interest cost related to employee benefits",
        "documentation": "Net interest cost related to employee benefits."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NetSalesAndOtherRevenuesRelatedPartyDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NetSalesAndOtherRevenuesRelatedPartyDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales and Other Revenues, Related Party Disclosures",
        "terseLabel": "Net Sales and Other Revenues",
        "documentation": "Net Sales and Other Revenues, Related Party Disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NexviazymeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NexviazymeMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nexviazyme [Member]",
        "terseLabel": "Nexviazyme",
        "documentation": "Nexviazyme"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentAssetsMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Assets [Member]",
        "terseLabel": "non-current",
        "documentation": "Non-current assets."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current assets, Related Party Transactions",
        "terseLabel": "Non-current assets",
        "documentation": "Non Current assets, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentLiabilitiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Liabilities [Member]",
        "terseLabel": "non-current",
        "documentation": "Non-current liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentLiabilitiesRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentLiabilitiesRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non Current Liabilities, Related Party Transactions",
        "terseLabel": "Non Current Liabilities",
        "documentation": "Non Current Liabilities, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 23.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsParantheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Liabilities Related To Business Combinations And To Non-Controlling Interests",
        "terseLabel": "Non-current liabilities related to business combinations and to non-controlling interests",
        "verboseLabel": "Non-current portion",
        "documentation": "This account includes non-current portion of contingent considerations that satisfy the recognition criteria of IFRS 3 Business combinations, measured initially at their fair value as at the date of acquisition. This account also includes non-current portion of liabilities related to non-controlling interests."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentLoansAndReceivables": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentLoansAndReceivables",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non current loans and receivables",
        "terseLabel": "Long-term loans and advances and other non-current receivables",
        "documentation": "Non current loans and receivables"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentProvisionsAndOtherNonCurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 24.0
      },
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Provisions And Other Non-Current Liabilities",
        "verboseLabel": "Non-current provisions and other non-current liabilities",
        "totalLabel": "Non-current provisions",
        "documentation": "The amount of non-current provisions and non-current other liabilities that the entity does not separately disclose in the same statement or note."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Provisions And Other Non-Current Liabilities, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Non-current provisions and other non-current liabilities",
        "documentation": "Non-Current Provisions And Other Non-Current Liabilities, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonCurrentRestructuringProvisionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonCurrentRestructuringProvisionMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Current Restructuring Provision [Member]",
        "terseLabel": "Restructuring provisions",
        "documentation": "Restructuring provisions."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NonOperatingForeignExchangeGainsLosses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NonOperatingForeignExchangeGainsLosses",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Operating Foreign Exchange Gains/(Losses)",
        "terseLabel": "Non-operating foreign exchange gains/(losses)",
        "documentation": "Non-operating foreign exchange gains/(losses)."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodAxis",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [axis]",
        "terseLabel": "Non-adjusting events after reporting period [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r206"
     ]
    },
    "ifrs-full_NonadjustingEventsAfterReportingPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NonadjustingEventsAfterReportingPeriodDomain",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-adjusting events after reporting period [domain]",
        "terseLabel": "Non-adjusting events after reporting period [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for events that occur between the end of the reporting period and the date when the financial statements are authorised for issue and are indicative of conditions that arose after the reporting period. It also represents the standard value for the 'Non-adjusting events after reporting period' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r206"
     ]
    },
    "ifrs-full_NoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests",
        "verboseLabel": "Equity attributable to non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r87",
      "r308"
     ]
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncontrollingInterestsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]",
        "terseLabel": "Attributable to\u00a0non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets",
        "totalLabel": "Non-current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r93",
      "r315",
      "r354"
     ]
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets [abstract]",
        "terseLabel": "Non-current assets [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets or disposal groups classified as held for sale",
        "terseLabel": "Assets held for sale"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets or disposal groups classified as held for sale. [Refer: Disposal groups classified as held for sale [member]]"
       }
      }
     },
     "auth_ref": [
      "r146"
     ]
    },
    "ifrs-full_NoncurrentDerivativeFinancialAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentDerivativeFinancialAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current derivative financial assets",
        "terseLabel": "Derivative financial instruments"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current derivative financial assets. [Refer: Derivative financial assets]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current financial assets at fair value through other comprehensive income",
        "terseLabel": "Instruments at fair value through other comprehensive income"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets at fair value through other comprehensive income. [Refer: Financial assets at fair value through other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r163",
      "r262"
     ]
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLeaseLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current lease liabilities",
        "terseLabel": "Non-current lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "ifrs-full_NoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities",
        "totalLabel": "Non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r95",
      "r316",
      "r354"
     ]
    },
    "ifrs-full_NoncurrentProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NoncurrentProvisions",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails": {
       "parentTag": "sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current provisions",
        "terseLabel": "Provisions",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current provisions, including provisions for employee benefits. [Refer: Provisions]"
       }
      }
     },
     "auth_ref": [
      "r304"
     ]
    },
    "sny_NotEligibleForHedgeAccountingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NotEligibleForHedgeAccountingMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not Eligible For Hedge Accounting [Member]",
        "terseLabel": "Not eligible for hedge accounting",
        "documentation": "Not eligible for hedge accounting."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NotLaterThanOneMonthMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanOneMonthMember",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not later than one month [member]",
        "terseLabel": "Overdue by less than 1 month"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one month."
       }
      }
     },
     "auth_ref": [
      "r373",
      "r377",
      "r383"
     ]
    },
    "ifrs-full_NotLaterThanOneYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotLaterThanOneYearMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Not later than one year [member]",
        "terseLabel": "2025"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a time band of not later than one year."
       }
      }
     },
     "auth_ref": [
      "r121",
      "r122",
      "r126",
      "r187",
      "r191",
      "r312",
      "r376",
      "r383"
     ]
    },
    "ifrs-full_NotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NotionalAmount",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfFinancialCurrencyHedgingInstrumentsInPlaceWithNotionalAmountTranslatedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Notional amount",
        "terseLabel": "Notional amount"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "sny_NumberOfClassActionLawsuits": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfClassActionLawsuits",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Class Action Lawsuits",
        "terseLabel": "Number Of Class Action Lawsuits",
        "documentation": "Number Of Class Action Lawsuits"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfInstrumentsOtherEquityInstrumentsGranted",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of other equity instruments granted in share-based payment arrangement",
        "terseLabel": "Total number of shares awarded (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r422"
     ]
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfOutstandingShareOptions",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "verboseLabel": "Outstanding, number\u00a0of options (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r251",
      "r252"
     ]
    },
    "sny_NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of restricted shares alloted in regards of capital increase",
        "terseLabel": "Number of restricted shares alloted in regards of capital increase",
        "documentation": "Number of restricted shares alloted in regards of capital increase"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Restricted Shares Issued In Regards Of Capital Increase",
        "terseLabel": "Capital increase by issuance of restricted shares (in shares)",
        "documentation": "Number of restricted shares issued in regards of capital increase."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfRestrictedSharesNotYetFullyVested": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfRestrictedSharesNotYetFullyVested",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Restricted Shares Not Yet Fully Vested",
        "verboseLabel": "Number of shares not yet fully vested",
        "documentation": "Number of restricted shares not yet fully vested."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Restricted Shares Vested In Regards Of Capital Increase",
        "terseLabel": "Number of restricted shares vested (in shares)",
        "documentation": "Number Of Restricted Shares Vested In Regards Of Capital Increase"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfShareOptionsExercisableInSharebasedPaymentArrangement": {
     "xbrltype": "decimalItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfShareOptionsExercisableInSharebasedPaymentArrangement",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of share options exercisable in share-based payment arrangement",
        "terseLabel": "Exercisable, number of options (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of share options exercisable in a share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r253"
     ]
    },
    "sny_NumberOfSharesHeld": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfSharesHeld",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Held",
        "terseLabel": "Number of shares (in shares)",
        "documentation": "Number of shares held."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_NumberOfSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "NumberOfSharesIssued",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number of shares issued",
        "terseLabel": "Number of shares (in shares)"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "sny_NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Issued In Regards Of Capital Increase By Exercise Of Stock Subscription Options",
        "terseLabel": "Capital\u00a0increase\u00a0by\u00a0exercise\u00a0of stock subscription options (in shares)",
        "documentation": "Number of shares issued in regards of capital increase by exercise of stock subscription options."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfSharesRepurchased": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfSharesRepurchased",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Repurchased",
        "terseLabel": "Number of shares repurchased (in shares)",
        "documentation": "Number of shares repurchased."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfSharesSubscribed": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfSharesSubscribed",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Shares Subscribed",
        "terseLabel": "Number of shares subscribed (in shares)",
        "documentation": "Number of shares subscribed."
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfTranches": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfTranches",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Tranches",
        "terseLabel": "Number Of Tranches",
        "documentation": "Number Of Tranches"
       }
      }
     },
     "auth_ref": []
    },
    "sny_NumberOfYearsServicePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "NumberOfYearsServicePeriod",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Number Of Years, Service Period",
        "terseLabel": "Service period",
        "documentation": "Number Of Years, Service Period"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OPALJVCoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OPALJVCoMember",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "OPAL JV Co [Member]",
        "documentation": "OPAL JV Co."
       }
      }
     },
     "auth_ref": []
    },
    "sny_OffBalanceSheetCommitmentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OffBalanceSheetCommitmentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Off-Balance Sheet Commitments [Abstract]",
        "documentation": "Off-Balance Sheet Commitments"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OneBillionFiveHundredMillionBondsIssuedInJune2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OneBillionFiveHundredMillionBondsIssuedInJune2025Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Billion Five Hundred Million Bonds, Issued In June 2025 [Member]",
        "terseLabel": "One Billion Five Hundred Million Bonds, Issued In June 2025",
        "documentation": "One Billion Five Hundred Million Bonds, Issued In June 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OneBillionFiveHundredMillionBondsIssuedInMarch2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OneBillionFiveHundredMillionBondsIssuedInMarch2025Member",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "One Billion Five Hundred Million Bonds, Issued In March 2025 [Member]",
        "terseLabel": "One Billion Five Hundred Million Bonds, Issued In March 2025",
        "documentation": "One Billion Five Hundred Million Bonds, Issued In March 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OpellaBusinessMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OpellaBusinessMember",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Opella Business [Member]",
        "terseLabel": "Opella Business",
        "documentation": "Opella Business [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OpellaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OpellaMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Opella [Member]",
        "terseLabel": "Opella",
        "documentation": "Opella"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OperatingRevenueDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OperatingRevenueDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Revenue, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Operating income",
        "documentation": "Operating Revenue, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OperatingSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OperatingSegmentsMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating segments [member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_OtherAdjustmentsToReconcileProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherAdjustmentsToReconcileProfitLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other adjustments to reconcile profit (loss)",
        "terseLabel": "Other profit or loss items with no cash effect on cash flows generated by operating activities"
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "sny_OtherAssetsDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherAssetsDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Other assets",
        "documentation": "Other Assets, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherAssetsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherAssetsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets, Related Party Transactions",
        "terseLabel": "Other Assets",
        "documentation": "Other Assets, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherBankBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherBankBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Bank Borrowings",
        "terseLabel": "Other bank borrowings",
        "documentation": "Other bank borrowings."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails": {
       "parentTag": "ifrs-full_Borrowings",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other borrowings",
        "terseLabel": "Other borrowings"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of borrowings that the entity does not separately disclose in the same statement or note. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncome",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income",
        "terseLabel": "Other comprehensive income for the period"
       }
      }
     },
     "auth_ref": [
      "r99",
      "r291",
      "r322",
      "r333"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income [abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherComprehensiveIncomeFromContinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherComprehensiveIncomeFromContinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income from continued operations",
        "totalLabel": "Other comprehensive income/(loss) from continuing operations for the period, net of taxes (A+B)",
        "documentation": "Other comprehensive income from continued operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherComprehensiveIncomeFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherComprehensiveIncomeFromDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income from discontinued operations",
        "terseLabel": "Other comprehensive income/(loss) for the period from discontinued operations, net of taxes (C)",
        "documentation": "Other comprehensive income from discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherComprehensiveIncomeRelatedPartyDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherComprehensiveIncomeRelatedPartyDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfKeyItemsWhichHaveNotBeenAuditedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income, Related Party Disclosures",
        "terseLabel": "Other Comprehensive Income",
        "documentation": "Other Comprehensive Income, Related Party Disclosures"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "sny_OtherComprehensiveIncomeFromContinuedOperations",
       "weight": 1.0,
       "order": 13.0
      },
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will be reclassified to profit or loss, net of tax",
        "totalLabel": "Items subsequently reclassifiable to profit or loss",
        "terseLabel": "Other comprehensive income that will be reclassified to profit or loss, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403"
     ]
    },
    "ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "sny_OtherComprehensiveIncomeFromContinuedOperations",
       "weight": 1.0,
       "order": 9.0
      },
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other comprehensive income that will not be reclassified to profit or loss, net of tax",
        "totalLabel": "Items not subsequently reclassifiable to profit or loss from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of other comprehensive income that will not be reclassified to profit or loss, net of tax. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r402",
      "r403"
     ]
    },
    "sny_OtherCountriesExcludingEuropeAndNorthAmericaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherCountriesExcludingEuropeAndNorthAmericaMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Countries, Excluding Europe And North America [Member]",
        "terseLabel": "Rest of the World",
        "documentation": "Other Countries, Excluding Europe And North America"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Countries [member]",
        "terseLabel": "Other Countries",
        "documentation": "Other countries."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherCurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherCurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other current assets",
        "terseLabel": "Other current assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_OtherFinanceIncomeCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherFinanceIncomeCost",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails": {
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/FinancialExpensesAndIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other finance income (cost)",
        "terseLabel": "Other"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "sny_OtherFinancialAssetsAtFairValueThroughProfitOrLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherFinancialAssetsAtFairValueThroughProfitOrLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Financial Assets At Fair Value Through Profit Or Loss",
        "terseLabel": "Other financial assets at fair value through profit or loss",
        "documentation": "Other Financial Assets At Fair Value Through Profit Or Loss"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherGainsLossesAndLitigation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherGainsLossesAndLitigation",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/OtherGainsAndLossesAndLitigationDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Gains, (Losses) And Litigation",
        "verboseLabel": "Other gains and losses, and litigation",
        "negatedNetLabel": "Other gains and litigation",
        "documentation": "The line item other gains and losses, and litigation includes the impact of material transactions of an unusual nature or amount. [note B.20.2.]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets",
        "periodEndLabel": "Other intangible assets, ending balance"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "sny_OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Intangible Assets, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Other intangible assets",
        "documentation": "Other Intangible Assets, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ImpairmentOfIntangibleAssetsDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other intangible assets [member]",
        "terseLabel": "Other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets that the entity does not separately disclose in the same statement or note. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r412"
     ]
    },
    "sny_OtherLiabilities1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherLiabilities1Member",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities1 [member]",
        "terseLabel": "Other",
        "documentation": "Other liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Liabilities, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Other liabilities",
        "documentation": "Other Liabilities, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "terseLabel": "Other non-current assets",
        "totalLabel": "Total"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherNoncurrentLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails": {
       "parentTag": "sny_NonCurrentProvisionsAndOtherNonCurrentLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other non-current liabilities",
        "terseLabel": "Other non-current liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "sny_OtherOperatingExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherOperatingExpensesTableTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Expenses [Table Text Block]",
        "terseLabel": "Schedule of Other Operating Expenses",
        "documentation": "Other Operating Expenses [Table Text Block]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherOperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherOperatingIncomeExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other operating income (expense)",
        "terseLabel": "Other operating income/(expenses), net related to Regeneron"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "sny_OtherOperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherOperatingIncomeExpenseMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Operating Income (Expense) [Member]",
        "terseLabel": "Other operating income (expense)",
        "documentation": "Other Operating Income (Expense)"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherProvisionsContingentLiabilitiesAndContingentAssetsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]",
        "documentation": "Other Provisions, Contingent Liabilities And Contingent Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherRelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherRelatedPartiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other related parties [member]",
        "terseLabel": "Other related parties"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for related parties that the entity does not separately disclose in the same statement or note. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r28",
      "r224"
     ]
    },
    "sny_OtherRestructuringCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OtherRestructuringCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails": {
       "parentTag": "ifrs-full_ExpenseOfRestructuringActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/RestructuringCostsAndSimilarItemsSummaryOfRestructuringCostsAndSimilarItemsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Restructuring Costs",
        "terseLabel": "Other restructuring costs",
        "documentation": "Other restructuring costs."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_OtherRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherRevenue",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other revenue",
        "terseLabel": "Other revenues"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails": {
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other tax rate effects for reconciliation between accounting profit and tax expense (income)",
        "terseLabel": "Other"
       }
      },
      "en": {
       "role": {
        "documentation": "Tax rate effects, in aggregate, on the reconciliation between the average effective tax rate and the applicable tax rate that the entity does not separately disclose in the reconciliation. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r209"
     ]
    },
    "sny_OthersCounterpartyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OthersCounterpartyMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Others Counterparty [Member]",
        "terseLabel": "Other (mainly Zaltrap and Libtayo)",
        "documentation": "Others Counterparty [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_OverdueReceivablesGrossValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "OverdueReceivablesGrossValue",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/AccountsReceivableSummaryOfGrossValueOfOverdueReceivablesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Overdue Receivables Gross Value",
        "verboseLabel": "Overdue receivables gross value",
        "documentation": "Overdue receivables gross value."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ParValuePerShare",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Par value per share",
        "terseLabel": "Par value per share (in euros per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r280",
      "r318"
     ]
    },
    "sny_PaymentOfDamagesClaimedByCounterparty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PaymentOfDamagesClaimedByCounterparty",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payment Of Damages Claimed By Counterparty",
        "terseLabel": "Payment Of Damages Claimed By Counterparty",
        "documentation": "Payment Of Damages Claimed By Counterparty"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 37.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Repayment of lease liabilities"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      }
     },
     "auth_ref": [
      "r351"
     ]
    },
    "ifrs-full_PaymentsToAcquireOrRedeemEntitysShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PaymentsToAcquireOrRedeemEntitysShares",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 39.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments to acquire or redeem entity's shares",
        "negatedLabel": "Acquisitions of treasury shares and related tax effect"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow to acquire or redeem entity's shares."
       }
      }
     },
     "auth_ref": [
      "r350"
     ]
    },
    "sny_PenaltyFeeIncurred": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PenaltyFeeIncurred",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Penalty Fee Incurred",
        "terseLabel": "Penalty Fee Incurred",
        "documentation": "Penalty Fee Incurred"
       }
      }
     },
     "auth_ref": []
    },
    "sny_PensionsAndOtherPostEmploymentBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PensionsAndOtherPostEmploymentBenefitsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pensions And Other Post-Employment Benefits [Member]",
        "terseLabel": "Pensions and other post-employment benefits",
        "documentation": "Pensions and other post-employment benefits."
       }
      }
     },
     "auth_ref": []
    },
    "sny_PerShareValueOfSharesRepurchased": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PerShareValueOfSharesRepurchased",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Per Share Value of Shares Repurchased",
        "terseLabel": "Per Share Value of Shares Repurchased",
        "documentation": "Per Share Value of Shares Repurchased"
       }
      }
     },
     "auth_ref": []
    },
    "sny_PercentageIncreaseInFairValueLiabilities": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PercentageIncreaseInFairValueLiabilities",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Increase In Fair Value Liabilities",
        "terseLabel": "Increase in fair value of liability",
        "documentation": "Percentage increase in fair value liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfEntitysRevenue",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationPrincipalCustomersAndCreditRiskDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of entity's revenue",
        "terseLabel": "Percentage of entity's revenue"
       }
      }
     },
     "auth_ref": [
      "r424"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleDecreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleDecreaseInActuarialAssumption",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible decrease in actuarial assumption",
        "negatedTerseLabel": "Decrease in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the decrease in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "ifrs-full_PercentageOfReasonablyPossibleIncreaseInActuarialAssumption": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfReasonablyPossibleIncreaseInActuarialAssumption",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of reasonably possible increase in actuarial assumption",
        "terseLabel": "Increase in actuarial assumption"
       }
      },
      "en": {
       "role": {
        "documentation": "The reasonably possible percentage of the increase in the actuarial assumption used to determine the present value of defined benefit obligation. [Refer: Actuarial assumptions [domain]]"
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "sny_PercentageOfShareCapitalForThePeriod": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PercentageOfShareCapitalForThePeriod",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfTreasurySharesHeldDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage Of Share Capital For The Period",
        "terseLabel": "% of share capital for the period",
        "documentation": "Percentage of share capital for the period."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "terseLabel": "Percentage of voting equity interests acquired"
       }
      },
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Total for all business combinations [member]]"
       }
      }
     },
     "auth_ref": [
      "r135",
      "r255"
     ]
    },
    "sny_PeriodOfShareRepurchaseProgram": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PeriodOfShareRepurchaseProgram",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Period Of Share Repurchase Program",
        "terseLabel": "Period of share repurchase program",
        "documentation": "Period of share repurchase program."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PlanAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PlanAssetsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plan assets [member]",
        "terseLabel": "Plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for defined benefit plan assets. Plan assets comprise: (a) assets held by a long-term employee benefit fund; and (b) qualifying insurance policies."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r218"
     ]
    },
    "sny_PlavixAttorneyGeneralActionInHawaiiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PlavixAttorneyGeneralActionInHawaiiMember",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Plavix Attorney General Action In Hawaii [Member]",
        "terseLabel": "Plavix Attorney General action in Hawaii",
        "documentation": "Plavix Attorney General Action In Hawaii"
       }
      }
     },
     "auth_ref": []
    },
    "sny_PolioPertussisHibVaccinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PolioPertussisHibVaccinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Polio Pertussis Hib Vaccines [Member]",
        "terseLabel": "Polio Pertussis Hib Vaccines [Member]",
        "documentation": "Polio Pertussis Hib Vaccines."
       }
      }
     },
     "auth_ref": []
    },
    "sny_PotentialFuturePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PotentialFuturePayments",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Potential Future Payments",
        "terseLabel": "Potential Future Payments",
        "documentation": "Potential Future Payments"
       }
      }
     },
     "auth_ref": []
    },
    "sny_PreFundedPensionObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PreFundedPensionObligations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails": {
       "parentTag": "ifrs-full_OtherNoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Funded Pension Obligations",
        "terseLabel": "Pre-funded pension obligations",
        "documentation": "Pre-funded pension obligations."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_Prepayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "Prepayments",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prepayments",
        "terseLabel": "Prepayments"
       }
      },
      "en": {
       "role": {
        "documentation": "Receivables that represent amounts paid for goods and services before they have been delivered."
       }
      }
     },
     "auth_ref": [
      "r394",
      "r400"
     ]
    },
    "sny_PrincipalAlliancesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PrincipalAlliancesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Alliances [Axis]",
        "terseLabel": "Principal Alliances [Axis]",
        "documentation": "Principal Alliances"
       }
      }
     },
     "auth_ref": []
    },
    "sny_PrincipalAlliancesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PrincipalAlliancesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal Alliances [Domain]",
        "terseLabel": "Principal Alliances [Domain]",
        "documentation": "Principal Alliances [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": 1.0,
       "order": 25.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets",
        "terseLabel": "Proceeds from disposals of property, plant and equipment, intangible assets and other non-current assets, net of tax"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from the disposal of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_ProceedsFromIssuingShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromIssuingShares",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 32.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from issuing shares",
        "terseLabel": "Issuance of Sanofi shares"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from issuing shares."
       }
      }
     },
     "auth_ref": [
      "r349"
     ]
    },
    "ifrs-full_ProceedsFromNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromNoncurrentBorrowings",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": 1.0,
       "order": 35.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from non-current borrowings",
        "terseLabel": "Additional long-term debt contracted"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from non-current borrowings obtained. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "ifrs-full_ProceedsFromSalesOfInvestmentProperty": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProceedsFromSalesOfInvestmentProperty",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from sales of investment property",
        "terseLabel": "Proceeds from sales of investment property"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash inflow from sales of investment property. [Refer: Investment property]"
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "sny_ProductLiabilitiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ProductLiabilitiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/LitigationAndArbitrationProceedingsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product Liabilities [Member]",
        "terseLabel": "Product Liabilities",
        "documentation": "Product Liabilities"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "verboseLabel": "Product and service [axis]",
        "terseLabel": "Product and service [axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [axis]",
        "verboseLabel": "Products and services [axis]",
        "terseLabel": "Products and services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r359",
      "r384"
     ]
    },
    "ifrs-full_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products and services [domain]",
        "terseLabel": "Products and services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r174",
      "r359",
      "r384"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "verboseLabel": "Product and service [domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ProductsTrademarksAndOtherRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ProductsTrademarksAndOtherRightsMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsScheduleOfMovementsInOtherIntangibleAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Products, Trademarks And Other Rights [Member]",
        "terseLabel": "Products, trademarks and other rights",
        "documentation": "Products, trademarks and other rights"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss)",
        "totalLabel": "Net income",
        "verboseLabel": "Net income for the period"
       }
      },
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r84",
      "r168",
      "r170",
      "r227",
      "r250",
      "r290",
      "r321",
      "r354",
      "r366"
     ]
    },
    "ifrs-full_ProfitLossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 6.0
      },
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to non-controlling interests",
        "verboseLabel": "Net income attributable to non-controlling interests",
        "terseLabel": "Attributable to non-controlling interests",
        "definitionGuidance": "Non-controlling interests"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r324"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to ordinary equity holders of parent entity, used in calculating basic earnings per share",
        "verboseLabel": "Net income attributable to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r40"
     ]
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss), attributable to owners of parent",
        "verboseLabel": "Net income attributable to equity holders of Sanofi",
        "terseLabel": "Attributable to equity holders of Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r325"
     ]
    },
    "ifrs-full_ProfitLossFromContinuingOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromContinuingOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from continuing operations",
        "totalLabel": "Net income from continuing operations"
       }
      },
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing operations. [Refer: Continuing operations, unless line item indicates otherwise [member]; Profit (loss)]"
       }
      }
     },
     "auth_ref": [
      "r97",
      "r168",
      "r170",
      "r321"
     ]
    },
    "ifrs-full_ProfitLossFromDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromDiscontinuedOperations",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from discontinued operations",
        "terseLabel": "Net (income)/loss of the exchanged/held-for-exchange Animal Health business",
        "verboseLabel": "Net income from discontinued operations (Opella)"
       }
      }
     },
     "auth_ref": [
      "r98",
      "r143",
      "r331",
      "r337"
     ]
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProfitLossFromOperatingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "sny_IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit (loss) from operating activities",
        "totalLabel": "Operating income",
        "verboseLabel": "Operating income"
       }
      }
     },
     "auth_ref": [
      "r345",
      "r434"
     ]
    },
    "sny_PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant And Equipmenet, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Property, plant and equipment owned",
        "documentation": "Property, Plant And Equipmenet, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipment",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment",
        "terseLabel": "Property, plant and equipment owned",
        "verboseLabel": "Property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period. Note that right-of-use assets are not included. [Contrast: Property, plant and equipment including right-of-use assets]"
       }
      }
     },
     "auth_ref": [
      "r12",
      "r215",
      "r299"
     ]
    },
    "ifrs-full_PropertyPlantAndEquipmentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PropertyPlantAndEquipmentAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, plant and equipment [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ProportionOfOwnershipInterestInAssociate": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInAssociate",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in associate",
        "terseLabel": "Proportion of ownership interest in associate"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in an associate attributable to the entity. [Refer: Total for all associates [member]]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r34",
      "r89"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInJointVenture": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInJointVenture",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in joint venture",
        "terseLabel": "Proportion of ownership interest in joint venture"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Total for all joint ventures [member]]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r34",
      "r89"
     ]
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary",
        "terseLabel": "Proportion of ownership interest in subsidiary"
       }
      },
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Total for all subsidiaries [member]]"
       }
      }
     },
     "auth_ref": [
      "r32",
      "r34",
      "r88"
     ]
    },
    "ifrs-full_ProvisionUsedOtherProvisions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ProvisionUsedOtherProvisions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provision used, other provisions",
        "negatedLabel": "Provisions utilized"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount used (ie incurred and charged against the provision) for other provisions. [Refer: Other provisions]"
       }
      }
     },
     "auth_ref": [
      "r47",
      "r232"
     ]
    },
    "sny_ProvisionsForOtherLongTermBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ProvisionsForOtherLongTermBenefitsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions For Other Long Term Benefits [member]",
        "terseLabel": "Provisions for other long-term benefits",
        "documentation": "Provisions for other long term benefits."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ProvisionsForPensionsAndOtherPostemploymentBenefitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ProvisionsForPensionsAndOtherPostemploymentBenefitsMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Provisions For Pensions And Other Postemployment Benefits [member]",
        "terseLabel": "Provisions for pensions &amp; other post-employment benefits",
        "documentation": "Provisions for pensions and other post-employment benefits."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": -1.0,
       "order": 24.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of financial instruments, classified as investing activities",
        "negatedTerseLabel": "Acquisitions of other equity investments"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of financial instruments. [Refer: Classes of financial instruments [domain]]"
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "terseLabel": "Acquisitions of other intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "terseLabel": "Acquisitions of property, plant and equipment"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "sny_NetCashProvidedByusedInContinuingInvestingActivities",
       "weight": -1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets",
        "negatedTerseLabel": "Acquisitions of property, plant and equipment and intangible assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchase of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets. [Refer: Intangible assets other than goodwill; Investment property; Other non-current assets; Property, plant and equipment]"
       }
      }
     },
     "auth_ref": [
      "r416"
     ]
    },
    "ifrs-full_PurchaseOfTreasuryShares": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchaseOfTreasuryShares",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase of treasury shares",
        "negatedLabel": "Share repurchase program"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from the purchase of treasury shares. [Refer: Treasury shares]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "ifrs-full_PurchasesOfGoodsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "PurchasesOfGoodsRelatedPartyTransactions",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchases of goods, related party transactions",
        "terseLabel": "Purchases of goods and services (including research expenses)"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of goods purchased by the entity in related party transactions. [Refer: Total for all related parties [member]]"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r392"
     ]
    },
    "sny_RSVVaccinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RSVVaccinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "RSV Vaccines [Member]",
        "terseLabel": "RSV Vaccines",
        "documentation": "RSV Vaccines"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails",
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [axis]",
        "terseLabel": "Range [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r125",
      "r131",
      "r201",
      "r356",
      "r358",
      "r423"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangeDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails",
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Range [domain]",
        "terseLabel": "Ranges [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r125",
      "r131",
      "r201",
      "r356",
      "r358",
      "r423"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RangeMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [axis]",
        "terseLabel": "Ranges of exercise prices for outstanding share options [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_RangesOfExercisePricesForOutstandingShareOptionsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RangesOfExercisePricesForOutstandingShareOptionsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ranges of exercise prices for outstanding share options [domain]",
        "terseLabel": "Ranges of exercise prices for outstanding share options [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for aggregated ranges of exercise prices for outstanding share options that are meaningful for assessing the number and timing of additional shares that may be issued and the cash that may be received upon exercise of those options. It also represents the standard value for the 'Ranges of exercise prices for outstanding share options' axis if no other member is used. [Refer: Range [domain]]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_ReclassifiedItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReclassifiedItemsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassified items [axis]",
        "terseLabel": "Reclassified items [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r284",
      "r297"
     ]
    },
    "ifrs-full_ReclassifiedItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReclassifiedItemsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reclassified items [domain]",
        "terseLabel": "Reclassified items [Member]"
       }
      }
     },
     "auth_ref": [
      "r196",
      "r284",
      "r297"
     ]
    },
    "ifrs-full_ReconciliationOfChangesInOtherProvisionsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReconciliationOfChangesInOtherProvisionsAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfMovementsInNonCurrentProvisionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation of changes in other provisions [abstract]",
        "terseLabel": "Reconciliation of changes in other provisions [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RedemptionOfDebtInstrumentIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RedemptionOfDebtInstrumentIssued",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Redemption Of Debt Instrument Issued",
        "terseLabel": "Value on redemption",
        "documentation": "Redemption of debt instrument issued."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReductionOfIssuedCapital": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReductionOfIssuedCapital",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reduction of issued capital",
        "negatedLabel": "Reduction in share capital"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease in equity resulting from a reduction in issued capital. [Refer: Issued capital]"
       }
      }
     },
     "auth_ref": [
      "r427"
     ]
    },
    "sny_RegeneronMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RegeneronMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Regeneron [Member]",
        "terseLabel": "Regeneron",
        "documentation": "Regeneron"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RelatedPartiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RelatedPartiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OffBalanceSheetCommitmentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total for all related parties [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for related parties. Related parties are persons or entities that are related to the entity that is preparing its financial statements (the reporting entity). (a) A person or a close member of that person\u2019s family is related to a reporting entity if that person: (i) has control or joint control over the reporting entity; (ii) has significant influence over the reporting entity; or (iii) is a member of the key management personnel of the reporting entity or of a parent of the reporting entity. (b) An entity is related to a reporting entity if any of the following conditions applies: (i) The entity and the reporting entity are members of the same group (which means that each parent, subsidiary and fellow subsidiary is related to the others). (ii) One entity is an associate or joint venture of the other entity (or an associate or joint venture of a member of a group of which the other entity is a member). (iii) Both entities are joint ventures of the same third party. (iv) One entity is a joint venture of a third entity and the other entity is an associate of the third entity. (v) The entity is a post-employment benefit plan for the benefit of employees of either the reporting entity or an entity related to the reporting entity. If the reporting entity is itself such a plan, the sponsoring employers are also related to the reporting entity. (vi) The entity is controlled or jointly controlled by a person identified in (a). (vii) A person identified in (a)(i) has significant influence over the entity or is a member of the key management personnel of the entity (or of a parent of the entity). (viii) The entity, or any member of a group of which it is a part, provides key management personnel services to the reporting entity or to the parent of the reporting entity. [Refer: Total for all joint ventures [member]; Key management personnel of entity or parent [member]]"
       }
      }
     },
     "auth_ref": [
      "r29",
      "r225"
     ]
    },
    "ifrs-full_RepaymentsOfNoncurrentBorrowings": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RepaymentsOfNoncurrentBorrowings",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows": {
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivitiesContinuingOperations",
       "weight": -1.0,
       "order": 36.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repayments of non-current borrowings",
        "negatedLabel": "Repayments of long-term debt"
       }
      },
      "en": {
       "role": {
        "documentation": "The cash outflow for repayments of non-current borrowings. [Refer: Borrowings]"
       }
      }
     },
     "auth_ref": [
      "r417"
     ]
    },
    "sny_ReportableGeographicalZonesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ReportableGeographicalZonesMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reportable Geographical Zones [Member]",
        "terseLabel": "Reportable Geographical Zones [Member]",
        "documentation": "Reportable geographical zones."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ReportableSegmentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReportableSegmentsMember",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reportable segments [member]",
        "verboseLabel": "Reportable segments [member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for operating segments for which IFRS 8 requires information to be disclosed. The entity shall report separately information about an operating segment that meets any of the following quantitative thresholds: (a) reported revenue, including both sales to external customers and intersegment sales or transfers, is 10 per cent or more of the combined revenue, internal and external, of all operating segments; (b) the absolute amount of its reported profit or loss is 10 per cent or more of the greater, in absolute amount, of (i) the combined reported profit of all operating segments that did not report a loss and (ii) the combined reported loss of all operating segments that reported a loss; or (c) assets are 10 per cent or more of the combined assets of all operating segments. Additionally operating segments that do not meet any of the quantitative thresholds may be considered reportable, and separately disclosed, if management believes that information about the segment would be useful to users of the financial statements. [Refer: Operating segments [member]]"
       }
      }
     },
     "auth_ref": [
      "r114",
      "r168",
      "r182",
      "r341",
      "r369"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0,
       "order": 4.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Research and development expense",
        "negatedLabel": "Research and development expenses"
       }
      }
     },
     "auth_ref": [
      "r60",
      "r243"
     ]
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReserveOfSharebasedPaymentsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]",
        "terseLabel": "Stock options and other share-based payments"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      }
     },
     "auth_ref": [
      "r397"
     ]
    },
    "sny_RestrictedSharePlan2021Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharePlan2021Member",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share Plan 2021 [Member]",
        "terseLabel": "Restricted share plan 2021",
        "documentation": "Restricted Share Plan 2021"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RestrictedSharePlan2022Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharePlan2022Member",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share Plan 2022 [Member]",
        "terseLabel": "Restricted share plan 2022",
        "documentation": "Restricted Share Plan 2022"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RestrictedSharePlan2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharePlan2023Member",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share Plan 2023 [Member]",
        "terseLabel": "Restricted share plan 2023",
        "documentation": "Restricted Share Plan 2023"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RestrictedSharePlan2024Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharePlan2024Member",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share Plan 2024 [Member]",
        "terseLabel": "Restricted Share Plan 2024",
        "documentation": "Restricted Share Plan 2024"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RestrictedSharePlan2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharePlan2025Member",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Share Plan 2025 [Member]",
        "terseLabel": "Restricted Share Plan 2025",
        "documentation": "Restricted Share Plan 2025 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RestrictedSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RestrictedSharesMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Shares [Member]",
        "terseLabel": "Restricted shares",
        "documentation": "Restricted shares."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained earnings [member]",
        "terseLabel": "Reserves and retained earnings"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      }
     },
     "auth_ref": [
      "r293",
      "r397"
     ]
    },
    "ifrs-full_ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from return on plan assets excluding interest income or expense",
        "negatedLabel": "Actuarial gains/(losses) on plan assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from the return on plan assets, excluding amounts included in interest income or expense. The return on plan assets is interest, dividends and other revenue derived from the plan assets, together with realised and unrealised gains or losses on the plan assets, less any costs of managing plan assets and less any tax payable by the plan itself, other than tax included in the actuarial assumptions used to measure the present value of the defined benefit obligation. [Refer: Plan assets [member]; Net defined benefit liability (asset); Actuarial assumptions [domain]; Increase (decrease) in net defined benefit liability (asset) resulting from interest expense (income)]"
       }
      }
     },
     "auth_ref": [
      "r19",
      "r220"
     ]
    },
    "ifrs-full_RevenueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RevenueFromDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RevenueFromDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue From Disposal Group Including Discontinued Operations",
        "verboseLabel": "Net sales and other revenues",
        "documentation": "Revenue From Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from intragroup sales from continuing to discontinued operations",
        "terseLabel": "Sales to Opella",
        "documentation": "Revenue from intragroup sales from continuing to discontinued operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RevenueFromRoyalties": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromRoyalties",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalty income",
        "terseLabel": "Royalties"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoods": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromSaleOfGoods",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from sale of goods",
        "terseLabel": "Net sales"
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "ifrs-full_RevenueFromSaleOfGoodsRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RevenueFromSaleOfGoodsRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from sale of goods, related party transactions",
        "terseLabel": "Sales"
       }
      }
     },
     "auth_ref": [
      "r343",
      "r392"
     ]
    },
    "sny_RevenueFromVaxServeSalesOfNonSanofiProducts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RevenueFromVaxServeSalesOfNonSanofiProducts",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from VaxServe sales of non-Sanofi products",
        "verboseLabel": "VaxServe sales of non-Sanofi products",
        "documentation": "Revenue from VaxServe sales of non-Sanofi products"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RevisionsToTaxExposuresAndSettlementsOfTaxDisputes": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RevisionsToTaxExposuresAndSettlementsOfTaxDisputes",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails": {
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revisions To Tax Exposures And Settlements Of Tax Disputes",
        "terseLabel": "Revisions to tax exposures and settlements of tax disputes",
        "documentation": "Revisions to tax exposures and settlements of tax disputes."
       }
      }
     },
     "auth_ref": []
    },
    "sny_RezurockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RezurockMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rezurock [Member]",
        "terseLabel": "Rezurock",
        "documentation": "Rezurock"
       }
      }
     },
     "auth_ref": []
    },
    "sny_RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails": {
       "parentTag": "sny_AssetsOfDisposalGroupIncludingDiscontinuedOperations",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right Of Use Assets, Disposal Group Including Discontinued Operations",
        "verboseLabel": "Right-of-use assets",
        "documentation": "Right Of Use Assets, Disposal Group Including Discontinued Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_RightofuseAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "RightofuseAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "terseLabel": "Right-of-use assets"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term that do not meet the definition of investment property. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      }
     },
     "auth_ref": [
      "r116",
      "r119",
      "r185"
     ]
    },
    "sny_RoyaltiesAndOtherIncomeRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "RoyaltiesAndOtherIncomeRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Royalties And Other Income, Related Party Transactions",
        "terseLabel": "Royalties and other income",
        "documentation": "Royalties and other income, related party transactions."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SalesChannelsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SalesChannelsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales channels [axis]",
        "terseLabel": "Sales channels [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r390"
     ]
    },
    "ifrs-full_SalesChannelsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SalesChannelsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sales channels [domain]",
        "terseLabel": "Sales channels [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all sales channels. It also represents the standard value for the 'Sales channels' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r390"
     ]
    },
    "sny_SanofiEuroMediumTermNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SanofiEuroMediumTermNotesMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sanofi Euro Medium Term Notes [Member]",
        "terseLabel": "Sanofi Euro Medium Term Notes",
        "documentation": "Sanofi Euro Medium Term Notes"
       }
      }
     },
     "auth_ref": []
    },
    "sny_SanofiMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SanofiMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sanofi [member]",
        "terseLabel": "Sanofi",
        "documentation": "Sanofi."
       }
      }
     },
     "auth_ref": []
    },
    "sny_SarclisaMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SarclisaMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sarclisa [Member]",
        "terseLabel": "Sarclisa",
        "documentation": "Sarclisa"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment, Name [Axis]",
        "terseLabel": "Investment, Name [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Seasonality Or Cyclicality Of Interim Operations [Policy Text Block]",
        "terseLabel": "Seasonal Trends",
        "documentation": "Seasonality Or Cyclicality Of Interim Operations"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentConsolidationItemsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]",
        "terseLabel": "Segment consolidation items [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ifrs-full_SegmentConsolidationItemsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentConsolidationItemsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment consolidation items [domain]",
        "terseLabel": "Entity's total for segment consolidation items [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "ifrs-full_SegmentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [axis]",
        "terseLabel": "Segments [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r114",
      "r168",
      "r182",
      "r341",
      "r369"
     ]
    },
    "ifrs-full_SegmentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SegmentsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/PropertyPlantAndEquipmentSummaryOfAcquisitionsAndCapitalizedInterestByOperatingSegmentDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfAcquisitionOfIntangibleAssetsPropertyPlantAndEquipmentAndInvestmentsAccountedForUsingTheEquityMethodBySegmentDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segments [domain]",
        "terseLabel": "Segments [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r114",
      "r173",
      "r182",
      "r341",
      "r369"
     ]
    },
    "ifrs-full_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": -1.0,
       "order": 5.0
      },
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Selling, general and administrative expense",
        "negatedLabel": "Selling and general expenses"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Settled liabilities, contingent liabilities recognised in business combination",
        "negatedLabel": "Payments made"
       }
      },
      "en": {
       "role": {
        "documentation": "The amount of contingent liabilities recognised in a business combination that were settled. [Refer: Contingent liabilities recognised in business combination]"
       }
      }
     },
     "auth_ref": [
      "r140"
     ]
    },
    "sny_ShareBasedPaymentPlansAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareBasedPaymentPlansAbstract",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Payment Plans [abstract]",
        "terseLabel": "Share-based payment plans:",
        "documentation": "Share based payment plans."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareCapitalReservesAndOtherEquityInterestAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareCapitalReservesAndOtherEquityInterestAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Capital, Reserves And Other Equity Interest [Abstract]",
        "documentation": "Share Capital, Reserves And Other Equity Interest [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements": {
       "parentTag": "ifrs-full_ProfitLossFromContinuingOperations",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates accounted for using equity method",
        "terseLabel": "Share of profit/(loss) from investments accounted for using the\u00a0equity method"
       }
      }
     },
     "auth_ref": [
      "r434"
     ]
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails": {
       "parentTag": "sny_BusinessOperatingIncome",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfReconciliationBetweenBusinessOperatingIncomeForTheSegmentsAndIncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDetails",
      "http://www.Sanofi.com/role/SegmentInformationScheduleOfSegmentResultsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share of profit (loss) of associates and joint ventures accounted for using equity method",
        "verboseLabel": "Share of profit/(loss) from investments accounted for using the equity method",
        "terseLabel": "Share of profit/(loss) from investments accounted for using the equity method"
       }
      }
     },
     "auth_ref": [
      "r166",
      "r172",
      "r329"
     ]
    },
    "sny_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Of Profit Or Loss From Commercialization Of Monoclonal Antibodies [Member]",
        "terseLabel": "Income &amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance",
        "documentation": "Share of profit or loss from commercialization of monoclonal antibodies member."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareOfProfitOrLossFromCommercializationOfZaltrapMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareOfProfitOrLossFromCommercializationOfZaltrapMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Of Profit Or Loss From Commercialization Of Zaltrap [Member]",
        "terseLabel": "Additional share of profit paid by Regeneron towards development costs",
        "documentation": "Share of profit or loss from commercialization of Zaltrap."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareProgramAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Program [Axis]",
        "terseLabel": "Share Program [Axis]",
        "documentation": "Share Program [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareProgramDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Program [Domain]",
        "terseLabel": "Share Program [Domain]",
        "documentation": "Share Program [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareRepurchase2024ProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareRepurchase2024ProgramMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase 2024 Program [Member]",
        "terseLabel": "Share Repurchase 2024 Program",
        "documentation": "Share Repurchase 2024 Program"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShareRepurchase2025ProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShareRepurchase2025ProgramMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Repurchase 2025 Program [Member]",
        "terseLabel": "Share Repurchase 2025 Program",
        "documentation": "Share Repurchase 2025 Program [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember",
     "presentation": [
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsAdditionalInformationDetails",
      "http://www.Sanofi.com/role/LiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsSummaryOfMovementsInLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterestsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shire Contingent Consideration Arising From Acquisition Of Translate Bio [Member]",
        "terseLabel": "Shire contingent consideration arising from acquisition of Translate Bio",
        "documentation": "Shire Contingent Consideration Arising From Acquisition Of Translate Bio"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SignificantInvestmentsInAssociatesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInAssociatesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Associates [axis]",
        "terseLabel": "Associates [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r105",
      "r272"
     ]
    },
    "ifrs-full_SignificantInvestmentsInAssociatesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInAssociatesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesAdditionalInformationDetails",
      "http://www.Sanofi.com/role/OtherOperatingIncomeAndExpensesScheduleOfOtherOperatingExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Associates [domain]",
        "terseLabel": "Entity's total for associates [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Associates' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r105",
      "r272"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]",
        "terseLabel": "Subsidiaries [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r103",
      "r270"
     ]
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SignificantInvestmentsInSubsidiariesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfMovementsWithinOtherComprehensiveIncomeDetails",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfCashFlowsParenthetical",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails",
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails",
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails",
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails",
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsidiaries [domain]",
        "terseLabel": "Subsidiaries [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r35",
      "r103",
      "r270"
     ]
    },
    "sny_SpecialtyCareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SpecialtyCareMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Specialty Care [Member]",
        "terseLabel": "Specialty Care [Member]",
        "documentation": "Specialty Care."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityLineItems",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [line items]",
        "terseLabel": "Statement of changes in equity [line items]"
       }
      },
      "en": {
       "role": {
        "documentation": "Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfChangesInEquityTable",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity",
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquityParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]",
        "terseLabel": "Statement of changes in equity [table]"
       }
      },
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "ifrs-full_StatementOfComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of comprehensive income [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_StatementOfIFRSCompliance": {
     "xbrltype": "textBlockItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "StatementOfIFRSCompliance",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of IFRS compliance [text block]",
        "terseLabel": "International Financial Reporting Standards (IFRS)"
       }
      }
     },
     "auth_ref": [
      "r296"
     ]
    },
    "sny_StockOptionPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "StockOptionPlanMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Option Plan [member]",
        "terseLabel": "Stock Option Plan",
        "documentation": "Stock Option Plan [member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_StockPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "StockPrice",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfInvestmentsInAssociatesAndJointVenturesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price",
        "terseLabel": "Stock price (in euro per share)",
        "documentation": "Stock Price"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "SubclassificationsOfAssetsLiabilitiesAndEquitiesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subclassifications of assets, liabilities and equities [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_SubordinateHybridBondRelatedPartyTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SubordinateHybridBondRelatedPartyTransactions",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/InvestmentsAccountedForUsingTheEquityMethodSummaryOfPrincipalTransactionsAndBalancesWithRelatedPartiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subordinate Hybrid Bond, Related Party Transactions",
        "terseLabel": "Subordinate Hybrid Bond, Related Party Transactions",
        "documentation": "Subordinate Hybrid Bond, Related Party Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "sny_SubscriptionPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SubscriptionPricePerShare",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subscription Price Per Share",
        "terseLabel": "Subscription price (in euros per share)",
        "documentation": "Subscription price per share."
       }
      }
     },
     "auth_ref": []
    },
    "sny_SwedishOrphanBiovitrumABMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "SwedishOrphanBiovitrumABMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesSummaryOfNonCurrentProvisionsAndOtherNonCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Swedish Orphan Biovitrum AB [Member]",
        "terseLabel": "Swedish Orphan Biovitrum AB",
        "documentation": "Swedish Orphan Biovitrum AB"
       }
      }
     },
     "auth_ref": []
    },
    "country_TR": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "TR",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "T\u00dcRKIYE",
        "terseLabel": "Turkey"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TaxRateEffectOfForeignTaxRates": {
     "xbrltype": "percentItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TaxRateEffectOfForeignTaxRates",
     "calculation": {
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails": {
       "parentTag": "ifrs-full_AverageEffectiveTaxRate",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax rate effect of foreign tax rates",
        "terseLabel": "Difference between the standard French tax rate and the rates applicable to Sanofi"
       }
      },
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from the application of foreign tax rates. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      }
     },
     "auth_ref": [
      "r5",
      "r209"
     ]
    },
    "sny_TaxesOnShareCancellations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TaxesOnShareCancellations",
     "crdr": "debit",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes on Share Cancellations",
        "documentation": "Taxes on Share Cancellations"
       }
      }
     },
     "auth_ref": []
    },
    "sny_TechnologicalPlatformsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TechnologicalPlatformsMember",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Technological Platforms [Member]",
        "terseLabel": "Technological platforms",
        "documentation": "Technological Platforms"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [axis]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r212"
     ]
    },
    "ifrs-full_TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TemporaryDifferenceUnusedTaxLossesAndUnusedTaxCreditsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/IncomeTaxExpenseSummaryOfDifferenceBetweenEffectiveTaxRateAndStandardCorporateIncomeTaxRateParentheticalDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary difference, unused tax losses and unused tax credits [domain]",
        "terseLabel": "Temporary difference, unused tax losses and unused tax credits [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for temporary differences, unused tax losses and unused tax credits. It also represents the standard value for the 'Temporary difference, unused tax losses and unused tax credits' axis if no other member is used. [Refer: Temporary differences [member]; Unused tax credits [member]; Unused tax losses [member]]"
       }
      }
     },
     "auth_ref": [
      "r8",
      "r212"
     ]
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TimingOfTransferOfGoodsOrServicesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [axis]",
        "terseLabel": "Timing of transfer of goods or services [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r389"
     ]
    },
    "ifrs-full_TimingOfTransferOfGoodsOrServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TimingOfTransferOfGoodsOrServicesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of transfer of goods or services [domain]",
        "terseLabel": "Timing of transfer of goods or services [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all timings of the transfer of goods or services in contracts with customers. It also represents the standard value for the 'Timing of transfer of goods or services' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r364",
      "r389"
     ]
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Axis]",
        "terseLabel": "Title and Position [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2025",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title and Position [Domain]",
        "terseLabel": "Title and Position [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TopOfRangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TopOfRangeMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Top of range [member]",
        "terseLabel": "Top of range"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r112",
      "r125",
      "r131",
      "r201",
      "r356",
      "r358",
      "r423"
     ]
    },
    "sny_TotalMilestonePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TotalMilestonePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Milestone Payments",
        "terseLabel": "Total Milestone Payments",
        "documentation": "Total Milestone Payments"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers": {
     "xbrltype": "monetaryItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherCurrentPayablesToTradeSuppliers",
     "crdr": "credit",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0,
       "order": 28.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current trade payables",
        "terseLabel": "Accounts payable"
       }
      },
      "en": {
       "role": {
        "documentation": "The current amount of payment due to suppliers for goods and services used in entity's business. [Refer: Current liabilities; Trade payables]"
       }
      }
     },
     "auth_ref": [
      "r399",
      "r433"
     ]
    },
    "ifrs-full_TradeAndOtherReceivablesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradeAndOtherReceivablesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade and other receivables [abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TradingEquitySecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TradingEquitySecuritiesMember",
     "presentation": [
      "http://www.Sanofi.com/role/OtherNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading equity securities [member]",
        "terseLabel": "Trading equity securities"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that (a) are acquired or incurred principally for the purpose of selling or repurchasing it in the near term; or (b) on initial recognition are part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking."
       }
      }
     },
     "auth_ref": [
      "r355",
      "r357"
     ]
    },
    "ifrs-full_TreasurySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TreasurySharesMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedStatementsOfChangesInEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares [member]",
        "terseLabel": "Treasury shares"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      }
     },
     "auth_ref": [
      "r293"
     ]
    },
    "sny_TypesOfAgreementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TypesOfAgreementAxis",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types Of Agreement [Axis]",
        "terseLabel": "Types Of Agreement [Axis]",
        "documentation": "Types Of Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "sny_TypesOfAgreementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TypesOfAgreementDomain",
     "presentation": [
      "http://www.Sanofi.com/role/BasisOfPreparationOfTheHalfYearFinancialStatementsAndAccountingPoliciesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types Of Agreement [Domain]",
        "terseLabel": "Types Of Agreement [Domain]",
        "documentation": "Types Of Agreement [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_TypesOfContractsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfContractsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [axis]",
        "terseLabel": "Types of contracts [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r367",
      "r387"
     ]
    },
    "ifrs-full_TypesOfContractsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfContractsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of contracts [domain]",
        "terseLabel": "Types of contracts [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of contracts with customers. It also represents the standard value for the 'Types of contracts' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r362",
      "r367",
      "r387"
     ]
    },
    "ifrs-full_TypesOfCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfCustomersAxis",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [axis]",
        "terseLabel": "Types of customers [axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r386"
     ]
    },
    "ifrs-full_TypesOfCustomersDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfCustomersDomain",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of customers [domain]",
        "terseLabel": "Types of customers [domain]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of customers. It also represents the standard value for the 'Types of customers' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r361",
      "r386"
     ]
    },
    "ifrs-full_TypesOfHedgesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfHedgesAxis",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of hedges [axis]",
        "terseLabel": "Types of Hedges [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r263",
      "r264",
      "r265"
     ]
    },
    "ifrs-full_TypesOfHedgesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfHedgesDomain",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of hedges [domain]",
        "terseLabel": "Hedges [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for all types of hedges. It also represents the standard value for the 'Types of hedges' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r151",
      "r152",
      "r263",
      "r264",
      "r265"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]",
        "terseLabel": "Types of share-based payment arrangements [Axis]"
       }
      },
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r254"
     ]
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "TypesOfSharebasedPaymentArrangementsDomain",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquityAdditionalInformationDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfRestrictedSharesNotYetFullyVestedDetails",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [domain]",
        "terseLabel": "Stock options and other share-based payment [Member]"
       }
      },
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "auth_ref": [
      "r132",
      "r254"
     ]
    },
    "sny_TzieldMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "TzieldMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tzield [Member]",
        "terseLabel": "Tzield",
        "documentation": "Tzield"
       }
      }
     },
     "auth_ref": []
    },
    "sny_UKZONEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "UKZONEMember",
     "presentation": [
      "http://www.Sanofi.com/role/NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UKZONE [Member]",
        "terseLabel": "UKZONE",
        "documentation": "UKZONE"
       }
      }
     },
     "auth_ref": []
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2025",
     "localname": "US",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails",
      "http://www.Sanofi.com/role/SegmentInformationSummaryOfGeographicalInformationOnNetSalesAndNonCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "UNITED STATES",
        "verboseLabel": "United States"
       }
      }
     },
     "auth_ref": []
    },
    "sny_UpfrontPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "UpfrontPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Upfront Payments",
        "terseLabel": "Upfront payment",
        "documentation": "Upfront payments."
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "presentation": [
      "http://www.Sanofi.com/role/GoodwillAndOtherIntangibleAssetsAdditionalInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Useful life measured as period of time, intangible assets other than goodwill",
        "terseLabel": "Weighted average amortization period"
       }
      },
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "auth_ref": [
      "r51",
      "r235"
     ]
    },
    "sny_VaccinesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "VaccinesMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vaccines [Member]",
        "terseLabel": "Vaccines [Member]",
        "documentation": "Vaccines."
       }
      }
     },
     "auth_ref": []
    },
    "sny_ValueOfHedgeRecognizedInEquityMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ValueOfHedgeRecognizedInEquityMember",
     "presentation": [
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsDisclosureOfInstrumentsDetails",
      "http://www.Sanofi.com/role/DerivativeFinancialInstrumentsSummaryOfOperatingCurrencyHedgingInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value Of Hedge Recognized In Equity [Member]",
        "terseLabel": "Value of hedge recognized in equity",
        "documentation": "Value Of Hedge Recognized In Equity [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_ValueOnRedemptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "ValueOnRedemptionMember",
     "presentation": [
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfMarketValueOfNetDebtDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfNetDebtByTypeValuationOfRedemptionDetails",
      "http://www.Sanofi.com/role/DebtCashAndCashEquivalentsSummaryOfReconciliationOfCarryingAmountToValueOnRedemptionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value On Redemption [Member]",
        "terseLabel": "Value on redemption",
        "documentation": "Value on redemption."
       }
      }
     },
     "auth_ref": []
    },
    "sny_VicebioLtdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "VicebioLtdMember",
     "presentation": [
      "http://www.Sanofi.com/role/EventsSubsequentToJune302025Details"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vicebio Ltd [Member]",
        "terseLabel": "Vicebio Ltd",
        "documentation": "Vicebio Ltd [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "sny_VigilNeuroscienceIncMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "VigilNeuroscienceIncMember",
     "presentation": [
      "http://www.Sanofi.com/role/PrincipalChangesInScopeOfConsolidationInThePeriodAndAmendmentsToPrincipalAgreementsPrincipalChangesInScopeOfConsolidationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vigil Neuroscience, Inc [Member]",
        "terseLabel": "Vigil Neuroscience, Inc",
        "documentation": "Vigil Neuroscience, Inc [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options exercisable in share-based payment arrangement",
        "terseLabel": "Weighted average exercise\u00a0price per share, options exercisable (in euros per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercisable in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r130",
      "r253"
     ]
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "xbrltype": "perShareItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "terseLabel": "Weighted average exercise price of share options outstanding in share-based payment arrangement (in euros per share)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r128",
      "r129",
      "r251",
      "r252"
     ]
    },
    "ifrs-full_WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019": {
     "xbrltype": "durationItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfOptionsOutstandingAndExercisableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average remaining contractual life of outstanding share options",
        "terseLabel": "Weighted average residual life (years)"
       }
      },
      "en": {
       "role": {
        "documentation": "The weighted average remaining contractual life of outstanding share options. [Refer: Weighted average [member]]"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ifrs-full_WeightedAverageShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full",
     "localname": "WeightedAverageShares",
     "calculation": {
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails": {
       "parentTag": "ifrs-full_AdjustedWeightedAverageShares",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedIncomeStatements",
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfNumberOfSharesUsedToComputeDilutedEarningsPerShareDetails",
      "http://www.Sanofi.com/role/InformationRelatedToOpellaPresentedWithinAssetsHeldForSaleAndDiscontinuedOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average number of ordinary shares used in calculating basic earnings per share",
        "terseLabel": "Average number of shares outstanding",
        "verboseLabel": "Average number of shares outstanding"
       }
      },
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "sny_WithMarketConditionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "WithMarketConditionMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "With Market Condition [Member]",
        "terseLabel": "With market condition",
        "documentation": "With Market Condition"
       }
      }
     },
     "auth_ref": []
    },
    "sny_WithoutMarketConditionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "WithoutMarketConditionMember",
     "presentation": [
      "http://www.Sanofi.com/role/ConsolidatedShareholdersEquitySummaryOfPrincipalCharacteristicsOfRestrictedSharePlansDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Without Market Condition [Member]",
        "terseLabel": "Without market condition",
        "documentation": "Without Market Condition"
       }
      }
     },
     "auth_ref": []
    },
    "sny_XenpozymeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.Sanofi.com/20250630",
     "localname": "XenpozymeMember",
     "presentation": [
      "http://www.Sanofi.com/role/RevenueFromContractsWithCustomersSummaryOfNetSalesBySegmentAndGeographicalAreaDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Xenpozyme [Member]",
        "terseLabel": "Xenpozyme",
        "documentation": "Xenpozyme"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&anchor=para_21&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=10&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2025-03-27"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "ab",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_ab&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_81_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2025-03-27"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2025-03-27"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_140_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "140",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_140_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "141",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_141_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=2&code=ifrs-tx-2025-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "A19",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_A19_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "18",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "19",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "26",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=26&code=ifrs-tx-2025-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "27",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=27&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "29",
   "IssueDate": "2025-01-01",
   "Section": "Disclosures",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=29&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IAS29_g39-40_TI",
   "URIDate": "2025-03-27"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "34",
   "IssueDate": "2025-01-01",
   "Paragraph": "16A",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=34&code=ifrs-tx-2025-en-r&anchor=para_16A_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "130",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "36",
   "IssueDate": "2025-01-01",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=36&code=ifrs-tx-2025-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "88",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "126",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "39",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2025-en-r&anchor=para_86_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "39",
   "IssueDate": "2025-01-01",
   "Paragraph": "86",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=39&code=ifrs-tx-2025-en-r&anchor=para_86_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "32A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "76",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "25",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "39",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "44H",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_44H_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IAS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "30",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=8&code=ifrs-tx-2025-en-r&anchor=para_30_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "10",
   "IssueDate": "2025-01-01",
   "Paragraph": "22",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2025-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_a_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_21_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "ix",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vi&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_vii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "Clause": "viii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B16&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "93",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "14",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "114",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "53",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "97",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2025-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "109A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "120",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "C32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2025-03-27"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_51_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f_iv&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B67",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_33_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Paragraph": "38",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&anchor=para_38&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "5",
   "IssueDate": "2025-01-01",
   "Section": "Presentation and disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS05_g30-42_TI",
   "URIDate": "2025-03-27"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24B",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24B&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24C",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24C&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "24G",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_24G&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35H",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35K",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35K&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35M",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "42I",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "8",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_8_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B52",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B52&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "23",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "32",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Section": "Disclosure",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2025-03-27"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.42",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2026-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "30A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_30A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_108_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "115",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "124",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "128",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_128&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "129",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_129&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "160",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_160&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "164",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_164_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "168",
   "Subparagraph": "b",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_168_b_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "169",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_169&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "178",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_178&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "180",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_180_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "182",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_182&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "190",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_190&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "192",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_192&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "c",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_c_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "194",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_194_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "200",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_200&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "204",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_204&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "206",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_206_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "206",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_206_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "207",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_207_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "223",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_223_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "230",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "231",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_231&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "246",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_246_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "250",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_250&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "254",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_254_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "255",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_255_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "257",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "257",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_257&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "259",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_259&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "263",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_263&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "266",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_266&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "269",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_269&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "271",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_271_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "273",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_273&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "274",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_274_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "28",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_28_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vi",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vi&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "Subparagraph": "b",
   "Clause": "vii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31_b_vii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "31",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "Clause": "iv",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e_iv&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "43",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_43&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "44",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_44_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "60",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_60&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "62",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_62&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "64A",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_64A_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "71",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_71&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "75",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_75_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "88",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_88_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "89",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_89&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "95",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_95&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a_iii&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B10&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B15",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B15&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expired 2023-01-01",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "37",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2025-03-27"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2026-01-01",
   "Name": "IFRS",
   "Number": "9",
   "IssueDate": "2025-01-01",
   "Paragraph": "7.2.49",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2025-en-r&anchor=para_7.2.49&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "125",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_125&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_16&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "41",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_41&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "51",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_51&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_l&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_n&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "o",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_o&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "p",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_p&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_q&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_54_r&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "56",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_56&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "61",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_61&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "66",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_66&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "69",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_69&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "Clause": "iii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_79&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "81B",
   "Subparagraph": "b",
   "Clause": "ii",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_81B_b_ii&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82",
   "Subparagraph": "ea",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82_ea&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "90",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_90&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "91",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_91&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "98",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_98_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "99",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_99&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=12&code=ifrs-tx-2025-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_21_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "24",
   "IssueDate": "2025-01-01",
   "Paragraph": "21",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_21_i&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "32",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE33",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=32&code=ifrs-tx-2025-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A_TI",
   "URIDate": "2025-03-27"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2025-en-r&anchor=para_IG63&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "12",
   "IssueDate": "2025-01-01",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2025-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "94",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "B6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE60",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE60&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "13",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE63",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2025-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_e&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "15",
   "IssueDate": "2025-01-01",
   "Paragraph": "B89",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2025-en-r&anchor=para_B89_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "17",
   "IssueDate": "2025-01-01",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2025-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "3",
   "IssueDate": "2025-01-01",
   "Paragraph": "IE72",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2025-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2025-03-27"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "35N",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B11",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_a&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_d&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "B35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG31A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_103_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "193",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_193_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "234",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_234_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "Subparagraph": "g",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_35_g&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_b&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Effective 2027-01-01",
   "Name": "IFRS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "B9",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_B9_f&doctype=Appendix&subtype=B",
   "URIDate": "2025-03-27"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "103",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_103&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "68",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_68&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_70&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "82A",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_82A&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "IG6",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2025-03-27"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r405": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "16",
   "IssueDate": "2025-01-01",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=16&code=ifrs-tx-2025-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r406": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "19",
   "IssueDate": "2025-01-01",
   "Paragraph": "145",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=19&code=ifrs-tx-2025-en-r&anchor=para_145&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r407": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "21",
   "IssueDate": "2025-01-01",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=21&code=ifrs-tx-2025-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r408": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "33",
   "IssueDate": "2025-01-01",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=33&code=ifrs-tx-2025-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r409": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "37",
   "IssueDate": "2025-01-01",
   "Paragraph": "84",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=37&code=ifrs-tx-2025-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r410": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r411": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r412": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "38",
   "IssueDate": "2025-01-01",
   "Paragraph": "119",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=38&code=ifrs-tx-2025-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r413": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "40",
   "IssueDate": "2025-01-01",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=40&code=ifrs-tx-2025-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r414": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "41",
   "IssueDate": "2025-01-01",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=41&code=ifrs-tx-2025-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r415": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "14",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_14&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r416": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "16",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_16&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r417": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "17",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r418": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r419": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r420": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "20",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r421": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IAS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=7&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r422": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "2",
   "IssueDate": "2025-01-01",
   "Paragraph": "45",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r423": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "7",
   "IssueDate": "2025-01-01",
   "Paragraph": "7",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2025-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r424": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "IFRS",
   "Number": "8",
   "IssueDate": "2025-01-01",
   "Paragraph": "34",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2025-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r425": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_10_e&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r426": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "104",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_104&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r427": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_106_d&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r428": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "108",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_108&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r429": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_112_c&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r430": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "117",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_117&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r431": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "35",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_35&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r432": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "55",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_55&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r433": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "78",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_78&doctype=Standard",
   "URIDate": "2025-03-27"
  },
  "r434": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Note": "Expiry date 2027-01-01",
   "Name": "IAS",
   "Number": "1",
   "IssueDate": "2025-01-01",
   "Paragraph": "85",
   "URI": "https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2025-en-b&anchor=para_85&doctype=Standard",
   "URIDate": "2025-03-27"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>124
<FILENAME>0001193125-25-250744-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-25-250744-xbrl.zip
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M$#$]\;7\I[F+/6**+X4?YB_T)W3%E?#+W*7/]AHI_?MK F.!3]=P''Z=2G]
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MW-&OKK> O=F5V.)WRC[04G1CIF7M1FSB"A8RE+]--F72 IG^0>S "@?KJ?=
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M$W#804'AIK+)M)[TO>>[YH_P"]:X75R'@A?E19/=2-+E+;P/:5HKVI)C?/$
M 8WP@B"\C <G++/AR@VH!G@1 3Z3;)D0SO,T7G('>3C9PIS'O&J"91+R;$OU
M/9KP3N<A1>-KYXK.C@28]EZYE+I/+&ESGC@: CGN@+#^M1MLD6#,]E/<NM/
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M7PGJ$YOX9'&S6MOSL,^Z@Q-7)+8Y.UULX?&$F8JUNI5MG*^:9+PU?B67MF>
M5[ WGSC3('L59!IA2@@#ZW].;!MFP78T? D<BV+K)OSFW'4L[]KS G8DP&^!
M@]F(>2"=NY2Z3[#4>><OMVB,LX\F,<5,KF]D13[E?D6>L=4%'X#-+'03G.$-
M F>]5CFN%E?(:>9=/(G6FN64:#SO?$HTM4&*9ZN-\Q(O\BGY.4SSF5U1=]R>
M4&+#[[7BBCG5Q(LHTTI995K)M4S=@,9F"9DL_GA9]"E2"/9[#SGN@%P&U+W!
M%@G&#YB.;UT_#F5ZMW]<X+X_RR;E&@VI6:80P;$'B5C&OG^%V84#X@4V^0S2
M>8$:BZNXIN&XH>BR+.[+BGD72*)1(N2T9 *=GW8^Y=GV 98_L%^XL^##(NS2
MY/(II<YM+)3/V!U2-!D1$]EM"I/.OFA6D,S/1J8O9YW;?,KDSA]AVN&3(-B[
M?#;MP *CP%;P">;=;-0?M<?P '/A76[%D2'/R$CS(9_R#B=46$E2_RPYPWS*
MZ*I;/,G$=O*JFT^9?.L55R;?>OF4R3EQ)R-$QZ@74C=OU:(O<R">>4K9:B2>
M63ZE]/E\K>9\O[>1$S9%S,OO%OL7>$ <;)UC!SY,FR)>^-79%^LK6O?Y7"$'
MDVA^2\.FV>6+W,XGIMI 0]^UP%/KL.[;ODL1:UUI#RG&,WWIW?YQ#Q&N228@
M -LFR#'QJL-'5_=F?N\]88MXHSL**NF 9CX2EO9JG\\/X;XCIA-$9QT]64:G
MB%Z>P5L[VXU -OUQI!O)58HQ$,76J8!4<B41[VW2JI-%U4DE*ZU0>U$HK0T;
MT88R0[#CCL>8F@39]PAN<T^9BSF^=JXH8T**@JCNP=YO#_;JXDP:T6YF#2E\
M&_@J5G[KM;6*%%!%IG+5^K&%C</7;'G'GL\*Q_S\]'OT\O#DWKO$\?^#J7M)
MAB/_'N0" [K8Q.!K7H*3"NONPPB6W)OYN[]VD$5\9,+B20KL5H4]RV(S+-Y-
MA)%20-M3Q6)M2LZ<)I9DXW(.5$YO^-_A*Y]%>.B@"?&1S=XBW+N[ZG[K741(
MJ'*85)L1/E+I52E?"*W.U6V[=/IUT7LZCB8^.2$;ZJE5+ O+R::42@BNO&I5
MRF-KM(;D34,*=Y",>C2C 9MEP!8M0DC_HD[E4&+387JQP+VOP'LC%EE' HHO
M)]7*50KEVF= 4"3=4H@'M*+D05%T7*"!FTO@%B\^R!IN$YWK;D!%==@4;;D:
M_)L _ZM-[.D$I#4Q[YHXZWQ8E'2, *V*>VY922DAK8L[S_)>>O!SA(_*:4VO
M@:K)82%#]8JGM>S-6J;7MVRIF5[-"JIGNO,Y4VJF^YR+J&7E>U%F=E5,OS2S
M,/I5XET#>]4EO4=@SWL$-IY7U/L$,EC5TGL%<MMYI[:P%4NE=K-4Z:ZZ#/AX
M6G'RKSBZ8VZG:\UFMZ1IG2G?8E.H?6?[V\VI5:=TRTVA-&<S.S:U%N1G <DV
M'O>;&]:@U'E7-4P6O^%+]U;E 'W%;832/4>YP%]1&X1T+TX.T%?,QAG=HY)1
MW!6HH43W;F2T=T.QYTEW:NP])M9]&;FHE64;[KJ&E(D5O]"0TK65[.6RU<]T
M+D%J* _G%.KLE=;! J?'"J&".H-7? TL9HJP".JGLY@%U;T"I4ESK&<ZDYO%
MK),^83[S^J0S;UNJC5#7\\*W=)HO3,"7SQ-" 0WPZVFQH9UBZH63Z7'!&S%3
M3#V?,KURZ1.B5CRU^X":(^1AC[W3]H*]O9Q^ZYV[CE5L\<IQH1"2[B$[.;]2
MR5<X]WQ*M>>[YH\[_D+H>QLMO/"[XXXGKL-8<3<("]+9%^,JFID8A9/-I]PN
MG]E[Q#U\3XF)N\@9XH<G=UYZ_%O&A>2E'D#Y+O 9(1:@O3="%(<<"2,.C8>-
MN.EOX7U(TQK!%@6IK&BEH5I$J,XD6Q2LAJ?S:+ 6$*P)T>83K5T,KBHQ?6SQ
M*8NSB?RG/@0CUCUZX7DJ2MGL<^*5IY\%$[*8(X60+E,D^/Y8"WDM8XHDZQ,M
MZ[6,*9*LZUK6:QE3)%E7M:S7,J9(LJYI6:]E3#YE?1E0%TW(O&Q[9.@ <TUX
MR+7S")/F?+AVVI[GF@3Y>6C[3SL''E$EF9!/.=Y-L&VC<HLQR8-\2C$Q*\?Z
MC;5Z_ YD!4L1<0<N&;J4,-O5Q3;\!8:+^B0/$GV-=MY1]0H?\BG=&T1_8#9=
MZEJ!Z2_*U$:>QYAR[< 3AZ1O8V #]KT[?Q2VLWUV7>N)V'8.9"PY%R9S,7?R
M*>D';(X<UW:'8+AL<!/\@4O'6MYS\E['HWQ*?:DUIMBM!"NFFU/9N>,Q2ZL#
M%!'<!HS0D*(QZXQHSTOQW*74?0*>>.<OMVB,PYH(<MP!86[D#;9(,'[ ='SK
M^O%RU;O]XP+W_1D7LR]XT30CL;_&*87R"+N_B%.\%+.>Q\6"W16$GR;6R$N%
MO"2S-/@D.J9&A.(.7 #,!GK@DP="I(C5&]N4>/#U%77';?// /Y@W]X-'H#7
M'G/:S\E"D\YY  ,PK CNN$\<E"A:9AIM*ZGF8M\(A_*)CK;I!XB"LH$G%XPG
MX>0NGR>8Y;_89@7N[@ULSHQY* B&AKT#W_[YG[O;R_F+/V.FQI,1<P/;%*,<
M@&;5_.8V3<BS;R-]!2O8R="<Y'Z!,'E!/)-MN^),30G$&^*0<3 .K_:HS]LH
M"@P\ 8]45DKJGR4XQOZ<8VC9P86>-;@V"JXD0W,*KN&0XB%+=EX[%GDD5H!L
M^^5Z/&9[54-^1AG/>9#-)3^SCR$!N0GP2/(@GY*^Z=W_CDP3O$K66(B<EZ()
ME"=KQ9/,I\3 #:/(P_3Q\[@_:CM6Q_WBFB//_^?G(HKNM=GF4X:P,,'TKUSZ
M+_!\1__"X/I>X %V+!3ODN:ID.@;ODQ_=FV+;66+"@Y?(7X;<F_\VGD8X6^]
MZ;"O8+1LX%2;]HE/D0T#3(Q9@VZXWD]O@/K$)JR2M2+3/XLD$]=F'TAIZ&?(
M6L4'Y9Q,0FI1??!5:2L^\Q61AU2D U ^]4FFGZ 7]#UB$41S@>;TLRA&3\%<
M<XN%"8?V)2<LJ\("*L^6R"Q(HTY8,//#\NB*=2+\L3T[V-KI8@N'X=;\D%R=
M92V87Y387^;)1G)A:\ZI7N)H/M%TZSH:4,N $K-%8VHUIJJU[\=5AJF3[[R:
M0;'5Q1Y&U&0QP@5^Q+8[8;3J)I9D$TL:7FT1!2>'U=KA<74[*#"#<<#;\R[P
MA&*6F&%5K[%+?>*%GQWK&H)_0@6X0)2^@+<<'H@F>R_XXS-O+IF_2R+6\AXH
M EU#] ?K$.0"ZI+AJ- ]=5MBZ7QZ]RU"WXA=?8OVI0.#UK\-ZA]+]P4^ICUW
MX#\ABK6^E43?YO?++T- :]DF(:(58[.*D64,"MBA8;8;F*UD?3Z1E$UK5MZ
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MP>\F5H7E1MS/=VW+@IC<8XB<4.*89()L S]C,_#)(X:O!P2B=0W$;0"1/YD
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M@_?+A[YKO<#?X/S:G_X_4$L#!!0    (  @_6UOS=L^53-,! !I))  0
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MRS*/NX " G+%K46M*+FZ7\FK%P%@4OPZ4\VR65>/5F\T.^U"5BF =7&O]/(
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M4SW,U<Z_X4ODN):LHGP,FK4N5';M)9^E%Y]L<K%6 FLR4%-<Y'H-+,K4[4Y
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M(PHL%J_PNYD-%/N @P,.3M8[VW@[ 5SL<V*('D'D?$0^T2VMB4SLTJ1;5_W
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MRX%I*7]:_*1,ATV+:FKLI^TG8;,_L)^)#;-UU&QE$!,KU"[2!N=LWBVORWD
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MAG:.BH$ I-?LB@(H!O![ZG&?TFL$N'1J\/_/WKLV)XXLZ\+?WU^A8)U9X8[
M-.*.O181M-N>\>SNMH_MZ1WS?ND0J#":%A(C"=O,KS^95:4;2""!) 2NM7=,
MVQA055;>*_-)G/IRM.%,8O#SG$ZC,/#VHDP:#L8]X';R/([CY-]R:1/AQF7G
MQA5R^84CW]K5YH:QP>_:CQ,!GM ,)=8,>69^>I5!I]KMO_>;K4T!'OQ'&>DD
M](WXL7,>>O1J=0@^9HKUK!GGCCF_"/S*5,-% Z,3TU*)Y;XBS]]6"::ISO2B
MT?HEO!H@.SY=&A-=GRNJJAG/_ZW4*_1WI*[[.U]8@/5M1[&<2U>?7=U]^3*\
M?[R^<']8B6\H3</QC;MD_IB+.E^C7*__4DD20X4#)+[!7R*0\X,2JY-)E,#2
MGV.[9#*>2BGSJ91IL/2V;D,*LP@$F&$F0;99.8"((PH\XJ^%[6B396IB/4V)
M34"E* M5PX%;H'E48B!^U531)]*2*!:^1MF33N3R)X$"3SF$#0)EW4>_+PS"
M.X_JM/.HC1-%%[HJC8@$#*'2>D/3^&MA,'7XJCE3Z5$QS(E&"XB[E_!5_D(2
M/32ZY:DF)9??C=+*#L<_B5X0-H%^=_PW[7*F:955#P@G]]N7_)_'X;>[FUOZ
M2^O2^Y._VM^&7V[._[P>/D@WM]^&WZYNAU^DA^O[NX>G=(^5UC<?JY6Y(5[[
M#F20)%^SISI?X828_T:_$*/E#32K_L*DR)4%F$$FLS5FP)<"JG)$P%:#JM1?
ME:5=<1<Q];0JIV6?_L]/=+T%U/#E6 =I10]TBGV2D5I01B9<HUE0&TERK=-=
M7Z_[,BQ-D:86NA__<LPQ*!!JD4 0$46<U0TK$026]B=H0-N-X4'$"O^9$:)7
M:VO&JNYU91I_O@ -XYCN*]0E9"_%GMYV4>YM5<\1KN<6Z4BIQZ_?IMI(<Z1^
MOR:[%%]AYXBM=;9KJ5H[Z>;D&O) P'J<)[0>,4J /K^SU9^JI]#(*76[\+<2
M^5O1Q[<Y,(HY\HT/.E,^G)K[=:,]+W#F*79S(]PZ^BX@,;.Y@LC!+X1GX4&<
MX.<1(4:H93PBKEI[@D7.Y_ $5)@\F8\00@H52\U&C2V-%/@)V]%!K>MD[-"5
MN,UF8XI@C J>H[^#VZ6$8>%-%^<XC=?E4[>16L*%7"82E]')B<NM,=87*LA+
M6BDP3.-\S 9I<R'P+9%"6RD%[Y:*=\<GQ[M/4U"R^+,$[#H#%Y>S,NI12QLM
MV#SLN:)19) YN%&H=R<+0[6E,YL0Z9OI$.E336[4/@AF+16SJJ?.K#,%_K*D
MCHFEV<"T"P/HK<,:*! ->'J&CU/X#&]F4]QUT\8W*_ 96B-M4,_" K<?![Y3
M[Q\=BYEI$&"7)7V6C4FB7=3[A&>5%)UK>*;OQQH?*0]/AW4YUH(%'12C'01M
M2E18L[T83]GCA6B52K3(R8G6W40"EAY/+W9B-#E]/%P4IT54106S4VM,QY9]
M4>?9%^2["+[J-7Y)!!?*WMUVW[S^WST^GB-H6GGQT')"!RL.*LNC7&.U@#"[
M9Q\60B9TX<)^H$GUD?5Q<-9A+X!Q=:;VAS5=4\R9Y(EUE.7Y;C[&#.YUDB6#
M\V2+5I@%TMU=R67;XUE'XIP= :*XUWVO\B&"4'D"=^53.7ZDX.X'K,_>P5\,
MWBO)M3J]U*-"H.$]B'-Q[KZX_=J7UV7C/XV.>W5[:T#(121'>:.)@3T!F,N!
MGY[3 , #CK)DI_2DO!'['D[I@6#2YLH#:QO:?!!@OO. MM9Z:6\OY\U&'?MX
MY&JS'5_F=7".$',K2\J=!8V<Z32015O-UI&/JCR96/!X[*5#+&([PEJ6V5JR
M,T)E5%XCV</ZM(XPD>_$1.[-DD59QE9E .PI[**PBSO918N,B?9"A&T\B&U,
MJH<>^"F5UCQV<'Y.-W,U5! G".MX *8LRD!VP''KQ(,7'>QPWZ5]W!7_KX0F
M]#/P-WR1:GLV5)I8YFRW2L1 23PO5H$E4O$I_(:NQ .&#H"M<2 7 *=^> SF
M*EH<"OW--(+,<LVYI+R.0:,R2)Q8/CX>.^I)/8<3I^.6FOPGZ'1ZVR?HE)EO
MCKMN[<@K)"<G5R$95RD_5Y:L=G>FJ'1V#80E<\*FI+-NI&>L**:=32IO29)0
M.SALX"96 8/S9CX;M'"9-C+IFC+2=,U9XO>-%C8\U<::_-E(,^@7V#7IAC=G
MV=H;+SI!C#3XAO6&]RJ\,7KQ^ 4&3MY!O#5SX4QT\]6KC*:>)+Y#&?^]@)?<
MEJO/%C'.Z^",ACL :K0%(/FR6K"6/5=R:TRUD?56A1_&HD2Z5 K@^>040 J!
MHT*]SO!K<KC6P3"WS#$A$,Y1CL<EF#:8<.3U,XVGMUEG&'V$JQK@D^J"T X=
MTW(F8'!-B6D:;(>@/U3I!\XT]UL07!'T"[ZHDI$3[$(0DE0J29J^9TGB(J/,
M((@*6 OP2YN=UN76.[0=0.Y^L([BKQ2_!;\)O^@1MDO;C@WGUG@AMD,%Y=9X
M7(R )S2P4\0>OFEV/N%KJS+H1(RLY9(,9Z-3GR+L>L2.^Z:#ND?+0.<TO'T(
M"D@/DUZH@5*I 4VH@4V6$[$#9C-BT>;IN0*!-!K39TM!;Y<^!@42OOP1(3X8
MM@'7(IMGWMZ (VIC_/Z'3=1;(V(R%.O@_F1:EOD*7&2#PKF#!UHW;C/WK6];
M$R7!?EQY6[G'G=RSC=P:?SP.PWK)?^BGY3=8=GXZJ%T9-*O-=G--"X644)7#
M1 "=*8Q6B2@<2IB4D<(=!#JL=];O+]?4?,+XJB:MQ*RP.M.WH2EZ9<T-$UES
MZ(RMNN)-Q?914DTP5%;5;9@%C0T/1R 2OV%VIAB@H?$#LZ-%64N2D=S8?B)P
MUJ* Y0- =/UML&O1!RJ0TMXC4MHI :/EB8,F;:5UA-9$PT?>^OT?<J??;_=^
M]"H[G9S<*?SH,-U)<:DH'M5.)(T%)DVND1K;F3H!1MZNGOO9'RXT:T9MCMV:
M3-L<-S';KE\JY_&E/!C[$#XRYKA] T?4TL9KR8C/FCT&AVIAD;O)K\0@%OJM
MS#T$/V@X,A>.Y] ^>MQR_08+,13'M)8);] ).)]S5+C6@O@NIMSJPA^CI:\?
M)7T)>(R]99W%5BT48F0YEJDNF/N_D;5;V7(V _*%^-%\)A@RL+A$ RFT [D;
MZ0R4!*+,@5,)?B<MLJE?^B# #?FRZKZ*<O^K92[F_ \2BR3=/UUA &0L^1\_
M5"5,7TG/NCD")3 %G]N9CB% DL#8@R,+SOLS>!&JZ]8C*)YBC:=5\')A*>:<
MPM&@XPLD^4D</M43=P)GO "VQ?M5#M,T,<?4'P82SX&G\),&9I-KFRF^W:SL
M0'&)1AZVP[9VCS<YTMGUPC(-^,B%!*[J![JM;^25*<$_3>NG=/9-L57E;_C[
MMS\_%+OLIY ZWZ[$)RFN UZ)A4?[HI%70G-O^$%.IT^F8M'11I\U"QC0M(!=
M&-@A^\N,\%,WX)OU95R.+J1ZTFBB3XBS>#>YMPB#=S2-NTD.:L@#9AQ"+/P$
M'WXD5-Y,@]4;=)OU9DA9->LQRDJN1VJK7H;::OA1HF2A$Z=\PG#)"]CZ:/,.
M;*V,QYBQQH.; Q]1O*=]+;HL%^[L#&O@-]):6X-?)P6V#(0Q+;I%V+RA K."
MB-_>/#Q^B')D-G.DQVAW$_P&5**Z!L\A^]J\9CLV,,C8TCR%.&.[ O'14QF+
M\5H #Q>5X])SA<3\!'P-6<M2D3;,EMT.'[E2: 'Y\:RTF>1)L/3@GM('S <1
M^G%JH?#@#.;,@C6A\2L<J0[K0^_6]F\\)+!$+E\[EF+8+"]EN^+ T&!9>B8!
MM#[WFQ.J5TI,IEBW@.H79B6B9)O:76[#(S3&3C&!CYU#LZK@ES#?);TX*M0V
M@6GQK0^:XCE1#$R+(_2N04M/--M>^.\)"_[0W_:C]P!FH\Z !S\!?^'3DCPL
M+OY!OTAY432=)B5>-(5^>@*N&4W!@AT=83KSYT6A9SYUG+E]\?'CZ^MKC4PL
MY;EF6L\?K]D>J7]6!@Y4YJ Q@>1D,F%^K/2[8BP4BWL,<H#$K/H( AX6QIHV
M"6N=HY;0.T,:+I[A-[[O-EU$L\HX&OC497+NLW]1QC^1':]Y]IM77GE>/W M
MV"I#I0<-](*OD!JR=(;G<$UI3;GYBGZ89L-O>#[=_4;I 6^<(!*@VA4/#1$>
MS5?\1R4@8C/,T./RO R\A5KX=4HH)C;+BR_1HP9][;T)982K=&]](S*&7Q@O
MC%EFSXCD Z:M59.P[Z2V2(%30.L!QZR!A<![9"/HJ49Q0;%G>VO0R(TR\F8G
MK.HN>JIPY8SG"($^WA+X(H(8-I36SA2=;N4G/4$X%RYA=/OW&EX_2$^O9NJ+
M#J#!^6+.,WSXL,#)T!*?B+-IL4.-6&3X_D9)O1J(O<[-R80OAY^Q5UOGH;S#
MVQ@$*F=),N<6( @*O%)N<(,L.H5W6&"$<*V:!Q)$5I""^T&DX)6P)<8W3N#;
M'\(W;M2D/VR:/"? H#-ZKXQB]=="?0XE3W?+$?D&]W?X0L;70T.]=I^586:H
MU2W22UYQD"*MBX57C#B$@-WLN=IW!B**KJ4-#(E"%":\ II]-F?.Z4CAJ1#-
MS[$%G L>8ZM,^$F,4V:Q/]![4A1+-)7QCYPI2TFA8LMS.>B0H>JAU4O43+#B
MO:I7X4MO.RUTL!?\"\D;HFPS2Q*W,*Z]/5ZQ5XJ- R6"@5<#S^0NF$<!_C-+
M4;B_1>O[ZS<%?%'VR'A2<"T5Y:@%K@^.IE:(L7@>U4)RLFHAWO:WWBH:_R6Q
MW3WY%0QM)E^4.G!% [S'Q=AQVQ=M1><E.G/+_(O0/[#7+.(L+ ,$ 'P@ZYE@
M@Q7R&OJS+TR41AX_SD'!(D_SM+-]Z:GC4RME$^R9$WNBCZ19+B3\'*-8RUE6
M)32\+"V/9LI/TH/O"*ZY1@T,U<&"YP3/I>0Y-+TOBK[P_*-GTU1?(09A";C0
M7_$5B&[ =03K/J%VG+;(6$3PHN#%;'AQ92Y&;$\;0R"@Y\_2O@8)9'TI"X++
MZA7/LVJ^#=\W5Y;X98)K!=?NS[6K@[4H]_DOAD(C!P,VV,T_]![8=@0'"@[<
M@0-YSQ+ZC<!$YP2B9G/)L[0&F6CPIQ%\2A&QB>"Q_7DLJ,%8W/RBV;PJR,),
MK6-!&+RP@/J8?7(XXU59=EFS?]JAZXGH1"[+.Q'C1;-, UD9KQWQLY?T#X*%
M!0OOP<(JF1 +(Q=Z4<+,-##N0G=\# #XBSN_S4OE(H./%<M:GL-/KW@?S;J:
M:=X'W^" [@5FMI;@?T[@&<08DT"7<\(&D>V7$*D2X4.01GIKCQM$< >LFV#K
M\^YD@MGF8F_:L#<OZH;-+S*8+T!#V*Y.0-@*O*6'TUL86->(UZ3-5N@:SKOK
M5 -*Q<UWNW>-([?N2C&\O7MW4>M78NXE-%Z>!):)J\9\/?AR3(GY]^.@W#Q$
M#=/%VW$7--<7=N!K^*NT_%(S0G]RT_1L^ZS]P^_1IX6!4[P^8&DCL/8?D6_Q
M5\T(Q$#LBH?5]T@+"G9!=\JZ\V?$F9KJ2N<^HF2X"W/8?1P5 R?]]22'?7,L
M4X=7GMV+08ZM:/.+2'X**B4R8XB(D] "5RZX!?</-KM;I0F,4>AJ&N$*O/1N
MVJ7/+7(.C^!+9B2FEF]EO"._17F!WTTX0%S57V %;54;NS<5;/*=RZF,)X+Z
M(?Z.,M@#TZMM!1-J^%;$FV#TMHJ/Q'J(6[^4P_0=5Y-TQD.79%[EGP:W]7C:
MKY^H?5FXG1PKO2S2OKTL"2H!_?IZN7L)7^4O)-%#MU0;'5O[)P.4(V_TXC1E
MFZ-<#S<Z'FDGZ,=-!,BR+32R#W1%SZ\4;? "=A>_:T,1>WRI^W .3H/JO_>'
M''_H6?2?ANCY<643"785L=XTNVNL[&Z?=MC,M])(M97F%ND\1'?N9HH$5IA_
MYVUZ\J>3DU;FW;W)QD)F5"H69)UPZV_H#-7<^X"C=AU8PJY-PJ%]!/WF?86T
ME8I+VDF$M),>\S-#ER%S-=9.1:'.'G)TD!++9DUZ9-5^NN18%.D\84TEHLNX
M'X58^LZZ6HXQ\J2_3'B?# ?<!?Z^QSKZ)5+ODVZ.?^Y94-EKRT455*XZT1YR
M,*U>Q.)N>S'ZB]8DAKMZ;)>N$QTSPRZNZ$E4YK:H(N-*RRV4<'%NO()ZVLRD
MAQIU(L,-^%NH61ABF>D2NYZ,"?LTIA8),(PY"_3Y[5;T^]OJ%WO]6]F5^_;:
M\7H@8^Z\-7B[ <^NN+J*(BBX1?:8^PH1F"62@,S?B4'^61!=">3&:*IO'#I=
MEB>KAG.(F'8*;G(]",#WL@,:6QKM?&"Y9)81PR@3Z]L93"\L!KN;>*%^73J[
M"AI%O]W.[YC]0 40Z #+A06R9%JHA)[SG+=)(TP%'V-B2S@,F]5F;N]&X1T9
M0PN+-V!=K,5FO)@M=(K.Q/*"-.,Y<:7LA;!\K:[86"1M$=8_Q/9 (:@(RY)N
M@ SS'H!'@")UCX6>M^Y#L-OF#IX#Y/X"3WG"A_R)S]@,^SA\<"&_?B4(!C:?
MHK$88JUY%.;7'*0U"/K5\#"_SALI0+_Z&+NO0W[]4O63J4H0^)F14X7]!K"O
M6*E#@,PTZ:E@00V(E[5DRI#\O8!STI>AG/R9C=6S@<YRFD61>Q_0VE*.\XZ7
M05/'*3X&)8M?Z2;:O;[41I_QOMM4Y-::NS<[F&N.YF6LQ>"+Q3$*<TE'4(3"
M.?QI8?TDRUCVWJAD_$-ABRZQ!#P=0@*Z]9)(P'HC5L,7 L8!Y9. X_;2VC7I
M1M$L6L]*PE5: 3CJ'?PI<'PL;<ZP+/PN*N;BWYB1L)&YXUNTVKV0#]8I#)C@
M#W8AB[W9<E,ZHR3_3DG^U2^28V@L]$U=>(]W$ $274B^HXKMK!/_[ +5=K8T
M@P=CWG_L33;AWAO(C@;QEC6>+L-WA9HQ7SCKXDR]O1"#L#>[*^( E_Z7HO Q
ME4K%Q!;M1Z( 96,!2KI; \8$7Y"UN)VXD/Y>F&@@:*^1S> YJ'/ X)I8]97?
M;\^K6O":.E"O=8:W8>;"D6:F2J-S9N>P; O.^J?RC.@=HD)0<'=*[@YP:B,9
MI]H:/$.QHOFTBK_[O2<.&4\-[>\%"=10*#K%#C M1Z%P_52M8QA,,7O=]CYS
M9!.+=0JPAV,3JB)J" 63[\?DS8LM[(G9T'U8-'7-X*Y7!-M]^BQ!IG<N.SC2
M,H,\*PO"=1BRO!*]K-WW15P"I2H\B+CB27,AU#VR H1NJMWURER T$NUE?[1
M%2 <&WIX^A/LIZOUJ6=>Q/ N:A9R+%'8IT @N"C7YJUK]^S<@N17B)^)HV@Z
MCE*) 9?.,.WE)[3Z<B^)$ 6R87M(0UK$(>;SCP@.E;2GYBN;-QD$T.%X0U[[
M DN$!5NB5KM*(9 ":E(HG$!O060*,^K&(J"URQO%/(#'MNI3!BSD6CC#EGU1
MYSH5(QH:.'S<%#[PF?!N(%+Y&!6?-%=?CYYH'?79?J*/;GY^)\UWK*V5O=S-
M8!UR?7<ZR*TL%M#(XDOHZS2 2A#T2MN9DL?%%DCV7#'^6VE6-I,G62C!6S+V
MC @0]VZM)#WE<IGLKT;CNVTWFU+U=;\C&VH]+>>\D\"<L'\]C9IX.D;$MN0#
M;\LW!E&5YT4SQ.46;SKC/$/4(S*E;N >*W<F*71CGH]Q#%R3LQX-)/HTXS\C
MZ^, [P;9"_2"D+[F70:^:UI]=].@E"9>*C2:)FZ2EON$3W?W%_5:%SSLE=9$
M]PV?[IZ>[KY&OR<5,6'+C)A=CYBYK>' !_*5=?*Z-]P^[+-_OQW=MI:I?[0+
MQR?Y3"PO9<\J[556.3I.\*\3CO+$#Z;%9J9*](T:++-=GII_Y"+1GY9SA/67
MF_RBHKDB9VFXY; ,;,GKFS_1;7\W,07'*A"*4Y@Y^"$S355ULHUV:_O_5.O4
M2N.QE8XZ-RNX?LQ2L'!0Q>+90/W@&:^ X> J@?SLAW=#X/3"O$[RE:CKW9 N
M I9F?VK*[X=^^Q.+^<[OD?E2D^K_,EW'BY=HT5]IB!4?S!V+U'[[.!1>B!"V
M."]$VN*!J&3D"/]C#_]#>E_:7[@>!^<ZGK9[7WPGO(Y2":SP.H2PI?<ZV#[.
M%D8H_>%>I H?1/@@!U1IS?=#O_V)-0R-)?DHW1-BT8FM"'9L&M(9&%PPO? -
MY1'F8N[X=]2@MQ-*26D,BI,![B!"-;;=LG'8#.?#;4='@ )/[NE@:#Z*70^T
MG;&^=N\@L,-]OG),&NMTKPE;?K+"GK,M3S"#JSP:X @4JS#GPIP7SW4/;.SS
M.3,9RGQNF<IX6AH*EMIR/ZU!PR2:2Q@:0C):2HI*VX0XLF#L5_!AX81-+/1G
M>],Y*,323#6 3\B'=J@4A&C$H .Q!T#Z7.LBGFEB6#]WM@F;N&&H\+X8R'OA
M29RLGDE-G5!7;()!*E],X_D<98+M3#<5@]?9(!X'>U%17Q2<F<1_,]*/:S&!
MD3G7TJ$S%(*5%^L')-1^-^=ZH!)#+X0LK/P/ ZSW<ZH%Y'U/G(*G1:[2.U'A
M4;=TDJ1K$"1J"]AX-VX V-!FU.6[S1J+4_M)/"QPWA"_QT7&U/UI?HXW, \<
M0M\K%&[1Z:J)?!,L4Z)SS\<QV;\S0D+S>MFK#"L@K22LC /FTN .!48\!N$&
MB>2-J <I-=>)4E11%%(*J15%(4+8-ODY*L&A/YAEY-D;KK3V\WF\6=UXKTD,
MF[Z#O4$X,,*!$0Y,Z;E.%+0*W^70 OL.?9>^\%WBR[&,%V([? J.(<T6S@+'
M$X+'(?P)X4\(?Z+47"?\B406#TA$ [.2$4KX$L*7.#%!>S8=C59]K7;;5C%I
M,2,69DEXRD*9$ZM*WX-#090QG<&HDKEI:XY?]<+3(W@UZO[MW1R J%<YR5,5
M]2J"@L=<PO*)C)6%34=%VB0T-72JO& OSTQQ%A;"/6%E"VIU9ZH84E.:P7=/
MP12LU+]H. G@6;&PV!8GN1K4&,P9VCXMT7[39MX<VD %,KR9CQ-@%;]8PF*8
M3HHQWN^N7,5S7Q"S2XI0[4%5OJKMMV-Y?ZK)#>$@;;\HXG6__IR_=T.SS%LR
M^096OX*Q:?N72VEE&3@X;^4K_0^T:[WY6V5PIGBM7._E6$[>I H*'J]3DLGX
MC%OF((P5>V7N>7 L,$X%+M:#836W^SHP61/KQK224PB(058IE.4F5WK(B$:+
MH4=+^%I:BSPF^%5_KU\;)JIQ=@'"@K@<.'5WM*3>)1]DSP:C+QQL2@<6FDH3
M'4=:>2/5HX>7)GJ^AQ(27$'J@TTX;27^8+VMO"@62^+,E26CO[W .<-PC.92
MT=E8XL#YAD^'CY>';X/78<\N#5%67+K!Z9A_L=ED[]@%/[Q&+QUUOB HA"3\
M8I'K.Y%3/7FG4%#P>-WJ)!D+YO'H5"][_@ =W>[;=;\/7S/&;"08^!8CT[+,
M5_P+SDUX=V9>K@L['\]6IO4*X1);)^M0'"\I%H2EC,4-GZ@\.H!-:+P?^IT\
MCLX14/">P=WY8#HLN<!5HI=A$"3--P#ZJA47^O!RO<>Y^8XBH,,<Z[]UAV]5
M9O\@H-,%^Q&.G/]@&F0IL5,IC G^_9Q@9?\_L4SIRES,3>/]<(HH41211P']
M#JL3_=A/]JLR%\96Q!TY4TT$&3D;?C<PR>5>-.J!- (JS'MX=Y'6?G$56ZT(
MKHXGN-K]6<6Z\2*(*U,05S"7K72G7"\L6,1;:N;;>15:C!/+M)Q=V#H2Q[*%
MB:6(F47,+&+FPFLKKRS3ML_=B[R<2M=$B"Y"=!&B'[];)T+TTV(C$:(?L3"*
M$%VPCPC118@N0G01HI<\1)??:XB>I''&;YGA&H?H/OXP#EG%(FWL9!R;LY%F
M,'1A.EH$_KC37!$LUC5U>.693U-P59[PV42,GC/5Q,Q+$:.?5(Q>ZB:@/RC\
M_.WP46HVJO$3.^?*DDW\-"0ETMY@I[ 2T7V\K$GKLT5ISW&P/_FP@T17_0_J
M<L%_<,?K]&1@(L".*_R[)BPN/[!O!E:@%!P379\KJ@JK^F^E7J&_HT5V?^>/
M"C"V[2B6X['$U=V7+\/[Q^L+]X<HL5@1G)%I <G.^6,NZI>OFNI,+^1Z_9=*
M$M\R[#BR#S=^6>5 1%\)+%LG$R>"'>G/%YH#;QJOLV, G65%;M,^; 7A2-I;
MFU&&G"Q3;VD%FX*B)_I#)"BFA#0EZC,RI$-F3,0"\H)_HYUVZ/6A9S?5YE7^
ME9:UQ#\I,^S6<P$80I@+(T7'27.2/<7I$YHQUA?P<&D\54">*"QT$,W!<4 R
M%HQ1.8(#7YJEV3_/[ \U:0T\)RPM'[6W"R:N"[I:]@HXE=\6,Q#(\28+L'9
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M0ZE1=DSS)\M.<='@S.^*%<J.:2"U+J0S[0-ONP$)7DGM Z\M#(N@"&)*RK3
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MXFN,;"T3W&$G]4,^G2.X"7^$2ES:@IN<]IO Q3T?P\_8X^'>W& Y,^W1</\
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M$[WAW@'0Y+CODZ#L\NO^?_RKT%P3KW?L7M\[9"[\JXG6J%*J9H\E*%5MPEJ
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M/\43$)Y&*7;M051%UXM">PD1"\6?XYT7,Q CRCNV[T.BBOL_O5J]CH54G+-
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MY#6IR*HH0K9F.ZB:1@K\A"Z%128Z&3M4_[FXFV.%"J@WA0JY7)'@,2B#FK$
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M>"*0,SA&N=?;JZRC!'SW'M1R>L>Q3)H[%N>U='I:%/8=2<U/(19A'03S]$Q
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MI)JOAJ38\#VZ;K[: O#(O;7: ?"HNQ_@4<S'1;[SN &/F#0(U".!>I0CZI'
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MC'6 :G'Z9'M97FIUPBJW1@14B61/S5>;4@OB,@Q,*-ZK3EG49/N/TC!5::0
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MF39&0G/"_F7:)T-LJ,-O\VP5A'Q#1?K>#"E8O%1G_TL$=[,?N6]\4ISNW@^
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M>E$!E^3&6IP^JJ92;VU!_3OD\:"=WQQ3;&&#S), 34P"J NFK#1C!72CR!S
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M6A%T*.M$-L\@WTUHHZN#1>YW$^I7EZ $+Y..<!D[PIOQL/VE8I0R"$PL,G#
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M3\5&H^C!'W'4:[H69H\E& W"CK6K/::%"=]@[*=2C)9K[$<<WDIM6=!3<%F
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MX 53#UIO9RYR#O-_-LM"_YT"A\U/5$/GALV?/0] K'7(,>?!Y^[:=]!+X#N
M%:_<5)1NJUM0K#D+\4BD^U+HED#"+98,=P(RW,E,AOM<ACO#5BZE4LNV(5;@
M%9N(2GC&W"[, <SD+X:?!#5RF37R%V\R;_E<[N30&^L N@5]4ZUW$10VS)O4
MDE%9H[+.6;SST>7#W,0;]7B-]/A>( /5=OG4MAOYB\-H3^OI%D!E]Z7&J(LJ
M&U5VKJ*=B[KNRXU1I]6NLKK&K'S,RG>OCO3/Q\]KR2RG'S,;:Y79Z%JW="9>
M0*&O<&=L6VI%;U[#9$0$-X([77#G8^ZU.;B[[59T3=)Z@?ND7%LIW?30*YO9
M(EM9+H11?)-\H5.>F.Y]+O//.SRS<^_R3I.HNKX;\* 6)8[Z%S6(9H"%HTZG
M, \._.(9.RRA]$ :[X1.5;".6%+J.W_\0IT1=3>$$I94>BR+E.S9L%LS%/VD
MPP/?/SKL/E_ 5-.WJ;Z:T822]'SU\'AW[^40\F_=RV#;?[OZ>O?YS]NK)W)W
M_W#U< /V.GFZ_?;X-$[VGJA,W3",>+2X]PR>"!?C,6>#RQL%_DT>DFV<!8=Z
M\Q'C0<U8J?OLL_-'SF L[?N9ZI23U=5R28W9=[DS:"M]J3/XWG-I%>X NG6.
M7=V/GOX@S-ER94?8V$>!==J$ O/".DU_5=_M1GA_]WJ:O'?]1+T;[/1N8>VL
MIH;\WR:+ZRV82#W5@0:88;/@:]2TNS)(U)7A$9QN]C7LR6APU4I@1=K?GTW_
M8WB)2A86T[:_ 'LV1GR? >-D5B:/;0/ZVZ]JS,D-B#$O53OZVR[X&&0^>V-O
M,+V]01\)A5^ NZ;0&&IM_]E+9&]U-2-(<VPE?AE<E?-$>/\33H(77F[\"=,X
M3#2-LA0+<#'4:FR7 ;%^3#[*"E.-\'];^G1)=.HX@2T"1 +!)UP\V$_'&9#_
M?$%VYNS8]9H#\Q&2 GO[MM FFD.&0^99#DI-D G#!ZIW7 U&V!^LXB&3ZADU
MF,]CH>KSSZPP(IM-GN.I,D-@KAFJ,87+X=WP 0O"V"0K<N/"$0KLGA1K-TI0
MLGP]O*]QBC=-DNV_&K3((UA=%K?3++J "6,&EV; [XFV5UU-IZN7E<XFEC_P
M)OB\>_ZXVS>034-U3.L]U2U60Z6=UQ:KW\V?GIRR'!\P;\WHP6.&K;TP7PTP
M;W7S]0*W1&UI$B7)EJC^>5NB(F['P'QF6Z*(BZ&DVI";]D/<,A6[/9[O(\1)
MDD+4W9_$@*W3[C8)6#O]WGF63J*%(+52W(V5LR!DM#NH**&JA.P$?2J[WT[>
M!):N7)V\%2Q7-56F X*"Z_00(YKLA9=)6'R9?):WH\MD;ZVXUGR!!;B_FFN,
MKE@Q?'8!^:'",/SZ$>QGF]J?+O)(-$N8"W1:?8G,;ZY!;6I$?'40#XI%47J7
M) KYQ/4@L B)9ORD;C*J[8=0F)O$M (U.R@O%$1>J+,P9Q7,3CUYX2!P]NJ)
M?8I. 5S+TC^8*'WE@@3O8$+"#J:[6?#RQO?&G>]AN[+MU8L;K'N@SA<ZAS?,
MKJD!/SA?-76BZ:SZ%#S&N?6E$7XSX58'GFS,_FEJAO._()BKN(DCWV,XA&(=
M)W;OT!?[P72>5Q,;A!_^KK\_T:FNVK8VU[@?R?QFF="11XN-Q$ZAY_65=,:?
M%%&5>2OHW3LIZ-UMC&1)U.VQ6<"JG.772T PB<NSUX1@MI)7ZD<PO<9(:1=%
M,'G!"DW?&IF^YCRYS=LD!G78G8[Z5LG]62504)6V@.'/C_.Q^O9HH F<4$.Q
M"AMH *,!C 9P1OQ2?0MXKKW1V>?_4LO<II:!:T[(RB4:P&@ E\P !K1[.>QH
ML%;:8/T8K5%</@9)>*+ V/"PL9F'E\6E^?O-*@M-UU#3=<@.R*R6[?H)C=<J
M&Z\EYIKJF[&'N&; "KV(>F9G:ER#=FQU[%@79 1&P+%6KJ]6,_B^AQG;X[G9
MR*$R/K#YSM'-A[K'%AJU,<T)TYPPS:F*%.$O=5U#@K."JEGDIZJO*/EX1HY3
M5/(^KI@KL6*.-F)=20*+%.3H?YD8/1J^@;E60\)E*^VU\-[3D]N6-2C)G<<Q
MVY.=2+]S5;D,6QD6T8I2K54T+J)KNHC.F'^R60-7DG]LF'_X+ $1L>IB$JZP
MT7RNAOE\9I(4FM!H0D>JL#O3"GALKWSI@H__8+(U7E#WEM^Y8/G)"VA5YY'U
M,&@7G?6 1C4:U:4F)#2S4R6D3M&$5/LT++2AC]G07K3*TNR_R(+.?KANYTWH
M:D;9@I*7(%/MH)W-+L8M!74UEEVQ>0*I^<T5F@"]?UF+S)6SUEV_<7%!2S@7
MQ=,M6O$(8PEG8O"6B#NJ0Q%HFZ9*$;U<*:+&)J@P_MU32YL);;X>WRR07]W"
M\\:^9-JVJ%Z*EBJ\[Z291P<^@[X8-(7S2[7H-T:]LR*<I<3OX2T-:?+B"<[E
M;$=4%/]S'KVL/".BY9\^(P+;G)5Z5DKXGI<5XG5Y_/@MO+^!545T]>'-"B'^
MXQ+433[K/8?KZ.+2).;2).+@$U$*.G-B@=;"  =(BEA;+,5.7EURGB*F15@%
MHK "SKC>*F$Y[_TC]P0A_2I5W#]V'&64Y3)>J,Z_-%T'$^*:!LV!;;.AF,2B
MTA@W;'MZ)_H =0&EOI1"'IM+4CS&(9]YJO9T9"WDR.#G,WB]-_T/I<9([O4$
M9/!2RO)!9L# 6762NK[0B1.[\ "6%\#R EA>H(HTD%UY 1)^(&>_^^&2[(P/
M#,*N)MK<T&OUEF^-T4?UTT%ECFFD%4\C#=GBP'38)BHC7,V"[>8EC@T):WG?
MP=SX)T K<F,4[3ZI'JQP#U7)]U E*TR0&L-DLT@O*</$KSNP136LO%^U=D=A
M[8'ZVM98>Z",:JH$=C":OUGOB!AB^0 T?<MG^N;**6CP)N04K " )FYI35P\
MB*7V=FF\]/X(ATK!IZE46*W@_GXT5:MDJN9#,VB]GE,F=M@K[KQ2L:W8HSD9
MM35O8TZE(';OC6HOR%PW7[W:5N[)++L5KS!M"M.FSDV;0L:H!F-DEVCE(2/=
M;*L)9EO58#6?+!F"*;T[T'EN\2WATJU*8B,'4QID6)TK%4N?PM-1*[TR+X@R
M,MSD5#+*Z#1&G6JMK3$+J@XA(LR"0OLTTXR%;5WC[YI]-- ^C1DJ&F*H" W2
MTAFD!7%$!0W2F.&=CB1A> <MT/)9H)BD5&NS<5.0)2R'8$LQ/,ZC6+Q&)F/2
ML']'DANCZ$(LU4,'FHZ5-!TSY8D*FHW)>4)!^Q'MQ_+8CQO/Y71E6=28OA/'
M4@V;<0*PQDP#FY)]C D_F/"#=9(RX0".=2)Q=/,?Y98< G3)@W\<K >L"_+O
ME>UH\_<C"TCV39(O;XZ0 (%?017"0PQ>-UN;::JEP>="E5.:8H)/#5;",:+U
MOCB/-])\39G\@MV+.3[G!^RE86/4;2H'2I26$BV8YE/#I7$.O%'!!7(RN@"H
MRDVYU\<%,AK')5D@KU-\CEG&R=-],,$'[=,]/8.Y/6<Z8%G:.=JC:(^6QQ[-
MGR@J:(@F)XKJ;>3&9/,Z6*)N>):EB;-L\:#5J6V<L^:26IPF,!VHTD;F2:KC
MT?!#_*!$ A5#[HT[5WP>U])3(U,SMN+H-T;MX5GGJ)<,&VAAUM+"3($FT- $
MOF!>S\*6I&AJHJF)6>5E51!B^RH?#18/<^4##<5]XA\"\4M%^1C0%XF68F[K
MR>,\@):@TI$E6#D651)'Q."W=R+Q^/%;^''$ 3MQCRI";+[XCSMJH:3TGJW'
MY6IL)C]K7F![--@D=[J$.EB:TP?/A_5IB%A;/ 0-(4O.1,2TB Y<%'8*=2@+
MD.03F;X1GN+)X6=8*@+._,$CQ448U1,L!@&'.6)YLMG-%F5$C!>J\R]-UZ]I
M4-UOFP5^(+5&*YCDEHO,$GTE.3IS3T#9+Z6H?XI-*2=KAD3+KA0GJI3S(0S#
M5X+(B^3Q"JY 8],WVY7<E XD7A<GV*64XX.LP-=Y\(7-__Z3^0)(@?5/8&TE
M;7[U1ED*KAW9DV%&^$IB2G7=FY&_-Z0&_]T; OZ[]ZH 6]B.:L%JRYNRF\>O
M7Z^^/=]>^#_L+#;=(0]LPF.+9=.:!49:NGS59L[B0I:D#XTX"]KMU:I[<_O#
MKCBPK7V!9K/E9,C$\)_72\-SA"#P.,V!=TY#[$XUT4["HSV(M9P.+)/[*6SP
M+'8$@4GUU8S:@07QU T9[Z^)+XCV G1&61>)"6-+5%TG2_C=G-DM$@=MB)(B
M4)*LH#ZBY$R4_,\O@W:O<UF]-?$YQ;7+<N!4;).MW1@I>^:::Q& D.MLQC6#
M;RJ::Y;MD(6JSUE2*)N19I!)HZ[J(*6*2ZG)2A@@I>Y=?G(E"]6B,#KPG'<R
M6W'//4./N@1&8\S#'L,J=,-G?SR3F:GKJH5 .@-(&^\=^PSF+F/! .TI#SN7
M"*\<+1:UPC:+RR$A61&5LTC8Z1S=X1&;A$UXM&$"XN)6&_1Y%5X$,L,<1VMJ
M?5P"(:KDHTTI>3 =2JY;<NM3JRF&%'7&IJQ\;\OI>A%K)$7=QJA[1(8\^@ I
M8H/<Y =0IF?0^B]_6+W \Z;N[VRR-6.END[1K0L".5!?-'L* @[KC=UC>.U[
MVU[1V>T;T*2A.J;U/@;9N=;-Z5^Q^*A!*(SEDNE]:^55V(3VT-D5C"E[U#/5
M*1\KKYA&N]_=C*L\[$KM2)4D#_95THY&DN5=C<054F3FA:Q(3:+ _VWI/$]L
MB.8Z5S5=MX8MPF:G2:;L*%,F/?P'5GSA)\@KVRH7F7\19^K=5#BV#\)'X3?3
MUMCDC#G0SIKYX)P.(N>T<W1*!ZUNZ)P&+1G/Q/#+0+H["/T^D:77*;"#+;^
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M>[YZ>+R[]XHVKO^TJ_U_N_IZ]_G/VZLG<G?_</5P<W_UE3S=?GM\&N?8]&U
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M6%6<PQEQN(U9G#RULS!1_#:3;CK;3,24)\1)97 BF@>\7S?8H/E6;_--"/?
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M/IU")V?KS+HF$SF0>7?/=FG=="$G"0:KE.SI:[?9%Y)7F8*I[!"5W.]]B%7
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MJE,N4]_ESJ"M]"6P8M9&C:)T)*61FP"QB8 > NF"(@8-QK3Q!G_K60YC<::
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MP$^CA'J.%9)!7HO ;'A !AYH%[L2$U.P4R*!A(/P:X$W<U,5OJ@3G49D7_3
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MN,ZTWL<@Z->Z.?UK1^PE^3O\ST1^;&[$OT$H"-T2FN58*[J1**7=ZP\;T,?
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MR=':!WNJAW 5J6,EAJO :"UZ_>\#;H!+_Y+V3FSH":PI,U)A6WZ!+NBQZ%-
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MVY5Y;'YO5,+B JO=(%4"A1=?UQW PC-W*J385&$2'LH/_@W^Y 77/<5GL";
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M[@@XQJ^W/W^>^RD6V+T/MFSV&6<S%G!>_A1<YP7\:'B"N:C,&0U(Q E3 (H
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ML3#'&W@H$B?\<SM_]#&PRU:ALS=]Q\8M=SO>//'/-KJ.B']FRS\'1\<_?]J
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M[M11'-BSXS_F]^=-',_?ZL-T#/I&?X%N L2I;C',N53?GCQ?8''Z&%C=["R
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M*NQ/.X>,5(_"QAWUA=N/D=[37:7=+JF>9WX+K&IL9@M;,%%O<VH) 3A #67
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M3\ =Z^M/6,#4<73GJ[?3K5^C;O>:W_2>LNP.W^8P:4SDB69^;Y].RC%XAL"
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M;N]E!ZI'_YB:3)Q$M5P4'Y!;_;UG?^V<-<078WC*R,D*3O&]*BO(2PC@6BB
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M,&?> -!F?09B90#J(@!*T5YMQKB;CTL@T4@!)0%0W!M )4"< $_%\:81XQ5
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MCS#E4IR:A4Z[<I#B)!7J4=,B:EH47]G7S5(ZJ5=<RK#4>>@U'9A8-D])7<I
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M9#T3?G%N$[>5GT>:*0K3;-0I:J%=*2KUQJGS38KL(1 7"&4X*>I+1<FU=VM
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MG(%?=!'2*K1;S92G/DH1<D0BQ#O R%-+/J>68SBKM,J%=K.:\B"U?&5&XMU
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MEJ7'3-)L$QD9-19:[GSC-[EAI*<QO<^EY4 W7-PWU6P3=L8(8)VPD6;OZ,[
M=);5[D6=)U*ID+.;\$.?\*'GLHW-@JR-U\:F=E@;FXC;940XT=3N+'K49-I_
MYI@\6OLTETFH<4RL#KD'@5Y "&_N^R)[NGRJP,LI]G39/\0C SUY>[U$@,/I
M>G/3#_1@EH$,].07Z)'A'AGN$3K<HZ@RW"/[K1QVLL]K9APL#39.@+Q[7D=N
M[GQCQ'(=YF@FKQ,[6W8*B%<+-M8' X,*70NV98EI%<',A>B_.?W3@8]S[A#=
MSZQB_JUSP7GW<+N7Y*Q@8SM5K94.RN(4C#ZR&U;D;4L@ZA:+B#>J_N2(N,J)
MN-HJI3R--2EL2[U\O'I9&SKPGH?-D#VD:CX)U=P98-"4#D14T34NW2IP&I$J
M6JKHM(@Y(U5=Y\1<JY12+I>6JOK3J.HKGLRR)H'E3#<)=6V+2>5\U,J9(SC(
M)4(?Y$]J<V&6?+#B!9[PPI\=)>S*,80=SM8K53(YE$BU??1J.T$RW^9R3Y;,
M@<;*)27E+KU2H<M<C[G._QZ=MKI5ZY].[D7NQD,6NTA?\/K$=(P61HM;&)7<
M.S!D2HDGFM @"#NFVQ(N):[+U.!1RX<;/$+1U6)M"N[*![WF;\O;YX,[IK;>
M#S#KOUV#6-8W+!PWW1W>O/$V?^@S?Z03R\:Z/,"R;@UN/F!1IN98]G1'44H!
M4Q/X)<=V:0@?"N]"PT& G]&/5NM%J;=:M>:+,L^N#E?9J%NK;+Q+5D&YG(E1
M:%__1KP]$N;V&/W;A==81+20)LV+N3;/O*XF6_G3-6$%QM3/SU:+?CG9DV9:
M0YUHI@DRNH_E3B/-(3H66H(M!3C $>&Z">O73**]VI2._?UH_;]=':RK/_0^
M[>D6N0?RQIH%8(9+_S/^3KD\+Q*-3&S]37.H,?7&EL.W#NV/3- )KU/ ]GB"
M \%'5!O\[6IV\+/DWC('EEDDO_X7IXQ3[T>9-T2\9W,[#Y8RVP1:?\;T@CD8
MJ(&']G33&TG^IO7[6#/7Q_P)7M*)#7EMRB:ZS2F.L*G9GSH /?*FVRXC9X]/
M?YSS@JB1.X8GCZFC34SJCBW_^]&/GW_ S@ UHX4'\:]QS#K>2S]@7P/FKY W
MF6Y<,EC&9#:/';<9+&] L>N25X9%WZAA33BT>0E5"*;\&?Q%_?*'9="^:V@V
MN3:T\<3_FLR!6R*_P*;V:F@!KF->GX9O9MB<4<&[Y0)J L1J!J]?6_Y=SZ:&
M'6#]"@>C!CC U^YD: ,MDHDVY<N&F_\KN@SQEW?U3^_B%3G>>%'5@.5GKU_\
MQ0"M>>6$3P]_=G#N/>O,"6-=V>"OI^\+266-F91OQ9#R(%64DK*:%^$Q5<^+
M^Q4]=$V ODU.3\"8E#D6H-<'#,> .T'*W0"?9X3IC^#>?,"T5^Z=JA;:U5IY
M2WEE3V.8*V\N$#H2ODU?@9PY*VG]D0[?\HU[_._8FLE\4.F,E[WV_2)-U#!8
M%.L5BUNN#4CP9<F\8!Q$\E]P![\>)*,%\G7*[\2D*H#L@(.&A5MRV[1/]0FG
MYO#2)A/;>@,HS0L[EU3B>JF^MGZ1K!S5%Q1R])/VJ4:.FTE8J?(3=NW2_]]3
MYZ%[>^>?NF=?S9?[>^?^]N+/F\XCN;U[Z#Q<WW7NR>/-S^[C<[S?C2H+79<S
MV6B655I??4:HTNO DKV=EKK#WW]\^ZUG#:;P;N2,C?;_ U!+ P04    "  (
M/UM;S%[RIHG)  #OL D $    &0V.3DU.&1E>#DY,BYH=&WLO6M3(LFV,/S=
M"/]#AO/T#GT;:8J+0'>/$=YZFMG=K4?MF;//MP02J)FBBET7E?GU[UHK,ZL*
M!+F(4&C.GMBC6&1EKOL]/W^]_?[M^//7BY/SX]V=S[>-VV\7QQ?_>UBOYXN?
M/\A?X?,/Z@'V^?3R_#_L]+>SRV^7U[_N_?FU<7NQQVYN__/MXM<]QW;%84_8
MW5[X\8?G][FS=\QV=^#[9\(-A7_\^;SQAW[XWFZ'O8^U?,5V]QAW[*X+"XA.
MN$>ON=*/];G?M=W#T!M\+ S"3TS]WO3"T.O+CSJ>&QX&]C_B8RW^M</[MC/\
M>.+;L EV\JWQVX]?]WS<V=[QYR^7/VZ9.L$OU5JA*([@T\;QQ4//;MHADX=O
M'+//'_#1X\\?KA (\9Z2%Q[!"\=V^&B#>\?_<IO!X!.NPB8N4EAXE<$4\#SZ
M&AL#S\@RB/"3TV\7[.SBV[>;JY.SQH_??MTK[-'O5R?GY_KW/QOGMU]_W;,*
MA7=[[/3R^OSBFCY7FY"?' )$OYU<W5Q\U#],P$5Z.U78CD9-BP@$<0_8QWU=
M'ZL?SO7;Z[5W@*4/M^?)7_Y0WY;G3?:I'Y2//?TS_-]UZK7Z3 />%8=-7_"_
M#VTWL-OB([_S[#:;<:8Z@GAL=X"<O33FV2C2V$2B5A\A1WRT\H6"Z']BH7@(
M83=M@-7'0_WAR+LG4?]T>F_\^')Y_?WDMG'Y@\&_7T^^?3G\S\7)-2L6BA7V
MI?'CY,=9X^0;N[ZX^?GM]@99(L41*4B.(T(1F2:UZ<\]ZV^$N5&L)<"P4HCX
M>M'X[>OMKWN5T463CQ$X0/_P@O+TM9>DB.I+4$0E;Y5'D5^=@OR3/+L!V6IW
M[!9W0R;N@'@"YG58V!.L8_M!R'K<Z> GB/7/)/4:2R/XQ^6?UR=74QZ?_>"8
MI+866]H0Q!P$<9IG%Y((@J@9B/]&\#,+/?9[Y I6*N0D&60"_16#_I6C_RS/
MSKQ^GP@ L(Y2H.6A2@E$FR3!X5!P'S\+/,=N\Q ^[M@N=UOP=1:$\('\<L?S
MZ=N!_<#Z\)Y>P 2LTR9"DE@QU/3:J>D\SZ[MX&_6X:W0\P/&W3;SA4-4,^!^
M.&2AS]T _FH#066##JRJ(825$\)%GIT,!B  0!H< @D$($1:/:*'-M@<CC=
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MJ1SECBH%A7*%1_@;/*V1"8ORP<#W'FQ@4.$,E\5G:0R?0(0HA5S"$&> GY;
ME\GE=W<6?H%5L/)PE $ E8Z39[?2Z6@Y4:#@%/9XF$8.#^3A[E T#9]@3O)
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M@1I@A_ ,R 7T@-029!U$ V3@_V?E1R-W*I_1Q3=% _B=AVB0ZC>GA92,T.H
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MZ0V3UKG&>5P)EV?G@#^0%"R.Q2;C#')86S1D^'QBT2 -H"\68]]N1XB\87\
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MQ7U;E9_08(D>MU7+U9?XKLNV_@$;SBZC^%<.M.<XJ5LY ZFKP[2 \[1,HUJ
MY ;'U/6: 5;;R,(V<._YW\*==D>H"N3I.(ZFYB38H :CN$,UUGYE]_:H<IM
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M$O5!+OGQJ#(R*G6["54Z@ZT7WXF4U 0" @O:PE5*:)TSQ1+'7Q5@-X7.EE&
M9G?G+[1*Y+TI$PGE=UPN=0OK^>7O"8#4-TY@H[XKDB)<14):^EUP#/BYH&+1
M*F[1NE=@3 1#YPZPP)/[=F?2EZ*KF)X4:]B8\E5W>>J^"IIO/ * #(JS&+P
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MCP;QMV2A-CPVP.2(%$7[.(^0&.$$L^0O'2?7^#MX-ID^486P,#6JN8A+DB*
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MD":@2>-9?7$X@#5A<Z*M9[-Z+N,8Q@_L((0_L":'GW"4EB\ZCFB%]/*6PX/
M[M@M\ONQ@^]R(!R',Q[ M]/A@:3EX?.'QC';#X1@/[Q0L--\-8_+XG)G\#I$
M"$>SJ&.[W&T!*%@0P@=]V$1RZB$834P /-OL7+0$]@]*U)6L'('D((^HNYJ"
M-JLV!6\I^[XXS:0[/3[+6WEV([JX)V:[L*F^!("TUJ:]=1JQI%YJS75#>[56
M*(HC(@G<"FSF4D(7TRV!W%? $- ITW'RGLHS]U3+5^:DT :03*OE^6W FV#W
M=MACC2_7-Q(Q-;8?;U+#+CC($3:#":#TQ<#SD0Z:0S6KC0'] 9D"H2,YN?1-
M295>9W>'9@F[0"U][H)W0NL!(7'XBG=G(Z$ D7F1S\YZMNBPBP?1BHA?+CM
MO\+/L?N>AZ\@NJ9GO'B_;=&R ]Q5G_\M.U7EEO+LMD<<1_O&4\.?Z$3P+4>D
M5HB/&+"^Y]JAAX< @6##WB+N.$,6X7=8? QY?F CMXWL#5^BQX'3/#^@]\81
MM]3RR'*.%Y"$\''H';XF C[Q"16LQM"]B$$";H9BPJ*5CP'DH9P*!,H0IW-(
MK-::FS,#^P%/&/8"Q9^_1ZY0O%D@WJSD&=(C\.=R3#(_0=Y.H:U8V*6(2XDZ
MF@W(I^+O(SNUO0'X:'V^UE/$;YU 4BC\?3L C".=")\PDPK&(@7A@;G?ZN6
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M[>?3Z^/](X5+ZOA99##AW A<^^"SER*,UTD&Y0ED('_9YR]"#Q/&<6E-,?=
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MEU)U-45XC^&5YHS*"-3IS55E#3[J^$P0]6%?H;19_4<I57"^;32&FT/:^KU
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MF?['90(R?1'R&  C*[XM@/3RXVRW <,":!"4?.IZ@K1/0$_?"^4;+.X9:,>
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M&'3(9F-0EUDAA'HA7YX$=5THU/6]^[#WE$E3F\U+A>F\=#U:6  ;2N"GB@@
MV\EG/,'*[HY&BR14B9O99ORC-L0)##PF");K"AHO*!DO.!F)KZ<*4Q8K<YG4
M=JHE1XOB\QAZEQD$ZH$:K5"I'KU3G:_Q7\8[Y=239?V@?.SIG[.[V,LV^(YU
M%ZYM3):N5=]?4N*/R/J#.=HG7Z(C=[Q+,&[.+HXES3(Q&&^DBDW^@ KX\^GU
M\?Z1@B<5YQ_,.3QO;@#.-2_LN?VNFT+/*I%1GH ,5<'$5XZ5M>) KY@E')R1
M,GY)L*HN7JW,S)B_S9W@M0P/WGWFS394;1&*AQ .V 9SZ^.A_G#V0(VI(X65
M,H_]/3,:.(-S6%<X&ECZVV8V<,8HTTP(/K9JN=)1X;6,"#:4^7HH\SW&(U\+
M82XS&"US)N'+SZY>\7(;-UA7/<OMF?:H,CLOXI#\:-S;W$[TW-N):D?;<S_1
MS/C/Q#66_=M:WVVD;29.8$((:PPAI#-GC^2ZB2YDSE)>872A6,A9U8J)+F2,
M,HT/9Z(+AC(S2IGOL6CGM1#F/,-OK<+2=2ZO<2R+F7Z[YNFWDPLU5UD]^6</
M0$(]=FK(JK2!::8%%MVZ(MS=F64K4^W?@2ROQV)3-\ E">2JQZ8MYRI-B:%@
MX1_V)SG8DT>M/>ZCHDY?..(.7ZT0FA3*CJVEN@9](;LH]/<'6++N18'Z?BXN
MY<7OBX%&&#5H8>?K[@Y6"H:J862(WW([LO"?^T,]^T$$>I;%R0TKUMF^G1=Y
M=N)WL9;=Y52B>!OY?XNA+(VD$;8G^;+N73J;,,%VI#UH4G5]?*;9HRXK!T_7
M_,YN:+:L1?O,L1+82M<"8UFGG$>I:'U6V_DJ"?Q2$K':BAX$%L\I5@6=U%$7
MRJ8;Q,O$29IOM!CRJ#QO,61EE?6+KV2QM5969K**DF6D@'+NZC!3+)F90KV-
M%T9N=3WDW#6ILU_UPN-^I@5LSU*M#)X[%I.=8CV\^*9XW)DYMJ&Y@60MOQ]0
M3A.V1.[( B%K0Z\O3Z\\S B]:J\M,]0ZH47II6EWR2+ID8VL_%J]U3RR\?1@
M%LHS'CELIB[CN?>?J_+;[2W-6&*CZT;3PDA1N:%5O-R@8"D4J!)+@X'-84"F
MH3:&@64JI1(!&$=*%[$LMNE+F[=')NQL@Q;*J%W^A?Y)5R/=TM3^)-&R5.61
M/N?+&#$Q?N<.MJ2/N=K<]X1]+9W;3NURQ=U&ZX&>H8>7HX?55N$8>MAR>EAM
M9XTAAVTGAY660KTP\,9+G;)Z"0">H&;&_B\S]O_)6/#&+@$8V]5*K@0X6K0F
M;W?#5P(L5T%3'*N@T</,<NR.M_ 'JBWJ"AP /^@--U!9,[H]+N=WX]4F(SNS
M6S3<LDO3X) '&=TWP+&*R7&\^^#CVZVL*5?FK:PIKK)^Q2QF%EO%8MDJ;9HC
ME(<US+(T*563E!*;IBY)YF<I(B4W_#@B9:J/5C02#(N-="')=M<990B@6(B^
M 5B^+?D@+\5&>,M[L8U\,.2\Q>1\$?G>8.4C&@T1&R)>(Q%?BR!4=;(=A'K8
M4^5U]Y[OM UQ;RMQ3RE<W,AT[LG32Q:BEDR/!VGT^Y&\R'>5TS^6A=K<7#!*
MZRM TL(L_39?O64(7AM,,_BB%T/&"J&0E:6,0'NKKS9<8KAD2TC5<,E6+&6X
MY*V^VG#)-&=^DX[\1@OA]1U^+]::-P\ 7K0U;[D-+-P 4\V5K.)+[68#34ES
M$>Z:L;1P4Y)5SUMS="6]]%G?,@J*A7PU>R@P\FS6=BJY8JUDY)EA)L-,SV>F
M>KEL6"ECK%2<JV7<L%+&6,G*%6H5PTS98B:PLXN;9*:W[</_6]S]PWUN7/AG
MBI9BV0B6C F68CU_E#TM_:904#(^QU9*,ZMB&6F6+58J'QE6VD96.C)V0<8X
MR2ILUN$PG+2DB3W'\$K#26OEI&*^\*9=]U=3*7_-?8$7&@D>;/RJS&4+,U90
M6+--B[_$C7LK.,#T"W5?W>*F)"I;S7O;R\OK6-Q0JZ'6[5G<4*NAUNU9W%"K
M*8X><[6^\*;/_QGVA4FM/K>:L&A"J-D*_."@>ZOX*7M!U+>$A/?69H-O1IPM
M&<8^,KG5C'%2(5\SG+1]G&253&5TQCBI--=-3H:3,L=)<]Q!9SAIC9P$GF;E
M3:=6-^J\GWR[_?E'H]&X9/O_WX%QX)_KP)=-<W.VI,O[>LG41F\:!95\.7LH
M,-)LUG;*E2,CS;+%2M6:8:5M9"451S;LE"EVRFQTWS#4K.W4C&K*%B^]+Q7*
MFPTNOVU'_H=XN+,I#<\^,/E+&W\Q;OWSA4VI5C72)EO2IEC(8OS];:' RF)D
MQ4BSF2F0NJDRRA@K6273J+F5K%0R\?Z,L5*IED7#P+#2K.T<F;Q\QCC)JF[6
MOGO;_OR9\(4IJE^%\WYD!O1F2[(<6IDL0WU3**@9WWT;A5G=5-1GC)'*QG/?
M1D:R+#-C*6.<5#$J:2LYJ6+LZXQQDE5ZX]/*-EM2[PQ\S[$?C.?^7,^]8!)5
MV9(L. =QH\TZ!@68*S3CD;=0FA7+)L.1,5;:<(+#<)(IIG\]W&2*Z;>6H<SD
M_HSQTOMRR33%;\Z#_S[T3.I]%29OU0B6; F6PV(EB^5Q;PL%&^Z3,M+,Y-Y?
M#2<9!WX;.<FTTV6,DTJEO&4X:?LXR32F9HV3+..Y;S3WWH[,,/K5U/68NOF,
MR9;W5A9K3=\8!C(8/3&R;&8ED9D6E#%&*IH8V#8R4MG8!-EBI,.R&0BYC8Q4
M,Q<Z9(N1WE=,S?Q&N]W;PNERX[4_VVLWIF[&!$LABTFJ-X6!3,9-C"R;:2.9
M%MUL,1(H=),EW$)&.JH91LH4([TWA2M;R4A&(66+CS+0<_*V_?8+QVN%/#39
M]N=/DC6E\MF2+8?%>KZ4/27]ME!0,VG";91FIL W<YQD$NY;R4FFUSV+[)0!
MO\,PU)*E8"86EBU>.BQO.$'VMCWX,]YT[#O;W!.W$B?>)-^S)5SPGK@,UL<9
M%&P<!4::S=I.U?2[9XR3K%H6(Y*&DV9MIV)B^QGCI*(9-K^5G&29&:H9XR2K
M8.KF-^>]_Z]P!S2KSOCO*[D4QHB7C(F72B;S5F\+!>:*JZV49F63A,\8)Q6K
MF[65#"<MR4FF63=CG%0KF4C8-G*2N74Q<YQD;=; ?MO^^_]T[-"Q.=O_8H=1
M8/O</3">_"KDC!$SF1(SF2V8,TC( !*,/#/RS+"28:6UL)*IJ#<,91C*,)1A
MJ%?OVI]>7I]?7!^>7M[>7G[_: T>6. Y\+9?BJ5"H=P:H;8._;-W#"_96#1
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MYXM(#RR5ITCG519CPWQERCZ*>=9PD8X5X;OLJX6L6&%?;)>[+7B(78L@<L*
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MFSOE'_M]ROQ6$)?R[0!=^?:\3SU5(@^UK2GX?SH.4L_[N&ZU$CX/17'"B7"
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MX'KHH_H':"-G\ZH5.H-7"LIU)Q.>%\2598'.VD*RU=U>-JX4D,OAN-QAV*$
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M.TNTZJW%1@SFG8ES'I^'MZBK[!,>DO.'-5%/;$G#X<R-69@$@R^HX)HC6]%
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M+R/+X-NRL:E^ 80'&Z@:%2K0@G5GHQ*D6O%#">CMQF+](@?@>S/?/]S<LGO
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M*]SPGNZ*F].+[VM%[LM^U[&X"X51!GO5!$6"]2N^#1I&]V00K+X<'/BJN F
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MF\,A;F6/$2A_W-!Q@$T"6K9\]C5VJ:1"ZEB _'5''HCI!CE''D@]-F-6%NR
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M%L2EI<Q<7V9VVX<E,2,X#^)\J\C0]6_:I52=*0+S5[9#.1L/OGZD_\CW6BR
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M.5#'!LA3@Z3IFPJP?__O=N/+AO(&.]_<%? T<%6?4UP6..HGSKWY6G57'/3
M__9L*^B0LFGV*6*[6>HAO]_\WMQH GSG6_1UD^%AP:=A6$-;';BL/W4&GJF)
M4%?)50LBB>MPS=/?.C?Z:P5FLRPQ6WZY(*NYH 4]87V3 N:LVN,NGRO:0^#[
M"<^-4<'\D8M;ZE10>(!U3G3U@;H)"#_"20^PSDEPYHNPYJ7Y(LBT%&L[,!:^
M\==G7=U01>H.=>E6:U%WOML[<X '1 Q^8ID.=]F]-9[P,/[PTQL-RP-<J4=
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MXVK% 5&,D$6(8,+P@GWC+P8* W5H6C@;?3S["!PP=H'_XNAN;A/<-=P.==J
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MT6^/M-;M@;\^L:T4 URU1=+B!O2;C0@GGE7@HW:VK#<41LU"N!M*?!362?\
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M;TOBWMRVNF\O_?? #77B\/ZO-A_8JD;%)E^_EF;HCMVZ[EDK?SN<MT2?CX^
M91>,9NYB+W:5O"<^UEV7V^NG#?=QQY]4Q[4MRFM9$]74<%J?KC$3RXFXV;<T
M6\>,J3>V[/5*%)73S '-TPRV7-HUNV15)5O_CO7/Q73/]B,$DW'#66I";A4<
M2-W9QT!,<;M\I#MR,%*$9 ;GJJ9H.TF R5?OJ0K, /\PH_NGJFD@U)S2RRF]
MG,,QU.X;\)B]D(F%L63GY%DUP/1@1U<W__F??UX?LV?!FF]KFU^Y"8\MSWCL
MG'\ZIRMZ.>R-'N4?/WR[>IN\]O#X)SNRC#ZX:VK?,USGN.2YG?+<:?=M$=C;
M99TKS2RK\'?++-TW=ACX[3++1\-C1Y\[;**:?1P.6ZJ9G7).J]5Y6_1U9ZH:
MSF3 ,QQJ_R_O637QUY*7EL>96W-+!#+5""PK$BB>?\HC##_/$88Y92W;B.!N
MKJ9E+X\PA+4LY>F%[9]>*"V:]3-]YYW6RL?B1V\R7G7SX>KFZFOGY,F:6 J[
MNKUY8]L#065S#0LK-=74XIW\2M;;04>*3G.-D_#[2&*?[A]N.K=OKZ#LJV>X
M^L3@;#SEAC5>[810F5G?:.9\.744<7<I'[>?A]Z/"J0R3)DEM%+:$KL-Z;\Q
M7@&*^MLR.?M\^\]OWK/Z:CWK_3>WPW_>?/_S[O9$.2^9IV2>8DFK9U@_2LXI
M.6?_2IV:;S)T]'9MNX?'/_\Y^GI?UCOM%>.=9V@R?4A4]O;YYY_W=W^V2B8J
MN%?EVG6#:Y1"[6][SF*X:7_W=S,RU/&TG]*IJ1KM,=K7G]__!O\PQYT:_%^_
M: 97[0M8S^B2C;AH&!KO51(;48VW5RNIPZZ5QJK#KHMMV.)W"OW+<UQ], 68
MW>$\.'9E.!;[85HO)E,=]O7JNJDT:TP M%J1"W@9Z2X_<2:JQB_@4EL%NPR;
MJ^H:-QWN.PML8%MC? 2[U1T-6ZA. :1W[[>TFQO+,-2>)5K).NQ(/1; ?! =
M9BV3G;"CWC'#^:O?^*N+?VK'[):;8&WB'_UC]L2?U6KE?J3:8]BK1\:H@]_Q
M8_:@]G7K*^_KKTPU^^R[K9H6@[_QZP$\UC15ES-Q+WXV!.!>?V'7NH5_C8[9
M_0!V9&\3)%<]$+W/NH2(_^)J)74:>^YA[/&\_;(VMFG#[:--<9/-<Y/-=:/-
M='UE0]S*_L7FJ9M EX0-:@,9A$Z&#SOL%BP =_5T(< 5"JWH-;&[HYAD<1"R
M7+C$0I\4;,:D7!I+RIY:/CM&6VN=,&PV?<&N^MRT3E3'L32=:OB>==MSF#N=
M<-;$JWIP#=S7L_I3=E*MR'DY\"$RM6ZZ?&C#XZZ  ;YR5S4,2QZ*Q<GL+[H[
M8D\CD (]RYE8)@AS]M6"]3NL@\^^O0D??M*WO2'3+/,O;XA\(R;'7;"EF[P^
MN>&&X>]QK+J>X'C:+G Z/NGI]PMV;7MNI)N[.\5N0"9G/\1:3]B-XERP&VL\
M,3@V#X*UC&'-^)OBX-9OKN[A>Q4\4@.H"AZOT4S8H7\,&!]Q"U<8@")@:VO
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M.)UGML. XV^NZ7+$10PS6=PV_<&\FULG&*_L;*&>7BW(0)LX/D#&=H#  +,
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M!+5!0_)!E@>L8SF(2 74L44#$4(K8'BP'%S4O0$H@^_X.ZR1TBP)H)AMI'9
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M%,?FQ< <1K,04H/OB#^D)&MA+<B;P5UJD(WSI!X&W!J*07U_.1YVC0?HT+3
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MJD;TC( S;GAB57P<B^]PHS-"].N_NH1O?FW(BY[TV; ?J]N1A0IQ85R?.WW
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MI5+QN,]\LV^;/># P$>[R+@<5W13D91G >B+M.A<!CTTNT4_,# 537#H"%1
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M#F\[6+[U)_H6]"H*TLA^'X]\)/1D1)EYMY+Q'TTLI)#Q$QQY*^(GZ:FWRA8
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MY\?L;8+S) 9_PDVA_XG]%0(J@FE+_/'PX"C=\T+.#[KX=BRSZRAO,:N(4A4
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M1_IUZ\ZI0=*)OJNO'2XS4ADP>V8'!>W+4Z'74.7W F3M"O5]+^#TNUWD_@(
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MNOSCYI8-P9 -/7Y,1SD-?9-F'-OQ>G-'"Q_9CEW$M=1L8;7D;[??KEEZNK;
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MY^-S _T;8]1:+E4)GQ/NLP(*9/J33MB\399V"V "2((L%[*$-FQTAZ9M^H&
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M8 %ZP^ YTA! G8>KM7C"$2(U/4!L^=U[$W )7I'X3F2E^\FL$"1K> ,:%P.
M6N 4#@^PAJ 7@E4D<1O_9'H,=P;?&&U(C"(V(%9RVS?$O8B8&/R"?V>6.30#
M&3WJ<K\#MX0"L>V !014%U(.WGQT<=#W#3"BRC>9V@QPP@M+NB#$Y5)RO$U4
M#=L*90JS(1[!+&3+0;A3+0IR2EBUUS,[)JYJVCBM1V(?*3<(4T9I]Q%] C89
MF/;<1>5!)4)*OSP ?NYQ-D::I[QCA)B4 @>=#U2$4?9;P%NC/WN$9(R.;7A=
M>'57X:Q/YO((]CE2--P%-.L$<$TR4QPID:@*\6$).VB,3HB*162/7F%C5:5
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M[S0SU+/UWH#SIM4+-4RYN7%MZY^9>6C]9)O>I?5L\:SG,!TB]E%6"FWZE@,
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MVQOTZC,--W[4]4+;:M<*];+!=$B65FS7SWJA7F<[_%C)UF 9>B(D;8.C2G9
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MCN]S9)?S+?>Y176>0@7>*'S>^J!>5,X5TZTGEH! 6T.@S4 /D"1H!D#7X!$
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ME+-OQ-5KRMP=_4<Q%WYE]0_KY .V;^8R(,+T M(W2H2T_+^X3:SX#@KG8QE
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MASPK>[19[0M2&/''HY$[(U&<J?E".R2^YGA%LK+-$6Y%$:74?0C:&.)62,.
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MZ:81N/_"!^*1Y:H-<UJ_0$&HFE/9B%#;H^(4R\<U@8&Q)2]W08:3S>".7.O
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MF,;\+I@7_@C?VEN45N<M>Y"YO']D3BBZ[4Q2WTWR$NN^NV[.-A=F7.]W!'O
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MQR!:L3\_^/,%M=>ITL[H(I6R?'TZ,]"-NT_G#/XKK>4>RV!!W=@<;#W9%>A
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ML819X=)A-TE15(07$&NT@D]U $$0'0[HN,&:I1>P!]'UOUN5B24SB?!90&D
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MT<NNT8KA]Q%UN91NO%$++B .HAQ6H0SW)'Y<4$@%*X^R'6 P-&^YSIJC+[I
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MT25O:0N$8WY<?_EQ;T^QF3'&].C"LPH00\N/DY?L;WX8A,66>]M"6<KTJ*K
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M?I7? ,&AQ$'9E1]1R,_"SL!QJ;2(FYL <IA#._W8O HT4!5.V2F/- Q742-
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M/72'?D$'AQ"VL0N7@++Z 9M=+]H7&1U3Z+Y,8R=, J[2<S*+8H9#]W6[8^\
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MU="6L^^\@OYT?1T[H2L_^JC3%)# 9K=;TWBCJ *E(W+B#>6X')(K(GHU*'J
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M3U%/R\]FPF5HE#,5A*Y(G68< B1%>_I2O1$./9^DVI=_:EW(ZMH/G9#Y8S<
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M2,=DX5FU4/=G%^H<I48N61YGDZ<RRDO"6OO$RC+AB-YH<J[';GX"Q$/#6G)
MS79,9N?TSW-0]I3-!'+"BKY3S'&7G(<\F\;E,!?_LI,CN\V^-*W_VGUZD F=
M\_2!%-PAD:1R79%:-^.<8V!7#/Y_-,^SU6S^C977/\<5_U?QE+\I2\=O!K(F
MY[*#'W**]OB+P#N-,-S@"AR*VU/)V"5TFJ81<-/+TS1>8,+:Z0/'Z>NT\QE#
M$0M6VMZX9<PJ(\&<_ )P2\,]=#";A0<Z724]O[#\.?-T8A 8O.NJVQ^I^/U
MP_MT*'7UQ*BK9&I<8W_%.-;G?8CR*"WGK(S'4?(KX+%=$-R']Q\0=^2I+8V<
M"1KF6N?2#; * GF.8AM];MM].U]R8FF86@-HI0_F',5$'N.^/)A [QZ1)+)M
M[_-K'VT;3/ZQ2PN;(TX<^$3CPN%<UOX#4?8Y_)4X@'^^RECI3S3*>_G7$)N
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M$O,3A4&K;M-)0 HTOF^/E@9K.D@E-QY8V0PL$>;3 ,,T5J0.^M%%T6I$D,I
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M^CS*1G,6YS>KM#(+ZSM!64X&8J'A4G6_,[5F@U+,#Q'5,^DC93T=$$[#I^=
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M%NFIXN%U-/13&:63*)]<9ODRXQ\AV\XF'CC5X^QYE]QLGTERRV42CT5P\EI
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MZ>3PH6_^\";.]5_\]?U)(LBW?P2XU$*9[40H04.IEAY>O?VR>O%84YY3]B@
MI197;/GEZ;!U+6#7D\UV>ZC5'<1V'P1.*5N36IZ_I" I5;P+H D&IZW]1X$H
M:G9RJ2AU<J\!ZEH7S_M"?A%GRWF4+Z(U .52+G\8%CQJ%W!$(,TU7 /J1&K6
M/>399#6&CE<L?XG'3+^@(V. :\JVW99KNPYOY_)R:UUY8?ESUC=M,5CTT5'
M(+7X7)VX+=2D!K-S?;FUHB0^=H2G)1,M=\K72\Z3<CN0/%E!)-=-52^1YK:@
M M>Y=)O_NOJK9?Q3MYWO/P0['HV/4"> IK@0+*1JHTDE-5@]1[,X4PIJ[YD*
MVP<:GYB]G.10G-4C\U<@AJ4LCY)[-HG'<:HQ><@?!E:HV:K:K(T:?)TKAP7H
M.#-9%67.U;;R+VO:RTB>K;!^I&' ,I!(4X1J5/2K>?T1C?7?X?Y#P 8UGU^;
M[P_!1;_,UD.6Q-D#R\M54<3%[_&SD1@UHT!K:=@?%-)IBM$4%_U:5[?I-%FQ
M]-^1D3R1IP$OC>_32HXZ/+YK3KDH.O_S)8[^_;I07_CJCP%":I:>-BLJB@R)
MF+"VZ?B3W1/G)XF+2'U5WWL(T-&XZG6\I<MQ(5([3#24_-J7E*N7.-9=_/:?
MJO!]HG'UZR8W#!@B.$*6E4?V[U6>C?]6RFW_(4!W#!<_!!<B-4)6ELOH.8E?
M8J70]IX!;#0N>-UD)H>%B(R0Q>7_8^DRTQY):D\!/AIW@6YBPX A@B-D7!G]
M.V;)1"FUW4< &;4(RS8BDZ)"Y$7(E/+X](?1M:WQ'&"D%L33:E]#H2'B(V13
MN6=IG,[B,BY&>?3"$H[[.IVP13PVDJKI<&"$6HQ.&V%;(T9TX##VEU:!T6N:
MAOF:)"2T WL4;!_4ENC6$1U:F(C K0TV/@(Y+$5N%**A?!Y8H;'*:R6'"EJ!
M"TE[.,*PG:=XEL93_HVDY4Y-T=OT:?5<Q),X$D',^C!>PTF 7VH;AHL07UL"
M$ 4[NMP\$V),8H.-IP&&J=F?K?6CBZ+5B$!4[>@R_)2?\9UU:0Q\"F"6FJG<
MP2IF"1]1+ +)@6X5:Z<X@0B,X-QDV42M2/(A%7-$VDVVECJF/!K(B+(<>]T*
MRJ4HUB]O5'2B]BR?],-O9\CM[]"X]EI,Q44TF^6B44+5\$@K,+OR$^VF!_:H
MK0.8B$UVBXX\G$BA"K<)-9PZRC>ICBJ!:9V.CQ,I9^$^V^;#;^1Z)^AD;:$C
M-9ADRUI0K8S#":>F'0$6&S4;9,MI4*Z<P[\_:C=GM92-=:,&D5*]#H_:<1_E
M?S/11&+[:6G7&/D0()R:;@189#1TG$C)D"8+!LL,-DB0]XY<%Q>-H,WUHP;R
M1$J)C/BO6JTSL@&P/%/3C "KC)(,2B5) FJ02:5WZ1#X]*A%[RI%;*H7-8 G
M4NIDP\+F S->6W8' -?4M"+@VB(EPU4%E+ZID,7BLC\$OCUJ8>9*&9LJ1@V@
MJYHGU%5C@_]J!8V@M:N+; "034TM JPN2C)(E5T)J$(&JXM\"'Q\U+(AE#(V
M58P:0%)U7GQN//%"=)F?CO(H+3BNM>=]&PQI<)@QF0'$04UQ0IQNK-@A5;;F
MD%IG<OXQFP.^:!I% -JJ16OEJE% JHZ.S[A148'F<AZE*4L,XH_K3P/OU%0F
MP&*%,T&J?D\HS3$)+6X^#U\;M=P67+1&RE"#1JHP$,%2Y)Q9:@H08OF0D4"J
MUA#16N6<*6KQ?%)9Z@1? T2_3)&;8N5\3:0JOII$]@5H (I^M:+ADB5)=+$J
M1)ZMIG&(Y%% 2BT4TEA\2DBDBA91#=F^L\[M:?\3($AJRA;@9."8OCX4==J"
M^B/Z*:[CK#I/#Z??LA3R0#9QILAB93$#?/!'%6'9E'ES[6O#D*O"4HY2LW6Z
M<RNXF>79:EDAV_ 5IZLXG8TR03'\D4W6/4&SU$"A6DT+'!Y5B)VEEG6CC52!
MK# )CX_9:Y24,3-.=]P.J%@CU_;!J[(9$D*_7-<]9TF<2E.6K8JJH=T:$+(P
MH<\#YJ,*B3%9<?1\D"H!YG$IT2B/_$%@Z:A"'<R7#BD1ODN.'29[>GU'ODVG
M6;ZHYGP:S]ED);+'U__VR(I54I).HS9JZVY\-54WAL=2]$AS8)=2+1\.Z"D?
M7?6",[E::]"?2*)TZ_ZQ9^22/BR$:^B4 9 GDN?<J7_L&;D0?:DHC7TR (A2
M[K+/_K%GY$)^$(%8N&0 U(DD#@^2I#K,;FA#]4 W!(@C[Z"3:8,Q-$?IPO0+
M3CZR99:78N.ST ML$-!'[:9HJ1E:<(Y2@.GKAO*P=&?MYL.G &HI!S.W/"M:
MPC^1U&&G%?S.R,4:6 K=P&@M@WPB2<)M+9:<),K^VPYZ(05Z(HG!EUE1#J>5
MLU"3;+5]#BCJE:G*7!=D.#MG^)Z#+J3"G+Y^EJ8V/'+A<>+G@W1RQ;^')%L*
M^JY_+EE:J!<+Y<B*2=*NTDZ[B@GRSJG O=&A)Y;P'YJMNS-S5@:319S&PE9<
MQB_,1)G,I@!NJ5G '&F5)06=TX3=JI>ATWW+SVTZSA8;4%ATD/%X8(7:I;F3
M8K3#?RH9PD_S2+#ZD&?3N+S+BF(X'11%-HZY+HLBF?_,XK3\@_/,R2\&XW&V
M2KF2WV3Y]X*3=_VO55R^WK-RGDW4RY*SGP$)]>IZ;K%TN:?)5=(Q?0O1&VN#
MLLSCYU5E-QMEW[)41.YQ%$GUO?-/DA72R-S6<P';U'P2CI2R+1>N\I%]1N-N
M<BMJVP'FD)(_#8@IIP2VVC1U:)UE#6=EE/0B\.B1<84?QTE<_?T%*W\PEB(T
M\45Y--]:[?G:#7]]P?B\;!3]K/YFVZ6GL9;SL;O+^:\@IRI6YNPS8CLAS8&K
M(*>S+[VR S0$URW(J4)_6D%.EUE:9$D\J01;+=>F44_RD4!CKZ[]^^+7A,-H
M4)]67%23#/- *6PL4$G-/& F?6O=J4&F%%OET\=5_P(-0C"0,15UY!K1F,H;
M=7EIP)Y(!-=]Q-\PCI+MF9@?? 6+!NJB'@I$4O.7=M4:0\PGTAGB,HF*0N3R
MWG)9IK.8[_$#_A<EV&9'\R@5\04_XB31UT.UF@KDU"OKH=D)J"4-)])!PIP=
MD^*IEI,!V=2,@RT5IKO^U4@YD3"SBH8Z-R9'*WP<;!K4@DE:*X(RQ$C#P(G$
MG[EM$LEIIQ8W[V CU.$]D> T]TT@.7W4KG(Z65OH2 VFJ\X4B0^GU4,>\RO$
M,DH&21)'*;X*X \#4&J7K-:?OP%04@TE#,6*?K&JQP$QC6.!@5Q,!%D#=CJ-
M'81+,.<4BQHQ!IU!ZH_#^:A73B/#VRX.]50"M_8I,.KYT1P K%%S""FD:Z80
M-7!T^RY,H^*Y^I$B+RMM^ =+RD+\J=H>8&O(R\V!95OZ']OOD4>!"6INF_:[
MO0XFW4X(E@(W.KXKGP=.:!@\M7)#Q:S Y2H*B7Y\8_O*)V?4C(_N7/[[($^M
M<T&[TB=GU$(5I;+4";X&Z%0Z$83-@S\[0@NA)?P>]#EP%L3<KRIJ35DUC0DZ
MM*1:(/S*\]E/8#GO5\DVG3YZI>E4VD$<.,OGG%S=.$<JV98+5]T:?&;Y#!99
M7L;_!MFDD]O%,HISP8^!EQK91;M,"=SURAQCLM4ZH:1S"X?>)/OS@TC.HH)=
M,?C_VQ3:#<S688;Q9-UDH*+L+HZ>XX0O^\H%K>6<P#X-(Y'SA:TK)YT[.P2H
M#[!.7Q_DL3@?B"I-HSD3'^"8?WR#,3\O%''5KV*8BJ2SE,\J[]O0?C+@JU>&
M)I-%K2,9G?LY]&8Y6Q,EDB2+,E^-^=&5$S88E_%+K&T2HAL,?%(S6SE:H(S!
M=VX,$6 EJG;VKU&<%N(H65UF[C@*:(: +#C*,8"^5V8HDW7%#+.KW@[TG1MO
MUP^QQFXI-5P_M*.!T5[%.[6YNNG0(_ID;22GKT\W<2I"AT1-.K7J[#X(/!V5
M#50#%%$(<^/V_I8R(FX\6G. VL>1)RNZ^ER$ST O:DB1;%=KN[A/LXYQ18U=
M@^G.(\AQI.NTP.%1F0F=TH*HEKVE&JD;0V6Q>3. B:U9)'[.TKA@G!/8L(>Y
M^/LV!DCGOP&R.58#D&..$/TEU)]X'[&P3.QA,[5QVTX##!W5(;L3#8BB. M%
MIE<@:\<@UC3Z\Z^-TU^^/B116O+M0^P35<%?NU)8%Z_K-_A5$ZLJK73^ 3&Z
MDN; 54VL\P^]L@HV!-<J2&D?_6G5Q+(/?SW_T"OKX;YP=5&0>R!/J\!5N^C7
M\P_4LEBEHM3)O0;H1(I3.6\0=OZ!VG$5$3"F#UIPCLI1>2W"ZZ8IY/E':A8Z
MK7":EPT-O!.I#Q4TR/W\0Z\L_F;G TOX)U('ZNV:V3[$V7 .^&3[:U*KU */
MJ;+CX$2*/#VL\O$\*B"R6V[KJ,HCQ=.8308%L&CAY>X\/0BDOT%:2J5T2,^I
MU)/:,E:WU;E14\M9@?Y>V7/::&=;5CQ7KB)C35XM%E'^.IQ^9=DLCY;S>!PE
M._\^3+^QLNHRR+_L;UEZN<J%(('+7S9A,"U^1KXB2ASLRG<@0K/M;,+RX8"^
M5P:_AN!,SO0:]"=B$VZPH#4.2T< ;=3L@A;BQC1&C?9$S,4-$@SLQL@8H(Z:
MR5 M96/=J$&D9%*6F@W?K&N[4/XG2QEN%38:!Q10,PKIY-6T)9H#)=NSP+1>
MTO5*7/EPL=<>J8 3Z:9D)ZF:E#%<9.W$!1O_YRQ[^4=E-<IA8=_\X4VDZ[_X
MZ^91(LRW?P2X-&QL7<0H0436(&LGP.]/"@%^?P*X-.Q1+@2X@\B1R=.GWZV*
M7*LJ)XJ<Q>N?XV0U$1;<:D&I+M=Y.1\L6,Y)4.ZH]A,!331,/9T6X&[HR=H9
M[;[RRV^*K_SR&\"E<2=W\97O(#J1:O+*J^B=M3\6GP*(I9P[T?(F;@G?5?UY
MZHKUR%Y8NF(B;U&8=#DW6391*Y)\"##7*Q-.4^IXD(\2,JG2]AZ5190BVC7V
M&]G,L4' 'N4B/!T41@OZ5$KHHYY@M0<3&P7\4;/_::6-^B2U.%U5TZ>?,&Z4
M;K>7XD.DQX8#/6C HELQWW4\6*?D2Z.407+]-UJKB3E>5P7X\66#2K3"MEG-
MY:HH,W[)%U$)EQQ?7#[&Q=^_XA% K<X1(VU[X]7N;^_(8_"<K<K[Z'^S7"X0
M+,:@ZY2 DH8ELZV FJ8M)XR<2"Q"C0]=($+S<2",CDW4B?"QO40!_T3"$O89
M,(A)D T TFB85HV$:Z8/-7#D0Q$N^2V*O_"?<_XS193PW[E-1W/V/8U+-GDJ
M155OI0/%>#Q00NT"JA1><U>Q1TLI/D&N &OPPU01A"![#B!2NTG:"A1%12D.
M02FXT8_,2'#;YSC$#[^1ZT_04G!-5)3B#]2"X\^8?7,[3P),:FZFML*3X**4
M<.7R^G:G\#6ZF!;HIN%&\G0&=TH3V0 &QVX$EH^%Y&><K^NTC,O78NV34_L1
MT&'PH=+P/CE5"-35H*?B*/.;=LA\9$E5(S4;+EF21 _P.VSR9US.8^@^4/S.
M$I%)*[R\G&@AE:I7P8I-UN:;+"6=X_2T>AZOT]G&\+959R,F,N6@L4)<Y6U5
M6<+B/TW,C&TG%9KU[C/RD1V:J=TO;L 5_K6(.:RG.)UQT2]$I-%P*I>_79I4
MB[F!-QJ;H$,M, G-Z<+6B=@YG^)96LE ^$&V5?MN4RZ?(I[$46[2J]YT$B"7
MFKW#E<9@&FG-SHF83$UX,2D*9CP-$$S-.F.M'EWTK$8$>5,L'*XV;3_58>N2
M1RN@Y%SV+035O/0IX5*RL)(\=:DL#T[GKT1")#<MW);GDCCR1F<L[HZ5'.(R
M*Z+D:YZMEK?I.I5$#AQ9U=Q,#@L#Y7B&KEK27" =,^?(A.XS ^PQGLTY9=^+
M=427 _7K,B501R,"(I32.>&K!\F&FQA!!RK69BJ@BEJ@A%_5ZL23(\N^]_S5
M>E"J _WJ/"^02,V YE?9W)'FR _@M_/4MM6K WUK.1L0=CRV,1,MZTJ5J[Q*
MK]WJH:2JZ%3$XA=Q>W*A9!UG!0:I6<+\*ILKRESE9WK?2]WNH"VW@//C,7T8
M[YL=J'*5R>EU18-TH:F+9:S%5, 5M6@OSVM7%YY<97TZZ= HU:@[%G%=??/[
M.M"L+E,"<S3">4)IF!.^7"6:^ER]WFH,/^392UP( (-T4BW<;__F5AF]_B:P
M3Z-L6BAM#4.H_[Q7=]>+A^A5'&D=7BU:S C,G9:;P05=B**1<BZ@WYN7%=/3
MKP'CI^62\$TEHKRDW!457K<:VF5*X.ZTW!=.^$)TC90?8P>CDSMRZ_F M=/R
M6W0G"U$Q^\0%;[?EG?IQ+CS\[68#OD[+7=&5*B2NEY2[8EM79 W6Q4[984K@
M[K0<%4[X0G2-E)?B:Q2GPW0#KZIIDR21BY"2SA,+'M^3RP?W'&#BCC5$^TBY
M,3B6;,$NV#3+V2CZR6]%.\'8C4:8HSG;[87I)$X@T.^#5$[+81*>7$3E#U5;
M4Z'RG(_KGTN6%IR?E$UC%V'*#F8&)D_+Z^*2-D0!#^5\\5L&F)-TEQ7%^BAN
MIJ=V$P"OI^-6:<D.HG6'\I%XU+H_F8CM9I,!?]5HQI[F7&1J-9.. .9.QT=B
M2@>B2 1Z)+E5H\'D?U>%J!-AK4[*D<#CZ7@V;&E!U,O:2S'A^W,:BVF^KN))
ME(X9336[B(IX?!WE*>>Z$&OY \LK2EINF2WF ^Y/Q\OAABQ$40_EXO":O9NL
M^/?J4$E;S0C,GXZ;Q!5=B*(ZS.PX3(VG:Y&34(A<?/:O%?_/4?;/5<H^_";T
MF'*QIEV-^<9E4FV+HG-=A6<PY0<C:)7&_XZ+.<XFUE7A[::M2H%]0&RH_6/+
MKE"3Q9S $V7[7$NYX^M.-YY.I#13U822Y5Q@I4D1IN;C0!AEBUH;Z6-:I<!_
M(@65]ADP*)TD&P"D4;-[*81KI@\U<)0*'_GML6>R<.N6%O-I@&#*UBV72TX+
M7DZD,I,9,P9+E,U$0#(U&U@+)>FF;S4R*-5/\ME[-DIG3+N2;9\">B@;IUPN
M5$W8E#H"^-8*@V5FYSF@B)H]J"E!I:QK4"@U$/!I]%Y70[S,%L]Q"O8J[9*
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M%=*(BWYY\O>!&*6--@< ]C N5:O<8%1(9G*MH>N7B]VE9(FMW[Y$K%O'W3O
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M 5DA%+&!.9L+ \X+OTZ-LZXYI1Y^#YBGY7MVM))Y) M14Z)F;6D>J5+1I",
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M'IO;>!?@B)B)9F+N1;F:Q_L"6@I1.5ZR?N18$<D2M;]]6PG"U@P4@$@I8-D
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MM2-E]+ERC #RZ3=:QL,6'W#3>&B&VGT!8@NQ?6HAMD^[ &B%BGD46QVU^^+
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M N"&EIN(D&)948BH5VWUIUR#I(==O&60[JSK@"AGJ03\F6@3)1T*NRH<Z S
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M!S)#=;<7[^%=V]S^2,41UCK@)!3.$Y]F:<+]C#T93* 8M CSV=:+_A4XHM=
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M3Z,I,TN8O;(,7HH^&BQ?1KDXYFE-A,W'@3<Z%?*Z[F9&6'ME!-S'86!8D@T
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M%U8AO.LT9MVG-M=Y5I%M\[(3CSK30SF=$W:6)*(Y/0@K$DQ0+,^;:.C<\&L
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MGR'<%4_-24-Z!%6OM";#S1&M\H\9,>^T$Q,A(2$G?7BPS.Z*_ E3KU&^<QK
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MA'E0P+G7U%R7<NT\*$ANG9<OS&$"SJ5NE7-6U&BUBS,M]FG,#I*O&G@),X[
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M'D8^E^M/A2=<T]$BA"Y/M]DF+SA!3X% XLBF:7Q'M(OH%$I^Q]4.9[T>T/3
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MA"''DZ,PKVT>%J&^5=:2GPD$?4%T*Z'Z]2:-MP()[XSQ(]K=A78%XO1[1 ?
MD&7W:YY+> ?%HBVU.C(QF5V^)M\MXO0V2]#G_P<]2PUS;ZQ/R]Q?N,"NU0,C
M-C(B0V$(]!Q8S&N?!:+4-]!Z<C1% *QYW%ZNX_1_4%R\SI*;X<YA\N&>PF+B
MY?<B9'QHQ,=&='!$1D=T. SYGQ&9V4)_"O&ZB *:R=:$Q\<[5. \D6N"8*S?
M V5WX<)S&A\(3/[GP&+N@^>@* V=0'7D:$*1/VO=&_(74311.-JOV/<7+Q29
MML%D@V&)_M28S"W^ K$:4@ ]F9I<!;@>ZBO!Q7@(:G")@$I\:A,*5A6FQ<:/
M.@R(F%@AU/+E.T.H(AL67>]R<ZHZ<9>7F"5-B&_630',KUK&*':E\S0MRC?1
MIID8'>J9T=]B:+?U=EQMA-<)2WVWT.:5OW3DMCO4IX3VEMT+!K(!AB(WK;$W
M7CT\+1F6EKX^:(F*_^2[X9H24B60S/*I#S)DNL+5C'T5'>CH*";'2=2,AZ0F
MSI"*\D\92F9![0D5C_FLR,&S$DK-ZAL,4[7R_8R'IH[FFV/3>U5J,OJ#?5J*
M@:5WQ8T-^2[??$<&1;'V5C2769@.@WG51"1$?>W0E"#/2M&TI)4JPWF03R5H
M+;4K.LU/D"3>T7+G%>^N./3%6B$+GL6YVTR7O7=:[>),2\XU9OM4 !WDNJ)V
MGE.;U"BGLZ**3(NV<ZJ-MI-E@R8;$^$NLI#L@0U:UW%1/.-L&\5[^I2*AFBL
M<)S7B&@K8=^ZV&J@=[/35&*Q?UVH#<.O"=)%M&^(3L5JHKB9&VWR(J*OR;;L
M:%0]1WLV'Y;>3H4RD6USM.=692/!'E+H,5(-H;C*9#U99E)9$1+#6VB69]_5
M(P'NH6'@DE=QZ@Z7%04'SS*HZ[_K8 M1Z^L4+UJ&C:WRO&JIZLNF^=1_*3JB
ME#U"R%IE7K75")(M,,+K0\L48/9:O84B/.52BV!?PXSES[.:W: -(LM+3@N6
M:M? :)]*-;3X7MY'/<90TN;2GPE1F%=9A(+4UQ%=*0+32\:H<0P$Q=!P:#Z
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MO2%DH6'*Y>9MGB=R/U4TQ:>-$J+1E=)Z8$3E@ 6NJ6!NZ6!(2JB-#C4V% N
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M.U2P+QDV6!D!RT]NARWB7>ED<*(&$'^>\FU$@$4,VJOHHDO'*H\XQ&BYB>[
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MA,5\'64%+P2 CJ7ZM+(YJUI"AW* M26._%1;,LE:-Y)5-))U]IOK2#,^258
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M4'L@D+;*]U'=4"ID+<*'CC"%X"^OJS0,;3M ]9"ZX.\-K@6 ?.WXVDD84$_
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M-0>3>OI7YH!1<#:_S.:M94 9F:?B*%5\Y4RMJAM_JJA6LZ/X++Z*SRPJ@O6
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M_JDZQ0KI26Y2?H=>!^=.:"M^BFZEQ$"NLQHM_9S8E<Y%Z2R5W;]_)0TERR6
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M46T!_M4O 4X^M)'=D5II)*R-IQS,0_'\^)K3#*6:;J86:DIUY_):Y:\\09]
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M==0+NG0:C28WH5W\&6!.#N66 \W!T066-DT4D ($] KI-II%(0"_-R5%!2"
M>34&6[_:[Q.^.$=9<,3HQ8M\R/DUNE'4SP?(&34^QMD#L7Q"QK%H'>$/<90=
M%([*9-7<QKU(U&F'NV2('KXD=-H3H3C"Z$@K@#PJT])L_8H3.KM]N2"R1DJY
M?N^X=O#X-(S!KI 630 ZYEFKL:O(%W78D!;P/ZBDUS"0YI*5)LJW0D>[B$JC
M#J,ZBS,JB_\99O:.*8PA\/O=M[_+M85';&/0M_D^%>*AN &AO0U-GH,O^GY
M0QP(1Z"COL03U,C>X0S2X,LB7,$8<PB^X'??_@&^+]!&OL09C(4]%&]0MK:A
M!7%V?\=>HN,)%$6!\ *J:DL\@,#P#O[3F<*%2(+-?E,S",S_P[?OWL.GOA;,
M);0?@W$HE#>@-D0*:U#5#1D)1UYBW7FY*NU^N\_^C); /%V&+8!)QH<R#Y)@
MUVG%+_*$]4$Y@-3PE#6$%%!KU6"&QZT/\&)RYZ#AA.>N0QPT3W[%?;\0J_)3
M$J<I2UG3$\HEK^(HH95<C;X13RB/6 6>JP?".#Y"*R&:".V95J^J6EE+-Z4
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MF:<NQ.GSINJJMMX"I57+G=%O66UTXM61)]0'>.7/CMJ@-@#,X=WQ2.HX;"^
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MO3#ZVK<T$^M '3>N8DB1=G;?^DU _@@?>^D<5A+5Z12#Y Z4<"?Z 6>@4W$
M]OIH8J+_WH#HOX=(]-_KV_KWBR"ZB6+PB?Y[7:); )TYT6<%GS'C/WC)KSB[
MCB.?GU9V/^#16](-N[L;W30K+X7*8AHO7,S/X]E5L$5="8!$PEI&CPI-S;K
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M@E-;2*C[5G@"9%$KQE$4ZE]/3LF?Q4SLE!6=<&*G^<UE3.QT#3EZ#K)<GP;
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M0"!P>/_#[WXP=4HM > \4EM%S=YB A"5L!Q?-*'2"_%"/4A6=$$683S2_[B
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M.TC,5D2A2'*'$%3AN^7.<GSQEK21F,(+>3;^#J?17]3E%=I6L]NYXGB!_"$
M]WY@WK;;O0?;#9KV95<EQ#@F0"/?D4H&H+XJ+@G1J\90HB:(.8*,E2FR3H$9
M(E5QUN:.%LB,)Y%E7HC5*TZ\/;Y)O,]^_+EOC==?W,VT4=+\=F:IO.A;E!=&
M16GWT#?7Q<MU\35TL34W' *7."ET@2R5V: =A)DGD#[3.>EZMZ$I]@ZX;W>T
M7<Q1TNAV<UN3'U:$OJI6%()!S]F:;HN-?5"I)8BVB!.EU-!S&-W\0>;L@Y?\
MBC.%IY>[2CIZ9+FST:U'=#+$BQ6/)A\A[9^HZ9 K .\%Y'[8U-XZMHL9I5>-
M5;%S%$P_7VKHZHG ]:Z^*]N[:%.KYH:9"NHT32T\)DH<7G/+^1[(0LY0.> O
M&JNB3^2T2^BI$'P<!.,=?ZT\J"#(]Q*@I]T4GR>]CW9Q<F1&6KW$Y^R:):&[
M_7)B?T]O<!KL(R^C&=HZ'G7?')+XO#\\)O$NR-;)0YRF&^\EQ!VNR.[G7>Y%
M63&O_&78H/HL\NAWB^2"N/@R@6[Q:>2EZ)A_''D9VI'/Y\_&9KP!=%^)M #%
M"2+?2-$_,MH* +,C4$:_;QF=?QB57T8W-:-_$(Q./Y]//O,&H,?2Z _,Z!ME
MH]O=VK/G3MK;A,Y\B>N77*N&]Z[$I*6=OMO:T?B.6;7@A^"LQ_2TN"M5@$?;
M7@AU/+^JB)\16POUL[*!W87NPJXV&'J:WH'H\F23%P4$:RU-@![0#@.IOM]@
M&T5J6P[J:(KJW3#?Q@,C_GKW,_;W^ EOXWT4_)O&5M-TS=E%RE6UJFZ8JZA6
M]SI]O4.L(JIJTMAP7A=8_-4H1<G$]L 432I%@PAA5A<2]750*CH"UQ!5<0L
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MRF[DKW>;Q(M2ZM6O@ECJ#:<2[L8W3F::)@B8X'Y?F<M&5#@2I-.1M92/R >
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MBGN8 1[.XJ]2W6DTKHIZK>!37HD&?FS+:N5M:':C %R6_[&*5M70@Z@HJ'T
M$]AVA-*:8A8T515>!E 3 )>NO2L]!<("?#D A+*0:#OTLL (_)H?HA<[Z.5W
MY&?FO<4='9'W-[\=&%YL^ M( C7W'J<,%#:HH*IVBNT 4DJ'UK/VQMPA_ ^2
MY(9F8D"'\C^H9>U3".=_T$O79V'K?5(+*,3U:UH 6'!_"_@& ?Y64#]AD+]Z
MW[L*]/]XIJZ3S&SH%(=O,#QXG]-ST'E3;K"&&U\D5Z)I>%Z:NAQ6O@A8*FK
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MQI-I?:4:7W3<8RYQ/D_X(4BW."2MQ/$YE9VK]O@^C?INO)V.@JV=&;%N7[Q
M$467*JWPYG=F8Q3N">^DR]CB5!R2;](&K^B-0"!7Q?_,W*&+N!;=K7&'3U*L
MY_QJ=*]"<T1<S^MTIM7L^RK^YBV*<":N2\%=0]5":<]%:BV(&H_SN=CU[@FG
M67+>9F>ZJJ<YV%Y95MC;XRF,+Q@WXC][1GUC:6[F .;*-S&;_XDN96JR4"4,
M%=):<=WNJ3JQ,?*2WS9#?Z'0<P+@BS,&@*A7F3],W^$68[V'&I\W>A.3Y1EQ
MI-GE,:1O/T;^[;_. 5M2DW]OXOOHE?PS3@)CEV;R(9C>SLAD)HZP\'^;&!6?
M0NQ;+,EU^37V$RDC?' 9GG(20UX?O&2/T[=HS\,3^98 9H&*]-$%6+M!\]%1
MQ]'"XN(4/GA23L8[XJ!%3GH5)^NG/)R3)\9)MB8L.4G^'E0?<^??-XD7I;LX
M.3+K$NOL$^^87M-=4D-'+I4(TV/+C6#@FM^BNDA4R$37JOO/[MVOGE78[RDU
MLKKFI[S>DKRL BETW*DC1DSA-Z$Q8US85ZU1,A_76]IAT%=GX[OW?.K&!^1R
M=!6I#[/@SNX&0-6*\K*+*.4@KW$=,M_<Y3[:)MA+\0WF_[V/-G'FA4,^JX?3
MQM+<<-Y<^8YH)"8!O2ED?4/6@HB)0PHN>U[7\2,W183W=-XL<Q[36:200*;@
M9").S8"'I_:0',](9HB."2 M5!S7<N@Q21J&&YQY08C]^ZB<.:U>XG-V%T0T
M++!VM*&:G]U IOOT#":&D*<I*"0B021B,E$NM)&Y /TC YK1?6'&<9'0P9A(
M?<D=0+%(-]'#%(!YWAZP?PXQ\KE@?M1<H478$?/9Y]@NP2Y'3_.X'7JTQ,_8
MWQ-[T008@WEW6V5=1D6T&][L2%X"!;0(P'2XN@J NC\^"*!V\((:>N#002''
M;$=I()3HO4]=QQ3 U*_Z2FB$ACNCQE!&5E4DC=A[(/8G,_XG,G:M(O^:9LZ+
MMI<;G 2O9%Q[';A!IE[=U>Z"LGKM]1*OBFA==K9<U$9"=6 W$*;0-Z'ZTE.\
M;:&O+^A[3OD<YT"12?[RDD$AF F<ZSL$[K&LMB5@OX_M)&'4F:8_:"1E-)2[
MK%V !^6$A0:+W0?(:1QGL!)9N?F%E<1%GL>LU%C484,K0=\7:%%LBKT!*_R:
M<W] AB & #[]3/")M)R&P&@#"?K>0#&*%)O0T56<)/'G(-K+]PFD]5PND.0*
M]0ZBY6%*A%[*"A!.D4PUHV>BW/7!F=5IP:Z]@-+'W.BE%/<6 PNFHI#;95'9
MU%Z,\Q(PQGSU5@?*K;:],*F#HVOY,3\R=!894R%DQ-,/*7UEFGBDCSCK(56C
MC*N''.H-[72N;/;]DB%2Q.9 P0YY9=12:CP9&>A%.DBC0R]"ZD\H6(*'VDL)
M:I:F5J;FGF_E_3&.RCN#=W&"@WUT^V5[((W!+,7Q [L_T$,YU<INN*BL6M/Z
MI.*WU<W\O"HJZB)6^?LWO#J *[.C=:UNS>YR77&AZY[K&JKK:HOP>L 5/8%[
MU*JX"#L]"GV5F<_8;\YX$W^*R(S=)TH1STF6[33_WII&:;\&*3&C?-6I)<?E
M*E1/X;Z8="\)6&@"RP5S\M+4V[/MK"PXLI4J?ZWB5(J"M5X=9X.R!AM \SKY
MCWH:VUW9&D"]O=(=CW/SF03.BN4 G;Z4E]"*>[Y7.,*[H/<6@GIU1[,)=?5:
M'AG3!5*^4F)3.^$R:WD-NA  @8L3*!P4"M.X>3$N"A<*OV@H;&U6H0GBVKP"
M (*59A:V.A;ZY**U+?A  Z(? N\E"/LN5VC5!K6=W:&<RJ9VR,+%PZJ>U2T+
MM; @$UUK4!ZKK^,]\#[<*NR$*X(60MJNVCD<]5Q2>O95<9ZLJTN-[OMGS;!A
MZG ![#>8Z@./2')8]:384L648\KHL048450P=>>.';*-=#TEZ"C$:1YX83MI
M'3S*:+!E2J)TKCCI/AC=!EM'0MC;IY3.93]XD;?'=(.]9[FI6-?=8Y@JBG4]
M2HC8QO0W['%,(9J/UJ;+35Z?G3^Y'TE&ZTK?7^P(63QR):&=46GAM?EJIE.P
MJKZ?:0[:D(%VN#_G?497VOYK+SW04%OR'YI(Z=4+B45D3^P:20/J<7J5-_=!
M5!8/J:?_$*0NQ#'IF40.[2TU 0O%IO_ >K8 X[_D#-'R:/;I,8F/TZ2)BM?K
MA<9\KK#8#[@\X6V\CP+2H+LXN4VSX$AW9>[.]#GJI_CBA9(4)+I"W#@^;57;
MT;ZY %1)H#$#J)2!N!!42H'AWZ!J;LN;F8%<=&)P$*[BNR#VM^,]$GYK*MMX
M7_+]T-ZH784Z+O=+^A5I19;QDHC8K]SU?L/W'6;>/-&- C#2"8Z+4499>^-$
M#V*..72#=Y@TU]<B47\EERR2J-).JL6++H!'AEI!9-(0UMI4T@2:8RZM3J<P
MV-+4,Z2]]&:OE$0=I5VRIZOQK1?MRC*,./0"LOO)L)X*SQE9BWF)7RJ O$HI
MLJ:[2R ]7:J K39I5('EF"UYXVYW.[S-UKL\2#;_K3QV8ZBJ2QX-JM5$Y*8
M(F956,*I/.JWP"B )><(!6\"4I0F**"A1=EGC"/V='!:,/&._NT@$#+R60&F
MN4C/+$;/7A3O GCT5 -SFZM&2#;>&'K">?#H)N8C*KLZG:XB_QEG68CI&C1=
M[\C?;H+T=.ZFH:D@-QM$1BHW$5P*H=O?E*^E'+8!+DBBE\-H@4*8>^+.8 3"
MPWS>G!N!,C85C$!#U4D!7\,(MK:-S"D@;AW!PK_*]I%C"$"/)66A035GG!)?
M3#?*HFT0!LRR5WSP6FV+*PG\%6#Z&(O.XGGJ3SF/B)O2;-V1=%E]BI32"1)*
M:E\IIQ9>^9WB964VG["^SC<(Q9O=D% <\=R\ZPG]FYMTKK<?7G'B[7/U@E>U
M38B^.DZW(GH5:6U(\)*Y7R!%+>]+J$42JNMS:Z2'Y9T(.<PZ]B.T,.9Z/US(
M*+7!QU.<>,FE6L%^BNCQ/M& W]\EOJ'\S76"_2!+^S+:3_\)IWOM4YE)GK\M
M*T23B60A^RTZ1SS&@E D?Q^1#O'";[?\&]#RN\^%LHY]\SDAYGK?T$2?P?SG
M(Z0ZW6T<88S61N1(LH'+PKY(XUC>MQQ+IHXMS8F9M$1WHY!??I3<Q;F<WG3O
M8WD%,,O]8@VT -<SE&M_>E8M?3WR(,FQ/<]G%KTN>5#.+3UV;1*6>89!>:^O
MUX(+6^*UB#O#,F^(M>89/YLQD-6C]D$8>LGF<_S_ROO6Y\AUX]Y_A>54Y295
MWO.R?9.3Q+=J]-A=.=*.2IK=$]L?7!")F8&70XQ!4H_]ZR\:(#F<X0L$00!S
M\N6<E00"OVYT-QI H[OC:EGI2T?9096(Z@IO+>Z-Q17$PR'MBOPTX-^ZMP*>
M$&DMZ:BZD!ZE(G4KH4H)2MU.HD<^TP<,)=OW6Q(B+E<8C3R?[?K<%Q^GD[S^
ME7=3^RQ \)T_A4(](M2=Q] OMOV>P"B9':VJ:Y0^"2)3E@DM_1['60H_"2]
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M&?4^[F"R:AS=R/FH%TK7<>>C'_KI,60ZR?=\^@V80.W>'"7%T":^69!>]!1
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MWUF\R<FS+67D&XX^)Q%FM?!\@>WBK0S=O^>P\0.X,3[P<V:2C' \A0"4%06
M>89/'D"7CY^]8:86VNG[IC#?Y6)[V_7TU3-S. WQ9!^CW$=4[M\]E;LU'WBC
MCL[XCA Q]@8Q'#O(/K&B\DU7\H CO-O[PI[)H$W< W["$+/0&NYU\094+;(&
M#L]4< 8RIG+V#K&ON!AQS;$!1!]8I8)KLM=?G@1=%@D'/^)H(XXAJPO/7TBV
MY5X.@>.Y0MKA>8^PHC?)BE[GW ]?9)>\2TBI_AH*0_+ _^P#$ZT2.'4V*M,[
M!UC/#($K6J>?S\D#>A@F5<$,+NN>L+<K_^9@+EJ,>4HF+E)\8/2L!%F*0_%,
M=J>CGGR.T?+PSP?.J.":[L,7K_5DD*?P3M:0>:$HT5S.P)LXKO6!*],0:\>X
M5/Y'\2+7F82HH3$:M7%)N;6ZPADBL1>*H0S.F!]7)&E*HI+?GAE1+:"3SXWB
MN,B:#!Y(43O^ F<O&%>7/$G$M1/S?T<B^80/O#( V_3)R>*9J_,&RV0MY!D
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M^&)54%K&U<H  J_HQ,6)K=U9?40=Q+<4ZA#1PU6Q%2/<,JI!>]I][VWY/F,
MA<Y\/= W%!<YL8J@ +A<+F*<[Q'?ZXB#'PZ>V,H=/QJ3Z1*E<DV>D0>#:J@$
MP]R.\S%_HBP"WP1_?'MB)+J@2>22_I& +-2HK0]>"ZQP6J"V$].\559=LL(1
M%^1]A4BB=OH.Q(E^C,-C4ASJR5Q<<D 1B,$"5\Y)MD=K(5Y'-8KE[S[2&$Y"
M/9!]'7#F+<(1"GC TWSWY1NOQJ(TSC3W#+%";.NS-I>TCP1D?M7PA ^.F. )
M];;)/LT YX<&V%M+/^',O=L\#,+DC.,,*E4=[CSD:YC4,0/&83+(C\;SH-:D
MB#8JU:GAZ+Y3W+Y!L'C^A'ON% ='N26)^-["K>D8+-HOA:NWF$7$\:$*:G'_
M<\_HFF1+46K9VN'12%3F[-T]P^_S)((H,7']O'R*B[3C5HCO'=X<E;<4$LJS
M'1]NCTCU^M;* MXUM,$UZ^ IPLGZ L[>JO2=EEW5-@ FBX8>99F#5V_I82@'
MAKD3A#FKW!S"D4GN!:(7_\MD'.$W;%MB.X<V)ZM]F72MK"N]XQN\C4 )7YIL
MWJT=CZA=]:RH7&HG(JPYXK18L'I_-J/ VL;5GH$'O,]9N$4I_NF'GWY?]&I5
MD@91F*'M#U[0=HI"*PZF3'4-O1^ENK8:&C.(0BN(F3),-DF9*:_,@D?LOK$;
M1J%%6[F?6"9E 7#(1 <9:(K7ZW[$39C J57)%-P8J V!_Y'SW\9OA\+>\AR^
MO@&S&IBG TR' V7Z=9GI6E:8O$D>\ :Q*(5$LD<)[ \9POD7$(4$$$-&1!99
MF4G\=%65_1H^*)H!]!3FG>2N3V6R^FY$%EDT'II)1@Q-C4-&#$/3"G 7V K)
M/"S#Q1)\3&Z)W3#!0Q"F6XE#IY%U93\:6RLTO\B:,T#*3$?</:,;C12K[)L(
M$[7]%+4'P'3I*SI_,B!\PT=<G2-K>1O<Y,#LP1M3!N>_154.[M(4KBT3M5!%
M'( 0H[GI&X_(Y.H 2?_F72>5)U@#FN;R(/HO\LYWVJ")"JJT2 P F:ZH'W%L
M747EF)I3 QF6T*9D1S'A?&.VVF*YJ%K*RZ0&12N2O%ED"4X_;.YL!B"8H^H/
M[JGZPZ1W,>*5+[>^D<5D6:V#3CNS/.G2YK%EQ] ZLP'I^FF>G?1H4\3Z$>C2
MY)@@@]141T676X+7?,L?YI#:;KE><P>463VG5$(RZ3RO7+^+2H-B92BR\SUB
M]BQ=[JX5:PZ'0@/9M /-M2BTF$&QC.7Z T.V$DWT C 9H%7X-2+A8NN<SGJ*
MT#>\@37:ZF%JU]CF?(W?N?<U?F>>JI_<4_63>:I^=$_5CR9.[$^ENE$LU=WN
MN06*WHK>J$;Z8C7/8B\ 0Q3!XNB8ICH$,U2]I[EECZL/@?:K_D-M7*M7^.U#
MZV5GCX7K*4L_%*<)Q977,NE27PN'^KK M"]YN4GR]IY7 YN6FA;Y/#EJ68).
MIK"'4\Z30&2KJCL:E5[0X5-6&\,F@1U#ZZ65RG+$.$,^<)0IR -.%XQ @<;W
MC.Z:588YXW)9XC4=J,FE$&AAYX+,,8DF4Y+,1XHH\KM"K\N>>A_G/EUJ-!I-
MR574G1+OC3@%*VI#&DL#6!5QL3)Q_A!K, %SD>:M%DW66%U\L7/&L)I\ :R
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M= O.S#.*L9' &<-,ZH!I,*4$GP5A^UI'LI2,8 #"3-F-3JO#'Y>37M'"+WG
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MF;[&F 9%6"0SN",QUS4.WBI974/K4_=?WZ?A%N_0__O_4$L! A0#%     @
M"#];6]OR_.HM7   CU$'  T              ( !     &0V.3DU.&0V:RYH
M=&U02P$"% ,4    "  (/UM;\W;/E4S3 0 :220 $               @ %8
M7   9#8Y.34X9&5X.3DQ+FAT;5!+ 0(4 Q0    (  @_6UO,7O*FB<D  .^P
M"0 0              "  =(O @!D-CDY-3AD97@Y.3(N:'1M4$L! A0#%
M  @ "#];6RJ$<5>CR0  W"<, !               ( !B?D" &0V.3DU.&1E
M>#DY,RYH=&U02P$"% ,4    "  (/UM;-%[/>D,C @#IUR0 $
M    @ %:PP, <VYY+3(P,C4P-C,P+GAS9%!+!08     !0 % #,!  #+Y@4
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>d69958d6k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2025"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ifrs-full="https://xbrl.ifrs.org/taxonomy/2025-03-27/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sny="http://www.Sanofi.com/20250630"
  xmlns:srt="http://fasb.org/srt/2025"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sny-20250630.xsd" xlink:type="simple"/>
    <context id="PAsOn06_30_2025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn10_31_2024">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2024-10-31</instant>
        </period>
    </context>
    <context id="P05_01_2025To06_30_2025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn01_01_2025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
        </entity>
        <period>
            <instant>2025-01-01</instant>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ManufacturingAndSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CDRMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:CDRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OPALJVCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:BpifranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithoutMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">sny:ExcludingChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:MarketConditionAxis">sny:WithMarketConditionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_FRifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CertainWholesalersInTheUnitedStatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CustomerOneMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CustomerTwoMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CustomerThreeMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OthersCounterpartyMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:SanofiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarUSBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_MCMVaccineBVMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_MSPVaccineCompanyMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:MCMVaccineBVMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:AR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_TRifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:TR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_LaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_NotLaterThanOneMonthMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AdjustmentToDebtMeasuredAtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AmortizedCostNettingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInChineseYuanRenminbiMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInTurkishLiraMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">sny:NotEligibleForHedgeAccountingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsAndNotLaterThanSevenYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySellerSwapsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInHungarianFlorintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInHungarianFlorintMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInPoundSterlingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInSingaporeDollarMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInJapaneseYenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInJune2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2031MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2031Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2027MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:OneBillionFiveHundredMillionBondsIssuedInMarch2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondIssueFromApril2022MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondIssueFromApril2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondIssueFromApril2020MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondIssueFromApril2020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FourBillionFacilityMaturingMarch2030MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FourBillionFacilityMaturingMarch2030Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FourBillionFacilityMaturingDecember2027MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FourBillionFacilityMaturingDecember2027Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondMaturingMarch2032MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingMarch2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FixedRateBondMaturingJune2029MemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:FixedRateBondMaturingJune2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtMarketValueMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_GBifrsfullGeographicalAreasAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:PrincipalAlliancesAxis">sny:AntibodiesCollaborationAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CounterpartiesAxis">sny:SwedishOrphanBiovitrumABMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFourYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedEsterReceive092Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOfHedgeRecognizedInEquityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:CashFlowHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFourYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanTwoYearsAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanTwoYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtNotionalAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:AtFairValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfHedgesAxis">ifrs-full:FairValueHedgesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CrossCurrencySwapExpiring2029MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapExpiring2029Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CrossCurrencySwapExpiring2032MemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapExpiring2032Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencyPurchasesInUSDollarUSBondMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:ForwardCurrencySalesInUSDollarMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">sny:StockOptionPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangesOfExercisePricesForOutstandingShareOptionsAxis">sny:ExercisePriceRangeThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgingInstrumentsAxis">sny:CrossCurrencySwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DebtInstrumentAxis">sny:SanofiEuroMediumTermNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInFranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_UKZONEMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:UKZONEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ActionForWhichWeAreDefendantMemberSNYDefendantAxis_GoldBondProductLitigationInTheUSMemberSNYLegalAndArbitralProceedingsAxis_ProductLiabilitiesMemberifrsfullClassesOfContingentLiabilitiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichWeAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:GoldBondProductLitigationInTheUSMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">sny:ProductLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_EuroapiMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAmortisationAndImpairmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:DebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">ifrs-full:TradingEquitySecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedImpairmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_LaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanSixMonthsAndNotLaterThanOneYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneMonthAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_NotLaterThanOneMonthMemberifrsfullMaturityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:NotLaterThanOneMonthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:CurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AssetsAndLiabilitiesAxis">sny:NonCurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AtMarketValueMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:AtMarketValueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:TechnologicalPlatformsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:MarketedProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">ifrs-full:AggregatedIndividuallyImmaterialAssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_MSPVaccineCompanyMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:MSPVaccineCompanyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:JointVenturesAxis">sny:InfraservGmbhAndCoHochstKGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_EuroapiMemberdeiLegalEntityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">sny:EuroapiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:CurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">sny:NonCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">sny:ManufacturingAndSupplyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OpellaMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:AssociatesAndJointVenturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:InfluenzaVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:MeningitisTravelAndEndemicVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RSVVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:PolioPertussisHibVaccinesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:TzieldMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:IndustrialSalesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:RezurockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AubagioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:SarclisaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:XenpozymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:NexviazymeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:CabliviMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:AltuviiioMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">srt:EuropeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">sny:DupixentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:ReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:NetDefinedBenefitLiabilityAssetAxis">ifrs-full:PlanAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:OtherOperatingIncomeExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:OtherCountriesExcludingEuropeAndNorthAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CNifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:CN</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_FRifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">country:FR</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CustomerOneMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CustomerTwoMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CustomerThreeMemberifrsfullMajorCustomersAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MajorCustomersAxis">sny:CustomerThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:MaterialReconcilingItemsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:AntibodiesAllianceMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:ShareOfProfitOrLossFromCommercializationOfZaltrapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:AttributionOfExpensesByNatureToTheirFunctionAxis">sny:CommercializationRelatedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:OtherRelatedPartiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInAssociatesAxis">sny:RegeneronMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">sny:PensionsAndOtherPostEmploymentBenefitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:AllOtherSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OthersCounterpartyMembersrtCounterpartyNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">sny:OthersCounterpartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:EquityInstrumentsIncludedInFinancialAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsNotSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">sny:CommercialPaperProgramInUSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:DebtInstrumentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:HedgedItemsAxis">sny:InterestRateAndCurrencyDerivativesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P01_01_2024To06_30_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OPALJVCoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="P04_01_2025To04_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:BpifranceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="P04_01_2025To04_30_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:EarendilLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-01</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">sny:OpellaBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-30</instant>
        </period>
    </context>
    <context id="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VicebioLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-07-22</startDate>
            <endDate>2025-07-22</endDate>
        </period>
    </context>
    <context id="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:AssetsAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-27</instant>
        </period>
    </context>
    <context id="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:AssetsAcquisitionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-27</startDate>
            <endDate>2025-05-27</endDate>
        </period>
    </context>
    <context id="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VigilNeuroscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-22</startDate>
            <endDate>2025-05-22</endDate>
        </period>
    </context>
    <context id="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:VigilNeuroscienceIncMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-22</instant>
        </period>
    </context>
    <context id="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:AssetsAcquisitionAxis">sny:BlueprintMedicinesCorporationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-02</instant>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">sny:BiopharmaSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2024Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2021Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:RestrictedSharePlan2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_EUROZONEMemberifrsfullGeographicalAreasAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfExpectedRatesOfInflationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:GeographicalAreasAxis">sny:EUROZONEMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ActuarialAssumptionsAxis">ifrs-full:ActuarialAssumptionOfDiscountRatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="P04_30_2025To04_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-30</startDate>
            <endDate>2025-04-30</endDate>
        </period>
    </context>
    <context id="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:DefendantAxis">sny:ActionForWhichSanofiAreDefendantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="sny:LegalAndArbitralProceedingsAxis">sny:PlavixAttorneyGeneralActionInHawaiiMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-01</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">sny:EarendilLabsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-04-01</instant>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">sny:ValueOnRedemptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="P01_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">sny:ForeignCurrencyTranslationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ReclassifiedItemsAxis">sny:ItemsSubsequentlyReclassifiableToProfitOrLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-01-29</instant>
        </period>
    </context>
    <context id="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">sny:EmployeeShareOwnershipPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-01-31</instant>
        </period>
    </context>
    <context id="P01_29_2025To01_29_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-29</startDate>
            <endDate>2025-01-29</endDate>
        </period>
    </context>
    <context id="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2025ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-02</startDate>
            <endDate>2025-02-02</endDate>
        </period>
    </context>
    <context id="P04_30_2024To04_30_2024_ShareRepurchase2024ProgramMemberSNYShareProgramAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="sny:ShareProgramAxis">sny:ShareRepurchase2024ProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-30</startDate>
            <endDate>2024-04-30</endDate>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2024_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:MSDContingentConsiderationEuropeanVaccinesBusinessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">sny:OtherLiabilities1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForPensionsAndOtherPostemploymentBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:ProvisionsForOtherLongTermBenefitsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">sny:NonCurrentRestructuringProvisionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">ifrs-full:MiscellaneousOtherProvisionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:AcquiredResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">sny:ProductsTrademarksAndOtherRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn12_31_2023_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <context id="PAsOn06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001121404</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-06-30</instant>
        </period>
    </context>
    <unit id="Unit_EUR">
        <measure>iso4217:EUR</measure>
    </unit>
    <unit id="Unit_pure">
        <measure>pure</measure>
    </unit>
    <unit id="Unit_shares">
        <measure>shares</measure>
    </unit>
    <unit id="Unit_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Unit_Year">
        <measure>utr:Year</measure>
    </unit>
    <unit id="Unit_Month">
        <measure>utr:Month</measure>
    </unit>
    <unit id="Unit_EUR_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:EUR</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Unit_Proceeding">
        <measure>sny:Proceeding</measure>
    </unit>
    <unit id="Unit_USD_per_Share">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="P01_01_2025To06_30_2025" id="ixv-135">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="P01_01_2025To06_30_2025" id="ixv-136">0001121404</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="P01_01_2025To06_30_2025" id="ixv-137">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentPeriodEndDate contextRef="P01_01_2025To06_30_2025" id="ixv-138">2025-06-30</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalPeriodFocus contextRef="P01_01_2025To06_30_2025" id="ixv-139">Q2</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentType contextRef="P01_01_2025To06_30_2025" id="ixv-6201">6-K</dei:DocumentType>
    <dei:DocumentFiscalYearFocus contextRef="P01_01_2025To06_30_2025" id="ixv-6202">2025</dei:DocumentFiscalYearFocus>
    <dei:EntityRegistrantName contextRef="P01_01_2025To06_30_2025" id="ixv-6203">SANOFI</dei:EntityRegistrantName>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326473"
      unitRef="Unit_EUR">9574000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326475"
      unitRef="Unit_EUR">10091000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326474"
      unitRef="Unit_EUR">1433000000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326476"
      unitRef="Unit_EUR">1510000000</ifrs-full:RightofuseAssets>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326477"
      unitRef="Unit_EUR">40283000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326483"
      unitRef="Unit_EUR">43384000000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326478"
      unitRef="Unit_EUR">20431000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326484"
      unitRef="Unit_EUR">22629000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326479"
      unitRef="Unit_EUR">3563000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326485"
      unitRef="Unit_EUR">316000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326480"
      unitRef="Unit_EUR">4109000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326486"
      unitRef="Unit_EUR">3753000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326481"
      unitRef="Unit_EUR">541000000</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:CurrentTaxAssetsNoncurrent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326487"
      unitRef="Unit_EUR">560000000</ifrs-full:CurrentTaxAssetsNoncurrent>
    <ifrs-full:DeferredTaxAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326482"
      unitRef="Unit_EUR">8008000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:DeferredTaxAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326488"
      unitRef="Unit_EUR">7967000000</ifrs-full:DeferredTaxAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326489"
      unitRef="Unit_EUR">87942000000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326491"
      unitRef="Unit_EUR">90210000000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Inventories
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326490"
      unitRef="Unit_EUR">9618000000</ifrs-full:Inventories>
    <ifrs-full:Inventories
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326492"
      unitRef="Unit_EUR">9431000000</ifrs-full:Inventories>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326493"
      unitRef="Unit_EUR">7810000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326498"
      unitRef="Unit_EUR">7677000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:OtherCurrentAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326494"
      unitRef="Unit_EUR">3595000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326499"
      unitRef="Unit_EUR">3826000000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326495"
      unitRef="Unit_EUR">397000000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CurrentTaxAssetsCurrent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326500"
      unitRef="Unit_EUR">724000000</ifrs-full:CurrentTaxAssetsCurrent>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326496"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326501"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326497"
      unitRef="Unit_EUR">238000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326502"
      unitRef="Unit_EUR">13489000000</ifrs-full:NoncurrentAssetsOrDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327584"
      unitRef="Unit_EUR">37017000000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148327585"
      unitRef="Unit_EUR">42588000000</ifrs-full:CurrentAssets>
    <ifrs-full:Assets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326503"
      unitRef="Unit_EUR">124959000000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326504"
      unitRef="Unit_EUR">132798000000</ifrs-full:Assets>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326505"
      unitRef="Unit_EUR">70008000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326506"
      unitRef="Unit_EUR">77507000000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326507"
      unitRef="Unit_EUR">271000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326508"
      unitRef="Unit_EUR">350000000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326509"
      unitRef="Unit_EUR">70279000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326510"
      unitRef="Unit_EUR">77857000000</ifrs-full:Equity>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326511"
      unitRef="Unit_EUR">13200000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326512"
      unitRef="Unit_EUR">11791000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326513"
      unitRef="Unit_EUR">1524000000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326514"
      unitRef="Unit_EUR">1645000000</ifrs-full:NoncurrentLeaseLiabilities>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326515"
      unitRef="Unit_EUR">564000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326516"
      unitRef="Unit_EUR">569000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326517"
      unitRef="Unit_EUR">7116000000</sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326518"
      unitRef="Unit_EUR">8096000000</sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326519"
      unitRef="Unit_EUR">1502000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:CurrentTaxLiabilitiesNoncurrent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326520"
      unitRef="Unit_EUR">1512000000</ifrs-full:CurrentTaxLiabilitiesNoncurrent>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326521"
      unitRef="Unit_EUR">1715000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:DeferredTaxLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326522"
      unitRef="Unit_EUR">2166000000</ifrs-full:DeferredTaxLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326523"
      unitRef="Unit_EUR">25621000000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326524"
      unitRef="Unit_EUR">25779000000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326525"
      unitRef="Unit_EUR">7075000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326526"
      unitRef="Unit_EUR">7551000000</ifrs-full:TradeAndOtherCurrentPayablesToTradeSuppliers>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326527"
      unitRef="Unit_EUR">0</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326528"
      unitRef="Unit_EUR">72000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326529"
      unitRef="Unit_EUR">13697000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <sny:CurrentProvisionsAndOtherCurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326530"
      unitRef="Unit_EUR">14241000000</sny:CurrentProvisionsAndOtherCurrentLiabilities>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326531"
      unitRef="Unit_EUR">724000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326532"
      unitRef="Unit_EUR">697000000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326533"
      unitRef="Unit_EUR">252000000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326534"
      unitRef="Unit_EUR">261000000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326535"
      unitRef="Unit_EUR">7309000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326536"
      unitRef="Unit_EUR">4209000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326537"
      unitRef="Unit_EUR">2000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326538"
      unitRef="Unit_EUR">2131000000</ifrs-full:LiabilitiesIncludedInDisposalGroupsClassifiedAsHeldForSale>
    <ifrs-full:CurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326539"
      unitRef="Unit_EUR">29059000000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326540"
      unitRef="Unit_EUR">29162000000</ifrs-full:CurrentLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326543"
      unitRef="Unit_EUR">124959000000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326544"
      unitRef="Unit_EUR">132798000000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326545"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326546"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326547"
      unitRef="Unit_EUR">1452000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326548"
      unitRef="Unit_EUR">1529000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326549"
      unitRef="Unit_EUR">5881000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326550"
      unitRef="Unit_EUR">5966000000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326551"
      unitRef="Unit_EUR">15460000000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326552"
      unitRef="Unit_EUR">13923000000</ifrs-full:GrossProfit>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326553"
      unitRef="Unit_EUR">3717000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326554"
      unitRef="Unit_EUR">3335000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326555"
      unitRef="Unit_EUR">4506000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326556"
      unitRef="Unit_EUR">4303000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326557"
      unitRef="Unit_EUR">533000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326558"
      unitRef="Unit_EUR">563000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326559"
      unitRef="Unit_EUR">2476000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326560"
      unitRef="Unit_EUR">1977000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326561"
      unitRef="Unit_EUR">777000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326562"
      unitRef="Unit_EUR">898000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326563"
      unitRef="Unit_EUR">210000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326564"
      unitRef="Unit_EUR">-371000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326565"
      unitRef="Unit_EUR">61000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326566"
      unitRef="Unit_EUR">66000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326567"
      unitRef="Unit_EUR">430000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326568"
      unitRef="Unit_EUR">1060000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326569"
      unitRef="Unit_EUR">-57000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326570"
      unitRef="Unit_EUR">-450000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326571"
      unitRef="Unit_EUR">3759000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326572"
      unitRef="Unit_EUR">2768000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326573"
      unitRef="Unit_EUR">361000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326574"
      unitRef="Unit_EUR">583000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326575"
      unitRef="Unit_EUR">184000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326576"
      unitRef="Unit_EUR">277000000</ifrs-full:FinanceIncome>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326577"
      unitRef="Unit_EUR">3582000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326578"
      unitRef="Unit_EUR">2462000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326579"
      unitRef="Unit_EUR">711000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326580"
      unitRef="Unit_EUR">379000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326581"
      unitRef="Unit_EUR">85000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326582"
      unitRef="Unit_EUR">-22000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326585"
      unitRef="Unit_EUR">2956000000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326586"
      unitRef="Unit_EUR">2061000000</ifrs-full:ProfitLossFromContinuingOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326587"
      unitRef="Unit_EUR">2881000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326588"
      unitRef="Unit_EUR">202000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326583"
      unitRef="Unit_EUR">5837000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326584"
      unitRef="Unit_EUR">2263000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326669"
      unitRef="Unit_EUR">25000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326670"
      unitRef="Unit_EUR">17000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326671"
      unitRef="Unit_EUR">5812000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326672"
      unitRef="Unit_EUR">2246000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="Fact_148326673"
      unitRef="Unit_shares">1225500000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="Fact_148326674"
      unitRef="Unit_shares">1249400000</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="Fact_148326675"
      unitRef="Unit_shares">1230700000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="Fact_148326676"
      unitRef="Unit_shares">1253800000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326677"
      unitRef="Unit_EUR_per_Share">2.4</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326678"
      unitRef="Unit_EUR_per_Share">1.64</ifrs-full:BasicEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326679"
      unitRef="Unit_EUR_per_Share">2.34</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326680"
      unitRef="Unit_EUR_per_Share">0.16</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <sny:BasicEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326681"
      unitRef="Unit_EUR_per_Share">4.74</sny:BasicEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:BasicEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326682"
      unitRef="Unit_EUR_per_Share">1.8</sny:BasicEarningsLossPerShareAttributableToOwnersOfParent>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326683"
      unitRef="Unit_EUR_per_Share">2.39</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326684"
      unitRef="Unit_EUR_per_Share">1.63</ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326685"
      unitRef="Unit_EUR_per_Share">2.33</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326686"
      unitRef="Unit_EUR_per_Share">0.16</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="Fact_148326687"
      unitRef="Unit_EUR_per_Share">4.72</sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent>
    <sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="Fact_148326688"
      unitRef="Unit_EUR_per_Share">1.79</sny:DilutedEarningsLossPerShareAttributableToOwnersOfParent>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326689"
      unitRef="Unit_EUR">5837000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326690"
      unitRef="Unit_EUR">2263000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326691"
      unitRef="Unit_EUR">5812000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326692"
      unitRef="Unit_EUR">2246000000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326626"
      unitRef="Unit_EUR">25000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326625"
      unitRef="Unit_EUR">17000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326693"
      unitRef="Unit_EUR">-111000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326694"
      unitRef="Unit_EUR">-235000000</ifrs-full:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326695"
      unitRef="Unit_EUR">222000000</ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments>
    <ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326696"
      unitRef="Unit_EUR">-10000000</ifrs-full:GainsLossesRecognisedInOtherComprehensiveIncomeFairValueMeasurementEntitysOwnEquityInstruments>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326697"
      unitRef="Unit_EUR">92000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326698"
      unitRef="Unit_EUR">59000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326699"
      unitRef="Unit_EUR">241000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326700"
      unitRef="Unit_EUR">166000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326701"
      unitRef="Unit_EUR">3000000</sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax>
    <sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326702"
      unitRef="Unit_EUR">-5000000</sny:GainsLossesOnRemeasuringDebtInstrumentsBeforeTax>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326703"
      unitRef="Unit_EUR">-23000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326704"
      unitRef="Unit_EUR">-3000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326705"
      unitRef="Unit_EUR">-5203000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326706"
      unitRef="Unit_EUR">1040000000</ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326707"
      unitRef="Unit_EUR">95000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss>
    <ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326708"
      unitRef="Unit_EUR">-35000000</ifrs-full:IncomeTaxRelatingToComponentsOfOtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLoss>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326709"
      unitRef="Unit_EUR">-5318000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326710"
      unitRef="Unit_EUR">1067000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <sny:OtherComprehensiveIncomeFromContinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326711"
      unitRef="Unit_EUR">-5077000000</sny:OtherComprehensiveIncomeFromContinuedOperations>
    <sny:OtherComprehensiveIncomeFromContinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326712"
      unitRef="Unit_EUR">1233000000</sny:OtherComprehensiveIncomeFromContinuedOperations>
    <sny:OtherComprehensiveIncomeFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326638"
      unitRef="Unit_EUR">303000000</sny:OtherComprehensiveIncomeFromDiscontinuedOperations>
    <sny:OtherComprehensiveIncomeFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326637"
      unitRef="Unit_EUR">-23000000</sny:OtherComprehensiveIncomeFromDiscontinuedOperations>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326636"
      unitRef="Unit_EUR">1063000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326635"
      unitRef="Unit_EUR">3496000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326634"
      unitRef="Unit_EUR">1076000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326633"
      unitRef="Unit_EUR">3471000000</ifrs-full:ComprehensiveIncomeAttributableToOwnersOfParent>
    <sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326632"
      unitRef="Unit_EUR">-2097000000</sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations>
    <sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326631"
      unitRef="Unit_EUR">3264000000</sny:ComprehensiveIncomeAttributableToOwnersOfParentContinuingOperations>
    <sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326630"
      unitRef="Unit_EUR">3173000000</sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations>
    <sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326629"
      unitRef="Unit_EUR">207000000</sny:ComprehensiveIncomeAttributableToOwnersOfParentDiscontinuedOperations>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326628"
      unitRef="Unit_EUR">-13000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326627"
      unitRef="Unit_EUR">25000000</ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326649"
      unitRef="Unit_EUR">2530000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326650"
      unitRef="Unit_EUR">313000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326651"
      unitRef="Unit_EUR">-1184000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326652"
      unitRef="Unit_EUR">67499000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326653"
      unitRef="Unit_EUR">4944000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326654"
      unitRef="Unit_EUR">-62000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326655"
      unitRef="Unit_EUR">74040000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326656"
      unitRef="Unit_EUR">313000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2023"
      decimals="-6"
      id="Fact_148326657"
      unitRef="Unit_EUR">74353000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326658"
      unitRef="Unit_EUR">166000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326659"
      unitRef="Unit_EUR">1059000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326660"
      unitRef="Unit_EUR">1225000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326661"
      unitRef="Unit_EUR">8000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326662"
      unitRef="Unit_EUR">1233000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326663"
      unitRef="Unit_EUR">2246000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326664"
      unitRef="Unit_EUR">2246000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326665"
      unitRef="Unit_EUR">17000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326666"
      unitRef="Unit_EUR">2263000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326716"
      unitRef="Unit_EUR">2412000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326832"
      unitRef="Unit_EUR">1059000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326833"
      unitRef="Unit_EUR">3471000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326834"
      unitRef="Unit_EUR">25000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326835"
      unitRef="Unit_EUR">3496000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="ixv-31821"
      unitRef="Unit_EUR_per_Share">3.76</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326780"
      unitRef="Unit_EUR">4704000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326781"
      unitRef="Unit_EUR">4704000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326782"
      unitRef="Unit_EUR">4704000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326783"
      unitRef="Unit_EUR">31000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326784"
      unitRef="Unit_EUR">31000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326785"
      unitRef="Unit_EUR">302000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326836"
      unitRef="Unit_EUR">302000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326837"
      unitRef="Unit_EUR">302000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326838"
      unitRef="Unit_EUR">7000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326839"
      unitRef="Unit_EUR">7000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326840"
      unitRef="Unit_EUR">7000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2024To06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326841"
      unitRef="Unit_EUR">3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2024To06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326842"
      unitRef="Unit_EUR">-3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2024To06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326843"
      unitRef="Unit_EUR">115000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326844"
      unitRef="Unit_EUR">-115000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326845"
      unitRef="Unit_EUR">173000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326846"
      unitRef="Unit_EUR">173000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326847"
      unitRef="Unit_EUR">173000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2024To06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326848"
      unitRef="Unit_EUR">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326849"
      unitRef="Unit_EUR">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326850"
      unitRef="Unit_EUR">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2024To06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326862"
      unitRef="Unit_EUR">1000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2024To06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326851"
      unitRef="Unit_EUR">1000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326852"
      unitRef="Unit_EUR">1000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326853"
      unitRef="Unit_EUR">2533000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326854"
      unitRef="Unit_EUR">317000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326855"
      unitRef="Unit_EUR">-1371000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326856"
      unitRef="Unit_EUR">65093000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326857"
      unitRef="Unit_EUR">5121000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326858"
      unitRef="Unit_EUR">997000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326859"
      unitRef="Unit_EUR">72690000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326860"
      unitRef="Unit_EUR">307000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2024"
      decimals="-6"
      id="Fact_148326861"
      unitRef="Unit_EUR">72997000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326615"
      unitRef="Unit_EUR">-194000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326616"
      unitRef="Unit_EUR">1379000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326617"
      unitRef="Unit_EUR">1185000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326618"
      unitRef="Unit_EUR">14000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326619"
      unitRef="Unit_EUR">1199000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326620"
      unitRef="Unit_EUR">3314000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326621"
      unitRef="Unit_EUR">3314000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326667"
      unitRef="Unit_EUR">41000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326668"
      unitRef="Unit_EUR">3355000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326863"
      unitRef="Unit_EUR">3120000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326864"
      unitRef="Unit_EUR">1379000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326865"
      unitRef="Unit_EUR">4499000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326866"
      unitRef="Unit_EUR">55000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326867"
      unitRef="Unit_EUR">4554000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326868"
      unitRef="Unit_EUR">13000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326717"
      unitRef="Unit_EUR">13000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326871"
      unitRef="Unit_EUR">12000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326872"
      unitRef="Unit_EUR">492000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326873"
      unitRef="Unit_EUR">-530000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326874"
      unitRef="Unit_EUR">26000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326875"
      unitRef="Unit_EUR">1000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326876"
      unitRef="Unit_EUR">25000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326877"
      unitRef="Unit_EUR">26000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326878"
      unitRef="Unit_EUR">26000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P07_01_2024To12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326879"
      unitRef="Unit_EUR">1000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326880"
      unitRef="Unit_EUR">-1000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="P07_01_2024To12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326881"
      unitRef="Unit_EUR">4000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="P07_01_2024To12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326882"
      unitRef="Unit_EUR">150000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326883"
      unitRef="Unit_EUR">154000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326884"
      unitRef="Unit_EUR">154000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansEmployeeShareOwnershipPlans>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326885"
      unitRef="Unit_EUR">132000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326886"
      unitRef="Unit_EUR">132000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326887"
      unitRef="Unit_EUR">132000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P07_01_2024To12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326786"
      unitRef="Unit_EUR">7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326888"
      unitRef="Unit_EUR">7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P07_01_2024To12_31_2024"
      decimals="-6"
      id="Fact_148326889"
      unitRef="Unit_EUR">7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="P07_01_2024To12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326890"
      unitRef="Unit_EUR">-1000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="P07_01_2024To12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326891"
      unitRef="Unit_EUR">-1000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="P07_01_2024To12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326892"
      unitRef="Unit_EUR">1000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326893"
      unitRef="Unit_EUR">2526000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326894"
      unitRef="Unit_EUR">-840000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326895"
      unitRef="Unit_EUR">68185000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326896"
      unitRef="Unit_EUR">5260000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326897"
      unitRef="Unit_EUR">2376000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326898"
      unitRef="Unit_EUR">77507000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326899"
      unitRef="Unit_EUR">350000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326900"
      unitRef="Unit_EUR">77857000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326609"
      unitRef="Unit_EUR">2526000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326608"
      unitRef="Unit_EUR">0</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326607"
      unitRef="Unit_EUR">-840000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326605"
      unitRef="Unit_EUR">68185000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326604"
      unitRef="Unit_EUR">5260000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326603"
      unitRef="Unit_EUR">2376000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326602"
      unitRef="Unit_EUR">77507000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326601"
      unitRef="Unit_EUR">350000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326600"
      unitRef="Unit_EUR">77857000000</ifrs-full:Equity>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326599"
      unitRef="Unit_EUR">243000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326598"
      unitRef="Unit_EUR">-4979000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326597"
      unitRef="Unit_EUR">-4736000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326596"
      unitRef="Unit_EUR">-38000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326595"
      unitRef="Unit_EUR">-4774000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326594"
      unitRef="Unit_EUR">5812000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326593"
      unitRef="Unit_EUR">5812000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326592"
      unitRef="Unit_EUR">25000000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326591"
      unitRef="Unit_EUR">5837000000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326715"
      unitRef="Unit_EUR">6055000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326714"
      unitRef="Unit_EUR">-4979000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326713"
      unitRef="Unit_EUR">1076000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326590"
      unitRef="Unit_EUR">-13000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326589"
      unitRef="Unit_EUR">1063000000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:DividendsPaidOrdinarySharesPerShare
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-31925"
      unitRef="Unit_EUR_per_Share">3.92</ifrs-full:DividendsPaidOrdinarySharesPerShare>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326756"
      unitRef="Unit_EUR">4772000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326755"
      unitRef="Unit_EUR">4772000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326754"
      unitRef="Unit_EUR">4772000000</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParent>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326753"
      unitRef="Unit_EUR">32000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326752"
      unitRef="Unit_EUR">32000000</ifrs-full:DividendsRecognisedAsDistributionsToNoncontrollingInterests>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326751"
      unitRef="Unit_EUR">3988000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326750"
      unitRef="Unit_EUR">3988000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:PurchaseOfTreasuryShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326749"
      unitRef="Unit_EUR">3988000000</ifrs-full:PurchaseOfTreasuryShares>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326748"
      unitRef="Unit_EUR">74000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326747"
      unitRef="Unit_EUR">-3868000000</ifrs-full:ReductionOfIssuedCapital>
    <ifrs-full:ReductionOfIssuedCapital
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326746"
      unitRef="Unit_EUR">3794000000</ifrs-full:ReductionOfIssuedCapital>
    <sny:TaxesOnShareCancellations
      contextRef="P01_01_2025To06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148328206"
      unitRef="Unit_EUR">-15000000</sny:TaxesOnShareCancellations>
    <sny:TaxesOnShareCancellations
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148328207"
      unitRef="Unit_EUR">-15000000</sny:TaxesOnShareCancellations>
    <sny:TaxesOnShareCancellations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328208"
      unitRef="Unit_EUR">-15000000</sny:TaxesOnShareCancellations>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326745"
      unitRef="Unit_EUR">1000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326744"
      unitRef="Unit_EUR">14000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326743"
      unitRef="Unit_EUR">15000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <ifrs-full:IncreaseDecreaseThroughExerciseOfOptions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326742"
      unitRef="Unit_EUR">15000000</ifrs-full:IncreaseDecreaseThroughExerciseOfOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326741"
      unitRef="Unit_EUR">3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares
      contextRef="P01_01_2025To06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326740"
      unitRef="Unit_EUR">-3000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansIssuanceOfRestrictedSharesAndVestingOfExistingRestrictedShares>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326739"
      unitRef="Unit_EUR">177000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326738"
      unitRef="Unit_EUR">177000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326737"
      unitRef="Unit_EUR">177000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansValueOfServicesObtainedFromEmployees>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2025To06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326736"
      unitRef="Unit_EUR">-7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326735"
      unitRef="Unit_EUR">-7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326734"
      unitRef="Unit_EUR">-7000000</sny:IncreaseDecreaseThroughShareBasedPaymentPlansTaxEffectsOfTheExerciseOfStockOptions>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2025To06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326733"
      unitRef="Unit_EUR">15000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2025To06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326732"
      unitRef="Unit_EUR">15000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326731"
      unitRef="Unit_EUR">15000000</sny:IncreaseDecreaseThroughIssuanceOfRestrictedSharesEquity>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="P01_01_2025To06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326730"
      unitRef="Unit_EUR">-34000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326729"
      unitRef="Unit_EUR">-34000000</ifrs-full:IncreaseDecreaseThroughChangesInOwnershipInterestsInSubsidiariesThatDoNotResultInLossOfControl>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326728"
      unitRef="Unit_EUR">2456000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_AdditionalPaidinCapitalMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326727"
      unitRef="Unit_EUR">11000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_TreasurySharesMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326726"
      unitRef="Unit_EUR">-975000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_RetainedEarningsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326724"
      unitRef="Unit_EUR">65689000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_ReserveOfSharebasedPaymentsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326723"
      unitRef="Unit_EUR">5430000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326722"
      unitRef="Unit_EUR">-2603000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_EquityAttributableToOwnersOfParentMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326720"
      unitRef="Unit_EUR">70008000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025_NoncontrollingInterestsMemberifrsfullComponentsOfEquityAxis"
      decimals="-6"
      id="Fact_148326719"
      unitRef="Unit_EUR">271000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326718"
      unitRef="Unit_EUR">70279000000</ifrs-full:Equity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326901"
      unitRef="Unit_EUR">5812000000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326902"
      unitRef="Unit_EUR">2246000000</ifrs-full:ProfitLossAttributableToOrdinaryEquityHoldersOfParentEntity>
    <sny:AdjustmentsForLossesGainsOnTransferOfBusiness
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326959"
      unitRef="Unit_EUR">-2881000000</sny:AdjustmentsForLossesGainsOnTransferOfBusiness>
    <sny:AdjustmentsForLossesGainsOnTransferOfBusiness
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326960"
      unitRef="Unit_EUR">-202000000</sny:AdjustmentsForLossesGainsOnTransferOfBusiness>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326903"
      unitRef="Unit_EUR">25000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326904"
      unitRef="Unit_EUR">17000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326905"
      unitRef="Unit_EUR">15000000</ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod>
    <ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326906"
      unitRef="Unit_EUR">-96000000</ifrs-full:AdjustmentsForUndistributedProfitsOfInvestmentsAccountedForUsingEquityMethod>
    <sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326907"
      unitRef="Unit_EUR">1779000000</sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset>
    <sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326908"
      unitRef="Unit_EUR">1242000000</sny:AdjustmentsForDepreciationAndAmortisationExpenseAndImpairmentLossReversalOfImpairmentLossOfPropertyPlantAndEquipmentRightOfUseAssetsAndIntangibleAsset>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326909"
      unitRef="Unit_EUR">-266000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326910"
      unitRef="Unit_EUR">-229000000</ifrs-full:AdjustmentsForLossesGainsOnDisposalOfNoncurrentAssets>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326911"
      unitRef="Unit_EUR">-539000000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <ifrs-full:AdjustmentsForDeferredTaxExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326912"
      unitRef="Unit_EUR">-749000000</ifrs-full:AdjustmentsForDeferredTaxExpense>
    <sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326913"
      unitRef="Unit_EUR">-212000000</sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326914"
      unitRef="Unit_EUR">1002000000</sny:AdjustmentsForNonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326915"
      unitRef="Unit_EUR">171000000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326787"
      unitRef="Unit_EUR">157000000</ifrs-full:AdjustmentsForSharebasedPayments>
    <sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326916"
      unitRef="Unit_EUR">0</sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue>
    <sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326917"
      unitRef="Unit_EUR">7000000</sny:ImpactOfTheWorkdownOfAcquiredInventoriesRemeasuredAtFairValue>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326918"
      unitRef="Unit_EUR">106000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:OtherAdjustmentsToReconcileProfitLoss
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326919"
      unitRef="Unit_EUR">21000000</ifrs-full:OtherAdjustmentsToReconcileProfitLoss>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326920"
      unitRef="Unit_EUR">3980000000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326921"
      unitRef="Unit_EUR">3608000000</ifrs-full:CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326922"
      unitRef="Unit_EUR">-635000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326923"
      unitRef="Unit_EUR">-917000000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326924"
      unitRef="Unit_EUR">-785000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326925"
      unitRef="Unit_EUR">81000000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326926"
      unitRef="Unit_EUR">187000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326927"
      unitRef="Unit_EUR">78000000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326928"
      unitRef="Unit_EUR">620000000</sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities>
    <sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326929"
      unitRef="Unit_EUR">-1612000000</sny:NetChangeInOtherCurrentAssetsAndOtherCurrentLiabilities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326930"
      unitRef="Unit_EUR">3367000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326931"
      unitRef="Unit_EUR">1238000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326932"
      unitRef="Unit_EUR">188000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326933"
      unitRef="Unit_EUR">184000000</ifrs-full:CashFlowsFromUsedInOperatingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326934"
      unitRef="Unit_EUR">3555000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326935"
      unitRef="Unit_EUR">1422000000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326936"
      unitRef="Unit_EUR">1420000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326937"
      unitRef="Unit_EUR">1804000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326938"
      unitRef="Unit_EUR">538000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326939"
      unitRef="Unit_EUR">1885000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326940"
      unitRef="Unit_EUR">423000000</ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326941"
      unitRef="Unit_EUR">208000000</ifrs-full:PurchaseOfFinancialInstrumentsClassifiedAsInvestingActivities>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326942"
      unitRef="Unit_EUR">434000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326943"
      unitRef="Unit_EUR">516000000</ifrs-full:ProceedsFromDisposalsOfPropertyPlantAndEquipmentIntangibleAssetsOtherThanGoodwillInvestmentPropertyAndOtherNoncurrentAssets>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326944"
      unitRef="Unit_EUR">0</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326945"
      unitRef="Unit_EUR">42000000</ifrs-full:CashFlowsFromLosingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <sny:NetChangeInOtherNonCurrentAssets
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326946"
      unitRef="Unit_EUR">-32000000</sny:NetChangeInOtherNonCurrentAssets>
    <sny:NetChangeInOtherNonCurrentAssets
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326947"
      unitRef="Unit_EUR">-16000000</sny:NetChangeInOtherNonCurrentAssets>
    <sny:NetCashProvidedByusedInContinuingInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326788"
      unitRef="Unit_EUR">-1979000000</sny:NetCashProvidedByusedInContinuingInvestingActivities>
    <sny:NetCashProvidedByusedInContinuingInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326789"
      unitRef="Unit_EUR">-3355000000</sny:NetCashProvidedByusedInContinuingInvestingActivities>
    <sny:NetCashProvidedByusedInDiscontinuingInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326790"
      unitRef="Unit_EUR">-36000000</sny:NetCashProvidedByusedInDiscontinuingInvestingActivities>
    <sny:NetCashProvidedByusedInDiscontinuingInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326791"
      unitRef="Unit_EUR">-58000000</sny:NetCashProvidedByusedInDiscontinuingInvestingActivities>
    <sny:NetCashInflowFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326792"
      unitRef="Unit_EUR">10742000000</sny:NetCashInflowFromDiscontinuedOperations>
    <sny:NetCashInflowFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326793"
      unitRef="Unit_EUR">0</sny:NetCashInflowFromDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326794"
      unitRef="Unit_EUR">8727000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326795"
      unitRef="Unit_EUR">-3413000000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326796"
      unitRef="Unit_EUR">29000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:ProceedsFromIssuingShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326797"
      unitRef="Unit_EUR">21000000</ifrs-full:ProceedsFromIssuingShares>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326798"
      unitRef="Unit_EUR">4772000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326799"
      unitRef="Unit_EUR">4704000000</ifrs-full:DividendsPaidToEquityHoldersOfParentClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326800"
      unitRef="Unit_EUR">27000000</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326801"
      unitRef="Unit_EUR">25000000</ifrs-full:DividendsPaidToNoncontrollingInterestsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326802"
      unitRef="Unit_EUR">2993000000</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:ProceedsFromNoncurrentBorrowings
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326803"
      unitRef="Unit_EUR">0</ifrs-full:ProceedsFromNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326804"
      unitRef="Unit_EUR">1859000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:RepaymentsOfNoncurrentBorrowings
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326805"
      unitRef="Unit_EUR">638000000</ifrs-full:RepaymentsOfNoncurrentBorrowings>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326806"
      unitRef="Unit_EUR">124000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326807"
      unitRef="Unit_EUR">136000000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326808"
      unitRef="Unit_EUR">3322000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326809"
      unitRef="Unit_EUR">5876000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326810"
      unitRef="Unit_EUR">4003000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:PaymentsToAcquireOrRedeemEntitysShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326811"
      unitRef="Unit_EUR">302000000</ifrs-full:PaymentsToAcquireOrRedeemEntitysShares>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326812"
      unitRef="Unit_EUR">-4441000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326813"
      unitRef="Unit_EUR">92000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesContinuingOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326814"
      unitRef="Unit_EUR">-48000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326815"
      unitRef="Unit_EUR">-3000000</ifrs-full:CashFlowsFromUsedInFinancingActivitiesDiscontinuedOperations>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326816"
      unitRef="Unit_EUR">-4489000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326948"
      unitRef="Unit_EUR">89000000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326949"
      unitRef="Unit_EUR">-42000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326950"
      unitRef="Unit_EUR">-13000000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326951"
      unitRef="Unit_EUR">167000000</sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale>
    <sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326952"
      unitRef="Unit_EUR">0</sny:CashAndCashEquivalentsReclassifiedToAssetsHeldForSale>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148326953"
      unitRef="Unit_EUR">7918000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326954"
      unitRef="Unit_EUR">-1915000000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148326955"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2023"
      decimals="-6"
      id="Fact_148326956"
      unitRef="Unit_EUR">8710000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148326957"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2024"
      decimals="-6"
      id="Fact_148326958"
      unitRef="Unit_EUR">6795000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32056"
      unitRef="Unit_EUR">1355000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326962"
      unitRef="Unit_EUR">1434000000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32058"
      unitRef="Unit_EUR">206000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestPaidClassifiedAsOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326964"
      unitRef="Unit_EUR">320000000</ifrs-full:InterestPaidClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32060"
      unitRef="Unit_EUR">170000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <ifrs-full:InterestReceivedClassifiedAsOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326966"
      unitRef="Unit_EUR">261000000</ifrs-full:InterestReceivedClassifiedAsOperatingActivities>
    <sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32062"
      unitRef="Unit_EUR">5000000</sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities>
    <sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148326968"
      unitRef="Unit_EUR">0</sny:DividendsReceivedFromNonconsolidatedEntitiesClassifiedAsOperatingActivities>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-6"
      id="ixv-32064"
      unitRef="Unit_EUR">667000000</ifrs-full:CashAndCashEquivalents>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32065"
      unitRef="Unit_EUR">3353000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments
      contextRef="P01_01_2024To06_30_2024_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32066"
      unitRef="Unit_EUR">6060000000</sny:CashFlowsFromUsedInIncreaseDecreaseInCurrentBorrowingsAndOtherFinancialInstruments>
    <ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14725">&lt;div id="ex99_169958_9" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold"&gt;Introduction &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi, together with its subsidiaries (collectively &#x201c;Sanofi&#x201d;, &#x201c;the Group&#x201d; or &#x201c;the Company&#x201d;), is a global healthcare leader engaged in the research, development and marketing of therapeutic solutions focused on patient needs. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi is listed in Paris (Euronext: SAN) and New&#160;York (Nasdaq: SNY). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The condensed consolidated financial statements for the six months ended June&#160;30, 2025 were reviewed by the Sanofi Board of Directors at the Board meeting on July&#160;30, 2025. &lt;/div&gt;</ifrs-full:DisclosureOfGeneralInformationAboutFinancialStatementsExplanatory>
    <ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14730">&lt;div id="ex99_169958_10" style="margin-top:18pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold"&gt;A/ Basis of preparation of the half-year financial statements and accounting policies &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.1. International financial reporting standards (IFRS) &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The half-year consolidated financial statements have been prepared and presented in condensed format in accordance with IAS&#160;34 (Interim Financial Reporting). The accompanying notes therefore relate to significant events and transactions of the period, and should be read in conjunction with the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The accounting policies used in the preparation of the consolidated financial statements as of June&#160;30,&#160;2025 comply with international financial reporting standards (IFRS) as endorsed by the European Union and as issued by the International Accounting Standards Board (IASB). IFRS as endorsed by the European Union as of June&#160;30, 2025 are available via the following web link: &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;https://www.efrag.org/Endorsement &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The accounting policies applied effective January&#160;1, 2025 are identical to those presented in the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On August&#160;15, 2023, the IASB issued &#x201c;Lack of Exchangeability&#x201d;, an amendment to IAS 21 (The Effects of Changes in Foreign Exchange Rates), relating to how to determine the exchange rate when a currency is not exchangeable. The amendment became applicable on January&#160;1, 2025, and does not have a material impact on the Sanofi financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In its 2025 half-year financial statements, Sanofi has used an average effective tax rate that takes into account the Pillar Two &lt;div style="white-space:nowrap;display:inline;"&gt;top-up&lt;/div&gt; tax applicable from January&#160;1, 2024. The effective tax rate also includes a &lt;div style="white-space:nowrap;display:inline;"&gt;one-off&lt;/div&gt; impact from the 2024 component of the exceptional contribution in respect of French corporate income taxes (see Note B.19.). &lt;/div&gt;&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.2. Use of estimates and judgments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date the financial statements are finalized. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;impairment of property, plant and equipment and intangible assets; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the valuation of goodwill and the valuation and useful life of acquired intangible assets; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the measurement of contingent consideration receivable in connection with asset divestments and of contingent consideration payable; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the measurement of financial assets and financial liabilities at amortized cost; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of post-employment benefit obligations; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Actual results could differ from these estimates. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;For half-year financial reporting purposes, and as allowed under IAS 34, Sanofi has determined income tax expense on the basis of an estimate of the effective tax rate for the full financial year. That rate is applied to business operating income plus financial income and minus financial expenses, and before (i)&#160;the share of profit/loss of investments accounted for using the equity method and (ii)&#160;net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests. The estimated full-year effective tax rate is based on the tax rates that will be applicable to projected &lt;div style="white-space:nowrap;display:inline;"&gt;pre-tax&lt;/div&gt; profits or losses arising in the various tax jurisdictions in which Sanofi operates. &lt;/div&gt;&lt;div style="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #23004c;width:24%"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(1)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#x2019;s audited consolidated financial statements as of December&#160;31, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"&gt; &lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.3. Seasonal trends &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi&#x2019;s activities are not subject to significant seasonal fluctuations. &lt;/div&gt;&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.4. Consolidation and foreign currency translation of the financial statements of subsidiaries in hyperinflationary economies &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In 2025, Sanofi continues to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that&lt;div style="display:inline;"&gt; the &lt;/div&gt;criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. The contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since July&#160;1, 2018) treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In Turkey, the cumulative rate of &lt;div style="display:inline;"&gt;inflation &lt;/div&gt;over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since January&#160;1, 2022) treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. &lt;/div&gt;&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.5. Fair value of financial instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Under IFRS 13 (Fair Value Measurement) and IFRS 7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;Level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging); &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;Level&#160;2: quoted prices in active markets for similar assets or liabilities, or valuation techniques in which all important inputs are derived from observable market data; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;Level&#160;3: valuation techniques in which not all important inputs are derived from observable market data. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:13%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:9%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:6%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:7%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:10%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:14%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:12%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:11%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type&#160;of&#160;financial&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;instrument&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Measurement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;principle&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;technique&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Method used to determine fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Market data&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;model&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exchange&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest&#160;rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Volatilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets&lt;br/&gt;measured at fair value (quoted equity instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost/ Peer comparison (primarily)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(contingent consideration receivable)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;Long-term&#160;loans&lt;/div&gt; and&#160;advances&#160;and &lt;div style="white-space:nowrap;display:inline;"&gt;other&#160;non-current&lt;/div&gt; receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The amortized cost of long-term loans and advances and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; receivables at the end of the reporting period is not materially different from their fair value.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under &lt;div style="white-space:nowrap;display:inline;"&gt;post-employment&lt;/div&gt; benefit plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Investments in mutual funds&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Net asset value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;br/&gt; &lt;div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial"&gt;B.12.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial&#160;liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Future lease payments are discounted using the incremental borrowing rate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Forward&#160;currency contracts&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Interest&#160;rate&#160;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;Cross-currency&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.11.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Liabilities&#160;related&#160;to business combinations and to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;A.6. New pronouncements issued by the IASB and applicable from 2026 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;9, 2024, the IASB issued IFRS 18 (Presentation and Disclosure in Financial Statements), applicable from January&#160;1, 2027 (subject to endorsement by the European Union). An impact assessment is currently under way. Sanofi will not early adopt this new standard. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On May&#160;30, 2024, the IASB issued amendments to IFRS 9 and IFRS 7 relating to the classification and measurement of financial instruments, applicable no earlier than January&#160;1, 2026. Sanofi does not expect any material impact, and will not early adopt these amendments. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On July&#160;18, 2024, the IASB issued Volume 11 of &#x201c;Annual Improvements to IFRS&#x201d;, applicable from January&#160;1, 2026. Sanofi does not expect any material impact from those improvements to various standards, which are essentially in the nature of clarifications, and will not early adopt them. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On December&#160;18, 2024, the IASB issued &#x201c;Contracts referencing nature-dependent electricity&#x201d;, amendments to IFRS 9 and IFRS&#160;7, applicable from January&#160;1, 2026. The amendments clarify the application of the &#x2018;own use&#x2019; exemption to Power Purchase Agreements (PPAs) with physical delivery of renewable electricity, and modify the hedge accounting requirements for contracts without physical delivery (VPPAs). Sanofi does not expect any material impact and will not early adopt these amendments. Renewable energy purchase contracts entered into by Sanofi as of December&#160;31, 2024 are described in Note D.21. to the consolidated financial statements included in the 2024 Form &lt;div style="white-space:nowrap;display:inline;"&gt;20-F&lt;/div&gt; for the year ended December&#160;31, 2024 (the &#x201c;2024 &lt;div style="white-space:nowrap;display:inline;"&gt;20-F&#x201d;).&lt;/div&gt; &lt;/div&gt;</ifrs-full:DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory>
    <ifrs-full:StatementOfIFRSCompliance contextRef="P01_01_2025To06_30_2025" id="ixv-14735">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The half-year consolidated financial statements have been prepared and presented in condensed format in accordance with IAS&#160;34 (Interim Financial Reporting). The accompanying notes therefore relate to significant events and transactions of the period, and should be read in conjunction with the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The accounting policies used in the preparation of the consolidated financial statements as of June&#160;30,&#160;2025 comply with international financial reporting standards (IFRS) as endorsed by the European Union and as issued by the International Accounting Standards Board (IASB). IFRS as endorsed by the European Union as of June&#160;30, 2025 are available via the following web link: &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;https://www.efrag.org/Endorsement &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The accounting policies applied effective January&#160;1, 2025 are identical to those presented in the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On August&#160;15, 2023, the IASB issued &#x201c;Lack of Exchangeability&#x201d;, an amendment to IAS 21 (The Effects of Changes in Foreign Exchange Rates), relating to how to determine the exchange rate when a currency is not exchangeable. The amendment became applicable on January&#160;1, 2025, and does not have a material impact on the Sanofi financial statements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In its 2025 half-year financial statements, Sanofi has used an average effective tax rate that takes into account the Pillar Two &lt;div style="white-space:nowrap;display:inline;"&gt;top-up&lt;/div&gt; tax applicable from January&#160;1, 2024. The effective tax rate also includes a &lt;div style="white-space:nowrap;display:inline;"&gt;one-off&lt;/div&gt; impact from the 2024 component of the exceptional contribution in respect of French corporate income taxes (see Note B.19.). &lt;/div&gt;</ifrs-full:StatementOfIFRSCompliance>
    <ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14747">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The preparation of financial statements requires management to make reasonable estimates and assumptions based on information available at the date the financial statements are finalized. Those estimates and assumptions may affect the reported amounts of assets, liabilities, revenues and expenses in the financial statements, and disclosures of contingent assets and contingent liabilities as of the date of the review of the financial statements. Examples of estimates and assumptions include: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;amounts deducted from sales for projected sales returns, chargeback incentives, rebates and price reductions; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;impairment of property, plant and equipment and intangible assets; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the valuation of goodwill and the valuation and useful life of acquired intangible assets; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the measurement of contingent consideration receivable in connection with asset divestments and of contingent consideration payable; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the measurement of financial assets and financial liabilities at amortized cost; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of post-employment benefit obligations; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of liabilities or provisions for restructuring, litigation, tax risks relating to corporate income taxes, and environmental risks; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;the amount of deferred tax assets resulting from tax losses available for carry-forward and deductible temporary differences. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Actual results could differ from these estimates. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;For half-year financial reporting purposes, and as allowed under IAS 34, Sanofi has determined income tax expense on the basis of an estimate of the effective tax rate for the full financial year. That rate is applied to business operating income plus financial income and minus financial expenses, and before (i)&#160;the share of profit/loss of investments accounted for using the equity method and (ii)&#160;net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests. The estimated full-year effective tax rate is based on the tax rates that will be applicable to projected &lt;div style="white-space:nowrap;display:inline;"&gt;pre-tax&lt;/div&gt; profits or losses arising in the various tax jurisdictions in which Sanofi operates. &lt;/div&gt;</ifrs-full:DisclosureOfAccountingJudgementsAndEstimatesExplanatory>
    <sny:SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-14851">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi&#x2019;s activities are not subject to significant seasonal fluctuations. &lt;/div&gt;</sny:SeasonalityOrCyclicalityOfInterimOperationsPolicyTextBlock>
    <ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14856">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In 2025, Sanofi continues to account for subsidiaries based in Venezuela using the full consolidation method, on the basis that&lt;div style="display:inline;"&gt; the &lt;/div&gt;criteria for control as specified in IFRS&#160;10 (Consolidated Financial Statements) are still met. The contribution of the Venezuelan subsidiaries to the consolidated financial statements is immaterial. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In Argentina, the cumulative rate of inflation over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since July&#160;1, 2018) treated Argentina as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In Turkey, the cumulative rate of &lt;div style="display:inline;"&gt;inflation &lt;/div&gt;over the last three years is in excess of 100%, based on a combination of indices used to measure inflation in that country. Consequently, Sanofi has (since January&#160;1, 2022) treated Turkey as a hyperinflationary economy and has applied IAS&#160;29. The impact of the resulting restatements is immaterial at Sanofi group level. &lt;/div&gt;</ifrs-full:DisclosureOfHyperinflationaryReportingExplanatory>
    <sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears
      contextRef="PAsOn06_30_2025_ARifrsfullGeographicalAreasAxis"
      decimals="2"
      id="ixv-32069"
      unitRef="Unit_pure">1</sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears>
    <sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears
      contextRef="PAsOn06_30_2025_TRifrsfullGeographicalAreasAxis"
      decimals="2"
      id="ixv-32070"
      unitRef="Unit_pure">1</sny:CumulativeConsumerPriceInflationRateOverTheLastThreeYears>
    <ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14865">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Under IFRS 13 (Fair Value Measurement) and IFRS 7 (Financial Instruments: Disclosures), fair value measurements must be classified using a hierarchy based on the inputs used to measure the fair value of the instrument. This hierarchy has three levels: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;Level&#160;1: quoted prices in active markets for identical assets or liabilities (without modification or repackaging); &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;Level&#160;2: quoted prices in active markets for similar assets or liabilities, or valuation techniques in which all important inputs are derived from observable market data; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;Level&#160;3: valuation techniques in which not all important inputs are derived from observable market data. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:13%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:9%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:6%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:7%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:10%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:14%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:12%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:11%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type&#160;of&#160;financial&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;instrument&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Measurement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;principle&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;technique&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Method used to determine fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Market data&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;model&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exchange&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest&#160;rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Volatilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets&lt;br/&gt;measured at fair value (quoted equity instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost/ Peer comparison (primarily)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(contingent consideration receivable)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;Long-term&#160;loans&lt;/div&gt; and&#160;advances&#160;and &lt;div style="white-space:nowrap;display:inline;"&gt;other&#160;non-current&lt;/div&gt; receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The amortized cost of long-term loans and advances and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; receivables at the end of the reporting period is not materially different from their fair value.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under &lt;div style="white-space:nowrap;display:inline;"&gt;post-employment&lt;/div&gt; benefit plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Investments in mutual funds&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Net asset value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;br/&gt; &lt;div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial"&gt;B.12.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial&#160;liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Future lease payments are discounted using the incremental borrowing rate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Forward&#160;currency contracts&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Interest&#160;rate&#160;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;Cross-currency&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.11.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Liabilities&#160;related&#160;to business combinations and to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DescriptionOfAccountingPolicyForFinancialInstrumentsExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-14918">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the disclosures required under IFRS 7 relating to the measurement principles applied to financial instruments. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:13%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:9%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:6%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td style="width:7%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:10%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:14%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:12%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td style="width:11%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Note&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Type&#160;of&#160;financial&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;instrument&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Measurement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;principle&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Level&#160;in&lt;br/&gt;fair&#160;value&lt;br/&gt;hierarchy&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td rowspan="3" style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;technique&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Method used to determine fair value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Market data&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Valuation&lt;br/&gt;model&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exchange&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Interest&#160;rate&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Volatilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets&lt;br/&gt;measured at fair value (quoted equity instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value (quoted debt instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(unquoted equity&#160;instruments)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost/ Peer comparison (primarily)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;If cost ceases to be a representative measure of fair value, an internal valuation based primarily on peer comparison is used.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;(contingent consideration receivable)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The fair value of contingent consideration receivable is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note D.7.3. to the consolidated financial statements for the year ended December&#160;31, 2024.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;Long-term&#160;loans&lt;/div&gt; and&#160;advances&#160;and &lt;div style="white-space:nowrap;display:inline;"&gt;other&#160;non-current&lt;/div&gt; receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;The amortized cost of long-term loans and advances and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; receivables at the end of the reporting period is not materially different from their fair value.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets measured at fair value&#160;held&#160;to&#160;meet obligations&#160;under &lt;div style="white-space:nowrap;display:inline;"&gt;post-employment&lt;/div&gt; benefit plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market&#160;value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.6.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial assets designated&#160;at&#160;fair value&#160;held&#160;to&#160;meet obligations&#160;under deferred compensation&#160;plans&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Quoted market price&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Investments in mutual funds&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Net asset value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="5" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Negotiable debt instruments, commercial&#160;paper, instant access deposits&#160;and&#160;term deposits&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Because these instruments have a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as disclosed in the notes to the consolidated financial statements.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;br/&gt; &lt;div style="margin-bottom:1pt; margin-top:0pt; font-size:7pt; font-family:Arial"&gt;B.12.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Financial&#160;liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Amortized cost&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;In the case of financial liabilities with a maturity of less than 3 months, amortized cost is regarded as an acceptable approximation of fair value as reported in the notes to the consolidated financial statements.&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities with a maturity of more than 3 months, fair value as reported in the notes to the consolidated financial statements is determined either by reference to quoted market prices at the end of the reporting period (quoted instruments) or by discounting the future cash flows based on observable market data at the end of the reporting period (unquoted instruments).&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;For financial liabilities based on variable payments such as royalties, fair value is determined on the basis of discounted cash flow projections.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.9.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Amortized&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;cost&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Future lease payments are discounted using the incremental borrowing rate.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Forward&#160;currency contracts&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Revenue-based approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Interest&#160;rate&#160;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.10.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;Cross-currency&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial"&gt;swaps&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Present value&#160;of future&#160;cash flows&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Mid&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Spot&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;lt;&#160;1&#160;year:&#160;Mid&#160;Money&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Market&#160;and&#160;Euronext&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;interest&#160;rate&#160;futures&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;&amp;gt;&#160;1&#160;year:&#160;Mid&#160;Zero&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Coupon&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;N/A&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;B.11.&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Liabilities&#160;related&#160;to business combinations and to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Fair value&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;Revenue-&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:center"&gt;based&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:center"&gt;approach&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="7" style="BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Under IAS 32, contingent consideration payable in a business combination is a financial liability. The fair value of such liabilities is determined by adjusting the contingent consideration at the end of the reporting period using the method described in Note B.11.&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:5pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In the case of debt designated as a hedged item in a fair value hedging relationship, the carrying amount in the consolidated balance sheet includes changes in fair value attributable to the hedged risk(s). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDetailedInformationAboutFinancialInstrumentsExplanatory>
    <ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations contextRef="P01_01_2025To06_30_2025" id="ixv-15390">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;9, 2024, the IASB issued IFRS 18 (Presentation and Disclosure in Financial Statements), applicable from January&#160;1, 2027 (subject to endorsement by the European Union). An impact assessment is currently under way. Sanofi will not early adopt this new standard. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On May&#160;30, 2024, the IASB issued amendments to IFRS 9 and IFRS 7 relating to the classification and measurement of financial instruments, applicable no earlier than January&#160;1, 2026. Sanofi does not expect any material impact, and will not early adopt these amendments. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On July&#160;18, 2024, the IASB issued Volume 11 of &#x201c;Annual Improvements to IFRS&#x201d;, applicable from January&#160;1, 2026. Sanofi does not expect any material impact from those improvements to various standards, which are essentially in the nature of clarifications, and will not early adopt them. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On December&#160;18, 2024, the IASB issued &#x201c;Contracts referencing nature-dependent electricity&#x201d;, amendments to IFRS 9 and IFRS&#160;7, applicable from January&#160;1, 2026. The amendments clarify the application of the &#x2018;own use&#x2019; exemption to Power Purchase Agreements (PPAs) with physical delivery of renewable electricity, and modify the hedge accounting requirements for contracts without physical delivery (VPPAs). Sanofi does not expect any material impact and will not early adopt these amendments. Renewable energy purchase contracts entered into by Sanofi as of December&#160;31, 2024 are described in Note D.21. to the consolidated financial statements included in the 2024 Form &lt;div style="white-space:nowrap;display:inline;"&gt;20-F&lt;/div&gt; for the year ended December&#160;31, 2024 (the &#x201c;2024 &lt;div style="white-space:nowrap;display:inline;"&gt;20-F&#x201d;).&lt;/div&gt; &lt;/div&gt;</ifrs-full:DescriptionOfExpectedImpactOfInitialApplicationOfNewStandardsOrInterpretations>
    <sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-15398">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.1. Significant transactions for the first half of 2025 &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.1.1. Opella - Loss of control and equity interest in OPAL JV Co &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;30, 2025, Sanofi and CD&amp;amp;R closed the Opella transaction following the signature of the share purchase agreement (SPA) on February&#160;18, 2025. Sanofi retains a significant shareholding in Opella, through a 48.2% equity interest in OPAL JV Co (formed in Luxembourg), which indirectly holds 100% of Opella. Bpifrance owns a 1.8% equity interest, and is represented on Opella&#x2019;s Board. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Completion of the deal resulted in the loss of control of Opella by Sanofi and the derecognition of Opella&#x2019;s assets and liabilities. This resulted in a net gain of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2.7&#160;billion, reported within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net income from discontinued operations &lt;/div&gt;&lt;/div&gt;in the consolidated income statement. The proceeds from the divestment of Opella, determined on the basis of a &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;16&#160;billion enterprise value, reflected the estimated share price. That price is subject to adjustments following finalization of the Opella completion accounts, expected at the earliest in the fourth quarter of 2025. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of the closing date of the transaction, the carrying amount of Opella&#x2019;s assets and liabilities in the Sanofi consolidated balance sheet was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;11.3&#160;billion. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The gain took into account the following components: (i)&#160;a reclassification of unrealized foreign exchange losses amounting to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;0.5&#160;billion associated with Opella operations, in accordance with IAS 21 (&#x201c;The Effects of Changes in Foreign Exchange Rates&#x201d;); (ii) recognition of the retained 48.2% equity interest in OPAL JV Co (over which Sanofi exercises significant influence as defined in IAS 28 &#x201c;Investments in Associates and Joint Ventures&#x201d;), reported within the balance sheet line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt; at an amount of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;3.2&#160;billion (representing the fair value of the equity interest at the date of initial recognition in accordance with IFRS 10 and included in the estimated share price, plus capitalized transaction costs); and (iii)&#160;other items, mainly comprising compensation as agreed under the separation agreements. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The Opella transaction generated a net cash inflow of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;10.7&#160;billion, presented within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net cash inflow from the Opella transaction&lt;/div&gt;&lt;/div&gt; in the statement of cash flows. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As a reminder, on October&#160;21, 2024, Sanofi and CD&amp;amp;R entered into exclusive negotiations for the transfer of a controlling interest in Opella. As of December&#160;31, 2024, completion of the transaction was considered highly probable. In accordance with the classification and presentation requirements of IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), all assets of Opella and all liabilities directly related to those assets were classified from October&#160;21, 2024 in the line items &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Assets held for sale &lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;and&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; Liabilities related to assets held for sale&lt;/div&gt;&lt;/div&gt;, respectively, in the consolidated balance sheet (see Notes D.8. and D.36. to the consolidated financial statements for the year ended December&#160;31, 2024). Opella (formerly known as Consumer Healthcare) constituted an operating segment of Sanofi until October&#160;21, 2024 (see Note D.35., &#x201c;Segment Information&#x201d; to the consolidated financial statements for the year ended December&#160;31, 2024). Consequently, Opella met the definition of a discontinued operation under IFRS 5 (see Note B.7. to the consolidated financial statements for the year ended December&#160;31, 2024), as a result of which the net income from that business was presented separately within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net income from discontinued operations&lt;/div&gt;&lt;/div&gt; in the consolidated income statement. This presentation in a separate income statement line item applied to operations for the year ended December&#160;31, 2024, and on a consistent basis for the comparative periods presented. The cash flows arising from operating, investing and financing activities of the Opella business were also presented in separate line items in the consolidated statements of cash flows for the year ended December&#160;31, 2024 and for the comparative periods presented. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.1.2. Acquisition of Dren-0201, Inc. &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On May&#160;27, 2025, Sanofi announced the completion of the acquisition of 100% of Dren-0201, Inc., adding SAR448501 (formerly &lt;div style="white-space:nowrap;display:inline;"&gt;DR-0201)&lt;/div&gt; to Sanofi&#x2019;s immunology pipeline. &lt;div style="white-space:nowrap;display:inline;"&gt;DR-0201,&lt;/div&gt; now named SAR448501, has shown robust &lt;div style="white-space:nowrap;display:inline;"&gt;B-cell&lt;/div&gt; depletion in &lt;div style="white-space:nowrap;display:inline;"&gt;pre-clinical&lt;/div&gt; and early clinical studies. This potential &lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;first-in-class&lt;/div&gt;&lt;/div&gt; targeted bispecific myeloid cell engager targets and engages specific tissue-resident and trafficking myeloid cells to induce deep &lt;div style="white-space:nowrap;display:inline;"&gt;B-cell&lt;/div&gt; depletion via targeted phagocytosis. Recent &lt;div style="white-space:nowrap;display:inline;"&gt;pre-clinical&lt;/div&gt; and early clinical study data in autoimmune diseases suggest that deep &lt;div style="white-space:nowrap;display:inline;"&gt;B-cell&lt;/div&gt; depletion has the potential to reset the adaptive immune system, leading to sustained treatment-free remission in patients with refractory &lt;div style="white-space:nowrap;display:inline;"&gt;B-cell&lt;/div&gt; mediated autoimmune diseases such as lupus, where significant unmet medical needs remain. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The transaction did not meet the criteria for a business combination under IFRS 3, and consequently was accounted for as an acquisition of a group of assets. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The acquisition price was $600&#160;million. Of that amount (plus acquisition-related costs), $562&#160;million was allocated to &lt;div style="white-space:nowrap;display:inline;"&gt;in-process&lt;/div&gt; development in respect of SAR448501, and recognized within &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other intangible assets&lt;/div&gt;&lt;/div&gt; in accordance with IAS 38. The difference between that amount and the acquisition price corresponds to the other assets acquired and liabilities assumed in the transaction. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In addition, potential future payments totalling $1.3&#160;billion contingent on attainment of certain development and launch milestones have been recognized as off balance sheet commitments. These milestones will be added to the value of the SAR448501 intangible asset if and when attained. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The impact of this acquisition, as reflected within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Acquisitions of consolidated undertakings and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt; in the consolidated statement of cash flows, is a net cash outflow of $602&#160;million. &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.1.3. Agreed transactions expected to be finalized in the second half of 2025 &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold"&gt;Acquisition of Vigil Neuroscience, Inc. &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On May&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vigil Neuroscience, Inc. (&#x201c;Vigil&#x201d;), a publicly traded clinical-stage biotechnology company focused on developing novel therapies for neurodegenerative diseases. This acquisition in neurology, one of Sanofi&#x2019;s four strategic disease areas, enhances Sanofi&#x2019;s early-stage pipeline and includes &lt;div style="white-space:nowrap;display:inline;"&gt;VG-3927,&lt;/div&gt; which will be evaluated in a phase 2 clinical study in Alzheimer&#x2019;s disease. &lt;div style="white-space:nowrap;display:inline;"&gt;VG-3927&lt;/div&gt; is an oral small molecule TREM2 agonist. Activating TREM2 is expected to enhance the neuroprotective function of microglia in Alzheimer&#x2019;s disease. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Under the terms of a share purchase agreement (including the exclusive right of first negotiation for an exclusive license to &lt;div style="white-space:nowrap;display:inline;"&gt;VG-3927&lt;/div&gt; or for transfer of the rights to research, develop, manufacture, and commercialize &lt;div style="white-space:nowrap;display:inline;"&gt;VG-3927)&lt;/div&gt; entered into by Sanofi and Vigil in June 2024 for an amount of $40&#160;million, Sanofi already held an equity interest in Vigil Neuroscience, Inc., representing approximately 12% of Vigil&#x2019;s share capital. That equity interest was remeasured at market value as at June&#160;30, 2025 through &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;VGL101, Vigil&#x2019;s second molecule program, is not being acquired by Sanofi. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi will acquire all outstanding common shares of Vigil for $8.00 per share in cash at closing. Based on $8.00 per share, the total equity value of Vigil represents approximately $470&#160;million (on a fully diluted basis). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In addition, Vigil&#x2019;s shareholders will receive one &lt;div style="white-space:nowrap;display:inline;"&gt;non-transferable&lt;/div&gt; and &lt;div style="white-space:nowrap;display:inline;"&gt;non-tradeable&lt;/div&gt; contractual contingent value right (CVR) per Vigil share entitling the holder to receive a deferred cash payment of $2.00, contingent upon the first commercial sales of &lt;div style="white-space:nowrap;display:inline;"&gt;VG-3927.&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The acquisition is expected to close in the third quarter of 2025 subject to closing conditions. &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold"&gt;Acquisition of Blueprint Medicines Corporation &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On June&#160;2, 2025, Sanofi and Blueprint Medicines Corporation (Blueprint), a &lt;div style="white-space:nowrap;display:inline;"&gt;US-based,&lt;/div&gt; publicly traded biopharmaceutical company specializing in systemic mastocytosis (SM), a rare immunological disease, and other &lt;div style="white-space:nowrap;display:inline;"&gt;KIT-driven&lt;/div&gt; diseases, entered into an agreement under which Sanofi agreed to acquire Blueprint. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The acquisition included a rare immunology disease medicine, Ayvakit/Ayvakyt (avapritinib), approved in the US and the EU, and a promising advanced and early-stage immunology pipeline. Blueprint&#x2019;s established presence among allergists, dermatologists, and immunologists is expected to enhance Sanofi&#x2019;s growing immunology pipeline. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Under the terms of the acquisition, Sanofi agreed to pay $129.00 per share in cash at closing, representing an equity value of approximately $9.1&#160;billion for 100% of the shares. Blueprint shareholders also received one &lt;div style="white-space:nowrap;display:inline;"&gt;non-tradable&lt;/div&gt; contractual contingent value right (CVR) per share which entitles the holder to receive two potential milestone payments of $2.00 and $4.00 per CVR on the attainment of future development and regulatory milestones within the applicable milestone period, respectively, for &lt;div style="white-space:nowrap;display:inline;"&gt;BLU-808.&lt;/div&gt; The total equity value of the transaction, including potential CVR payments, represents approximately $9.5&#160;billion on a fully diluted basis. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In July 2025, Sanofi obtained control of Blueprint after all tender offer and merger conditions had been met. &lt;/div&gt;</sny:DisclosureOfImpactOfChangesInTheScopeOfConsolidationDueToAcquisitionsAndDivestmentsExplanatoryTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="3"
      id="ixv-32077"
      unitRef="Unit_pure">0.482</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="2"
      id="ixv-32078"
      unitRef="Unit_pure">1</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P04_01_2025To04_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="3"
      id="ixv-32079"
      unitRef="Unit_pure">0.018</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-8"
      id="ixv-32080"
      unitRef="Unit_EUR">2700000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProceedsFromSalesOfInvestmentProperty
      contextRef="P04_01_2025To04_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-9"
      id="ixv-32081"
      unitRef="Unit_EUR">16000000000</ifrs-full:ProceedsFromSalesOfInvestmentProperty>
    <ifrs-full:NetAssetsLiabilities
      contextRef="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-8"
      id="ixv-32082"
      unitRef="Unit_EUR">11300000000</ifrs-full:NetAssetsLiabilities>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="P04_01_2025To04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-8"
      id="ixv-32083"
      unitRef="Unit_EUR">500000000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P04_01_2025To04_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="3"
      id="ixv-32084"
      unitRef="Unit_pure">0.482</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn04_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-8"
      id="ixv-32085"
      unitRef="Unit_EUR">3200000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <sny:NetCashInflowFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-8"
      id="ixv-32086"
      unitRef="Unit_EUR">10700000000</sny:NetCashInflowFromDiscontinuedOperations>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-32090"
      unitRef="Unit_USD">600000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="PAsOn05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-32091"
      unitRef="Unit_USD">562000000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <sny:PotentialFuturePayments
      contextRef="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"
      decimals="-8"
      id="ixv-32092"
      unitRef="Unit_USD">1300000000</sny:PotentialFuturePayments>
    <ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities
      contextRef="P05_27_2025To05_27_2025_AssetsAcquisitionMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-32093"
      unitRef="Unit_USD">602000000</ifrs-full:CashFlowsUsedInObtainingControlOfSubsidiariesOrOtherBusinessesClassifiedAsInvestingActivities>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-32094"
      unitRef="Unit_USD">40000000</ifrs-full:OtherComprehensiveIncome>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"
      decimals="INF"
      id="ixv-32095"
      unitRef="Unit_pure">0.12</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <sny:EquityInterestsOfAcquirerPerShare
      contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"
      decimals="INF"
      id="ixv-32096"
      unitRef="Unit_USD_per_Share">8</sny:EquityInterestsOfAcquirerPerShare>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="PAsOn05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-32097"
      unitRef="Unit_USD">470000000</ifrs-full:EquityInterestsOfAcquirer>
    <sny:DeferredCashPayments
      contextRef="P05_22_2025To05_22_2025_VigilNeuroscienceIncMemberSNYAssetsAcquisitionAxis"
      decimals="2"
      id="ixv-32098"
      unitRef="Unit_USD">2</sny:DeferredCashPayments>
    <sny:CashTransferredPerShare
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="INF"
      id="ixv-32099"
      unitRef="Unit_USD_per_Share">129</sny:CashTransferredPerShare>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="-8"
      id="ixv-32100"
      unitRef="Unit_USD">9100000000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="INF"
      id="ixv-32101"
      unitRef="Unit_pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="2"
      id="ixv-32102"
      unitRef="Unit_USD_per_Share">2</sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfFutureDevelopment>
    <sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="2"
      id="ixv-32103"
      unitRef="Unit_USD_per_Share">4</sny:MilestonePaymentPerCvrRecognisedInBusinessCombinationAttainmentOfRegulatoryMilestones>
    <ifrs-full:EquityInterestsOfAcquirer
      contextRef="PAsOn06_02_2025_BlueprintMedicinesCorporationMemberSNYAssetsAcquisitionAxis"
      decimals="-8"
      id="ixv-32104"
      unitRef="Unit_USD">9500000000</ifrs-full:EquityInterestsOfAcquirer>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-15524"> &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.2. Property, plant and equipment &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below sets forth acquisitions and capitalized interest by operating segment for the first half of 2025: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2009;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Acquisitions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;702&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;591&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;Biopharma&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;663&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;535&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Of which Manufacturing&#160;&amp;amp; Supply&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;453&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;366&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;Opella (discontinued operation, see Note B.1.)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;39&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;56&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Of which capitalized interest&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Firm orders for property, plant and equipment stood at &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;732&#160;million as of June&#160;30, 2025. &lt;/div&gt; </ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-15528"> &lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below sets forth acquisitions and capitalized interest by operating segment for the first half of 2025: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2009;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-size:2pt; margin-top:0pt; margin-bottom:0pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Acquisitions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;702&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;591&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;Biopharma&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;663&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;535&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Of which Manufacturing&#160;&amp;amp; Supply&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;453&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;366&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.43em; font-size:7pt; font-family:Arial"&gt;Opella (discontinued operation, see Note B.1.)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;39&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;56&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.86em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Of which capitalized interest&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentByOperatingSegmentsExplanatoryTableTextBlock>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32105"
      unitRef="Unit_EUR">702000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32106"
      unitRef="Unit_EUR">591000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32107"
      unitRef="Unit_EUR">663000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32108"
      unitRef="Unit_EUR">535000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis"
      decimals="-6"
      id="ixv-32109"
      unitRef="Unit_EUR">453000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_ManufacturingAndSupplyMemberifrsfullClassesOfPropertyPlantAndEquipmentAxis"
      decimals="-6"
      id="ixv-32110"
      unitRef="Unit_EUR">366000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32111"
      unitRef="Unit_EUR">39000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="P01_01_2024To06_30_2024_OpellaMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32112"
      unitRef="Unit_EUR">56000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:InterestCostsCapitalised
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32113"
      unitRef="Unit_EUR">22000000</ifrs-full:InterestCostsCapitalised>
    <ifrs-full:InterestCostsCapitalised
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32114"
      unitRef="Unit_EUR">22000000</ifrs-full:InterestCostsCapitalised>
    <sny:FirmOrdersOfPropertyPlantAndEquipment
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32115"
      unitRef="Unit_EUR">732000000</sny:FirmOrdersOfPropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-15697"> &lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.3. Goodwill and other intangible assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Goodwill amounted to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;40,283&#160;million as of &lt;div style="display:inline;"&gt;June&#160;&lt;/div&gt;30, 2025, versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;43,384&#160;million as of December&#160;31, 2024. The movement during the period was mainly due to the impact of changes in exchange rates. &lt;/div&gt;  &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements in other intangible assets during the first half of 2025 were as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:65%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2007;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Acquired&#160;R&amp;amp;D&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Products,&lt;br/&gt; trademarks&#160;and&lt;br/&gt; other rights&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&#160;other&lt;br/&gt; intangible&#160;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross value at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,866&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;66,348&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,852&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;81,066&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Changes in scope of consolidation&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt; (b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;500&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;500&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Acquisitions and other increases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;332&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;302&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;42&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;676&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Disposals and other decreases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(199&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(228&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,339&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,159&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(49&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6,547&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(244&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(292&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross value at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,297&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;61,048&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,830&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;75,175&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization and impairment at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(4,497&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(52,507&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,433&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(58,437&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Amortization expense&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(800&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(52&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(852&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Impairment losses, net of reversals &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(201&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(210&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Disposals and other decreases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;199&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;229&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;427&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,772&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;281&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;287&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization and impairment at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(4,249&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(49,064&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(54,744&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,369&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13,841&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;419&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,629&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,048&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,984&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;399&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The &#x201c;Transfers&#x201d; line mainly comprises (i)&#160;acquired R&amp;amp;D that came into commercial use during the period and (ii)&#160;reclassifications of assets to &lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style:italic;display:inline;"&gt;. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The &#x201c;Changes in scope of consolidation&#x201d; line mainly comprises the intangible asset recognized as part of the Dren-0201, Inc. acquisition (see Note B.1.) &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.4. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:16pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&#x201c;Products, trademarks and other products&#x201d; mainly comprise: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;marketed products, with a carrying amount of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;11.0&#160;billion as of June&#160;30, 2025 (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;12.7&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately 10 years; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;technological platforms brought into service, with a carrying amount of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1.0&#160;billion as of June&#160;30, 2025 (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1.1&#160;billion as of December&#160;31, 2024) and a weighted average amortization period of approximately 18 years. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ifrs-full:DisclosureOfIntangibleAssetsAndGoodwillExplanatory>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32116"
      unitRef="Unit_EUR">40283000000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32117"
      unitRef="Unit_EUR">43384000000</ifrs-full:Goodwill>
    <sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-15705"> &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements in other intangible assets during the first half of 2025 were as follows: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:65%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2007;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Acquired&#160;R&amp;amp;D&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Products,&lt;br/&gt; trademarks&#160;and&lt;br/&gt; other rights&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Software&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&#160;other&lt;br/&gt; intangible&#160;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross value at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,866&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;66,348&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,852&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;81,066&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Changes in scope of consolidation&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt; (b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;500&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;500&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Acquisitions and other increases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;332&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;302&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;42&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;676&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Disposals and other decreases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(199&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(228&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,339&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,159&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(49&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6,547&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(244&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(292&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Gross value at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,297&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;61,048&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,830&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;75,175&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization and impairment at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(4,497&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(52,507&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,433&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(58,437&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Amortization expense&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(800&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(52&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(852&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Impairment losses, net of reversals &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(201&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(210&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Disposals and other decreases&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;199&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;229&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;427&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,772&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;281&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;287&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Accumulated amortization and impairment at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(4,249&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(49,064&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(54,744&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:top"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,369&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13,841&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;419&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,629&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#7802e6"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.86em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Carrying amount at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,048&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,984&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;399&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The &#x201c;Transfers&#x201d; line mainly comprises (i)&#160;acquired R&amp;amp;D that came into commercial use during the period and (ii)&#160;reclassifications of assets to &lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style:italic;display:inline;"&gt;. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The &#x201c;Changes in scope of consolidation&#x201d; line mainly comprises the intangible asset recognized as part of the Dren-0201, Inc. acquisition (see Note B.1.) &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.4. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfReconciliationOfChangesInOtherIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32118"
      unitRef="Unit_EUR">12866000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32119"
      unitRef="Unit_EUR">66348000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32120"
      unitRef="Unit_EUR">1852000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32121"
      unitRef="Unit_EUR">81066000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32122"
      unitRef="Unit_EUR">500000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32123"
      unitRef="Unit_EUR">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32124"
      unitRef="Unit_EUR">0</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32125"
      unitRef="Unit_EUR">500000000</sny:ChangeInScopeOfConsolidationThroughBusinessCombinationIntangibleAssets>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32126"
      unitRef="Unit_EUR">332000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32127"
      unitRef="Unit_EUR">302000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32128"
      unitRef="Unit_EUR">42000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32129"
      unitRef="Unit_EUR">676000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32130"
      unitRef="Unit_EUR">22000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32131"
      unitRef="Unit_EUR">199000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32132"
      unitRef="Unit_EUR">7000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32133"
      unitRef="Unit_EUR">228000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32134"
      unitRef="Unit_EUR">-1339000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32135"
      unitRef="Unit_EUR">-5159000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32136"
      unitRef="Unit_EUR">-49000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32137"
      unitRef="Unit_EUR">-6547000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32138"
      unitRef="Unit_EUR">-40000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32139"
      unitRef="Unit_EUR">-244000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32140"
      unitRef="Unit_EUR">-8000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32141"
      unitRef="Unit_EUR">-292000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32142"
      unitRef="Unit_EUR">12297000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32143"
      unitRef="Unit_EUR">61048000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32144"
      unitRef="Unit_EUR">1830000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32145"
      unitRef="Unit_EUR">75175000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32146"
      unitRef="Unit_EUR">-4497000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32147"
      unitRef="Unit_EUR">-52507000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32148"
      unitRef="Unit_EUR">-1433000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32149"
      unitRef="Unit_EUR">-58437000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32150"
      unitRef="Unit_EUR">0</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32151"
      unitRef="Unit_EUR">800000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32152"
      unitRef="Unit_EUR">52000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32153"
      unitRef="Unit_EUR">852000000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32154"
      unitRef="Unit_EUR">201000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32155"
      unitRef="Unit_EUR">9000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32156"
      unitRef="Unit_EUR">0</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32157"
      unitRef="Unit_EUR">210000000</ifrs-full:ImpairmentLossRecognisedInOtherComprehensiveIncomeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32158"
      unitRef="Unit_EUR">-22000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32159"
      unitRef="Unit_EUR">-199000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32160"
      unitRef="Unit_EUR">-8000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32161"
      unitRef="Unit_EUR">-229000000</ifrs-full:DisposalsAndRetirementsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32162"
      unitRef="Unit_EUR">427000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32163"
      unitRef="Unit_EUR">3772000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32164"
      unitRef="Unit_EUR">40000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32165"
      unitRef="Unit_EUR">4239000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32166"
      unitRef="Unit_EUR">0</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32167"
      unitRef="Unit_EUR">281000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32168"
      unitRef="Unit_EUR">6000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32169"
      unitRef="Unit_EUR">287000000</ifrs-full:IncreaseDecreaseThroughTransfersIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32170"
      unitRef="Unit_EUR">-4249000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32171"
      unitRef="Unit_EUR">-49064000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32172"
      unitRef="Unit_EUR">-1431000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_AccumulatedDepreciationAmortisationAndImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32173"
      unitRef="Unit_EUR">-54744000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32174"
      unitRef="Unit_EUR">8369000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32175"
      unitRef="Unit_EUR">13841000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32176"
      unitRef="Unit_EUR">419000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32177"
      unitRef="Unit_EUR">22629000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:OtherIntangibleAssets
      contextRef="PAsOn06_30_2025_AcquiredResearchAndDevelopmentMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32178"
      unitRef="Unit_EUR">8048000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="PAsOn06_30_2025_ProductsTrademarksAndOtherRightsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32179"
      unitRef="Unit_EUR">11984000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="PAsOn06_30_2025_ComputerSoftwareMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32180"
      unitRef="Unit_EUR">399000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:OtherIntangibleAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32181"
      unitRef="Unit_EUR">20431000000</ifrs-full:OtherIntangibleAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-8"
      id="ixv-32182"
      unitRef="Unit_EUR">11000000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-8"
      id="ixv-32183"
      unitRef="Unit_EUR">12700000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_MarketedProductsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      id="ixv-32184">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-8"
      id="ixv-32185"
      unitRef="Unit_EUR">1000000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-8"
      id="ixv-32186"
      unitRef="Unit_EUR">1100000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_TechnologicalPlatformsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      id="ixv-32187">P18Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-16484"> &lt;div style="margin-top:22pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.4. Impairment of intangible assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;210&#160;million in the first half of 2025 linked to research and development projects. &lt;/div&gt; </sny:DisclosureOfImpairmentOfIntangibleAssetsAndPropertyPlantAndEquipmentExplanatoryTextBlock>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-32188"
      unitRef="Unit_EUR">210000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-16514">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.5. Investments accounted for using the equity method &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Investments accounted for using the equity method consist of associates and joint ventures (see Note B.1. to the consolidated financial statements for the year ended December&#160;31, 2024), and comprise: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:71%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2009;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;interest&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;OPAL JV Co &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;48.2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;EUROAPI &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29.6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;82&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;82&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;31.2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;93&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;102&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;MSP Vaccine Company &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;50.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;79&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;81&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Other investments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;70&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;51&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,563&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;316&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June&#160;30, 2025, the investment includes a &#x20ac;241&#160;million loan to OPAL JV Co being in substance part of the investment. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#x20ac;2.89 as of June&#160;30, 2025, and &#x20ac;2.88 as of December&#160;31, 2024). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint venture. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt; showed net income of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;85&#160;million for the first half of 2025 (versus a net loss of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;22&#160;million for the first half of 2024), including &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;11&#160;million for Sanofi&#x2019;s share of profits from OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The financial statements include commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Sales &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c) (d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;59&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Royalties and other income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt; &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;63&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Purchases of goods and services (including research expenses) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt; &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;371&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;333&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Accounts receivable and other receivables &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Other assets &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;189&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;189&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Accounts payable and other payables&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;637&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;160&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes loans to joint ventures and associates. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In October 2024, Sanofi raised its investment in EUROAPI by &#x20ac;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#x20ac;189&#160;million (and was also &#x20ac;189&#160;million as of December&#160;31, 2024). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative periods have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Key items from the OPAL JV Co 2025 unaudited half-year consolidated financial statements, as provided in accordance with Sanofi&#x2019;s consolidation timelines, are presented below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:91%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated income statement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Net sales and other revenues &lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;887&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Net income &lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;24&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated statement of comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:91%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated balance sheet&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; assets&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;16,179&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Current assets&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;2,937&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,116&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&#x2002;Equity attributable to equity holders of OPAL JV Co&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;5,754&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Equity attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;541&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total equity&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,295&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; liabilities&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;11,039&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Current liabilities&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;1,782&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,821&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total equity and liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,116&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfInvestmentsAccountedForUsingEquityMethodExplanatory>
    <sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-16518">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Investments accounted for using the equity method consist of associates and joint ventures (see Note B.1. to the consolidated financial statements for the year ended December&#160;31, 2024), and comprise: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:71%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2009;&#x2009;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;interest&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #795c8c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #795c8c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;OPAL JV Co &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;48.2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;EUROAPI &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29.6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;82&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;82&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst KG &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;31.2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;93&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;102&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;MSP Vaccine Company &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;50.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;79&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;81&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;Other investments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;70&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;51&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.43em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,563&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;316&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June&#160;30, 2025, the investment includes a &#x20ac;241&#160;million loan to OPAL JV Co being in substance part of the investment. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#x20ac;2.89 as of June&#160;30, 2025, and &#x20ac;2.88 as of December&#160;31, 2024). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint venture. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfInvestmentsInAssociatesAndJointVenturesTableTextBlock>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="3"
      id="Fact_148327452"
      unitRef="Unit_pure">0.482</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="Fact_148327453"
      unitRef="Unit_EUR">3239000000</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="Fact_148327454"
      unitRef="Unit_EUR">0</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2025To06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="3"
      id="Fact_148327455"
      unitRef="Unit_pure">0.296</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="Fact_148327456"
      unitRef="Unit_EUR">82000000</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024_EuroapiMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="Fact_148327457"
      unitRef="Unit_EUR">82000000</ifrs-full:InvestmentsInAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="P01_01_2025To06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"
      decimals="3"
      id="Fact_148327158"
      unitRef="Unit_pure">0.312</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="Fact_148327157"
      unitRef="Unit_EUR">93000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024_InfraservGmbhAndCoHochstKGMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="Fact_148327156"
      unitRef="Unit_EUR">102000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="P01_01_2025To06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"
      decimals="3"
      id="Fact_148327155"
      unitRef="Unit_pure">0.50</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="Fact_148327154"
      unitRef="Unit_EUR">79000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024_MSPVaccineCompanyMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="Fact_148327153"
      unitRef="Unit_EUR">81000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProportionOfOwnershipInterestInJointVenture
      contextRef="P01_01_2025To06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"
      decimals="-2"
      id="ixv-32201"
      unitRef="Unit_pure">0</ifrs-full:ProportionOfOwnershipInterestInJointVenture>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="ixv-32202"
      unitRef="Unit_EUR">70000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024_AggregatedIndividuallyImmaterialAssociatesMemberifrsfullJointVenturesAxis"
      decimals="-6"
      id="ixv-32203"
      unitRef="Unit_EUR">51000000</ifrs-full:InvestmentsInJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32204"
      unitRef="Unit_EUR">3563000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32205"
      unitRef="Unit_EUR">316000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2025To06_30_2025_OPALJVCoMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="3"
      id="ixv-32206"
      unitRef="Unit_pure">0.482</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2025To06_30_2025_CDRMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="2"
      id="ixv-32207"
      unitRef="Unit_pure">0.50</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <ifrs-full:ProportionOfOwnershipInterestInAssociate
      contextRef="P01_01_2025To06_30_2025_BpifranceMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="3"
      id="ixv-32208"
      unitRef="Unit_pure">0.018</ifrs-full:ProportionOfOwnershipInterestInAssociate>
    <sny:LoansToAssociates
      contextRef="P01_01_2025To06_30_2025_OpellaMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32209"
      unitRef="Unit_EUR">241000000</sny:LoansToAssociates>
    <sny:StockPrice
      contextRef="PAsOn06_30_2025_EuroapiMemberdeiLegalEntityAxis"
      decimals="INF"
      id="ixv-32210"
      unitRef="Unit_EUR_per_Share">2.89</sny:StockPrice>
    <sny:StockPrice
      contextRef="PAsOn12_31_2024_EuroapiMemberdeiLegalEntityAxis"
      decimals="INF"
      id="ixv-32211"
      unitRef="Unit_EUR_per_Share">2.88</sny:StockPrice>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="P01_01_2025To06_30_2025_MCMVaccineBVMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_MSPVaccineCompanyMemberdeiLegalEntityAxis"
      decimals="2"
      id="ixv-32212"
      unitRef="Unit_pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32213"
      unitRef="Unit_EUR">85000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32214"
      unitRef="Unit_EUR">-22000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod
      contextRef="P05_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32215"
      unitRef="Unit_EUR">11000000</ifrs-full:ShareOfProfitLossOfAssociatesAccountedForUsingEquityMethod>
    <ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-16778">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The financial statements include commercial transactions between Sanofi and some equity-accounted investments that are classified as related parties. The principal transactions and balances with related parties are summarized below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Sales &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c) (d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;59&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Royalties and other income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt; &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;63&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Purchases of goods and services (including research expenses) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(c)&lt;/div&gt; &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;371&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;333&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Accounts receivable and other receivables &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Other assets &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;189&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;189&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Accounts payable and other payables&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;637&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;160&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes loans to joint ventures and associates. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In October 2024, Sanofi raised its investment in EUROAPI by &#x20ac;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#x20ac;189&#160;million (and was also &#x20ac;189&#160;million as of December&#160;31, 2024). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative periods have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfTransactionsBetweenRelatedPartiesExplanatory>
    <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327131"
      unitRef="Unit_EUR">29000000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
    <ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions
      contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327130"
      unitRef="Unit_EUR">59000000</ifrs-full:RevenueFromSaleOfGoodsRelatedPartyTransactions>
    <sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327129"
      unitRef="Unit_EUR">63000000</sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions>
    <sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions
      contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327128"
      unitRef="Unit_EUR">33000000</sny:RoyaltiesAndOtherIncomeRelatedPartyTransactions>
    <ifrs-full:PurchasesOfGoodsRelatedPartyTransactions
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327127"
      unitRef="Unit_EUR">371000000</ifrs-full:PurchasesOfGoodsRelatedPartyTransactions>
    <ifrs-full:PurchasesOfGoodsRelatedPartyTransactions
      contextRef="P01_01_2024To06_30_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327126"
      unitRef="Unit_EUR">333000000</ifrs-full:PurchasesOfGoodsRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327125"
      unitRef="Unit_EUR">299000000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions
      contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327124"
      unitRef="Unit_EUR">184000000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <sny:OtherAssetsRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327123"
      unitRef="Unit_EUR">189000000</sny:OtherAssetsRelatedPartyTransactions>
    <sny:OtherAssetsRelatedPartyTransactions
      contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327122"
      unitRef="Unit_EUR">189000000</sny:OtherAssetsRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32226"
      unitRef="Unit_EUR">637000000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="PAsOn12_31_2024_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32227"
      unitRef="Unit_EUR">160000000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <sny:SubordinateHybridBondRelatedPartyTransactions
      contextRef="PAsOn10_31_2024"
      decimals="-6"
      id="ixv-32228"
      unitRef="Unit_EUR">200000000</sny:SubordinateHybridBondRelatedPartyTransactions>
    <sny:OtherAssetsRelatedPartyTransactions
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32229"
      unitRef="Unit_EUR">189000000</sny:OtherAssetsRelatedPartyTransactions>
    <sny:OtherAssetsRelatedPartyTransactions
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32230"
      unitRef="Unit_EUR">189000000</sny:OtherAssetsRelatedPartyTransactions>
    <sny:DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-17006">&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Key items from the OPAL JV Co 2025 unaudited half-year consolidated financial statements, as provided in accordance with Sanofi&#x2019;s consolidation timelines, are presented below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:91%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated income statement&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Net sales and other revenues &lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;887&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Net income &lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;24&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated statement of comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:7pt; font-family:Arial"&gt;&#x2002;Comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:91%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Consolidated balance sheet&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; assets&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;16,179&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Current assets&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;2,937&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,116&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&#x2002;Equity attributable to equity holders of OPAL JV Co&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;5,754&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Equity attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;541&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total equity&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,295&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:top"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; liabilities&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;11,039&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:top"&gt;&#x2002;Current liabilities&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;1,782&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,821&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:Arial; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total equity and liabilities&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,116&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfUnauditedFinancialStatementsOfSubsidiariesExplanatoryTableTextBlock>
    <sny:NetSalesAndOtherRevenuesRelatedPartyDisclosures
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327108"
      unitRef="Unit_EUR">887000000</sny:NetSalesAndOtherRevenuesRelatedPartyDisclosures>
    <sny:NetIncomeRelatedPartyDisclosures
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="Fact_148327107"
      unitRef="Unit_EUR">24000000</sny:NetIncomeRelatedPartyDisclosures>
    <sny:OtherComprehensiveIncomeRelatedPartyDisclosures
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32233"
      unitRef="Unit_EUR">-1000000</sny:OtherComprehensiveIncomeRelatedPartyDisclosures>
    <sny:ComprehensiveIncomeRelatedPartyDisclosures
      contextRef="P01_01_2025To06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32234"
      unitRef="Unit_EUR">23000000</sny:ComprehensiveIncomeRelatedPartyDisclosures>
    <sny:NonCurrentAssetsRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32238"
      unitRef="Unit_EUR">16179000000</sny:NonCurrentAssetsRelatedPartyTransactions>
    <sny:CurrentAssetsRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32239"
      unitRef="Unit_EUR">2937000000</sny:CurrentAssetsRelatedPartyTransactions>
    <sny:AssetsRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32240"
      unitRef="Unit_EUR">19116000000</sny:AssetsRelatedPartyTransactions>
    <sny:EquityAttributableToEquityHoldersRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32241"
      unitRef="Unit_EUR">5754000000</sny:EquityAttributableToEquityHoldersRelatedPartyTransactions>
    <sny:EquityAttributableToNonControllingInterestRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32242"
      unitRef="Unit_EUR">541000000</sny:EquityAttributableToNonControllingInterestRelatedPartyTransactions>
    <sny:EquityRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32243"
      unitRef="Unit_EUR">6295000000</sny:EquityRelatedPartyTransactions>
    <sny:NonCurrentLiabilitiesRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32244"
      unitRef="Unit_EUR">11039000000</sny:NonCurrentLiabilitiesRelatedPartyTransactions>
    <sny:CurrentLiabilitiesRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32245"
      unitRef="Unit_EUR">1782000000</sny:CurrentLiabilitiesRelatedPartyTransactions>
    <sny:LiabilitiesRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32246"
      unitRef="Unit_EUR">12821000000</sny:LiabilitiesRelatedPartyTransactions>
    <sny:EquityAndLiabilitiesRelatedPartyTransactions
      contextRef="PAsOn06_30_2025_AssociatesAndJointVenturesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32247"
      unitRef="Unit_EUR">19116000000</sny:EquityAndLiabilitiesRelatedPartyTransactions>
    <ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-17300">&lt;div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.6. Other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; assets &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; assets comprise: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Equity instruments at fair value through other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,105&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,559&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Debt instruments at fair value through other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;362&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;357&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Other financial assets at fair value through profit or loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;965&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,027&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Pre-funded&lt;/div&gt; pension obligations&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;146&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;156&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Long-term prepaid expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;143&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;152&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Long-term loans and advances and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;382&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;502&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Derivative financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,109&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,753&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherNoncurrentAssetsExplanatory>
    <sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-17305">&lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; assets comprise: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Equity instruments at fair value through other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,105&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,559&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Debt instruments at fair value through other comprehensive income&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;362&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;357&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Other financial assets at fair value through profit or loss&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;965&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,027&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Pre-funded&lt;/div&gt; pension obligations&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;146&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;156&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Long-term prepaid expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;143&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;152&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Long-term loans and advances and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; receivables&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;382&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;502&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Derivative financial instruments&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,109&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,753&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfComponentsOfOtherNonCurrentAssetsTableTextBlock>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="PAsOn06_30_2025_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis"
      decimals="-6"
      id="ixv-32248"
      unitRef="Unit_EUR">2105000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="PAsOn12_31_2024_TradingEquitySecuritiesMemberifrsfullClassesOfAssetsAxis"
      decimals="-6"
      id="ixv-32249"
      unitRef="Unit_EUR">1559000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="PAsOn06_30_2025_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis"
      decimals="-6"
      id="ixv-32250"
      unitRef="Unit_EUR">362000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome
      contextRef="PAsOn12_31_2024_DebtSecuritiesMemberifrsfullClassesOfAssetsAxis"
      decimals="-6"
      id="ixv-32251"
      unitRef="Unit_EUR">357000000</ifrs-full:NoncurrentFinancialAssetsAtFairValueThroughOtherComprehensiveIncome>
    <sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32252"
      unitRef="Unit_EUR">965000000</sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss>
    <sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32253"
      unitRef="Unit_EUR">1027000000</sny:OtherFinancialAssetsAtFairValueThroughProfitOrLoss>
    <sny:PreFundedPensionObligations
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32254"
      unitRef="Unit_EUR">146000000</sny:PreFundedPensionObligations>
    <sny:PreFundedPensionObligations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32255"
      unitRef="Unit_EUR">156000000</sny:PreFundedPensionObligations>
    <sny:LongTermPrepaidExpenses
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32256"
      unitRef="Unit_EUR">143000000</sny:LongTermPrepaidExpenses>
    <sny:LongTermPrepaidExpenses
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32257"
      unitRef="Unit_EUR">152000000</sny:LongTermPrepaidExpenses>
    <sny:NonCurrentLoansAndReceivables
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32258"
      unitRef="Unit_EUR">382000000</sny:NonCurrentLoansAndReceivables>
    <sny:NonCurrentLoansAndReceivables
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32259"
      unitRef="Unit_EUR">502000000</sny:NonCurrentLoansAndReceivables>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32260"
      unitRef="Unit_EUR">6000000</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:NoncurrentDerivativeFinancialAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32261"
      unitRef="Unit_EUR">0</ifrs-full:NoncurrentDerivativeFinancialAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32262"
      unitRef="Unit_EUR">4109000000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32263"
      unitRef="Unit_EUR">3753000000</ifrs-full:OtherNoncurrentAssets>
    <sny:DisclosureOfTradeReceivablesTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-17515">&lt;div style="margin-top:16pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.7. Accounts receivable &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Accounts receivable break down as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Gross value&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,896&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,777&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Allowances&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(100&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Carrying amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,810&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,677&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The impact of allowances against accounts receivable in the first half of 2025 was a net expense of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;4&#160;million (versus a net expense of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;3&#160;million for the first half of 2024). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the ageing profile of overdue accounts receivable, based on gross value: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:49%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;accounts&lt;br/&gt;gross value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;lt;1&#160;month&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;1-3&lt;/div&gt; months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;3-6&lt;/div&gt; months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;6-12&#160;months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;gt;&#160;12&#160;months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;As of June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;386&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;122&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;103&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;73&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;48&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;40&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;As of December&#160;31, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;316&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;194&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;87&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Amounts overdue by more than one month relate mainly to public-sector customers. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Some Sanofi subsidiaries have assigned receivables to factoring companies or banks without recourse. The amount of receivables that met the conditions described in Note B.8.6. to the consolidated financial statements for the year ended December&#160;31, 2024 and hence were derecognized was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;12&#160;million as of June&#160;30, 2025 (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;14&#160;million as of December&#160;31, 2024). The residual guarantees relating to those transfers were immaterial as of June&#160;30, 2025. &lt;/div&gt;</sny:DisclosureOfTradeReceivablesTextBlock>
    <sny:DisclosureOfCurrentTradeReceivablesTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-17519">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Accounts receivable break down as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Gross value&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,896&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,777&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Allowances&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(100&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Carrying amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,810&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,677&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfCurrentTradeReceivablesTableTextBlock>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn06_30_2025_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32264"
      unitRef="Unit_EUR">7896000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn12_31_2024_GrossCarryingAmountMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32265"
      unitRef="Unit_EUR">7777000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn06_30_2025_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32266"
      unitRef="Unit_EUR">-86000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn12_31_2024_AccumulatedImpairmentMemberifrsfullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis"
      decimals="-6"
      id="ixv-32267"
      unitRef="Unit_EUR">-100000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32268"
      unitRef="Unit_EUR">7810000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32269"
      unitRef="Unit_EUR">7677000000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32270"
      unitRef="Unit_EUR">-4000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32271"
      unitRef="Unit_EUR">-3000000</ifrs-full:ImpairmentLossReversalOfImpairmentLossRecognisedInProfitOrLossTradeReceivables>
    <sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-17624">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the ageing profile of overdue accounts receivable, based on gross value: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:7pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:49%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;accounts&lt;br/&gt;gross value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;lt;1&#160;month&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;1-3&lt;/div&gt; months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;3-6&lt;/div&gt; months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;6-12&#160;months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#ffffff;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Overdue&#160;by&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&amp;gt;&#160;12&#160;months&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;As of June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;386&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;122&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;103&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;73&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;48&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;40&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:7pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;As of December&#160;31, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;316&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;194&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;87&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfOverdueReceivablesGrossValueTableTextBlock>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32272"
      unitRef="Unit_EUR">386000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025_NotLaterThanOneMonthMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32273"
      unitRef="Unit_EUR">122000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32274"
      unitRef="Unit_EUR">103000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32275"
      unitRef="Unit_EUR">73000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32276"
      unitRef="Unit_EUR">48000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn06_30_2025_LaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32277"
      unitRef="Unit_EUR">40000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32278"
      unitRef="Unit_EUR">650000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024_NotLaterThanOneMonthMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32279"
      unitRef="Unit_EUR">316000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024_LaterThanOneMonthAndNotLaterThanThreeMonthsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32280"
      unitRef="Unit_EUR">194000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024_LaterThanThreeMonthsAndNotLaterThanSixMonthsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32281"
      unitRef="Unit_EUR">87000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024_LaterThanSixMonthsAndNotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32282"
      unitRef="Unit_EUR">9000000</sny:OverdueReceivablesGrossValue>
    <sny:OverdueReceivablesGrossValue
      contextRef="PAsOn12_31_2024_LaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32283"
      unitRef="Unit_EUR">44000000</sny:OverdueReceivablesGrossValue>
    <sny:DerecognizedReceivables
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32284"
      unitRef="Unit_EUR">12000000</sny:DerecognizedReceivables>
    <sny:DerecognizedReceivables
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32285"
      unitRef="Unit_EUR">14000000</sny:DerecognizedReceivables>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-17870">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.8. Consolidated shareholders&#x2019; equity &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.1. Share capital &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, the share capital was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2,455,512,548 and consisted of 1,227,756,274 shares (the total number of shares outstanding) with a par value of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Treasury shares held by Sanofi are as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:73%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;shares&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(million)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;of&#160;share&#160;capital&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;for the period&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10.66&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;0.868&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9.53&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.755&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;June&#160;30, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;15.33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.211&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;January&#160;1, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;13.45&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.063&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;A total of 171,150 shares were issued in the first half of 2025 as a result of the exercise of Sanofi stock subscription options. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In addition, 2,682,051 shares vested under Sanofi restricted share plans during the first half of 2025, of which 1,156,205&#160;were fulfilled by issuance of new shares and 1,525,846 by allotment of existing shares free of charge. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.2. Repurchase of Sanofi shares &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;30, 2024, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of 18&#160;months. Under that program, Sanofi repurchased 39,344,633 of its own shares during the first half of 2025 for a total amount of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;3,988&#160;million. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;During the meeting of the Board of Directors on January&#160;29, 2025, the Board authorized Sanofi to repurchase the Company&#x2019;s shares, for an amount not exceeding &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;5&#160;billion, under the terms and conditions set by the General Meeting of April&#160;30, 2024 in its 19th resolution. As part of this authorization, Sanofi entered into a share buyback agreement with its historical shareholder L&#x2019;Or&#xe9;al on February&#160;2, 2025 for the acquisition of &lt;div style="display:inline;"&gt;2.34&lt;/div&gt;% of Sanofi&#x2019;s share capital, equivalent to 29,556,650 shares, for a total amount of approximately &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;3&#160;billion, representing a price of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;101.50 per share. The conclusion of that agreement was approved by the Board of Directors on the same day prior to the signing of the agreement, and in accordance with the procedure set forth in Articles L. &lt;div style="white-space:nowrap;display:inline;"&gt;225-38&lt;/div&gt; et seq. of the French Commercial Code. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;30, 2025, the Annual General Meeting of Sanofi shareholders authorized a share repurchase program for a period of 18 months. Sanofi did not use that authorization during the first half of 2025. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.3. Reduction in share capital &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;During the first half of 2025, treasury shares amounting to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;3,868&#160;million were cancelled further to decisions taken by the Sanofi Board of Directors on March&#160;13, 2025 and April&#160;23, 2025. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Those reductions have no impact on shareholders&#x2019; equity, except for the impact of the tax on share cancellations. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.4. Restricted share plans &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. to the consolidated financial statements for the year ended December&#160;31, 2024. The principal features of the plans awarded in 2025 are set forth below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Type of plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Performance&#160;share&#160;plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Date of Board meeting approving the plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;30&#160;April, 2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Total number of shares subject to a &lt;div style="white-space:nowrap;display:inline;"&gt;3-year&lt;/div&gt; service period&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,021,370&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Of which with no market condition&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,599,478&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;83.94&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Of which with market conditions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,421,892&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded other than to the Chief Executive Officer (1,331,892 shares in total) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;79.25&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded to the Chief Executive Officer (90,000 shares) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;75.10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value of plan at the date of grant (&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;331&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Total expense for restricted share plans (&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;146&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;128&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Number of shares not yet fully vested&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11,550,347&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11,192,984&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2025 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,020,451&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2024 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,110,089&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,498,109&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2023 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,313,588&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,652,352&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2022 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;106,219&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,031,060&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2021 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;11,463&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.5. Capital increases &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On January&#160;29, 2025, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;72.97 per share. The subscription period was open from June&#160;10 through June&#160;30, 2025. Sanofi employees subscribed for a total of 2,260,776 shares, and this capital increase was supplemented by the immediate issuance of a further 116,794 shares for the employer&#x2019;s contribution. The total expense recognized for this capital increase in the first half of 2025 was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;31&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On January&#160;31, 2024, the Sanofi Board of Directors approved a capital increase reserved for employees, offering the opportunity for them to subscribe for new Sanofi shares at a price of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;72.87 per share. The subscription period was open from June&#160;4 through June&#160;24, 2024. Sanofi employees subscribed for a total of 2,124,445 shares, and this capital increase was supplemented by the immediate issuance of a further 119,951 shares for the employer&#x2019;s contribution. The total expense recognized for this capital increase in the first half of 2024 was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;45&#160;million, determined in accordance with IFRS 2 (Share-Based Payment) on the basis of the discount granted to the employees. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.6. Stock subscription option plans &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;No stock subscription option plans were awarded in the first half of 2025 or in 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;No further stock option plan expenses were recognized through equity in either the first half of 2025 or 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below provides summary information about options outstanding and exercisable as of June&#160;30, 2025: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Range of exercise prices per share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;residual life&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(years)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;br/&gt;per&#160;share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;br/&gt;per&#160;share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;60.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;70.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;168,784&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;65.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;168,784&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;65.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;70.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;80.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299,250&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.98&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299,250&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;80.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;90.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;257,010&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;88.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;257,010&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;88.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;725,044&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;725,044&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.7. Number of shares used to compute diluted earnings per share &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Average number of shares outstanding&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,225.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,249.4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Adjustment for stock options with dilutive effect&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Adjustment for restricted shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average number of shares used to compute diluted earnings per share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,230.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,253.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, December&#160;31, 2024 and June&#160;30, 2024, all stock options were taken into account in computing diluted earnings per share because they all had a dilutive effect. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.8. Other comprehensive income &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements within other comprehensive income are shown below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2007;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2002;&#x2002;&#x2002;&#x2002;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses):&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Actuarial gains/(losses) excluding investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;105&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;235&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(25&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(57&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Equity instruments included in financial assets and financial liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;222&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Equity risk hedging instruments designated as fair value hedges&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Items not subsequently reclassifiable to profit or loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;243&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;166&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Debt instruments included in financial assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash flow hedges and fair value hedges:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Change in currency translation differences:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin: 0pt 0.63em 0pt 1.13em; text-indent: -0.63em; font-size: 8pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&#x2022;&#x2009;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(5,266&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Currency translation differences (investments accounted for using the equity method)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(26&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Hedges of net investments in foreign operations&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;390&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(126&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(101&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Items subsequently reclassifiable to profit or loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(5,017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,067&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: immaterial over all periods. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: &#x20ac;2&#160;million in the first half of 2025, immaterial in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; background: none; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: a &#x20ac;459&#160;million loss in the first half of 2025 relating to the deconsolidation of Opella (see Note B.1.)., a &#x20ac;5&#160;million profit in 2024, and immaterial in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-17874">&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.8.1. Share capital &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, the share capital was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2,455,512,548 and consisted of 1,227,756,274 shares (the total number of shares outstanding) with a par value of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Treasury shares held by Sanofi are as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:73%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:10%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;shares&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(million)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;of&#160;share&#160;capital&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;for the period&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10.66&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;0.868&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9.53&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.755&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;June&#160;30, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;15.33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.211&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;January&#160;1, 2024&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;13.45&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.063&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;A total of 171,150 shares were issued in the first half of 2025 as a result of the exercise of Sanofi stock subscription options. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In addition, 2,682,051 shares vested under Sanofi restricted share plans during the first half of 2025, of which 1,156,205&#160;were fulfilled by issuance of new shares and 1,525,846 by allotment of existing shares free of charge. &lt;/div&gt;</ifrs-full:DisclosureOfClassesOfShareCapitalExplanatory>
    <ifrs-full:IssuedCapital
      contextRef="PAsOn06_30_2025"
      decimals="0"
      id="ixv-32286"
      unitRef="Unit_EUR">2455512548</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="PAsOn06_30_2025"
      decimals="INF"
      id="ixv-32287"
      unitRef="Unit_shares">1227756274</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ParValuePerShare
      contextRef="PAsOn06_30_2025"
      decimals="INF"
      id="ixv-32288"
      unitRef="Unit_EUR_per_Share">2</ifrs-full:ParValuePerShare>
    <sny:NumberOfSharesHeld
      contextRef="PAsOn06_30_2025"
      decimals="-4"
      id="ixv-32289"
      unitRef="Unit_shares">10660000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="PAsOn06_30_2025"
      decimals="5"
      id="ixv-32290"
      unitRef="Unit_pure">0.00868</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="PAsOn12_31_2024"
      decimals="-4"
      id="ixv-32291"
      unitRef="Unit_shares">9530000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="PAsOn12_31_2024"
      decimals="5"
      id="ixv-32292"
      unitRef="Unit_pure">0.00755</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="PAsOn06_30_2024"
      decimals="-4"
      id="ixv-32293"
      unitRef="Unit_shares">15330000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="PAsOn06_30_2024"
      decimals="5"
      id="ixv-32294"
      unitRef="Unit_pure">0.01211</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesHeld
      contextRef="PAsOn12_31_2023"
      decimals="-4"
      id="ixv-32295"
      unitRef="Unit_shares">13450000</sny:NumberOfSharesHeld>
    <sny:PercentageOfShareCapitalForThePeriod
      contextRef="PAsOn12_31_2023"
      decimals="5"
      id="ixv-32296"
      unitRef="Unit_pure">0.01063</sny:PercentageOfShareCapitalForThePeriod>
    <sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions
      contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis"
      decimals="INF"
      id="ixv-32297"
      unitRef="Unit_shares">171150</sny:NumberOfSharesIssuedInRegardsOfCapitalIncreaseByExerciseOfStockSubscriptionOptions>
    <sny:NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-32298"
      unitRef="Unit_shares">2682051</sny:NumberOfRestrictedSharesVestedInRegardsOfCapitalIncrease>
    <sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease
      contextRef="P01_01_2025To06_30_2025_IssuedCapitalMemberifrsfullComponentsOfEquityAxis_SanofiMemberdeiLegalEntityAxis"
      decimals="INF"
      id="ixv-32299"
      unitRef="Unit_shares">1156205</sny:NumberOfRestrictedSharesIssuedInRegardsOfCapitalIncrease>
    <sny:NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease
      contextRef="PAsOn06_30_2025"
      decimals="INF"
      id="ixv-32300"
      unitRef="Unit_shares">1525846</sny:NumberOfRestrictedSharesAllotedInRegardsOfCapitalIncrease>
    <sny:PeriodOfShareRepurchaseProgram
      contextRef="P04_30_2024To04_30_2024_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"
      id="ixv-32301">P18M</sny:PeriodOfShareRepurchaseProgram>
    <sny:NumberOfSharesRepurchased
      contextRef="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"
      decimals="INF"
      id="ixv-32302"
      unitRef="Unit_shares">39344633</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="P01_01_2025To06_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"
      decimals="-6"
      id="ixv-32303"
      unitRef="Unit_EUR">3988000000</sny:AmountOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="P01_29_2025To01_29_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"
      decimals="-9"
      id="ixv-32304"
      unitRef="Unit_EUR">5000000000</sny:AmountOfSharesRepurchased>
    <sny:NumberOfSharesRepurchased
      contextRef="P01_01_2025To06_30_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"
      decimals="INF"
      id="ixv-32305"
      unitRef="Unit_shares">29556650</sny:NumberOfSharesRepurchased>
    <sny:AmountOfSharesRepurchased
      contextRef="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"
      decimals="-9"
      id="ixv-32306"
      unitRef="Unit_EUR">3000000000</sny:AmountOfSharesRepurchased>
    <sny:PerShareValueOfSharesRepurchased
      contextRef="P02_02_2025To02_02_2025_ShareRepurchase2025ProgramMemberSNYShareProgramAxis"
      decimals="INF"
      id="ixv-32307"
      unitRef="Unit_EUR_per_Share">101.5</sny:PerShareValueOfSharesRepurchased>
    <sny:PeriodOfShareRepurchaseProgram
      contextRef="P04_30_2025To04_30_2025_ShareRepurchase2024ProgramMemberSNYShareProgramAxis"
      id="ixv-32308">P18M</sny:PeriodOfShareRepurchaseProgram>
    <ifrs-full:CancellationOfTreasuryShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32309"
      unitRef="Unit_EUR">3868000000</ifrs-full:CancellationOfTreasuryShares>
    <sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-18025">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Restricted share plans are accounted for in accordance with the policies described in Note B.24.3. to the consolidated financial statements for the year ended December&#160;31, 2024. The principal features of the plans awarded in 2025 are set forth below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:83%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Type of plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Performance&#160;share&#160;plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Date of Board meeting approving the plan&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;30&#160;April, 2025&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Total number of shares subject to a &lt;div style="white-space:nowrap;display:inline;"&gt;3-year&lt;/div&gt; service period&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,021,370&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Of which with no market condition&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,599,478&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;83.94&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Of which with market conditions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,421,892&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded other than to the Chief Executive Officer (1,331,892 shares in total) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;79.25&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Fair value per share awarded to the Chief Executive Officer (90,000 shares) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;75.10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair value of plan at the date of grant (&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;331&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfEmployeeStockOwnershipPlanAwardedInCapitalIncreaseReservedExplanatoryTableTextBlock>
    <sny:NumberOfYearsServicePeriod
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      id="ixv-32310">P3Y</sny:NumberOfYearsServicePeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32311"
      unitRef="Unit_shares">4021370</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis"
      decimals="INF"
      id="ixv-32312"
      unitRef="Unit_shares">2599478</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithoutMarketConditionMemberSNYMarketConditionAxis"
      decimals="2"
      id="Fact_148327162"
      unitRef="Unit_EUR_per_Share">83.94</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"
      decimals="INF"
      id="ixv-32314"
      unitRef="Unit_shares">1421892</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"
      decimals="INF"
      id="ixv-32315"
      unitRef="Unit_shares">1331892</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="P01_01_2025To06_30_2025_ExcludingChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"
      decimals="2"
      id="Fact_148327161"
      unitRef="Unit_EUR_per_Share">79.25</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted
      contextRef="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"
      decimals="INF"
      id="ixv-32317"
      unitRef="Unit_shares">90000</ifrs-full:NumberOfInstrumentsOtherEquityInstrumentsGranted>
    <sny:FairValuePerShareAwardedForThreeYearServicePeriod
      contextRef="P01_01_2025To06_30_2025_ChiefExecutiveOfficerMembersrtTitleOfIndividualAxis_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis_WithMarketConditionMemberSNYMarketConditionAxis"
      decimals="2"
      id="Fact_148327160"
      unitRef="Unit_EUR_per_Share">75.1</sny:FairValuePerShareAwardedForThreeYearServicePeriod>
    <sny:FairValueOfPlanAtDateOfGrant
      contextRef="P01_01_2025To06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-6"
      id="ixv-32319"
      unitRef="Unit_EUR">331000000</sny:FairValueOfPlanAtDateOfGrant>
    <sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-18222">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The total expense recognized for all restricted share plans, and the number of restricted shares not yet fully vested, are shown in the table below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Total expense for restricted share plans (&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;146&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;128&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Number of shares not yet fully vested&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11,550,347&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11,192,984&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2025 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,020,451&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2024 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,110,089&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;4,498,109&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2023 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,313,588&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,652,352&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2022 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;106,219&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,031,060&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.50em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;Under 2021 plans&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;11,463&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfNumberOfRestrictedSharePlansNotYetFullyVestedTableTextBlock>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="P01_01_2025To06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-6"
      id="ixv-32321"
      unitRef="Unit_EUR">146000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="P01_01_2024To06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-6"
      id="ixv-32322"
      unitRef="Unit_EUR">128000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32323"
      unitRef="Unit_shares">11550347</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharesMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32324"
      unitRef="Unit_shares">11192984</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32325"
      unitRef="Unit_shares">4020451</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharePlan2025MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32326"
      unitRef="Unit_shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32327"
      unitRef="Unit_shares">4110089</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharePlan2024MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32328"
      unitRef="Unit_shares">4498109</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32329"
      unitRef="Unit_shares">3313588</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharePlan2023MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32330"
      unitRef="Unit_shares">3652352</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32331"
      unitRef="Unit_shares">106219</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharePlan2022MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32332"
      unitRef="Unit_shares">3031060</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2025_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32333"
      unitRef="Unit_shares">0</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:NumberOfRestrictedSharesNotYetFullyVested
      contextRef="PAsOn06_30_2024_RestrictedSharePlan2021MemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32334"
      unitRef="Unit_shares">11463</sny:NumberOfRestrictedSharesNotYetFullyVested>
    <sny:SubscriptionPricePerShare
      contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      id="ixv-32335"
      unitRef="Unit_EUR_per_Share">72.97</sny:SubscriptionPricePerShare>
    <sny:NumberOfSharesSubscribed
      contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32336"
      unitRef="Unit_shares">2260776</sny:NumberOfSharesSubscribed>
    <sny:IssuanceOfFurtherSharesAsAnEmployersContribution
      contextRef="PAsOn01_29_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32337"
      unitRef="Unit_shares">116794</sny:IssuanceOfFurtherSharesAsAnEmployersContribution>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="P01_01_2025To06_30_2025_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-6"
      id="ixv-32338"
      unitRef="Unit_EUR">31000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <sny:SubscriptionPricePerShare
      contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="2"
      id="ixv-32339"
      unitRef="Unit_EUR_per_Share">72.87</sny:SubscriptionPricePerShare>
    <sny:NumberOfSharesSubscribed
      contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32340"
      unitRef="Unit_shares">2124445</sny:NumberOfSharesSubscribed>
    <sny:IssuanceOfFurtherSharesAsAnEmployersContribution
      contextRef="PAsOn01_31_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="INF"
      id="ixv-32341"
      unitRef="Unit_shares">119951</sny:IssuanceOfFurtherSharesAsAnEmployersContribution>
    <ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
      contextRef="P01_01_2024To06_30_2024_EmployeeShareOwnershipPlanMemberifrsfullTypesOfSharebasedPaymentArrangementsAxis"
      decimals="-6"
      id="ixv-32342"
      unitRef="Unit_EUR">45000000</ifrs-full:ExpenseFromEquitysettledSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets>
    <sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-18445">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below provides summary information about options outstanding and exercisable as of June&#160;30, 2025: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Range of exercise prices per share&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Outstanding&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Exercisable&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;residual life&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(years)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;br/&gt;per&#160;share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Number&#160;of&#160;options&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Weighted&#160;average&lt;br/&gt;exercise price&lt;br/&gt;per&#160;share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;)&lt;/div&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;60.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;70.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;168,784&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;65.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;168,784&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;65.84&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;70.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;80.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299,250&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.98&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;299,250&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76.48&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;From &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;80.00 to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;90.00 per share&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;257,010&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1.86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;88.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;257,010&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;88.97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;725,044&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;725,044&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTableTextBlock>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32343"
      unitRef="Unit_EUR_per_Share">60</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"
      decimals="2"
      id="ixv-32344"
      unitRef="Unit_EUR_per_Share">70</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32345"
      unitRef="Unit_shares">168784</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      id="ixv-32346">P2Y10M2D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32347"
      unitRef="Unit_EUR_per_Share">65.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32348"
      unitRef="Unit_shares">168784</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeTwoMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32349"
      unitRef="Unit_EUR_per_Share">65.84</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32350"
      unitRef="Unit_EUR_per_Share">70</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"
      decimals="2"
      id="ixv-32351"
      unitRef="Unit_EUR_per_Share">80</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32352"
      unitRef="Unit_shares">299250</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      id="ixv-32353">P2Y11M23D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32354"
      unitRef="Unit_EUR_per_Share">76.48</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32355"
      unitRef="Unit_shares">299250</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeThreeMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32356"
      unitRef="Unit_EUR_per_Share">76.48</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_BottomOfRangeMemberifrsfullRangeAxis_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32357"
      unitRef="Unit_EUR_per_Share">80</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:ExercisePriceOfOutstandingShareOptions2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis_TopOfRangeMemberifrsfullRangeAxis"
      decimals="2"
      id="ixv-32358"
      unitRef="Unit_EUR_per_Share">90</ifrs-full:ExercisePriceOfOutstandingShareOptions2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32359"
      unitRef="Unit_shares">257010</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019
      contextRef="P01_01_2025To06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      id="ixv-32360">P1Y10M9D</ifrs-full:WeightedAverageRemainingContractualLifeOfOutstandingShareOptions2019>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32361"
      unitRef="Unit_EUR_per_Share">88.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32362"
      unitRef="Unit_shares">257010</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019
      contextRef="PAsOn06_30_2025_ExercisePriceRangeFourMemberifrsfullRangesOfExercisePricesForOutstandingShareOptionsAxis_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="2"
      id="ixv-32363"
      unitRef="Unit_EUR_per_Share">88.97</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisableInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions
      contextRef="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32364"
      unitRef="Unit_shares">725044</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement
      contextRef="PAsOn06_30_2025_StockOptionPlanMemberifrsfullComponentsOfEquityAxis"
      decimals="INF"
      id="ixv-32365"
      unitRef="Unit_shares">725044</ifrs-full:NumberOfShareOptionsExercisableInSharebasedPaymentArrangement>
    <sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-18762">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Diluted earnings per share is computed using the number of shares outstanding plus stock options with dilutive effect and restricted shares. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Average number of shares outstanding&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,225.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,249.4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Adjustment for stock options with dilutive effect&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Adjustment for restricted shares&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5.1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Average number of shares used to compute diluted earnings per share&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,230.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,253.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfSharesUsedToComputeDilutedEarningsPerShareTableTextBlock>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="ixv-32366"
      unitRef="Unit_shares">1225500000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="ixv-32367"
      unitRef="Unit_shares">1249400000</ifrs-full:WeightedAverageShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="ixv-32368"
      unitRef="Unit_shares">100000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="ixv-32369"
      unitRef="Unit_shares">100000</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="ixv-32370"
      unitRef="Unit_shares">5100000</sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares>
    <sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="ixv-32371"
      unitRef="Unit_shares">4300000</sny:DilutiveEffectOfShareOptionsOnNumberOfRestrictedShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="-5"
      id="ixv-32372"
      unitRef="Unit_shares">1230700000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="-5"
      id="ixv-32373"
      unitRef="Unit_shares">1253800000</ifrs-full:AdjustedWeightedAverageShares>
    <sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-18923">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements within other comprehensive income are shown below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2007;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2002;&#x2002;&#x2002;&#x2002;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses):&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Actuarial gains/(losses) excluding investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;105&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;235&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Actuarial gains/(losses) of investments accounted for using the equity method, net of taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(25&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(57&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Equity instruments included in financial assets and financial liabilities:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;222&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Equity risk hedging instruments designated as fair value hedges&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Items not subsequently reclassifiable to profit or loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;243&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;166&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Debt instruments included in financial assets:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash flow hedges and fair value hedges:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (excluding investments accounted for using the equity method)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Change in fair value (investments accounted for using the equity method, net of taxes)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Change in currency translation differences:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin: 0pt 0.63em 0pt 1.13em; text-indent: -0.63em; font-size: 8pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&#x2022;&#x2009;Currency translation differences on foreign subsidiaries (excluding investments accounted for using the equity method) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(5,266&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Currency translation differences (investments accounted for using the equity method)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(26&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Hedges of net investments in foreign operations&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;390&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(126&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Tax effects&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(101&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.63em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Items subsequently reclassifiable to profit or loss&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(5,017&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,067&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: immaterial over all periods. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: &#x20ac;2&#160;million in the first half of 2025, immaterial in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; background: none; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes reclassifications to profit or loss: a &#x20ac;459&#160;million loss in the first half of 2025 relating to the deconsolidation of Opella (see Note B.1.)., a &#x20ac;5&#160;million profit in 2024, and immaterial in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfAccumulatedOtherComprehensiveIncomeExplanatoryTableTextBlock>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32375"
      unitRef="Unit_EUR">105000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32376"
      unitRef="Unit_EUR">235000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32377"
      unitRef="Unit_EUR">1000000</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32378"
      unitRef="Unit_EUR">0</sny:ActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetNetOfTaxOnAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32379"
      unitRef="Unit_EUR">25000000</sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments>
    <sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32380"
      unitRef="Unit_EUR">57000000</sny:IncomeTaxRelatingToActuarialGainsLossesArisingFromChangesInFinancialAssumptionsNetDefinedBenefitLiabilityAssetExcludingEquityInvestments>
    <sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32381"
      unitRef="Unit_EUR">222000000</sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32382"
      unitRef="Unit_EUR">-10000000</sny:ChangeInFairValueOnEquityInstrumentsExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32383"
      unitRef="Unit_EUR">0</sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax>
    <sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32384"
      unitRef="Unit_EUR">0</sny:ChangeInFairValueOnEquityInstrumentsForInvestmentsAccountedForUsingTheEquityMethodNetOfTax>
    <sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32385"
      unitRef="Unit_EUR">0</sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges>
    <sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32386"
      unitRef="Unit_EUR">0</sny:EquityRiskHedgingInstrumentsDesignatedAtFairValueHedges>
    <sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32387"
      unitRef="Unit_EUR">60000000</sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod>
    <sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_EquityInstrumentsIncludedInFinancialAssetsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32388"
      unitRef="Unit_EUR">2000000</sny:IncomeTaxRelatingToChangeInFairValueOfEquityInstrumentsExcludingEquityMethod>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32389"
      unitRef="Unit_EUR">243000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsNotSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32390"
      unitRef="Unit_EUR">166000000</ifrs-full:OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax>
    <sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327021"
      unitRef="Unit_EUR">3000000</sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327020"
      unitRef="Unit_EUR">-5000000</sny:ChangeInFairValueOnDebtInstrumentExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32393"
      unitRef="Unit_EUR">0</sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32394"
      unitRef="Unit_EUR">0</sny:ChangeInFairValueOnDebtInstrumentAssociatesAndJointVentures>
    <sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32395"
      unitRef="Unit_EUR">0</sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments>
    <sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_DebtInstrumentsMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32396"
      unitRef="Unit_EUR">-1000000</sny:IncomeTaxRelatingToChangeInFairValueOfDebtInstrumentExcludingEquityInvestments>
    <sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327015"
      unitRef="Unit_EUR">-23000000</sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327014"
      unitRef="Unit_EUR">-4000000</sny:ChangeInFairValueOnCashFlowHedgesExcludingAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32399"
      unitRef="Unit_EUR">0</sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32400"
      unitRef="Unit_EUR">1000000</sny:ChangeInFairValueOnCashFlowHedgesNetOfTaxOnAssociatesAndJointVentures>
    <ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32401"
      unitRef="Unit_EUR">-6000000</ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome>
    <ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32402"
      unitRef="Unit_EUR">-1000000</ifrs-full:IncomeTaxRelatingToCashFlowHedgesOfOtherComprehensiveIncome>
    <sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327009"
      unitRef="Unit_EUR">-5266000000</sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="Fact_148327008"
      unitRef="Unit_EUR">1167000000</sny:ChangeInCurrencyTranslationBeforeTaxExcludingAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32405"
      unitRef="Unit_EUR">-26000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32406"
      unitRef="Unit_EUR">-1000000</sny:ChangeInCurrencyTranslationNetOfTaxOnAssociatesAndJointVentures>
    <sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32407"
      unitRef="Unit_EUR">390000000</sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations>
    <sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32408"
      unitRef="Unit_EUR">-126000000</sny:ChangeInCurrencyTranslationOnHedgesOfNetInvestmentsInForeignOperations>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32409"
      unitRef="Unit_EUR">101000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <sny:ChangeInCurrencyTranslationOnTaxEffects
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32410"
      unitRef="Unit_EUR">-33000000</sny:ChangeInCurrencyTranslationOnTaxEffects>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32411"
      unitRef="Unit_EUR">-5017000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2024To06_30_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32412"
      unitRef="Unit_EUR">1067000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_FairValueOnCashFlowHedgesExcludingAssociatesAndJointVenturesMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32413"
      unitRef="Unit_EUR">2000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2025To06_30_2025_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32414"
      unitRef="Unit_EUR">459000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax
      contextRef="P01_01_2024To12_31_2024_AccumulatedOtherComprehensiveIncomeMemberifrsfullComponentsOfEquityAxis_ForeignCurrencyTranslationMemberifrsfullClassesOfFinancialAssetsAxis_ItemsSubsequentlyReclassifiableToProfitOrLossMemberifrsfullReclassifiedItemsAxis"
      decimals="-6"
      id="ixv-32415"
      unitRef="Unit_EUR">5000000</ifrs-full:OtherComprehensiveIncomeThatWillBeReclassifiedToProfitOrLossNetOfTax>
    <sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-19503">&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style: normal;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.9. Debt, cash and cash equivalents &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Changes in financial position during the period were as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2006;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,791&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Short-term debt and current portion of long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,309&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;137&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,519&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,137&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,102&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,772&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net debt does not include lease liabilities, which amounted to &#x20ac;1,776&#160;million as of June&#160;30, 2025 and &#x20ac;1,906&#160;million as of December&#160;31, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&#x201c;Net debt&#x201d; is a &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-IFRS&lt;/div&gt; financial measure used by management and investors to measure Sanofi&#x2019;s overall net indebtedness. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family: Arial; background: none; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="background: none; text-decoration: none;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style: normal;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:7.5pt; font-family:Arial;text-align:right"&gt; &lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.9.1. Net debt at value on redemption &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;A reconciliation of the carrying amount of net debt in the balance sheet to value on redemption as of June&#160;30, 2025 is shown below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Value on redemption&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Carrying&#160;amount&#160;at&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Amortized&#160;cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Adjustment&#160;to&#160;debt&lt;br/&gt;measured at fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;39&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,317&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,940&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Short-term debt and current portion of long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,309&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,311&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,218&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,519&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;41&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,560&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,171&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,102&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;41&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,143&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,806&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net debt does not include lease liabilities, which amounted to &#x20ac;1,776&#160;million as of June&#160;30, 2025 and &#x20ac;1,906&#160;million as of December&#160;31, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows an analysis of net debt by type, at value on redemption: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:26%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Bond issues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,259&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,322&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;15,581&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,876&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,716&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;14,592&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Other bank borrowings&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,847&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,905&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;64&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,290&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,354&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Other borrowings&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Bank credit balances&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;141&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;141&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;13,317&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;7,243&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,560&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;11,940&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;4,231&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,171&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;13,317&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(8,174&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,143&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;11,940&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(3,134&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,806&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;As of June 30, 2025, current other bank borrowings include &#x20ac;4,535&#160;million related to the US commercial paper program and &#x20ac;230&#160;million related to the Negotiable European Commercial Paper program in France. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial"&gt;Principal financing and debt reduction transactions during the period &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi carried out the following bond issues during the period: &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify"&gt;i. March 2025: a bond issue of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1.5&#160;billion in two tranches: &lt;/div&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;850&#160;million of floating-rate bonds maturing March 2027, with quarterly coupons and bearing interest at an annual rate of &lt;div style="white-space:nowrap;display:inline;"&gt;3-month&lt;/div&gt; Euribor plus 30 basis points; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;650&#160;million of fixed-rate bonds maturing March 2031, with annual coupons and bearing interest at an annual rate of 2.750%. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; margin-left:3%; text-indent:-3%; font-size:9pt; font-family:Arial;text-align:justify"&gt;ii. June 2025: a bond issue of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1.5&#160;billion in two tranches: &lt;/div&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;750&#160;million of fixed-rate bonds maturing June 2029, with annual coupons and bearing interest at an annual rate of 2.625%; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;750&#160;million of fixed-rate bonds maturing June 2032, with annual coupons and bearing interest at an annual rate of 3.000%. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Two bond issues were redeemed in 2025: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;i.&#x2006;&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;the &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1&#160;billion fixed-rate bond issue from April 2020, which was redeemed at maturity on April&#160;1, 2025; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;ii.&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;the &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;850&#160;million fixed-rate bond issue from April 2022, which was redeemed at maturity on April&#160;6, 2025. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, Sanofi had two syndicated credit facilities linked to social and environmental criteria in place to manage its liquidity in connection with current operations: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;i.&#x2006;&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;a syndicated credit facility of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;4&#160;billion, drawable in euros and US dollars and expiring on December&#160;6, 2027, for which no further extension options are available; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;ii.&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;a syndicated credit facility of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;4&#160;billion, drawable in euros and US dollars and expiring on March&#160;6, 2030, for which no further extension options are available. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, neither facility was drawn down. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi also has two short-term debt programs: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;i.&#x2006;&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;a &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;6&#160;billion Negotiable European Commercial Paper program in France; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;ii.&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;a $10&#160;billion Commercial Paper program in the United States. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;During the first half of 2025: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;i.&#x2006;&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;the average drawdown under the US Commercial Paper program was $2.63&#160;billion; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:9pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:right"&gt;ii.&lt;/td&gt;
&lt;td style="font-size:8pt;width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:9pt;text-align:justify"&gt;the average drawdown under the Negotiable European Commercial Paper program in France was &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;0.02&#160;billion. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:2pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The financing in place as of June&#160;30, 2025 at the level of the holding company (which manages most of Sanofi&#x2019;s financing needs centrally) is not subject to any financial covenants, and contains no clauses linking credit spreads or fees to the credit rating. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.9.2. Market value of net debt &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The market value of Sanofi&#x2019;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:76%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,589&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,165&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Value on redemption&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,143&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,806&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfDebtInstrumentsIssuedExplanatoryTextBlock>
    <sny:DisclosureOfChangesInFinancialPositionTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-19508">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Changes in financial position during the period were as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:82%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2006;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,791&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Short-term debt and current portion of long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,309&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;137&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,519&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,137&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,102&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,772&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net debt does not include lease liabilities, which amounted to &#x20ac;1,776&#160;million as of June&#160;30, 2025 and &#x20ac;1,906&#160;million as of December&#160;31, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfChangesInFinancialPositionTableTextBlock>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32416"
      unitRef="Unit_EUR">13200000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32417"
      unitRef="Unit_EUR">11791000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32418"
      unitRef="Unit_EUR">7309000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32419"
      unitRef="Unit_EUR">4209000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32420"
      unitRef="Unit_EUR">-10000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32421"
      unitRef="Unit_EUR">-137000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32422"
      unitRef="Unit_EUR">20519000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32423"
      unitRef="Unit_EUR">16137000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32424"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32425"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32426"
      unitRef="Unit_EUR">58000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32427"
      unitRef="Unit_EUR">-76000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327271"
      unitRef="Unit_EUR">5102000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148327264"
      unitRef="Unit_EUR">8772000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32430"
      unitRef="Unit_EUR">1776000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32431"
      unitRef="Unit_EUR">1906000000</ifrs-full:LeaseLiabilities>
    <sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-19769">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;A reconciliation of the carrying amount of net debt in the balance sheet to value on redemption as of June&#160;30, 2025 is shown below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:43%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Value on redemption&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Carrying&#160;amount&#160;at&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Amortized&#160;cost&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Adjustment&#160;to&#160;debt&lt;br/&gt;measured at fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;39&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,317&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,940&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Short-term debt and current portion of long-term debt&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,309&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;7,311&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,218&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,519&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;41&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,560&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,171&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,102&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;41&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,143&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,806&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net debt does not include lease liabilities, which amounted to &#x20ac;1,776&#160;million as of June&#160;30, 2025 and &#x20ac;1,906&#160;million as of December&#160;31, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfReconciliationOfCarryingAmountToValueOnRedemptionTableTextBlock>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32435"
      unitRef="Unit_EUR">13200000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32436"
      unitRef="Unit_EUR">39000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32437"
      unitRef="Unit_EUR">78000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32438"
      unitRef="Unit_EUR">13317000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32439"
      unitRef="Unit_EUR">11940000000</ifrs-full:LongtermBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32440"
      unitRef="Unit_EUR">7309000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32441"
      unitRef="Unit_EUR">2000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32442"
      unitRef="Unit_EUR">0</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32443"
      unitRef="Unit_EUR">7311000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32444"
      unitRef="Unit_EUR">4218000000</ifrs-full:CurrentBorrowingsAndCurrentPortionOfNoncurrentBorrowings>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32445"
      unitRef="Unit_EUR">-10000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32446"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32447"
      unitRef="Unit_EUR">78000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32448"
      unitRef="Unit_EUR">68000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32449"
      unitRef="Unit_EUR">-13000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32450"
      unitRef="Unit_EUR">20519000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32451"
      unitRef="Unit_EUR">41000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32452"
      unitRef="Unit_EUR">0</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32453"
      unitRef="Unit_EUR">20560000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32454"
      unitRef="Unit_EUR">16171000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32455"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32456"
      unitRef="Unit_EUR">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32457"
      unitRef="Unit_EUR">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32458"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32459"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32460"
      unitRef="Unit_EUR">58000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32461"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32462"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32463"
      unitRef="Unit_EUR">58000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32464"
      unitRef="Unit_EUR">-76000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327902"
      unitRef="Unit_EUR">5102000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AmortizedCostNettingMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="Fact_148327896"
      unitRef="Unit_EUR">41000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AdjustmentToDebtMeasuredAtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="Fact_148327676"
      unitRef="Unit_EUR">0</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="Fact_148327887"
      unitRef="Unit_EUR">5143000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="Fact_148327880"
      unitRef="Unit_EUR">8806000000</sny:DebtNetOfCashAndCashEquivalents>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32470"
      unitRef="Unit_EUR">1776000000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32471"
      unitRef="Unit_EUR">1906000000</ifrs-full:LeaseLiabilities>
    <sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-20250">&lt;div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows an analysis of net debt by type, at value on redemption: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:26%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;current&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Bond issues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13,259&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,322&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;15,581&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;11,876&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,716&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;14,592&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Other bank borrowings&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,847&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;4,905&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;64&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,290&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1,354&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Other borrowings&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Bank credit balances&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;141&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;141&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage debt&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: middle; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;13&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;13,317&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;7,243&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;20,560&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;11,940&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;4,231&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;16,171&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(15,359&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7,441&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Interest rate and currency derivatives used to manage cash and cash equivalents&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(58&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Net debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;13,317&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(8,174&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,143&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;11,940&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(3,134&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,806&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;As of June 30, 2025, current other bank borrowings include &#x20ac;4,535&#160;million related to the US commercial paper program and &#x20ac;230&#160;million related to the Negotiable European Commercial Paper program in France. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;</sny:DisclosureOfDebtNetOfCashAndCashEquivalentsByTypeAtValueOnRedemptionExplanatoryTableTextBlock>
    <ifrs-full:BondsIssued
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32472"
      unitRef="Unit_EUR">13259000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32473"
      unitRef="Unit_EUR">2322000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32474"
      unitRef="Unit_EUR">15581000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32475"
      unitRef="Unit_EUR">11876000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32476"
      unitRef="Unit_EUR">2716000000</ifrs-full:BondsIssued>
    <ifrs-full:BondsIssued
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32477"
      unitRef="Unit_EUR">14592000000</ifrs-full:BondsIssued>
    <sny:OtherBankBorrowings
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32478"
      unitRef="Unit_EUR">58000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="Fact_148327861"
      unitRef="Unit_EUR">4847000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32480"
      unitRef="Unit_EUR">4905000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32481"
      unitRef="Unit_EUR">64000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32482"
      unitRef="Unit_EUR">1290000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32483"
      unitRef="Unit_EUR">1354000000</sny:OtherBankBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32484"
      unitRef="Unit_EUR">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32485"
      unitRef="Unit_EUR">1000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32486"
      unitRef="Unit_EUR">1000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32487"
      unitRef="Unit_EUR">0</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32488"
      unitRef="Unit_EUR">3000000</ifrs-full:OtherBorrowings>
    <ifrs-full:OtherBorrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32489"
      unitRef="Unit_EUR">3000000</ifrs-full:OtherBorrowings>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32490"
      unitRef="Unit_EUR">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32491"
      unitRef="Unit_EUR">141000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32492"
      unitRef="Unit_EUR">141000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32493"
      unitRef="Unit_EUR">0</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32494"
      unitRef="Unit_EUR">209000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <ifrs-full:BankOverdraftsClassifiedAsCashEquivalents
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32495"
      unitRef="Unit_EUR">209000000</ifrs-full:BankOverdraftsClassifiedAsCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32496"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32497"
      unitRef="Unit_EUR">68000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32498"
      unitRef="Unit_EUR">68000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32499"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32500"
      unitRef="Unit_EUR">-13000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageDebt
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32501"
      unitRef="Unit_EUR">-13000000</sny:InterestRateAndCurrencyDerivativesUsedToManageDebt>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32502"
      unitRef="Unit_EUR">13317000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32503"
      unitRef="Unit_EUR">7243000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32504"
      unitRef="Unit_EUR">20560000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024_NonCurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32505"
      unitRef="Unit_EUR">11940000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32506"
      unitRef="Unit_EUR">4231000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32507"
      unitRef="Unit_EUR">16171000000</ifrs-full:Borrowings>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32508"
      unitRef="Unit_EUR">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32509"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32510"
      unitRef="Unit_EUR">15359000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32511"
      unitRef="Unit_EUR">0</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32512"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32513"
      unitRef="Unit_EUR">7441000000</ifrs-full:CashAndCashEquivalents>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32514"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32515"
      unitRef="Unit_EUR">58000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32516"
      unitRef="Unit_EUR">58000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32517"
      unitRef="Unit_EUR">0</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32518"
      unitRef="Unit_EUR">-76000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32519"
      unitRef="Unit_EUR">-76000000</sny:InterestRateAndCurrencyDerivativesUsedToManageCashAndCashEquivalent>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32520"
      unitRef="Unit_EUR">13317000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32521"
      unitRef="Unit_EUR">-8174000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32522"
      unitRef="Unit_EUR">5143000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn12_31_2024_NonCurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32523"
      unitRef="Unit_EUR">11940000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn12_31_2024_CurrentAssetsMemberifrsfullClassesOfAssetsAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32524"
      unitRef="Unit_EUR">-3134000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:DebtNetOfCashAndCashEquivalents
      contextRef="PAsOn12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32525"
      unitRef="Unit_EUR">8806000000</sny:DebtNetOfCashAndCashEquivalents>
    <sny:OtherBankBorrowings
      contextRef="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32526"
      unitRef="Unit_EUR">4535000000</sny:OtherBankBorrowings>
    <sny:OtherBankBorrowings
      contextRef="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_CurrentLiabilitiesMemberifrsfullAssetsAndLiabilitiesAxis_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32527"
      unitRef="Unit_EUR">230000000</sny:OtherBankBorrowings>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis"
      decimals="-8"
      id="ixv-32529"
      unitRef="Unit_EUR">1500000000</ifrs-full:NotionalAmount>
    <sny:NumberOfTranches
      contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInMarch2025MemberifrsfullBorrowingsByNameAxis"
      decimals="INF"
      id="ixv-32530"
      unitRef="Unit_EUR_per_Share">2</sny:NumberOfTranches>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2027MemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32531"
      unitRef="Unit_EUR">850000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2031MemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32532"
      unitRef="Unit_EUR">650000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis"
      decimals="-8"
      id="ixv-32533"
      unitRef="Unit_EUR">1500000000</ifrs-full:NotionalAmount>
    <sny:NumberOfTranches
      contextRef="PAsOn06_30_2025_OneBillionFiveHundredMillionBondsIssuedInJune2025MemberifrsfullBorrowingsByNameAxis"
      decimals="INF"
      id="ixv-32534"
      unitRef="Unit_EUR_per_Share">2</sny:NumberOfTranches>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondMaturingJune2029MemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32535"
      unitRef="Unit_EUR">750000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondMaturingMarch2032MemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32536"
      unitRef="Unit_EUR">750000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondIssueFromApril2020MemberifrsfullBorrowingsByNameAxis"
      decimals="-9"
      id="ixv-32537"
      unitRef="Unit_EUR">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FixedRateBondIssueFromApril2022MemberifrsfullBorrowingsByNameAxis"
      decimals="-6"
      id="ixv-32538"
      unitRef="Unit_EUR">850000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FourBillionFacilityMaturingDecember2027MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-9"
      id="ixv-32539"
      unitRef="Unit_EUR">4000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_FourBillionFacilityMaturingMarch2030MemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-9"
      id="ixv-32540"
      unitRef="Unit_EUR">4000000000</ifrs-full:NotionalAmount>
    <ifrs-full:CommercialPapersIssued
      contextRef="PAsOn06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-9"
      id="ixv-32541"
      unitRef="Unit_EUR">6000000000</ifrs-full:CommercialPapersIssued>
    <ifrs-full:CommercialPapersIssued
      contextRef="PAsOn06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-9"
      id="ixv-32542"
      unitRef="Unit_USD">10000000000</ifrs-full:CommercialPapersIssued>
    <sny:BorrowingAverageDrawdown
      contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInUSAMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-7"
      id="ixv-32543"
      unitRef="Unit_USD">2630000000</sny:BorrowingAverageDrawdown>
    <sny:BorrowingAverageDrawdown
      contextRef="P01_01_2025To06_30_2025_CommercialPaperProgramInFranceMemberifrsfullBorrowingsByNameAxis_SanofiEuroMediumTermNotesMemberSNYDebtInstrumentAxis"
      decimals="-7"
      id="ixv-32544"
      unitRef="Unit_EUR">20000000.00</sny:BorrowingAverageDrawdown>
    <sny:DisclosureOfMarketValueOfNetDebtTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-21101">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The market value of Sanofi&#x2019;s debt, net of cash and cash equivalents and derivatives and excluding accrued interest, is as follows: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:76%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Market value&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,589&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,165&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.88em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;Value on redemption&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,143&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,806&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfMarketValueOfNetDebtTableTextBlock>
    <ifrs-full:Borrowings
      contextRef="PAsOn06_30_2025_AtMarketValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32545"
      unitRef="Unit_EUR">4589000000</ifrs-full:Borrowings>
    <ifrs-full:Borrowings
      contextRef="PAsOn12_31_2024_AtMarketValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32546"
      unitRef="Unit_EUR">8165000000</ifrs-full:Borrowings>
    <sny:RedemptionOfDebtInstrumentIssued
      contextRef="P01_01_2025To06_30_2025_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32547"
      unitRef="Unit_EUR">5143000000</sny:RedemptionOfDebtInstrumentIssued>
    <sny:RedemptionOfDebtInstrumentIssued
      contextRef="P01_01_2024To12_31_2024_ValueOnRedemptionMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32548"
      unitRef="Unit_EUR">8806000000</sny:RedemptionOfDebtInstrumentIssued>
    <ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-21194">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.10. Derivative financial instruments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.10.1 Currency derivatives used to manage operating risk exposures &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows operating currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:46%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of which derivatives designated&lt;br/&gt;as&#160;cash&#160;flow hedges&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&lt;br/&gt;accounting&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in&#160;equity&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,619&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;133&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,619&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;133&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,351&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;100&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,351&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;100&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;539&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;539&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Chinese yuan renminbi&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;480&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;480&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Japanese yen&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;253&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;253&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which pound sterling&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;173&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;173&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency purchases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,418&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,418&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,540&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(55&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,540&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(55&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;610&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(15&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;610&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(15&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Chinese yuan renminbi&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Turkish lira&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;159&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;159&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which United Arab Emirates dirham&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;120&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;120&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,037&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;49&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,037&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;49&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The above positions mainly hedge material foreign currency cash flows arising after the end of the reporting period in relation to transactions carried out during the six months ended June&#160;&lt;div style="display:inline;"&gt;30,&lt;/div&gt; 2025 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange difference on those items (hedging instruments and hedged transactions) will be immaterial in the second half of 2025. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.10.2. Currency and interest rate derivatives used to manage financial exposure &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The cash pooling arrangements for foreign subsidiaries outside the eurozone, and some of Sanofi&#x2019;s financing activities, expose certain Sanofi entities to financial foreign exchange risk (i.e.&#160;the risk of changes in the value of loans and borrowings denominated in a currency other than the functional currency of the lender or borrower). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;That foreign exchange exposure is hedged using derivative instruments (currency swaps or forward contracts) that alter the currency split of Sanofi&#x2019;s debt once those instruments are taken into account. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows financial currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Maximum&lt;br/&gt;&#x2003;&#x2003;expiry&#160;date&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Cross currency seller swaps&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,476&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,476&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2032&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,723&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;176&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;6,007&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;148&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Pound sterling&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;601&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Japanese yen&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;303&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency purchases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,609&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,289&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,094&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(c)&#160;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(33&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Hungarian forint&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;639&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,808&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;137&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp;amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#x20ac;5&#160;million, with &#x20ac;18&#160;million debited to &lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style:italic;display:inline;"&gt; under the cost of hedging accounting treatment. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes forward sales with a notional amount of $3,615&#160;million expiring in 2025, designated as a hedge of Sanofi&#x2019;s net investment in Bioverativ. As of June&#160;30, 2025, the fair value of these forward contracts represented an asset of &#x20ac;77&#160;million; the opposite entry was recognized in &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;, with the impact on financial income and expense being immaterial. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes forward purchases with a notional amount of $1,000&#160;million expiring in 2025, designated as a fair value hedge of the exposure of $1,000&#160;million of bond issues to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of these contracts represented a liability of &#x20ac;25&#160;million, with &#x20ac;0&#160;million credited to &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; to recognize the hedging cost. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:20pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;To optimize the cost of debt or reduce the volatility of debt, Sanofi uses derivative instruments (interest rate swaps and cross currency swaps) to alter the fixed/floating rate split of its net debt. &lt;/div&gt;  &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows instruments of this type in place as of June&#160;30, 2025: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:36%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which&lt;br/&gt;designated&#160;as&#160;fair&lt;br/&gt;value&#160;hedges&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which designated&lt;br/&gt;as&#160;cash&#160;flow hedges&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2027&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2028&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2029&lt;br/&gt;and&lt;br/&gt;beyond&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Interest rate swaps&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay capitalized SOFR USD / receive 1.17%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(54&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;(54&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay 2.08% / receive Euribor 3m&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay capitalized Ester / receive 0.92%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;850&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;848&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;650&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2,348&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(88&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,498&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(81&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;850&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(7&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </ifrs-full:DisclosureOfDerivativeFinancialInstrumentsExplanatory>
    <sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-21199">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows operating currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:46%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of which derivatives designated&lt;br/&gt;as&#160;cash&#160;flow hedges&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of&#160;which&#160;derivatives&#160;not&lt;br/&gt;eligible&#160;for&#160;hedge&lt;br/&gt;accounting&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in&#160;equity&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,619&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;133&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,619&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;133&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,351&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;100&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,351&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;100&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;539&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;539&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;10&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Chinese yuan renminbi&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;480&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;480&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Japanese yen&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;253&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;253&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which pound sterling&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;173&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;173&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency purchases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,418&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,418&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(84&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,540&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(55&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,540&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(55&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;610&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(15&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;610&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(15&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Chinese yuan renminbi&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Turkish lira&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;159&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;159&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which United Arab Emirates dirham&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;120&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;120&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,037&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;49&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;11,037&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;49&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The above positions mainly hedge material foreign currency cash flows arising after the end of the reporting period in relation to transactions carried out during the six months ended June&#160;&lt;div style="display:inline;"&gt;30,&lt;/div&gt; 2025 and recognized in the balance sheet at that date. Gains and losses on hedging instruments (forward contracts) are calculated and recognized in parallel with the recognition of gains and losses on the hedged items. Due to this hedging relationship, the commercial foreign exchange difference on those items (hedging instruments and hedged transactions) will be immaterial in the second half of 2025. &lt;/div&gt;</sny:DisclosureOfOperatingCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateTableTextBlock>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32549"
      unitRef="Unit_EUR">6619000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32550"
      unitRef="Unit_EUR">133000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32551"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32552"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32553"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32554"
      unitRef="Unit_EUR">6619000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32555"
      unitRef="Unit_EUR">133000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32556"
      unitRef="Unit_EUR">3351000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32557"
      unitRef="Unit_EUR">100000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32558"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32559"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32560"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32561"
      unitRef="Unit_EUR">3351000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32562"
      unitRef="Unit_EUR">100000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32563"
      unitRef="Unit_EUR">539000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32564"
      unitRef="Unit_EUR">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32565"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32566"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32567"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32568"
      unitRef="Unit_EUR">539000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32569"
      unitRef="Unit_EUR">10000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32570"
      unitRef="Unit_EUR">480000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32571"
      unitRef="Unit_EUR">14000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32572"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32573"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32574"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32575"
      unitRef="Unit_EUR">480000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32576"
      unitRef="Unit_EUR">14000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32577"
      unitRef="Unit_EUR">253000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32578"
      unitRef="Unit_EUR">9000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32579"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32580"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32581"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32582"
      unitRef="Unit_EUR">253000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32583"
      unitRef="Unit_EUR">9000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32584"
      unitRef="Unit_EUR">173000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32585"
      unitRef="Unit_EUR">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32586"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32587"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32588"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32589"
      unitRef="Unit_EUR">173000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32590"
      unitRef="Unit_EUR">2000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32591"
      unitRef="Unit_EUR">4418000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32592"
      unitRef="Unit_EUR">-84000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32593"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32594"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32595"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32596"
      unitRef="Unit_EUR">4418000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32597"
      unitRef="Unit_EUR">-84000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32598"
      unitRef="Unit_EUR">2540000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32599"
      unitRef="Unit_EUR">-55000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32600"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32601"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32602"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32603"
      unitRef="Unit_EUR">2540000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32604"
      unitRef="Unit_EUR">-55000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32605"
      unitRef="Unit_EUR">610000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32606"
      unitRef="Unit_EUR">-15000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32607"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32608"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32609"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32610"
      unitRef="Unit_EUR">610000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32611"
      unitRef="Unit_EUR">-15000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32612"
      unitRef="Unit_EUR">277000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32613"
      unitRef="Unit_EUR">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32614"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32615"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32616"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32617"
      unitRef="Unit_EUR">277000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInChineseYuanRenminbiMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32618"
      unitRef="Unit_EUR">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32619"
      unitRef="Unit_EUR">159000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32620"
      unitRef="Unit_EUR">-4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32621"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32622"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32623"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32624"
      unitRef="Unit_EUR">159000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInTurkishLiraMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32625"
      unitRef="Unit_EUR">-4000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32626"
      unitRef="Unit_EUR">120000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32627"
      unitRef="Unit_EUR">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32628"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32629"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32630"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32631"
      unitRef="Unit_EUR">120000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUnitedArabEmiratesDirhamMemberifrsfullHedgingInstrumentsAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32632"
      unitRef="Unit_EUR">-5000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32633"
      unitRef="Unit_EUR">11037000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32634"
      unitRef="Unit_EUR">49000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32635"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32636"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32637"
      unitRef="Unit_EUR">0</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32638"
      unitRef="Unit_EUR">11037000000</sny:DerivativeFinancialInstruments>
    <sny:DerivativeFinancialInstruments
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_NotEligibleForHedgeAccountingMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32639"
      unitRef="Unit_EUR">49000000</sny:DerivativeFinancialInstruments>
    <sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-22402">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows financial currency hedging instruments in place as of June&#160;30, 2025. The notional amount is translated into euros at the relevant closing exchange rate. &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Notional&#160;amount&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Fair&#160;value&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Maximum&lt;br/&gt;&#x2003;&#x2003;expiry&#160;date&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Cross currency seller swaps&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,476&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,476&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2032&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;7,723&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;176&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;6,007&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;148&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Pound sterling&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;601&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Japanese yen&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;303&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Forward currency purchases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,609&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Singapore dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,289&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(14&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which US dollar&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,094&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;(c)&#160;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(33&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.60em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which Hungarian forint&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;639&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;12,808&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;137&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp;amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#x20ac;5&#160;million, with &#x20ac;18&#160;million debited to &lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style:italic;display:inline;"&gt; under the cost of hedging accounting treatment. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="line-height:normal;display: inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes forward sales with a notional amount of $3,615&#160;million expiring in 2025, designated as a hedge of Sanofi&#x2019;s net investment in Bioverativ. As of June&#160;30, 2025, the fair value of these forward contracts represented an asset of &#x20ac;77&#160;million; the opposite entry was recognized in &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;, with the impact on financial income and expense being immaterial. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes forward purchases with a notional amount of $1,000&#160;million expiring in 2025, designated as a fair value hedge of the exposure of $1,000&#160;million of bond issues to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of these contracts represented a liability of &#x20ac;25&#160;million, with &#x20ac;0&#160;million credited to &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other comprehensive income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt; to recognize the hedging cost. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfFinancialCurrencyHedgingInstrumentsWithNotionalAmountTranslatedInToEurosAtClosingExchangeRateExplanatoryTableTextBlock>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32640"
      unitRef="Unit_EUR">1476000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32641"
      unitRef="Unit_EUR">5000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="Fact_148327950"
      unitRef="Unit_EUR">1476000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CrossCurrencySellerSwapsInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanFiveYearsAndNotLaterThanSevenYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32643"
      unitRef="Unit_EUR">5000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32644"
      unitRef="Unit_EUR">7723000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32645"
      unitRef="Unit_EUR">176000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="Fact_148327946"
      unitRef="Unit_EUR">6007000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32647"
      unitRef="Unit_EUR">148000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32648"
      unitRef="Unit_EUR">601000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInPoundSterlingMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32649"
      unitRef="Unit_EUR">7000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32650"
      unitRef="Unit_EUR">303000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencySalesInJapaneseYenMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32651"
      unitRef="Unit_EUR">9000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32652"
      unitRef="Unit_EUR">3609000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32653"
      unitRef="Unit_EUR">-44000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32654"
      unitRef="Unit_EUR">1289000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInSingaporeDollarMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32655"
      unitRef="Unit_EUR">-14000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="Fact_148327936"
      unitRef="Unit_EUR">1094000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInUSDollarMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32657"
      unitRef="Unit_EUR">-33000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32658"
      unitRef="Unit_EUR">639000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_ForwardCurrencyPurchasesInHungarianFlorintMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32659"
      unitRef="Unit_EUR">7000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32660"
      unitRef="Unit_EUR">12808000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <sny:DerivativeFinancialInstrumentsToManageFinancialExposure
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32661"
      unitRef="Unit_EUR">137000000</sny:DerivativeFinancialInstrumentsToManageFinancialExposure>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_CrossCurrencySwapExpiring2029MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32662"
      unitRef="Unit_EUR">870000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_CrossCurrencySwapExpiring2032MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32663"
      unitRef="Unit_EUR">870000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialAssets
      contextRef="PAsOn06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32664"
      unitRef="Unit_EUR">5000000</ifrs-full:DerivativeFinancialAssets>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="P01_01_2025To06_30_2025_CrossCurrencySwapMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32665"
      unitRef="Unit_EUR">18000000</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32666"
      unitRef="Unit_EUR">3615000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="PAsOn06_30_2025_ForwardCurrencySalesInUSDollarMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32667"
      unitRef="Unit_EUR">77000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32668"
      unitRef="Unit_EUR">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:NotionalAmount
      contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32669"
      unitRef="Unit_EUR">1000000000</ifrs-full:NotionalAmount>
    <ifrs-full:DerivativeFinancialLiabilities
      contextRef="PAsOn06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32670"
      unitRef="Unit_EUR">25000000</ifrs-full:DerivativeFinancialLiabilities>
    <ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax
      contextRef="P01_01_2025To06_30_2025_ForwardCurrencyPurchasesInUSDollarUSBondMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32671"
      unitRef="Unit_EUR">0</ifrs-full:GainsLossesOnCashFlowHedgesBeforeTax>
    <sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-22946"> &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows instruments of this type in place as of June&#160;30, 2025: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:36%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align: bottom; padding-bottom: 0.375pt;"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:center"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which&lt;br/&gt;designated&#160;as&#160;fair&lt;br/&gt;value&#160;hedges&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which designated&lt;br/&gt;as&#160;cash&#160;flow hedges&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #000000;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2026&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2027&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2028&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2029&lt;br/&gt;and&lt;br/&gt;beyond&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Notional&lt;br/&gt;amount&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Fair&lt;br/&gt;value&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Of which&lt;br/&gt;recognized&lt;br/&gt;in equity&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Interest rate swaps&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay capitalized SOFR USD / receive 1.17%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(54&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;848&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;div style="display:inline;"&gt;(54&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay 2.08% / receive Euribor 3m&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;850&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;pay capitalized Ester / receive 0.92%&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;650&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1.88em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;850&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;848&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;650&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2,348&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(88&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,498&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(81&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;850&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(7&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfInterestRatesHedgingInstrumentsWithNotionalAmountByExpiryDateExplanatoryTableTextBlock>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32672"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32673"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32674"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32675"
      unitRef="Unit_EUR">848000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32676"
      unitRef="Unit_EUR">848000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32677"
      unitRef="Unit_EUR">-54000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32678"
      unitRef="Unit_EUR">848000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32679"
      unitRef="Unit_EUR">-54000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedSOFRUSDReceive1Point17PercentMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32680"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32681"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32682"
      unitRef="Unit_EUR">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32683"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32684"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32685"
      unitRef="Unit_EUR">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32686"
      unitRef="Unit_EUR">-7000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32687"
      unitRef="Unit_EUR">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32688"
      unitRef="Unit_EUR">-7000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayTwoPointZeroEightPercentReceiveEuriborThreeMMemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32689"
      unitRef="Unit_EUR">-3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32690"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32691"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32692"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32693"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32694"
      unitRef="Unit_EUR">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32695"
      unitRef="Unit_EUR">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32696"
      unitRef="Unit_EUR">-27000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32697"
      unitRef="Unit_EUR">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32698"
      unitRef="Unit_EUR">-27000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32699"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis"
      decimals="-6"
      id="ixv-32700"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_InterestRateSwapsPayCapitalizedEsterReceive092MemberifrsfullHedgingInstrumentsAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32701"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_NotLaterThanOneYearMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32702"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanOneYearAndNotLaterThanTwoYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32703"
      unitRef="Unit_EUR">0</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanTwoYearsAndNotLaterThanThreeYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32704"
      unitRef="Unit_EUR">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanThreeYearsAndNotLaterThanFourYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32705"
      unitRef="Unit_EUR">848000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_LaterThanFourYearsAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis"
      decimals="-6"
      id="ixv-32706"
      unitRef="Unit_EUR">650000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32707"
      unitRef="Unit_EUR">2348000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32708"
      unitRef="Unit_EUR">-88000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32709"
      unitRef="Unit_EUR">1498000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_FairValueHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32710"
      unitRef="Unit_EUR">-81000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtNotionalAmountMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32711"
      unitRef="Unit_EUR">850000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_AtFairValueMemberifrsfullMeasurementAxis_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis"
      decimals="-6"
      id="ixv-32712"
      unitRef="Unit_EUR">-7000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents
      contextRef="PAsOn06_30_2025_CashFlowHedgesMemberifrsfullTypesOfHedgesAxis_ValueOfHedgeRecognizedInEquityMemberifrsfullMeasurementAxis"
      decimals="-6"
      id="ixv-32713"
      unitRef="Unit_EUR">-3000000</sny:CurrencyAndInterestRateDerivativesUsedToManageDebtNetOfCashAndCashEquivalents>
    <sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-23679"> &lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style: normal;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.11. Liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; &lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;For a description of the nature of the liabilities reported in the line item &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;, refer to Note B.8.4. to the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt; &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests shown in the table below are level&#160;3 instruments under the IFRS 13 and IFRS 7 fair value hierarchy (see Note A.5.). &lt;/div&gt;  &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements in liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests in the first half of 2025 are shown below: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;MSD&#160;contingent&lt;br/&gt;consideration&lt;br/&gt;(European&lt;br/&gt;Vaccines&lt;br/&gt;business)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Shire&#160;contingent&lt;br/&gt;consideration&lt;br/&gt;arising from&lt;br/&gt;acquisition&#160;of&lt;br/&gt;Translate&#160;Bio&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;72&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;568&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;641&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Payments made&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;71&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;563&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;564&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Of which:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Current portion&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-current&lt;/div&gt; portion&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;564&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;As of January&#160;1, 2025, this comprised a &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; portion of &#x20ac;569&#160;million and a current portion of &#x20ac;72&#160;million. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Amounts mainly reported within the income statement line item &#x201c;Fair value remeasurement of contingent consideration&#x201d;. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; mainly comprised the contingent consideration liability towards Shire Human Genetic Therapies Inc. (Shire) arising from Sanofi&#x2019;s acquisition of Translate Bio in September 2021. The fair value of the Shire liability is determined by applying the contractual terms to development and sales projections that are weighted to reflect the probability of success, and discounted. The liability was measured at &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x20ac;&lt;/div&gt;563&#160;million as of June&#160;30, 2025, compared with &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x20ac;&lt;/div&gt;568&#160;million as of December&#160;31, 2024. If the discount rate were to fall by one percentage point, the fair value of the Shire liability would increase by approximately 10%. &lt;/div&gt; &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The MSD contingent consideration liability arising from the 2016 acquisition of the Sanofi Pasteur activities carried on within the former Sanofi Pasteur MSD joint venture was extinguished during 2024 in accordance with the contractual terms. Sanofi has no further liability in respect of this contingent consideration following settlement of the milestone linked to 2024 sales. &lt;/div&gt; </sny:DisclosureOfLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsExplanatoryTextBlock>
    <sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-23692"> &lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Movements in liabilities related to business combinations and to &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-controlling&lt;/div&gt; interests in the first half of 2025 are shown below: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:66%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;MSD&#160;contingent&lt;br/&gt;consideration&lt;br/&gt;(European&lt;br/&gt;Vaccines&lt;br/&gt;business)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Shire&#160;contingent&lt;br/&gt;consideration&lt;br/&gt;arising from&lt;br/&gt;acquisition&#160;of&lt;br/&gt;Translate&#160;Bio&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;72&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;568&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;641&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Payments made&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;71&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;563&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;564&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Of which:&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; Current portion&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:middle;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.63em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2022; &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-current&lt;/div&gt; portion&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-size: x-small; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;564&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;As of January&#160;1, 2025, this comprised a &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; portion of &#x20ac;569&#160;million and a current portion of &#x20ac;72&#160;million. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Amounts mainly reported within the income statement line item &#x201c;Fair value remeasurement of contingent consideration&#x201d;. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfChangesInLiabilitiesRelatedToBusinessCombinationsAndToNoncontrollingInterestsTableTextBlock>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn12_31_2024_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32714"
      unitRef="Unit_EUR">72000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32715"
      unitRef="Unit_EUR">568000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn12_31_2024_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32716"
      unitRef="Unit_EUR">1000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148327667"
      unitRef="Unit_EUR">641000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32718"
      unitRef="Unit_EUR">72000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32719"
      unitRef="Unit_EUR">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32720"
      unitRef="Unit_EUR">0</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327663"
      unitRef="Unit_EUR">72000000</ifrs-full:SettledLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="Fact_148327662"
      unitRef="Unit_EUR">1000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="Fact_148327661"
      unitRef="Unit_EUR">71000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="Fact_148327660"
      unitRef="Unit_EUR">0</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327659"
      unitRef="Unit_EUR">72000000</ifrs-full:GainsLossesRecognisedInProfitOrLossFairValueMeasurementLiabilities>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32726"
      unitRef="Unit_EUR">-1000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32727"
      unitRef="Unit_EUR">-76000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32728"
      unitRef="Unit_EUR">0</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327655"
      unitRef="Unit_EUR">-77000000</sny:IncreaseDecreaseThroughNetExchangeDifferencesBusinessCombinationsAndNoncontrollingInterests>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn06_30_2025_MSDContingentConsiderationEuropeanVaccinesBusinessMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32730"
      unitRef="Unit_EUR">0</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32731"
      unitRef="Unit_EUR">563000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn06_30_2025_OtherLiabilities1MemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32732"
      unitRef="Unit_EUR">1000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327651"
      unitRef="Unit_EUR">564000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327650"
      unitRef="Unit_EUR">0</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327649"
      unitRef="Unit_EUR">564000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn01_01_2025"
      decimals="-6"
      id="ixv-32736"
      unitRef="Unit_EUR">569000000</sny:NonCurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests
      contextRef="PAsOn01_01_2025"
      decimals="-6"
      id="ixv-32737"
      unitRef="Unit_EUR">72000000</sny:CurrentLiabilitiesRelatedToBusinessCombinationsAndToNonControllingInterests>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32738"
      unitRef="Unit_EUR">563000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination
      contextRef="PAsOn12_31_2024_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="-6"
      id="ixv-32739"
      unitRef="Unit_EUR">568000000</ifrs-full:ContingentLiabilitiesRecognisedInBusinessCombination>
    <sny:PercentageIncreaseInFairValueLiabilities
      contextRef="PAsOn06_30_2025_ShireContingentConsiderationArisingFromAcquisitionOfTranslateBioMemberifrsfullBusinessCombinationsAxis"
      decimals="2"
      id="ixv-32740"
      unitRef="Unit_pure">0.10</sny:PercentageIncreaseInFairValueLiabilities>
    <sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-24141"> &lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color: rgb(120, 2, 230); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style: normal;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.12. &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-current&lt;/div&gt; provisions and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt; liabilities &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;  &lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The line item &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-current&lt;/div&gt; provisions and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; comprises the following: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2002;Provisions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;5,003&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;5,762&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2002;Other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,113&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,334&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; background-color: rgb(120, 2, 230); width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;7,116&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,096&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes &#x20ac;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#x20ac;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#x20ac;2,293&#160;million. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows movements in provisions: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:44%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Provisions&#160;for&lt;br/&gt;pensions&#160;&amp;amp;&#160;other&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;post-employment&lt;/div&gt;&lt;br/&gt;benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Provisions&#160;for&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;other&#160;long-term&lt;/div&gt;&lt;br/&gt;benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Restructuring&lt;br/&gt;provisions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Other&lt;br/&gt;provisions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,992&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;821&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;799&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2,150&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,762&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Increases in provisions and other liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;69&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;175&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;293&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;615&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Provisions utilized&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(378&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(616&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Reversals of unutilized provisions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(17&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(178&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(197&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(158&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(93&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(94&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(74&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(83&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains and losses on defined-benefit plans&#160;(B.12.1.)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(111&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(111&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,705&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;765&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;802&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,731&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,003&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In the case of &#x201c;Provisions for pensions and other post-employment benefits&#x201d;, the &#x201c;Increases in provisions&#x201d; line corresponds to rights vesting in employees during the period, and past service cost; the &#x201c;Provisions utilized&#x201d; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#x201c;Reversals of unutilized provisions&#x201d; line corresponds to plan curtailments, settlements and amendments. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Mainly transfers to &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Current provisions and other current liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;  &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;font-weight:bold"&gt;Provisions for pensions and other post-employment benefits &lt;/div&gt; &lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;For an analysis of the sensitivity of obligations in respect of pensions and other employee benefits as of December&#160;31, 2024, and of the assumptions used as of that date, see Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt; &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The principal assumptions used (in particular, discount and inflation rates) and the market value of plan assets for the eurozone, the United States and the United Kingdom were reviewed as of June&#160;30, 2025 to take into account changes during the first half of the year. &lt;/div&gt; &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;During the first half of 2025, Sanofi completed a further &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;buy-in&lt;/div&gt; (amounting to &lt;div style="font-family: &amp;quot;Times New Roman&amp;quot;; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x20ac;&lt;/div&gt;101&#160;million) to cover the remaining uninsured liabilities arising under the main defined benefit pension scheme in the United Kingdom. Consequently, all scheme members are now fully insured as a result of &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;buy-in&lt;/div&gt; transactions, except for liabilities rising from guaranteed minimum pension equalization (as described in Note D.19.1. to the consolidated financial statements for the year ended December&#160;31, 2024). &lt;/div&gt;  &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Actuarial gains and losses arising on pensions and other post-employment benefits and recognized in equity are as follows (amounts reported before tax): &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:76%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:5pt;color:#23004c;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(6&#160;months)&#x2003;&#x2004;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2024&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:5pt;color:#23004c;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(6&#160;months)&#x2003;&#x2004;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses) on plan assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(45&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses) on benefit obligations&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;152&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;373&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the &lt;div style="white-space:nowrap;display:inline;"&gt;-0.30%&lt;/div&gt; change in the inflation rate in the United Kingdom in the first half of 2025. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes actuarial gains/ (losses) related to Opella of &#x20ac;(4)&#160;million for the first half of 2025 and &#x20ac;(6)&#160;million for the first half of 2024 . &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesTextBlock>
    <sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-24148"> &lt;div style="margin-top:8pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The line item &lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;Non-current&lt;/div&gt; provisions and other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt; comprises the following: &lt;/div&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2002;Provisions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;5,003&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;5,762&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&#x2002;Other &lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(255, 255, 255); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,113&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2,334&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom: 3pt; vertical-align: bottom; background-color: rgb(120, 2, 230); width: 76%;"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; text-indent: -1em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;7,116&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align: bottom; background-color: rgb(120, 2, 230); width: 8%;"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;8,096&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes &#x20ac;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#x20ac;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#x20ac;2,293&#160;million. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfProvisionsAndOtherNonCurrentLiabilitiesExplanatoryTableTextBlock>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32741"
      unitRef="Unit_EUR">5003000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32742"
      unitRef="Unit_EUR">5762000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="Fact_148327633"
      unitRef="Unit_EUR">2113000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="Fact_148327632"
      unitRef="Unit_EUR">2334000000</ifrs-full:OtherNoncurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32745"
      unitRef="Unit_EUR">7116000000</sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32746"
      unitRef="Unit_EUR">8096000000</sny:NonCurrentProvisionsAndOtherNonCurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"
      decimals="-6"
      id="ixv-32747"
      unitRef="Unit_EUR">1756000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanOneYearAndNotLaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"
      decimals="-6"
      id="ixv-32748"
      unitRef="Unit_EUR">1027000000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities
      contextRef="PAsOn06_30_2025_AntibodiesCollaborationAgreementMemberSNYPrincipalAlliancesAxis_LaterThanFiveYearsMemberifrsfullMaturityAxis_SwedishOrphanBiovitrumABMemberifrsfullCounterpartiesAxis"
      decimals="-6"
      id="ixv-32749"
      unitRef="Unit_EUR">2293000000</ifrs-full:OtherNoncurrentLiabilities>
    <sny:DisclosureOfNonCurrentProvisionsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-24267"> &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows movements in provisions: &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:44%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Provisions&#160;for&lt;br/&gt;pensions&#160;&amp;amp;&#160;other&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;post-employment&lt;/div&gt;&lt;br/&gt;benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Provisions&#160;for&lt;br/&gt;&lt;div style="white-space: nowrap; letter-spacing: 0px; top: 0px;display:inline;"&gt;other&#160;long-term&lt;/div&gt;&lt;br/&gt;benefits&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Restructuring&lt;br/&gt;provisions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Other&lt;br/&gt;provisions&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at January&#160;1, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,992&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;821&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;799&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;2,150&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,762&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #000000;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Increases in provisions and other liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;69&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2007;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;78&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;175&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;293&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;615&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Provisions utilized&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(378&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(616&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Reversals of unutilized provisions&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(17&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(178&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(197&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Transfers &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(158&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(93&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Net interest related to employee benefits, and unwinding of discount&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Currency translation differences&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(94&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(74&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(83&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains and losses on defined-benefit plans&#160;(B.12.1.)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(111&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(111&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;&lt;div style="color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;Balance at June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,705&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;765&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;802&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;1,731&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;5,003&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family: Arial; color: rgb(255, 255, 255); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In the case of &#x201c;Provisions for pensions and other post-employment benefits&#x201d;, the &#x201c;Increases in provisions&#x201d; line corresponds to rights vesting in employees during the period, and past service cost; the &#x201c;Provisions utilized&#x201d; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#x201c;Reversals of unutilized provisions&#x201d; line corresponds to plan curtailments, settlements and amendments. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Mainly transfers to &lt;/div&gt;&lt;/div&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Current provisions and other current liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfNonCurrentProvisionsTableTextBlock>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32750"
      unitRef="Unit_EUR">1992000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32751"
      unitRef="Unit_EUR">821000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32752"
      unitRef="Unit_EUR">799000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32753"
      unitRef="Unit_EUR">2150000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-32754"
      unitRef="Unit_EUR">5762000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327489"
      unitRef="Unit_EUR">69000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32756"
      unitRef="Unit_EUR">78000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32757"
      unitRef="Unit_EUR">175000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32758"
      unitRef="Unit_EUR">293000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ChangesInOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32759"
      unitRef="Unit_EUR">615000000</ifrs-full:ChangesInOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327494"
      unitRef="Unit_EUR">167000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32761"
      unitRef="Unit_EUR">61000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32762"
      unitRef="Unit_EUR">10000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32763"
      unitRef="Unit_EUR">378000000</ifrs-full:ProvisionUsedOtherProvisions>
    <ifrs-full:ProvisionUsedOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32764"
      unitRef="Unit_EUR">616000000</ifrs-full:ProvisionUsedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327925"
      unitRef="Unit_EUR">17000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32766"
      unitRef="Unit_EUR">0</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32767"
      unitRef="Unit_EUR">2000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32768"
      unitRef="Unit_EUR">178000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32769"
      unitRef="Unit_EUR">197000000</sny:IncreaseDecreaseOfUnusedProvisionReversedOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327930"
      unitRef="Unit_EUR">-4000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327929"
      unitRef="Unit_EUR">0</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327928"
      unitRef="Unit_EUR">-158000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="Fact_148327927"
      unitRef="Unit_EUR">-93000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327926"
      unitRef="Unit_EUR">-255000000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesOtherProvisions>
    <sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32775"
      unitRef="Unit_EUR">37000000</sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions>
    <sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32776"
      unitRef="Unit_EUR">1000000</sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions>
    <sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32777"
      unitRef="Unit_EUR">2000000</sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions>
    <sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32778"
      unitRef="Unit_EUR">20000000</sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions>
    <sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32779"
      unitRef="Unit_EUR">60000000</sny:IncreaseDecreaseThroughNetInterestRelatedToEmployeesBenefitsAndUnwindingOfDiscountOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32780"
      unitRef="Unit_EUR">-94000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32781"
      unitRef="Unit_EUR">-74000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32782"
      unitRef="Unit_EUR">-4000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32783"
      unitRef="Unit_EUR">-83000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32784"
      unitRef="Unit_EUR">-255000000</ifrs-full:IncreaseDecreaseThroughNetExchangeDifferencesOtherProvisions>
    <sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32785"
      unitRef="Unit_EUR">-111000000</sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions>
    <sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions
      contextRef="P01_01_2025To06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32786"
      unitRef="Unit_EUR">0</sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions>
    <sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions
      contextRef="P01_01_2025To06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32787"
      unitRef="Unit_EUR">0</sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions>
    <sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions
      contextRef="P01_01_2025To06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32788"
      unitRef="Unit_EUR">0</sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions>
    <sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32789"
      unitRef="Unit_EUR">-111000000</sny:IncreaseDecreaseThroughActuarialGainsAndLossesOnDefinedBenefitPlansOtherProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025_ProvisionsForPensionsAndOtherPostemploymentBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32790"
      unitRef="Unit_EUR">1705000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025_ProvisionsForOtherLongTermBenefitsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32791"
      unitRef="Unit_EUR">765000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025_NonCurrentRestructuringProvisionMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32792"
      unitRef="Unit_EUR">802000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025_MiscellaneousOtherProvisionsMemberifrsfullClassesOfProvisionsAxis"
      decimals="-6"
      id="ixv-32793"
      unitRef="Unit_EUR">1731000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:NoncurrentProvisions
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-32794"
      unitRef="Unit_EUR">5003000000</ifrs-full:NoncurrentProvisions>
    <ifrs-full:LiabilityAssetOfDefinedBenefitPlans
      contextRef="PAsOn06_30_2025_GBifrsfullGeographicalAreasAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"
      decimals="-6"
      id="ixv-32795"
      unitRef="Unit_EUR">101000000</ifrs-full:LiabilityAssetOfDefinedBenefitPlans>
    <sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-24849"> &lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Actuarial gains and losses arising on pensions and other post-employment benefits and recognized in equity are as follows (amounts reported before tax): &lt;/div&gt; &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:76%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2025&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:5pt;color:#23004c;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(6&#160;months)&#x2003;&#x2004;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;June&#160;30,&#160;2024&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;div style="font-size: 5pt; color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;font-size:5.5px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:5pt;color:#23004c;display:inline;"&gt;&lt;div style="letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top: 0pt; margin-bottom: 1pt; font-size: 8pt; font-family: Arial; text-align: right; line-height: normal;"&gt;&lt;div style="color: rgb(35, 0, 76); letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="display:inline;"&gt;&lt;div style="font-weight:bolder;display:inline;"&gt;(6&#160;months)&#x2003;&#x2004;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses) on plan assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(45&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;(138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.38em; font-size: 8pt; font-family: Arial; line-height: normal;"&gt;Actuarial gains/(losses) on benefit obligations&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;152&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(a)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;373&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family: Arial; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;&#x2002;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; &lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the &lt;div style="white-space:nowrap;display:inline;"&gt;-0.30%&lt;/div&gt; change in the inflation rate in the United Kingdom in the first half of 2025. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 7pt; font-family: Arial; text-align: justify; line-height: normal;"&gt;&lt;div style="font-style: normal; letter-spacing: 0px; top: 0px;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes actuarial gains/ (losses) related to Opella of &#x20ac;(4)&#160;million for the first half of 2025 and &#x20ac;(6)&#160;million for the first half of 2024 . &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt; </sny:DisclosureOfRemeasurementOfNetDefinedBenefitLiabilityAssetTableTextBlock>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"
      decimals="-6"
      id="Fact_148327911"
      unitRef="Unit_EUR">45000000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis_PlanAssetsMemberifrsfullNetDefinedBenefitLiabilityAssetAxis"
      decimals="-6"
      id="Fact_148327910"
      unitRef="Unit_EUR">138000000</ifrs-full:ReturnOnPlanAssetsNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2025To06_30_2025_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"
      decimals="-6"
      id="Fact_148327909"
      unitRef="Unit_EUR">152000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2024To06_30_2024_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"
      decimals="-6"
      id="Fact_148327908"
      unitRef="Unit_EUR">373000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis"
      decimals="4"
      id="ixv-32800"
      unitRef="Unit_pure">0</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="PAsOn06_30_2025_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis"
      decimals="4"
      id="ixv-32801"
      unitRef="Unit_pure">0.003</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption
      contextRef="PAsOn06_30_2025_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_UKZONEMemberifrsfullGeographicalAreasAxis"
      decimals="4"
      id="ixv-32802"
      unitRef="Unit_pure">0.003</ifrs-full:PercentageOfReasonablyPossibleDecreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MinimumMembersrtRangeAxis"
      decimals="4"
      id="ixv-32803"
      unitRef="Unit_pure">0.004</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="PAsOn06_30_2024_ActuarialAssumptionOfDiscountRatesMemberifrsfullActuarialAssumptionsAxis_MaximumMembersrtRangeAxis"
      decimals="4"
      id="ixv-32804"
      unitRef="Unit_pure">0.0065</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption
      contextRef="PAsOn06_30_2024_ActuarialAssumptionOfExpectedRatesOfInflationMemberifrsfullActuarialAssumptionsAxis_EUROZONEMemberifrsfullGeographicalAreasAxis"
      decimals="4"
      id="ixv-32805"
      unitRef="Unit_pure">0.001</ifrs-full:PercentageOfReasonablyPossibleIncreaseInActuarialAssumption>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"
      decimals="-6"
      id="ixv-32806"
      unitRef="Unit_EUR">-4000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset
      contextRef="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis_PensionsAndOtherPostEmploymentBenefitsMemberifrsfullDefinedBenefitPlansAxis"
      decimals="-6"
      id="ixv-32807"
      unitRef="Unit_EUR">-6000000</ifrs-full:GainLossOnRemeasurementOfNetDefinedBenefitLiabilityAsset>
    <sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25008">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.13. Off balance sheet commitments &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Off balance sheet commitments to third parties as of December&#160;31, 2024 are presented in Note D.21.1. to the consolidated financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The principal commitments entered into, amended or discontinued during the period are described below: &lt;/div&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:1%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;In April 2025, Sanofi entered into a license and collaboration agreement with Earendil Labs for two bispecific antibodies in the field of autoimmune and inflammatory bowel diseases: &lt;div style="white-space:nowrap;display:inline;"&gt;HXN-1002&lt;/div&gt; (targeting &lt;div style="font-family:Times New Roman;display:inline;"&gt;&lt;div style="FONT-FAMILY:SYMBOL;display:inline;"&gt;a&lt;/div&gt;&lt;/div&gt;4&#xdf;7 and TL1A for potential treatment of moderate to severe ulcerative colitis and Crohn&#x2019;s disease) and &lt;div style="white-space:nowrap;display:inline;"&gt;HXN-1003&lt;/div&gt; (targeting TL1A and IL23 for potential treatment of colitis and skin inflammation). Under the terms of the agreement, Earendil Labs received an upfront payment of $125&#160;million, is eligible to receive up to a total of $1.7&#160;billion in development and commercial milestone payments, and is eligible to receive tiered royalties on product sales. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, Sanofi has not entered into any material new long-term renewable energy contract agreements as part of its sustainability strategy. The main existing agreements are presented in Note D.21.1. to the consolidated financial statements in the 2024 Form &lt;div style="white-space:nowrap;display:inline;"&gt;20-F.&lt;/div&gt; &lt;/div&gt;</sny:DisclosureOfOffBalanceSheetCommitmentsExplanatoryTextBlock>
    <ifrs-full:Prepayments
      contextRef="PAsOn04_01_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32808"
      unitRef="Unit_EUR">125000000</ifrs-full:Prepayments>
    <ifrs-full:CommitmentsMadeByEntityRelatedPartyTransactions
      contextRef="P04_01_2025To04_30_2025_EarendilLabsMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-8"
      id="ixv-32809"
      unitRef="Unit_EUR">1700000000</ifrs-full:CommitmentsMadeByEntityRelatedPartyTransactions>
    <sny:DisclosureOfLegalAndArbitralProceedingsTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25028">&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.14. Litigation and arbitration proceedings &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi and its affiliates are involved in litigation, arbitration and other legal proceedings. These proceedings typically are related to product liability claims, intellectual property rights (particularly claims against generic companies seeking to limit the patent protection of Sanofi products), competition law and trade practices, commercial claims, employment and wrongful discharge claims, tax assessment claims, waste disposal and pollution claims, and claims under warranties or indemnification arrangements relating to business divestitures. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The matters discussed below constitute the most significant developments since publication of the financial statements for the year ended December&#160;31, 2024. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.14.1. Products &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Zantac product litigation in the US &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As regards the ongoing Zantac product litigation in the US, the Separation Agreement (see Notes D.1 and D.22 to the consolidated financial statements in the 2024 Form &lt;div style="white-space:nowrap;display:inline;"&gt;20-F)&lt;/div&gt; entered into between Sanofi and Opella specifies that Sanofi will indemnify the Opella group in respect of liabilities relating to (i)&#160;the commercialization of any Zantac branded products (i.e. products containing ranitidine as their active pharmaceutical ingredient) prior to closing, and (ii)&#160;all personal injury claims resulting from the manufacturing or handling of Zantac prior to closing. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In April 2025, Sanofi reached several settlement deals that in total resolve a majority of the Delaware State Court consolidated litigation. In addition, in May 2025, Sanofi reached settlements with the City of Baltimore and the New Mexico Attorney General, amicably resolving both those matters. Other cases are pending in various state courts. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On July&#160;10, 2025, the Delaware Supreme Court unanimously reversed the Superior Court&#x2019;s denial of Defendants&#x2019; &lt;div style="font-style:italic;display:inline;"&gt;Daubert &lt;/div&gt;motion based on the lack of reliability of plaintiff&#x2019;s experts on causation and remanded its findings back to the Superior Court for proceedings consistent with the rulings in the opinion. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Talc product litigation in the US &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As of June&#160;30, 2025, Sanofi was named as a defendant in approximately 900 ongoing product liability actions. To date, no cases have proceeded to trial. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;It is not possible, at this stage, to assess with certainty the outcome of these lawsuits. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.14.2. Patents &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Praluent (alirocumab)-related Amgen patent litigation in Europe &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Regarding Amgen&#x2019;s EP 3 666 797, in April 2025, the Opposition Division of the European Patent Office ruled in Amgen&#x2019;s favor and decided to maintain the patent as granted. Sanofi has appealed this decision to the Technical Board of Appeals of the European Patent Office, and the appeal hearing is scheduled for April 2026. &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plavix (clopidogrel) Litigation (Commonwealth) Litigation in Australia &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;This matter has been finalized with no possibility of appeal. The matter is closed. &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.14.3. Other litigation &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plavix (clopidogrel) - Attorney General action in Hawaii &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In May 2025, the parties agreed to settle the Hawaii action, with Sanofi US to pay $350&#160;million pursuant to its settlement agreement and Bristol-Myers Squibb to pay $350&#160;million pursuant to its separate settlement agreement. The appeal and the underlying case were dismissed pursuant to the settlement. This matter is closed. &lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-size:60pt;margin-top:0pt;margin-bottom:0pt"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Plavix (clopidogrel)-related litigation in France &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In the claim filed by the &lt;div style="font-style:italic;display:inline;"&gt;Caisse Nationale d&#x2019;Assurance Maladie&lt;/div&gt; &lt;div style="font-style:italic;display:inline;"&gt;&#x2013; CNAM&lt;/div&gt; (French Social Security), hearings were held in June 2025. &lt;/div&gt;&lt;div style="margin-top:8pt; margin-bottom:0pt; margin-left:2%; font-size:10pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;340B drug pricing program in the US &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In the action filed by Sanofi against the Department of Health and Human Services (HHS), the Health Resources and Services Administration (HRSA) and their respective administrators, following a joint hearing held on April&#160;29, 2025 in Sanofi&#x2019;s case and the similar cases filed by Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos, the district court held on May&#160;15, 2025 that, although Section&#160;340B does not categorically prohibit the use of manufacturer rebates, it does not allow HRSA to require preapproval of a manufacturer rebate program. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The district court also held that HRSA&#x2019;s letter determining that Sanofi would violate Section&#160;340B if it launched its Credit (rebate) Model was arbitrary and capricious and remanded the Sanofi matter back to HRSA for further consideration. Eli Lilly, Bristol Myers Squibb, Novartis, and Kalderos appealed the district court&#x2019;s decision to the Circuit Court. Those appeals, along with a similar appeal by Johnson&#160;&amp;amp; Johnson, have been expedited and consolidated. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;ADR Proceedings in the US&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In June 2025, Sanofi received notice that Hudson Headwaters Health Network (Hudson Headwaters) had filed a petition for monetary relief against Sanofi before the HRSA ADR (Administrative Dispute Resolution) Panel. Hudson Headwaters alleges that Sanofi has violated Section&#160;340B by allowing only one contract pharmacy to be selected and utilized per covered entity, if the covered entity does not have an &lt;div style="white-space:nowrap;display:inline;"&gt;in-house&lt;/div&gt; pharmacy capable of dispensing its drug. Hudson Headwaters alleges that this Sanofi policy is an &#x201c;overcharge&#x201d; under Section&#160;340B. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial;text-align:justify"&gt;&lt;div style="text-decoration:underline;display:inline;"&gt;State Litigation in the US&lt;/div&gt; &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In lawsuits filed by PhRMA and certain other manufacturers challenging a contract pharmacy law passed by the State of Mississippi, the court denied for each of the plaintiffs their preliminary injunctions in their respective lawsuits. The plaintiffs appealed the denials of the preliminary injunction motions. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Various other challenges to similar state laws have been filed by PhRMA and/or certain manufacturers in a number of other states, including in Colorado, Kansas, Louisiana, Maryland, Minnesota, Missouri, Nebraska, North Dakota, Oklahoma, Tennessee, Utah, South Dakota, and Vermont. &lt;/div&gt;</sny:DisclosureOfLegalAndArbitralProceedingsTextBlock>
    <sny:NumberOfClassActionLawsuits
      contextRef="PAsOn06_30_2025_ActionForWhichWeAreDefendantMemberSNYDefendantAxis_GoldBondProductLitigationInTheUSMemberSNYLegalAndArbitralProceedingsAxis_ProductLiabilitiesMemberifrsfullClassesOfContingentLiabilitiesAxis"
      decimals="INF"
      id="ixv-32810"
      unitRef="Unit_Proceeding">900</sny:NumberOfClassActionLawsuits>
    <sny:PaymentOfDamagesClaimedByCounterparty
      contextRef="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis"
      decimals="-6"
      id="ixv-32811"
      unitRef="Unit_USD">350000000</sny:PaymentOfDamagesClaimedByCounterparty>
    <sny:PenaltyFeeIncurred
      contextRef="P05_01_2025To05_31_2025_ActionForWhichSanofiAreDefendantMemberSNYDefendantAxis_PlavixAttorneyGeneralActionInHawaiiMemberSNYLegalAndArbitralProceedingsAxis"
      decimals="-6"
      id="ixv-32812"
      unitRef="Unit_USD">350000000</sny:PenaltyFeeIncurred>
    <ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-25113">&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.15. Other operating income and expenses &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other operating income&lt;/div&gt;&lt;/div&gt; amounted to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;533&#160;million in the first half of 2025 (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;563&#160;million in the first half of 2024), and &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other operating expenses&lt;/div&gt;&lt;/div&gt; to &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2,476&#160;million (&lt;div style="font-style:italic;display:inline;"&gt;versus&lt;/div&gt; &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;1,977&#160;million in the first half of 2024). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The main items included in &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other operating income&lt;/div&gt;&lt;/div&gt; were: in the first half of 2025, (i) income from pharmaceutical partners of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;87&#160;million (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;121&#160;million in the first half of 2024), of which &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;70&#160;million came from Regeneron (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;96&#160;million in the first half of 2024, see table below) and (ii)&#160;gains on disposals of assets and operations of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;344&#160;million, primarily on divestments of non strategic products (versus &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;319&#160;million in the first half of 2024). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other operating expenses&lt;/div&gt;&lt;/div&gt; for the first half of 2025 included &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2,331&#160;million of expenses related to Regeneron (compared with &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1,841&#160;million in the first half of 2024), as shown in the table below. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Income&#160;&amp;amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(2,475&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,934&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Additional share of profit paid by Regeneron towards development costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;494&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;389&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Reimbursement to Regeneron of selling expenses incurred&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(346)&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(292)&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total: Monoclonal Antibody Alliance&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,327&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,837&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other (mainly Zaltrap and Libtayo)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;66&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;92&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other operating income/(expenses), net related to Regeneron&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,261&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,745&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.75em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which amount presented in &#x201c;Other operating income&#x201d;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;70&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOtherOperatingIncomeExpenseExplanatory>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32814"
      unitRef="Unit_EUR">533000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327520"
      unitRef="Unit_EUR">563000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32816"
      unitRef="Unit_EUR">2476000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327518"
      unitRef="Unit_EUR">1977000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32818"
      unitRef="Unit_EUR">87000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32819"
      unitRef="Unit_EUR">121000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32820"
      unitRef="Unit_EUR">70000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32821"
      unitRef="Unit_EUR">96000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <sny:GainsOnDivestmentOfProducts
      contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32822"
      unitRef="Unit_EUR">344000000</sny:GainsOnDivestmentOfProducts>
    <sny:GainsOnDivestmentOfProducts
      contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis"
      decimals="-6"
      id="ixv-32823"
      unitRef="Unit_EUR">319000000</sny:GainsOnDivestmentOfProducts>
    <sny:OtherOperatingExpensesTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25138">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other operating expenses&lt;/div&gt;&lt;/div&gt; for the first half of 2025 included &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;2,331&#160;million of expenses related to Regeneron (compared with &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;1,841&#160;million in the first half of 2024), as shown in the table below. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Income&#160;&amp;amp; expense related to profit/loss sharing under the Monoclonal Antibody Alliance&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(2,475&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,934&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Additional share of profit paid by Regeneron towards development costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;494&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;389&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Reimbursement to Regeneron of selling expenses incurred&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(346)&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(292)&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total: Monoclonal Antibody Alliance&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,327&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,837&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other (mainly Zaltrap and Libtayo)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;66&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;92&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other operating income/(expenses), net related to Regeneron&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(2,261&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(1,745&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.75em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which amount presented in &#x201c;Other operating income&#x201d;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;70&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:OtherOperatingExpensesTableTextBlock>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32824"
      unitRef="Unit_EUR">2331000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_OtherRelatedPartiesMemberifrsfullCategoriesOfRelatedPartiesAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32825"
      unitRef="Unit_EUR">1841000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32826"
      unitRef="Unit_EUR">2475000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfMonoclonalAntibodiesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32827"
      unitRef="Unit_EUR">1934000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32828"
      unitRef="Unit_EUR">494000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_ShareOfProfitOrLossFromCommercializationOfZaltrapMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32829"
      unitRef="Unit_EUR">389000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32830"
      unitRef="Unit_EUR">346000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis_CommercializationRelatedExpensesMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis"
      decimals="-6"
      id="ixv-32831"
      unitRef="Unit_EUR">292000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2025To06_30_2025_AntibodiesAllianceMembersrtCounterpartyNameAxis"
      decimals="-6"
      id="ixv-32832"
      unitRef="Unit_EUR">2327000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <ifrs-full:MiscellaneousOtherOperatingExpense
      contextRef="P01_01_2024To06_30_2024_AntibodiesAllianceMembersrtCounterpartyNameAxis"
      decimals="-6"
      id="ixv-32833"
      unitRef="Unit_EUR">1837000000</ifrs-full:MiscellaneousOtherOperatingExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2025To06_30_2025_OthersCounterpartyMembersrtCounterpartyNameAxis"
      decimals="-6"
      id="ixv-32834"
      unitRef="Unit_EUR">66000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2024To06_30_2024_OthersCounterpartyMembersrtCounterpartyNameAxis"
      decimals="-6"
      id="ixv-32835"
      unitRef="Unit_EUR">92000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32836"
      unitRef="Unit_EUR">-2261000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:OtherOperatingIncomeExpense
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32837"
      unitRef="Unit_EUR">-1745000000</ifrs-full:OtherOperatingIncomeExpense>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2025To06_30_2025_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32838"
      unitRef="Unit_EUR">70000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <ifrs-full:MiscellaneousOtherOperatingIncome
      contextRef="P01_01_2024To06_30_2024_OtherOperatingIncomeExpenseMemberifrsfullAttributionOfExpensesByNatureToTheirFunctionAxis_RegeneronMemberifrsfullSignificantInvestmentsInAssociatesAxis"
      decimals="-6"
      id="ixv-32839"
      unitRef="Unit_EUR">96000000</ifrs-full:MiscellaneousOtherOperatingIncome>
    <sny:DisclosureOfRestructuringTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25381">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.16. Restructuring costs and similar items &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Restructuring costs and similar items &lt;/div&gt;&lt;/div&gt;comprise the following: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2006;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Employee-related expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;201&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;810&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Charges, gains or losses on assets&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;109&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Costs of transformation programs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;80&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;114&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other restructuring costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;163&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;430&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,060&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Restructuring and similar costs decreased by &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;630&#160;million between June&#160;30, 2024 and June&#160;30, 2025. In the first half of 2024, restructuring and similar costs mainly comprised the impacts of (i)&#160;the renewal of the Job Management and Career Paths (GEPP) program in France to cover the 2024-2026 period, including scope extensions in the job profiles affected by transformations and (ii)&#160;a voluntary redundancy &lt;div style="display:inline;"&gt;program&lt;/div&gt; &lt;div style="display:inline;"&gt;announced&lt;/div&gt; in 2024 in connection with the reorganization of R&amp;amp;D operations to make Sanofi a leader in &lt;div style="display:inline;"&gt;immunology&lt;/div&gt;. &lt;/div&gt;</sny:DisclosureOfRestructuringTextBlock>
    <sny:DisclosureOfRestructuringCostsDetailsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25385">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Restructuring costs and similar items &lt;/div&gt;&lt;/div&gt;comprise the following: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2006;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Employee-related expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;201&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;810&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Charges, gains or losses on assets&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;109&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Costs of transformation programs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;80&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;114&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other restructuring costs&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;163&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;430&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,060&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfRestructuringCostsDetailsTableTextBlock>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32840"
      unitRef="Unit_EUR">201000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328215"
      unitRef="Unit_EUR">810000000</sny:ExpenseOfRestructuringActivitiesEmployeeRelatedExpenses>
    <sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328216"
      unitRef="Unit_EUR">109000000</sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories>
    <sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328217"
      unitRef="Unit_EUR">-27000000</sny:ExpenseOfRestructuringActivitiesRelatedToPropertyPlantAndEquipmentAndToInventories>
    <sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32844"
      unitRef="Unit_EUR">80000000</sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts>
    <sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328219"
      unitRef="Unit_EUR">114000000</sny:ExpenseOfRestructuringActivitiesTransformationProgramsCosts>
    <sny:OtherRestructuringCosts
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32846"
      unitRef="Unit_EUR">40000000</sny:OtherRestructuringCosts>
    <sny:OtherRestructuringCosts
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328221"
      unitRef="Unit_EUR">163000000</sny:OtherRestructuringCosts>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32848"
      unitRef="Unit_EUR">430000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328223"
      unitRef="Unit_EUR">1060000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32850"
      unitRef="Unit_EUR">-630000000</sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities>
    <sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32851"
      unitRef="Unit_EUR">-630000000</sny:IncreaseDecreaseInTotalExpenseOfRestructuringActivities>
    <sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25563">&lt;div style="margin-top:20pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.17. Other gains and losses, and litigation &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;For the first half of 2025, &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other gains and losses, and litigation&lt;/div&gt;&lt;/div&gt; is a charge of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;57&#160;million, mainly related to major litigation. That compares with a charge of &lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;450&#160;million in the first half of 2024, mainly comprising a provision recognized in respect of the litigation related to Plavix (clopidogrel) in the US state of Hawaii. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;</sny:DisclosureOfOtherGainsAndLossesAndLitigationTextBlock>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32852"
      unitRef="Unit_EUR">-57000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32853"
      unitRef="Unit_EUR">-450000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-25574">&lt;div style="margin-top:18pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.18. Financial expenses and income &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;An analysis of financial expenses and income is set forth below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(219&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(306&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Interest income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;162&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of net debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(57&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(67&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;Non-operating&lt;/div&gt; foreign exchange gains/(losses)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Unwinding of discounting of provisions &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(19&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net interest cost related to employee benefits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(39&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net interest expense on lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(161&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net financial income/(expenses)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(177&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(306&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;comprising: Financial expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(361&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(583&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2004;Financial income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;184&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#x20ac;(25)&#160;million in the first half of 2025 and &#x20ac;(24)&#160;million in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#x20ac;(4)&#160;million in the first half of 2025 and &#x20ac;(18)&#160;million in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(e)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes a financial expense of &#x20ac;50&#160;million for the six months ended June&#160;30, 2025 and &#x20ac;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The impact of the ineffective portion of hedging relationships was not material in either 2025 or 2024. &lt;/div&gt;</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25578">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;An analysis of financial expenses and income is set forth below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of debt &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(219&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(306&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Interest income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;162&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;239&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Cost of net debt&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(57&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(67&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;Non-operating&lt;/div&gt; foreign exchange gains/(losses)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Unwinding of discounting of provisions &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(19&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net interest cost related to employee benefits&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(39&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net interest expense on lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(161&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net financial income/(expenses)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(177&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(306&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;comprising: Financial expenses&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(361&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(583&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:6.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2004;Financial income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;184&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;277&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#x20ac;(25)&#160;million in the first half of 2025 and &#x20ac;(24)&#160;million in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#x20ac;(4)&#160;million in the first half of 2025 and &#x20ac;(18)&#160;million in the first half of 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(e)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Includes a financial expense of &#x20ac;50&#160;million for the six months ended June&#160;30, 2025 and &#x20ac;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfFinancialIncomeAndExpensesExplanatoryTableTextBlock>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328226"
      unitRef="Unit_EUR">219000000</ifrs-full:InterestExpenseOnBorrowings>
    <ifrs-full:InterestExpenseOnBorrowings
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328227"
      unitRef="Unit_EUR">306000000</ifrs-full:InterestExpenseOnBorrowings>
    <sny:InterestIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328228"
      unitRef="Unit_EUR">162000000</sny:InterestIncome>
    <sny:InterestIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328229"
      unitRef="Unit_EUR">239000000</sny:InterestIncome>
    <sny:CostOfDebtNet
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32858"
      unitRef="Unit_EUR">57000000</sny:CostOfDebtNet>
    <sny:CostOfDebtNet
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32859"
      unitRef="Unit_EUR">67000000</sny:CostOfDebtNet>
    <sny:NonOperatingForeignExchangeGainsLosses
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32860"
      unitRef="Unit_EUR">1000000</sny:NonOperatingForeignExchangeGainsLosses>
    <sny:NonOperatingForeignExchangeGainsLosses
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32861"
      unitRef="Unit_EUR">0</sny:NonOperatingForeignExchangeGainsLosses>
    <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328234"
      unitRef="Unit_EUR">22000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
    <ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328235"
      unitRef="Unit_EUR">19000000</ifrs-full:ExpenseDueToUnwindingOfDiscountOnProvisions>
    <sny:NetInterestCostRelatedToEmployeeBenefits
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32864"
      unitRef="Unit_EUR">37000000</sny:NetInterestCostRelatedToEmployeeBenefits>
    <sny:NetInterestCostRelatedToEmployeeBenefits
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32865"
      unitRef="Unit_EUR">39000000</sny:NetInterestCostRelatedToEmployeeBenefits>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32866"
      unitRef="Unit_EUR">22000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32867"
      unitRef="Unit_EUR">20000000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148328240"
      unitRef="Unit_EUR">-40000000</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:OtherFinanceIncomeCost
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328241"
      unitRef="Unit_EUR">-161000000</ifrs-full:OtherFinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32870"
      unitRef="Unit_EUR">-177000000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32871"
      unitRef="Unit_EUR">-306000000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32872"
      unitRef="Unit_EUR">361000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32873"
      unitRef="Unit_EUR">583000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32874"
      unitRef="Unit_EUR">184000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32875"
      unitRef="Unit_EUR">277000000</ifrs-full:FinanceIncome>
    <sny:GainLossOnDerivativesUsedToManageDebt
      contextRef="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"
      decimals="-6"
      id="ixv-32876"
      unitRef="Unit_EUR">-25000000</sny:GainLossOnDerivativesUsedToManageDebt>
    <sny:GainLossOnDerivativesUsedToManageDebt
      contextRef="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"
      decimals="-6"
      id="ixv-32877"
      unitRef="Unit_EUR">-24000000</sny:GainLossOnDerivativesUsedToManageDebt>
    <sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents
      contextRef="P01_01_2025To06_30_2025_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"
      decimals="-6"
      id="ixv-32878"
      unitRef="Unit_EUR">-4000000</sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents>
    <sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents
      contextRef="P01_01_2024To06_30_2024_InterestRateAndCurrencyDerivativesMemberifrsfullHedgedItemsAxis"
      decimals="-6"
      id="ixv-32879"
      unitRef="Unit_EUR">-18000000</sny:GainLossOnDerivativesUsedToManageCashAndCashEquivalents>
    <sny:LiabilityRecognisedForEstimatedFutureRoyalties
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32880"
      unitRef="Unit_EUR">50000000</sny:LiabilityRecognisedForEstimatedFutureRoyalties>
    <sny:LiabilityRecognisedForEstimatedFutureRoyalties
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32881"
      unitRef="Unit_EUR">176000000</sny:LiabilityRecognisedForEstimatedFutureRoyalties>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-25941">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.19. Income tax expense &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sanofi has elected for tax consolidations in a number of countries, principally France, Germany, the United Kingdom and the United States. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the allocation of income tax expense between current and deferred taxes: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2006;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Current taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,202&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,108&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Deferred taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2007;&#x2002;&#x2002;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;491&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;729&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(711&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(379&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,582&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,462&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The difference between the effective tax rate (on income before tax and investments accounted for using the equity method) and the standard corporate income tax rate applicable in France is explained as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:79%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(as a percentage)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Standard tax rate applicable in France&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;25.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;25.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Difference between the standard French tax rate and the rates applicable to Sanofi&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(15.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Revisions to tax exposures and settlements of tax disputes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective tax rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The 2024 component of the temporary exceptional corporate income tax contribution, introduced under the 2025 French Finance Bill, is included in the tax charge but excluded from the calculation of the annual average effective tax rate in accordance with IAS 34. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the six months ended June&#160;30, 2025, this line includes a tax expense of &#x20ac;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#x2019;s current understanding of Pillar Two rules, and &#x20ac;52&#160;million for the six months ended June&#160;30, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-25946">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the allocation of income tax expense between current and deferred taxes: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:69%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2006;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt;&#160;million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(6 months)&#160;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Current taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,202&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,108&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Deferred taxes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2007;&#x2002;&#x2002;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;491&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;&#x2003;729&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(711&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;(379&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,582&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,462&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfAllocationOfIncomeTaxBetweenCurrentAndDeferredTaxesTableTextBlock>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32882"
      unitRef="Unit_EUR">1202000000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328187"
      unitRef="Unit_EUR">1108000000</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32884"
      unitRef="Unit_EUR">-491000000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328189"
      unitRef="Unit_EUR">-729000000</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32886"
      unitRef="Unit_EUR">711000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328191"
      unitRef="Unit_EUR">379000000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32888"
      unitRef="Unit_EUR">3582000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328193"
      unitRef="Unit_EUR">2462000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-26093">&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The difference between the effective tax rate (on income before tax and investments accounted for using the equity method) and the standard corporate income tax rate applicable in France is explained as follows: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:79%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:7%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(as a percentage)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)(b)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Standard tax rate applicable in France&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;25.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;25.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Difference between the standard French tax rate and the rates applicable to Sanofi&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(15.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Revisions to tax exposures and settlements of tax disputes&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.3&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt; (d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1.0&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Effective tax rate&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;15.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The 2024 component of the temporary exceptional corporate income tax contribution, introduced under the 2025 French Finance Bill, is included in the tax charge but excluded from the calculation of the annual average effective tax rate in accordance with IAS 34. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the six months ended June&#160;30, 2025, this line includes a tax expense of &#x20ac;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#x2019;s current understanding of Pillar Two rules, and &#x20ac;52&#160;million for the six months ended June&#160;30, 2024. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfReconciliationOfAverageEffectiveTaxRateAndApplicableTaxRateExplanatoryTableTextBlock>
    <ifrs-full:ApplicableTaxRate
      contextRef="P01_01_2025To06_30_2025"
      decimals="3"
      id="Fact_148328194"
      unitRef="Unit_pure">0.258</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="P01_01_2024To06_30_2024"
      decimals="3"
      id="Fact_148328195"
      unitRef="Unit_pure">0.258</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="P01_01_2025To06_30_2025"
      decimals="3"
      id="Fact_148328196"
      unitRef="Unit_pure">-0.073</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <ifrs-full:TaxRateEffectOfForeignTaxRates
      contextRef="P01_01_2024To06_30_2024"
      decimals="3"
      id="Fact_148328197"
      unitRef="Unit_pure">-0.155</ifrs-full:TaxRateEffectOfForeignTaxRates>
    <sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes
      contextRef="P01_01_2025To06_30_2025"
      decimals="3"
      id="Fact_148328198"
      unitRef="Unit_pure">0.023</sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes>
    <sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes
      contextRef="P01_01_2024To06_30_2024"
      decimals="3"
      id="Fact_148328199"
      unitRef="Unit_pure">0.023</sny:RevisionsToTaxExposuresAndSettlementsOfTaxDisputes>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="3"
      id="Fact_148328200"
      unitRef="Unit_pure">-0.01</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="3"
      id="Fact_148328201"
      unitRef="Unit_pure">0.028</ifrs-full:OtherTaxRateEffectsForReconciliationBetweenAccountingProfitAndTaxExpenseIncome>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="P01_01_2025To06_30_2025"
      decimals="3"
      id="Fact_148328202"
      unitRef="Unit_pure">0.198</ifrs-full:AverageEffectiveTaxRate>
    <ifrs-full:AverageEffectiveTaxRate
      contextRef="P01_01_2024To06_30_2024"
      decimals="3"
      id="Fact_148328203"
      unitRef="Unit_pure">0.154</ifrs-full:AverageEffectiveTaxRate>
    <sny:CurrentTaxExpenseRelatedToPillarTwo
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-32900"
      unitRef="Unit_EUR">17000000</sny:CurrentTaxExpenseRelatedToPillarTwo>
    <sny:CurrentTaxExpenseRelatedToPillarTwo
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-32901"
      unitRef="Unit_EUR">52000000</sny:CurrentTaxExpenseRelatedToPillarTwo>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-26301">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.20. Revenue from contracts with customers &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.20.1. Analysis of net sales &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial"&gt;The table below sets forth net sales for the six months ended June&#160;30, 2025 and June&#160;30, 2024: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:8%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:33%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Europe&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;United&lt;br/&gt;States&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;countries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Europe&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;United&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;States&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;countries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2024 &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Group&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,144&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,535&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,210&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,072&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,292&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,996&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Immunology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Dupixent&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;944&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,283&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,085&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,312&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;770&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,437&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;931&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6,138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rare diseases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;ALTUVIIIO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;456&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;542&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;259&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;21&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;280&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Nexviazyme/Nexviadyme&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;132&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;195&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;387&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;174&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;51&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;320&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Cablivi&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;55&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;71&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;136&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;43&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;113&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Xenpozyme&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;47&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;19&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;110&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;24&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Neurology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Aubagio&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;18&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Oncology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Sarclisa&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;83&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;119&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;74&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;276&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;64&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;100&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;63&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;227&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other medicines&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Rezurock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;220&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;263&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;12&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;188&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;207&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Tzield&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;21&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Industrial sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;241&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;251&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;273&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;274&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vaccines&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"&gt;Polio/Pertussis/&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial"&gt;Hib Vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;223&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;320&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;818&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,361&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;248&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;311&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;789&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,348&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Meningitis, travel and endemics vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;319&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;194&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;609&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;301&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;185&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;583&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;RSV vaccine (Beyfortus)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;85&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;203&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;356&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;116&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Influenza Vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;52&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;54&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;108&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;214&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;30&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;142&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;188&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,144&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,535&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,210&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,072&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,292&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,996&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.20.2. Other revenues &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;VaxServe sales of &lt;div style="white-space:nowrap;display:inline;"&gt;non-Sanofi&lt;/div&gt; products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;842&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;854&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Sales to Opella &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;62&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;275&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;341&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2007;Total Biopharma Other revenues&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,246&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,352&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Sales / Revenues from Opella products&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;206&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;177&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2007;Total Other revenues&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,452&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,529&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfRevenueExplanatory>
    <ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-26306">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:9pt; font-family:Arial"&gt;The table below sets forth net sales for the six months ended June&#160;30, 2025 and June&#160;30, 2024: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:8%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="width:33%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:1%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Europe&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;United&lt;br/&gt;States&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;countries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Europe&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;United&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;States&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial;text-align:right"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;countries&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2024 &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#23004c"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total Group&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,144&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,535&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,210&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,072&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,292&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,996&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#23004c"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#23004c"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Immunology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Dupixent&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;944&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,283&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,085&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,312&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;770&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,437&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;931&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6,138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Rare diseases&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;ALTUVIIIO&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;456&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;86&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;542&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;259&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;21&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;280&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Nexviazyme/Nexviadyme&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;132&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;195&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;387&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;174&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;51&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;320&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Cablivi&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;55&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;71&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;136&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;43&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;60&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;10&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;113&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Xenpozyme&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;44&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;47&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;19&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;110&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;24&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;37&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;11&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;72&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Neurology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Aubagio&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;40&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;76&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;22&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;138&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;18&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;209&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Oncology&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Sarclisa&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;83&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;119&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;74&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;276&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;64&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;100&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;63&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;227&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other medicines&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Rezurock&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;23&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;220&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;263&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;12&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;188&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;207&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Tzield&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;27&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;29&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;20&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;21&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Industrial sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;241&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;251&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;273&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;274&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Vaccines&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;of which&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Arial"&gt;Polio/Pertussis/&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Arial"&gt;Hib Vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;223&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;320&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;818&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,361&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;248&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;311&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;789&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,348&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:middle"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Meningitis, travel and endemics vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;96&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;319&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;194&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;609&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;97&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;301&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;185&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;583&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;RSV vaccine (Beyfortus)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;85&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;203&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;356&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;116&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;200&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="2" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;white-space:nowrap"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;Influenza Vaccines&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;52&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;54&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;108&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;214&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;30&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;142&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;188&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td colspan="3" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td colspan="3" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.63em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,144&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,535&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;6,210&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,072&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;8,292&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,996&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32902"
      unitRef="Unit_EUR">4144000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32903"
      unitRef="Unit_EUR">9535000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32904"
      unitRef="Unit_EUR">6210000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32905"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32906"
      unitRef="Unit_EUR">4072000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32907"
      unitRef="Unit_EUR">8292000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32908"
      unitRef="Unit_EUR">5996000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328117"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32910"
      unitRef="Unit_EUR">944000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32911"
      unitRef="Unit_EUR">5283000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32912"
      unitRef="Unit_EUR">1085000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32913"
      unitRef="Unit_EUR">7312000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32914"
      unitRef="Unit_EUR">770000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32915"
      unitRef="Unit_EUR">4437000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32916"
      unitRef="Unit_EUR">931000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_DupixentMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328121"
      unitRef="Unit_EUR">6138000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32918"
      unitRef="Unit_EUR">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32919"
      unitRef="Unit_EUR">456000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32920"
      unitRef="Unit_EUR">86000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32921"
      unitRef="Unit_EUR">542000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32922"
      unitRef="Unit_EUR">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32923"
      unitRef="Unit_EUR">259000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32924"
      unitRef="Unit_EUR">21000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AltuviiioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328125"
      unitRef="Unit_EUR">280000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32926"
      unitRef="Unit_EUR">132000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32927"
      unitRef="Unit_EUR">195000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32928"
      unitRef="Unit_EUR">60000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32929"
      unitRef="Unit_EUR">387000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32930"
      unitRef="Unit_EUR">95000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32931"
      unitRef="Unit_EUR">174000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32932"
      unitRef="Unit_EUR">51000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_NexviazymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328129"
      unitRef="Unit_EUR">320000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32934"
      unitRef="Unit_EUR">55000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32935"
      unitRef="Unit_EUR">71000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32936"
      unitRef="Unit_EUR">10000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32937"
      unitRef="Unit_EUR">136000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32938"
      unitRef="Unit_EUR">43000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32939"
      unitRef="Unit_EUR">60000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32940"
      unitRef="Unit_EUR">10000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_CabliviMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328133"
      unitRef="Unit_EUR">113000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32942"
      unitRef="Unit_EUR">44000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32943"
      unitRef="Unit_EUR">47000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32944"
      unitRef="Unit_EUR">19000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32945"
      unitRef="Unit_EUR">110000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32946"
      unitRef="Unit_EUR">24000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32947"
      unitRef="Unit_EUR">37000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32948"
      unitRef="Unit_EUR">11000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_XenpozymeMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328137"
      unitRef="Unit_EUR">72000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32950"
      unitRef="Unit_EUR">40000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32951"
      unitRef="Unit_EUR">76000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32952"
      unitRef="Unit_EUR">22000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-32953"
      unitRef="Unit_EUR">138000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32954"
      unitRef="Unit_EUR">95000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32955"
      unitRef="Unit_EUR">96000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32956"
      unitRef="Unit_EUR">18000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_AubagioMemberifrsfullProductsAndServicesAxis_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328141"
      unitRef="Unit_EUR">209000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32958"
      unitRef="Unit_EUR">83000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32959"
      unitRef="Unit_EUR">119000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32960"
      unitRef="Unit_EUR">74000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32961"
      unitRef="Unit_EUR">276000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32962"
      unitRef="Unit_EUR">64000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32963"
      unitRef="Unit_EUR">100000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32964"
      unitRef="Unit_EUR">63000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_SarclisaMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328145"
      unitRef="Unit_EUR">227000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32966"
      unitRef="Unit_EUR">23000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32967"
      unitRef="Unit_EUR">220000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32968"
      unitRef="Unit_EUR">20000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32969"
      unitRef="Unit_EUR">263000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32970"
      unitRef="Unit_EUR">12000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32971"
      unitRef="Unit_EUR">188000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32972"
      unitRef="Unit_EUR">7000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RezurockMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328149"
      unitRef="Unit_EUR">207000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32974"
      unitRef="Unit_EUR">1000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32975"
      unitRef="Unit_EUR">27000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32976"
      unitRef="Unit_EUR">1000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32977"
      unitRef="Unit_EUR">29000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32978"
      unitRef="Unit_EUR">1000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32979"
      unitRef="Unit_EUR">20000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32980"
      unitRef="Unit_EUR">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_TzieldMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328153"
      unitRef="Unit_EUR">21000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32982"
      unitRef="Unit_EUR">241000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32983"
      unitRef="Unit_EUR">1000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32984"
      unitRef="Unit_EUR">9000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32985"
      unitRef="Unit_EUR">251000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32986"
      unitRef="Unit_EUR">273000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32987"
      unitRef="Unit_EUR">1000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32988"
      unitRef="Unit_EUR">0</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_IndustrialSalesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328157"
      unitRef="Unit_EUR">274000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32990"
      unitRef="Unit_EUR">223000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32991"
      unitRef="Unit_EUR">320000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32992"
      unitRef="Unit_EUR">818000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32993"
      unitRef="Unit_EUR">1361000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32994"
      unitRef="Unit_EUR">248000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32995"
      unitRef="Unit_EUR">311000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32996"
      unitRef="Unit_EUR">789000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_PolioPertussisHibVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328161"
      unitRef="Unit_EUR">1348000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-32998"
      unitRef="Unit_EUR">96000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-32999"
      unitRef="Unit_EUR">319000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33000"
      unitRef="Unit_EUR">194000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33001"
      unitRef="Unit_EUR">609000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33002"
      unitRef="Unit_EUR">97000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33003"
      unitRef="Unit_EUR">301000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33004"
      unitRef="Unit_EUR">185000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_MeningitisTravelAndEndemicVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328165"
      unitRef="Unit_EUR">583000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33006"
      unitRef="Unit_EUR">85000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33007"
      unitRef="Unit_EUR">68000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33008"
      unitRef="Unit_EUR">203000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33009"
      unitRef="Unit_EUR">356000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33010"
      unitRef="Unit_EUR">7000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33011"
      unitRef="Unit_EUR">116000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33012"
      unitRef="Unit_EUR">77000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_RSVVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328169"
      unitRef="Unit_EUR">200000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33014"
      unitRef="Unit_EUR">52000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33015"
      unitRef="Unit_EUR">54000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33016"
      unitRef="Unit_EUR">108000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33017"
      unitRef="Unit_EUR">214000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_EuropeMemberifrsfullGeographicalAreasAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="ixv-33018"
      unitRef="Unit_EUR">30000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33019"
      unitRef="Unit_EUR">16000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33020"
      unitRef="Unit_EUR">142000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis_InfluenzaVaccinesMemberifrsfullProductsAndServicesAxis"
      decimals="-6"
      id="Fact_148328173"
      unitRef="Unit_EUR">188000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33022"
      unitRef="Unit_EUR">4144000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33023"
      unitRef="Unit_EUR">9535000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33024"
      unitRef="Unit_EUR">6210000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33025"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33026"
      unitRef="Unit_EUR">4072000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33027"
      unitRef="Unit_EUR">8292000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_OtherCountriesMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33028"
      unitRef="Unit_EUR">5996000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328177"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <sny:DisclosureOfOtherRevenueTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-28055">
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;VaxServe sales of &lt;div style="white-space:nowrap;display:inline;"&gt;non-Sanofi&lt;/div&gt; products&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;842&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;854&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Sales to Opella &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;95&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Royalties&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;68&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;62&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Other&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;275&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;341&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2007;Total Biopharma Other revenues&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,246&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,352&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2007;Sales / Revenues from Opella products&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;206&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;177&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2007;Total Other revenues&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,452&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,529&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfOtherRevenueTextBlock>
    <sny:RevenueFromVaxServeSalesOfNonSanofiProducts
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33030"
      unitRef="Unit_EUR">842000000</sny:RevenueFromVaxServeSalesOfNonSanofiProducts>
    <sny:RevenueFromVaxServeSalesOfNonSanofiProducts
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328037"
      unitRef="Unit_EUR">854000000</sny:RevenueFromVaxServeSalesOfNonSanofiProducts>
    <sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328038"
      unitRef="Unit_EUR">61000000</sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations>
    <sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328039"
      unitRef="Unit_EUR">95000000</sny:RevenueFromIntragroupSalesFromContinuingToDiscontinuedOperations>
    <ifrs-full:RevenueFromRoyalties
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33034"
      unitRef="Unit_EUR">68000000</ifrs-full:RevenueFromRoyalties>
    <ifrs-full:RevenueFromRoyalties
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328041"
      unitRef="Unit_EUR">62000000</ifrs-full:RevenueFromRoyalties>
    <sny:MiscellaneousOtherRevenue
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328042"
      unitRef="Unit_EUR">275000000</sny:MiscellaneousOtherRevenue>
    <sny:MiscellaneousOtherRevenue
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328043"
      unitRef="Unit_EUR">341000000</sny:MiscellaneousOtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33038"
      unitRef="Unit_EUR">1246000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328045"
      unitRef="Unit_EUR">1352000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328046"
      unitRef="Unit_EUR">206000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024_OpellaBusinessMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148328047"
      unitRef="Unit_EUR">177000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33042"
      unitRef="Unit_EUR">1452000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148328049"
      unitRef="Unit_EUR">1529000000</ifrs-full:OtherRevenue>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-28307">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.21. Segment information &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The segment information presented by Sanofi consists of a single operating segment: Biopharma. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The Biopharma operating segment comprises commercial operations and research, development and production activities relating to the Specialty Care, General Medicines and Vaccines franchises plus support and corporate functions, for all geographical territories. It also includes revenues generated from the manufacture of Consumer Healthcare products invoiced to Opella, which constitutes a related party with effect from the deconsolidation date (April 30, 2025). Those revenues, which before that date represented intragroup transactions classified within continuing operations, are presented within &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other Revenues&lt;/div&gt;&lt;/div&gt; in the income statement. The Biopharma operating segment also includes the purchase price of Biopharma products manufactured by Opella. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The &#x201c;Other&#x201d; category comprises primarily, but not exclusively, Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights). &lt;/div&gt;&lt;div style="margin-top:14pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.21.1. Segment results &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial"&gt;Sanofi reports segment results on the basis of &#x201c;Business operating income&#x201d;. This indicator is used internally by Sanofi&#x2019;s chief operating decision maker to measure the performance of the operating segment and to allocate resources. &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;&#x201c;Business operating income&#x201d; is derived from &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Operating income&lt;/div&gt;&lt;/div&gt;, adjusted as follows: &lt;/div&gt;&lt;div style="font-size:4pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;amortization and impairment losses charged against intangible assets (other than software and other rights of an industrial or operational nature), are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;fair value remeasurements of contingent consideration relating to business combinations (IFRS 3) or business divestments, and presented within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Fair value remeasurement of contingent consideration&lt;/div&gt;&lt;/div&gt;, are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;expenses arising from the remeasurement of inventories following business combinations (IFRS 3) or acquisitions of groups of assets that do not constitute a business within the meaning of paragraph 2b of IFRS 3, are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;amounts reported within the line items &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Restructuring costs and similar items &lt;/div&gt;&lt;/div&gt;are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;other gains and losses (including gains and losses on major divestments), presented within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other gains and losses, and litigation&lt;/div&gt;&lt;/div&gt;, are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;other costs and provisions related to litigation, presented within the line item &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Other gains and losses, and litigation&lt;/div&gt;&lt;/div&gt;, are eliminated; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;the share of profits/losses from investments accounted for using the equity method is added, to the extent that this relates to joint ventures and associates with which Sanofi has a strategic alliance; and &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:2pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8.5pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:2%;vertical-align:top;text-align:left"&gt;&#x2022;&lt;/td&gt;
&lt;td style="width:1%;vertical-align:top"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-family:Arial; font-size:8.5pt;text-align:justify"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;/div&gt;the portion attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests related to continuing operations and excluding the effects of the above reconciliation items, is deducted. &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:right"&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Segment results are shown in the table below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:44%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="36" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="34" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025 (6 months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+8.3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+9.9&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+8.3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+9.9&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,246&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-7.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-6.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;206&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+16.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+15.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,452&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-5.0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-3.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of sales&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,753&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-1.6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-0.1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(128&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+16.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+14.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,881&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-1.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+0.2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Research and development expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,716&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+11.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+12.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,717&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+11.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+12.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Selling and general expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,447&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+4.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(59&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,506&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+4.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other operating income and expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,941&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,943&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,347&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+8.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+11.0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;-27.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;-27.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,363&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+8.6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+10.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;As % of net sales&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;26.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;&#x2007;27.0%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:75%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2024 (6 months) (a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,352&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;177&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,529&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of sales&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,849&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(110&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,959&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Research and development expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,334&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,335&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Selling and general expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,247&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(56&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,303&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other operating income and expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,426&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;12&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,414&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,916&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,938&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial"&gt;The table below, presented in compliance with IFRS 8, shows a reconciliation between &#x201c;Business operating income&#x201d; and &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:79%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,363&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,938&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Amortization and impairment of intangible assets&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(987&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(527&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Fair value remeasurement of contingent consideration&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Expense arising from the impact of acquisitions on inventories&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Restructuring costs and similar items&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(f)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(430&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,060&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other gains and losses, and litigation&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(g)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(57&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(450&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,759&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,768&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Financial expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(361&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(583&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Financial income&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;277&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,582&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,462&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint ventures and associates with which Sanofi has entered into a strategic alliance. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#x20ac;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#x20ac;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(e)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(f)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.16. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(g)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.17. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:7pt; font-family:Arial"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt; &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;/div&gt;&lt;div style="margin-top:0pt;margin-bottom:0pt ; font-size:8pt"&gt;&#160;&lt;/div&gt;&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.21.2. Other segment information &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The tables below show the split by operating segment of (i)&#160;the carrying amount of investments in joint ventures and associates accounted for using the equity method with which Sanofi has entered into a collaboration agreement; (ii)&#160;acquisitions of property, plant and equipment; and (iii)&#160;acquisitions of intangible assets. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Investments accounted for using the equity method mainly comprise MSP Vaccine Company and Infraserv GmbH&#160;&amp;amp; Co. H&#xf6;chst&#160;KG (see Note B.5.). &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Investments accounted for using the equity method &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;483&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;229&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Acquisitions of property, plant and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;845&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;882&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Acquisitions of other intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;575&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;922&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Carrying amount at the end of the reporting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.21.3. Information by geographical region &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The geographical information on net sales provided below is based on the geographical location of the customer. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,144&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,072&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which France&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;835&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;855&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9,535&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,292&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Rest of the World&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6,210&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,996&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which China&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,388&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,406&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In accordance with IFRS 8, the &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; assets reported below exclude financial instruments, deferred tax assets, &lt;div style="white-space:nowrap;display:inline;"&gt;pre-funded&lt;/div&gt; pension obligations, and &lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets as determined under IFRS 16. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;br/&gt;intangible&lt;br/&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;br/&gt;intangible&lt;br/&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,438&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,550&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,307&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which France&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,953&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,112&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,080&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;16,725&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,411&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;18,711&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Rest of the World&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,056&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;539&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,130&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;611&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which China&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;83&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,574&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;40,283&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,091&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;43,384&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,629&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;As stated in Note D.5. to the consolidated financial statements for the year ended December&#160;31, 2024, goodwill is not allocated by geographical region. &lt;/div&gt;&lt;div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Arial;font-weight:bold"&gt;B.21.4. Disclosures about major customers &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Sales generated by Sanofi with its biggest customers, in particular certain wholesalers in the United States, represented 35% of net sales in the first half of 2025. Sanofi&#x2019;s three largest customers respectively accounted for approximately 18%, 12% and 5% of consolidated net sales in the first half of 2025 (versus approximately 13%, 9% and 7% in the first half of 2024). &lt;/div&gt;</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-28425">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Segment results are shown in the table below: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:44%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:2%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="36" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="34" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025 (6 months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&lt;br/&gt;2025&lt;/div&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 on a&lt;br/&gt;reported&lt;br/&gt;basis&#160;(IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Change&#160;vs.&lt;br/&gt;June&#160;30,&lt;br/&gt;2024 at&lt;br/&gt;constant&lt;br/&gt;exchange&lt;br/&gt;rates&lt;br/&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;(non-IFRS)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+8.3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+9.9&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+8.3&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+9.9&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&lt;/div&gt;&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,246&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-7.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-6.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;206&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+16.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+15.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,452&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-5.0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-3.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of sales&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,753&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-1.6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-0.1&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(128&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+16.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+14.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,881&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;-1.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+0.2&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Research and development expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,716&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+11.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+12.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,717&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+11.5&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+12.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Selling and general expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,447&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+4.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(59&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.4&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,506&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+4.7&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;+5.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other operating income and expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,941&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(2&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,943&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,347&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+8.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+11.0&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;16&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;-27.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;-27.3&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,363&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+8.6&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;+10.8&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2003;As % of net sales&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;26.9&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;%&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2007;&#x2007;27.0%&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:75%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:4%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2024 (6 months) (a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Other&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;white-space:nowrap;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2003;&#x2003;Total&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#ffffff"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-size:x-small;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other revenues&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,352&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;177&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,529&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Cost of sales&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,849&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(110&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(5,959&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Research and development expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,334&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(3,335&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Selling and general expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,247&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(56&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(4,303&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other operating income and expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,426&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;12&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,414&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,916&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,938&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33044"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33045"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33046"
      unitRef="Unit_EUR">1246000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33047"
      unitRef="Unit_EUR">206000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33048"
      unitRef="Unit_EUR">1452000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33049"
      unitRef="Unit_EUR">5753000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33050"
      unitRef="Unit_EUR">128000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33051"
      unitRef="Unit_EUR">5881000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33052"
      unitRef="Unit_EUR">3716000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33053"
      unitRef="Unit_EUR">1000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33054"
      unitRef="Unit_EUR">3717000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33055"
      unitRef="Unit_EUR">4447000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33056"
      unitRef="Unit_EUR">59000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33057"
      unitRef="Unit_EUR">4506000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33058"
      unitRef="Unit_EUR">-1941000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33059"
      unitRef="Unit_EUR">-2000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33060"
      unitRef="Unit_EUR">-1943000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33061"
      unitRef="Unit_EUR">77000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33062"
      unitRef="Unit_EUR">0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33063"
      unitRef="Unit_EUR">77000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33064"
      unitRef="Unit_EUR">-8000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33065"
      unitRef="Unit_EUR">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33066"
      unitRef="Unit_EUR">-8000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33067"
      unitRef="Unit_EUR">5347000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2025To06_30_2025_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33068"
      unitRef="Unit_EUR">16000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2025To06_30_2025_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33069"
      unitRef="Unit_EUR">5363000000</sny:BusinessOperatingIncome>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327680"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327681"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327682"
      unitRef="Unit_EUR">1352000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327683"
      unitRef="Unit_EUR">177000000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327684"
      unitRef="Unit_EUR">1529000000</ifrs-full:OtherRevenue>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327685"
      unitRef="Unit_EUR">5849000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327686"
      unitRef="Unit_EUR">110000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327687"
      unitRef="Unit_EUR">5959000000</ifrs-full:CostOfSales>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327688"
      unitRef="Unit_EUR">3334000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327689"
      unitRef="Unit_EUR">1000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:ResearchAndDevelopmentExpense
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327690"
      unitRef="Unit_EUR">3335000000</ifrs-full:ResearchAndDevelopmentExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327691"
      unitRef="Unit_EUR">4247000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327692"
      unitRef="Unit_EUR">56000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <ifrs-full:SellingGeneralAndAdministrativeExpense
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327693"
      unitRef="Unit_EUR">4303000000</ifrs-full:SellingGeneralAndAdministrativeExpense>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327694"
      unitRef="Unit_EUR">-1426000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327695"
      unitRef="Unit_EUR">12000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <sny:MiscellaneousOtherOperatingIncomeExpenses
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327696"
      unitRef="Unit_EUR">-1414000000</sny:MiscellaneousOtherOperatingIncomeExpenses>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327697"
      unitRef="Unit_EUR">66000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327698"
      unitRef="Unit_EUR">0</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327699"
      unitRef="Unit_EUR">66000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327700"
      unitRef="Unit_EUR">-6000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327701"
      unitRef="Unit_EUR">0</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327702"
      unitRef="Unit_EUR">-6000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327703"
      unitRef="Unit_EUR">4916000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2024To06_30_2024_AllOtherSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327704"
      unitRef="Unit_EUR">22000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2024To06_30_2024_ReportableSegmentsMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327705"
      unitRef="Unit_EUR">4938000000</sny:BusinessOperatingIncome>
    <sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-29815">&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:9pt; font-family:Arial"&gt;The table below, presented in compliance with IFRS 8, shows a reconciliation between &#x201c;Business operating income&#x201d; and &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:79%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;br/&gt;(6&#160;months)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;br/&gt;(6&#160;months)&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Business operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;5,363&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;4,938&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Share of profit/(loss) from investments accounted for using the equity method&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(77&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Net income attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(c)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Amortization and impairment of intangible assets&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(d)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(987&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(527&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Fair value remeasurement of contingent consideration&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(61&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(66&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Expense arising from the impact of acquisitions on inventories&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(e)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Restructuring costs and similar items&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(f)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(430&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(1,060&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#ffffff"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Other gains and losses, and litigation&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(g)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(57&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(450&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Operating income&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,759&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,768&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Financial expenses&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(361&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(583&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;Financial income&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;184&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;277&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.38em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Income before tax and investments accounted for using the equity method&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;3,582&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,462&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for the 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(b)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Joint ventures and associates with which Sanofi has entered into a strategic alliance. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(c)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to &lt;div style="white-space:nowrap;display:inline;"&gt;non-controlling&lt;/div&gt; interests. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(d)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#x20ac;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#x20ac;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(e)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(f)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.16. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(g)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;See Note B.17. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfOperatingSegmentsReconcilingItemsTableTextBlock>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2025To06_30_2025_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="ixv-33096"
      unitRef="Unit_EUR">5363000000</sny:BusinessOperatingIncome>
    <sny:BusinessOperatingIncome
      contextRef="P01_01_2024To06_30_2024_OperatingSegmentsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327707"
      unitRef="Unit_EUR">4938000000</sny:BusinessOperatingIncome>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327708"
      unitRef="Unit_EUR">-77000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327709"
      unitRef="Unit_EUR">-66000000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327710"
      unitRef="Unit_EUR">8000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327711"
      unitRef="Unit_EUR">6000000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327712"
      unitRef="Unit_EUR">987000000</sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill>
    <sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327713"
      unitRef="Unit_EUR">527000000</sny:AmortizationAndImpairmentOfIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="ixv-33104"
      unitRef="Unit_EUR">61000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327715"
      unitRef="Unit_EUR">66000000</ifrs-full:IncreaseDecreaseInContingentConsiderationAssetLiability>
    <sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327716"
      unitRef="Unit_EUR">0</sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories>
    <sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327717"
      unitRef="Unit_EUR">7000000</sny:ExpenseArisingFromTheImpactOfAcquisitionsOnInventories>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327718"
      unitRef="Unit_EUR">430000000</ifrs-full:ExpenseOfRestructuringActivities>
    <ifrs-full:ExpenseOfRestructuringActivities
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327719"
      unitRef="Unit_EUR">1060000000</ifrs-full:ExpenseOfRestructuringActivities>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2025To06_30_2025_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327720"
      unitRef="Unit_EUR">-57000000</sny:OtherGainsLossesAndLitigation>
    <sny:OtherGainsLossesAndLitigation
      contextRef="P01_01_2024To06_30_2024_MaterialReconcilingItemsMemberifrsfullSegmentConsolidationItemsAxis"
      decimals="-6"
      id="Fact_148327721"
      unitRef="Unit_EUR">-450000000</sny:OtherGainsLossesAndLitigation>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33112"
      unitRef="Unit_EUR">3759000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327723"
      unitRef="Unit_EUR">2768000000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33114"
      unitRef="Unit_EUR">361000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327725"
      unitRef="Unit_EUR">583000000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33116"
      unitRef="Unit_EUR">184000000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327727"
      unitRef="Unit_EUR">277000000</ifrs-full:FinanceIncome>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33118"
      unitRef="Unit_EUR">3582000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327729"
      unitRef="Unit_EUR">2462000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForEquityMethodInvestments>
    <sny:ImpairmentLossOnIntangibleAssetOtherThanGoodwill
      contextRef="P01_01_2025To06_30_2025_OtherIntangibleAssetsMemberifrsfullClassesOfIntangibleAssetsOtherThanGoodwillAxis"
      decimals="-6"
      id="ixv-33120"
      unitRef="Unit_EUR">210000000</sny:ImpairmentLossOnIntangibleAssetOtherThanGoodwill>
    <ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-33121"
      unitRef="Unit_EUR">-371000000</ifrs-full:ImpairmentLossRecognisedInProfitOrLossIntangibleAssetsOtherThanGoodwill>
    <sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-30224">&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;Acquisitions of intangible assets and property, plant and equipment correspond to acquisitions paid for during the period. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:8%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Biopharma&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Investments accounted for using the equity method &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;483&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;229&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Acquisitions of property, plant and equipment&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;845&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;882&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Acquisitions of other intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;575&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;922&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Carrying amount at the end of the reporting period. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfAcquisitionsOfPropertyPlantAndEquipmentAndOtherIntangibleAssetsAndCarryingAmountOfInvestmentsInAssociatesAndJointVenturesByOperatingSegmentTableTextBlock>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327730"
      unitRef="Unit_EUR">483000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:InvestmentAccountedForUsingEquityMethod
      contextRef="PAsOn06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="Fact_148327731"
      unitRef="Unit_EUR">229000000</ifrs-full:InvestmentAccountedForUsingEquityMethod>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33124"
      unitRef="Unit_EUR">845000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33125"
      unitRef="Unit_EUR">882000000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="P01_01_2025To06_30_2025_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33126"
      unitRef="Unit_EUR">575000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="P01_01_2024To06_30_2024_BiopharmaSegmentMemberifrsfullSegmentsAxis"
      decimals="-6"
      id="ixv-33127"
      unitRef="Unit_EUR">922000000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:DisclosureOfGeographicalAreasExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-30339">&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The geographical information on net sales provided below is based on the geographical location of the customer. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:78%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="8" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="6" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Net sales&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&#160;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,144&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;4,072&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which France&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;835&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;855&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;9,535&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;8,292&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Rest of the World&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;6,210&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,996&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which China&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,388&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;1,406&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;19,889&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;18,360&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:8pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;(a)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Figures for 2024 comparative period have been &lt;div style="white-space:nowrap;display:inline;"&gt;re-presented&lt;/div&gt; on a consistent basis to reflect the classification of Opella as a discontinued operation. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In accordance with IFRS 8, the &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; assets reported below exclude financial instruments, deferred tax assets, &lt;div style="white-space:nowrap;display:inline;"&gt;pre-funded&lt;/div&gt; pension obligations, and &lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;right-of-use&lt;/div&gt;&lt;/div&gt; assets as determined under IFRS 16. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:47%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:3%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="12" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td rowspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30, 2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="10" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:center"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31, 2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;br/&gt;intangible&lt;br/&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Property,&#160;plant&lt;br/&gt;and&#160;equipment&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Goodwill&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;Other&lt;br/&gt;intangible&lt;br/&gt;assets&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-TOP:0.75pt solid #23004c; BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Europe&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,438&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,167&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;5,550&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,307&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which France&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;2,953&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;3,112&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;United States&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,080&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;16,725&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,411&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;18,711&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Rest of the World&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,056&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;539&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,130&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;611&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;of which China&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;83&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;96&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;9,574&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;40,283&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;20,431&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;10,091&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;43,384&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#7802e6"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;22,629&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#7802e6"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfGeographicalAreasExplanatory>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33128"
      unitRef="Unit_EUR">4144000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="Fact_148327737"
      unitRef="Unit_EUR">4072000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33130"
      unitRef="Unit_EUR">835000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="Fact_148327739"
      unitRef="Unit_EUR">855000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33132"
      unitRef="Unit_EUR">9535000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="Fact_148327741"
      unitRef="Unit_EUR">8292000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33134"
      unitRef="Unit_EUR">6210000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="Fact_148327743"
      unitRef="Unit_EUR">5996000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33136"
      unitRef="Unit_EUR">1388000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="Fact_148327745"
      unitRef="Unit_EUR">1406000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33138"
      unitRef="Unit_EUR">19889000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:RevenueFromSaleOfGoods
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327747"
      unitRef="Unit_EUR">18360000000</ifrs-full:RevenueFromSaleOfGoods>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33140"
      unitRef="Unit_EUR">5438000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33141"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33142"
      unitRef="Unit_EUR">3167000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33143"
      unitRef="Unit_EUR">5550000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33144"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_EuropeMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33145"
      unitRef="Unit_EUR">3307000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33146"
      unitRef="Unit_EUR">2953000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33147"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33148"
      unitRef="Unit_EUR">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33149"
      unitRef="Unit_EUR">3112000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33150"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_FRifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33151"
      unitRef="Unit_EUR">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33152"
      unitRef="Unit_EUR">2080000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33153"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33154"
      unitRef="Unit_EUR">16725000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33155"
      unitRef="Unit_EUR">2411000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33156"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_USifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33157"
      unitRef="Unit_EUR">18711000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33158"
      unitRef="Unit_EUR">2056000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33159"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33160"
      unitRef="Unit_EUR">539000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33161"
      unitRef="Unit_EUR">2130000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33162"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_OtherCountriesExcludingEuropeAndNorthAmericaMemberifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33163"
      unitRef="Unit_EUR">611000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33164"
      unitRef="Unit_EUR">83000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33165"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33166"
      unitRef="Unit_EUR">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33167"
      unitRef="Unit_EUR">96000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33168"
      unitRef="Unit_EUR">0</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024_CNifrsfullGeographicalAreasAxis"
      decimals="-6"
      id="ixv-33169"
      unitRef="Unit_EUR">0</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-33170"
      unitRef="Unit_EUR">9574000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-33171"
      unitRef="Unit_EUR">40283000000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn06_30_2025"
      decimals="-6"
      id="ixv-33172"
      unitRef="Unit_EUR">20431000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33173"
      unitRef="Unit_EUR">10091000000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:Goodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33174"
      unitRef="Unit_EUR">43384000000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33175"
      unitRef="Unit_EUR">22629000000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2025To06_30_2025_CertainWholesalersInTheUnitedStatesMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33176"
      unitRef="Unit_pure">0.35</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2025To06_30_2025_CustomerOneMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33177"
      unitRef="Unit_pure">0.18</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2025To06_30_2025_CustomerTwoMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33178"
      unitRef="Unit_pure">0.12</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2025To06_30_2025_CustomerThreeMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33179"
      unitRef="Unit_pure">0.05</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2024To06_30_2024_CustomerOneMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33180"
      unitRef="Unit_pure">0.13</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2024To06_30_2024_CustomerTwoMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33181"
      unitRef="Unit_pure">0.09</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="P01_01_2024To06_30_2024_CustomerThreeMemberifrsfullMajorCustomersAxis"
      decimals="2"
      id="ixv-33182"
      unitRef="Unit_pure">0.07</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-31026">&lt;div style="margin-top:0pt; margin-bottom:0pt; font-size:11pt; font-family:Arial"&gt;&lt;div style="color:#7802e6;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;B.22. Information related to Opella, presented within assets held for sale and discontinued operations &lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On April&#160;30 2025, the Opella transaction was closed (see Note B.1.) triggering loss of control, and resulting in the derecognition of all assets and liabilities of Opella subsidiaries. As of December&#160;31, 2024, all Opella assets and associated liabilities were classified as held for sale, in accordance with IFRS 5. &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:86%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Property, plant and equipment owned&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;760&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;116&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Goodwill&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,928&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Inventories&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;600&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Accounts receivable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;989&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;841&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#661de8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#661de8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13,489&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;112&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; provisions and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;204&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Accounts payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;797&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Current provisions and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;570&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;448&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#661de8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total liabilities related to assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#661de8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,131&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In accordance with IFRS 5, the Opella held for sale asset group, and the related liabilities, were measured at the lower of carrying amount and fair value less costs to sell. This valuation did not result in the recognition of any impairment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the main items presented within &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net income from discontinued operations&lt;/div&gt;&lt;/div&gt;: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net sales and other revenues &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,736&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,645&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Operating income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;266&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;277&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Gain on disposal of Opella before tax&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,781&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:Arial"&gt;Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,039&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;278&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Income tax expense &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(158&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(85&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net income from discontinued operations (Opella)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,881&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;202&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In 2025, this line includes an expense of &#x20ac;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below presents basic and diluted earnings per share from discontinued operations (Opella), in accordance with IAS 33 (Earnings per Share): &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net income from discontinued operations (Opella)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,881&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;202&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Average number of shares outstanding (million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,225.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,249.4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Average number of shares after dilution (million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,230.7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,253.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Basic earnings per share (in euros)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.34&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Diluted earnings per share (in euros)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</ifrs-full:DisclosureOfNoncurrentAssetsHeldForSaleAndDiscontinuedOperationsExplanatory>
    <sny:DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock contextRef="P01_01_2025To06_30_2025" id="ixv-33183">As of December&#160;31, 2024, all Opella assets and associated liabilities were classified as held for sale, in accordance with IFRS 5. &lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:86%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:9%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;(&lt;div style="font-family:Times New Roman;display:inline;"&gt;&#x20ac;&lt;/div&gt; million)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;December&#160;31,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#ffffff"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Assets&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#ffffff"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Property, plant and equipment owned&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;760&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Right-of-use&lt;/div&gt;&lt;/div&gt; assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;116&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Goodwill&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;7,255&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other intangible assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,928&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Inventories&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;600&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Accounts receivable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;989&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other assets&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;841&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#661de8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#661de8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;13,489&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Liabilities&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Lease liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;112&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="white-space:nowrap;display:inline;"&gt;&#x2002;Non-current&lt;/div&gt; provisions and other &lt;div style="white-space:nowrap;display:inline;"&gt;non-current&lt;/div&gt; liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;204&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Accounts payable&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;797&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Current provisions and other current liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;570&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Other liabilities&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;448&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt;background-color:#7802e6"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#661de8"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom;background-color:#7802e6"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Total liabilities related to assets held for sale&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#661de8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,131&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#661de8"&gt;&lt;div style="font-family:Arial;color:#FFFFFF;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;In accordance with IFRS 5, the Opella held for sale asset group, and the related liabilities, were measured at the lower of carrying amount and fair value less costs to sell. This valuation did not result in the recognition of any impairment. &lt;/div&gt;&lt;div style="margin-top:6pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below shows the main items presented within &lt;div style="font-weight:bold;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;Net income from discontinued operations&lt;/div&gt;&lt;/div&gt;: &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:6%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net sales and other revenues &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;1,736&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,645&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Operating income &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;266&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;277&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Gain on disposal of Opella before tax&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2,781&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2014;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:0.63em; font-size:8pt; font-family:Arial"&gt;Income before tax and investments accounted for using the equity method, including gain on disposal of Opella before tax&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;3,039&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;278&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#x2002;Income tax expense &lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:6.6px"&gt;(b)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(158&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;(85&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;)&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net income from discontinued operations (Opella)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,881&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;202&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="font-size:6pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(a)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.). &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:Arial; font-size:7pt;border-spacing:0;width:100%"&gt;
&lt;tr style="page-break-inside:avoid"&gt;
&lt;td style="width:3%;vertical-align:top;text-align:left"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&lt;div style="font-size:75%; vertical-align:top;display:inline;font-size:5.8px"&gt;(b)&lt;/div&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:top;text-align:left"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; font-size:7pt; font-family:Arial;text-align:justify"&gt;&lt;div style="font-style:italic;display:inline;"&gt;In 2025, this line includes an expense of &#x20ac;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella. &lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;div style="margin-top:10pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;The table below presents basic and diluted earnings per share from discontinued operations (Opella), in accordance with IAS 33 (Earnings per Share): &lt;/div&gt;&lt;div style="font-size:12pt;margin-top:0pt;margin-bottom:0pt"&gt;&#160;&lt;/div&gt;
&lt;table cellpadding="0" cellspacing="0" style="text-align:start; BORDER-COLLAPSE:COLLAPSE; font-family:ARIAL; font-size:8pt;width:100%;border-spacing:0;margin:0 auto"&gt;
&lt;tr&gt;
&lt;td style="width:80%"&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;width:5%"&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;
&lt;td&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&lt;div style="font-style:italic;display:inline;"&gt;&#x2002;(&#x20ac; million)&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2025&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td colspan="2" style="padding-bottom:3pt ;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;June&#160;30,&#160;2024&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt;background-color:#e7e7e8"&gt;&#160;&lt;/td&gt;
&lt;td colspan="4" style="BORDER-TOP:0.75pt solid #23004c;height:3pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&lt;div style="color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#x2002;Net income from discontinued operations (Opella)&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;2,881&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;202&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;color:#23004c;display:inline;"&gt;&lt;div style="font-weight:bold;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Average number of shares outstanding (million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,225.5&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,249.4&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Average number of shares after dilution (million)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,230.7&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;1,253.8&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Basic earnings per share (in euros)&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.34&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;white-space:nowrap;vertical-align:middle"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font-size:1pt"&gt;
&lt;td style="height:3pt"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt;background-color:#e7e7e8"&gt;&lt;/td&gt;
&lt;td colspan="4" style="height:3pt"&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="page-break-inside:avoid ; font-family:ARIAL; font-size:8pt"&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&lt;div style=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Arial"&gt;&#x2002;Diluted earnings per share (in euros)&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom;background-color:#e7e7e8"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;2.33&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:middle;background-color:#e7e7e8"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style=" BORDER-BOTTOM:0.75pt solid #23004c;vertical-align:bottom"&gt;&#160;&#160;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom;text-align:right"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;0.16&lt;/div&gt;&lt;/td&gt;
&lt;td style="padding-bottom:3pt ;BORDER-BOTTOM:0.75pt solid #23004c;white-space:nowrap;vertical-align:bottom"&gt;&lt;div style="font-family:Arial;display:inline;"&gt;&#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</sny:DisclosureOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock>
    <sny:PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33184"
      unitRef="Unit_EUR">760000000</sny:PropertyPlantAndEquipmenetDisposalGroupIncludingDiscontinuedOperations>
    <sny:RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33185"
      unitRef="Unit_EUR">116000000</sny:RightOfUseAssetsDisposalGroupIncludingDiscontinuedOperations>
    <sny:GoodwillDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33186"
      unitRef="Unit_EUR">7255000000</sny:GoodwillDisposalGroupIncludingDiscontinuedOperations>
    <sny:OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33187"
      unitRef="Unit_EUR">2928000000</sny:OtherIntangibleAssetsDisposalGroupIncludingDiscontinuedOperations>
    <sny:InventoriesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33188"
      unitRef="Unit_EUR">600000000</sny:InventoriesDisposalGroupIncludingDiscontinuedOperations>
    <sny:AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33189"
      unitRef="Unit_EUR">989000000</sny:AccountsReceivablesDisposalGroupIncludingDiscontinuedOperations>
    <sny:OtherAssetsDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33190"
      unitRef="Unit_EUR">841000000</sny:OtherAssetsDisposalGroupIncludingDiscontinuedOperations>
    <sny:AssetsOfDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33191"
      unitRef="Unit_EUR">13489000000</sny:AssetsOfDisposalGroupIncludingDiscontinuedOperations>
    <sny:LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33192"
      unitRef="Unit_EUR">112000000</sny:LeaseLiabilitiesDisposalGroupIncludingDiscontinuedOperations>
    <sny:NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33193"
      unitRef="Unit_EUR">204000000</sny:NonCurrentProvisionsAndOtherNonCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations>
    <sny:AccountsPayableDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33194"
      unitRef="Unit_EUR">797000000</sny:AccountsPayableDisposalGroupIncludingDiscontinuedOperations>
    <sny:CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33195"
      unitRef="Unit_EUR">570000000</sny:CurrentProvisionsAndOtherCurrentLiabilitiesDisposalGroupIncludingDiscontinuedOperations>
    <sny:OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33196"
      unitRef="Unit_EUR">448000000</sny:OtherLiabilitiesDisposalGroupIncludingDiscontinuedOperations>
    <sny:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations
      contextRef="PAsOn12_31_2024"
      decimals="-6"
      id="ixv-33197"
      unitRef="Unit_EUR">2131000000</sny:LiabilitiesOfDisposalGroupIncludingDiscontinuedOperations>
    <sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327602"
      unitRef="Unit_EUR">1736000000</sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations>
    <sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327603"
      unitRef="Unit_EUR">2645000000</sny:RevenueFromDisposalGroupIncludingDiscontinuedOperations>
    <sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327604"
      unitRef="Unit_EUR">266000000</sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations>
    <sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327605"
      unitRef="Unit_EUR">277000000</sny:OperatingRevenueDisposalGroupIncludingDiscontinuedOperations>
    <sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33202"
      unitRef="Unit_EUR">2781000000</sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations>
    <sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-33203"
      unitRef="Unit_EUR">0</sny:GainOnDisposalOfOpellaDisposalGroupIncludingDiscontinuedOperations>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33204"
      unitRef="Unit_EUR">3039000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations>
    <sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-33205"
      unitRef="Unit_EUR">278000000</sny:IncomeBeforeTaxAndInvestmentsAccountedForUsingTheEquityMethodDisposalGroupIncludingDiscontinuedOperations>
    <sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="Fact_148327610"
      unitRef="Unit_EUR">-158000000</sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations>
    <sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="Fact_148327611"
      unitRef="Unit_EUR">-85000000</sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33208"
      unitRef="Unit_EUR">2881000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-33209"
      unitRef="Unit_EUR">202000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025_OpellaBusinessMemberifrsfullSignificantInvestmentsInSubsidiariesAxis"
      decimals="-6"
      id="ixv-33210"
      unitRef="Unit_EUR">88000000</sny:IncomeTaxExpenseBenefitDisposalGroupIncludingDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="-6"
      id="ixv-33211"
      unitRef="Unit_EUR">2881000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:ProfitLossFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="-6"
      id="ixv-33212"
      unitRef="Unit_EUR">202000000</ifrs-full:ProfitLossFromDiscontinuedOperations>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-33213"
      unitRef="Unit_shares">1225500000</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="ixv-33214"
      unitRef="Unit_shares">1249400000</ifrs-full:WeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-33215"
      unitRef="Unit_shares">1230700000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="ixv-33216"
      unitRef="Unit_shares">1253800000</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-33217"
      unitRef="Unit_EUR_per_Share">2.34</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="ixv-33218"
      unitRef="Unit_EUR_per_Share">0.16</ifrs-full:BasicEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2025To06_30_2025"
      decimals="INF"
      id="ixv-33219"
      unitRef="Unit_EUR_per_Share">2.33</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations
      contextRef="P01_01_2024To06_30_2024"
      decimals="INF"
      id="ixv-33220"
      unitRef="Unit_EUR_per_Share">0.16</ifrs-full:DilutedEarningsLossPerShareFromDiscontinuedOperations>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="P01_01_2025To06_30_2025" id="ixv-31611">&lt;div id="ex99_169958_12" style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Arial;font-weight:bold"&gt;C/ Events subsequent to June&#160;30, 2025 &lt;/div&gt;&lt;div style="margin-top:4pt; margin-bottom:0pt; font-size:8.5pt; font-family:Arial;text-align:justify"&gt;On July&#160;22, 2025, Sanofi announced that it had entered into an agreement to acquire Vicebio Ltd (&#x201c;Vicebio&#x201d;), a privately held biotechnology company headquartered in London, UK. The acquisition brings to Sanofi an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (hMPV), both respiratory viruses, and expands Sanofi&#x2019;s capabilities in vaccine design and development with Vicebio&#x2019;s &#x2018;Molecular Clamp&#x2019; technology. Under the terms of the agreement, Sanofi would acquire all of Vicebio&#x2019;s share capital for a total upfront payment of $1.15&#160;billion, with potential milestone payments of up to $450&#160;million based on development and regulatory achievements. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions, including receipt of regulatory approvals. &lt;/div&gt;</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <sny:UpfrontPayments
      contextRef="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis"
      decimals="-7"
      id="ixv-33221"
      unitRef="Unit_USD">1150000000</sny:UpfrontPayments>
    <sny:TotalMilestonePayments
      contextRef="P07_22_2025To07_22_2025_VicebioLtdMemberSNYAssetsAcquisitionAxis"
      decimals="-6"
      id="ixv-33222"
      unitRef="Unit_USD">450000000</sny:TotalMilestonePayments>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact_148326473"
          xlink:label="Fact_148326473"
          xlink:type="locator"/>
        <link:footnote id="FN_601990" xlink:label="FN_601990" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">These unaudited condensed half year consolidated financial statements as of June&#160;30, 2025 should be read in conjunction with Sanofi&#x2019;s audited consolidated financial statements as of December&#160;31, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326473"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326474"
          xlink:label="Fact_148326474"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326474"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326475"
          xlink:label="Fact_148326475"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326475"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326476"
          xlink:label="Fact_148326476"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326476"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326477"
          xlink:label="Fact_148326477"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326477"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326478"
          xlink:label="Fact_148326478"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326478"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326479"
          xlink:label="Fact_148326479"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326479"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326480"
          xlink:label="Fact_148326480"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326480"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326481"
          xlink:label="Fact_148326481"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326481"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326482"
          xlink:label="Fact_148326482"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326482"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326483"
          xlink:label="Fact_148326483"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326483"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326484"
          xlink:label="Fact_148326484"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326484"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326485"
          xlink:label="Fact_148326485"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326485"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326486"
          xlink:label="Fact_148326486"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326486"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326487"
          xlink:label="Fact_148326487"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326487"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326488"
          xlink:label="Fact_148326488"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326488"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326489"
          xlink:label="Fact_148326489"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326489"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326490"
          xlink:label="Fact_148326490"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326490"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326491"
          xlink:label="Fact_148326491"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326491"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326492"
          xlink:label="Fact_148326492"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326492"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326493"
          xlink:label="Fact_148326493"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326493"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326494"
          xlink:label="Fact_148326494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326494"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326495"
          xlink:label="Fact_148326495"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326495"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326496"
          xlink:label="Fact_148326496"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326496"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326497"
          xlink:label="Fact_148326497"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326497"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326498"
          xlink:label="Fact_148326498"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326498"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326499"
          xlink:label="Fact_148326499"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326499"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326500"
          xlink:label="Fact_148326500"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326500"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326501"
          xlink:label="Fact_148326501"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326501"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326502"
          xlink:label="Fact_148326502"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326502"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326503"
          xlink:label="Fact_148326503"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326503"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326504"
          xlink:label="Fact_148326504"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326504"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326505"
          xlink:label="Fact_148326505"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326505"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326506"
          xlink:label="Fact_148326506"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326506"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326507"
          xlink:label="Fact_148326507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326507"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326508"
          xlink:label="Fact_148326508"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326508"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326509"
          xlink:label="Fact_148326509"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326509"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326510"
          xlink:label="Fact_148326510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326510"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326511"
          xlink:label="Fact_148326511"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326511"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326512"
          xlink:label="Fact_148326512"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326512"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326513"
          xlink:label="Fact_148326513"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326513"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326514"
          xlink:label="Fact_148326514"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326514"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326515"
          xlink:label="Fact_148326515"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326515"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326516"
          xlink:label="Fact_148326516"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326516"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326517"
          xlink:label="Fact_148326517"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326517"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326518"
          xlink:label="Fact_148326518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326518"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326519"
          xlink:label="Fact_148326519"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326519"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326520"
          xlink:label="Fact_148326520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326520"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326521"
          xlink:label="Fact_148326521"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326521"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326522"
          xlink:label="Fact_148326522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326522"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326523"
          xlink:label="Fact_148326523"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326523"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326524"
          xlink:label="Fact_148326524"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326524"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326525"
          xlink:label="Fact_148326525"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326525"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326526"
          xlink:label="Fact_148326526"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326526"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326527"
          xlink:label="Fact_148326527"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326527"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326528"
          xlink:label="Fact_148326528"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326528"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326529"
          xlink:label="Fact_148326529"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326529"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326530"
          xlink:label="Fact_148326530"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326530"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326531"
          xlink:label="Fact_148326531"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326531"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326532"
          xlink:label="Fact_148326532"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326532"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326533"
          xlink:label="Fact_148326533"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326533"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326534"
          xlink:label="Fact_148326534"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326534"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326535"
          xlink:label="Fact_148326535"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326535"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326536"
          xlink:label="Fact_148326536"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326536"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326537"
          xlink:label="Fact_148326537"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326537"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326538"
          xlink:label="Fact_148326538"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326538"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326539"
          xlink:label="Fact_148326539"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326539"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326540"
          xlink:label="Fact_148326540"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326540"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326543"
          xlink:label="Fact_148326543"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326543"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326544"
          xlink:label="Fact_148326544"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326544"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326545"
          xlink:label="Fact_148326545"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326545"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326546"
          xlink:label="Fact_148326546"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326546"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601986" xlink:label="FN_601986" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Figures for the 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326546"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326547"
          xlink:label="Fact_148326547"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326547"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326548"
          xlink:label="Fact_148326548"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326548"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326548"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326549"
          xlink:label="Fact_148326549"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326549"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326550"
          xlink:label="Fact_148326550"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326550"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326550"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326551"
          xlink:label="Fact_148326551"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326551"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326552"
          xlink:label="Fact_148326552"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326552"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326552"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326553"
          xlink:label="Fact_148326553"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326553"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326554"
          xlink:label="Fact_148326554"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326554"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326554"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326555"
          xlink:label="Fact_148326555"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326555"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326556"
          xlink:label="Fact_148326556"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326556"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326556"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326557"
          xlink:label="Fact_148326557"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326557"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326558"
          xlink:label="Fact_148326558"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326558"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326558"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326559"
          xlink:label="Fact_148326559"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326559"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326560"
          xlink:label="Fact_148326560"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326560"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326560"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326561"
          xlink:label="Fact_148326561"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326561"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326562"
          xlink:label="Fact_148326562"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326562"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326562"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326563"
          xlink:label="Fact_148326563"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326563"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326564"
          xlink:label="Fact_148326564"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326564"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326564"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326565"
          xlink:label="Fact_148326565"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326565"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326566"
          xlink:label="Fact_148326566"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326566"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326566"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326567"
          xlink:label="Fact_148326567"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326567"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326568"
          xlink:label="Fact_148326568"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326568"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326568"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326569"
          xlink:label="Fact_148326569"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326569"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326570"
          xlink:label="Fact_148326570"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326570"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326570"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326571"
          xlink:label="Fact_148326571"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326571"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326572"
          xlink:label="Fact_148326572"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326572"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326572"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326573"
          xlink:label="Fact_148326573"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326573"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326574"
          xlink:label="Fact_148326574"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326574"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326574"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326575"
          xlink:label="Fact_148326575"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326575"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326576"
          xlink:label="Fact_148326576"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326576"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326576"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326577"
          xlink:label="Fact_148326577"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326577"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326578"
          xlink:label="Fact_148326578"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326578"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326578"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326579"
          xlink:label="Fact_148326579"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326579"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326580"
          xlink:label="Fact_148326580"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326580"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326580"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326581"
          xlink:label="Fact_148326581"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326581"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326582"
          xlink:label="Fact_148326582"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326582"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326582"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326583"
          xlink:label="Fact_148326583"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326583"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326584"
          xlink:label="Fact_148326584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326584"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326584"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326585"
          xlink:label="Fact_148326585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326585"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326586"
          xlink:label="Fact_148326586"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326586"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326586"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326587"
          xlink:label="Fact_148326587"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326587"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326588"
          xlink:label="Fact_148326588"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326588"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326588"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326589"
          xlink:label="Fact_148326589"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326589"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326590"
          xlink:label="Fact_148326590"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326590"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326591"
          xlink:label="Fact_148326591"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326591"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326592"
          xlink:label="Fact_148326592"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326592"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326593"
          xlink:label="Fact_148326593"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326593"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326594"
          xlink:label="Fact_148326594"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326594"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326595"
          xlink:label="Fact_148326595"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326595"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326596"
          xlink:label="Fact_148326596"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326596"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326597"
          xlink:label="Fact_148326597"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326597"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326598"
          xlink:label="Fact_148326598"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326598"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326599"
          xlink:label="Fact_148326599"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326599"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326600"
          xlink:label="Fact_148326600"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326600"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326601"
          xlink:label="Fact_148326601"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326601"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326602"
          xlink:label="Fact_148326602"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326602"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326603"
          xlink:label="Fact_148326603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326603"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326604"
          xlink:label="Fact_148326604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326604"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326605"
          xlink:label="Fact_148326605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326605"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326607"
          xlink:label="Fact_148326607"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326607"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326608"
          xlink:label="Fact_148326608"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326608"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326609"
          xlink:label="Fact_148326609"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326609"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326615"
          xlink:label="Fact_148326615"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326615"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326616"
          xlink:label="Fact_148326616"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326616"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326617"
          xlink:label="Fact_148326617"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326617"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326618"
          xlink:label="Fact_148326618"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326618"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326619"
          xlink:label="Fact_148326619"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326619"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326620"
          xlink:label="Fact_148326620"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326620"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326621"
          xlink:label="Fact_148326621"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326621"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326625"
          xlink:label="Fact_148326625"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326625"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326625"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326626"
          xlink:label="Fact_148326626"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326626"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326627"
          xlink:label="Fact_148326627"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326627"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326627"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326628"
          xlink:label="Fact_148326628"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326628"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326629"
          xlink:label="Fact_148326629"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326629"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326629"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326630"
          xlink:label="Fact_148326630"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326630"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326631"
          xlink:label="Fact_148326631"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326631"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326631"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326632"
          xlink:label="Fact_148326632"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326632"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326633"
          xlink:label="Fact_148326633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326633"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326633"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326634"
          xlink:label="Fact_148326634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326634"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326635"
          xlink:label="Fact_148326635"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326635"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326635"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326636"
          xlink:label="Fact_148326636"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326636"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326637"
          xlink:label="Fact_148326637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326637"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326637"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326638"
          xlink:label="Fact_148326638"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326638"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326649"
          xlink:label="Fact_148326649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326649"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326650"
          xlink:label="Fact_148326650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326650"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326651"
          xlink:label="Fact_148326651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326651"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326652"
          xlink:label="Fact_148326652"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326652"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326653"
          xlink:label="Fact_148326653"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326653"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326654"
          xlink:label="Fact_148326654"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326654"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326655"
          xlink:label="Fact_148326655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326655"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326656"
          xlink:label="Fact_148326656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326656"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326657"
          xlink:label="Fact_148326657"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326657"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326658"
          xlink:label="Fact_148326658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326658"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326659"
          xlink:label="Fact_148326659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326659"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326660"
          xlink:label="Fact_148326660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326660"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326661"
          xlink:label="Fact_148326661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326661"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326662"
          xlink:label="Fact_148326662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326662"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326663"
          xlink:label="Fact_148326663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326663"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326664"
          xlink:label="Fact_148326664"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326664"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326665"
          xlink:label="Fact_148326665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326665"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326666"
          xlink:label="Fact_148326666"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326666"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326667"
          xlink:label="Fact_148326667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326667"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326668"
          xlink:label="Fact_148326668"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326668"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326669"
          xlink:label="Fact_148326669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326669"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326670"
          xlink:label="Fact_148326670"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326670"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326670"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326671"
          xlink:label="Fact_148326671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326671"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326672"
          xlink:label="Fact_148326672"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326672"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326672"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326673"
          xlink:label="Fact_148326673"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326673"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326674"
          xlink:label="Fact_148326674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326674"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326674"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326675"
          xlink:label="Fact_148326675"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326675"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326676"
          xlink:label="Fact_148326676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326676"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326676"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326677"
          xlink:label="Fact_148326677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326677"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326678"
          xlink:label="Fact_148326678"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326678"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326678"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326679"
          xlink:label="Fact_148326679"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326679"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326680"
          xlink:label="Fact_148326680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326680"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326680"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326681"
          xlink:label="Fact_148326681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326681"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326682"
          xlink:label="Fact_148326682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326682"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326682"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326683"
          xlink:label="Fact_148326683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326683"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326684"
          xlink:label="Fact_148326684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326684"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326684"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326685"
          xlink:label="Fact_148326685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326685"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326686"
          xlink:label="Fact_148326686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326686"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326686"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326687"
          xlink:label="Fact_148326687"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326687"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326688"
          xlink:label="Fact_148326688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326688"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326688"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326689"
          xlink:label="Fact_148326689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326689"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326690"
          xlink:label="Fact_148326690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326690"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326690"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326691"
          xlink:label="Fact_148326691"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326691"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326692"
          xlink:label="Fact_148326692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326692"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326692"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326693"
          xlink:label="Fact_148326693"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326693"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326694"
          xlink:label="Fact_148326694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326694"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326694"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326695"
          xlink:label="Fact_148326695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326695"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326696"
          xlink:label="Fact_148326696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326696"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326696"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326697"
          xlink:label="Fact_148326697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326697"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326698"
          xlink:label="Fact_148326698"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326698"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326698"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326699"
          xlink:label="Fact_148326699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326699"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326700"
          xlink:label="Fact_148326700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326700"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326700"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326701"
          xlink:label="Fact_148326701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326701"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326702"
          xlink:label="Fact_148326702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326702"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326702"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326703"
          xlink:label="Fact_148326703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326703"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326704"
          xlink:label="Fact_148326704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326704"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326704"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326705"
          xlink:label="Fact_148326705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326705"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326706"
          xlink:label="Fact_148326706"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326706"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326706"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326707"
          xlink:label="Fact_148326707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326707"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326708"
          xlink:label="Fact_148326708"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326708"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326708"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326709"
          xlink:label="Fact_148326709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326709"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326710"
          xlink:label="Fact_148326710"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326710"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326710"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326711"
          xlink:label="Fact_148326711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326711"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326712"
          xlink:label="Fact_148326712"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326712"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326712"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326713"
          xlink:label="Fact_148326713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326713"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326714"
          xlink:label="Fact_148326714"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326714"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326715"
          xlink:label="Fact_148326715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326715"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326716"
          xlink:label="Fact_148326716"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326716"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326717"
          xlink:label="Fact_148326717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326717"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326718"
          xlink:label="Fact_148326718"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326718"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326719"
          xlink:label="Fact_148326719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326719"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326720"
          xlink:label="Fact_148326720"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326720"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326722"
          xlink:label="Fact_148326722"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326722"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326723"
          xlink:label="Fact_148326723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326723"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326724"
          xlink:label="Fact_148326724"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326724"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326726"
          xlink:label="Fact_148326726"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326726"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326727"
          xlink:label="Fact_148326727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326727"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326728"
          xlink:label="Fact_148326728"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326728"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326729"
          xlink:label="Fact_148326729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326729"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602025" xlink:label="FN_602025" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line comprises the impact of the derecognition of the non-controlling interests in Opella (see Note B.1.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326729"
          xlink:to="FN_602025"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326730"
          xlink:label="Fact_148326730"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326730"
          xlink:to="FN_602025"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326730"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326731"
          xlink:label="Fact_148326731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326731"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602024" xlink:label="FN_602024" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For 2025, this line comprises the impact of the issuance of restricted shares to former employees of Opella subsequent to the date on which Sanofi lost control of Opella.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326731"
          xlink:to="FN_602024"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326732"
          xlink:label="Fact_148326732"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326732"
          xlink:to="FN_602024"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326732"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326733"
          xlink:label="Fact_148326733"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326733"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326733"
          xlink:to="FN_602024"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326734"
          xlink:label="Fact_148326734"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326734"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326735"
          xlink:label="Fact_148326735"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326735"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326736"
          xlink:label="Fact_148326736"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326736"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326737"
          xlink:label="Fact_148326737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326737"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326738"
          xlink:label="Fact_148326738"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326738"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326739"
          xlink:label="Fact_148326739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326739"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326740"
          xlink:label="Fact_148326740"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326740"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326741"
          xlink:label="Fact_148326741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326741"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326742"
          xlink:label="Fact_148326742"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326742"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326743"
          xlink:label="Fact_148326743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326743"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326744"
          xlink:label="Fact_148326744"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326744"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326745"
          xlink:label="Fact_148326745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326745"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326746"
          xlink:label="Fact_148326746"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326746"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602013" xlink:label="FN_602013" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note B.8.2. (for amounts relating to 2024, see Note D.15.4. to the consolidated financial statements for the year ended December 31, 2024).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326746"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326747"
          xlink:label="Fact_148326747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326747"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326747"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326748"
          xlink:label="Fact_148326748"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326748"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326748"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326749"
          xlink:label="Fact_148326749"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326749"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326749"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326750"
          xlink:label="Fact_148326750"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326750"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326750"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326751"
          xlink:label="Fact_148326751"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326751"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326751"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326752"
          xlink:label="Fact_148326752"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326752"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326753"
          xlink:label="Fact_148326753"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326753"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326754"
          xlink:label="Fact_148326754"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326754"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326755"
          xlink:label="Fact_148326755"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326755"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326756"
          xlink:label="Fact_148326756"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326756"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326780"
          xlink:label="Fact_148326780"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326780"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326781"
          xlink:label="Fact_148326781"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326781"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326782"
          xlink:label="Fact_148326782"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326782"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326783"
          xlink:label="Fact_148326783"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326783"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326784"
          xlink:label="Fact_148326784"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326784"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326785"
          xlink:label="Fact_148326785"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326785"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326785"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326786"
          xlink:label="Fact_148326786"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326786"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326787"
          xlink:label="Fact_148326787"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326787"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326787"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326788"
          xlink:label="Fact_148326788"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326788"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326789"
          xlink:label="Fact_148326789"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326789"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326789"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326790"
          xlink:label="Fact_148326790"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326790"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326791"
          xlink:label="Fact_148326791"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326791"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326791"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326792"
          xlink:label="Fact_148326792"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326792"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601997" xlink:label="FN_601997" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the six months ended June 30, 2025, this amount includes &#x20ac;(667) million in respect of cash and cash equivalents held by Opella as of April 30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326792"
          xlink:to="FN_601997"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326793"
          xlink:label="Fact_148326793"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326793"
          xlink:to="FN_601997"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326793"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326793"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326794"
          xlink:label="Fact_148326794"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326794"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326795"
          xlink:label="Fact_148326795"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326795"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326795"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326796"
          xlink:label="Fact_148326796"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326796"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326797"
          xlink:label="Fact_148326797"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326797"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326797"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326798"
          xlink:label="Fact_148326798"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326798"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326799"
          xlink:label="Fact_148326799"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326799"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326799"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326800"
          xlink:label="Fact_148326800"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326800"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326801"
          xlink:label="Fact_148326801"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326801"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326801"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326802"
          xlink:label="Fact_148326802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326802"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326803"
          xlink:label="Fact_148326803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326803"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326803"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326804"
          xlink:label="Fact_148326804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326804"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326805"
          xlink:label="Fact_148326805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326805"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326805"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326806"
          xlink:label="Fact_148326806"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326806"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326807"
          xlink:label="Fact_148326807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326807"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326807"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326808"
          xlink:label="Fact_148326808"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326808"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601999" xlink:label="FN_601999" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the six months ended June 30, 2025, this line item mainly comprises a commercial paper program in the United States for &#x20ac;3,353 million, compared with &#x20ac;6,060 million in the six months ended June 30, 2024. This line item also includes realized foreign exchange gains and losses on cash and cash equivalents in non-functional currencies, mainly the US dollar, and on derivatives used to manage them.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326808"
          xlink:to="FN_601999"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326809"
          xlink:label="Fact_148326809"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326809"
          xlink:to="FN_601999"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326809"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326809"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326810"
          xlink:label="Fact_148326810"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326810"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326811"
          xlink:label="Fact_148326811"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326811"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326811"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326812"
          xlink:label="Fact_148326812"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326812"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326813"
          xlink:label="Fact_148326813"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326813"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326813"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326814"
          xlink:label="Fact_148326814"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326814"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326815"
          xlink:label="Fact_148326815"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326815"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326815"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326816"
          xlink:label="Fact_148326816"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326816"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326832"
          xlink:label="Fact_148326832"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326832"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326833"
          xlink:label="Fact_148326833"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326833"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326834"
          xlink:label="Fact_148326834"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326834"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326835"
          xlink:label="Fact_148326835"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326835"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326836"
          xlink:label="Fact_148326836"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326836"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326836"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326837"
          xlink:label="Fact_148326837"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326837"
          xlink:to="FN_602013"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326837"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326838"
          xlink:label="Fact_148326838"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326838"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326839"
          xlink:label="Fact_148326839"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326839"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326840"
          xlink:label="Fact_148326840"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326840"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326841"
          xlink:label="Fact_148326841"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326841"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326842"
          xlink:label="Fact_148326842"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326842"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326843"
          xlink:label="Fact_148326843"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326843"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326844"
          xlink:label="Fact_148326844"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326844"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326845"
          xlink:label="Fact_148326845"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326845"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326846"
          xlink:label="Fact_148326846"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326846"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326847"
          xlink:label="Fact_148326847"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326847"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326848"
          xlink:label="Fact_148326848"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326848"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326849"
          xlink:label="Fact_148326849"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326849"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326850"
          xlink:label="Fact_148326850"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326850"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326851"
          xlink:label="Fact_148326851"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326851"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602014" xlink:label="FN_602014" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For 2024, this line comprises the impact of the issuance of restricted shares to former employees of EUROAPI subsequent to the date on which Sanofi lost control of EUROAPI.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326851"
          xlink:to="FN_602014"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326852"
          xlink:label="Fact_148326852"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326852"
          xlink:to="FN_602014"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326852"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326853"
          xlink:label="Fact_148326853"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326853"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326854"
          xlink:label="Fact_148326854"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326854"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326855"
          xlink:label="Fact_148326855"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326855"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326856"
          xlink:label="Fact_148326856"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326856"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326857"
          xlink:label="Fact_148326857"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326857"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326858"
          xlink:label="Fact_148326858"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326858"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326859"
          xlink:label="Fact_148326859"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326859"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326860"
          xlink:label="Fact_148326860"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326860"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326861"
          xlink:label="Fact_148326861"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326861"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326862"
          xlink:label="Fact_148326862"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326862"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326862"
          xlink:to="FN_602014"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326863"
          xlink:label="Fact_148326863"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326863"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326864"
          xlink:label="Fact_148326864"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326864"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326865"
          xlink:label="Fact_148326865"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326865"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326866"
          xlink:label="Fact_148326866"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326866"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326867"
          xlink:label="Fact_148326867"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326867"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326868"
          xlink:label="Fact_148326868"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326868"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326871"
          xlink:label="Fact_148326871"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326871"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326872"
          xlink:label="Fact_148326872"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326872"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326873"
          xlink:label="Fact_148326873"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326873"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326874"
          xlink:label="Fact_148326874"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326874"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326875"
          xlink:label="Fact_148326875"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326875"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326876"
          xlink:label="Fact_148326876"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326876"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326877"
          xlink:label="Fact_148326877"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326877"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326878"
          xlink:label="Fact_148326878"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326878"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326879"
          xlink:label="Fact_148326879"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326879"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326880"
          xlink:label="Fact_148326880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326880"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326881"
          xlink:label="Fact_148326881"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326881"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326882"
          xlink:label="Fact_148326882"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326882"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326883"
          xlink:label="Fact_148326883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326883"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326884"
          xlink:label="Fact_148326884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326884"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326885"
          xlink:label="Fact_148326885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326885"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326886"
          xlink:label="Fact_148326886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326886"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326887"
          xlink:label="Fact_148326887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326887"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326888"
          xlink:label="Fact_148326888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326888"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326889"
          xlink:label="Fact_148326889"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326889"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326890"
          xlink:label="Fact_148326890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326890"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326891"
          xlink:label="Fact_148326891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326891"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326892"
          xlink:label="Fact_148326892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326892"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326893"
          xlink:label="Fact_148326893"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326893"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326894"
          xlink:label="Fact_148326894"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326894"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326895"
          xlink:label="Fact_148326895"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326895"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326896"
          xlink:label="Fact_148326896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326896"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326897"
          xlink:label="Fact_148326897"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326897"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326898"
          xlink:label="Fact_148326898"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326898"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326899"
          xlink:label="Fact_148326899"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326899"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326900"
          xlink:label="Fact_148326900"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326900"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326901"
          xlink:label="Fact_148326901"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326901"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326902"
          xlink:label="Fact_148326902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326902"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326902"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326903"
          xlink:label="Fact_148326903"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326903"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326904"
          xlink:label="Fact_148326904"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326904"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326904"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326905"
          xlink:label="Fact_148326905"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326905"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326906"
          xlink:label="Fact_148326906"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326906"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326906"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326907"
          xlink:label="Fact_148326907"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326907"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326908"
          xlink:label="Fact_148326908"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326908"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326908"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326909"
          xlink:label="Fact_148326909"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326909"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601991" xlink:label="FN_601991" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes non-current financial assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326909"
          xlink:to="FN_601991"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326910"
          xlink:label="Fact_148326910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326910"
          xlink:to="FN_601991"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326910"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326910"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326911"
          xlink:label="Fact_148326911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326911"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326912"
          xlink:label="Fact_148326912"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326912"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326912"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326913"
          xlink:label="Fact_148326913"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326913"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601992" xlink:label="FN_601992" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line item includes contributions paid to pension funds (see Note B.12.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326913"
          xlink:to="FN_601992"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326914"
          xlink:label="Fact_148326914"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326914"
          xlink:to="FN_601992"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326914"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326914"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326915"
          xlink:label="Fact_148326915"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326915"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326916"
          xlink:label="Fact_148326916"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326916"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326917"
          xlink:label="Fact_148326917"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326917"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326917"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326918"
          xlink:label="Fact_148326918"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326918"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601993" xlink:label="FN_601993" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line item mainly comprises unrealized foreign exchange gains and losses arising on the remeasurement of monetary items in non-functional currencies and on instruments used to hedge such items</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326918"
          xlink:to="FN_601993"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326919"
          xlink:label="Fact_148326919"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326919"
          xlink:to="FN_601993"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326919"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326919"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326920"
          xlink:label="Fact_148326920"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326920"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326921"
          xlink:label="Fact_148326921"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326921"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326921"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326922"
          xlink:label="Fact_148326922"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326922"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326923"
          xlink:label="Fact_148326923"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326923"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326923"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326924"
          xlink:label="Fact_148326924"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326924"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326925"
          xlink:label="Fact_148326925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326925"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326925"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326926"
          xlink:label="Fact_148326926"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326926"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326927"
          xlink:label="Fact_148326927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326927"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326927"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326928"
          xlink:label="Fact_148326928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326928"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326929"
          xlink:label="Fact_148326929"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326929"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326929"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326930"
          xlink:label="Fact_148326930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326930"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326931"
          xlink:label="Fact_148326931"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326931"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326931"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326932"
          xlink:label="Fact_148326932"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326932"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326933"
          xlink:label="Fact_148326933"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326933"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326933"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326934"
          xlink:label="Fact_148326934"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326934"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602005" xlink:label="FN_602005" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Of which: June 30, 2025 (6 months) June 30, 2024 (6 months) (a) &#x2022;Income tax paid (1,355) (1,434) &#x2022;Interest paid (206) (320) &#x2022;Interest received 170 261 &#x2022;Dividends received from non-consolidated entities 5 &#x2014;</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326934"
          xlink:to="FN_602005"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326935"
          xlink:label="Fact_148326935"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326935"
          xlink:to="FN_602005"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326935"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326935"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326936"
          xlink:label="Fact_148326936"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326936"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326937"
          xlink:label="Fact_148326937"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326937"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326937"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326938"
          xlink:label="Fact_148326938"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326938"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601995" xlink:label="FN_601995" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line item includes payments made in respect of contingent consideration identified and recognized as a liability in business combinations. For the six months ended June 30, 2025, this line item includes the net cash outflow arising from the acquisition of Dren-0201 (see Note B.1.2.). For the six months ended June 30, 2024 it includes the net cash outflow arising from the acquisition of Inhibrx, Inc.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326938"
          xlink:to="FN_601995"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326939"
          xlink:label="Fact_148326939"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326939"
          xlink:to="FN_601995"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326939"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326939"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326940"
          xlink:label="Fact_148326940"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326940"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326941"
          xlink:label="Fact_148326941"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326941"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326941"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326942"
          xlink:label="Fact_148326942"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326942"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_601996" xlink:label="FN_601996" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the six months ended June 30, 2025 and June 30, 2024, this line item mainly comprises proceeds from disposals of (i) assets and businesses due to portfolio rationalization, and (ii) equity and debt instruments.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326942"
          xlink:to="FN_601996"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326943"
          xlink:label="Fact_148326943"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326943"
          xlink:to="FN_601996"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326943"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326943"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326944"
          xlink:label="Fact_148326944"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326944"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326945"
          xlink:label="Fact_148326945"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326945"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326945"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326946"
          xlink:label="Fact_148326946"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326946"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326947"
          xlink:label="Fact_148326947"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326947"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326947"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326948"
          xlink:label="Fact_148326948"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326948"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326948"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326949"
          xlink:label="Fact_148326949"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326949"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326950"
          xlink:label="Fact_148326950"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326950"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326950"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326951"
          xlink:label="Fact_148326951"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326951"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326952"
          xlink:label="Fact_148326952"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326952"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326952"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326953"
          xlink:label="Fact_148326953"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326953"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326954"
          xlink:label="Fact_148326954"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326954"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326954"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326955"
          xlink:label="Fact_148326955"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326955"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326956"
          xlink:label="Fact_148326956"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326956"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326956"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326957"
          xlink:label="Fact_148326957"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326957"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326958"
          xlink:label="Fact_148326958"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326958"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326958"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326959"
          xlink:label="Fact_148326959"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326959"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326960"
          xlink:label="Fact_148326960"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326960"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326960"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326962"
          xlink:label="Fact_148326962"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326962"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326964"
          xlink:label="Fact_148326964"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326964"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326966"
          xlink:label="Fact_148326966"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326966"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148326968"
          xlink:label="Fact_148326968"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148326968"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327008"
          xlink:label="Fact_148327008"
          xlink:type="locator"/>
        <link:footnote id="FN_602034" xlink:label="FN_602034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Currency translation differences on foreign subsidiaries are mainly due to the appreciation of the US dollar.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327008"
          xlink:to="FN_602034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327009"
          xlink:label="Fact_148327009"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327009"
          xlink:to="FN_602034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327014"
          xlink:label="Fact_148327014"
          xlink:type="locator"/>
        <link:footnote id="FN_602035" xlink:label="FN_602035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes reclassifications to profit or loss: &#x20ac;2&#160;million in the first half of 2025, immaterial in the first half of 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327014"
          xlink:to="FN_602035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327015"
          xlink:label="Fact_148327015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327015"
          xlink:to="FN_602035"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327020"
          xlink:label="Fact_148327020"
          xlink:type="locator"/>
        <link:footnote id="FN_602036" xlink:label="FN_602036" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes reclassifications to profit or loss: immaterial over all periods.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327020"
          xlink:to="FN_602036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327021"
          xlink:label="Fact_148327021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327021"
          xlink:to="FN_602036"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327107"
          xlink:label="Fact_148327107"
          xlink:type="locator"/>
        <link:footnote id="FN_602033" xlink:label="FN_602033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">With effect from May&#160;1, 2025, OPAL JV Co is accounted for using the equity method following the loss of control of Opella by Sanofi on April&#160;30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327107"
          xlink:to="FN_602033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327108"
          xlink:label="Fact_148327108"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327108"
          xlink:to="FN_602033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327122"
          xlink:label="Fact_148327122"
          xlink:type="locator"/>
        <link:footnote id="FN_602022" xlink:label="FN_602022" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In October 2024, Sanofi raised its investment in EUROAPI by &#x20ac;200&#160;million in the form of a perpetual subordinated hybrid bond. The fair value of this investment as of June&#160;30, 2025 was &#x20ac;189&#160;million (and was also &#x20ac;189&#160;million as of December&#160;31, 2024).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327122"
          xlink:to="FN_602022"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327123"
          xlink:label="Fact_148327123"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327123"
          xlink:to="FN_602022"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327124"
          xlink:label="Fact_148327124"
          xlink:type="locator"/>
        <link:footnote id="FN_602021" xlink:label="FN_602021" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes loans to joint ventures and associates.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327124"
          xlink:to="FN_602021"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327125"
          xlink:label="Fact_148327125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327125"
          xlink:to="FN_602021"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327126"
          xlink:label="Fact_148327126"
          xlink:type="locator"/>
        <link:footnote id="FN_602019" xlink:label="FN_602019" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Figures for 2024 comparative periods have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327126"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:footnote id="FN_602020" xlink:label="FN_602020" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the six months ended June&#160;30, 2025, these amounts include transactions between Sanofi and OPAL JV Co for the period from May&#160;1, 2025 through June&#160;30, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327126"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327127"
          xlink:label="Fact_148327127"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327127"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327127"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327128"
          xlink:label="Fact_148327128"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327128"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327128"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327129"
          xlink:label="Fact_148327129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327129"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327129"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327130"
          xlink:label="Fact_148327130"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327130"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327130"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327131"
          xlink:label="Fact_148327131"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327131"
          xlink:to="FN_602020"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327131"
          xlink:to="FN_602019"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327153"
          xlink:label="Fact_148327153"
          xlink:type="locator"/>
        <link:footnote id="FN_602009" xlink:label="FN_602009" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Joint venture. MSP Vaccine Company owns 100% of MCM Vaccine BV.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327153"
          xlink:to="FN_602009"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327154"
          xlink:label="Fact_148327154"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327154"
          xlink:to="FN_602009"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327155"
          xlink:label="Fact_148327155"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327155"
          xlink:to="FN_602009"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327156"
          xlink:label="Fact_148327156"
          xlink:type="locator"/>
        <link:footnote id="FN_602008" xlink:label="FN_602008" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Joint venture.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327156"
          xlink:to="FN_602008"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327157"
          xlink:label="Fact_148327157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327157"
          xlink:to="FN_602008"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327158"
          xlink:label="Fact_148327158"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327158"
          xlink:to="FN_602008"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327160"
          xlink:label="Fact_148327160"
          xlink:type="locator"/>
        <link:footnote id="FN_602039" xlink:label="FN_602039" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Weighting between (i)&#160;fair value determined using the Monte Carlo model and (ii)&#160;market price of Sanofi shares at the date of grant, adjusted for dividends expected during the vesting period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327160"
          xlink:to="FN_602039"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327161"
          xlink:label="Fact_148327161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327161"
          xlink:to="FN_602039"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327162"
          xlink:label="Fact_148327162"
          xlink:type="locator"/>
        <link:footnote id="FN_602038" xlink:label="FN_602038" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Quoted market price per share at the date of grant, adjusted for dividends expected during the vesting period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327162"
          xlink:to="FN_602038"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327264"
          xlink:label="Fact_148327264"
          xlink:type="locator"/>
        <link:footnote id="FN_602045" xlink:label="FN_602045" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Net debt does not include lease liabilities, which amounted to &#x20ac;1,776&#160;million as of June&#160;30, 2025 and &#x20ac;1,906&#160;million as of December&#160;31, 2024. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327264"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327271"
          xlink:label="Fact_148327271"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327271"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327452"
          xlink:label="Fact_148327452"
          xlink:type="locator"/>
        <link:footnote id="FN_602006" xlink:label="FN_602006" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Following the loss of control of Opella, Sanofi holds 48.2% of OPAL JV Co (CD&amp;R holds 50% and Bpifrance holds 1.8%), see Note B.1.. As of June 30, 2025, the investment includes a &#x20ac;241 million loan to OPAL JV Co being in substance part of the investment.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327452"
          xlink:to="FN_602006"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327453"
          xlink:label="Fact_148327453"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327453"
          xlink:to="FN_602006"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327454"
          xlink:label="Fact_148327454"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327454"
          xlink:to="FN_602006"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327455"
          xlink:label="Fact_148327455"
          xlink:type="locator"/>
        <link:footnote id="FN_602007" xlink:label="FN_602007" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The investment in EUROAPI includes an impairment loss booked in prior years determined by reference to the quoted market price (&#x20ac;2.89 as of June&#160;30, 2025, and &#x20ac;2.88 as of December&#160;31, 2024).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327455"
          xlink:to="FN_602007"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327456"
          xlink:label="Fact_148327456"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327456"
          xlink:to="FN_602007"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327457"
          xlink:label="Fact_148327457"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327457"
          xlink:to="FN_602007"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327489"
          xlink:label="Fact_148327489"
          xlink:type="locator"/>
        <link:footnote id="FN_602040" xlink:label="FN_602040" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In the case of &#x201c;Provisions for pensions and other post-employment benefits&#x201d;, the &#x201c;Increases in provisions&#x201d; line corresponds to rights vesting in employees during the period, and past service cost; the &#x201c;Provisions utilized&#x201d; line corresponds to contributions paid into pension funds and to beneficiaries; and the &#x201c;Reversals of unutilized provisions&#x201d; line corresponds to plan curtailments, settlements and amendments.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327489"
          xlink:to="FN_602040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327494"
          xlink:label="Fact_148327494"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327494"
          xlink:to="FN_602040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327518"
          xlink:label="Fact_148327518"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327518"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327520"
          xlink:label="Fact_148327520"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327520"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327584"
          xlink:label="Fact_148327584"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327584"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327585"
          xlink:label="Fact_148327585"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327585"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327602"
          xlink:label="Fact_148327602"
          xlink:type="locator"/>
        <link:footnote id="FN_601984" xlink:label="FN_601984" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the first half of 2025, these lines include the net sales and operating income of Opella until the date of loss of control date (see Note B.1.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327602"
          xlink:to="FN_601984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327603"
          xlink:label="Fact_148327603"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327603"
          xlink:to="FN_601984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327604"
          xlink:label="Fact_148327604"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327604"
          xlink:to="FN_601984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327605"
          xlink:label="Fact_148327605"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327605"
          xlink:to="FN_601984"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327610"
          xlink:label="Fact_148327610"
          xlink:type="locator"/>
        <link:footnote id="FN_601985" xlink:label="FN_601985" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">In 2025, this line includes an expense of &#x20ac;88&#160;million related to the tax impact on the gain arising on the loss of control of Opella.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327610"
          xlink:to="FN_601985"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327611"
          xlink:label="Fact_148327611"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327611"
          xlink:to="FN_601985"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327632"
          xlink:label="Fact_148327632"
          xlink:type="locator"/>
        <link:footnote id="FN_602037" xlink:label="FN_602037" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes &#x20ac;1,756&#160;million at June&#160;30, 2025 relating to the liability for royalties payable to Sobi on net sales of Beyfortus in the United States ( see Note C.2. to the consolidated financial statements for the year ended December&#160;31, 2024) . Given the method used to calculate royalties payable, an increase or decrease in sales forecasts would lead to a proportionate change in the amount of the liability. The nominal value of payments estimated to be due within more than one year but less than five years is &#x20ac;1,027&#160;million; the nominal value of payments estimated to be due after more than five years is &#x20ac;2,293&#160;million.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327632"
          xlink:to="FN_602037"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327633"
          xlink:label="Fact_148327633"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327633"
          xlink:to="FN_602037"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327649"
          xlink:label="Fact_148327649"
          xlink:type="locator"/>
        <link:footnote id="FN_602026" xlink:label="FN_602026" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of January 1, 2025, this comprised a non-current portion of &#x20ac;569 million and a current portion of &#x20ac;72 million.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327649"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327650"
          xlink:label="Fact_148327650"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327650"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327651"
          xlink:label="Fact_148327651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327651"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327655"
          xlink:label="Fact_148327655"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327655"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327659"
          xlink:label="Fact_148327659"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327659"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:footnote id="FN_602028" xlink:label="FN_602028" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts mainly reported within the income statement line item &#x201c;Fair value remeasurement of contingent consideration&#x201d;.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327659"
          xlink:to="FN_602028"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327660"
          xlink:label="Fact_148327660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327660"
          xlink:to="FN_602028"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327661"
          xlink:label="Fact_148327661"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327661"
          xlink:to="FN_602028"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327662"
          xlink:label="Fact_148327662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327662"
          xlink:to="FN_602028"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327663"
          xlink:label="Fact_148327663"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327663"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327667"
          xlink:label="Fact_148327667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327667"
          xlink:to="FN_602026"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327676"
          xlink:label="Fact_148327676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327676"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327680"
          xlink:label="Fact_148327680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327680"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327681"
          xlink:label="Fact_148327681"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327681"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327682"
          xlink:label="Fact_148327682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327682"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327683"
          xlink:label="Fact_148327683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327683"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327684"
          xlink:label="Fact_148327684"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327684"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327685"
          xlink:label="Fact_148327685"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327685"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327686"
          xlink:label="Fact_148327686"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327686"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327687"
          xlink:label="Fact_148327687"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327687"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327688"
          xlink:label="Fact_148327688"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327688"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327689"
          xlink:label="Fact_148327689"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327689"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327690"
          xlink:label="Fact_148327690"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327690"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327691"
          xlink:label="Fact_148327691"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327691"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327692"
          xlink:label="Fact_148327692"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327692"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327693"
          xlink:label="Fact_148327693"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327693"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327694"
          xlink:label="Fact_148327694"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327694"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327695"
          xlink:label="Fact_148327695"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327695"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327696"
          xlink:label="Fact_148327696"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327696"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327697"
          xlink:label="Fact_148327697"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327697"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327698"
          xlink:label="Fact_148327698"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327698"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327699"
          xlink:label="Fact_148327699"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327699"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327700"
          xlink:label="Fact_148327700"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327700"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327701"
          xlink:label="Fact_148327701"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327701"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327702"
          xlink:label="Fact_148327702"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327702"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327703"
          xlink:label="Fact_148327703"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327703"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327704"
          xlink:label="Fact_148327704"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327704"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327705"
          xlink:label="Fact_148327705"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327705"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327707"
          xlink:label="Fact_148327707"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327707"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327708"
          xlink:label="Fact_148327708"
          xlink:type="locator"/>
        <link:footnote id="FN_601998" xlink:label="FN_601998" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Joint ventures and associates with which Sanofi has entered into a strategic alliance.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327708"
          xlink:to="FN_601998"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327709"
          xlink:label="Fact_148327709"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327709"
          xlink:to="FN_601998"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327709"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327710"
          xlink:label="Fact_148327710"
          xlink:type="locator"/>
        <link:footnote id="FN_602000" xlink:label="FN_602000" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Excludes (i)&#160;restructuring costs and (ii)&#160;other adjustments attributable to non-controlling interests.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327710"
          xlink:to="FN_602000"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327711"
          xlink:label="Fact_148327711"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327711"
          xlink:to="FN_602000"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327711"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327712"
          xlink:label="Fact_148327712"
          xlink:type="locator"/>
        <link:footnote id="FN_602001" xlink:label="FN_602001" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The monitoring of impairment indicators for other intangible assets led to the recognition of impairment losses of &#x20ac;210&#160;million in the first half of 2025 linked to research and development projects. As of June&#160;30, 2024, this line includes a net reversal of impairment losses amounting to &#x20ac;371&#160;million, mainly due to an increase in the expected recoverable amounts of certain marketed products and other rights.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327712"
          xlink:to="FN_602001"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327713"
          xlink:label="Fact_148327713"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327713"
          xlink:to="FN_602001"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327713"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327715"
          xlink:label="Fact_148327715"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327715"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327716"
          xlink:label="Fact_148327716"
          xlink:type="locator"/>
        <link:footnote id="FN_602002" xlink:label="FN_602002" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line records the impact of the workdown of acquired inventories remeasured at fair value at the acquisition date.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327716"
          xlink:to="FN_602002"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327717"
          xlink:label="Fact_148327717"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327717"
          xlink:to="FN_602002"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327717"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327718"
          xlink:label="Fact_148327718"
          xlink:type="locator"/>
        <link:footnote id="FN_602003" xlink:label="FN_602003" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note B.16.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327718"
          xlink:to="FN_602003"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327719"
          xlink:label="Fact_148327719"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327719"
          xlink:to="FN_602003"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327719"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327720"
          xlink:label="Fact_148327720"
          xlink:type="locator"/>
        <link:footnote id="FN_602004" xlink:label="FN_602004" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See Note B.17.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327720"
          xlink:to="FN_602004"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327721"
          xlink:label="Fact_148327721"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327721"
          xlink:to="FN_602004"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327721"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327723"
          xlink:label="Fact_148327723"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327723"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327725"
          xlink:label="Fact_148327725"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327725"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327727"
          xlink:label="Fact_148327727"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327727"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327729"
          xlink:label="Fact_148327729"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327729"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327730"
          xlink:label="Fact_148327730"
          xlink:type="locator"/>
        <link:footnote id="FN_602050" xlink:label="FN_602050" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Carrying amount at the end of the reporting period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327730"
          xlink:to="FN_602050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327731"
          xlink:label="Fact_148327731"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327731"
          xlink:to="FN_602050"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327737"
          xlink:label="Fact_148327737"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327737"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327739"
          xlink:label="Fact_148327739"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327739"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327741"
          xlink:label="Fact_148327741"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327741"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327743"
          xlink:label="Fact_148327743"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327743"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327745"
          xlink:label="Fact_148327745"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327745"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327747"
          xlink:label="Fact_148327747"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327747"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327861"
          xlink:label="Fact_148327861"
          xlink:type="locator"/>
        <link:footnote id="FN_602049" xlink:label="FN_602049" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As of June 30, 2025, current other bank borrowings include &#x20ac;4,535&#160;million related to the US commercial paper program and &#x20ac;230&#160;million related to the Negotiable European Commercial Paper program in France. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327861"
          xlink:to="FN_602049"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327880"
          xlink:label="Fact_148327880"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327880"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327887"
          xlink:label="Fact_148327887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327887"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327896"
          xlink:label="Fact_148327896"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327896"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327902"
          xlink:label="Fact_148327902"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327902"
          xlink:to="FN_602045"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327908"
          xlink:label="Fact_148327908"
          xlink:type="locator"/>
        <link:footnote id="FN_602042" xlink:label="FN_602042" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes actuarial gains/ (losses) related to Opella of &#x20ac;(4)&#160;million for the first half of 2025 and &#x20ac;(6)&#160;million for the first half of 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327908"
          xlink:to="FN_602042"
          xlink:type="arc"/>
        <link:footnote id="FN_602044" xlink:label="FN_602044" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the effects of (i)&#160;the change in discount rates (in a range between +0.40% and +0.65%) and (ii)&#160;the +0.10% change in the inflation rate in the United Kingdom in the first half of 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327908"
          xlink:to="FN_602044"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327909"
          xlink:label="Fact_148327909"
          xlink:type="locator"/>
        <link:footnote id="FN_602043" xlink:label="FN_602043" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes the effects of (i)&#160;the change in discount rates (in a range between 0.00% and +0.30%) and (ii)&#160;the -0.30% change in the inflation rate in the United Kingdom in the first half of 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327909"
          xlink:to="FN_602043"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327909"
          xlink:to="FN_602042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327910"
          xlink:label="Fact_148327910"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327910"
          xlink:to="FN_602042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327911"
          xlink:label="Fact_148327911"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327911"
          xlink:to="FN_602042"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327925"
          xlink:label="Fact_148327925"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327925"
          xlink:to="FN_602040"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327926"
          xlink:label="Fact_148327926"
          xlink:type="locator"/>
        <link:footnote id="FN_602041" xlink:label="FN_602041" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Mainly transfers to Current provisions and other current liabilities.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327926"
          xlink:to="FN_602041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327927"
          xlink:label="Fact_148327927"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327927"
          xlink:to="FN_602041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327928"
          xlink:label="Fact_148327928"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327928"
          xlink:to="FN_602041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327929"
          xlink:label="Fact_148327929"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327929"
          xlink:to="FN_602041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327930"
          xlink:label="Fact_148327930"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327930"
          xlink:to="FN_602041"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327936"
          xlink:label="Fact_148327936"
          xlink:type="locator"/>
        <link:footnote id="FN_602048" xlink:label="FN_602048" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes forward purchases with a notional amount of $1,000 million expiring in 2025, designated as a fair value hedge of the exposure of $1,000 million of bond issues to fluctuations in the EUR/USD spot rate. As of June 30, 2025, the fair value of these contracts represented a liability of &#x20ac;25 million, with &#x20ac;0 million credited to Other comprehensive income to recognize the hedging cost. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327936"
          xlink:to="FN_602048"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327946"
          xlink:label="Fact_148327946"
          xlink:type="locator"/>
        <link:footnote id="FN_602047" xlink:label="FN_602047" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes forward sales with a notional amount of $3,615 million expiring in 2025, designated as a hedge of Sanofi&#x2019;s net investment in Bioverativ. As of June 30, 2025, the fair value of these forward contracts represented an asset of &#x20ac;77 million; the opposite entry was recognized in Other comprehensive income, with the impact on financial income and expense being immaterial. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327946"
          xlink:to="FN_602047"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148327950"
          xlink:label="Fact_148327950"
          xlink:type="locator"/>
        <link:footnote id="FN_602046" xlink:label="FN_602046" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Comprises two cross currency swaps, (i)&#160;with a notional amount of $870&#160;million, pay 4.16% receive EUR 2.50%, expiring 2029 and (ii)&#160;with a notional amount of $870&#160;million, pay 4.53% receive EUR 3.00%, expiring 2032, designated as a fair value hedge of the exposure of an equivalent amount of cash&#160;&amp; cash equivalents to fluctuations in the EUR/USD spot rate. As of June&#160;30, 2025, the fair value of the swaps was an asset of &#x20ac;5&#160;million, with &#x20ac;18&#160;million debited to Other comprehensive income under the cost of hedging accounting treatment. </link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148327950"
          xlink:to="FN_602046"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328037"
          xlink:label="Fact_148328037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328037"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328038"
          xlink:label="Fact_148328038"
          xlink:type="locator"/>
        <link:footnote id="FN_602010" xlink:label="FN_602010" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Revenues generated from the manufacture of Consumer Healthcare products on behalf of Opella entities. Until April&#160;30, 2025, Opella entities were within the scope of discontinued operations (see Note B.1). With effect from May&#160;1, 2025, Opella entities are treated as related parties in accordance with IAS24 (see Note B.5.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328038"
          xlink:to="FN_602010"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328039"
          xlink:label="Fact_148328039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328039"
          xlink:to="FN_602010"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328039"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328041"
          xlink:label="Fact_148328041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328041"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328042"
          xlink:label="Fact_148328042"
          xlink:type="locator"/>
        <link:footnote id="FN_602011" xlink:label="FN_602011" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line mainly comprises revenues received under agreements for Sanofi to provide manufacturing services to third parties.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328042"
          xlink:to="FN_602011"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328043"
          xlink:label="Fact_148328043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328043"
          xlink:to="FN_602011"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328043"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328045"
          xlink:label="Fact_148328045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328045"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328046"
          xlink:label="Fact_148328046"
          xlink:type="locator"/>
        <link:footnote id="FN_602012" xlink:label="FN_602012" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Consumer Healthcare activities not transferred on the effective date of loss of control of Opella. These are primarily (i)&#160;hospital sales of Opella products in China, the transfer of which will be finalized no earlier than 2028; (ii) sales made by the dedicated entity Opella Russie, of which Sanofi continues to hold the capital (Sanofi is continuing to distribute Opella products in Russian territory under a distribution agreement signed in connection with the separation, the parties reserving the right to discuss the transfer of that entity during the term of the distribution agreement); and (iii)&#160;sales of the Gold Bond product range, which are continuing in the United States through the retained subsidiary Gold Bond LLC (holder of the associated worldwide property rights).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328046"
          xlink:to="FN_602012"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328047"
          xlink:label="Fact_148328047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328047"
          xlink:to="FN_602012"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328047"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328049"
          xlink:label="Fact_148328049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328049"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328117"
          xlink:label="Fact_148328117"
          xlink:type="locator"/>
        <link:footnote id="FN_602015" xlink:label="FN_602015" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Figures for 2024 comparative period have been re-presented on a consistent basis to reflect the classification of Opella as a discontinued operation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328117"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328121"
          xlink:label="Fact_148328121"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328121"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328125"
          xlink:label="Fact_148328125"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328125"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328129"
          xlink:label="Fact_148328129"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328129"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328133"
          xlink:label="Fact_148328133"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328133"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328137"
          xlink:label="Fact_148328137"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328137"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328141"
          xlink:label="Fact_148328141"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328141"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328145"
          xlink:label="Fact_148328145"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328145"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328149"
          xlink:label="Fact_148328149"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328149"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328153"
          xlink:label="Fact_148328153"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328153"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328157"
          xlink:label="Fact_148328157"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328157"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328161"
          xlink:label="Fact_148328161"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328161"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328165"
          xlink:label="Fact_148328165"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328165"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328169"
          xlink:label="Fact_148328169"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328169"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328173"
          xlink:label="Fact_148328173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328173"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328177"
          xlink:label="Fact_148328177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328177"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328187"
          xlink:label="Fact_148328187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328187"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328189"
          xlink:label="Fact_148328189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328189"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328191"
          xlink:label="Fact_148328191"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328191"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328193"
          xlink:label="Fact_148328193"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328193"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328194"
          xlink:label="Fact_148328194"
          xlink:type="locator"/>
        <link:footnote id="FN_602016" xlink:label="FN_602016" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Rate calculated on the basis of the estimated effective tax rate for the full financial year (see Note A.2.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328194"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328195"
          xlink:label="Fact_148328195"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328195"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328195"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328196"
          xlink:label="Fact_148328196"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328196"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnote id="FN_602017" xlink:label="FN_602017" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The difference between the French tax rate and tax rates applicable to foreign subsidiaries reflects the fact that Sanofi has operations in many countries, most of which have lower tax rates than France.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328196"
          xlink:to="FN_602017"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328197"
          xlink:label="Fact_148328197"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328197"
          xlink:to="FN_602017"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328197"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328197"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328198"
          xlink:label="Fact_148328198"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328198"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328199"
          xlink:label="Fact_148328199"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328199"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328199"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328200"
          xlink:label="Fact_148328200"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328200"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnote id="FN_602018" xlink:label="FN_602018" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">For the six months ended June&#160;30, 2025, this line includes a tax expense of &#x20ac;17&#160;million, representing the estimated impact of Pillar Two based on Sanofi&#x2019;s current understanding of Pillar Two rules, and &#x20ac;52&#160;million for the six months ended June&#160;30, 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328200"
          xlink:to="FN_602018"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328201"
          xlink:label="Fact_148328201"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328201"
          xlink:to="FN_602018"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328201"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328201"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328202"
          xlink:label="Fact_148328202"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328202"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328203"
          xlink:label="Fact_148328203"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328203"
          xlink:to="FN_602016"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328203"
          xlink:to="FN_601986"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328206"
          xlink:label="Fact_148328206"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328206"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnote id="FN_602023" xlink:label="FN_602023" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects new regulations implemented on the taxation of share cancellations in Article 95 of the French Finance Bill for 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328206"
          xlink:to="FN_602023"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328207"
          xlink:label="Fact_148328207"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328207"
          xlink:to="FN_602023"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328207"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328208"
          xlink:label="Fact_148328208"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328208"
          xlink:to="FN_601990"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328208"
          xlink:to="FN_602023"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328215"
          xlink:label="Fact_148328215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328215"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328216"
          xlink:label="Fact_148328216"
          xlink:type="locator"/>
        <link:footnote id="FN_602027" xlink:label="FN_602027" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">This line consists of impairment losses and accelerated depreciation charges related to closed or divested sites (including leased sites), and gains or losses on divestments of assets arising from reorganization decisions made by Sanofi.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328216"
          xlink:to="FN_602027"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328217"
          xlink:label="Fact_148328217"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328217"
          xlink:to="FN_602027"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328217"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328219"
          xlink:label="Fact_148328219"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328219"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328221"
          xlink:label="Fact_148328221"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328221"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328223"
          xlink:label="Fact_148328223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328223"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328226"
          xlink:label="Fact_148328226"
          xlink:type="locator"/>
        <link:footnote id="FN_602029" xlink:label="FN_602029" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes net gain/(loss) on interest rate and currency derivatives used to manage debt: &#x20ac;(25)&#160;million in the first half of 2025 and &#x20ac;(24)&#160;million in the first half of 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328226"
          xlink:to="FN_602029"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328227"
          xlink:label="Fact_148328227"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328227"
          xlink:to="FN_602029"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328227"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328228"
          xlink:label="Fact_148328228"
          xlink:type="locator"/>
        <link:footnote id="FN_602030" xlink:label="FN_602030" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes net gain/(loss) on interest rate and currency derivatives used to manage cash and cash equivalents: &#x20ac;(4)&#160;million in the first half of 2025 and &#x20ac;(18)&#160;million in the first half of 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328228"
          xlink:to="FN_602030"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328229"
          xlink:label="Fact_148328229"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328229"
          xlink:to="FN_602030"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328229"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328234"
          xlink:label="Fact_148328234"
          xlink:type="locator"/>
        <link:footnote id="FN_602031" xlink:label="FN_602031" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Primarily on provisions for environmental risks, restructuring provisions, and provisions for product-related risks (see Note B.12.).</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328234"
          xlink:to="FN_602031"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328235"
          xlink:label="Fact_148328235"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328235"
          xlink:to="FN_602031"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328235"
          xlink:to="FN_602015"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328240"
          xlink:label="Fact_148328240"
          xlink:type="locator"/>
        <link:footnote id="FN_602032" xlink:label="FN_602032" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Includes a financial expense of &#x20ac;50&#160;million for the six months ended June&#160;30, 2025 and &#x20ac;176&#160;million for the six months ended June&#160;30, 2024 for the remeasurement of the liability recorded in the balance sheet for estimated future royalties on Beyfortus sales in the US.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328240"
          xlink:to="FN_602032"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact_148328241"
          xlink:label="Fact_148328241"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328241"
          xlink:to="FN_602032"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact_148328241"
          xlink:to="FN_602015"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
